data_2ncm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ncm _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.39 141.73 37.54 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.746 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 t -149.38 143.32 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 O-C-N 123.253 0.346 . . . . 0.0 110.867 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -160.07 127.07 4.44 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.771 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.7 mt -99.74 138.63 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.367 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.7 t -128.49 135.48 27.63 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.671 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -77.23 170.26 71.93 Favored 'Cis proline' 0 C--N 1.366 1.492 0 C-N-CA 124.767 -0.93 . . . . 0.0 111.815 -0.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.2 p -66.63 -45.08 80.21 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.809 0.338 . . . . 0.0 110.323 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -131.8 110.86 11.15 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.398 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -111.54 97.94 0.98 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.756 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -78.62 134.44 37.18 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.3 mm -136.84 170.01 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.401 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.03 156.68 29.22 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.18 137.81 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.53 -8.75 78.49 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.6 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -100.03 155.05 17.92 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 117.302 0.551 . . . . 0.0 109.751 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.1 p -98.62 163.53 12.62 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.16 119.52 1.54 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -112.97 141.4 46.84 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.601 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -117.79 118.49 32.17 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.839 0.352 . . . . 0.0 111.205 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.94 115.07 18.39 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.9 t -99.6 94.89 6.62 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.355 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -88.91 158.75 17.97 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.744 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.1 m -138.49 171.77 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.208 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.51 179.224 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 . . . . . 0 N--CA 1.461 0.081 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.6 mp -127.9 146.83 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 123.373 0.421 . . . . 0.0 110.787 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 m -144.47 158.94 43.51 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.308 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.427 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 55.4 m95 -133.7 128.02 34.09 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.04 0.212 . . . . 0.0 110.44 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 94.0 m-85 -116.6 117.98 31.36 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.7 p -66.61 149.43 98.19 Favored Pre-proline 0 C--O 1.247 0.932 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.477 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo . . . . . 0 C--N 1.378 2.112 0 C-N-CA 124.741 3.627 . . . . 0.0 115.516 -178.955 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 31.0 tttt . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 pp -109.42 143.62 38.76 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.58 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.9 m -84.24 157.11 62.73 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.219 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.64 -27.6 3.97 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.444 2.096 . . . . 0.0 112.731 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -118.34 65.86 0.76 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.369 0.604 . . . . 0.0 110.025 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.11 -59.7 1.31 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.564 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -140.95 -162.21 1.33 Allowed 'General case' 0 CA--C 1.54 0.575 0 O-C-N 123.008 0.193 . . . . 0.0 110.508 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -51.76 -23.06 4.11 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.466 HD11 HG22 ' A' ' 52' ' ' ILE . 46.3 mt -82.18 99.15 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.7 t -105.04 122.88 46.79 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.949 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.3 t -93.07 158.03 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.139 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 p -151.55 147.9 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 20.4 m-90 -122.1 114.9 21.55 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.51 -80.35 0.58 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -56.24 -176.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -51.17 -37.83 48.67 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -152.78 22.68 0.59 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 p -99.6 138.89 36.05 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 m -143.28 134.4 25.74 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.104 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -103.11 141.05 36.5 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 111.626 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.427 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -103.66 94.32 5.39 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.324 179.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.96 139.59 31.07 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 123.468 0.48 . . . . 0.0 110.351 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.1 mt -137.44 93.22 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -60.2 -113.88 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.473 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.21 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.81 1.186 . . . . 0.0 110.967 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.84 148.92 48.45 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.16 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -141.52 154.68 45.64 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.715 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.5 pt -53.9 -24.48 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -71.51 -40.97 69.81 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -66.47 -35.53 80.5 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.885 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.37 107.81 0.21 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.69 -179.35 47.81 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.446 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.2 mm -82.18 95.22 3.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.588 0.194 . . . . 0.0 111.006 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -71.76 160.12 33.16 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -128.09 158.15 38.78 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.908 0.385 . . . . 0.0 111.563 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 9.5 t -138.93 99.86 3.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.4 t -109.8 126.33 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 121.066 0.46 . . . . 0.0 112.116 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.72 155.1 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.66 143.45 49.66 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.13 176.5 6.95 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.371 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.94 -40.77 87.66 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.199 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.8 -36.24 28.63 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.392 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 150.06 -18.15 1.07 Allowed Glycine 0 C--N 1.339 0.75 0 CA-C-O 119.556 -0.58 . . . . 0.0 113.813 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.7 m -58.52 103.46 0.16 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.876 0.838 . . . . 0.0 110.702 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -109.39 132.54 54.03 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.796 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.1 p -99.65 -176.86 3.39 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -161.3 175.51 12.19 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -159.7 176.42 12.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.127 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.2 163.86 39.61 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.5 p -152.63 123.11 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.75 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -80.97 96.03 6.96 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.988 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.0 t -97.94 123.59 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.531 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -108.53 160.28 16.04 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.911 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.432 HG22 HD11 ' A' ' 97' ' ' ILE . 12.0 mt -151.58 125.74 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.684 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -116.58 127.98 54.99 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.342 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.735 -179.873 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 120.803 0.335 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -127.18 148.37 50.18 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.422 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 t -145.76 147.23 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 123.12 0.262 . . . . 0.0 111.445 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -160.3 126.2 4.09 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.323 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.7 mt -97.28 139.48 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.656 0.265 . . . . 0.0 110.648 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.6 t -128.17 130.86 23.55 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.942 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.56 172.03 64.51 Favored 'Cis proline' 0 C--N 1.365 1.443 0 CA-C-N 119.73 0.939 . . . . 0.0 112.377 -0.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 p -69.83 -53.2 19.23 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.337 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -129.96 107.61 9.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.211 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.41 158.97 24.81 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 116.077 -0.51 . . . . 0.0 113.545 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -143.37 119.5 10.76 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.13 164.24 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.711 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.97 157.62 16.73 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.69 138.49 22.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.87 -15.18 63.68 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.436 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -99.04 162.63 12.96 Favored 'General case' 0 C--N 1.348 0.511 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.1 p -102.73 168.35 9.31 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.94 121.44 1.77 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.483 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -115.05 142.29 46.84 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.622 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -118.42 118.4 31.64 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.004 0.43 . . . . 0.0 111.283 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.0 tp -79.21 116.44 19.48 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.9 t -97.93 100.65 12.01 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.404 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 -91.4 158.78 16.32 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.86 174.36 13.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.764 179.112 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 . . . . . 0 N--CA 1.466 0.331 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.2 mp -130.21 153.39 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 123.318 0.386 . . . . 0.0 110.856 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.2 m -152.31 160.63 43.3 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.34 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.431 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 59.1 m95 -132.63 130.82 40.68 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.216 0.206 . . . . 0.0 110.792 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 67.3 m-85 -122.12 117.96 27.53 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.9 p -62.51 152.85 79.42 Favored Pre-proline 0 C--O 1.253 1.285 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.425 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 C--N 1.38 2.235 0 C-N-CA 124.472 3.448 . . . . 0.0 115.947 -178.77 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 19.1 tttt . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 120.549 0.214 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.12 152.69 26.68 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.605 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 m -79.36 163.05 61.36 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.341 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.22 -28.06 12.99 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.66 2.24 . . . . 0.0 112.696 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -139.41 72.99 1.41 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.13 0.491 . . . . 0.0 111.009 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -80.61 -68.76 0.65 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.992 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -156.67 -72.73 0.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -99.74 -35.85 9.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.426 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 52' ' ' ILE . 48.7 mt -85.7 110.33 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.777 0.322 . . . . 0.0 110.78 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.3 t -114.49 118.66 34.4 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.659 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.6 t -90.33 158.78 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.268 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 p -153.99 152.09 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.963 0.411 . . . . 0.0 111.64 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 24.8 m-90 -123.16 104.56 9.25 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -91.16 -80.77 0.33 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -176.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -65.26 -177.92 0.44 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.41 0.148 . . . . 0.0 110.912 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.94 -33.73 62.53 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -141.43 7.4 1.94 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.9 p -94.52 136.41 34.85 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.282 0.492 . . . . 0.0 110.459 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.93 132.99 27.85 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.372 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 m -102.89 146.3 28.51 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 111.921 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.431 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -111.47 94.95 5.23 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.532 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.18 142.49 29.43 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.822 0.344 . . . . 0.0 110.274 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.9 mt -139.53 90.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -59.57 -113.46 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.304 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -53.28 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.968 1.258 . . . . 0.0 111.154 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.63 143.0 42.5 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.294 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -136.11 153.49 51.28 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.689 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.67 -25.68 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -71.21 -42.15 69.31 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -62.99 -34.72 78.14 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.678 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.28 112.03 0.8 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.67 179.06 47.69 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.547 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.4 mm -80.72 95.5 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 122.051 0.14 . . . . 0.0 111.175 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -71.95 167.08 20.85 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -132.03 158.16 42.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 112.258 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 4.2 t -140.12 100.39 3.9 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.304 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.2 t -107.67 129.7 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 111.872 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.6 t -108.2 156.41 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.9 m -132.78 149.11 52.31 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.28 -173.65 3.14 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.692 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.69 -48.47 21.88 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.116 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.27 -37.81 71.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.23 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 150.0 -18.54 1.08 Allowed Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.06 -0.59 . . . . 0.0 113.86 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 96.2 m -57.92 108.3 0.57 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.859 0.829 . . . . 0.0 110.582 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.53 134.55 54.62 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.265 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.6 p -97.15 -177.89 4.0 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -160.53 171.76 18.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -154.51 172.83 17.17 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.009 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.79 155.76 38.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.728 0.299 . . . . 0.0 111.248 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.92 118.93 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.348 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -76.15 88.27 3.04 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.347 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.0 t -87.9 131.63 35.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.058 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.23 153.57 32.66 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.559 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.8 mt -145.67 128.61 10.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.563 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.77 133.24 53.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.358 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.929 -179.817 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 mp . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.798 0.332 . . . . 0.0 111.583 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -138.74 140.55 38.72 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.232 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 t -144.92 141.25 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.672 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -157.37 124.82 5.25 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.587 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.6 mt -92.39 143.66 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.594 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.6 t -131.11 133.03 24.18 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.887 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.24 169.99 73.05 Favored 'Cis proline' 0 C--N 1.363 1.303 0 CA-C-N 119.719 0.935 . . . . 0.0 112.029 0.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.4 p -68.2 -42.15 80.3 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -133.47 111.87 11.08 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.289 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.2 100.39 1.64 Allowed Glycine 0 C--N 1.341 0.855 0 C-N-CA 120.895 -0.669 . . . . 0.0 114.251 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.64 128.91 34.91 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.0 mp -144.53 162.92 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.662 0.268 . . . . 0.0 110.733 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.17 156.45 17.7 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.729 0.3 . . . . 0.0 110.367 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.4 t -62.91 138.55 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.999 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.1 -15.75 62.47 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.343 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -97.16 159.17 15.07 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.0 p -97.36 164.47 12.45 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.31 116.62 2.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -177.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -111.52 143.28 42.63 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.64 0.257 . . . . 0.0 111.143 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -120.72 110.02 15.88 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.5 tp -77.56 112.53 14.44 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.2 t -94.05 108.17 20.02 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.208 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -96.88 155.37 16.8 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.755 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.24 175.49 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.281 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.828 179.578 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.469 0.524 0 CA-C-O 120.357 0.122 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.2 mp -66.77 150.01 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.209 0.528 . . . . 0.0 112.115 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.3 m -150.46 155.54 39.72 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.463 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.459 ' O ' ' HA ' ' A' ' 44' ' ' LYS . 43.8 m95 -134.86 117.92 16.41 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 119.239 -0.41 . . . . 0.0 111.136 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -117.5 109.83 17.22 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.287 0.367 . . . . 0.0 111.885 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 p -59.89 154.67 47.11 Favored Pre-proline 0 C--O 1.246 0.905 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.941 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo . . . . . 0 C--N 1.383 2.385 1 C-N-CA 125.696 4.264 . . . . 0.0 114.618 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 27.9 tttt . . . . . 0 N--CA 1.466 0.367 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.2 mt -77.95 175.9 9.62 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.587 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.5 m -94.28 156.11 39.17 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.884 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.91 -34.53 90.94 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.322 2.015 . . . . 0.0 112.5 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -152.69 63.6 0.8 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.229 0.538 . . . . 0.0 110.568 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.11 -73.58 0.12 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.577 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -147.84 -74.51 0.19 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.638 0.256 . . . . 0.0 110.782 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -99.35 -36.62 9.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.758 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.0 mt -84.64 104.96 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.936 0.398 . . . . 0.0 110.796 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.3 t -107.56 120.34 41.92 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.838 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.2 t -90.99 159.1 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.6 p -151.63 146.43 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.96 0.409 . . . . 0.0 111.839 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 23.1 m-90 -121.38 106.59 11.59 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -98.72 -79.97 0.47 Allowed 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -62.64 -177.63 0.16 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.653 0.263 . . . . 0.0 111.628 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -50.25 -35.92 28.97 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -149.37 17.89 0.94 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.9 t -98.06 139.07 34.42 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.71 131.28 18.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.87 151.96 19.69 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.043 0.449 . . . . 0.0 111.958 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.424 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -114.25 92.9 4.12 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.43 139.99 29.99 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 123.382 0.426 . . . . 0.0 110.614 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 49.3 mt -136.84 93.9 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -58.36 -107.59 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 119.049 -0.5 . . . . 0.0 111.251 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.42 95.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.796 1.18 . . . . 0.0 110.591 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.77 149.74 31.0 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.676 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -146.37 157.42 43.78 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.174 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.7 pt -53.86 -24.68 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -71.68 -39.87 69.95 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -67.07 -35.93 80.9 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.36 117.57 2.48 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.97 174.87 38.52 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.023 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.6 mm -73.75 91.27 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 122.18 0.192 . . . . 0.0 111.271 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -68.43 172.6 5.83 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -135.32 158.21 44.95 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.3 t -142.0 97.78 3.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.149 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.6 t -102.85 131.65 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.0 0.429 . . . . 0.0 111.931 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.87 139.84 43.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.9 m -125.71 143.99 50.8 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.26 -176.13 4.04 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.958 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -69.76 -57.41 5.14 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.076 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -60.55 -31.78 70.87 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 138.84 -18.85 3.16 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.477 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.8 m -59.55 107.81 0.64 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.335 0.568 . . . . 0.0 111.199 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -115.2 134.14 55.41 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.444 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -115.12 119.76 37.5 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -104.63 -179.62 4.0 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -154.06 178.06 10.38 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.132 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.04 154.85 36.78 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.592 0.234 . . . . 0.0 111.051 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.86 123.17 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.965 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -75.2 96.91 3.39 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.26 0.553 . . . . 0.0 110.261 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.8 t -96.71 131.96 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.441 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -121.4 147.63 45.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.383 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.1 mt -141.25 137.22 33.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.22 134.01 37.68 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.948 -177.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.305 -0.855 . . . . 0.0 110.94 -179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.3 tp . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 120.658 0.266 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.85 136.47 40.61 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.654 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -143.77 142.66 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.46 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -156.43 158.83 37.99 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.127 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.9 mt -128.13 138.71 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.8 128.1 24.98 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.269 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.37 173.79 50.97 Favored 'Cis proline' 0 C--N 1.366 1.498 0 CA-C-N 119.68 0.922 . . . . 0.0 112.332 -0.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.8 p -69.66 -46.5 65.98 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.69 101.96 5.9 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.46 101.75 2.61 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.786 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.85 119.95 26.72 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.4 mp -135.6 166.57 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.42 161.6 18.83 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.481 0.657 . . . . 0.0 111.962 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.6 t -65.42 137.4 25.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.861 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.72 -18.47 57.21 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.194 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -114.76 145.22 42.34 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 117.593 0.696 . . . . 0.0 110.291 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.5 p -79.01 173.99 12.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.79 118.99 0.97 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.976 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -115.81 146.57 41.85 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.612 0.244 . . . . 0.0 110.831 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -121.49 112.85 19.02 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.07 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.0 tp -79.12 111.26 15.16 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.5 t -92.82 110.1 21.54 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.217 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -95.31 164.73 12.71 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.871 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.01 170.6 12.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.235 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.252 179.057 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.51 155.16 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.371 0.605 . . . . 0.0 111.779 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.9 m -155.11 157.66 37.82 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.275 178.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.411 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 58.7 m95 -131.82 123.69 28.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.577 0.172 . . . . 0.0 111.004 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 80.0 m-85 -116.76 113.22 22.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.9 p -62.78 152.51 82.1 Favored Pre-proline 0 C--O 1.254 1.323 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.306 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo . . . . . 0 C--N 1.381 2.265 0 C-N-CA 124.374 3.383 . . . . 0.0 115.267 -179.274 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 12.6 ttmt . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.459 0.171 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.3 pp -83.99 135.16 34.56 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.815 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.5 m -69.75 155.03 94.22 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.046 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.62 -30.57 7.72 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 122.364 2.043 . . . . 0.0 112.761 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -117.19 56.5 0.82 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.151 0.501 . . . . 0.0 111.155 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -76.01 -80.46 0.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.285 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -155.78 -72.68 0.11 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -99.74 -29.72 12.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.718 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 52' ' ' ILE . 47.4 mt -89.36 106.01 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.811 0.338 . . . . 0.0 110.871 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 t -111.91 123.38 50.12 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.724 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 t -95.5 157.33 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -152.87 143.36 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.5 m-90 -116.41 115.02 25.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.09 -76.34 0.58 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.92 -173.41 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -48.94 -42.1 36.19 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.563 0.345 . . . . 0.0 111.818 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -156.57 28.61 0.33 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.228 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.9 t -99.73 141.33 32.68 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.66 132.49 18.01 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -177.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m -98.36 143.68 28.56 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.142 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.411 ' HB2' ' CE2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -106.17 92.78 4.29 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.67 136.83 33.58 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 123.426 0.453 . . . . 0.0 110.745 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.9 mt -134.87 91.0 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -60.46 -111.84 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 118.921 -0.562 . . . . 0.0 111.283 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.55 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.841 1.2 . . . . 0.0 110.923 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.59 136.71 40.5 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.04 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.4 ' N ' HD11 ' A' ' 97' ' ' ILE . 14.2 m-80 -132.86 152.63 51.81 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.127 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.0 pt -51.72 -25.11 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -68.39 -44.49 74.99 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -64.96 -35.47 81.27 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.81 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.79 118.31 2.78 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.43 176.48 39.36 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.064 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.3 mt -82.29 101.82 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.638 0.219 . . . . 0.0 110.892 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -75.35 171.28 14.5 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -132.84 156.5 47.04 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.9 t -140.72 105.73 4.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.296 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.1 t -109.19 144.79 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.39 130.61 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 m -110.17 148.19 32.28 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.22 -178.92 4.91 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.616 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -74.33 -37.69 63.5 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.162 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -81.6 -31.08 32.67 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.422 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.92 -16.58 2.8 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-O 119.856 -0.413 . . . . 0.0 113.281 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 59.3 m -59.0 110.06 0.96 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.328 0.564 . . . . 0.0 111.23 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.65 134.26 55.3 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.146 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.4 t -121.98 133.63 54.82 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -117.25 -178.59 3.49 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.62 173.99 13.5 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.848 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.57 155.92 43.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.564 0.221 . . . . 0.0 110.87 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.84 115.75 6.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.746 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.8 97.36 1.37 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.453 0.471 . . . . 0.0 110.535 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -99.92 136.29 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.769 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -125.54 152.41 45.08 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.226 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.4 HD11 ' N ' ' A' ' 70' ' ' ASN . 12.3 mt -139.86 110.77 4.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.357 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.56 125.35 52.44 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.353 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.258 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 120.394 0.14 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -133.33 157.74 44.73 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.591 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -151.87 155.27 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.433 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -160.04 130.33 5.49 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.156 0.285 . . . . 0.0 110.84 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.0 mt -96.25 142.53 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.639 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.89 128.69 24.17 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.38 -176.17 17.06 Favored 'Cis proline' 0 C--N 1.365 1.396 0 CA-C-N 120.084 1.066 . . . . 0.0 112.301 0.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.1 p -76.24 -40.67 51.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.144 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -126.03 124.68 41.19 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.032 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.06 72.53 0.22 Allowed Glycine 0 C--N 1.341 0.86 0 C-N-CA 121.142 -0.551 . . . . 0.0 114.359 -178.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -76.92 112.65 13.76 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 2.9 mp -135.77 164.83 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.7 154.88 17.64 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.8 t -63.06 141.52 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.094 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.86 -11.0 71.86 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.463 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -101.95 153.3 20.0 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.1 p -91.45 156.55 17.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.517 0.199 . . . . 0.0 111.061 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.407 ' HG2' ' HB ' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -151.59 117.39 5.46 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.666 -177.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -112.64 144.11 42.69 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.65 0.262 . . . . 0.0 111.12 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -122.99 118.0 26.78 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.38 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.8 tp -79.26 113.8 17.69 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.403 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 23.2 t -96.6 97.56 9.49 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -92.54 162.86 14.03 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.16 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.1 m -119.31 174.86 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.3 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.305 179.412 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 t70 . . . . . 0 N--CA 1.466 0.357 0 N-CA-C 111.388 0.144 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.1 mp -73.84 157.41 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 O-C-N 123.476 0.485 . . . . 0.0 111.36 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.6 m -155.6 162.49 40.63 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.686 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.423 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 56.5 m95 -139.94 126.68 20.56 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.873 0.108 . . . . 0.0 110.942 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 84.2 m-85 -121.98 111.68 17.35 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.76 161.39 53.81 Favored Pre-proline 0 C--O 1.256 1.423 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.384 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo . . . . . 0 C--N 1.382 2.294 0 C-N-CA 125.298 3.999 . . . . 0.0 115.805 -179.093 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 9.7 ttpt . . . . . 0 C--O 1.234 0.256 0 CA-C-O 120.455 0.169 . . . . 0.0 111.425 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.6 mt -74.37 145.67 43.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.548 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.5 m -77.42 162.14 69.9 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.776 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.15 -30.42 65.15 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 122.318 2.012 . . . . 0.0 112.432 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -141.98 75.31 1.49 Allowed 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.01 0.433 . . . . 0.0 111.032 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -76.21 -82.81 0.07 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.827 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -150.15 -72.8 0.17 Allowed 'General case' 0 C--N 1.342 0.277 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 -99.8 -33.36 10.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.504 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.2 mt -88.1 103.3 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.726 0.298 . . . . 0.0 110.779 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.6 t -109.28 122.14 46.7 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.255 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 t -94.34 160.8 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.99 133.99 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -109.58 114.97 29.04 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -113.94 -73.84 0.64 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -171.47 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.84 -36.16 74.1 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.59 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -153.37 23.17 0.54 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.174 -0.467 . . . . 0.0 112.177 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.2 t -109.47 141.18 42.27 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 m -134.36 -173.77 3.37 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.342 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 m -154.91 142.15 19.45 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.011 0.434 . . . . 0.0 111.213 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.423 ' HB2' ' CE2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -109.69 93.84 4.71 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.756 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.33 139.05 31.03 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.363 0.415 . . . . 0.0 110.64 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.407 ' HB ' ' HG2' ' A' ' 20' ' ' LYS . 14.7 mt -135.17 86.46 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -49.49 -65.57 0.54 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -176.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.59 -66.33 0.56 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 75.4 125.96 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.084 0.553 . . . . 0.0 111.37 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -147.16 167.37 24.32 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.4 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.8 pt -55.92 -22.98 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -75.29 -38.25 60.47 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -68.75 -32.96 73.09 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.542 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.95 109.17 0.34 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.06 173.42 45.59 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.742 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.7 mt -79.95 97.1 2.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.978 0.389 . . . . 0.0 110.823 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -72.16 169.32 16.35 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -132.06 154.55 49.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.023 0.44 . . . . 0.0 111.777 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.17 103.47 4.95 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.6 t -108.36 143.33 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.26 147.15 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.07 140.93 52.19 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.933 0.397 . . . . 0.0 111.751 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.24 -171.09 3.39 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.182 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -78.97 -35.62 42.75 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.458 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -88.38 -34.75 17.47 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.01 -18.94 1.22 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.77 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 62.6 m -51.17 114.61 1.25 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.499 0.65 . . . . 0.0 111.148 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -106.71 138.95 41.93 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.99 0.424 . . . . 0.0 111.984 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.0 p -125.97 108.0 10.99 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -104.4 177.91 4.71 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -149.38 169.7 20.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.936 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.66 152.09 37.27 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.999 0.428 . . . . 0.0 111.399 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.0 p -139.72 114.59 7.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.897 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.59 87.58 1.22 Allowed 'General case' 0 C--O 1.235 0.331 0 O-C-N 123.511 0.507 . . . . 0.0 110.34 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.4 t -87.4 130.08 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.396 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -115.46 158.13 22.98 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.815 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 9.5 mt -148.25 135.19 13.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.736 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.91 129.96 52.25 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.561 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.018 -179.776 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.97 141.42 47.28 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.468 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.6 t -148.1 144.38 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 123.169 0.293 . . . . 0.0 111.189 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -154.88 148.21 25.02 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.597 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.8 mt -122.29 108.61 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.8 t -92.74 126.41 51.92 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.552 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -83.64 175.31 37.08 Favored 'Cis proline' 0 C--N 1.364 1.353 0 CA-C-N 119.969 1.025 . . . . 0.0 112.21 -0.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.2 p -71.1 -40.23 71.63 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -141.04 118.63 11.59 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.753 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.55 105.63 1.66 Allowed Glycine 0 C--N 1.343 0.934 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.974 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.73 130.71 34.49 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mp -146.71 164.96 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.09 157.66 17.38 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.842 0.353 . . . . 0.0 110.507 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.4 t -62.07 141.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.164 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.06 -7.38 81.57 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.356 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -104.78 152.0 23.1 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 76.6 p -92.58 155.66 17.63 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.576 0.227 . . . . 0.0 110.888 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.405 ' CE ' HD12 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -154.8 119.58 4.87 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.949 -178.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -112.47 147.77 35.81 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.913 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -124.75 118.77 27.16 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.196 0.522 . . . . 0.0 111.32 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.8 130.57 36.86 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.813 -178.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.0 t -114.48 98.46 6.91 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -88.87 157.69 18.35 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.849 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.7 m -137.89 169.9 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.269 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.47 178.907 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.1 mp -72.13 147.99 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.925 0.393 . . . . 0.0 110.994 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.9 m -147.06 154.49 41.24 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.318 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.413 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 43.3 m95 -129.59 113.86 15.34 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.062 0.145 . . . . 0.0 111.24 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -113.35 110.96 21.2 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 p -59.73 154.23 47.95 Favored Pre-proline 0 C--O 1.244 0.809 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.472 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 C--N 1.379 2.176 0 C-N-CA 125.252 3.968 . . . . 0.0 113.779 -179.169 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.1 tttt . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 pp -80.55 148.69 30.26 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.203 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.7 m -67.46 155.47 90.92 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.33 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -83.96 -22.11 3.66 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 122.522 2.148 . . . . 0.0 113.388 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -139.4 73.39 1.43 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.282 0.563 . . . . 0.0 110.328 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -104.94 -57.38 2.03 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.924 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.51 -83.76 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.79 -32.54 11.67 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.6 mt -90.47 107.56 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 120.662 0.267 . . . . 0.0 110.374 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.8 t -112.77 121.63 45.27 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.587 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 t -92.82 159.9 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.6 p -156.22 147.13 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -125.84 123.01 37.74 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.101 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.55 -73.94 0.63 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.2 -173.14 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -53.71 -40.28 65.9 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.663 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -152.6 22.91 0.61 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.948 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.75 141.31 31.72 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.8 m -135.28 -170.56 2.62 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.055 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -159.24 142.05 14.18 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.664 0.269 . . . . 0.0 110.697 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.413 ' HB2' ' CE2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -113.15 92.76 4.12 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.902 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.79 138.88 31.23 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.269 0.355 . . . . 0.0 110.131 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 40.5 mt -135.22 82.12 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -49.36 -56.81 8.29 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -176.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -71.06 -71.69 0.24 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 81.12 120.97 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.501 0.721 . . . . 0.0 110.679 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.7 159.99 41.1 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.267 0.556 . . . . 0.0 110.564 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 30.3 pt -51.01 -25.84 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -75.14 -39.83 60.13 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -64.46 -32.55 74.23 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.929 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.51 106.22 0.17 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.92 178.64 48.65 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.869 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 mp -79.21 100.49 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.915 0.357 . . . . 0.0 110.816 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -72.14 172.73 9.63 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -135.3 157.5 46.75 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 6.4 t -141.18 97.93 3.27 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.634 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.5 t -104.24 132.54 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -112.29 139.96 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.68 132.91 49.61 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.5 -176.06 5.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.441 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -72.26 -52.78 14.8 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.158 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -63.77 -29.33 70.55 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.86 0.85 5.99 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.59 -0.561 . . . . 0.0 114.225 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.8 m -65.95 113.74 4.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.807 0.804 . . . . 0.0 110.019 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -105.46 145.64 30.59 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.873 0.368 . . . . 0.0 111.658 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.7 107.41 4.45 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -109.01 -179.28 3.81 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -151.49 176.11 11.63 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.193 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -147.13 155.89 42.53 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.633 0.254 . . . . 0.0 111.138 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.9 p -139.6 117.81 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.205 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -71.6 93.32 1.22 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.814 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.6 t -95.48 116.59 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.621 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -101.91 150.33 23.3 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.292 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.405 HD12 ' CE ' ' A' ' 20' ' ' LYS . 8.5 mt -141.59 130.93 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.221 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -117.77 129.12 55.49 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.028 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.191 -179.547 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 C--O 1.239 0.537 0 CA-C-O 121.157 0.503 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.21 139.51 31.6 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.545 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.6 t -145.78 135.02 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 123.419 0.449 . . . . 0.0 110.105 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -154.34 121.73 5.75 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.628 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.4 mt -89.74 138.94 18.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.35 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.4 t -122.96 129.4 24.99 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.086 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.63 166.61 77.35 Favored 'Cis proline' 0 C--N 1.364 1.362 0 CA-C-N 119.655 0.913 . . . . 0.0 112.105 -0.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 p -64.06 -41.17 97.46 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.133 0.492 . . . . 0.0 109.92 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -133.96 110.81 9.93 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.755 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.8 102.01 1.52 Allowed Glycine 0 C--N 1.341 0.859 0 C-N-CA 121.008 -0.615 . . . . 0.0 114.44 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -87.82 134.93 33.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 4.4 mp -146.48 163.64 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.653 0.263 . . . . 0.0 110.47 -178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.21 154.58 18.64 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.09 138.27 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.95 -7.91 78.52 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.522 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -103.03 155.82 18.11 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 117.49 0.645 . . . . 0.0 109.418 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.2 p -92.95 159.46 15.32 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 123.081 0.238 . . . . 0.0 110.784 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.24 119.99 4.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.662 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -114.72 140.24 49.03 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.506 0.193 . . . . 0.0 110.795 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -117.12 110.64 18.43 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.312 0.577 . . . . 0.0 110.512 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.0 tp -79.03 107.16 11.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.206 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.8 t -89.79 106.3 18.38 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.041 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -95.17 165.5 12.37 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.725 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.9 m -141.95 173.23 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.3 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.017 178.575 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.6 t0 . . . . . 0 N--CA 1.462 0.147 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.1 mp -126.93 150.29 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 123.245 0.341 . . . . 0.0 110.865 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 57.6 m -147.81 162.82 38.47 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.024 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.401 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 56.5 m95 -138.46 134.58 34.2 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 75.6 m-85 -129.18 115.73 18.12 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.0 p -65.1 154.57 86.56 Favored Pre-proline 0 C--O 1.253 1.266 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.974 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo . . . . . 0 C--N 1.38 2.194 0 C-N-CA 124.97 3.78 . . . . 0.0 115.59 -179.228 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 9.0 tttm . . . . . 0 N--CA 1.464 0.228 0 CA-C-O 120.693 0.282 . . . . 0.0 111.382 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.01 135.09 53.97 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.472 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.72 171.75 11.07 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.783 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.52 -39.12 2.13 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 122.651 2.234 . . . . 0.0 112.623 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -142.36 74.11 1.44 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.134 0.492 . . . . 0.0 111.613 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.69 -48.77 3.85 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -146.51 -155.6 0.64 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -24.29 3.86 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.3 mt -78.92 113.92 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.867 0.365 . . . . 0.0 111.046 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.9 t -118.0 117.96 30.64 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.572 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 t -93.99 158.81 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 p -156.48 156.74 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 16.1 m-90 -129.99 118.93 22.36 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.58 -77.07 0.57 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -54.53 -177.72 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -51.65 -37.85 52.16 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -155.25 26.08 0.41 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.078 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.4 t -107.97 140.95 40.36 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 m -130.04 -171.72 2.6 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 m -155.23 138.11 15.38 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.401 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -108.31 91.53 3.68 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.284 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.9 146.95 26.49 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 49.6 mt -145.46 91.19 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -56.43 -107.18 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.096 0 O-C-N 123.721 0.638 . . . . 0.0 111.63 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.98 93.42 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.892 1.223 . . . . 0.0 110.335 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.25 159.85 30.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.205 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -152.36 162.89 40.52 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.26 0.552 . . . . 0.0 111.323 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 27.4 pt -55.39 -26.4 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.791 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -69.84 -40.51 75.78 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.281 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.02 -32.31 73.43 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.426 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.54 106.33 0.2 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.49 173.44 44.63 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.2 mt -78.42 98.04 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.812 0.306 . . . . 0.0 111.262 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -72.37 173.25 9.01 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 155.68 50.25 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 47.3 t -136.44 96.18 3.31 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.7 t -101.28 126.74 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.954 0.407 . . . . 0.0 111.557 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.3 t -106.72 147.85 11.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -127.76 150.7 49.69 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.05 -178.39 5.43 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.865 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -72.08 -34.6 68.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.343 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -90.33 -39.37 12.76 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.491 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.38 -25.17 0.28 Allowed Glycine 0 C--N 1.34 0.8 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.885 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.5 m -55.14 108.1 0.38 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 117.387 0.593 . . . . 0.0 111.99 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -113.1 136.5 52.64 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.8 t -119.89 117.65 28.69 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -105.53 -179.41 3.93 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.63 174.65 13.71 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.532 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.27 155.36 43.81 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.576 0.227 . . . . 0.0 111.251 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.8 p -138.57 116.51 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.119 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -72.83 98.43 2.43 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 123.416 0.447 . . . . 0.0 110.763 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.4 t -98.35 124.5 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.238 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -109.31 152.64 24.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.928 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 9.1 mt -146.67 139.27 19.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.071 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.99 133.03 29.5 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.729 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.171 -0.919 . . . . 0.0 111.016 179.97 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 tp . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -118.28 144.83 45.51 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.772 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -145.69 143.74 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.626 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -160.19 131.62 5.9 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.3 mt -104.06 136.99 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.727 0.299 . . . . 0.0 110.768 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.61 130.97 24.44 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.059 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.81 170.27 69.93 Favored 'Cis proline' 0 C--N 1.364 1.386 0 CA-C-N 119.549 0.875 . . . . 0.0 112.07 -0.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 p -67.67 -44.02 78.82 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.102 0.477 . . . . 0.0 109.819 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -131.26 105.47 7.67 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.76 97.33 1.51 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 121.156 -0.545 . . . . 0.0 114.331 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -83.92 131.13 34.88 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 mp -141.69 165.0 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 123.049 0.218 . . . . 0.0 110.701 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.83 153.61 22.75 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.098 0.475 . . . . 0.0 110.848 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -66.36 134.84 29.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.344 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.97 -15.83 56.37 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.228 -177.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -115.86 149.24 38.95 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 117.661 0.73 . . . . 0.0 110.098 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.8 p -78.13 174.71 10.86 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.406 ' CG ' ' HB ' ' A' ' 66' ' ' ILE . 1.3 ptmm? -165.34 118.37 1.19 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.965 -177.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -117.93 147.18 43.39 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.7 0.286 . . . . 0.0 111.13 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -123.83 112.72 17.63 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.869 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.4 tp -79.21 112.97 16.95 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.5 t -95.2 100.48 12.27 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.71 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -92.28 160.45 15.13 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.8 m -139.99 165.71 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.342 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.232 178.619 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 111.173 0.064 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.4 mp -71.08 156.36 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 123.493 0.496 . . . . 0.0 111.657 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.2 m -152.76 160.13 43.12 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.727 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -137.4 118.69 14.61 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.143 0.177 . . . . 0.0 110.662 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 96.5 m-85 -112.63 113.03 24.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 80.3 p -63.28 150.67 88.77 Favored Pre-proline 0 C--O 1.245 0.834 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.043 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo . . . . . 0 C--N 1.38 2.222 1 C-N-CA 125.397 4.065 . . . . 0.0 115.927 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 5.1 ttpt . . . . . 0 N--CA 1.468 0.439 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.0 pp -103.14 141.12 36.4 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.96 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m -75.61 158.03 83.57 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.799 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -90.04 19.65 1.17 Allowed 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.592 2.195 . . . . 0.0 113.8 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -155.73 34.26 0.35 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.735 0.303 . . . . 0.0 111.034 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -69.14 -70.4 0.28 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.696 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -154.89 -78.62 0.09 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -100.08 -35.11 9.8 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.717 0.407 . . . . 0.0 111.734 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.1 mt -78.02 97.82 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 123.224 0.328 . . . . 0.0 110.714 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 t -108.65 122.48 47.2 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.797 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.81 159.88 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 p -154.63 136.22 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.166 0.508 . . . . 0.0 111.634 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -109.91 110.59 21.59 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -100.63 -76.19 0.56 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -175.37 0.11 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.35 0.119 . . . . 0.0 110.972 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -57.16 -36.61 70.97 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.26 0.224 . . . . 0.0 111.519 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -145.74 16.22 1.43 Allowed 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 p -102.44 141.01 35.96 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.9 m -135.88 -168.52 2.23 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.891 -0.141 . . . . 0.0 110.902 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.7 m -157.91 140.95 15.05 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.893 0.378 . . . . 0.0 110.779 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.49 91.2 3.55 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.36 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.87 142.86 27.74 Favored 'General case' 0 C--N 1.333 -0.135 0 O-C-N 123.463 0.477 . . . . 0.0 109.793 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.406 ' HB ' ' CG ' ' A' ' 20' ' ' LYS . 60.1 mt -141.19 94.84 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -60.64 -111.95 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.157 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.0 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.089 1.313 . . . . 0.0 110.699 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.6 153.06 33.6 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.367 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -149.99 161.4 42.41 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.493 0.663 . . . . 0.0 111.202 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.7 pt -55.48 -23.55 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.198 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -71.36 -41.28 69.94 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.44 -34.42 77.17 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.83 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.25 114.54 1.24 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.84 174.06 42.07 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.11 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.9 mt -81.81 100.54 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.734 0.267 . . . . 0.0 110.418 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -75.67 171.77 13.76 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -134.76 157.73 45.96 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.885 0.374 . . . . 0.0 111.885 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.7 t -140.14 113.14 8.22 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.7 t -119.08 137.93 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.902 0.382 . . . . 0.0 111.94 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.9 134.89 64.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.0 m -115.48 150.07 37.07 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.78 -175.01 2.94 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.296 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -71.24 -57.84 4.11 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.389 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.34 -28.65 70.15 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.46 -10.03 4.05 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 119.568 -0.573 . . . . 0.0 113.743 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 38.3 m -62.11 107.04 0.81 Allowed 'General case' 0 C--N 1.345 0.394 0 CA-C-N 117.793 0.796 . . . . 0.0 110.938 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -121.9 130.12 53.1 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.182 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.6 t -102.47 177.39 4.88 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -154.53 179.2 9.26 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -158.25 171.56 19.98 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.284 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.6 155.1 42.22 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.737 0.303 . . . . 0.0 111.17 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.57 116.54 7.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.693 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -70.8 96.86 1.3 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.8 t -99.21 129.67 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.597 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.5 155.25 31.16 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.096 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.6 mt -147.93 125.37 3.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.646 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.42 137.08 53.99 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.284 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.072 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.65 142.65 23.97 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.417 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.4 t -148.02 141.35 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 123.15 0.281 . . . . 0.0 110.452 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -159.62 124.84 4.09 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.367 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.2 mt -91.77 141.33 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.892 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.8 t -126.74 128.27 24.3 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.146 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -79.11 173.88 53.36 Favored 'Cis proline' 0 C--N 1.365 1.44 0 CA-C-N 119.885 0.995 . . . . 0.0 112.076 -0.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 93.6 p -71.36 -47.21 57.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.621 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -128.52 102.83 6.8 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.08 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.02 99.27 1.68 Allowed Glycine 0 C--N 1.341 0.807 0 CA-C-N 116.202 -0.453 . . . . 0.0 114.19 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.24 143.56 30.35 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 1.2 mp -150.32 158.57 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.692 0.282 . . . . 0.0 111.192 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.72 152.63 20.25 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.1 t -68.11 127.45 29.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.29 -14.16 25.7 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.841 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -115.21 145.41 42.44 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 117.506 0.653 . . . . 0.0 110.286 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.6 p -81.7 171.53 14.47 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.02 120.98 1.7 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.584 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -114.21 143.59 44.59 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.626 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -119.63 115.72 24.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.059 0.457 . . . . 0.0 111.214 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp -79.43 111.62 15.87 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.3 t -92.32 102.14 14.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.101 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -90.88 163.0 14.55 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.581 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.6 m -138.94 172.88 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.36 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.417 179.023 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.3 t70 . . . . . 0 N--CA 1.464 0.232 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 27.2 mm -114.27 151.91 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 120.749 0.309 . . . . 0.0 111.164 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 m -151.37 156.71 41.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.69 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.402 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 67.3 m95 -134.74 131.46 37.64 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.394 0.278 . . . . 0.0 111.272 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 94.8 m-85 -120.71 117.81 28.44 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.0 p -69.42 150.6 97.01 Favored Pre-proline 0 C--O 1.25 1.105 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.882 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo . . . . . 0 C--N 1.382 2.327 0 C-N-CA 124.932 3.755 . . . . 0.0 116.062 -179.188 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 36.7 tttt . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.02 132.27 36.58 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.153 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.97 162.37 74.88 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.762 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -75.92 -28.8 7.41 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 122.719 2.279 . . . . 0.0 112.221 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -138.31 77.42 1.63 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.22 0.533 . . . . 0.0 109.85 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.07 -58.89 1.53 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.348 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -140.27 -160.57 1.09 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -50.6 -26.65 5.59 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.4 mt -83.68 96.89 4.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.67 0.271 . . . . 0.0 110.825 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.0 t -94.14 169.77 10.01 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.505 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 t -141.9 159.7 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.46 137.89 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.248 0.547 . . . . 0.0 112.221 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 17.4 m-90 -115.1 113.96 24.7 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.82 -77.82 0.59 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -57.65 -177.44 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -56.53 -35.48 68.14 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -149.03 22.32 0.97 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 t -109.19 138.73 45.09 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.1 m -132.26 -170.64 2.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 m -158.24 137.88 12.0 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.715 0.293 . . . . 0.0 110.837 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.402 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -109.37 93.79 4.69 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.752 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.59 143.12 29.49 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.4 0.438 . . . . 0.0 110.245 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.9 mt -140.28 91.36 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -59.86 -112.8 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 O-C-N 123.641 0.588 . . . . 0.0 111.581 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.9 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.726 1.148 . . . . 0.0 110.921 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.13 146.0 41.73 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.414 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.21 159.01 43.4 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.322 0.582 . . . . 0.0 110.454 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.7 pt -51.75 -26.13 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -42.87 74.03 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -66.21 -34.3 77.72 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.736 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.27 107.04 0.2 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.73 179.25 46.16 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.249 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.2 mm -83.13 92.41 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -68.39 165.6 18.43 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -129.94 155.66 45.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.248 0.547 . . . . 0.0 111.925 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 8.9 t -139.23 94.52 2.81 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 t -101.36 135.91 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.174 0.512 . . . . 0.0 112.203 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 t -118.16 157.13 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.221 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 m -135.07 150.64 50.29 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.57 -179.62 4.26 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.337 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -71.05 -46.4 62.06 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.75 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.91 -29.62 58.49 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.557 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 141.37 -10.34 2.72 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-O 119.561 -0.577 . . . . 0.0 113.828 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.2 m -59.46 108.43 0.71 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.97 0.885 . . . . 0.0 111.064 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -105.22 135.57 46.33 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.376 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.6 t -122.97 110.92 15.99 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -106.45 178.93 4.42 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -157.43 179.5 9.19 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.203 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.39 157.71 41.64 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.775 0.321 . . . . 0.0 111.538 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.61 121.52 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.607 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.01 98.21 5.64 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.684 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.3 t -102.84 122.65 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.352 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -108.41 159.71 16.45 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.808 0.337 . . . . 0.0 111.145 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 11.3 mt -149.1 123.03 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.597 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.36 130.71 53.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.104 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.224 -0.894 . . . . 0.0 110.973 -179.76 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 120.522 0.201 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -129.53 152.45 49.04 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.868 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -152.5 148.76 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.415 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -159.68 130.41 5.79 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.827 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.7 mt -95.13 133.86 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.277 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.5 t -116.31 126.17 27.84 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 119.266 -0.397 . . . . 0.0 109.977 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.47 -176.34 16.64 Favored 'Cis proline' 0 C--N 1.366 1.473 0 CA-C-N 119.993 1.033 . . . . 0.0 112.343 -0.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.8 p -77.77 -46.85 20.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.297 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -131.92 111.29 11.43 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.14 103.04 1.63 Allowed Glycine 0 C--N 1.34 0.766 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.962 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -84.65 134.06 34.38 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.463 HG21 ' HG3' ' A' ' 18' ' ' GLU . 1.7 mp -143.94 162.4 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.154 0.502 . . . . 0.0 111.618 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.29 150.09 23.35 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.503 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 51.8 t -66.25 131.77 31.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.88 -15.25 44.69 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.149 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.463 ' HG3' HG21 ' A' ' 14' ' ' ILE . 4.3 pt-20 -116.14 147.26 41.55 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 117.625 0.712 . . . . 0.0 110.11 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 93.5 p -79.49 173.7 12.32 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.26 121.68 1.02 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.996 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -113.69 152.35 30.58 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -129.64 119.18 23.14 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.17 0.509 . . . . 0.0 112.152 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.68 109.67 13.12 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -177.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.439 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 44.8 t -89.5 88.17 7.34 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -81.17 158.78 24.81 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.17 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.5 m -129.43 167.97 23.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.516 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.303 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.248 179.794 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.2 t70 . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.4 mp -75.24 157.13 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.991 0.425 . . . . 0.0 111.507 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.7 m -155.48 160.79 40.86 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.484 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.439 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 46.1 m95 -136.11 115.07 12.23 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.245 0.091 . . . . 0.0 111.245 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -111.74 116.24 30.4 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.0 p -61.7 152.5 75.08 Favored Pre-proline 0 C--O 1.246 0.908 0 CA-C-O 119.092 -0.48 . . . . 0.0 110.135 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo . . . . . 0 C--N 1.381 2.24 1 C-N-CA 125.655 4.237 . . . . 0.0 114.133 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 pp -76.97 156.01 32.25 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.953 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 m -78.29 159.18 75.7 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.079 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.75 -35.69 1.4 Allowed 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 122.618 2.212 . . . . 0.0 112.289 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -125.11 68.59 1.12 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.404 0.621 . . . . 0.0 110.124 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.29 -53.06 2.73 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.412 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -145.97 -157.48 0.8 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -51.08 -24.28 3.81 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.451 HD11 HG22 ' A' ' 52' ' ' ILE . 53.1 mt -82.82 104.94 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 120.704 0.288 . . . . 0.0 110.574 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.3 t -108.55 122.67 47.55 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.073 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.6 t -94.19 159.85 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.701 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.0 p -151.42 155.31 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.777 0.323 . . . . 0.0 111.537 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 -132.86 112.14 11.66 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -106.49 -79.47 0.57 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.28 -174.19 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -51.96 -40.65 61.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.676 0.39 . . . . 0.0 111.922 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -148.9 21.55 0.99 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.103 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 p -99.76 141.34 32.7 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.1 m -136.22 -172.88 3.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.293 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.3 m -157.52 145.51 18.98 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.905 0.383 . . . . 0.0 110.754 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -115.34 93.65 4.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.392 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.81 140.66 29.48 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 123.497 0.498 . . . . 0.0 109.95 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.1 mt -137.01 95.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -61.42 -115.75 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.361 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -53.13 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.846 1.203 . . . . 0.0 111.197 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.46 147.44 41.96 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.394 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -143.31 152.26 41.45 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.828 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.5 pt -51.3 -24.43 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 112.702 0.631 . . . . 0.0 112.702 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.22 -44.33 75.97 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -65.8 -35.4 80.6 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.677 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.26 102.23 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.79 172.61 45.39 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.762 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.5 mt -77.17 94.02 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.783 0.292 . . . . 0.0 111.289 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -65.59 177.04 1.29 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.412 ' O ' ' CE3' ' A' ' 37' ' ' TRP . 8.3 ttmt -139.54 155.4 47.53 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 120.74 0.305 . . . . 0.0 111.633 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.34 102.78 4.29 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.06 140.51 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.83 139.49 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.19 146.09 48.91 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.14 -174.43 4.66 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.968 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -76.74 -35.06 58.02 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.514 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -86.49 -37.97 17.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.498 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.74 -24.3 0.63 Allowed Glycine 0 C--N 1.34 0.758 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.369 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.9 m -55.38 107.96 0.37 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.247 0.523 . . . . 0.0 111.492 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -116.87 134.61 54.55 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.551 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.4 t -114.37 121.55 43.95 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -107.35 -178.14 3.55 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.88 174.54 12.98 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.256 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.84 155.54 38.38 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 123.119 0.262 . . . . 0.0 110.781 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.89 114.58 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.172 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -71.2 94.15 1.14 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.86 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.8 t -96.2 113.69 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -98.67 157.11 16.47 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.729 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.426 HG23 HD11 ' A' ' 97' ' ' ILE . 13.3 mt -146.64 143.6 20.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.107 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.42 131.69 14.55 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.752 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.898 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.538 0.208 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.5 140.18 37.15 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.308 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.5 t -145.23 140.41 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.058 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -160.49 125.78 3.88 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.488 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.9 mt -95.52 137.6 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.688 0.28 . . . . 0.0 110.833 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.93 130.1 24.54 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.807 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.25 168.91 75.98 Favored 'Cis proline' 0 C--N 1.365 1.406 0 CA-C-N 119.704 0.93 . . . . 0.0 112.042 0.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 p -67.39 -44.59 78.51 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.761 0.315 . . . . 0.0 110.415 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -133.54 107.17 7.84 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.585 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.35 160.46 36.36 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.266 -0.492 . . . . 0.0 114.196 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -154.77 103.78 2.46 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.9 mp -128.42 161.85 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.658 0.266 . . . . 0.0 111.178 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.01 153.1 17.79 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.86 139.84 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.29 -19.33 55.0 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.774 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -96.72 160.84 14.16 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 91.8 p -96.08 162.52 13.51 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.06 115.15 3.79 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.601 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -111.22 140.38 45.83 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.583 0.23 . . . . 0.0 110.956 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -117.81 114.63 23.56 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.052 0.454 . . . . 0.0 110.807 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.2 tp -79.99 110.51 15.44 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.3 t -92.67 97.1 10.58 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.465 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -87.33 163.93 16.54 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.7 m -147.43 175.91 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.272 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.608 179.528 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.465 0.321 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.4 mp -125.71 144.55 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 123.368 0.418 . . . . 0.0 111.204 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 m -144.04 149.94 37.43 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.088 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.416 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 52.5 m95 -125.85 122.3 35.72 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.305 0.242 . . . . 0.0 111.133 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -119.52 112.7 19.69 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.5 m -55.88 150.45 28.27 Favored Pre-proline 0 C--O 1.244 0.814 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.365 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 C--N 1.381 2.242 1 C-N-CA 125.499 4.133 . . . . 0.0 113.634 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt . . . . . 0 N--CA 1.469 0.499 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 pp -84.26 143.05 29.82 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.142 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.5 m -66.41 150.18 97.37 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.215 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.24 -14.72 13.13 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.472 2.115 . . . . 0.0 113.701 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -136.42 37.24 2.71 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.87 0.367 . . . . 0.0 110.976 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.15 -75.2 0.07 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.736 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -151.8 -75.35 0.14 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.603 0.24 . . . . 0.0 111.12 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -99.66 -31.34 11.62 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.4 mt -89.18 104.82 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 t -108.48 120.39 42.29 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.1 t -93.93 154.03 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.2 m -150.9 173.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.337 0.589 . . . . 0.0 112.421 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -141.82 120.17 12.32 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.97 -82.52 0.54 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -42.04 -64.47 0.58 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 179.49 -44.09 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.382 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -114.71 -35.8 4.73 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.329 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.6 t -65.53 136.91 56.99 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.048 0.452 . . . . 0.0 111.099 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.7 m -122.76 -173.62 2.74 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.81 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.0 m -156.57 130.73 8.56 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.87 0.366 . . . . 0.0 111.04 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.416 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -101.42 93.05 5.2 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.944 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.18 139.1 30.84 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 123.254 0.346 . . . . 0.0 110.323 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 44.9 mt -135.39 85.02 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -50.29 -59.56 3.84 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -176.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -63.96 -65.6 0.66 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 73.98 118.82 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.051 0.54 . . . . 0.0 110.869 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.39 164.64 30.88 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.706 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 34.5 pt -54.85 -27.07 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -73.51 -36.53 65.76 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -68.13 -33.75 75.07 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.597 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.77 117.18 2.96 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.42 176.69 40.06 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.52 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.7 mm -75.99 89.61 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 122.283 0.233 . . . . 0.0 111.435 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -66.85 171.66 5.13 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -131.87 155.79 47.22 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 11.9 t -142.48 88.43 2.07 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.759 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.4 t -96.25 126.22 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.078 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.88 157.91 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.5 m -139.48 148.74 43.11 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.56 -177.18 3.84 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.552 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -71.31 -54.2 11.65 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.121 0.263 . . . . 0.0 111.068 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.7 -31.12 70.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.621 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 141.73 -10.47 2.63 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.603 -0.554 . . . . 0.0 113.978 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.5 m -58.55 104.65 0.23 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 117.902 0.851 . . . . 0.0 111.173 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -102.31 136.1 42.74 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.847 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.6 t -128.43 109.89 11.82 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -101.47 179.43 4.36 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -153.62 175.89 12.7 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.916 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.05 155.18 36.37 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.7 p -139.89 120.87 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.668 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -76.5 84.88 3.21 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.337 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.6 t -84.07 138.5 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.511 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -124.97 156.84 37.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.471 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.425 HG22 HD11 ' A' ' 97' ' ' ILE . 9.6 mt -148.7 140.38 17.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.775 177.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -127.27 128.53 46.14 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.273 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.994 -179.589 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mp . . . . . 0 CA--C 1.531 0.237 0 CA-C-O 120.783 0.325 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.84 151.25 31.98 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.113 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 t -150.56 144.59 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.606 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -157.07 130.59 8.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.429 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.7 mt -107.91 120.46 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.143 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t -105.64 130.07 23.64 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -81.93 173.49 48.03 Favored 'Cis proline' 0 C--N 1.367 1.545 0 CA-C-N 119.882 0.994 . . . . 0.0 112.282 -0.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 76.1 p -69.27 -41.48 76.81 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -137.2 109.77 7.48 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.649 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.92 98.73 1.7 Allowed Glycine 0 C--N 1.343 0.937 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.927 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -83.09 126.48 32.62 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mp -140.45 164.5 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 123.21 0.319 . . . . 0.0 110.389 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.57 156.28 18.1 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.7 t -63.07 141.07 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.09 -11.58 71.71 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.301 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -101.67 150.09 23.47 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 117.33 0.565 . . . . 0.0 109.536 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.3 p -90.45 164.46 14.27 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.62 129.47 3.6 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.996 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 28.9 p90 -120.77 157.96 28.58 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.2 0.313 . . . . 0.0 110.732 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -133.36 120.35 20.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.68 117.27 19.67 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 t -102.07 96.37 6.96 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.626 0.251 . . . . 0.0 111.148 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -93.62 162.19 14.05 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.94 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.7 m -137.93 152.93 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.323 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.543 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 10.9 m-20 . . . . . 0 N--CA 1.462 0.17 0 N-CA-C 111.199 0.074 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.5 mm -65.5 152.44 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.459 0.647 . . . . 0.0 111.653 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.4 m -147.23 161.25 41.31 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.022 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -138.69 109.41 6.65 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 119.632 -0.223 . . . . 0.0 110.616 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -110.75 111.04 21.95 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 p -60.02 154.07 51.92 Favored Pre-proline 0 C--O 1.243 0.722 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.388 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 C--N 1.375 1.955 0 C-N-CA 125.105 3.87 . . . . 0.0 113.704 -179.282 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.5 tttm . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.48 153.94 18.19 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.056 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 m -78.2 164.37 57.01 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.334 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.43 -25.4 2.6 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 122.816 2.344 . . . . 0.0 113.42 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -129.42 22.4 5.57 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.58 -59.02 3.68 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -137.63 -159.83 1.0 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.24 0.216 . . . . 0.0 110.574 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 mtm-85 -51.35 -22.8 3.13 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.46 HG22 HD11 ' A' ' 52' ' ' ILE . 52.6 mt -84.59 105.78 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.7 t -111.65 115.28 28.86 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.337 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.9 t -85.83 150.88 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.452 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -143.43 139.21 26.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 CA-C-O 120.75 0.31 . . . . 0.0 111.286 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 24.5 m-90 -109.18 107.49 17.79 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -92.37 -77.84 0.43 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -72.43 -178.6 2.62 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.494 -0.188 . . . . 0.0 110.494 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.82 -35.85 69.26 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -134.84 5.7 3.38 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 p -100.56 137.34 39.09 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.999 0.363 . . . . 0.0 110.317 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.02 136.82 20.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.52 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.0 m -108.85 139.34 43.82 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.842 0.353 . . . . 0.0 111.787 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 27.8 tp -94.85 113.67 25.44 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.36 141.42 31.27 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.7 mt -138.0 90.78 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -59.94 -110.97 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.657 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.2 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.794 1.179 . . . . 0.0 111.063 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.47 148.06 48.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.674 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -140.98 153.56 45.64 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.276 0.56 . . . . 0.0 110.901 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.2 pt -54.3 -23.94 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.81 -41.24 68.47 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -66.67 -34.81 78.69 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.704 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.61 99.63 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.76 176.23 46.31 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.528 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.2 mt -80.24 101.16 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.877 0.339 . . . . 0.0 111.701 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -71.37 172.37 9.54 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -135.51 157.95 45.6 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 2.9 t -143.13 118.6 10.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.341 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.7 t -126.54 133.03 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER -115.24 129.58 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 m -110.73 148.25 32.69 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.95 173.06 7.48 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.091 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.0 -46.32 78.43 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.195 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -71.97 -28.24 63.3 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.632 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.31 -12.31 4.36 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 119.899 -0.389 . . . . 0.0 113.521 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.8 m -60.82 108.05 0.79 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 117.455 0.627 . . . . 0.0 111.278 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -119.75 132.43 55.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.762 0.315 . . . . 0.0 111.288 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.2 t -114.71 125.35 53.62 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -105.02 -177.71 3.44 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -158.28 172.38 18.48 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.004 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.86 156.46 41.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.69 0.281 . . . . 0.0 111.375 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -144.63 115.26 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.405 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -70.25 94.63 0.93 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.928 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.1 t -96.27 115.52 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.573 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -101.03 155.06 18.2 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.409 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 97' ' ' ILE . 10.6 mt -146.79 122.97 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.473 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -111.39 127.63 55.73 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.505 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.306 -0.854 . . . . 0.0 111.087 -179.727 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 tp . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 111.43 0.159 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.32 140.59 51.89 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.741 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 t -149.31 137.69 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.653 -0.248 . . . . 0.0 110.973 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -159.29 123.71 3.97 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.311 0.382 . . . . 0.0 110.514 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.1 mt -89.87 140.2 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 O-C-N 123.15 0.281 . . . . 0.0 111.042 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.9 t -128.1 134.39 26.18 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.856 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.44 173.82 56.13 Favored 'Cis proline' 0 C--N 1.365 1.436 0 CA-C-N 119.698 0.928 . . . . 0.0 112.161 0.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.4 p -69.14 -49.01 60.82 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -128.37 114.22 16.58 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.44 93.16 0.72 Allowed Glycine 0 C--N 1.343 0.94 0 C-N-CA 121.087 -0.578 . . . . 0.0 114.46 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -79.99 132.86 36.1 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.0 mp -143.47 164.12 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.09 0.472 . . . . 0.0 111.384 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.47 150.22 22.87 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.549 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.2 t -66.0 135.28 28.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.599 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.17 -15.07 59.45 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.251 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -114.67 146.63 40.65 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 117.747 0.773 . . . . 0.0 110.111 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.404 ' CB ' ' HA ' ' A' ' 67' ' ' TYR . 60.1 p -79.42 168.56 19.31 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -176.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.31 121.38 3.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.805 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -115.2 142.22 46.96 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.578 0.227 . . . . 0.0 110.951 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -117.51 117.0 28.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.918 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.8 tp -82.43 109.81 17.0 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.935 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.66 107.44 19.17 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -92.01 163.11 14.1 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.2 m -147.42 176.64 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.508 179.562 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 . . . . . 0 N--CA 1.464 0.247 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.8 mm -70.93 148.66 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 123.603 0.565 . . . . 0.0 110.168 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.7 m -144.93 156.12 43.8 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.183 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.408 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 55.9 m95 -134.65 121.84 21.43 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -119.5 110.84 17.38 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 m -62.73 152.6 81.6 Favored Pre-proline 0 C--O 1.249 1.071 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.117 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo . . . . . 0 C--N 1.38 2.209 1 C-N-CA 126.047 4.498 . . . . 0.0 116.532 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp . . . . . 0 C--O 1.234 0.242 0 CA-C-O 120.649 0.261 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 pp -86.84 131.64 34.06 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.495 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.8 m -63.52 163.29 20.79 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.667 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.34 -60.29 0.11 Allowed 'Trans proline' 0 C--N 1.363 1.321 0 C-N-CA 122.621 2.214 . . . . 0.0 112.597 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -114.38 62.65 0.67 Allowed 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.285 0.564 . . . . 0.0 110.697 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.83 -62.13 1.41 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.102 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -139.03 -154.42 0.52 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.0 -23.91 1.32 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.2 mt -86.17 105.04 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.5 t -109.07 122.17 46.7 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.189 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.77 158.07 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.15 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.2 m -150.32 171.75 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.852 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -139.58 120.1 14.07 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.1 -81.78 0.57 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -56.33 -178.43 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -52.96 -34.19 54.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -141.37 -12.97 0.9 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.6 p -76.89 147.55 36.97 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 118.725 0.693 . . . . 0.0 111.297 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.2 m -134.79 -170.17 2.5 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.817 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.2 m -154.23 138.49 16.61 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 111.799 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.408 ' HB2' ' CE2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -108.08 94.68 5.2 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.684 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.54 140.1 29.88 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 123.295 0.372 . . . . 0.0 110.563 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.0 mt -136.44 91.06 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.404 ' HA ' ' CB ' ' A' ' 19' ' ' SER . 11.0 m-85 -56.25 -69.92 0.13 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.18 -66.19 0.5 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 73.76 119.77 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.1 0.56 . . . . 0.0 111.232 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -142.39 163.03 33.95 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.03 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.7 pt -51.73 -26.28 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.95 -43.77 70.92 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.437 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -65.7 -33.39 75.77 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.004 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.14 109.31 0.32 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.14 174.9 45.68 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.726 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.7 mt -80.54 99.78 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.829 0.315 . . . . 0.0 111.296 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -72.57 171.5 12.31 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -132.89 158.01 43.64 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 34.2 t -139.82 100.8 4.03 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.895 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -107.22 133.02 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.69 134.83 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.17 146.43 41.39 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.32 -175.59 4.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.464 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -73.7 -46.32 46.89 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 123.132 0.27 . . . . 0.0 111.49 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.4 -35.46 65.88 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.559 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.48 -19.31 1.5 Allowed Glycine 0 C--N 1.339 0.719 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.643 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.8 m -56.14 108.7 0.49 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.348 0.574 . . . . 0.0 111.7 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -117.78 133.81 55.56 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.867 0.365 . . . . 0.0 111.565 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.2 t -120.94 127.18 51.59 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -111.49 -177.94 3.32 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -177.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.75 177.13 10.39 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.614 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.82 158.39 44.13 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.822 0.344 . . . . 0.0 111.816 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.18 114.36 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.908 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -71.33 91.48 0.99 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.914 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.4 t -92.39 129.37 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.549 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -115.76 158.42 22.87 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.798 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.45 HG22 HD11 ' A' ' 97' ' ' ILE . 11.2 mt -148.99 135.47 12.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.178 178.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.25 135.56 45.03 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.355 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.878 -179.838 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 121.08 0.466 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.9 147.71 52.29 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.883 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.41 140.22 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 O-C-N 123.188 0.305 . . . . 0.0 111.068 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -154.99 130.61 9.89 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.601 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.4 mt -91.69 130.11 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 123.196 0.31 . . . . 0.0 110.992 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.0 t -115.07 123.76 31.31 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.83 -179.29 24.9 Favored 'Cis proline' 0 C--N 1.364 1.374 0 CA-C-N 119.985 1.03 . . . . 0.0 112.276 0.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 86.3 p -78.69 -40.97 32.34 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.307 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -132.85 118.15 18.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.699 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -117.93 99.37 0.8 Allowed Glycine 0 C--N 1.341 0.844 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.97 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -87.55 132.26 34.11 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 4.5 mp -143.59 163.63 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.811 0.338 . . . . 0.0 111.083 -178.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.36 154.46 18.17 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.5 t -63.49 140.43 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.901 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.64 -12.0 70.8 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.24 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.06 156.64 17.54 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.8 p -96.16 165.51 12.2 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.63 0.253 . . . . 0.0 111.286 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -162.61 126.58 3.03 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -119.72 153.42 35.65 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.072 0.232 . . . . 0.0 111.039 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -131.57 119.17 21.12 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.287 0.565 . . . . 0.0 112.078 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.9 111.96 14.29 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -176.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.431 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 54.0 t -87.61 87.53 7.41 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -79.9 158.39 26.69 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.427 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.5 m -133.49 165.07 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 O-C-N 123.473 0.483 . . . . 0.0 112.081 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.403 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.715 179.188 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 13.5 m-20 . . . . . 0 N--CA 1.468 0.435 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.4 mp -121.7 158.75 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 123.189 0.306 . . . . 0.0 111.155 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 64.1 m -159.88 160.92 34.2 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.768 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.431 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 58.8 m95 -136.96 130.89 32.22 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.673 0.273 . . . . 0.0 111.134 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 91.6 m-85 -118.92 117.55 29.14 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.5 p -65.73 152.76 92.36 Favored Pre-proline 0 C--O 1.249 1.055 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.903 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo . . . . . 0 C--N 1.38 2.225 0 C-N-CA 124.904 3.736 . . . . 0.0 116.133 -178.778 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 21.9 tttt . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -110.35 134.4 52.33 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.172 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.4 m -68.55 158.01 86.5 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.085 -178.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -85.93 -26.7 1.13 Allowed 'Trans proline' 0 C--N 1.363 1.334 0 C-N-CA 122.831 2.354 . . . . 0.0 113.55 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -121.28 69.59 0.91 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.375 0.607 . . . . 0.0 110.182 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.99 -60.01 1.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.149 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -141.79 -159.5 0.97 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 121.99 0.116 . . . . 0.0 110.856 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.7 mtm-85 -47.54 -25.57 1.16 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.476 HD11 HG22 ' A' ' 52' ' ' ILE . 47.9 mt -84.83 106.62 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.801 0.334 . . . . 0.0 110.378 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 t -112.52 123.06 49.45 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.517 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.4 t -92.81 159.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.361 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -154.09 153.43 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.734 0.302 . . . . 0.0 111.422 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 23.0 m-90 -126.08 112.57 16.0 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -105.35 -75.33 0.63 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.2 -179.05 0.13 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.494 0.188 . . . . 0.0 111.421 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -54.62 -35.76 63.78 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.496 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -151.07 24.45 0.74 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.946 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.9 t -110.4 136.25 49.85 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.3 m -128.66 -169.38 2.07 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.525 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 m -159.33 144.85 15.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.937 0.399 . . . . 0.0 110.995 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.82 93.55 4.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.334 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.22 144.25 27.55 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.561 0.538 . . . . 0.0 110.286 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.427 HG22 HD11 ' A' ' 66' ' ' ILE . 61.9 mt -142.52 93.05 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -59.71 -108.51 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.405 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -56.61 95.17 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.465 1.03 . . . . 0.0 110.551 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.25 151.8 39.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.153 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -145.71 154.43 42.07 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.139 0.495 . . . . 0.0 111.281 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.5 pt -53.98 -24.52 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -72.64 -41.3 65.61 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.92 -34.23 77.91 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.736 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.69 104.25 0.08 Allowed 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.02 171.44 44.17 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.81 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.9 mt -79.62 95.92 2.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.81 0.305 . . . . 0.0 110.245 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -69.93 171.42 9.41 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -133.66 154.69 50.73 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.741 0.305 . . . . 0.0 111.155 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.31 97.71 3.44 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 t -101.01 140.85 18.8 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.857 -176.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 34' ' ' ASP . 1.7 t -125.78 144.92 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 m -124.3 155.97 37.76 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.28 -176.01 3.39 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.26 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -77.3 -37.93 51.73 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 123.023 0.202 . . . . 0.0 110.901 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -79.87 -35.8 37.57 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.256 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 148.37 -19.49 1.34 Allowed Glycine 0 C--N 1.34 0.751 0 C-N-CA 121.232 -0.509 . . . . 0.0 113.563 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 89.4 m -59.87 112.83 2.0 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 117.314 0.557 . . . . 0.0 111.333 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.63 134.06 55.39 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.488 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.6 t -114.73 124.98 53.17 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -108.83 -179.86 3.98 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -147.84 173.94 12.34 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.148 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.0 154.95 39.08 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 111.269 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.87 112.71 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.979 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -70.88 93.26 0.96 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.919 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.5 t -95.05 118.03 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.553 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.63 157.73 16.86 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.153 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.409 HG23 HD11 ' A' ' 97' ' ' ILE . 10.5 mt -148.57 139.73 17.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.8 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.86 131.58 51.15 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.404 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.962 -179.788 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 29.6 mt . . . . . 0 C--O 1.234 0.274 0 CA-C-O 120.566 0.222 . . . . 0.0 111.529 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.71 134.48 21.19 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.293 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.7 t -143.91 139.56 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 123.22 0.325 . . . . 0.0 110.499 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -155.66 121.14 4.92 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.413 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.5 mt -89.64 136.24 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.023 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.48 128.05 25.83 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.549 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -74.4 -172.9 11.05 Favored 'Cis proline' 0 C--N 1.366 1.489 0 CA-C-N 119.669 0.917 . . . . 0.0 112.041 -0.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 97.2 p -85.57 -50.12 7.49 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.574 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -131.92 104.07 6.65 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.326 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.78 144.88 17.19 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 121.421 -0.418 . . . . 0.0 113.596 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -126.6 129.52 48.69 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 4.9 mp -141.75 165.12 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 120.579 0.228 . . . . 0.0 111.226 -178.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.4 157.45 17.33 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.47 136.91 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.393 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.69 -8.25 80.08 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.942 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -100.78 153.06 19.78 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.0 p -100.06 134.73 42.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.193 0.521 . . . . 0.0 112.083 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -116.98 172.04 7.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.582 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.65 149.91 13.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -137.87 105.14 5.47 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.444 0.64 . . . . 0.0 110.812 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.6 tp -79.41 111.92 16.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 114.88 -1.054 . . . . 0.0 112.228 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.4 t -90.49 108.87 20.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.786 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -92.32 160.24 15.21 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.9 m -140.71 176.52 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.332 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.332 179.455 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 18.4 m-20 . . . . . 0 N--CA 1.466 0.372 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.87 155.7 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 123.39 0.431 . . . . 0.0 110.845 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.8 m -156.65 162.0 39.86 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.079 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -133.08 135.55 45.38 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.941 0.151 . . . . 0.0 110.783 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 95.2 m-85 -128.91 109.07 10.93 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.6 p -58.77 151.44 53.43 Favored Pre-proline 0 C--O 1.251 1.151 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.166 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 C--N 1.382 2.33 0 C-N-CA 124.648 3.565 . . . . 0.0 115.534 -178.865 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 10.9 ttmt . . . . . 0 N--CA 1.464 0.243 0 CA-C-O 120.664 0.268 . . . . 0.0 111.384 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.7 mt -111.85 139.21 47.52 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.694 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.26 155.92 66.51 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.215 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.22 -24.46 9.44 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.439 2.093 . . . . 0.0 113.321 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -138.98 78.61 1.68 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.213 0.53 . . . . 0.0 109.97 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.95 -59.05 1.28 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.585 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -146.02 -157.95 0.85 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -24.28 3.48 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.1 mt -84.17 97.81 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.692 0.282 . . . . 0.0 110.457 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.8 t -101.32 117.96 36.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.552 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.6 t -93.63 160.33 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.0 p -158.58 157.69 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 13.1 m-90 -136.04 121.9 19.92 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -81.73 0.64 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.69 -177.9 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -31.55 -59.33 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.323 1.049 . . . . 0.0 113.08 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -147.24 21.62 1.21 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.034 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.6 145.22 25.41 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 m -134.58 -170.78 2.62 Favored 'General case' 0 N--CA 1.458 -0.07 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.069 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.4 m -160.12 145.71 15.27 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.868 0.366 . . . . 0.0 111.325 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.7 98.44 6.37 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.172 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.61 138.68 34.65 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.607 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.5 mt -134.95 89.2 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -53.97 -98.65 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.94 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.75 100.78 0.73 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.234 0.925 . . . . 0.0 110.109 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.17 149.18 29.21 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -142.72 155.54 44.89 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.545 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.3 pt -53.1 -24.54 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -71.56 -42.31 68.0 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -65.33 -35.1 79.94 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.115 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.36 126.81 15.92 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.63 -177.64 37.82 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.895 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.42 108.61 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -83.52 166.18 18.49 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -127.57 158.4 37.57 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.139 0.495 . . . . 0.0 112.303 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 23.7 t -138.84 94.01 2.77 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.272 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.6 t -100.46 132.31 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 34' ' ' ASP . 3.6 t -111.73 153.6 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.4 m -137.61 111.04 7.97 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.56 -176.19 0.1 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.244 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -73.08 -49.97 25.53 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.715 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -62.62 -31.28 72.1 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 134.28 -19.19 4.1 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 121.348 -0.453 . . . . 0.0 113.51 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 m -61.59 114.02 3.03 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.397 0.599 . . . . 0.0 110.505 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -100.64 136.92 39.76 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.279 0.362 . . . . 0.0 111.973 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.6 t -116.79 106.42 13.47 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -102.85 -179.39 3.94 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -155.86 -178.62 7.43 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.161 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.11 160.58 43.39 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.701 0.286 . . . . 0.0 111.463 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.09 120.47 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.55 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -74.85 91.43 2.44 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.752 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.9 t -95.27 142.42 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.31 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.88 156.34 46.27 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.938 0.399 . . . . 0.0 111.398 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.446 HG22 HD11 ' A' ' 97' ' ' ILE . 11.3 mt -145.09 132.27 15.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.052 178.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.23 132.2 39.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.249 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.219 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 121.192 0.52 . . . . 0.0 112.287 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -146.43 124.58 12.16 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.14 150.89 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.236 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -160.1 130.37 5.46 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.765 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.9 mt -92.1 144.69 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.361 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -128.42 126.13 23.43 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.19 179.69 28.5 Favored 'Cis proline' 0 C--N 1.365 1.421 0 CA-C-N 120.149 1.089 . . . . 0.0 112.348 0.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 96.4 p -73.33 -51.67 16.64 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.451 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -130.53 101.25 5.63 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.885 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.2 111.24 4.19 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 121.3 -0.476 . . . . 0.0 113.799 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.02 123.06 35.1 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.8 mp -137.73 164.69 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.593 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.75 162.23 14.17 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.634 0.731 . . . . 0.0 111.625 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.8 t -68.51 135.7 27.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.323 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.07 -17.35 58.82 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-O 119.545 -0.586 . . . . 0.0 112.449 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -111.46 146.55 37.03 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-N 117.799 0.8 . . . . 0.0 109.896 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 96.7 p -79.67 176.95 9.25 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.33 118.74 0.46 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.249 -178.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -112.09 150.6 30.48 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.469 0.176 . . . . 0.0 111.137 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -128.58 118.52 23.12 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.197 0.522 . . . . 0.0 111.44 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.8 tp -79.13 117.3 20.04 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.403 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 41.6 t -94.74 96.56 9.46 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -88.41 148.72 24.08 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.168 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.89 175.96 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.252 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.093 179.209 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.9 mp -73.25 157.98 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 123.385 0.428 . . . . 0.0 111.136 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.0 m -157.88 161.79 38.3 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.249 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.421 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 60.3 m95 -137.39 124.99 22.2 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.65 0.262 . . . . 0.0 111.094 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 94.8 m-85 -114.38 117.32 30.7 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.9 p -68.12 153.12 95.89 Favored Pre-proline 0 C--O 1.249 1.074 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.947 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo . . . . . 0 C--N 1.382 2.314 0 C-N-CA 124.887 3.725 . . . . 0.0 116.048 -178.595 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 19.8 tttm . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.76 152.85 26.11 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.268 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m -79.33 159.48 72.44 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.984 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.79 -8.06 13.4 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.29 1.994 . . . . 0.0 113.548 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -141.92 48.59 1.6 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.03 0.443 . . . . 0.0 110.763 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -66.33 -77.31 0.07 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.658 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -150.76 -74.53 0.15 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 -99.86 -34.71 10.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.639 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 53.4 mt -84.54 107.23 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.849 0.357 . . . . 0.0 111.189 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.5 t -110.64 124.35 51.74 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.597 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.5 t -98.42 159.3 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.742 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.0 m -149.95 170.32 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.862 0.363 . . . . 0.0 111.518 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.1 m-90 -139.64 104.5 4.93 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -90.79 -85.57 0.22 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -175.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -174.56 0.07 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.952 0.342 . . . . 0.0 111.804 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.89 -36.05 62.26 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.844 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -145.18 17.77 1.56 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.5 t -103.09 139.12 39.03 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.6 m -133.27 -173.73 3.29 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.993 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m -155.73 146.55 22.2 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.902 0.382 . . . . 0.0 111.826 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.421 ' HB2' ' CE2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -115.84 91.57 3.64 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.447 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.2 139.01 31.45 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 66.2 mt -135.56 95.59 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -61.93 -116.07 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 O-C-N 123.759 0.662 . . . . 0.0 110.884 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.43 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.824 1.193 . . . . 0.0 111.409 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.56 142.53 44.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.992 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -136.9 152.28 50.03 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.63 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.2 pt -51.41 -26.01 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -69.08 -43.67 74.08 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -65.21 -33.42 75.95 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.88 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.47 104.3 0.07 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.54 174.27 46.47 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.043 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.3 mt -81.23 98.66 4.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -71.73 172.47 9.71 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -134.01 155.11 50.56 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.744 0.307 . . . . 0.0 111.095 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.74 101.38 4.31 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.0 t -104.73 140.85 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.427 -176.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.36 135.49 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 m -117.14 149.88 39.63 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.55 -177.63 5.09 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.357 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -74.23 -34.46 63.66 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.314 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.32 -35.6 23.15 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.361 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.61 -22.15 1.5 Allowed Glycine 0 C--N 1.34 0.785 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.584 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.8 m -59.19 111.66 1.42 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.208 0.504 . . . . 0.0 111.446 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.12 135.22 54.76 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.922 0.391 . . . . 0.0 111.687 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.7 t -116.61 127.13 54.18 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -111.19 -178.54 3.49 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -147.67 173.55 12.64 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.18 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.48 155.78 42.23 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.613 0.244 . . . . 0.0 111.051 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.97 116.82 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.273 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.02 102.68 2.49 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.1 t -105.57 111.49 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.681 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.0 mtmm -98.91 149.73 22.64 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.406 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.446 HG23 HD11 ' A' ' 97' ' ' ILE . 10.3 mt -139.36 117.72 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.42 132.3 56.29 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.382 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.895 -179.718 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.238 0 CA-C-O 120.698 0.285 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -134.76 142.17 46.66 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.901 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -149.59 141.1 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.82 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -155.04 132.55 11.21 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.644 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.6 mt -92.17 131.93 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 O-C-N 123.173 0.295 . . . . 0.0 111.11 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.04 125.91 28.74 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.57 172.7 48.93 Favored 'Cis proline' 0 C--N 1.364 1.365 0 CA-C-N 120.103 1.072 . . . . 0.0 112.369 0.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.9 p -70.05 -39.8 75.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.458 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -134.42 113.15 11.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.85 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.03 97.89 1.11 Allowed Glycine 0 C--N 1.342 0.867 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.803 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -86.19 124.19 32.31 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 mp -141.06 164.45 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.593 0.235 . . . . 0.0 110.727 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.76 156.98 17.17 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.786 0.327 . . . . 0.0 110.439 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.0 t -63.52 140.77 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.38 -11.57 70.85 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.472 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -98.99 159.55 14.88 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 117.481 0.64 . . . . 0.0 109.454 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 66.7 p -101.49 149.24 24.28 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.63 0.252 . . . . 0.0 111.213 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.26 124.53 10.86 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.552 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -114.57 148.32 38.19 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.958 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -127.45 119.85 27.04 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.223 0.535 . . . . 0.0 112.028 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.05 109.49 12.18 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -177.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.452 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 35.5 t -84.54 90.7 7.7 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -83.35 150.82 25.86 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.093 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.35 169.96 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.3 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.799 179.334 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 t70 . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.2 mp -76.43 155.44 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.064 0.459 . . . . 0.0 112.01 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.9 m -152.3 159.2 43.53 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.645 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.452 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 44.2 m95 -135.4 115.18 12.9 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 119.684 -0.198 . . . . 0.0 111.384 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -116.51 112.16 20.98 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.52 156.01 55.74 Favored Pre-proline 0 C--O 1.245 0.821 0 CA-C-O 119.325 -0.369 . . . . 0.0 110.627 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo . . . . . 0 C--N 1.381 2.253 0 C-N-CA 125.094 3.863 . . . . 0.0 113.484 -179.387 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 23.2 tttm . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mt -72.39 171.48 12.16 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.987 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m -86.75 150.4 50.55 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.06 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.08 -24.75 23.39 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.254 1.97 . . . . 0.0 112.886 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -150.01 80.3 1.37 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.989 0.423 . . . . 0.0 110.301 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.71 -79.08 0.46 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.295 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -145.04 -74.3 0.24 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.588 0.232 . . . . 0.0 110.902 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -97.95 -39.57 8.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.565 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 mt -88.33 112.83 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.6 t -119.37 117.98 29.97 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.364 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.3 t -89.04 157.61 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.8 p -155.0 157.98 3.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 CA-C-O 120.963 0.411 . . . . 0.0 111.894 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.7 m-90 -131.72 107.51 8.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -97.39 -79.28 0.46 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.73 -178.82 0.22 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.587 0.232 . . . . 0.0 111.473 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -52.71 -34.26 51.54 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -148.29 16.51 1.05 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 p -103.14 139.15 39.02 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.97 0.35 . . . . 0.0 110.078 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -130.84 -174.29 3.33 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.455 -177.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -155.82 147.57 23.07 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.003 0.43 . . . . 0.0 111.35 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.417 ' HB2' ' CE2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -118.94 92.51 3.82 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.285 179.425 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.87 145.14 27.96 Favored 'General case' 0 N--CA 1.461 0.106 0 O-C-N 123.37 0.419 . . . . 0.0 110.157 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 51.2 mt -141.19 79.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -45.79 -66.94 0.33 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -64.38 -67.07 0.46 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 78.22 123.75 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.345 0.658 . . . . 0.0 110.926 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.24 159.77 42.1 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.069 0.462 . . . . 0.0 110.737 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.3 pt -50.23 -27.79 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -71.19 -41.42 70.33 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -64.08 -34.05 77.15 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.98 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.76 102.87 0.06 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.75 178.23 46.59 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.656 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 mp -80.77 100.58 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 117.051 0.426 . . . . 0.0 110.437 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -73.32 174.57 7.91 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -135.01 154.27 51.78 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.31 101.26 4.09 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.0 t -106.89 137.41 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -176.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -120.39 142.42 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.4 m -128.2 126.31 40.74 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.89 -175.84 2.27 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.752 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -78.18 -39.54 40.47 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.181 0.301 . . . . 0.0 111.04 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.38 -33.84 65.24 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.394 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.02 -8.52 4.16 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-O 119.72 -0.489 . . . . 0.0 114.013 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.3 m -62.58 110.32 1.66 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.687 0.744 . . . . 0.0 110.61 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -103.07 134.36 46.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.889 0.376 . . . . 0.0 111.784 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.8 t -131.22 115.01 15.77 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -112.1 -176.97 3.05 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.5 172.77 16.04 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.34 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.23 152.29 39.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.66 0.266 . . . . 0.0 110.535 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.55 117.71 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.126 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -71.7 92.24 1.17 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.084 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.6 t -95.09 112.73 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.476 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.95 155.54 17.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.948 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.444 HG22 HD11 ' A' ' 97' ' ' ILE . 11.2 mt -144.04 135.49 22.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.144 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.67 127.62 37.32 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.229 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.951 -179.901 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 120.625 0.25 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.84 150.08 41.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.903 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.1 t -147.35 138.14 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.456 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -155.31 125.84 6.86 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.878 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 71.2 mt -89.71 135.14 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -134.6 120.68 14.66 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 118.918 -0.563 . . . . 0.0 110.908 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -66.23 149.56 78.42 Favored 'Cis proline' 0 C--N 1.364 1.343 0 CA-C-N 120.531 1.225 . . . . 0.0 113.053 -0.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.1 p -71.72 -40.4 69.49 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.888 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -112.16 120.2 40.99 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.64 75.74 0.21 Allowed Glycine 0 C--N 1.341 0.854 0 N-CA-C 114.542 0.577 . . . . 0.0 114.542 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -81.24 115.25 20.54 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 mp -141.74 162.17 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.411 -178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.34 153.94 18.26 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.94 0.4 . . . . 0.0 110.488 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.01 141.18 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.093 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.8 -13.1 67.68 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.188 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -102.61 159.51 15.39 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.2 p -94.35 168.51 10.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.578 0.228 . . . . 0.0 110.648 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -167.0 115.34 0.83 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.222 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -120.66 151.79 39.03 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.69 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -131.74 122.68 26.26 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.264 0.554 . . . . 0.0 111.339 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp -79.81 114.43 18.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.718 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 t -90.19 104.32 16.91 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.075 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -95.44 166.99 11.6 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.512 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.0 m -139.58 171.48 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.691 0.281 . . . . 0.0 111.596 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.274 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.041 178.931 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 N--CA 1.464 0.248 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.51 152.17 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 123.322 0.389 . . . . 0.0 111.205 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.5 m -152.68 157.66 41.24 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.297 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.419 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 60.5 m95 -131.98 122.38 25.45 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -119.22 111.95 18.87 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 p -57.02 152.83 26.65 Favored Pre-proline 0 C--O 1.244 0.793 0 CA-C-O 119.327 -0.368 . . . . 0.0 110.783 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 C--N 1.379 2.135 0 C-N-CA 125.273 3.982 . . . . 0.0 114.15 -178.923 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.2 tttt . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.89 158.15 16.45 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.797 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.6 m -75.25 147.22 82.65 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.451 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.47 -27.16 81.02 Favored 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 122.39 2.06 . . . . 0.0 113.066 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -148.63 79.24 1.43 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.004 0.431 . . . . 0.0 110.807 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.72 -68.45 0.79 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.991 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -150.95 -79.26 0.12 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -99.7 -32.77 10.89 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.412 HD11 HG22 ' A' ' 52' ' ' ILE . 63.3 mt -88.53 100.4 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 120.868 0.366 . . . . 0.0 111.212 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.6 t -107.19 123.21 47.94 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.027 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.9 t -95.91 158.13 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.268 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.3 m -150.54 172.5 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 120.938 0.399 . . . . 0.0 111.642 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.7 m-90 -142.23 117.0 9.83 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.55 -79.55 0.57 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -59.48 -179.92 0.1 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.598 0.181 . . . . 0.0 111.024 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -57.08 -32.35 66.18 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -136.99 -12.37 1.69 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.8 t -85.25 139.75 31.39 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 118.734 0.697 . . . . 0.0 111.499 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.8 m -126.0 -169.37 2.0 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.268 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.3 m -160.53 132.92 6.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.419 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -99.98 99.08 9.78 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.225 178.635 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.38 131.4 37.59 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.242 0.339 . . . . 0.0 110.092 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.415 HG22 HD11 ' A' ' 66' ' ' ILE . 63.7 mt -130.1 93.14 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -60.68 -116.06 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 CA-C-O 118.895 -0.574 . . . . 0.0 111.199 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -51.48 95.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.912 1.233 . . . . 0.0 110.876 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.22 154.05 37.77 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.883 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -148.34 154.13 39.55 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.382 0.61 . . . . 0.0 111.326 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.4 pt -53.42 -25.97 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -71.53 -40.52 70.02 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.29 -34.23 77.84 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.584 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.89 108.4 0.24 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.49 179.69 48.83 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 121.411 -0.423 . . . . 0.0 112.299 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.0 mm -82.04 90.26 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 122.152 0.181 . . . . 0.0 111.459 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.435 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . 40.3 m-85 -67.68 176.0 2.67 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -136.58 159.0 43.12 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 8.3 t -140.4 92.54 2.53 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.705 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 5.2 t -96.51 128.74 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.92 159.1 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.5 m -136.34 154.06 50.96 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.47 -172.66 2.2 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.315 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -76.79 -45.6 28.2 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.233 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -74.74 -32.01 61.97 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 141.73 -9.88 2.6 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.402 -0.666 . . . . 0.0 114.433 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.6 m -63.79 116.98 6.27 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 117.98 0.89 . . . . 0.0 110.336 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -108.92 135.77 49.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.466 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.8 t -122.0 108.38 13.32 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 6.2 pt-20 -99.78 179.83 4.4 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.2 -179.39 7.48 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.716 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.26 152.56 31.31 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.025 0.44 . . . . 0.0 111.478 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.435 ' CG1' ' HB2' ' A' ' 77' ' ' TYR . 2.7 p -132.01 119.87 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.34 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -80.72 88.4 5.78 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 t -91.96 124.66 44.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.934 -177.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -111.99 155.19 24.15 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.585 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.471 HD11 HG22 ' A' ' 97' ' ' ILE . 7.9 mt -145.96 132.04 13.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.697 177.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -119.29 125.65 49.59 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.535 -178.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.856 -179.844 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -99.95 152.01 20.67 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.0 t -146.57 146.76 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -158.13 127.95 5.97 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.705 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.4 mt -94.2 142.83 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.2 t -124.46 122.91 25.87 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-O 119.21 -0.424 . . . . 0.0 110.03 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.49 -171.17 9.36 Favored 'Cis proline' 0 C--N 1.366 1.452 0 CA-C-N 119.925 1.009 . . . . 0.0 112.361 -0.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.3 p -85.83 -50.22 7.3 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.309 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -125.38 99.98 6.29 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.733 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.28 156.55 37.6 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.874 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -151.75 104.92 3.07 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.3 mp -130.15 166.85 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.806 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.6 155.46 18.27 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.603 0.716 . . . . 0.0 111.339 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.0 t -65.88 138.49 22.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.887 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.87 -16.96 60.11 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.312 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -115.52 149.94 37.35 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 117.87 0.835 . . . . 0.0 110.116 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.4 p -79.86 165.58 22.55 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.77 119.88 3.36 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.267 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -112.8 153.57 27.63 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.538 0.209 . . . . 0.0 111.245 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.33 113.58 15.15 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.271 0.558 . . . . 0.0 111.234 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.1 tp -78.42 111.73 14.73 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.436 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 43.7 t -93.4 90.1 6.6 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -86.7 157.51 19.63 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.861 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.96 169.15 16.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.448 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.503 179.537 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 . . . . . 0 N--CA 1.466 0.342 0 N-CA-C 111.207 0.077 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 mp -77.74 156.62 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.183 0.516 . . . . 0.0 111.411 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 m -152.36 157.74 41.72 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.087 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.436 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 39.8 m95 -135.13 109.13 8.17 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 117.61 0.187 . . . . 0.0 110.934 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -107.73 112.07 24.57 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 56.0 p -62.33 153.78 74.33 Favored Pre-proline 0 C--O 1.246 0.918 0 CA-C-O 119.159 -0.448 . . . . 0.0 110.535 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo . . . . . 0 C--N 1.382 2.334 1 C-N-CA 125.938 4.425 . . . . 0.0 115.038 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 8.6 ttpp . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.85 148.05 49.56 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.542 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.36 150.75 95.37 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.067 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.88 -30.84 6.96 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 122.286 1.99 . . . . 0.0 112.579 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -120.61 52.13 1.19 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.028 0.442 . . . . 0.0 111.254 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -68.81 -82.2 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.352 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -150.98 -73.17 0.16 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -98.99 -31.56 11.74 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.689 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.6 mt -89.05 101.66 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.735 0.302 . . . . 0.0 110.405 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.0 t -108.42 122.77 47.7 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.157 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.63 159.62 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.8 p -153.97 146.95 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.077 0.465 . . . . 0.0 112.239 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 21.2 m-90 -123.73 112.06 16.9 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -109.49 -74.35 0.66 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.745 1.016 . . . . 0.0 113.745 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -60.74 -175.16 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -53.26 -36.55 61.23 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.745 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -153.96 22.32 0.51 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.2 t -103.47 139.23 39.1 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 m -134.64 -174.03 3.46 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.603 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -155.8 145.29 21.0 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.022 0.439 . . . . 0.0 111.256 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -113.29 91.23 3.57 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.247 179.466 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.71 138.02 31.83 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.338 0.399 . . . . 0.0 110.295 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.9 mt -134.79 87.29 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -52.89 -67.46 0.25 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -60.57 -63.64 1.23 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 73.6 120.55 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.883 0.473 . . . . 0.0 110.952 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -141.71 162.4 35.57 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.033 0.444 . . . . 0.0 110.356 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.6 pt -54.83 -24.59 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -72.95 -40.45 65.35 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -66.52 -32.97 74.66 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.792 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.58 114.65 1.19 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.26 171.45 37.89 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.037 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.0 mt -76.93 95.86 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.786 0.293 . . . . 0.0 111.691 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -70.23 179.03 2.55 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -140.66 156.25 46.29 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 120.757 0.313 . . . . 0.0 111.626 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.96 102.38 4.0 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 t -104.59 139.78 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.11 137.96 53.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.4 m -127.93 150.95 49.66 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.51 -173.65 2.7 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.532 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -73.01 -52.86 12.82 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.504 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -65.47 -36.26 83.35 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 146.78 -19.23 1.63 Allowed Glycine 0 C--N 1.34 0.76 0 C-N-CA 121.161 -0.542 . . . . 0.0 113.644 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 77.5 m -57.85 109.1 0.66 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.39 0.595 . . . . 0.0 111.213 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -119.67 134.26 55.3 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.682 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.9 t -110.96 117.64 33.9 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -105.65 -178.57 3.69 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.46 172.38 15.54 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.255 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.01 153.23 36.17 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.46 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.26 111.67 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.757 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.68 89.51 0.74 Allowed 'General case' 0 C--O 1.235 0.293 0 O-C-N 123.408 0.442 . . . . 0.0 110.281 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.29 138.05 19.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.589 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -122.83 156.96 33.51 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.625 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 97' ' ' ILE . 7.2 mt -147.11 136.02 15.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.785 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.7 133.36 43.42 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.335 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.949 -179.664 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 111.498 0.185 . . . . 0.0 111.498 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -92.78 149.53 21.23 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -144.02 146.4 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 123.162 0.289 . . . . 0.0 110.933 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -160.38 133.06 6.41 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.64 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.1 mt -99.72 124.31 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 36.3 t -108.1 128.44 25.73 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.598 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.77 -172.9 11.78 Favored 'Cis proline' 0 C--N 1.365 1.433 0 CA-C-N 119.946 1.016 . . . . 0.0 112.327 -0.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.9 p -78.84 -48.82 14.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.932 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -132.0 112.34 12.29 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.883 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.08 106.99 2.34 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.071 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -88.31 132.54 34.37 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.1 mp -145.47 162.87 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 120.628 0.252 . . . . 0.0 110.697 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.41 154.34 19.17 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.284 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.6 t -61.53 136.3 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.231 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.71 -6.81 74.09 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.417 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -104.39 158.18 16.64 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.3 p -101.48 149.71 23.79 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.628 0.251 . . . . 0.0 111.58 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.25 119.11 8.1 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.607 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -113.74 148.13 37.02 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.684 0.278 . . . . 0.0 110.537 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -125.92 144.74 50.56 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.048 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.21 110.03 22.28 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.5 t -87.48 86.35 7.22 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -92.4 161.62 14.58 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.014 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.93 175.46 8.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.727 179.285 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 t0 . . . . . 0 N--CA 1.462 0.151 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 mp -75.4 156.1 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.294 0.568 . . . . 0.0 112.173 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.0 m -157.55 162.96 38.82 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.499 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -135.61 130.36 34.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 110.53 -0.174 . . . . 0.0 110.53 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 87.1 m-85 -125.54 112.68 16.49 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.7 p -57.71 154.67 25.1 Favored Pre-proline 0 C--O 1.251 1.152 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo . . . . . 0 C--N 1.377 2.042 0 C-N-CA 124.649 3.566 . . . . 0.0 116.084 -178.375 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 10.0 tttt . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 120.57 0.224 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.18 122.02 25.87 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.047 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.98 158.91 73.83 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.252 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -83.52 -13.76 8.31 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 122.511 2.141 . . . . 0.0 113.808 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -153.85 84.74 1.16 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.011 0.434 . . . . 0.0 110.536 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.91 -57.75 0.81 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.977 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -137.24 -159.17 0.93 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -48.91 -26.47 2.49 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.7 mt -82.58 122.78 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.8 t -134.44 124.29 25.41 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.971 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.6 t -98.33 156.91 3.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.218 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.2 p -152.21 141.29 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.876 0.37 . . . . 0.0 111.735 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -117.11 121.91 42.62 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.44 -76.73 0.57 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -58.04 -175.68 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -56.33 -37.55 70.13 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.954 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -148.98 20.87 0.99 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.7 t -105.25 142.05 35.69 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 120.65 0.262 . . . . 0.0 110.441 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.9 m -138.36 -176.53 4.49 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.023 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 m -157.69 136.69 11.61 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.921 0.391 . . . . 0.0 111.629 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 tp -96.08 141.67 29.19 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.46 96.46 3.36 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.772 0.715 . . . . 0.0 112.676 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 mt -92.47 90.74 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.469 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -57.51 -96.05 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.975 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.46 97.64 0.78 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.066 0.848 . . . . 0.0 110.142 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.76 157.52 29.99 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.528 ' O ' HD11 ' A' ' 97' ' ' ILE . 10.4 m-80 -152.21 158.18 42.5 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.059 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.34 -24.82 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -72.54 -42.72 64.41 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 110.478 -0.194 . . . . 0.0 110.478 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -63.73 -33.69 76.21 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.03 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.12 105.57 0.11 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.95 178.92 48.11 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.485 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.6 mm -81.0 92.89 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 123.394 0.114 . . . . 0.0 110.758 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -68.24 161.74 26.53 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -127.79 155.75 43.57 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.09 103.21 4.27 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.8 t -106.74 141.96 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.03 140.47 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -120.5 138.1 54.01 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.22 -174.27 4.35 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.11 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -73.47 -58.3 3.4 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.396 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -63.68 -22.78 67.08 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 120.9 19.77 3.58 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-O 119.785 -0.453 . . . . 0.0 113.811 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 93.7 m -84.68 109.05 17.73 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -101.93 130.82 48.52 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.3 t -122.2 113.98 20.21 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -108.68 -177.84 3.43 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.16 170.44 18.93 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.325 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.45 154.76 39.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.742 0.306 . . . . 0.0 111.113 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.2 121.04 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.963 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -76.85 95.62 4.12 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.845 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.2 t -97.07 108.12 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.524 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -90.46 149.97 22.01 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.599 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.528 HD11 ' O ' ' A' ' 70' ' ' ASN . 9.8 mt -146.56 115.41 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.731 0.3 . . . . 0.0 110.424 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.17 134.2 55.07 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.961 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.82 179.87 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.357 0.122 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -156.49 -43.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 120.752 0.311 . . . . 0.0 111.228 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 16.2 mt -57.21 134.06 55.59 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.39 141.73 37.54 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.746 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 t -149.38 143.32 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 O-C-N 123.253 0.346 . . . . 0.0 110.867 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -160.07 127.07 4.44 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.771 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.7 mt -99.74 138.63 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.367 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.7 t -128.49 135.48 27.63 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.671 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -77.23 170.26 71.93 Favored 'Cis proline' 0 C--N 1.366 1.492 0 C-N-CA 124.767 -0.93 . . . . 0.0 111.815 -0.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.2 p -66.63 -45.08 80.21 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.809 0.338 . . . . 0.0 110.323 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -131.8 110.86 11.15 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.398 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -111.54 97.94 0.98 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.756 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -78.62 134.44 37.18 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.3 mm -136.84 170.01 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.401 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.03 156.68 29.22 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.18 137.81 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.53 -8.75 78.49 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.6 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -100.03 155.05 17.92 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 117.302 0.551 . . . . 0.0 109.751 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.1 p -98.62 163.53 12.62 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.16 119.52 1.54 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -112.97 141.4 46.84 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.601 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -117.79 118.49 32.17 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.839 0.352 . . . . 0.0 111.205 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.94 115.07 18.39 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.9 t -99.6 94.89 6.62 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.355 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -88.91 158.75 17.97 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.744 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.1 m -138.49 171.77 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.72 137.61 11.23 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.51 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 140.5 -161.44 26.56 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.551 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -173.32 37.97 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.894 0.378 . . . . 0.0 110.761 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.19 79.24 9.16 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.067 0.46 . . . . 0.0 111.173 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm 60.22 -167.87 0.17 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.5 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -64.31 133.66 53.13 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -116.53 145.4 43.37 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.988 0.423 . . . . 0.0 111.712 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -121.85 164.91 16.72 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.485 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.6 mp -127.9 146.83 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 123.373 0.421 . . . . 0.0 110.787 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 m -144.47 158.94 43.51 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.308 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.427 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 55.4 m95 -133.7 128.02 34.09 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.04 0.212 . . . . 0.0 110.44 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 94.0 m-85 -116.6 117.98 31.36 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.7 p -66.61 149.43 98.19 Favored Pre-proline 0 C--O 1.247 0.932 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.477 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -49.93 -16.85 1.84 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 124.741 3.627 . . . . 0.0 115.516 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -79.14 7.71 7.06 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 117.972 0.351 . . . . 0.0 111.83 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.78 41.75 22.79 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 111.824 -0.511 . . . . 0.0 111.824 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -163.79 135.79 4.93 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 119.658 -0.817 . . . . 0.0 112.995 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 31.0 tttt -54.88 143.37 26.16 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.531 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 pp -109.42 143.62 38.76 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.58 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.9 m -84.24 157.11 62.73 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.219 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.64 -27.6 3.97 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.444 2.096 . . . . 0.0 112.731 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -118.34 65.86 0.76 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.369 0.604 . . . . 0.0 110.025 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.11 -59.7 1.31 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.564 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -140.95 -162.21 1.33 Allowed 'General case' 0 CA--C 1.54 0.575 0 O-C-N 123.008 0.193 . . . . 0.0 110.508 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -51.76 -23.06 4.11 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.466 HD11 HG22 ' A' ' 52' ' ' ILE . 46.3 mt -82.18 99.15 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.7 t -105.04 122.88 46.79 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.949 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.3 t -93.07 158.03 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.139 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 p -151.55 147.9 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 20.4 m-90 -122.1 114.9 21.55 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.51 -80.35 0.58 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -56.24 -176.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -51.17 -37.83 48.67 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -152.78 22.68 0.59 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 p -99.6 138.89 36.05 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 m -143.28 134.4 25.74 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.104 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -103.11 141.05 36.5 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 111.626 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.427 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -103.66 94.32 5.39 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.324 179.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.96 139.59 31.07 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 123.468 0.48 . . . . 0.0 110.351 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.1 mt -137.44 93.22 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -60.2 -113.88 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.473 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.21 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.81 1.186 . . . . 0.0 110.967 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.84 148.92 48.45 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.16 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -141.52 154.68 45.64 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.715 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.5 pt -53.9 -24.48 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -71.51 -40.97 69.81 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -66.47 -35.53 80.5 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.885 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.37 107.81 0.21 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.69 -179.35 47.81 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.446 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.2 mm -82.18 95.22 3.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.588 0.194 . . . . 0.0 111.006 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -71.76 160.12 33.16 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -128.09 158.15 38.78 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.908 0.385 . . . . 0.0 111.563 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 9.5 t -138.93 99.86 3.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.4 t -109.8 126.33 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 121.066 0.46 . . . . 0.0 112.116 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.72 155.1 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.66 143.45 49.66 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.13 176.5 6.95 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.371 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.94 -40.77 87.66 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.199 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.8 -36.24 28.63 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.392 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 150.06 -18.15 1.07 Allowed Glycine 0 C--N 1.339 0.75 0 CA-C-O 119.556 -0.58 . . . . 0.0 113.813 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.7 m -58.52 103.46 0.16 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.876 0.838 . . . . 0.0 110.702 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -109.39 132.54 54.03 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.796 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.1 p -99.65 -176.86 3.39 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -161.3 175.51 12.19 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -159.7 176.42 12.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.127 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.2 163.86 39.61 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.5 p -152.63 123.11 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.75 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -80.97 96.03 6.96 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.988 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.0 t -97.94 123.59 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.531 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -108.53 160.28 16.04 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.911 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.432 HG22 HD11 ' A' ' 97' ' ' ILE . 12.0 mt -151.58 125.74 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.684 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -116.58 127.98 54.99 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.342 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.735 -179.873 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.46 0.171 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.87 37.29 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 121.103 0.478 . . . . 0.0 110.977 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.26 124.3 24.28 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.957 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -127.18 148.37 50.18 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.422 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 t -145.76 147.23 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 123.12 0.262 . . . . 0.0 111.445 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -160.3 126.2 4.09 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.323 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.7 mt -97.28 139.48 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.656 0.265 . . . . 0.0 110.648 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.6 t -128.17 130.86 23.55 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.942 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.56 172.03 64.51 Favored 'Cis proline' 0 C--N 1.365 1.443 0 CA-C-N 119.73 0.939 . . . . 0.0 112.377 -0.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 p -69.83 -53.2 19.23 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.337 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -129.96 107.61 9.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.211 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.41 158.97 24.81 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 116.077 -0.51 . . . . 0.0 113.545 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -143.37 119.5 10.76 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.13 164.24 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.711 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.97 157.62 16.73 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.69 138.49 22.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.87 -15.18 63.68 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.436 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -99.04 162.63 12.96 Favored 'General case' 0 C--N 1.348 0.511 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.1 p -102.73 168.35 9.31 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.94 121.44 1.77 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.483 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -115.05 142.29 46.84 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.622 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -118.42 118.4 31.64 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.004 0.43 . . . . 0.0 111.283 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.0 tp -79.21 116.44 19.48 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.9 t -97.93 100.65 12.01 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.404 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 -91.4 158.78 16.32 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.86 174.36 13.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.27 118.55 2.96 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.764 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 140.11 179.45 17.9 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.982 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -147.9 78.6 1.45 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.117 0.484 . . . . 0.0 110.777 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -100.23 24.35 8.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.261 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? 59.98 -86.48 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -48.51 -28.45 3.36 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -3.63 106.47 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -121.1 168.35 11.65 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.906 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.2 mp -130.21 153.39 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 123.318 0.386 . . . . 0.0 110.856 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.2 m -152.31 160.63 43.3 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.34 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.431 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 59.1 m95 -132.63 130.82 40.68 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.216 0.206 . . . . 0.0 110.792 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 67.3 m-85 -122.12 117.96 27.53 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.9 p -62.51 152.85 79.42 Favored Pre-proline 0 C--O 1.253 1.285 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.425 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.32 -12.34 5.55 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 124.472 3.448 . . . . 0.0 115.947 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -76.73 -3.89 40.48 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.104 0.411 . . . . 0.0 111.388 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.03 41.04 4.43 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.758 -0.468 . . . . 0.0 112.019 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -162.14 177.15 9.95 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 119.76 -0.776 . . . . 0.0 112.122 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 19.1 tttt -91.41 149.58 21.65 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.522 0.514 . . . . 0.0 111.021 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.12 152.69 26.68 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.605 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 m -79.36 163.05 61.36 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.341 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.22 -28.06 12.99 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.66 2.24 . . . . 0.0 112.696 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -139.41 72.99 1.41 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.13 0.491 . . . . 0.0 111.009 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -80.61 -68.76 0.65 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.992 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -156.67 -72.73 0.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -99.74 -35.85 9.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.426 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 52' ' ' ILE . 48.7 mt -85.7 110.33 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.777 0.322 . . . . 0.0 110.78 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.3 t -114.49 118.66 34.4 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.659 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.6 t -90.33 158.78 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.268 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 p -153.99 152.09 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.963 0.411 . . . . 0.0 111.64 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 24.8 m-90 -123.16 104.56 9.25 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -91.16 -80.77 0.33 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -176.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -65.26 -177.92 0.44 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.41 0.148 . . . . 0.0 110.912 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.94 -33.73 62.53 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -141.43 7.4 1.94 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.9 p -94.52 136.41 34.85 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.282 0.492 . . . . 0.0 110.459 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.93 132.99 27.85 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.372 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 m -102.89 146.3 28.51 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 111.921 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.431 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -111.47 94.95 5.23 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.532 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.18 142.49 29.43 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.822 0.344 . . . . 0.0 110.274 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.9 mt -139.53 90.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -59.57 -113.46 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.304 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -53.28 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.968 1.258 . . . . 0.0 111.154 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.63 143.0 42.5 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.294 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -136.11 153.49 51.28 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.689 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.67 -25.68 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -71.21 -42.15 69.31 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -62.99 -34.72 78.14 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.678 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.28 112.03 0.8 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.67 179.06 47.69 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.547 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.4 mm -80.72 95.5 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 122.051 0.14 . . . . 0.0 111.175 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -71.95 167.08 20.85 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -132.03 158.16 42.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 112.258 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 4.2 t -140.12 100.39 3.9 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.304 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.2 t -107.67 129.7 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 111.872 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.6 t -108.2 156.41 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.9 m -132.78 149.11 52.31 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.28 -173.65 3.14 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.692 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.69 -48.47 21.88 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.116 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.27 -37.81 71.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.23 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 150.0 -18.54 1.08 Allowed Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.06 -0.59 . . . . 0.0 113.86 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 96.2 m -57.92 108.3 0.57 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.859 0.829 . . . . 0.0 110.582 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.53 134.55 54.62 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.265 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.6 p -97.15 -177.89 4.0 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -160.53 171.76 18.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -154.51 172.83 17.17 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.009 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.79 155.76 38.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.728 0.299 . . . . 0.0 111.248 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.92 118.93 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.348 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -76.15 88.27 3.04 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.347 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.0 t -87.9 131.63 35.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.058 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.23 153.57 32.66 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.559 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.8 mt -145.67 128.61 10.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.563 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.77 133.24 53.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.358 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.929 -179.817 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 6.4 ttm-85 . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.312 0.101 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.9 m -159.64 49.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 121.039 0.447 . . . . 0.0 111.258 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 mp -148.44 118.13 7.06 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.798 0.332 . . . . 0.0 111.583 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -138.74 140.55 38.72 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.232 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 t -144.92 141.25 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.672 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -157.37 124.82 5.25 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.587 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.6 mt -92.39 143.66 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.594 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.6 t -131.11 133.03 24.18 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.887 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.24 169.99 73.05 Favored 'Cis proline' 0 C--N 1.363 1.303 0 CA-C-N 119.719 0.935 . . . . 0.0 112.029 0.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.4 p -68.2 -42.15 80.3 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -133.47 111.87 11.08 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.289 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.2 100.39 1.64 Allowed Glycine 0 C--N 1.341 0.855 0 C-N-CA 120.895 -0.669 . . . . 0.0 114.251 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.64 128.91 34.91 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.0 mp -144.53 162.92 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.662 0.268 . . . . 0.0 110.733 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.17 156.45 17.7 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.729 0.3 . . . . 0.0 110.367 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.4 t -62.91 138.55 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.999 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.1 -15.75 62.47 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.343 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -97.16 159.17 15.07 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.0 p -97.36 164.47 12.45 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.31 116.62 2.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -177.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -111.52 143.28 42.63 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.64 0.257 . . . . 0.0 111.143 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -120.72 110.02 15.88 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.5 tp -77.56 112.53 14.44 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.2 t -94.05 108.17 20.02 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.208 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -96.88 155.37 16.8 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.755 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.24 175.49 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -168.57 124.26 0.96 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.828 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 166.24 153.45 7.76 Favored Glycine 0 C--N 1.34 0.764 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.452 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -104.67 31.27 4.83 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.714 0.257 . . . . 0.0 111.647 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.48 -178.8 1.19 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.853 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -86.43 -38.28 17.5 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.285 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -153.41 148.45 26.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.911 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -132.12 147.5 52.43 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -132.67 100.94 5.1 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.121 0.168 . . . . 0.0 111.133 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.2 mp -66.77 150.01 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.209 0.528 . . . . 0.0 112.115 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.3 m -150.46 155.54 39.72 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.463 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.459 ' O ' ' HA ' ' A' ' 44' ' ' LYS . 43.8 m95 -134.86 117.92 16.41 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 119.239 -0.41 . . . . 0.0 111.136 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -117.5 109.83 17.22 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.287 0.367 . . . . 0.0 111.885 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 p -59.89 154.67 47.11 Favored Pre-proline 0 C--O 1.246 0.905 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.941 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -29.12 -74.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.383 2.385 1 C-N-CA 125.696 4.264 . . . . 0.0 114.618 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.92 36.78 4.49 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.03 -16.78 4.3 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-O 119.41 -0.661 . . . . 0.0 113.198 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 71.04 -168.72 0.15 Allowed 'General case' 0 C--N 1.35 0.609 0 CA-C-N 117.958 0.879 . . . . 0.0 109.156 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 27.9 tttt -54.9 118.62 4.43 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.2 mt -77.95 175.9 9.62 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.587 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.5 m -94.28 156.11 39.17 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.884 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.91 -34.53 90.94 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.322 2.015 . . . . 0.0 112.5 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -152.69 63.6 0.8 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.229 0.538 . . . . 0.0 110.568 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.11 -73.58 0.12 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.577 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -147.84 -74.51 0.19 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.638 0.256 . . . . 0.0 110.782 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -99.35 -36.62 9.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.758 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.0 mt -84.64 104.96 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.936 0.398 . . . . 0.0 110.796 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.3 t -107.56 120.34 41.92 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.838 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.2 t -90.99 159.1 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.6 p -151.63 146.43 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.96 0.409 . . . . 0.0 111.839 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 23.1 m-90 -121.38 106.59 11.59 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -98.72 -79.97 0.47 Allowed 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -62.64 -177.63 0.16 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.653 0.263 . . . . 0.0 111.628 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -50.25 -35.92 28.97 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -149.37 17.89 0.94 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.9 t -98.06 139.07 34.42 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.71 131.28 18.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.87 151.96 19.69 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.043 0.449 . . . . 0.0 111.958 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.424 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -114.25 92.9 4.12 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.43 139.99 29.99 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 123.382 0.426 . . . . 0.0 110.614 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 49.3 mt -136.84 93.9 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -58.36 -107.59 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 119.049 -0.5 . . . . 0.0 111.251 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.42 95.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.796 1.18 . . . . 0.0 110.591 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.77 149.74 31.0 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.676 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -146.37 157.42 43.78 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.174 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.7 pt -53.86 -24.68 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -71.68 -39.87 69.95 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -67.07 -35.93 80.9 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.36 117.57 2.48 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.97 174.87 38.52 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.023 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.6 mm -73.75 91.27 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 122.18 0.192 . . . . 0.0 111.271 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -68.43 172.6 5.83 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -135.32 158.21 44.95 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 12.3 t -142.0 97.78 3.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.149 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.6 t -102.85 131.65 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.0 0.429 . . . . 0.0 111.931 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.87 139.84 43.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.9 m -125.71 143.99 50.8 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.26 -176.13 4.04 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.958 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -69.76 -57.41 5.14 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.076 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -60.55 -31.78 70.87 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 138.84 -18.85 3.16 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.477 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.8 m -59.55 107.81 0.64 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.335 0.568 . . . . 0.0 111.199 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -115.2 134.14 55.41 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.444 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -115.12 119.76 37.5 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -104.63 -179.62 4.0 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -154.06 178.06 10.38 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.132 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.04 154.85 36.78 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.592 0.234 . . . . 0.0 111.051 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.86 123.17 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.965 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -75.2 96.91 3.39 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.26 0.553 . . . . 0.0 110.261 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.8 t -96.71 131.96 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.441 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -121.4 147.63 45.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.383 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.1 mt -141.25 137.22 33.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.22 134.01 37.68 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.948 -177.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.305 -0.855 . . . . 0.0 110.94 -179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.592 0.234 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.3 m -122.02 119.51 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.02 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.3 tp -168.72 118.16 0.72 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.252 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.85 136.47 40.61 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.654 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -143.77 142.66 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.46 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -156.43 158.83 37.99 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.127 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.9 mt -128.13 138.71 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.8 128.1 24.98 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.269 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.37 173.79 50.97 Favored 'Cis proline' 0 C--N 1.366 1.498 0 CA-C-N 119.68 0.922 . . . . 0.0 112.332 -0.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.8 p -69.66 -46.5 65.98 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.69 101.96 5.9 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.46 101.75 2.61 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.786 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.85 119.95 26.72 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.4 mp -135.6 166.57 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.42 161.6 18.83 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.481 0.657 . . . . 0.0 111.962 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.6 t -65.42 137.4 25.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.861 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.72 -18.47 57.21 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.194 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -114.76 145.22 42.34 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 117.593 0.696 . . . . 0.0 110.291 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.5 p -79.01 173.99 12.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.79 118.99 0.97 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.976 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -115.81 146.57 41.85 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.612 0.244 . . . . 0.0 110.831 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -121.49 112.85 19.02 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.07 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.0 tp -79.12 111.26 15.16 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.5 t -92.82 110.1 21.54 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.217 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -95.31 164.73 12.71 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.871 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.01 170.6 12.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.89 125.15 3.09 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.252 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 145.91 151.91 5.52 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.264 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -106.87 42.72 1.25 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.065 0.46 . . . . 0.0 110.669 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.69 5.68 31.01 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? 57.96 -85.47 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -37.48 -31.76 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -12.52 80.73 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -95.48 111.7 23.55 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.963 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.51 155.16 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.371 0.605 . . . . 0.0 111.779 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.9 m -155.11 157.66 37.82 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.275 178.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.411 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 58.7 m95 -131.82 123.69 28.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.577 0.172 . . . . 0.0 111.004 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 80.0 m-85 -116.76 113.22 22.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.9 p -62.78 152.51 82.1 Favored Pre-proline 0 C--O 1.254 1.323 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.306 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -58.18 -9.15 5.89 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 124.374 3.383 . . . . 0.0 115.267 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -75.84 -6.25 49.85 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 118.097 0.408 . . . . 0.0 110.81 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.78 40.98 3.69 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-O 119.705 -0.497 . . . . 0.0 112.006 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -166.98 178.22 5.89 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 119.788 -0.765 . . . . 0.0 112.43 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 12.6 ttmt -91.37 125.81 36.24 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 123.589 0.556 . . . . 0.0 111.068 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.3 pp -83.99 135.16 34.56 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.815 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.5 m -69.75 155.03 94.22 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.046 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.62 -30.57 7.72 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 122.364 2.043 . . . . 0.0 112.761 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -117.19 56.5 0.82 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.151 0.501 . . . . 0.0 111.155 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -76.01 -80.46 0.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.285 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -155.78 -72.68 0.11 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -99.74 -29.72 12.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.718 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 52' ' ' ILE . 47.4 mt -89.36 106.01 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.811 0.338 . . . . 0.0 110.871 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 t -111.91 123.38 50.12 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.724 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 t -95.5 157.33 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -152.87 143.36 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.5 m-90 -116.41 115.02 25.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.09 -76.34 0.58 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.92 -173.41 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -48.94 -42.1 36.19 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.563 0.345 . . . . 0.0 111.818 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -156.57 28.61 0.33 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.228 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.9 t -99.73 141.33 32.68 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.66 132.49 18.01 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -177.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m -98.36 143.68 28.56 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.142 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.411 ' HB2' ' CE2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -106.17 92.78 4.29 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.67 136.83 33.58 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 123.426 0.453 . . . . 0.0 110.745 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.9 mt -134.87 91.0 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -60.46 -111.84 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 118.921 -0.562 . . . . 0.0 111.283 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.55 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.841 1.2 . . . . 0.0 110.923 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.59 136.71 40.5 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.04 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.4 ' N ' HD11 ' A' ' 97' ' ' ILE . 14.2 m-80 -132.86 152.63 51.81 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.127 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.0 pt -51.72 -25.11 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -68.39 -44.49 74.99 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -64.96 -35.47 81.27 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.81 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.79 118.31 2.78 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.43 176.48 39.36 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.064 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.3 mt -82.29 101.82 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.638 0.219 . . . . 0.0 110.892 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -75.35 171.28 14.5 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -132.84 156.5 47.04 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.9 t -140.72 105.73 4.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.296 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.1 t -109.19 144.79 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.39 130.61 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 m -110.17 148.19 32.28 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.22 -178.92 4.91 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.616 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -74.33 -37.69 63.5 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.162 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -81.6 -31.08 32.67 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.422 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.92 -16.58 2.8 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-O 119.856 -0.413 . . . . 0.0 113.281 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 59.3 m -59.0 110.06 0.96 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.328 0.564 . . . . 0.0 111.23 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.65 134.26 55.3 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.146 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.4 t -121.98 133.63 54.82 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -117.25 -178.59 3.49 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.62 173.99 13.5 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.848 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.57 155.92 43.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.564 0.221 . . . . 0.0 110.87 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.84 115.75 6.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.746 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.8 97.36 1.37 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.453 0.471 . . . . 0.0 110.535 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 t -99.92 136.29 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.769 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -125.54 152.41 45.08 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.226 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.4 HD11 ' N ' ' A' ' 70' ' ' ASN . 12.3 mt -139.86 110.77 4.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.357 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.56 125.35 52.44 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.353 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.258 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.453 0.168 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 m -79.11 94.16 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.157 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -173.66 97.18 0.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.301 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -133.33 157.74 44.73 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.591 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -151.87 155.27 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.433 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -160.04 130.33 5.49 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.156 0.285 . . . . 0.0 110.84 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.0 mt -96.25 142.53 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.639 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.89 128.69 24.17 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.38 -176.17 17.06 Favored 'Cis proline' 0 C--N 1.365 1.396 0 CA-C-N 120.084 1.066 . . . . 0.0 112.301 0.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.1 p -76.24 -40.67 51.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.144 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -126.03 124.68 41.19 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.032 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.06 72.53 0.22 Allowed Glycine 0 C--N 1.341 0.86 0 C-N-CA 121.142 -0.551 . . . . 0.0 114.359 -178.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -76.92 112.65 13.76 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 2.9 mp -135.77 164.83 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.7 154.88 17.64 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.8 t -63.06 141.52 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.094 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.86 -11.0 71.86 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.463 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -101.95 153.3 20.0 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.1 p -91.45 156.55 17.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.517 0.199 . . . . 0.0 111.061 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.407 ' HG2' ' HB ' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -151.59 117.39 5.46 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.666 -177.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -112.64 144.11 42.69 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.65 0.262 . . . . 0.0 111.12 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -122.99 118.0 26.78 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.38 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.8 tp -79.26 113.8 17.69 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.403 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 23.2 t -96.6 97.56 9.49 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -92.54 162.86 14.03 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.16 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.1 m -119.31 174.86 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -163.97 98.77 0.86 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.305 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.13 139.72 2.72 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.028 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -96.08 44.9 1.07 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.115 0.483 . . . . 0.0 111.253 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.4 -174.64 1.38 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.627 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.5 -63.95 1.28 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.617 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -129.7 136.9 50.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.537 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -127.63 87.71 2.67 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.051 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -79.93 110.79 15.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.388 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.1 mp -73.84 157.41 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 O-C-N 123.476 0.485 . . . . 0.0 111.36 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.6 m -155.6 162.49 40.63 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.686 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.423 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 56.5 m95 -139.94 126.68 20.56 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.873 0.108 . . . . 0.0 110.942 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 84.2 m-85 -121.98 111.68 17.35 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.76 161.39 53.81 Favored Pre-proline 0 C--O 1.256 1.423 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.384 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -52.24 -15.83 4.13 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 125.298 3.999 . . . . 0.0 115.805 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -78.31 3.66 14.92 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.626 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.82 43.6 14.14 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -158.29 159.71 36.26 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.357 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 9.7 ttpt -84.88 125.87 33.0 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 123.536 0.523 . . . . 0.0 111.425 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.6 mt -74.37 145.67 43.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.548 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.5 m -77.42 162.14 69.9 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.776 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.15 -30.42 65.15 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 122.318 2.012 . . . . 0.0 112.432 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -141.98 75.31 1.49 Allowed 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.01 0.433 . . . . 0.0 111.032 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -76.21 -82.81 0.07 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.827 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -150.15 -72.8 0.17 Allowed 'General case' 0 C--N 1.342 0.277 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 -99.8 -33.36 10.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.504 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.2 mt -88.1 103.3 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.726 0.298 . . . . 0.0 110.779 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.6 t -109.28 122.14 46.7 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.255 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 t -94.34 160.8 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.99 133.99 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -109.58 114.97 29.04 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -113.94 -73.84 0.64 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -171.47 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.84 -36.16 74.1 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.59 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -153.37 23.17 0.54 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.174 -0.467 . . . . 0.0 112.177 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.2 t -109.47 141.18 42.27 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 m -134.36 -173.77 3.37 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.342 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 m -154.91 142.15 19.45 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.011 0.434 . . . . 0.0 111.213 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.423 ' HB2' ' CE2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -109.69 93.84 4.71 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.756 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.33 139.05 31.03 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.363 0.415 . . . . 0.0 110.64 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.407 ' HB ' ' HG2' ' A' ' 20' ' ' LYS . 14.7 mt -135.17 86.46 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -49.49 -65.57 0.54 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -176.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.59 -66.33 0.56 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 75.4 125.96 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.084 0.553 . . . . 0.0 111.37 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -147.16 167.37 24.32 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.4 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.8 pt -55.92 -22.98 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -75.29 -38.25 60.47 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -68.75 -32.96 73.09 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.542 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.95 109.17 0.34 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.06 173.42 45.59 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.742 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.7 mt -79.95 97.1 2.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.978 0.389 . . . . 0.0 110.823 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -72.16 169.32 16.35 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -132.06 154.55 49.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.023 0.44 . . . . 0.0 111.777 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.17 103.47 4.95 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.6 t -108.36 143.33 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.26 147.15 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.07 140.93 52.19 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.933 0.397 . . . . 0.0 111.751 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.24 -171.09 3.39 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.182 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -78.97 -35.62 42.75 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.458 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -88.38 -34.75 17.47 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.01 -18.94 1.22 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.77 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 62.6 m -51.17 114.61 1.25 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.499 0.65 . . . . 0.0 111.148 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -106.71 138.95 41.93 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.99 0.424 . . . . 0.0 111.984 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.0 p -125.97 108.0 10.99 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -104.4 177.91 4.71 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -149.38 169.7 20.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.936 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.66 152.09 37.27 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.999 0.428 . . . . 0.0 111.399 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.0 p -139.72 114.59 7.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.897 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.59 87.58 1.22 Allowed 'General case' 0 C--O 1.235 0.331 0 O-C-N 123.511 0.507 . . . . 0.0 110.34 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.4 t -87.4 130.08 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.396 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -115.46 158.13 22.98 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.815 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 9.5 mt -148.25 135.19 13.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.736 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.91 129.96 52.25 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.561 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.018 -179.776 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.493 0.187 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.97 -37.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.387 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.3 mp -57.69 127.09 30.29 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.97 141.42 47.28 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.468 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.6 t -148.1 144.38 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 123.169 0.293 . . . . 0.0 111.189 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -154.88 148.21 25.02 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.597 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.8 mt -122.29 108.61 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.8 t -92.74 126.41 51.92 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.552 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -83.64 175.31 37.08 Favored 'Cis proline' 0 C--N 1.364 1.353 0 CA-C-N 119.969 1.025 . . . . 0.0 112.21 -0.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.2 p -71.1 -40.23 71.63 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -141.04 118.63 11.59 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.753 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.55 105.63 1.66 Allowed Glycine 0 C--N 1.343 0.934 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.974 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.73 130.71 34.49 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mp -146.71 164.96 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.09 157.66 17.38 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.842 0.353 . . . . 0.0 110.507 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.4 t -62.07 141.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.164 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.06 -7.38 81.57 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.356 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -104.78 152.0 23.1 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 76.6 p -92.58 155.66 17.63 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.576 0.227 . . . . 0.0 110.888 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.405 ' CE ' HD12 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -154.8 119.58 4.87 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.949 -178.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -112.47 147.77 35.81 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.913 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -124.75 118.77 27.16 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.196 0.522 . . . . 0.0 111.32 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.8 130.57 36.86 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.813 -178.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.0 t -114.48 98.46 6.91 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -88.87 157.69 18.35 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.849 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.7 m -137.89 169.9 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.8 125.68 3.69 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.47 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 153.48 -168.55 32.13 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.638 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -168.87 33.55 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.652 0.263 . . . . 0.0 111.358 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.98 84.43 6.97 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.724 0.297 . . . . 0.0 110.479 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.11 -174.33 0.07 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.901 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -60.75 136.87 58.2 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.616 0.246 . . . . 0.0 111.319 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.41 152.52 24.57 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.145 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -135.28 106.21 6.62 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.55 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.1 mp -72.13 147.99 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.925 0.393 . . . . 0.0 110.994 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.9 m -147.06 154.49 41.24 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.318 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.413 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 43.3 m95 -129.59 113.86 15.34 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.062 0.145 . . . . 0.0 111.24 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -113.35 110.96 21.2 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 p -59.73 154.23 47.95 Favored Pre-proline 0 C--O 1.244 0.809 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.472 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -33.26 -74.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 125.252 3.968 . . . . 0.0 113.779 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.83 36.72 4.06 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.38 -18.69 4.44 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.464 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 71.13 -171.45 0.16 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 117.815 0.808 . . . . 0.0 109.057 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -56.22 104.31 0.14 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 pp -80.55 148.69 30.26 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.203 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.7 m -67.46 155.47 90.92 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.33 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -83.96 -22.11 3.66 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 122.522 2.148 . . . . 0.0 113.388 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -139.4 73.39 1.43 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.282 0.563 . . . . 0.0 110.328 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -104.94 -57.38 2.03 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.924 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.51 -83.76 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.79 -32.54 11.67 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.6 mt -90.47 107.56 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 120.662 0.267 . . . . 0.0 110.374 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.8 t -112.77 121.63 45.27 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.587 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 t -92.82 159.9 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.6 p -156.22 147.13 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -125.84 123.01 37.74 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.101 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.55 -73.94 0.63 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.2 -173.14 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -53.71 -40.28 65.9 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.663 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -152.6 22.91 0.61 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.948 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.75 141.31 31.72 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.8 m -135.28 -170.56 2.62 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.055 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -159.24 142.05 14.18 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.664 0.269 . . . . 0.0 110.697 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.413 ' HB2' ' CE2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -113.15 92.76 4.12 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.902 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.79 138.88 31.23 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.269 0.355 . . . . 0.0 110.131 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 40.5 mt -135.22 82.12 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -49.36 -56.81 8.29 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -176.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -71.06 -71.69 0.24 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 81.12 120.97 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.501 0.721 . . . . 0.0 110.679 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.7 159.99 41.1 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.267 0.556 . . . . 0.0 110.564 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 30.3 pt -51.01 -25.84 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -75.14 -39.83 60.13 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -64.46 -32.55 74.23 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.929 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.51 106.22 0.17 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.92 178.64 48.65 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.869 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 mp -79.21 100.49 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.915 0.357 . . . . 0.0 110.816 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -72.14 172.73 9.63 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -135.3 157.5 46.75 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 6.4 t -141.18 97.93 3.27 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.634 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.5 t -104.24 132.54 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -112.29 139.96 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.68 132.91 49.61 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.5 -176.06 5.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.441 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -72.26 -52.78 14.8 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.158 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -63.77 -29.33 70.55 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.86 0.85 5.99 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.59 -0.561 . . . . 0.0 114.225 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.8 m -65.95 113.74 4.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.807 0.804 . . . . 0.0 110.019 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -105.46 145.64 30.59 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.873 0.368 . . . . 0.0 111.658 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.7 107.41 4.45 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -109.01 -179.28 3.81 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -151.49 176.11 11.63 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.193 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -147.13 155.89 42.53 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.633 0.254 . . . . 0.0 111.138 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.9 p -139.6 117.81 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.205 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -71.6 93.32 1.22 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.814 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.6 t -95.48 116.59 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.621 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -101.91 150.33 23.3 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.292 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.405 HD12 ' CE ' ' A' ' 20' ' ' LYS . 8.5 mt -141.59 130.93 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.221 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -117.77 129.12 55.49 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.028 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.191 -179.547 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.567 0.222 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.2 85.28 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.541 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.4 mt -150.43 68.85 0.98 Allowed 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.157 0.503 . . . . 0.0 110.649 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.21 139.51 31.6 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.545 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.6 t -145.78 135.02 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 123.419 0.449 . . . . 0.0 110.105 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -154.34 121.73 5.75 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.628 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.4 mt -89.74 138.94 18.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.35 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.4 t -122.96 129.4 24.99 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.086 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.63 166.61 77.35 Favored 'Cis proline' 0 C--N 1.364 1.362 0 CA-C-N 119.655 0.913 . . . . 0.0 112.105 -0.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 p -64.06 -41.17 97.46 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.133 0.492 . . . . 0.0 109.92 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -133.96 110.81 9.93 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.755 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.8 102.01 1.52 Allowed Glycine 0 C--N 1.341 0.859 0 C-N-CA 121.008 -0.615 . . . . 0.0 114.44 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -87.82 134.93 33.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 4.4 mp -146.48 163.64 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.653 0.263 . . . . 0.0 110.47 -178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.21 154.58 18.64 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.09 138.27 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.95 -7.91 78.52 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.522 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -103.03 155.82 18.11 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 117.49 0.645 . . . . 0.0 109.418 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.2 p -92.95 159.46 15.32 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 123.081 0.238 . . . . 0.0 110.784 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.24 119.99 4.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.662 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -114.72 140.24 49.03 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.506 0.193 . . . . 0.0 110.795 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -117.12 110.64 18.43 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.312 0.577 . . . . 0.0 110.512 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.0 tp -79.03 107.16 11.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.206 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.8 t -89.79 106.3 18.38 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.041 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -95.17 165.5 12.37 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.725 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.9 m -141.95 173.23 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.83 91.04 1.03 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.017 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -179.8 134.26 2.21 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.296 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.91 40.05 2.0 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 120.923 0.392 . . . . 0.0 110.649 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.58 87.27 2.68 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.822 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.77 -90.67 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.789 0.836 . . . . 0.0 113.043 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -127.96 138.73 52.74 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -130.59 164.34 25.14 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.888 0.375 . . . . 0.0 111.771 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -137.73 166.05 24.92 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.124 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.1 mp -126.93 150.29 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 123.245 0.341 . . . . 0.0 110.865 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 57.6 m -147.81 162.82 38.47 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.024 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.401 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 56.5 m95 -138.46 134.58 34.2 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 75.6 m-85 -129.18 115.73 18.12 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.0 p -65.1 154.57 86.56 Favored Pre-proline 0 C--O 1.253 1.266 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.974 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -53.23 -12.94 2.71 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 124.97 3.78 . . . . 0.0 115.59 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -77.33 -0.05 24.1 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.164 0.438 . . . . 0.0 111.611 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.1 39.74 7.83 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -156.47 170.51 22.16 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.129 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 9.0 tttm -85.07 162.32 19.35 Favored 'General case' 0 C--N 1.341 0.23 0 O-C-N 123.729 0.643 . . . . 0.0 111.382 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.01 135.09 53.97 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.472 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.72 171.75 11.07 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.783 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.52 -39.12 2.13 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 122.651 2.234 . . . . 0.0 112.623 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -142.36 74.11 1.44 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.134 0.492 . . . . 0.0 111.613 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.69 -48.77 3.85 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -146.51 -155.6 0.64 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -24.29 3.86 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.3 mt -78.92 113.92 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.867 0.365 . . . . 0.0 111.046 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.9 t -118.0 117.96 30.64 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.572 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 t -93.99 158.81 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 p -156.48 156.74 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 16.1 m-90 -129.99 118.93 22.36 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.58 -77.07 0.57 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -54.53 -177.72 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -51.65 -37.85 52.16 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -155.25 26.08 0.41 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.078 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.4 t -107.97 140.95 40.36 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 m -130.04 -171.72 2.6 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 m -155.23 138.11 15.38 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.401 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -108.31 91.53 3.68 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.284 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.9 146.95 26.49 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 49.6 mt -145.46 91.19 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -56.43 -107.18 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.096 0 O-C-N 123.721 0.638 . . . . 0.0 111.63 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.98 93.42 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.892 1.223 . . . . 0.0 110.335 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.25 159.85 30.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.205 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -152.36 162.89 40.52 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.26 0.552 . . . . 0.0 111.323 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 27.4 pt -55.39 -26.4 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.791 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -69.84 -40.51 75.78 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.281 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.02 -32.31 73.43 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.426 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.54 106.33 0.2 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.49 173.44 44.63 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.2 mt -78.42 98.04 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.812 0.306 . . . . 0.0 111.262 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -72.37 173.25 9.01 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 155.68 50.25 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 47.3 t -136.44 96.18 3.31 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.7 t -101.28 126.74 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.954 0.407 . . . . 0.0 111.557 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.3 t -106.72 147.85 11.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -127.76 150.7 49.69 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.05 -178.39 5.43 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.865 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -72.08 -34.6 68.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.343 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -90.33 -39.37 12.76 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.491 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.38 -25.17 0.28 Allowed Glycine 0 C--N 1.34 0.8 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.885 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.5 m -55.14 108.1 0.38 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 117.387 0.593 . . . . 0.0 111.99 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -113.1 136.5 52.64 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.8 t -119.89 117.65 28.69 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -105.53 -179.41 3.93 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.63 174.65 13.71 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.532 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.27 155.36 43.81 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.576 0.227 . . . . 0.0 111.251 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.8 p -138.57 116.51 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.119 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -72.83 98.43 2.43 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 123.416 0.447 . . . . 0.0 110.763 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.4 t -98.35 124.5 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.238 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -109.31 152.64 24.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.928 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 9.1 mt -146.67 139.27 19.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.071 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.99 133.03 29.5 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.729 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.171 -0.919 . . . . 0.0 111.016 179.97 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.527 0.204 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.7 m -135.21 109.43 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.067 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 tp -168.39 94.48 0.37 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -118.28 144.83 45.51 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.772 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -145.69 143.74 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.626 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -160.19 131.62 5.9 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.3 mt -104.06 136.99 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.727 0.299 . . . . 0.0 110.768 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.61 130.97 24.44 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.059 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.81 170.27 69.93 Favored 'Cis proline' 0 C--N 1.364 1.386 0 CA-C-N 119.549 0.875 . . . . 0.0 112.07 -0.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 p -67.67 -44.02 78.82 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.102 0.477 . . . . 0.0 109.819 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -131.26 105.47 7.67 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.76 97.33 1.51 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 121.156 -0.545 . . . . 0.0 114.331 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -83.92 131.13 34.88 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 mp -141.69 165.0 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 123.049 0.218 . . . . 0.0 110.701 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.83 153.61 22.75 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.098 0.475 . . . . 0.0 110.848 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -66.36 134.84 29.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.344 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.97 -15.83 56.37 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.228 -177.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -115.86 149.24 38.95 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 117.661 0.73 . . . . 0.0 110.098 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.8 p -78.13 174.71 10.86 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.406 ' CG ' ' HB ' ' A' ' 66' ' ' ILE . 1.3 ptmm? -165.34 118.37 1.19 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.965 -177.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -117.93 147.18 43.39 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.7 0.286 . . . . 0.0 111.13 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -123.83 112.72 17.63 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.869 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.4 tp -79.21 112.97 16.95 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.5 t -95.2 100.48 12.27 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.71 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -92.28 160.45 15.13 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.8 m -139.99 165.71 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.76 104.19 3.71 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.232 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 154.74 144.75 3.99 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.955 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -113.23 64.1 0.64 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.5 0.666 . . . . 0.0 110.209 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.53 40.16 1.14 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.491 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.37 -85.51 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -41.78 -40.02 1.91 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp 1.4 70.38 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.51 111.46 22.38 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.173 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.4 mp -71.08 156.36 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 123.493 0.496 . . . . 0.0 111.657 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.2 m -152.76 160.13 43.12 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.727 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -137.4 118.69 14.61 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.143 0.177 . . . . 0.0 110.662 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 96.5 m-85 -112.63 113.03 24.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 80.3 p -63.28 150.67 88.77 Favored Pre-proline 0 C--O 1.245 0.834 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.043 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -41.96 -22.06 0.18 Allowed 'Trans proline' 0 C--N 1.38 2.222 1 C-N-CA 125.397 4.065 . . . . 0.0 115.927 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -80.1 12.16 3.0 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.29 39.71 81.54 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -154.5 135.74 14.02 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 120.074 -0.65 . . . . 0.0 112.718 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 5.1 ttpt -60.01 136.04 57.89 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.978 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.0 pp -103.14 141.12 36.4 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.96 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m -75.61 158.03 83.57 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.799 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -90.04 19.65 1.17 Allowed 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.592 2.195 . . . . 0.0 113.8 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -155.73 34.26 0.35 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.735 0.303 . . . . 0.0 111.034 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -69.14 -70.4 0.28 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.696 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -154.89 -78.62 0.09 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -100.08 -35.11 9.8 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.717 0.407 . . . . 0.0 111.734 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.1 mt -78.02 97.82 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 123.224 0.328 . . . . 0.0 110.714 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 t -108.65 122.48 47.2 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.797 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.81 159.88 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 p -154.63 136.22 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.166 0.508 . . . . 0.0 111.634 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -109.91 110.59 21.59 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -100.63 -76.19 0.56 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -175.37 0.11 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.35 0.119 . . . . 0.0 110.972 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -57.16 -36.61 70.97 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.26 0.224 . . . . 0.0 111.519 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -145.74 16.22 1.43 Allowed 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 p -102.44 141.01 35.96 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.9 m -135.88 -168.52 2.23 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.891 -0.141 . . . . 0.0 110.902 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.7 m -157.91 140.95 15.05 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.893 0.378 . . . . 0.0 110.779 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.49 91.2 3.55 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.36 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.87 142.86 27.74 Favored 'General case' 0 C--N 1.333 -0.135 0 O-C-N 123.463 0.477 . . . . 0.0 109.793 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.406 ' HB ' ' CG ' ' A' ' 20' ' ' LYS . 60.1 mt -141.19 94.84 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -60.64 -111.95 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.157 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.0 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.089 1.313 . . . . 0.0 110.699 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.6 153.06 33.6 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.367 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -149.99 161.4 42.41 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.493 0.663 . . . . 0.0 111.202 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.7 pt -55.48 -23.55 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.198 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -71.36 -41.28 69.94 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.44 -34.42 77.17 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.83 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.25 114.54 1.24 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.84 174.06 42.07 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.11 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.9 mt -81.81 100.54 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.734 0.267 . . . . 0.0 110.418 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -75.67 171.77 13.76 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -134.76 157.73 45.96 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.885 0.374 . . . . 0.0 111.885 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.7 t -140.14 113.14 8.22 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.7 t -119.08 137.93 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.902 0.382 . . . . 0.0 111.94 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.9 134.89 64.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.0 m -115.48 150.07 37.07 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.78 -175.01 2.94 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.296 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -71.24 -57.84 4.11 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.389 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.34 -28.65 70.15 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.46 -10.03 4.05 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 119.568 -0.573 . . . . 0.0 113.743 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 38.3 m -62.11 107.04 0.81 Allowed 'General case' 0 C--N 1.345 0.394 0 CA-C-N 117.793 0.796 . . . . 0.0 110.938 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -121.9 130.12 53.1 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.182 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.6 t -102.47 177.39 4.88 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -154.53 179.2 9.26 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -158.25 171.56 19.98 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.284 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.6 155.1 42.22 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.737 0.303 . . . . 0.0 111.17 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.57 116.54 7.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.693 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -70.8 96.86 1.3 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.8 t -99.21 129.67 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.597 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.5 155.25 31.16 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.096 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.6 mt -147.93 125.37 3.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.646 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.42 137.08 53.99 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.284 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.072 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.5 m -159.79 52.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.229 0.538 . . . . 0.0 110.36 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 mp -143.38 142.17 31.17 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.65 142.65 23.97 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.417 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.4 t -148.02 141.35 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 123.15 0.281 . . . . 0.0 110.452 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -159.62 124.84 4.09 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.367 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.2 mt -91.77 141.33 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.892 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.8 t -126.74 128.27 24.3 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.146 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -79.11 173.88 53.36 Favored 'Cis proline' 0 C--N 1.365 1.44 0 CA-C-N 119.885 0.995 . . . . 0.0 112.076 -0.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 93.6 p -71.36 -47.21 57.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.621 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -128.52 102.83 6.8 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.08 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.02 99.27 1.68 Allowed Glycine 0 C--N 1.341 0.807 0 CA-C-N 116.202 -0.453 . . . . 0.0 114.19 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -83.24 143.56 30.35 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 1.2 mp -150.32 158.57 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.692 0.282 . . . . 0.0 111.192 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.72 152.63 20.25 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.1 t -68.11 127.45 29.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.29 -14.16 25.7 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.841 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -115.21 145.41 42.44 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 117.506 0.653 . . . . 0.0 110.286 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.6 p -81.7 171.53 14.47 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.02 120.98 1.7 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.584 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -114.21 143.59 44.59 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.626 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -119.63 115.72 24.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.059 0.457 . . . . 0.0 111.214 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp -79.43 111.62 15.87 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.3 t -92.32 102.14 14.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.101 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -90.88 163.0 14.55 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.581 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.6 m -138.94 172.88 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -162.06 165.23 27.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.417 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.59 -133.97 7.89 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.405 -0.426 . . . . 0.0 112.342 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -174.13 34.01 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.644 0.259 . . . . 0.0 111.639 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.66 -171.76 2.98 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -124.75 -25.6 3.93 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -97.72 -32.47 11.73 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt 1.26 69.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -78.26 156.28 29.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.667 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 27.2 mm -114.27 151.91 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 120.749 0.309 . . . . 0.0 111.164 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 m -151.37 156.71 41.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.69 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.402 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 67.3 m95 -134.74 131.46 37.64 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.394 0.278 . . . . 0.0 111.272 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 94.8 m-85 -120.71 117.81 28.44 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.0 p -69.42 150.6 97.01 Favored Pre-proline 0 C--O 1.25 1.105 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.882 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -43.91 -20.79 0.29 Allowed 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 124.932 3.755 . . . . 0.0 116.062 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -79.85 12.14 2.86 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.33 39.67 81.13 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 111.819 -0.512 . . . . 0.0 111.819 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -153.25 133.93 13.78 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.43 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 36.7 tttt -54.65 118.91 4.59 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.02 132.27 36.58 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.153 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.97 162.37 74.88 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.762 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -75.92 -28.8 7.41 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 122.719 2.279 . . . . 0.0 112.221 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -138.31 77.42 1.63 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.22 0.533 . . . . 0.0 109.85 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.07 -58.89 1.53 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.348 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -140.27 -160.57 1.09 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -50.6 -26.65 5.59 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.4 mt -83.68 96.89 4.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.67 0.271 . . . . 0.0 110.825 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.0 t -94.14 169.77 10.01 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.505 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 t -141.9 159.7 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.46 137.89 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.248 0.547 . . . . 0.0 112.221 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 17.4 m-90 -115.1 113.96 24.7 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.82 -77.82 0.59 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -57.65 -177.44 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -56.53 -35.48 68.14 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -149.03 22.32 0.97 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 t -109.19 138.73 45.09 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.1 m -132.26 -170.64 2.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 m -158.24 137.88 12.0 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.715 0.293 . . . . 0.0 110.837 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.402 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -109.37 93.79 4.69 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.752 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.59 143.12 29.49 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.4 0.438 . . . . 0.0 110.245 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.9 mt -140.28 91.36 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -59.86 -112.8 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 O-C-N 123.641 0.588 . . . . 0.0 111.581 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.9 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.726 1.148 . . . . 0.0 110.921 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.13 146.0 41.73 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.414 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.21 159.01 43.4 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.322 0.582 . . . . 0.0 110.454 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.7 pt -51.75 -26.13 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -42.87 74.03 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -66.21 -34.3 77.72 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.736 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.27 107.04 0.2 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.73 179.25 46.16 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.249 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.2 mm -83.13 92.41 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -68.39 165.6 18.43 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -129.94 155.66 45.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.248 0.547 . . . . 0.0 111.925 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 8.9 t -139.23 94.52 2.81 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 t -101.36 135.91 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.174 0.512 . . . . 0.0 112.203 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 t -118.16 157.13 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.221 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 m -135.07 150.64 50.29 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.57 -179.62 4.26 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.337 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -71.05 -46.4 62.06 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.75 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.91 -29.62 58.49 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.557 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 141.37 -10.34 2.72 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-O 119.561 -0.577 . . . . 0.0 113.828 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.2 m -59.46 108.43 0.71 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.97 0.885 . . . . 0.0 111.064 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -105.22 135.57 46.33 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.376 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.6 t -122.97 110.92 15.99 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -106.45 178.93 4.42 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -157.43 179.5 9.19 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.203 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.39 157.71 41.64 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.775 0.321 . . . . 0.0 111.538 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.61 121.52 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.607 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.01 98.21 5.64 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.684 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.3 t -102.84 122.65 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.352 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -108.41 159.71 16.45 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.808 0.337 . . . . 0.0 111.145 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 11.3 mt -149.1 123.03 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.597 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.36 130.71 53.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.104 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.224 -0.894 . . . . 0.0 110.973 -179.76 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.846 0.355 . . . . 0.0 111.054 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.3 m -92.2 94.49 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.98 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -171.34 93.18 0.16 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.005 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -129.53 152.45 49.04 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.868 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -152.5 148.76 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.415 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -159.68 130.41 5.79 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.827 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.7 mt -95.13 133.86 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.277 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.5 t -116.31 126.17 27.84 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 119.266 -0.397 . . . . 0.0 109.977 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.47 -176.34 16.64 Favored 'Cis proline' 0 C--N 1.366 1.473 0 CA-C-N 119.993 1.033 . . . . 0.0 112.343 -0.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.8 p -77.77 -46.85 20.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.297 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -131.92 111.29 11.43 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.14 103.04 1.63 Allowed Glycine 0 C--N 1.34 0.766 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.962 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -84.65 134.06 34.38 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.463 HG21 ' HG3' ' A' ' 18' ' ' GLU . 1.7 mp -143.94 162.4 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.154 0.502 . . . . 0.0 111.618 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.29 150.09 23.35 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.503 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 51.8 t -66.25 131.77 31.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.88 -15.25 44.69 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.149 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.463 ' HG3' HG21 ' A' ' 14' ' ' ILE . 4.3 pt-20 -116.14 147.26 41.55 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 117.625 0.712 . . . . 0.0 110.11 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 93.5 p -79.49 173.7 12.32 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.26 121.68 1.02 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.996 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -113.69 152.35 30.58 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -129.64 119.18 23.14 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.17 0.509 . . . . 0.0 112.152 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.68 109.67 13.12 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -177.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.439 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 44.8 t -89.5 88.17 7.34 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -81.17 158.78 24.81 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.17 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.5 m -129.43 167.97 23.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.516 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.54 103.89 1.23 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.248 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 164.04 126.66 0.83 Allowed Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.634 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -90.61 48.32 1.53 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.05 0.453 . . . . 0.0 111.542 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.14 -173.89 2.55 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.353 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -77.61 -28.63 51.56 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.286 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.71 161.43 11.22 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.682 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.3 86.22 1.22 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.361 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -69.55 109.62 4.37 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.504 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.4 mp -75.24 157.13 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.991 0.425 . . . . 0.0 111.507 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.7 m -155.48 160.79 40.86 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.484 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.439 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 46.1 m95 -136.11 115.07 12.23 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.245 0.091 . . . . 0.0 111.245 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -111.74 116.24 30.4 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.0 p -61.7 152.5 75.08 Favored Pre-proline 0 C--O 1.246 0.908 0 CA-C-O 119.092 -0.48 . . . . 0.0 110.135 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -29.52 -73.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.24 1 C-N-CA 125.655 4.237 . . . . 0.0 114.133 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.82 35.46 4.88 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.23 -17.96 5.59 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.187 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 75.23 -176.27 0.14 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 117.788 0.794 . . . . 0.0 109.438 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -52.44 102.41 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 pp -76.97 156.01 32.25 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.953 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 m -78.29 159.18 75.7 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.079 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.75 -35.69 1.4 Allowed 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 122.618 2.212 . . . . 0.0 112.289 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -125.11 68.59 1.12 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.404 0.621 . . . . 0.0 110.124 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.29 -53.06 2.73 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.412 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -145.97 -157.48 0.8 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -51.08 -24.28 3.81 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.451 HD11 HG22 ' A' ' 52' ' ' ILE . 53.1 mt -82.82 104.94 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 120.704 0.288 . . . . 0.0 110.574 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.3 t -108.55 122.67 47.55 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.073 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.6 t -94.19 159.85 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.701 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.0 p -151.42 155.31 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.777 0.323 . . . . 0.0 111.537 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 -132.86 112.14 11.66 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -106.49 -79.47 0.57 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.28 -174.19 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -51.96 -40.65 61.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.676 0.39 . . . . 0.0 111.922 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -148.9 21.55 0.99 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.103 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 p -99.76 141.34 32.7 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.1 m -136.22 -172.88 3.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.293 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.3 m -157.52 145.51 18.98 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.905 0.383 . . . . 0.0 110.754 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -115.34 93.65 4.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.392 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.81 140.66 29.48 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 123.497 0.498 . . . . 0.0 109.95 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.1 mt -137.01 95.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -61.42 -115.75 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.361 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -53.13 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.846 1.203 . . . . 0.0 111.197 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.46 147.44 41.96 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.394 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -143.31 152.26 41.45 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.828 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.5 pt -51.3 -24.43 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 112.702 0.631 . . . . 0.0 112.702 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.22 -44.33 75.97 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -65.8 -35.4 80.6 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.677 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.26 102.23 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.79 172.61 45.39 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.762 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.5 mt -77.17 94.02 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.783 0.292 . . . . 0.0 111.289 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -65.59 177.04 1.29 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.412 ' O ' ' CE3' ' A' ' 37' ' ' TRP . 8.3 ttmt -139.54 155.4 47.53 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 120.74 0.305 . . . . 0.0 111.633 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.34 102.78 4.29 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.06 140.51 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.83 139.49 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.19 146.09 48.91 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.14 -174.43 4.66 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.968 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -76.74 -35.06 58.02 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.514 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -86.49 -37.97 17.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.498 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.74 -24.3 0.63 Allowed Glycine 0 C--N 1.34 0.758 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.369 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.9 m -55.38 107.96 0.37 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.247 0.523 . . . . 0.0 111.492 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -116.87 134.61 54.55 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.551 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.4 t -114.37 121.55 43.95 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -107.35 -178.14 3.55 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.88 174.54 12.98 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.256 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.84 155.54 38.38 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 123.119 0.262 . . . . 0.0 110.781 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.89 114.58 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.172 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -71.2 94.15 1.14 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.86 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.8 t -96.2 113.69 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -98.67 157.11 16.47 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.729 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.426 HG23 HD11 ' A' ' 97' ' ' ILE . 13.3 mt -146.64 143.6 20.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.107 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.42 131.69 14.55 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.752 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.898 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 111.408 0.151 . . . . 0.0 111.408 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.74 58.63 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.302 0.572 . . . . 0.0 110.843 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.24 122.05 9.94 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.586 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.5 140.18 37.15 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.308 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.5 t -145.23 140.41 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.058 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -160.49 125.78 3.88 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.488 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.9 mt -95.52 137.6 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.688 0.28 . . . . 0.0 110.833 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.93 130.1 24.54 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.807 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.25 168.91 75.98 Favored 'Cis proline' 0 C--N 1.365 1.406 0 CA-C-N 119.704 0.93 . . . . 0.0 112.042 0.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 p -67.39 -44.59 78.51 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.761 0.315 . . . . 0.0 110.415 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -133.54 107.17 7.84 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.585 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.35 160.46 36.36 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.266 -0.492 . . . . 0.0 114.196 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -154.77 103.78 2.46 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.9 mp -128.42 161.85 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.658 0.266 . . . . 0.0 111.178 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.01 153.1 17.79 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.86 139.84 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.29 -19.33 55.0 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.774 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -96.72 160.84 14.16 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 91.8 p -96.08 162.52 13.51 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.06 115.15 3.79 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.601 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -111.22 140.38 45.83 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.583 0.23 . . . . 0.0 110.956 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -117.81 114.63 23.56 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.052 0.454 . . . . 0.0 110.807 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.2 tp -79.99 110.51 15.44 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.3 t -92.67 97.1 10.58 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.465 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -87.33 163.93 16.54 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.7 m -147.43 175.91 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.1 129.16 6.48 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.608 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 135.69 147.0 5.38 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 121.364 -0.446 . . . . 0.0 112.583 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -121.06 55.81 1.04 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.38 0.61 . . . . 0.0 110.364 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.45 68.43 7.85 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.404 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.8 mptt 61.29 -87.98 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.814 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -122.72 140.26 53.07 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.375 0.27 . . . . 0.0 110.765 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.22 90.15 3.18 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.204 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -73.74 153.91 39.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.247 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.4 mp -125.71 144.55 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 123.368 0.418 . . . . 0.0 111.204 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 m -144.04 149.94 37.43 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.088 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.416 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 52.5 m95 -125.85 122.3 35.72 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.305 0.242 . . . . 0.0 111.133 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -119.52 112.7 19.69 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.5 m -55.88 150.45 28.27 Favored Pre-proline 0 C--O 1.244 0.814 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.365 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -31.57 -73.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.242 1 C-N-CA 125.499 4.133 . . . . 0.0 113.634 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -120.46 37.06 4.37 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.8 -17.34 5.54 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.074 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 72.88 -174.99 0.16 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 117.807 0.804 . . . . 0.0 109.168 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -53.63 110.21 0.54 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 pp -84.26 143.05 29.82 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.142 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.5 m -66.41 150.18 97.37 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.215 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.24 -14.72 13.13 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.472 2.115 . . . . 0.0 113.701 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -136.42 37.24 2.71 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.87 0.367 . . . . 0.0 110.976 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.15 -75.2 0.07 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.736 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -151.8 -75.35 0.14 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.603 0.24 . . . . 0.0 111.12 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -99.66 -31.34 11.62 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.4 mt -89.18 104.82 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 t -108.48 120.39 42.29 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.1 t -93.93 154.03 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.2 m -150.9 173.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.337 0.589 . . . . 0.0 112.421 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -141.82 120.17 12.32 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.97 -82.52 0.54 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -42.04 -64.47 0.58 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 179.49 -44.09 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.382 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -114.71 -35.8 4.73 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.329 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.6 t -65.53 136.91 56.99 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.048 0.452 . . . . 0.0 111.099 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.7 m -122.76 -173.62 2.74 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.81 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.0 m -156.57 130.73 8.56 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.87 0.366 . . . . 0.0 111.04 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.416 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -101.42 93.05 5.2 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.944 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.18 139.1 30.84 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 123.254 0.346 . . . . 0.0 110.323 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 44.9 mt -135.39 85.02 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -50.29 -59.56 3.84 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -176.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -63.96 -65.6 0.66 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 73.98 118.82 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.051 0.54 . . . . 0.0 110.869 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.39 164.64 30.88 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.706 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 34.5 pt -54.85 -27.07 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -73.51 -36.53 65.76 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -68.13 -33.75 75.07 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.597 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.77 117.18 2.96 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.42 176.69 40.06 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.52 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.7 mm -75.99 89.61 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 122.283 0.233 . . . . 0.0 111.435 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -66.85 171.66 5.13 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -131.87 155.79 47.22 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 11.9 t -142.48 88.43 2.07 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.759 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.4 t -96.25 126.22 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.078 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.88 157.91 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.5 m -139.48 148.74 43.11 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.56 -177.18 3.84 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.552 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -71.31 -54.2 11.65 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.121 0.263 . . . . 0.0 111.068 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.7 -31.12 70.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.621 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 141.73 -10.47 2.63 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.603 -0.554 . . . . 0.0 113.978 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.5 m -58.55 104.65 0.23 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 117.902 0.851 . . . . 0.0 111.173 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -102.31 136.1 42.74 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.847 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.6 t -128.43 109.89 11.82 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -101.47 179.43 4.36 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -153.62 175.89 12.7 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.916 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.05 155.18 36.37 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.7 p -139.89 120.87 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.668 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -76.5 84.88 3.21 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.337 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.6 t -84.07 138.5 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.511 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -124.97 156.84 37.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.471 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.425 HG22 HD11 ' A' ' 97' ' ' ILE . 9.6 mt -148.7 140.38 17.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.775 177.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -127.27 128.53 46.14 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.273 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.994 -179.589 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 11.8 ttm-85 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.395 0.141 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.7 m -156.58 58.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.362 0.601 . . . . 0.0 110.895 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mp -151.03 133.72 15.67 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.862 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.84 151.25 31.98 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.113 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 t -150.56 144.59 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.606 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -157.07 130.59 8.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.429 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.7 mt -107.91 120.46 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.143 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t -105.64 130.07 23.64 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -81.93 173.49 48.03 Favored 'Cis proline' 0 C--N 1.367 1.545 0 CA-C-N 119.882 0.994 . . . . 0.0 112.282 -0.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 76.1 p -69.27 -41.48 76.81 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -137.2 109.77 7.48 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.649 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.92 98.73 1.7 Allowed Glycine 0 C--N 1.343 0.937 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.927 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -83.09 126.48 32.62 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mp -140.45 164.5 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 123.21 0.319 . . . . 0.0 110.389 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.57 156.28 18.1 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.7 t -63.07 141.07 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.09 -11.58 71.71 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.301 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -101.67 150.09 23.47 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 117.33 0.565 . . . . 0.0 109.536 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.3 p -90.45 164.46 14.27 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.62 129.47 3.6 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.996 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 28.9 p90 -120.77 157.96 28.58 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.2 0.313 . . . . 0.0 110.732 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -133.36 120.35 20.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.68 117.27 19.67 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 t -102.07 96.37 6.96 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.626 0.251 . . . . 0.0 111.148 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -93.62 162.19 14.05 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.94 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.7 m -137.93 152.93 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.0 163.55 28.15 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.57 -124.31 6.24 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -166.32 -82.16 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 45.82 -160.16 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 122.92 0.488 . . . . 0.0 112.255 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.48 -51.61 0.26 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -64.28 -36.86 85.49 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt 1.61 85.18 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 10.9 m-20 -104.19 108.81 20.36 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.199 -179.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.5 mm -65.5 152.44 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.459 0.647 . . . . 0.0 111.653 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.4 m -147.23 161.25 41.31 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.022 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -138.69 109.41 6.65 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 119.632 -0.223 . . . . 0.0 110.616 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -110.75 111.04 21.95 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 p -60.02 154.07 51.92 Favored Pre-proline 0 C--O 1.243 0.722 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.388 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -34.15 -73.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 125.105 3.87 . . . . 0.0 113.704 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.62 38.53 3.42 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -123.0 -18.63 3.12 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.592 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 69.01 -172.16 0.18 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 117.909 0.855 . . . . 0.0 108.911 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -53.27 115.63 2.0 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.48 153.94 18.19 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.056 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 m -78.2 164.37 57.01 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.334 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.43 -25.4 2.6 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 122.816 2.344 . . . . 0.0 113.42 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -129.42 22.4 5.57 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.58 -59.02 3.68 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -137.63 -159.83 1.0 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.24 0.216 . . . . 0.0 110.574 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 mtm-85 -51.35 -22.8 3.13 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.46 HG22 HD11 ' A' ' 52' ' ' ILE . 52.6 mt -84.59 105.78 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.7 t -111.65 115.28 28.86 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.337 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.9 t -85.83 150.88 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.452 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -143.43 139.21 26.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 CA-C-O 120.75 0.31 . . . . 0.0 111.286 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 24.5 m-90 -109.18 107.49 17.79 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -92.37 -77.84 0.43 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -72.43 -178.6 2.62 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.494 -0.188 . . . . 0.0 110.494 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.82 -35.85 69.26 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -134.84 5.7 3.38 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 p -100.56 137.34 39.09 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.999 0.363 . . . . 0.0 110.317 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.02 136.82 20.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.52 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.0 m -108.85 139.34 43.82 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.842 0.353 . . . . 0.0 111.787 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 21' ' ' PHE . 27.8 tp -94.85 113.67 25.44 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.36 141.42 31.27 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.7 mt -138.0 90.78 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -59.94 -110.97 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.657 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.2 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.794 1.179 . . . . 0.0 111.063 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.47 148.06 48.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.674 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -140.98 153.56 45.64 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.276 0.56 . . . . 0.0 110.901 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.2 pt -54.3 -23.94 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.81 -41.24 68.47 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -66.67 -34.81 78.69 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.704 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.61 99.63 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.76 176.23 46.31 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.528 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.2 mt -80.24 101.16 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.877 0.339 . . . . 0.0 111.701 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -71.37 172.37 9.54 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -135.51 157.95 45.6 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 2.9 t -143.13 118.6 10.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.341 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.7 t -126.54 133.03 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER -115.24 129.58 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 m -110.73 148.25 32.69 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.95 173.06 7.48 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.091 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.0 -46.32 78.43 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.195 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -71.97 -28.24 63.3 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.632 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.31 -12.31 4.36 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 119.899 -0.389 . . . . 0.0 113.521 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.8 m -60.82 108.05 0.79 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 117.455 0.627 . . . . 0.0 111.278 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -119.75 132.43 55.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.762 0.315 . . . . 0.0 111.288 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.2 t -114.71 125.35 53.62 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -105.02 -177.71 3.44 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -158.28 172.38 18.48 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.004 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.86 156.46 41.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.69 0.281 . . . . 0.0 111.375 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -144.63 115.26 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.405 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -70.25 94.63 0.93 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.928 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.1 t -96.27 115.52 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.573 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -101.03 155.06 18.2 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.409 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 97' ' ' ILE . 10.6 mt -146.79 122.97 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.473 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -111.39 127.63 55.73 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.505 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.306 -0.854 . . . . 0.0 111.087 -179.727 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.433 0.159 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 m -106.99 104.48 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.456 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 tp -176.0 94.1 0.06 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.43 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.32 140.59 51.89 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.741 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 t -149.31 137.69 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.653 -0.248 . . . . 0.0 110.973 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -159.29 123.71 3.97 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.311 0.382 . . . . 0.0 110.514 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.1 mt -89.87 140.2 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 O-C-N 123.15 0.281 . . . . 0.0 111.042 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.9 t -128.1 134.39 26.18 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.856 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.44 173.82 56.13 Favored 'Cis proline' 0 C--N 1.365 1.436 0 CA-C-N 119.698 0.928 . . . . 0.0 112.161 0.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.4 p -69.14 -49.01 60.82 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -128.37 114.22 16.58 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.44 93.16 0.72 Allowed Glycine 0 C--N 1.343 0.94 0 C-N-CA 121.087 -0.578 . . . . 0.0 114.46 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -79.99 132.86 36.1 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.0 mp -143.47 164.12 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.09 0.472 . . . . 0.0 111.384 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.47 150.22 22.87 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.549 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.2 t -66.0 135.28 28.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.599 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.17 -15.07 59.45 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.251 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -114.67 146.63 40.65 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 117.747 0.773 . . . . 0.0 110.111 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.404 ' CB ' ' HA ' ' A' ' 67' ' ' TYR . 60.1 p -79.42 168.56 19.31 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -176.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.31 121.38 3.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.805 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -115.2 142.22 46.96 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.578 0.227 . . . . 0.0 110.951 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -117.51 117.0 28.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.918 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.8 tp -82.43 109.81 17.0 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.935 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.66 107.44 19.17 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -92.01 163.11 14.1 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.2 m -147.42 176.64 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.84 108.59 0.78 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.508 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 154.04 132.87 1.72 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.689 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -93.43 60.18 3.07 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.543 0.687 . . . . 0.0 109.505 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.58 18.04 2.99 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.54 -87.07 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 177.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -51.86 -28.52 16.24 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 0.69 79.79 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -101.65 111.32 23.53 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.777 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.8 mm -70.93 148.66 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 123.603 0.565 . . . . 0.0 110.168 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.7 m -144.93 156.12 43.8 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.183 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.408 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 55.9 m95 -134.65 121.84 21.43 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -119.5 110.84 17.38 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 m -62.73 152.6 81.6 Favored Pre-proline 0 C--O 1.249 1.071 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.117 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -36.68 -24.29 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.209 1 C-N-CA 126.047 4.498 . . . . 0.0 116.532 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -80.12 12.17 3.0 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.29 37.76 91.06 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -142.15 147.34 36.48 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.266 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp -79.53 125.25 29.34 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.231 0.332 . . . . 0.0 111.66 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 pp -86.84 131.64 34.06 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.495 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.8 m -63.52 163.29 20.79 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.667 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.34 -60.29 0.11 Allowed 'Trans proline' 0 C--N 1.363 1.321 0 C-N-CA 122.621 2.214 . . . . 0.0 112.597 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -114.38 62.65 0.67 Allowed 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.285 0.564 . . . . 0.0 110.697 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.83 -62.13 1.41 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.102 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -139.03 -154.42 0.52 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.0 -23.91 1.32 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.2 mt -86.17 105.04 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.5 t -109.07 122.17 46.7 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.189 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.77 158.07 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.15 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.2 m -150.32 171.75 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.852 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -139.58 120.1 14.07 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.1 -81.78 0.57 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -56.33 -178.43 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -52.96 -34.19 54.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -141.37 -12.97 0.9 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.6 p -76.89 147.55 36.97 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 118.725 0.693 . . . . 0.0 111.297 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.2 m -134.79 -170.17 2.5 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.817 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.2 m -154.23 138.49 16.61 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 111.799 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.408 ' HB2' ' CE2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -108.08 94.68 5.2 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.684 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.54 140.1 29.88 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 123.295 0.372 . . . . 0.0 110.563 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 47.0 mt -136.44 91.06 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.404 ' HA ' ' CB ' ' A' ' 19' ' ' SER . 11.0 m-85 -56.25 -69.92 0.13 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.18 -66.19 0.5 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 73.76 119.77 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.1 0.56 . . . . 0.0 111.232 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -142.39 163.03 33.95 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.03 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.7 pt -51.73 -26.28 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.95 -43.77 70.92 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.437 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -65.7 -33.39 75.77 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.004 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.14 109.31 0.32 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.14 174.9 45.68 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.726 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.7 mt -80.54 99.78 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.829 0.315 . . . . 0.0 111.296 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -72.57 171.5 12.31 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -132.89 158.01 43.64 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 34.2 t -139.82 100.8 4.03 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.895 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -107.22 133.02 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.69 134.83 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.17 146.43 41.39 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.32 -175.59 4.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.464 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -73.7 -46.32 46.89 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 123.132 0.27 . . . . 0.0 111.49 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.4 -35.46 65.88 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.559 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.48 -19.31 1.5 Allowed Glycine 0 C--N 1.339 0.719 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.643 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.8 m -56.14 108.7 0.49 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.348 0.574 . . . . 0.0 111.7 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -117.78 133.81 55.56 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.867 0.365 . . . . 0.0 111.565 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.2 t -120.94 127.18 51.59 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -111.49 -177.94 3.32 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -177.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.75 177.13 10.39 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.614 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.82 158.39 44.13 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.822 0.344 . . . . 0.0 111.816 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.18 114.36 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.908 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -71.33 91.48 0.99 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.914 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.4 t -92.39 129.37 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.549 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -115.76 158.42 22.87 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.798 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.45 HG22 HD11 ' A' ' 97' ' ' ILE . 11.2 mt -148.99 135.47 12.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.178 178.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.25 135.56 45.03 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.355 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.878 -179.838 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -150.69 59.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.422 0.629 . . . . 0.0 109.869 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.03 139.33 44.72 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.088 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.9 147.71 52.29 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.883 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -152.41 140.22 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 O-C-N 123.188 0.305 . . . . 0.0 111.068 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -154.99 130.61 9.89 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.601 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.4 mt -91.69 130.11 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 123.196 0.31 . . . . 0.0 110.992 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.0 t -115.07 123.76 31.31 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.83 -179.29 24.9 Favored 'Cis proline' 0 C--N 1.364 1.374 0 CA-C-N 119.985 1.03 . . . . 0.0 112.276 0.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 86.3 p -78.69 -40.97 32.34 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.307 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -132.85 118.15 18.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.699 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -117.93 99.37 0.8 Allowed Glycine 0 C--N 1.341 0.844 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.97 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -87.55 132.26 34.11 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 4.5 mp -143.59 163.63 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.811 0.338 . . . . 0.0 111.083 -178.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.36 154.46 18.17 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.5 t -63.49 140.43 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.901 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.64 -12.0 70.8 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.24 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.06 156.64 17.54 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.8 p -96.16 165.51 12.2 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.63 0.253 . . . . 0.0 111.286 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -162.61 126.58 3.03 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -119.72 153.42 35.65 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.072 0.232 . . . . 0.0 111.039 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -131.57 119.17 21.12 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.287 0.565 . . . . 0.0 112.078 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.9 111.96 14.29 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -176.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.431 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 54.0 t -87.61 87.53 7.41 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -79.9 158.39 26.69 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.427 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.5 m -133.49 165.07 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 O-C-N 123.473 0.483 . . . . 0.0 112.081 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.08 129.73 5.25 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.715 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 149.66 -177.68 27.66 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.9 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -140.45 36.92 1.86 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.141 0.496 . . . . 0.0 110.759 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.16 -163.81 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.87 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.74 -52.4 4.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.848 0.356 . . . . 0.0 110.266 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -124.36 138.85 54.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.821 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.72 83.25 1.97 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.801 0.334 . . . . 0.0 111.517 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 13.5 m-20 -81.67 159.33 23.98 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.4 mp -121.7 158.75 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 123.189 0.306 . . . . 0.0 111.155 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 64.1 m -159.88 160.92 34.2 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.768 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.431 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 58.8 m95 -136.96 130.89 32.22 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.673 0.273 . . . . 0.0 111.134 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 91.6 m-85 -118.92 117.55 29.14 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.5 p -65.73 152.76 92.36 Favored Pre-proline 0 C--O 1.249 1.055 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.903 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -48.12 -17.14 0.77 Allowed 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 124.904 3.736 . . . . 0.0 116.133 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -78.86 6.79 8.31 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 118.155 0.434 . . . . 0.0 111.915 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.77 37.62 33.66 Favored Glycine 0 C--N 1.351 1.409 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -158.2 140.04 13.88 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 120.103 -0.639 . . . . 0.0 112.333 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 21.9 tttt -54.5 138.0 41.53 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -110.35 134.4 52.33 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.172 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.4 m -68.55 158.01 86.5 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.085 -178.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -85.93 -26.7 1.13 Allowed 'Trans proline' 0 C--N 1.363 1.334 0 C-N-CA 122.831 2.354 . . . . 0.0 113.55 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -121.28 69.59 0.91 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.375 0.607 . . . . 0.0 110.182 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.99 -60.01 1.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.149 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -141.79 -159.5 0.97 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 121.99 0.116 . . . . 0.0 110.856 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.7 mtm-85 -47.54 -25.57 1.16 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.476 HD11 HG22 ' A' ' 52' ' ' ILE . 47.9 mt -84.83 106.62 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.801 0.334 . . . . 0.0 110.378 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 t -112.52 123.06 49.45 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.517 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.4 t -92.81 159.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.361 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -154.09 153.43 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.734 0.302 . . . . 0.0 111.422 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 23.0 m-90 -126.08 112.57 16.0 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -105.35 -75.33 0.63 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.2 -179.05 0.13 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.494 0.188 . . . . 0.0 111.421 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -54.62 -35.76 63.78 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.496 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -151.07 24.45 0.74 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.946 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.9 t -110.4 136.25 49.85 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.3 m -128.66 -169.38 2.07 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.525 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 m -159.33 144.85 15.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.937 0.399 . . . . 0.0 110.995 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.82 93.55 4.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.334 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.22 144.25 27.55 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.561 0.538 . . . . 0.0 110.286 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.427 HG22 HD11 ' A' ' 66' ' ' ILE . 61.9 mt -142.52 93.05 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -59.71 -108.51 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.405 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -56.61 95.17 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.465 1.03 . . . . 0.0 110.551 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.25 151.8 39.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.153 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -145.71 154.43 42.07 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.139 0.495 . . . . 0.0 111.281 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.5 pt -53.98 -24.52 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -72.64 -41.3 65.61 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.92 -34.23 77.91 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.736 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.69 104.25 0.08 Allowed 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.02 171.44 44.17 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.81 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.9 mt -79.62 95.92 2.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.81 0.305 . . . . 0.0 110.245 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -69.93 171.42 9.41 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -133.66 154.69 50.73 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.741 0.305 . . . . 0.0 111.155 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.31 97.71 3.44 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 t -101.01 140.85 18.8 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.857 -176.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 34' ' ' ASP . 1.7 t -125.78 144.92 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 m -124.3 155.97 37.76 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.28 -176.01 3.39 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.26 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -77.3 -37.93 51.73 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 123.023 0.202 . . . . 0.0 110.901 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -79.87 -35.8 37.57 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.256 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 148.37 -19.49 1.34 Allowed Glycine 0 C--N 1.34 0.751 0 C-N-CA 121.232 -0.509 . . . . 0.0 113.563 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 89.4 m -59.87 112.83 2.0 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 117.314 0.557 . . . . 0.0 111.333 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.63 134.06 55.39 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.488 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.6 t -114.73 124.98 53.17 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -108.83 -179.86 3.98 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -147.84 173.94 12.34 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.148 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.0 154.95 39.08 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 111.269 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.87 112.71 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.979 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -70.88 93.26 0.96 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.919 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.5 t -95.05 118.03 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.553 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.63 157.73 16.86 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.153 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.409 HG23 HD11 ' A' ' 97' ' ' ILE . 10.5 mt -148.57 139.73 17.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.8 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.86 131.58 51.15 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.404 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.962 -179.788 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.384 0.135 . . . . 0.0 110.775 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 m -98.38 77.01 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.082 0.468 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 29.6 mt -149.11 131.08 15.26 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.529 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.71 134.48 21.19 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.293 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.7 t -143.91 139.56 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 123.22 0.325 . . . . 0.0 110.499 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -155.66 121.14 4.92 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.413 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.5 mt -89.64 136.24 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.023 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.48 128.05 25.83 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.549 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -74.4 -172.9 11.05 Favored 'Cis proline' 0 C--N 1.366 1.489 0 CA-C-N 119.669 0.917 . . . . 0.0 112.041 -0.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 97.2 p -85.57 -50.12 7.49 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.574 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -131.92 104.07 6.65 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.326 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.78 144.88 17.19 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 121.421 -0.418 . . . . 0.0 113.596 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -126.6 129.52 48.69 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 4.9 mp -141.75 165.12 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 120.579 0.228 . . . . 0.0 111.226 -178.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.4 157.45 17.33 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.47 136.91 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.393 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.69 -8.25 80.08 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.942 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -100.78 153.06 19.78 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.0 p -100.06 134.73 42.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.193 0.521 . . . . 0.0 112.083 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -116.98 172.04 7.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.582 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.65 149.91 13.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -137.87 105.14 5.47 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.444 0.64 . . . . 0.0 110.812 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.6 tp -79.41 111.92 16.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 114.88 -1.054 . . . . 0.0 112.228 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.4 t -90.49 108.87 20.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.786 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -92.32 160.24 15.21 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.9 m -140.71 176.52 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -168.61 143.76 3.41 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.332 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 139.62 143.32 4.37 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -95.06 40.39 1.1 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.768 0.318 . . . . 0.0 111.802 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.06 -172.8 0.73 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.412 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -111.92 -24.06 10.18 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -125.62 -34.07 2.69 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? 1.66 66.58 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -178.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 18.4 m-20 -69.59 179.4 2.13 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.631 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.87 155.7 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 123.39 0.431 . . . . 0.0 110.845 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.8 m -156.65 162.0 39.86 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.079 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -133.08 135.55 45.38 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.941 0.151 . . . . 0.0 110.783 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 95.2 m-85 -128.91 109.07 10.93 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.6 p -58.77 151.44 53.43 Favored Pre-proline 0 C--O 1.251 1.151 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.166 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -55.19 -13.02 6.15 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 124.648 3.565 . . . . 0.0 115.534 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -76.63 -3.72 39.26 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.11 0.414 . . . . 0.0 111.38 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.97 41.92 4.83 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.638 -0.534 . . . . 0.0 112.073 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.85 155.59 16.79 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.579 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 10.9 ttmt -68.84 159.42 32.49 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.517 0.51 . . . . 0.0 111.384 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.7 mt -111.85 139.21 47.52 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.694 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.26 155.92 66.51 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.215 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.22 -24.46 9.44 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.439 2.093 . . . . 0.0 113.321 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -138.98 78.61 1.68 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.213 0.53 . . . . 0.0 109.97 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.95 -59.05 1.28 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.585 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -146.02 -157.95 0.85 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -24.28 3.48 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.1 mt -84.17 97.81 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.692 0.282 . . . . 0.0 110.457 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.8 t -101.32 117.96 36.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.552 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.6 t -93.63 160.33 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.0 p -158.58 157.69 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 13.1 m-90 -136.04 121.9 19.92 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -81.73 0.64 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.69 -177.9 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -31.55 -59.33 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.323 1.049 . . . . 0.0 113.08 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -147.24 21.62 1.21 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.034 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.6 145.22 25.41 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 m -134.58 -170.78 2.62 Favored 'General case' 0 N--CA 1.458 -0.07 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.069 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.4 m -160.12 145.71 15.27 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.868 0.366 . . . . 0.0 111.325 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.7 98.44 6.37 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.172 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.61 138.68 34.65 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.607 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.5 mt -134.95 89.2 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -53.97 -98.65 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.94 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.75 100.78 0.73 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.234 0.925 . . . . 0.0 110.109 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.17 149.18 29.21 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -142.72 155.54 44.89 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.545 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.3 pt -53.1 -24.54 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -71.56 -42.31 68.0 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -65.33 -35.1 79.94 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.115 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.36 126.81 15.92 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.63 -177.64 37.82 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.895 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.42 108.61 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -83.52 166.18 18.49 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -127.57 158.4 37.57 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.139 0.495 . . . . 0.0 112.303 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 23.7 t -138.84 94.01 2.77 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.272 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.6 t -100.46 132.31 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 34' ' ' ASP . 3.6 t -111.73 153.6 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.4 m -137.61 111.04 7.97 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.56 -176.19 0.1 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.244 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -73.08 -49.97 25.53 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.715 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -62.62 -31.28 72.1 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 134.28 -19.19 4.1 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 121.348 -0.453 . . . . 0.0 113.51 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 m -61.59 114.02 3.03 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.397 0.599 . . . . 0.0 110.505 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -100.64 136.92 39.76 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.279 0.362 . . . . 0.0 111.973 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.6 t -116.79 106.42 13.47 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -102.85 -179.39 3.94 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -155.86 -178.62 7.43 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.161 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.11 160.58 43.39 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.701 0.286 . . . . 0.0 111.463 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.09 120.47 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.55 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -74.85 91.43 2.44 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.752 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.9 t -95.27 142.42 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.31 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.88 156.34 46.27 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.938 0.399 . . . . 0.0 111.398 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.446 HG22 HD11 ' A' ' 97' ' ' ILE . 11.3 mt -145.09 132.27 15.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.052 178.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.23 132.2 39.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.249 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.219 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 10.9 ttt85 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.598 0.237 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.5 m -153.55 55.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-O 121.228 0.537 . . . . 0.0 110.074 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.6 mp -142.97 123.49 13.99 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.287 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -146.43 124.58 12.16 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.14 150.89 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.236 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -160.1 130.37 5.46 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.765 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.9 mt -92.1 144.69 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.361 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -128.42 126.13 23.43 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.19 179.69 28.5 Favored 'Cis proline' 0 C--N 1.365 1.421 0 CA-C-N 120.149 1.089 . . . . 0.0 112.348 0.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 96.4 p -73.33 -51.67 16.64 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.451 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -130.53 101.25 5.63 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.885 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.2 111.24 4.19 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 121.3 -0.476 . . . . 0.0 113.799 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.02 123.06 35.1 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.8 mp -137.73 164.69 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.593 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.75 162.23 14.17 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.634 0.731 . . . . 0.0 111.625 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.8 t -68.51 135.7 27.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.323 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.07 -17.35 58.82 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-O 119.545 -0.586 . . . . 0.0 112.449 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -111.46 146.55 37.03 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-N 117.799 0.8 . . . . 0.0 109.896 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 96.7 p -79.67 176.95 9.25 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.33 118.74 0.46 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.249 -178.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -112.09 150.6 30.48 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.469 0.176 . . . . 0.0 111.137 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -128.58 118.52 23.12 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.197 0.522 . . . . 0.0 111.44 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.8 tp -79.13 117.3 20.04 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.403 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 41.6 t -94.74 96.56 9.46 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -88.41 148.72 24.08 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.168 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.89 175.96 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -171.06 112.63 0.38 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.093 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 150.34 149.42 5.01 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.228 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -96.64 51.01 1.14 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.006 0.431 . . . . 0.0 111.612 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.67 18.7 9.69 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.66 -84.32 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 114.555 1.316 . . . . 0.0 114.555 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -39.89 -31.12 0.1 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.8 mmmm 1.91 73.45 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 125.526 1.53 . . . . 0.0 115.04 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -83.16 108.8 16.67 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.652 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.9 mp -73.25 157.98 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 123.385 0.428 . . . . 0.0 111.136 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.0 m -157.88 161.79 38.3 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.249 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.421 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 60.3 m95 -137.39 124.99 22.2 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.65 0.262 . . . . 0.0 111.094 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 94.8 m-85 -114.38 117.32 30.7 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.9 p -68.12 153.12 95.89 Favored Pre-proline 0 C--O 1.249 1.074 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.947 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -50.51 -16.05 1.93 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 124.887 3.725 . . . . 0.0 116.048 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -77.98 3.02 15.76 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.072 0.397 . . . . 0.0 111.908 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.76 38.88 10.0 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-O 119.611 -0.55 . . . . 0.0 112.276 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -167.96 143.72 3.86 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 119.561 -0.856 . . . . 0.0 113.205 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 19.8 tttm -54.33 146.29 15.92 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.76 152.85 26.11 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.268 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m -79.33 159.48 72.44 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.984 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.79 -8.06 13.4 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.29 1.994 . . . . 0.0 113.548 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -141.92 48.59 1.6 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.03 0.443 . . . . 0.0 110.763 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -66.33 -77.31 0.07 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.658 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -150.76 -74.53 0.15 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 -99.86 -34.71 10.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.639 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 53.4 mt -84.54 107.23 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.849 0.357 . . . . 0.0 111.189 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.5 t -110.64 124.35 51.74 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.597 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.5 t -98.42 159.3 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.742 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.0 m -149.95 170.32 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.862 0.363 . . . . 0.0 111.518 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.1 m-90 -139.64 104.5 4.93 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -90.79 -85.57 0.22 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -175.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -174.56 0.07 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.952 0.342 . . . . 0.0 111.804 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.89 -36.05 62.26 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.844 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -145.18 17.77 1.56 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.5 t -103.09 139.12 39.03 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.6 m -133.27 -173.73 3.29 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.993 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m -155.73 146.55 22.2 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.902 0.382 . . . . 0.0 111.826 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.421 ' HB2' ' CE2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -115.84 91.57 3.64 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.447 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.2 139.01 31.45 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 66.2 mt -135.56 95.59 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -61.93 -116.07 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 O-C-N 123.759 0.662 . . . . 0.0 110.884 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.43 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.824 1.193 . . . . 0.0 111.409 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.56 142.53 44.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.992 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -136.9 152.28 50.03 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.63 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.2 pt -51.41 -26.01 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -69.08 -43.67 74.08 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -65.21 -33.42 75.95 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.88 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.47 104.3 0.07 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.54 174.27 46.47 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.043 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.3 mt -81.23 98.66 4.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -71.73 172.47 9.71 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -134.01 155.11 50.56 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.744 0.307 . . . . 0.0 111.095 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.74 101.38 4.31 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.0 t -104.73 140.85 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.427 -176.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.36 135.49 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 m -117.14 149.88 39.63 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.55 -177.63 5.09 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.357 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -74.23 -34.46 63.66 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.314 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.32 -35.6 23.15 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.361 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.61 -22.15 1.5 Allowed Glycine 0 C--N 1.34 0.785 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.584 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.8 m -59.19 111.66 1.42 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.208 0.504 . . . . 0.0 111.446 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.12 135.22 54.76 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.922 0.391 . . . . 0.0 111.687 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.7 t -116.61 127.13 54.18 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -111.19 -178.54 3.49 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -147.67 173.55 12.64 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.18 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.48 155.78 42.23 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.613 0.244 . . . . 0.0 111.051 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.97 116.82 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.273 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.02 102.68 2.49 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.1 t -105.57 111.49 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.681 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.0 mtmm -98.91 149.73 22.64 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.406 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.446 HG23 HD11 ' A' ' 97' ' ' ILE . 10.3 mt -139.36 117.72 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.42 132.3 56.29 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.382 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.895 -179.718 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.34 72.91 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.069 0.461 . . . . 0.0 109.97 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.85 105.8 3.59 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.237 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -134.76 142.17 46.66 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.901 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -149.59 141.1 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.82 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -155.04 132.55 11.21 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.644 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.6 mt -92.17 131.93 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 O-C-N 123.173 0.295 . . . . 0.0 111.11 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.04 125.91 28.74 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.57 172.7 48.93 Favored 'Cis proline' 0 C--N 1.364 1.365 0 CA-C-N 120.103 1.072 . . . . 0.0 112.369 0.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.9 p -70.05 -39.8 75.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.458 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -134.42 113.15 11.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.85 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.03 97.89 1.11 Allowed Glycine 0 C--N 1.342 0.867 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.803 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -86.19 124.19 32.31 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 mp -141.06 164.45 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.593 0.235 . . . . 0.0 110.727 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.76 156.98 17.17 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.786 0.327 . . . . 0.0 110.439 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.0 t -63.52 140.77 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.38 -11.57 70.85 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.472 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -98.99 159.55 14.88 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 117.481 0.64 . . . . 0.0 109.454 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 66.7 p -101.49 149.24 24.28 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.63 0.252 . . . . 0.0 111.213 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.26 124.53 10.86 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.552 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -114.57 148.32 38.19 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.958 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -127.45 119.85 27.04 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.223 0.535 . . . . 0.0 112.028 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.05 109.49 12.18 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -177.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.452 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 35.5 t -84.54 90.7 7.7 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -83.35 150.82 25.86 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.093 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.35 169.96 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.3 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -169.66 103.84 0.33 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.799 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 155.61 134.19 1.81 Allowed Glycine 0 C--N 1.338 0.664 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.529 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -95.54 50.98 1.26 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.167 0.508 . . . . 0.0 110.905 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.65 78.23 7.78 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.328 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.75 -88.0 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -128.69 137.6 51.7 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.735 0.303 . . . . 0.0 111.136 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -128.07 145.39 51.01 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.639 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -124.26 114.48 19.65 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.635 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.2 mp -76.43 155.44 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.064 0.459 . . . . 0.0 112.01 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.9 m -152.3 159.2 43.53 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.645 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.452 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 44.2 m95 -135.4 115.18 12.9 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 119.684 -0.198 . . . . 0.0 111.384 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -116.51 112.16 20.98 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.52 156.01 55.74 Favored Pre-proline 0 C--O 1.245 0.821 0 CA-C-O 119.325 -0.369 . . . . 0.0 110.627 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -33.79 -72.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 125.094 3.863 . . . . 0.0 113.484 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.86 37.3 4.14 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 176.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.9 -19.86 3.92 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.816 -0.629 . . . . 0.0 113.401 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 70.71 -170.89 0.16 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 117.893 0.846 . . . . 0.0 109.003 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 23.2 tttm -55.2 108.83 0.45 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mt -72.39 171.48 12.16 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.987 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m -86.75 150.4 50.55 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.06 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.08 -24.75 23.39 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.254 1.97 . . . . 0.0 112.886 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -150.01 80.3 1.37 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.989 0.423 . . . . 0.0 110.301 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.71 -79.08 0.46 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.295 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -145.04 -74.3 0.24 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.588 0.232 . . . . 0.0 110.902 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -97.95 -39.57 8.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.565 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 mt -88.33 112.83 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.6 t -119.37 117.98 29.97 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.364 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.3 t -89.04 157.61 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.8 p -155.0 157.98 3.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 CA-C-O 120.963 0.411 . . . . 0.0 111.894 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.7 m-90 -131.72 107.51 8.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -97.39 -79.28 0.46 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.73 -178.82 0.22 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.587 0.232 . . . . 0.0 111.473 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -52.71 -34.26 51.54 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -148.29 16.51 1.05 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 p -103.14 139.15 39.02 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.97 0.35 . . . . 0.0 110.078 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -130.84 -174.29 3.33 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.455 -177.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -155.82 147.57 23.07 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.003 0.43 . . . . 0.0 111.35 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.417 ' HB2' ' CE2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -118.94 92.51 3.82 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.285 179.425 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.87 145.14 27.96 Favored 'General case' 0 N--CA 1.461 0.106 0 O-C-N 123.37 0.419 . . . . 0.0 110.157 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 51.2 mt -141.19 79.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -45.79 -66.94 0.33 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -64.38 -67.07 0.46 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 78.22 123.75 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.345 0.658 . . . . 0.0 110.926 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.24 159.77 42.1 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.069 0.462 . . . . 0.0 110.737 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.3 pt -50.23 -27.79 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -71.19 -41.42 70.33 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -64.08 -34.05 77.15 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.98 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.76 102.87 0.06 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.75 178.23 46.59 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.656 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 mp -80.77 100.58 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 117.051 0.426 . . . . 0.0 110.437 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -73.32 174.57 7.91 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -135.01 154.27 51.78 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.31 101.26 4.09 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.0 t -106.89 137.41 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -176.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -120.39 142.42 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.4 m -128.2 126.31 40.74 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.89 -175.84 2.27 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.752 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -78.18 -39.54 40.47 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.181 0.301 . . . . 0.0 111.04 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.38 -33.84 65.24 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.394 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.02 -8.52 4.16 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-O 119.72 -0.489 . . . . 0.0 114.013 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.3 m -62.58 110.32 1.66 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.687 0.744 . . . . 0.0 110.61 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -103.07 134.36 46.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.889 0.376 . . . . 0.0 111.784 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.8 t -131.22 115.01 15.77 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -112.1 -176.97 3.05 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.5 172.77 16.04 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.34 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.23 152.29 39.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.66 0.266 . . . . 0.0 110.535 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.55 117.71 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.126 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -71.7 92.24 1.17 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.084 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.6 t -95.09 112.73 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.476 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.95 155.54 17.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.948 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.444 HG22 HD11 ' A' ' 97' ' ' ILE . 11.2 mt -144.04 135.49 22.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.144 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.67 127.62 37.32 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.229 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.951 -179.901 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.9 m -144.82 61.92 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 121.389 0.614 . . . . 0.0 110.25 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -159.27 89.37 0.91 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.705 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.84 150.08 41.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.903 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.1 t -147.35 138.14 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.456 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -155.31 125.84 6.86 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.878 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 71.2 mt -89.71 135.14 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -134.6 120.68 14.66 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 118.918 -0.563 . . . . 0.0 110.908 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -66.23 149.56 78.42 Favored 'Cis proline' 0 C--N 1.364 1.343 0 CA-C-N 120.531 1.225 . . . . 0.0 113.053 -0.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.1 p -71.72 -40.4 69.49 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.888 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -112.16 120.2 40.99 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.64 75.74 0.21 Allowed Glycine 0 C--N 1.341 0.854 0 N-CA-C 114.542 0.577 . . . . 0.0 114.542 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -81.24 115.25 20.54 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 mp -141.74 162.17 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.411 -178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.34 153.94 18.26 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.94 0.4 . . . . 0.0 110.488 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.01 141.18 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.093 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.8 -13.1 67.68 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.188 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -102.61 159.51 15.39 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.2 p -94.35 168.51 10.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.578 0.228 . . . . 0.0 110.648 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -167.0 115.34 0.83 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.222 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -120.66 151.79 39.03 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.69 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -131.74 122.68 26.26 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.264 0.554 . . . . 0.0 111.339 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp -79.81 114.43 18.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.718 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 t -90.19 104.32 16.91 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.075 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -95.44 166.99 11.6 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.512 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.0 m -139.58 171.48 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.691 0.281 . . . . 0.0 111.596 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -151.7 104.72 3.06 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.041 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 167.02 131.55 1.28 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.368 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -97.7 43.35 1.07 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.033 0.444 . . . . 0.0 111.071 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.76 -170.69 0.23 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.756 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -74.84 -59.52 2.7 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.934 0.397 . . . . 0.0 110.155 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -124.61 151.36 44.93 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.028 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt -133.57 84.42 2.12 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.78 0.324 . . . . 0.0 111.255 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -79.88 155.68 27.67 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.51 152.17 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 123.322 0.389 . . . . 0.0 111.205 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.5 m -152.68 157.66 41.24 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.297 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.419 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 60.5 m95 -131.98 122.38 25.45 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -119.22 111.95 18.87 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 p -57.02 152.83 26.65 Favored Pre-proline 0 C--O 1.244 0.793 0 CA-C-O 119.327 -0.368 . . . . 0.0 110.783 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -32.03 -76.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 125.273 3.982 . . . . 0.0 114.15 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.58 37.27 3.64 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 176.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.51 -16.16 4.74 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.617 -0.72 . . . . 0.0 113.371 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 70.02 -170.3 0.17 Allowed 'General case' 0 C--N 1.353 0.743 0 CA-C-N 117.978 0.889 . . . . 0.0 108.768 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -54.52 125.51 19.92 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.89 158.15 16.45 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.797 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.6 m -75.25 147.22 82.65 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.451 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.47 -27.16 81.02 Favored 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 122.39 2.06 . . . . 0.0 113.066 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -148.63 79.24 1.43 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.004 0.431 . . . . 0.0 110.807 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.72 -68.45 0.79 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.991 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -150.95 -79.26 0.12 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -99.7 -32.77 10.89 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.412 HD11 HG22 ' A' ' 52' ' ' ILE . 63.3 mt -88.53 100.4 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 120.868 0.366 . . . . 0.0 111.212 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.6 t -107.19 123.21 47.94 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.027 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.9 t -95.91 158.13 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.268 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.3 m -150.54 172.5 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 120.938 0.399 . . . . 0.0 111.642 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.7 m-90 -142.23 117.0 9.83 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.55 -79.55 0.57 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -59.48 -179.92 0.1 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.598 0.181 . . . . 0.0 111.024 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -57.08 -32.35 66.18 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -136.99 -12.37 1.69 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.8 t -85.25 139.75 31.39 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 118.734 0.697 . . . . 0.0 111.499 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.8 m -126.0 -169.37 2.0 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.268 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.3 m -160.53 132.92 6.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.419 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -99.98 99.08 9.78 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.225 178.635 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.38 131.4 37.59 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.242 0.339 . . . . 0.0 110.092 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.415 HG22 HD11 ' A' ' 66' ' ' ILE . 63.7 mt -130.1 93.14 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -60.68 -116.06 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 CA-C-O 118.895 -0.574 . . . . 0.0 111.199 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -51.48 95.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.912 1.233 . . . . 0.0 110.876 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.22 154.05 37.77 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.883 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -148.34 154.13 39.55 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.382 0.61 . . . . 0.0 111.326 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.4 pt -53.42 -25.97 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -71.53 -40.52 70.02 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.29 -34.23 77.84 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.584 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.89 108.4 0.24 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.49 179.69 48.83 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 121.411 -0.423 . . . . 0.0 112.299 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.0 mm -82.04 90.26 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 122.152 0.181 . . . . 0.0 111.459 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.435 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . 40.3 m-85 -67.68 176.0 2.67 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -136.58 159.0 43.12 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 8.3 t -140.4 92.54 2.53 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.705 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 5.2 t -96.51 128.74 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.92 159.1 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.5 m -136.34 154.06 50.96 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.47 -172.66 2.2 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.315 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -76.79 -45.6 28.2 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.233 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -74.74 -32.01 61.97 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 141.73 -9.88 2.6 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.402 -0.666 . . . . 0.0 114.433 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.6 m -63.79 116.98 6.27 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 117.98 0.89 . . . . 0.0 110.336 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -108.92 135.77 49.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.466 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.8 t -122.0 108.38 13.32 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 6.2 pt-20 -99.78 179.83 4.4 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.2 -179.39 7.48 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.716 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.26 152.56 31.31 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.025 0.44 . . . . 0.0 111.478 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.435 ' CG1' ' HB2' ' A' ' 77' ' ' TYR . 2.7 p -132.01 119.87 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.34 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -80.72 88.4 5.78 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 t -91.96 124.66 44.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.934 -177.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -111.99 155.19 24.15 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.585 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.471 HD11 HG22 ' A' ' 97' ' ' ILE . 7.9 mt -145.96 132.04 13.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.697 177.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -119.29 125.65 49.59 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.535 -178.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.856 -179.844 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 8.5 ttt85 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.427 0.156 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -160.94 42.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-O 121.019 0.438 . . . . 0.0 110.617 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.75 96.38 2.66 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.05 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -99.95 152.01 20.67 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.0 t -146.57 146.76 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -158.13 127.95 5.97 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.705 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.4 mt -94.2 142.83 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.2 t -124.46 122.91 25.87 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-O 119.21 -0.424 . . . . 0.0 110.03 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.49 -171.17 9.36 Favored 'Cis proline' 0 C--N 1.366 1.452 0 CA-C-N 119.925 1.009 . . . . 0.0 112.361 -0.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.3 p -85.83 -50.22 7.3 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.309 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -125.38 99.98 6.29 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.733 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.28 156.55 37.6 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.874 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -151.75 104.92 3.07 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.3 mp -130.15 166.85 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.806 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.6 155.46 18.27 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.603 0.716 . . . . 0.0 111.339 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.0 t -65.88 138.49 22.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.887 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.87 -16.96 60.11 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.312 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -115.52 149.94 37.35 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 117.87 0.835 . . . . 0.0 110.116 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.4 p -79.86 165.58 22.55 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.77 119.88 3.36 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.267 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -112.8 153.57 27.63 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.538 0.209 . . . . 0.0 111.245 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.33 113.58 15.15 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.271 0.558 . . . . 0.0 111.234 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.1 tp -78.42 111.73 14.73 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.436 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 43.7 t -93.4 90.1 6.6 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -86.7 157.51 19.63 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.861 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.96 169.15 16.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.448 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -157.9 98.04 1.59 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.503 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 175.76 -175.69 47.35 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.984 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -129.03 30.55 5.03 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.67 -176.09 0.76 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 110.484 -0.191 . . . . 0.0 110.484 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.48 -50.58 1.87 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.659 0.266 . . . . 0.0 111.638 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.67 -36.49 83.04 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.879 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt 0.15 96.68 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 125.61 1.564 . . . . 0.0 115.041 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -118.21 113.87 22.17 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.207 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 mp -77.74 156.62 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.183 0.516 . . . . 0.0 111.411 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 m -152.36 157.74 41.72 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.087 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.436 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 39.8 m95 -135.13 109.13 8.17 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 117.61 0.187 . . . . 0.0 110.934 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -107.73 112.07 24.57 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 56.0 p -62.33 153.78 74.33 Favored Pre-proline 0 C--O 1.246 0.918 0 CA-C-O 119.159 -0.448 . . . . 0.0 110.535 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -26.42 -71.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.334 1 C-N-CA 125.938 4.425 . . . . 0.0 115.038 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.97 36.48 4.59 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.35 -15.52 4.56 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.063 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 72.32 -170.2 0.14 Allowed 'General case' 0 C--N 1.354 0.773 0 CA-C-N 117.959 0.88 . . . . 0.0 109.363 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 8.6 ttpp -52.28 96.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.85 148.05 49.56 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.542 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.36 150.75 95.37 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.067 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.88 -30.84 6.96 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 122.286 1.99 . . . . 0.0 112.579 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -120.61 52.13 1.19 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.028 0.442 . . . . 0.0 111.254 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -68.81 -82.2 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.352 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -150.98 -73.17 0.16 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -98.99 -31.56 11.74 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.689 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.6 mt -89.05 101.66 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.735 0.302 . . . . 0.0 110.405 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.0 t -108.42 122.77 47.7 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.157 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.63 159.62 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.8 p -153.97 146.95 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.077 0.465 . . . . 0.0 112.239 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 21.2 m-90 -123.73 112.06 16.9 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -109.49 -74.35 0.66 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.745 1.016 . . . . 0.0 113.745 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -60.74 -175.16 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -53.26 -36.55 61.23 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.745 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -153.96 22.32 0.51 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.2 t -103.47 139.23 39.1 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 m -134.64 -174.03 3.46 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.603 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -155.8 145.29 21.0 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.022 0.439 . . . . 0.0 111.256 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -113.29 91.23 3.57 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.247 179.466 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.71 138.02 31.83 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.338 0.399 . . . . 0.0 110.295 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.9 mt -134.79 87.29 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -52.89 -67.46 0.25 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -60.57 -63.64 1.23 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 73.6 120.55 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.883 0.473 . . . . 0.0 110.952 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -141.71 162.4 35.57 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.033 0.444 . . . . 0.0 110.356 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.6 pt -54.83 -24.59 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -72.95 -40.45 65.35 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -66.52 -32.97 74.66 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.792 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.58 114.65 1.19 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.26 171.45 37.89 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.037 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.0 mt -76.93 95.86 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.786 0.293 . . . . 0.0 111.691 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -70.23 179.03 2.55 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -140.66 156.25 46.29 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 120.757 0.313 . . . . 0.0 111.626 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.96 102.38 4.0 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 t -104.59 139.78 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.11 137.96 53.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.4 m -127.93 150.95 49.66 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.51 -173.65 2.7 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.532 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -73.01 -52.86 12.82 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.504 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -65.47 -36.26 83.35 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 146.78 -19.23 1.63 Allowed Glycine 0 C--N 1.34 0.76 0 C-N-CA 121.161 -0.542 . . . . 0.0 113.644 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 77.5 m -57.85 109.1 0.66 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.39 0.595 . . . . 0.0 111.213 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -119.67 134.26 55.3 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.682 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.9 t -110.96 117.64 33.9 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -105.65 -178.57 3.69 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.46 172.38 15.54 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.255 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.01 153.23 36.17 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.46 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.26 111.67 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.757 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.68 89.51 0.74 Allowed 'General case' 0 C--O 1.235 0.293 0 O-C-N 123.408 0.442 . . . . 0.0 110.281 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.29 138.05 19.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.589 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -122.83 156.96 33.51 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.625 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 97' ' ' ILE . 7.2 mt -147.11 136.02 15.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.785 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.7 133.36 43.42 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.335 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.949 -179.664 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.517 0.198 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.9 m -160.14 54.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.286 0.565 . . . . 0.0 110.542 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.19 93.31 1.98 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.498 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -92.78 149.53 21.23 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -144.02 146.4 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 123.162 0.289 . . . . 0.0 110.933 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -160.38 133.06 6.41 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.64 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.1 mt -99.72 124.31 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 36.3 t -108.1 128.44 25.73 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.598 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.77 -172.9 11.78 Favored 'Cis proline' 0 C--N 1.365 1.433 0 CA-C-N 119.946 1.016 . . . . 0.0 112.327 -0.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.9 p -78.84 -48.82 14.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.932 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -132.0 112.34 12.29 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.883 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.08 106.99 2.34 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.071 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -88.31 132.54 34.37 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.1 mp -145.47 162.87 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 120.628 0.252 . . . . 0.0 110.697 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.41 154.34 19.17 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.284 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.6 t -61.53 136.3 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.231 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.71 -6.81 74.09 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.417 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -104.39 158.18 16.64 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.3 p -101.48 149.71 23.79 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.628 0.251 . . . . 0.0 111.58 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.25 119.11 8.1 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.607 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -113.74 148.13 37.02 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.684 0.278 . . . . 0.0 110.537 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -125.92 144.74 50.56 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.048 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.21 110.03 22.28 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.5 t -87.48 86.35 7.22 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -92.4 161.62 14.58 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.014 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.93 175.46 8.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -163.74 98.62 0.88 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.727 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -178.06 -143.77 5.24 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.794 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -162.27 32.15 0.11 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.598 0.237 . . . . 0.0 111.566 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.48 -167.32 0.91 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.09 -42.34 0.99 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.24 -34.3 68.17 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -9.86 82.03 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -97.96 116.34 29.97 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.34 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.7 mp -75.4 156.1 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.294 0.568 . . . . 0.0 112.173 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.0 m -157.55 162.96 38.82 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.499 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -135.61 130.36 34.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 110.53 -0.174 . . . . 0.0 110.53 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 87.1 m-85 -125.54 112.68 16.49 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.7 p -57.71 154.67 25.1 Favored Pre-proline 0 C--O 1.251 1.152 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.78 -15.81 4.98 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 124.649 3.566 . . . . 0.0 116.084 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -78.32 0.9 23.65 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.0 42.95 6.9 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -154.56 163.29 40.43 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.367 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 10.0 tttt -73.36 170.85 14.21 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.437 0.46 . . . . 0.0 110.722 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.18 122.02 25.87 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.047 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.98 158.91 73.83 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.252 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -83.52 -13.76 8.31 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 122.511 2.141 . . . . 0.0 113.808 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -153.85 84.74 1.16 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.011 0.434 . . . . 0.0 110.536 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.91 -57.75 0.81 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.977 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -137.24 -159.17 0.93 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -48.91 -26.47 2.49 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.7 mt -82.58 122.78 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.8 t -134.44 124.29 25.41 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.971 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.6 t -98.33 156.91 3.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.218 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.2 p -152.21 141.29 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.876 0.37 . . . . 0.0 111.735 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -117.11 121.91 42.62 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.44 -76.73 0.57 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -58.04 -175.68 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -56.33 -37.55 70.13 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.954 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -148.98 20.87 0.99 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.7 t -105.25 142.05 35.69 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 120.65 0.262 . . . . 0.0 110.441 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.9 m -138.36 -176.53 4.49 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.023 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 m -157.69 136.69 11.61 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.921 0.391 . . . . 0.0 111.629 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 tp -96.08 141.67 29.19 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.46 96.46 3.36 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.772 0.715 . . . . 0.0 112.676 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 mt -92.47 90.74 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.469 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -57.51 -96.05 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.975 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.46 97.64 0.78 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.066 0.848 . . . . 0.0 110.142 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.76 157.52 29.99 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.528 ' O ' HD11 ' A' ' 97' ' ' ILE . 10.4 m-80 -152.21 158.18 42.5 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.059 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.34 -24.82 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -72.54 -42.72 64.41 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 110.478 -0.194 . . . . 0.0 110.478 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -63.73 -33.69 76.21 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.03 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.12 105.57 0.11 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.95 178.92 48.11 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.485 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.6 mm -81.0 92.89 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 123.394 0.114 . . . . 0.0 110.758 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -68.24 161.74 26.53 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -127.79 155.75 43.57 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.09 103.21 4.27 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.8 t -106.74 141.96 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.03 140.47 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -120.5 138.1 54.01 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.22 -174.27 4.35 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.11 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -73.47 -58.3 3.4 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.396 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -63.68 -22.78 67.08 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 120.9 19.77 3.58 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-O 119.785 -0.453 . . . . 0.0 113.811 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 93.7 m -84.68 109.05 17.73 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -101.93 130.82 48.52 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.3 t -122.2 113.98 20.21 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -108.68 -177.84 3.43 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.16 170.44 18.93 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.325 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.45 154.76 39.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.742 0.306 . . . . 0.0 111.113 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.2 121.04 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.963 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -76.85 95.62 4.12 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.845 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.2 t -97.07 108.12 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.524 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -90.46 149.97 22.01 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.599 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.528 HD11 ' O ' ' A' ' 70' ' ' ASN . 9.8 mt -146.56 115.41 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.731 0.3 . . . . 0.0 110.424 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.17 134.2 55.07 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.961 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.82 179.87 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.427 HD12 HG22 ' A' ' 87' ' ' THR . 16.2 mt . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.594 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -139.39 141.73 37.54 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.746 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 t -149.38 143.32 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 O-C-N 123.253 0.346 . . . . 0.0 110.867 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -160.07 127.07 4.44 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.771 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' A' ' 79' ' ' CYS . 45.7 mt -99.74 138.63 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.367 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.7 t -128.49 135.48 27.63 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.671 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.429 ' O ' HG23 ' A' ' 93' ' ' VAL . 91.4 Cg_endo -77.23 170.26 71.93 Favored 'Cis proline' 0 C--N 1.366 1.492 0 C-N-CA 124.767 -0.93 . . . . 0.0 111.815 -0.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.2 p -66.63 -45.08 80.21 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.809 0.338 . . . . 0.0 110.323 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -131.8 110.86 11.15 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.398 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -111.54 97.94 0.98 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.756 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.805 ' O ' HD13 ' A' ' 14' ' ' ILE . 16.2 mt-10 -78.62 134.44 37.18 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.805 HD13 ' O ' ' A' ' 13' ' ' GLU . 4.3 mm -136.84 170.01 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.401 -178.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.492 ' H ' HG22 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -119.03 156.68 29.22 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.791 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.18 137.81 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.53 -8.75 78.49 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.6 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.426 ' HB2' HG22 ' A' ' 14' ' ' ILE . 4.0 mm-40 -100.03 155.05 17.92 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 117.302 0.551 . . . . 0.0 109.751 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.1 p -98.62 163.53 12.62 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.582 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -164.16 119.52 1.54 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -178.137 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.772 ' HB3' HG23 ' A' ' 65' ' ' THR . 31.5 p90 -112.97 141.4 46.84 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.601 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.644 ' CD2' HG21 ' A' ' 93' ' ' VAL . 94.7 m-85 -117.79 118.49 32.17 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.839 0.352 . . . . 0.0 111.205 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.94 115.07 18.39 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.9 t -99.6 94.89 6.62 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.355 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -88.91 158.75 17.97 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.744 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.661 HG21 ' CB ' ' A' ' 60' ' ' ASP . 32.1 m -138.49 171.77 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.233 0.208 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.51 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.638 ' C ' HD12 ' A' ' 35' ' ' ILE . 11.2 m-20 . . . . . 0 N--CA 1.461 0.081 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.638 HD12 ' C ' ' A' ' 34' ' ' ASP . 3.6 mp -127.9 146.83 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 123.373 0.421 . . . . 0.0 110.787 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 m -144.47 158.94 43.51 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.308 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.457 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 55.4 m95 -133.7 128.02 34.09 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.04 0.212 . . . . 0.0 110.44 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 94.0 m-85 -116.6 117.98 31.36 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.7 p -66.61 149.43 98.19 Favored Pre-proline 0 C--O 1.247 0.932 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.477 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo . . . . . 0 C--N 1.378 2.112 0 C-N-CA 124.741 3.627 . . . . 0.0 115.516 -178.955 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 31.0 tttt . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 pp -109.42 143.62 38.76 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.58 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.9 m -84.24 157.11 62.73 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.219 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.64 -27.6 3.97 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.444 2.096 . . . . 0.0 112.731 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -118.34 65.86 0.76 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.369 0.604 . . . . 0.0 110.025 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.11 -59.7 1.31 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.564 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -140.95 -162.21 1.33 Allowed 'General case' 0 CA--C 1.54 0.575 0 O-C-N 123.008 0.193 . . . . 0.0 110.508 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -51.76 -23.06 4.11 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.664 HG23 HG12 ' A' ' 66' ' ' ILE . 46.3 mt -82.18 99.15 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.7 t -105.04 122.88 46.79 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.949 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.414 HG22 HD23 ' A' ' 64' ' ' LEU . 16.3 t -93.07 158.03 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.139 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 p -151.55 147.9 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 20.4 m-90 -122.1 114.9 21.55 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.51 -80.35 0.58 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -56.24 -176.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -51.17 -37.83 48.67 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.661 ' CB ' HG21 ' A' ' 26' ' ' VAL . 5.4 m-20 -152.78 22.68 0.59 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 p -99.6 138.89 36.05 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.554 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.1 m -143.28 134.4 25.74 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.104 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.455 HG22 ' HB2' ' A' ' 21' ' ' PHE . 1.2 m -103.11 141.05 36.5 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 111.626 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.614 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -103.66 94.32 5.39 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.324 179.35 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.772 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -85.96 139.59 31.07 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 123.468 0.48 . . . . 0.0 110.351 -179.278 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.664 HG12 HG23 ' A' ' 52' ' ' ILE . 67.1 mt -137.44 93.22 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -60.2 -113.88 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.473 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.21 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.81 1.186 . . . . 0.0 110.967 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.864 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -69.84 148.92 48.45 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.16 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.768 ' O ' HD12 ' A' ' 97' ' ' ILE . 9.4 m120 -141.52 154.68 45.64 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.715 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.5 pt -53.9 -24.48 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -71.51 -40.97 69.81 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.421 ' OD1' HD11 ' A' ' 52' ' ' ILE . 77.8 m-20 -66.47 -35.53 80.5 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.885 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.568 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -51.37 107.81 0.21 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.69 -179.35 47.81 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.446 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.59 HD13 ' HA ' ' A' ' 94' ' ' ASN . 32.2 mm -82.18 95.22 3.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.588 0.194 . . . . 0.0 111.006 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.614 ' CD2' HD11 ' A' ' 64' ' ' LEU . 70.0 m-85 -71.76 160.12 33.16 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -128.09 158.15 38.78 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.908 0.385 . . . . 0.0 111.563 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.533 ' HB2' HD11 ' A' ' 7' ' ' ILE . 9.5 t -138.93 99.86 3.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 89' ' ' SER . 4.4 t -109.8 126.33 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 121.066 0.46 . . . . 0.0 112.116 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.503 HG22 HG13 ' A' ' 35' ' ' ILE . 2.3 t -102.72 155.1 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.699 HG23 ' HB3' ' A' ' 88' ' ' GLN . 0.5 OUTLIER -132.66 143.45 49.66 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.13 176.5 6.95 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.371 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.94 -40.77 87.66 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.199 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.8 -36.24 28.63 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.392 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 150.06 -18.15 1.07 Allowed Glycine 0 C--N 1.339 0.75 0 CA-C-O 119.556 -0.58 . . . . 0.0 113.813 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.427 HG22 HD12 ' A' ' 3' ' ' LEU . 55.7 m -58.52 103.46 0.16 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.876 0.838 . . . . 0.0 110.702 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.699 ' HB3' HG23 ' A' ' 82' ' ' THR . 6.2 pt20 -109.39 132.54 54.03 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.796 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.497 ' O ' HG13 ' A' ' 80' ' ' VAL . 66.1 p -99.65 -176.86 3.39 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -161.3 175.51 12.19 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -159.7 176.42 12.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.127 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.2 163.86 39.61 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.644 HG21 ' CD2' ' A' ' 22' ' ' PHE . 8.5 p -152.63 123.11 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.75 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.59 ' HA ' HD13 ' A' ' 76' ' ' ILE . 1.9 t-20 -80.97 96.03 6.96 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.988 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.433 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 14.0 t -97.94 123.59 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.531 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -108.53 160.28 16.04 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.911 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.864 HD13 ' HB1' ' A' ' 69' ' ' ALA . 12.0 mt -151.58 125.74 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.684 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -116.58 127.98 54.99 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.342 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.735 -179.873 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.493 HD11 ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 120.803 0.335 . . . . 0.0 110.957 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.722 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 9.2 tp-100 -127.18 148.37 50.18 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.422 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 t -145.76 147.23 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 123.12 0.262 . . . . 0.0 111.445 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -160.3 126.2 4.09 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.323 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.516 HD11 ' HB2' ' A' ' 79' ' ' CYS . 43.7 mt -97.28 139.48 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.656 0.265 . . . . 0.0 110.648 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.6 t -128.17 130.86 23.55 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.942 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.56 172.03 64.51 Favored 'Cis proline' 0 C--N 1.365 1.443 0 CA-C-N 119.73 0.939 . . . . 0.0 112.377 -0.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 p -69.83 -53.2 19.23 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.337 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -129.96 107.61 9.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.211 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.41 158.97 24.81 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 116.077 -0.51 . . . . 0.0 113.545 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -143.37 119.5 10.76 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.13 164.24 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.711 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.97 157.62 16.73 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 69' ' ' ALA . 38.9 t -63.69 138.49 22.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.87 -15.18 63.68 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.436 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -99.04 162.63 12.96 Favored 'General case' 0 C--N 1.348 0.511 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.1 p -102.73 168.35 9.31 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.639 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -163.94 121.44 1.77 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.483 -178.643 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.753 ' HB3' HG23 ' A' ' 65' ' ' THR . 35.7 p90 -115.05 142.29 46.84 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.622 178.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.644 ' CD2' HG21 ' A' ' 93' ' ' VAL . 93.4 m-85 -118.42 118.4 31.64 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.004 0.43 . . . . 0.0 111.283 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.0 tp -79.21 116.44 19.48 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.9 t -97.93 100.65 12.01 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.404 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 -91.4 158.78 16.32 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.777 HG21 ' CB ' ' A' ' 60' ' ' ASP . 34.1 m -134.86 174.36 13.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.722 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.234 0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.764 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.551 ' O ' HG22 ' A' ' 81' ' ' VAL . 54.7 m-20 . . . . . 0 N--CA 1.466 0.331 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.518 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.2 mp -130.21 153.39 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 123.318 0.386 . . . . 0.0 110.856 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.2 m -152.31 160.63 43.3 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.34 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.463 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 59.1 m95 -132.63 130.82 40.68 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.216 0.206 . . . . 0.0 110.792 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 67.3 m-85 -122.12 117.96 27.53 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.9 p -62.51 152.85 79.42 Favored Pre-proline 0 C--O 1.253 1.285 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.425 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 C--N 1.38 2.235 0 C-N-CA 124.472 3.448 . . . . 0.0 115.947 -178.77 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 19.1 tttt . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 120.549 0.214 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 45' ' ' LEU . 1.0 OUTLIER -111.12 152.69 26.68 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.605 179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 m -79.36 163.05 61.36 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.341 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.22 -28.06 12.99 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.66 2.24 . . . . 0.0 112.696 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -139.41 72.99 1.41 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.13 0.491 . . . . 0.0 111.009 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.416 ' NE2' ' HB2' ' A' ' 45' ' ' LEU . 4.2 mt-30 -80.61 -68.76 0.65 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.992 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -156.67 -72.73 0.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -99.74 -35.85 9.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.426 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.539 HG12 HG23 ' A' ' 66' ' ' ILE . 48.7 mt -85.7 110.33 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.777 0.322 . . . . 0.0 110.78 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.3 t -114.49 118.66 34.4 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.659 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 55' ' ' VAL . 12.6 t -90.33 158.78 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.268 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.41 ' N ' HG12 ' A' ' 54' ' ' VAL . 12.3 p -153.99 152.09 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.963 0.411 . . . . 0.0 111.64 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 24.8 m-90 -123.16 104.56 9.25 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -91.16 -80.77 0.33 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -176.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -65.26 -177.92 0.44 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.41 0.148 . . . . 0.0 110.912 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.94 -33.73 62.53 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.777 ' CB ' HG21 ' A' ' 26' ' ' VAL . 45.3 m-20 -141.43 7.4 1.94 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.9 p -94.52 136.41 34.85 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.282 0.492 . . . . 0.0 110.459 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.518 ' OG ' HG21 ' A' ' 35' ' ' ILE . 0.7 OUTLIER -140.93 132.99 27.85 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.372 -178.835 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 m -102.89 146.3 28.51 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 111.921 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.622 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -111.47 94.95 5.23 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.532 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.753 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -85.18 142.49 29.43 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.822 0.344 . . . . 0.0 110.274 -179.534 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.539 HG23 HG12 ' A' ' 52' ' ' ILE . 67.9 mt -139.53 90.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -59.57 -113.46 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.304 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -53.28 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.968 1.258 . . . . 0.0 111.154 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.877 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -75.63 143.0 42.5 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.294 -178.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.757 ' O ' HD12 ' A' ' 97' ' ' ILE . 10.7 m120 -136.11 153.49 51.28 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.689 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.492 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -52.67 -25.68 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -71.21 -42.15 69.31 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.432 ' OD2' HD11 ' A' ' 52' ' ' ILE . 4.6 m-20 -62.99 -34.72 78.14 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.678 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.535 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -53.28 112.03 0.8 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.67 179.06 47.69 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.547 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.828 HD13 ' HA ' ' A' ' 94' ' ' ASN . 23.4 mm -80.72 95.5 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 122.051 0.14 . . . . 0.0 111.175 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.622 ' CD2' HD11 ' A' ' 64' ' ' LEU . 61.0 m-85 -71.95 167.08 20.85 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -132.03 158.16 42.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 112.258 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.516 ' HB2' HD11 ' A' ' 7' ' ' ILE . 4.2 t -140.12 100.39 3.9 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.304 178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 89' ' ' SER . 5.2 t -107.67 129.7 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 111.872 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 34' ' ' ASP . 1.6 t -108.2 156.41 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.55 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.9 m -132.78 149.11 52.31 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.28 -173.65 3.14 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.692 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.69 -48.47 21.88 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.116 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.27 -37.81 71.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.23 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 150.0 -18.54 1.08 Allowed Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.06 -0.59 . . . . 0.0 113.86 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.493 ' O ' HD11 ' A' ' 3' ' ' LEU . 96.2 m -57.92 108.3 0.57 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.859 0.829 . . . . 0.0 110.582 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.55 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -113.53 134.55 54.62 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.265 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.569 ' O ' HG13 ' A' ' 80' ' ' VAL . 83.6 p -97.15 -177.89 4.0 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -160.53 171.76 18.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -154.51 172.83 17.17 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.009 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.79 155.76 38.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.728 0.299 . . . . 0.0 111.248 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.644 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.5 p -142.92 118.93 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.348 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.828 ' HA ' HD13 ' A' ' 76' ' ' ILE . 7.9 t30 -76.15 88.27 3.04 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.347 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.465 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 16.0 t -87.9 131.63 35.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.058 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.23 153.57 32.66 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.559 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.877 HD13 ' HB1' ' A' ' 69' ' ' ALA . 9.8 mt -145.67 128.61 10.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.563 178.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.77 133.24 53.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.358 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.929 -179.817 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.582 HD11 ' HB2' ' A' ' 83' ' ' ALA . 1.4 mp . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.798 0.332 . . . . 0.0 111.583 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.649 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 10.6 tp-100 -138.74 140.55 38.72 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.232 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.533 HG21 ' O ' ' A' ' 89' ' ' SER . 11.4 t -144.92 141.25 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.672 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -157.37 124.82 5.25 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.587 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.516 HD11 ' HB2' ' A' ' 79' ' ' CYS . 48.6 mt -92.39 143.66 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.594 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.6 t -131.11 133.03 24.18 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.887 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.24 169.99 73.05 Favored 'Cis proline' 0 C--N 1.363 1.303 0 CA-C-N 119.719 0.935 . . . . 0.0 112.029 0.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.4 p -68.2 -42.15 80.3 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -133.47 111.87 11.08 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.289 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.451 ' O ' HD12 ' A' ' 14' ' ' ILE . . . -106.2 100.39 1.64 Allowed Glycine 0 C--N 1.341 0.855 0 C-N-CA 120.895 -0.669 . . . . 0.0 114.251 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.51 ' C ' HD12 ' A' ' 14' ' ' ILE . 0.8 OUTLIER -85.64 128.91 34.91 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.487 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.51 HD12 ' C ' ' A' ' 13' ' ' GLU . 5.0 mp -144.53 162.92 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.662 0.268 . . . . 0.0 110.733 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.17 156.45 17.7 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.729 0.3 . . . . 0.0 110.367 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.647 HG13 ' O ' ' A' ' 69' ' ' ALA . 28.4 t -62.91 138.55 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.999 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.1 -15.75 62.47 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.343 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -97.16 159.17 15.07 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.0 p -97.36 164.47 12.45 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.647 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -159.31 116.62 2.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -177.192 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.879 ' HB3' HG23 ' A' ' 65' ' ' THR . 39.1 p90 -111.52 143.28 42.63 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.64 0.257 . . . . 0.0 111.143 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.523 ' CZ ' HG22 ' A' ' 95' ' ' VAL . 85.5 m-85 -120.72 110.02 15.88 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.5 tp -77.56 112.53 14.44 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.2 t -94.05 108.17 20.02 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.208 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -96.88 155.37 16.8 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.755 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.62 HG21 ' CB ' ' A' ' 60' ' ' ASP . 30.1 m -129.24 175.49 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.649 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 CA--C 1.532 0.281 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.828 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.469 0.524 0 CA-C-O 120.357 0.122 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.634 HD11 ' HA ' ' A' ' 60' ' ' ASP . 4.2 mp -66.77 150.01 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.209 0.528 . . . . 0.0 112.115 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.3 m -150.46 155.54 39.72 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.463 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.478 ' O ' ' HA ' ' A' ' 44' ' ' LYS . 43.8 m95 -134.86 117.92 16.41 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 119.239 -0.41 . . . . 0.0 111.136 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -117.5 109.83 17.22 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.287 0.367 . . . . 0.0 111.885 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 p -59.89 154.67 47.11 Favored Pre-proline 0 C--O 1.246 0.905 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.941 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo . . . . . 0 C--N 1.383 2.385 1 C-N-CA 125.696 4.264 . . . . 0.0 114.618 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 27.9 tttt . . . . . 0 N--CA 1.466 0.367 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.472 HD13 HG21 ' A' ' 52' ' ' ILE . 12.2 mt -77.95 175.9 9.62 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.587 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.5 m -94.28 156.11 39.17 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.884 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.91 -34.53 90.94 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.322 2.015 . . . . 0.0 112.5 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -152.69 63.6 0.8 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.229 0.538 . . . . 0.0 110.568 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.11 -73.58 0.12 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.577 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -147.84 -74.51 0.19 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.638 0.256 . . . . 0.0 110.782 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -99.35 -36.62 9.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.758 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.579 HG12 HG23 ' A' ' 66' ' ' ILE . 18.0 mt -84.64 104.96 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.936 0.398 . . . . 0.0 110.796 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.3 t -107.56 120.34 41.92 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.838 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.2 t -90.99 159.1 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.6 p -151.63 146.43 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.96 0.409 . . . . 0.0 111.839 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 23.1 m-90 -121.38 106.59 11.59 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -98.72 -79.97 0.47 Allowed 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -62.64 -177.63 0.16 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.653 0.263 . . . . 0.0 111.628 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -50.25 -35.92 28.97 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.634 ' HA ' HD11 ' A' ' 35' ' ' ILE . 42.0 m-20 -149.37 17.89 0.94 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.9 t -98.06 139.07 34.42 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.563 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -145.71 131.28 18.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -178.311 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.87 151.96 19.69 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.043 0.449 . . . . 0.0 111.958 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.605 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -114.25 92.9 4.12 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.254 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.879 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -87.43 139.99 29.99 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 123.382 0.426 . . . . 0.0 110.614 -179.027 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.579 HG23 HG12 ' A' ' 52' ' ' ILE . 49.3 mt -136.84 93.9 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -58.36 -107.59 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 119.049 -0.5 . . . . 0.0 111.251 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.42 95.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.796 1.18 . . . . 0.0 110.591 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.791 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -79.77 149.74 31.0 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.676 -178.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.764 ' O ' HD12 ' A' ' 97' ' ' ILE . 1.1 p30 -146.37 157.42 43.78 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.174 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.7 pt -53.86 -24.68 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -71.68 -39.87 69.95 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -67.07 -35.93 80.9 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.591 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -50.36 117.57 2.48 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.97 174.87 38.52 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.023 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.851 HD13 ' HA ' ' A' ' 94' ' ' ASN . 17.6 mm -73.75 91.27 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 122.18 0.192 . . . . 0.0 111.271 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.605 ' CD2' HD11 ' A' ' 64' ' ' LEU . 63.3 m-85 -68.43 172.6 5.83 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -135.32 158.21 44.95 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.516 ' HB2' HD11 ' A' ' 7' ' ' ILE . 12.3 t -142.0 97.78 3.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.149 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 90' ' ' GLU . 4.6 t -102.85 131.65 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.0 0.429 . . . . 0.0 111.931 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.87 139.84 43.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.643 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.9 m -125.71 143.99 50.8 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.582 ' HB2' HD11 ' A' ' 3' ' ' LEU . . . -93.26 -176.13 4.04 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.958 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -69.76 -57.41 5.14 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.076 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -60.55 -31.78 70.87 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 138.84 -18.85 3.16 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.477 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.8 m -59.55 107.81 0.64 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.335 0.568 . . . . 0.0 111.199 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.643 ' HB3' HG23 ' A' ' 82' ' ' THR . 1.1 pt20 -115.2 134.14 55.41 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.444 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.533 ' O ' HG21 ' A' ' 5' ' ' VAL . 31.8 t -115.12 119.76 37.5 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.458 ' HB3' HG13 ' A' ' 80' ' ' VAL . 18.6 pt-20 -104.63 -179.62 4.0 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -154.06 178.06 10.38 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.132 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.04 154.85 36.78 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.592 0.234 . . . . 0.0 111.051 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.505 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.2 p -138.86 123.17 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.965 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.851 ' HA ' HD13 ' A' ' 76' ' ' ILE . 6.0 t30 -75.2 96.91 3.39 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.26 0.553 . . . . 0.0 110.261 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.523 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 60.8 t -96.71 131.96 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.441 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -121.4 147.63 45.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.383 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.791 HD13 ' HB1' ' A' ' 69' ' ' ALA . 13.1 mt -141.25 137.22 33.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.22 134.01 37.68 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.948 -177.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.472 ' HB3' HG21 ' A' ' 16' ' ' VAL . 4.7 pt20 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.305 -0.855 . . . . 0.0 110.94 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.3 tp . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 120.658 0.266 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.649 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -135.85 136.47 40.61 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.654 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -143.77 142.66 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.46 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -156.43 158.83 37.99 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.127 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.421 HD11 ' HB2' ' A' ' 79' ' ' CYS . 50.9 mt -128.13 138.71 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.8 128.1 24.98 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.269 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.448 ' O ' HG23 ' A' ' 93' ' ' VAL . 98.5 Cg_endo -80.37 173.79 50.97 Favored 'Cis proline' 0 C--N 1.366 1.498 0 CA-C-N 119.68 0.922 . . . . 0.0 112.332 -0.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.8 p -69.66 -46.5 65.98 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -130.69 101.96 5.9 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.46 101.75 2.61 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.786 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.85 119.95 26.72 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.588 HD13 ' CB ' ' A' ' 20' ' ' LYS . 2.4 mp -135.6 166.57 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.42 161.6 18.83 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.481 0.657 . . . . 0.0 111.962 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 69' ' ' ALA . 57.6 t -65.42 137.4 25.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.861 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.72 -18.47 57.21 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.194 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -114.76 145.22 42.34 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 117.593 0.696 . . . . 0.0 110.291 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.5 p -79.01 173.99 12.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.638 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -166.79 118.99 0.97 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.976 -178.931 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.646 ' HB3' HG23 ' A' ' 65' ' ' THR . 44.6 p90 -115.81 146.57 41.85 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.612 0.244 . . . . 0.0 110.831 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.648 ' CD2' HG21 ' A' ' 93' ' ' VAL . 75.9 m-85 -121.49 112.85 19.02 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.07 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.0 tp -79.12 111.26 15.16 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.5 t -92.82 110.1 21.54 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.217 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -95.31 164.73 12.71 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.871 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' ' 60' ' ' ASP . 27.5 m -142.01 170.6 12.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.649 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.233 0.235 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.252 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.904 HD13 HG23 ' A' ' 81' ' ' VAL . 13.1 mm -70.51 155.16 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.371 0.605 . . . . 0.0 111.779 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.9 m -155.11 157.66 37.82 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.275 178.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.433 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 58.7 m95 -131.82 123.69 28.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.577 0.172 . . . . 0.0 111.004 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 80.0 m-85 -116.76 113.22 22.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.9 p -62.78 152.51 82.1 Favored Pre-proline 0 C--O 1.254 1.323 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.306 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo . . . . . 0 C--N 1.381 2.265 0 C-N-CA 124.374 3.383 . . . . 0.0 115.267 -179.274 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 12.6 ttmt . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.459 0.171 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.3 pp -83.99 135.16 34.56 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.815 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.5 m -69.75 155.03 94.22 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.046 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.62 -30.57 7.72 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 122.364 2.043 . . . . 0.0 112.761 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -117.19 56.5 0.82 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.151 0.501 . . . . 0.0 111.155 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -76.01 -80.46 0.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.285 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -155.78 -72.68 0.11 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -99.74 -29.72 12.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.718 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.499 HG12 HG23 ' A' ' 66' ' ' ILE . 47.4 mt -89.36 106.01 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.811 0.338 . . . . 0.0 110.871 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 t -111.91 123.38 50.12 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.724 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 t -95.5 157.33 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -152.87 143.36 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.5 m-90 -116.41 115.02 25.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.09 -76.34 0.58 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.92 -173.41 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -48.94 -42.1 36.19 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.563 0.345 . . . . 0.0 111.818 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.533 ' HB2' HG21 ' A' ' 26' ' ' VAL . 10.4 m-20 -156.57 28.61 0.33 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.228 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.9 t -99.73 141.33 32.68 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.421 ' OG ' HG21 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -147.66 132.49 18.01 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -177.759 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.46 HG22 ' HB2' ' A' ' 21' ' ' PHE . 1.5 m -98.36 143.68 28.56 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.142 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.669 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -106.17 92.78 4.29 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.717 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.646 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -84.67 136.83 33.58 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 123.426 0.453 . . . . 0.0 110.745 -178.713 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.561 HD12 ' HD2' ' A' ' 20' ' ' LYS . 53.9 mt -134.87 91.0 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -60.46 -111.84 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 118.921 -0.562 . . . . 0.0 111.283 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.55 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.841 1.2 . . . . 0.0 110.923 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.814 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -75.59 136.71 40.5 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.04 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.781 ' O ' HD12 ' A' ' 97' ' ' ILE . 10.9 m120 -132.86 152.63 51.81 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.127 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.0 pt -51.72 -25.11 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -68.39 -44.49 74.99 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -64.96 -35.47 81.27 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.81 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.506 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -49.79 118.31 2.78 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.43 176.48 39.36 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.064 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.3 mt -82.29 101.82 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.638 0.219 . . . . 0.0 110.892 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.669 ' CD2' HD11 ' A' ' 64' ' ' LEU . 52.0 m-85 -75.35 171.28 14.5 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -132.84 156.5 47.04 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.421 ' HB2' HD11 ' A' ' 7' ' ' ILE . 13.9 t -140.72 105.73 4.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.296 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.1 t -109.19 144.79 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.904 HG23 HD13 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -129.39 130.61 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.537 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.3 m -110.17 148.19 32.28 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.22 -178.92 4.91 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.616 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -74.33 -37.69 63.5 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.162 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -81.6 -31.08 32.67 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.422 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.92 -16.58 2.8 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-O 119.856 -0.413 . . . . 0.0 113.281 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 59.3 m -59.0 110.06 0.96 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.328 0.564 . . . . 0.0 111.23 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.537 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -120.65 134.26 55.3 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.146 179.27 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.4 t -121.98 133.63 54.82 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -117.25 -178.59 3.49 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.62 173.99 13.5 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.848 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.57 155.92 43.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.564 0.221 . . . . 0.0 110.87 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.648 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.2 p -140.84 115.75 6.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.746 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.8 97.36 1.37 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.453 0.471 . . . . 0.0 110.535 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.484 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 14.3 t -99.92 136.29 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.769 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -125.54 152.41 45.08 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.226 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.814 HD13 ' HB1' ' A' ' 69' ' ' ALA . 12.3 mt -139.86 110.77 4.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.357 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.56 125.35 52.44 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.353 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.258 -179.657 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 120.394 0.14 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.764 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 22.9 tt0 -133.33 157.74 44.73 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.591 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 89' ' ' SER . 0.9 OUTLIER -151.87 155.27 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.433 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -160.04 130.33 5.49 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.156 0.285 . . . . 0.0 110.84 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.46 HD11 ' HB3' ' A' ' 79' ' ' CYS . 28.0 mt -96.25 142.53 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.639 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.89 128.69 24.17 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.38 -176.17 17.06 Favored 'Cis proline' 0 C--N 1.365 1.396 0 CA-C-N 120.084 1.066 . . . . 0.0 112.301 0.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.1 p -76.24 -40.67 51.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.144 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -126.03 124.68 41.19 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.032 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.407 ' C ' HD12 ' A' ' 14' ' ' ILE . . . -106.06 72.53 0.22 Allowed Glycine 0 C--N 1.341 0.86 0 C-N-CA 121.142 -0.551 . . . . 0.0 114.359 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.472 ' C ' HD12 ' A' ' 14' ' ' ILE . 27.7 mt-10 -76.92 112.65 13.76 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.472 HD12 ' C ' ' A' ' 13' ' ' GLU . 2.9 mp -135.77 164.83 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.7 154.88 17.64 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.8 t -63.06 141.52 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.094 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.86 -11.0 71.86 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.463 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -101.95 153.3 20.0 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.1 p -91.45 156.55 17.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.517 0.199 . . . . 0.0 111.061 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.675 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -151.59 117.39 5.46 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.666 -177.69 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.84 ' HB3' HG23 ' A' ' 65' ' ' THR . 36.1 p90 -112.64 144.11 42.69 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.65 0.262 . . . . 0.0 111.12 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.635 ' CD2' HG21 ' A' ' 93' ' ' VAL . 82.6 m-85 -122.99 118.0 26.78 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.38 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.8 tp -79.26 113.8 17.69 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.436 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 23.2 t -96.6 97.56 9.49 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -92.54 162.86 14.03 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.16 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.513 HG21 ' HB2' ' A' ' 60' ' ' ASP . 35.1 m -119.31 174.86 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.764 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 CA--C 1.533 0.3 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.305 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 t70 . . . . . 0 N--CA 1.466 0.357 0 N-CA-C 111.388 0.144 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.522 ' H ' HD12 ' A' ' 35' ' ' ILE . 5.1 mp -73.84 157.41 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 O-C-N 123.476 0.485 . . . . 0.0 111.36 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.418 ' N ' HG22 ' A' ' 35' ' ' ILE . 11.6 m -155.6 162.49 40.63 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.686 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.443 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 56.5 m95 -139.94 126.68 20.56 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.873 0.108 . . . . 0.0 110.942 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 84.2 m-85 -121.98 111.68 17.35 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.766 ' OG ' HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -65.76 161.39 53.81 Favored Pre-proline 0 C--O 1.256 1.423 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.384 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo . . . . . 0 C--N 1.382 2.294 0 C-N-CA 125.298 3.999 . . . . 0.0 115.805 -179.093 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 9.7 ttpt . . . . . 0 C--O 1.234 0.256 0 CA-C-O 120.455 0.169 . . . . 0.0 111.425 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.766 HD11 ' OG ' ' A' ' 39' ' ' SER . 10.6 mt -74.37 145.67 43.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.548 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.5 m -77.42 162.14 69.9 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.776 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.15 -30.42 65.15 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 122.318 2.012 . . . . 0.0 112.432 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -141.98 75.31 1.49 Allowed 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.01 0.433 . . . . 0.0 111.032 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -76.21 -82.81 0.07 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.827 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -150.15 -72.8 0.17 Allowed 'General case' 0 C--N 1.342 0.277 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 -99.8 -33.36 10.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.504 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.697 HG12 HG23 ' A' ' 66' ' ' ILE . 21.2 mt -88.1 103.3 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.726 0.298 . . . . 0.0 110.779 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.6 t -109.28 122.14 46.7 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.255 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 55' ' ' VAL . 11.8 t -94.34 160.8 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.414 ' N ' HG12 ' A' ' 54' ' ' VAL . 7.2 p -156.99 133.99 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -109.58 114.97 29.04 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -113.94 -73.84 0.64 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -171.47 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.84 -36.16 74.1 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.59 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.513 ' HB2' HG21 ' A' ' 26' ' ' VAL . 42.3 m-20 -153.37 23.17 0.54 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.174 -0.467 . . . . 0.0 112.177 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.2 t -109.47 141.18 42.27 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.459 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.4 m -134.36 -173.77 3.37 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.342 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 m -154.91 142.15 19.45 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.011 0.434 . . . . 0.0 111.213 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.686 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -109.69 93.84 4.71 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.756 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.84 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -90.33 139.05 31.03 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.363 0.415 . . . . 0.0 110.64 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.697 HG23 HG12 ' A' ' 52' ' ' ILE . 14.7 mt -135.17 86.46 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -49.49 -65.57 0.54 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -176.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.422 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 5.0 t-20 -63.59 -66.33 0.56 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.477 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . . . 75.4 125.96 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.084 0.553 . . . . 0.0 111.37 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.768 ' O ' HD12 ' A' ' 97' ' ' ILE . 9.8 m120 -147.16 167.37 24.32 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.4 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.8 pt -55.92 -22.98 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -75.29 -38.25 60.47 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -68.75 -32.96 73.09 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.542 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.514 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -51.95 109.17 0.34 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.06 173.42 45.59 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.742 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.7 mt -79.95 97.1 2.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.978 0.389 . . . . 0.0 110.823 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.686 ' CD2' HD11 ' A' ' 64' ' ' LEU . 58.8 m-85 -72.16 169.32 16.35 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -132.06 154.55 49.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.023 0.44 . . . . 0.0 111.777 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.46 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -138.17 103.47 4.95 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.71 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.6 t -108.36 143.33 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.26 147.15 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.634 HG23 ' HG2' ' A' ' 88' ' ' GLN . 0.5 OUTLIER -126.07 140.93 52.19 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.933 0.397 . . . . 0.0 111.751 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.24 -171.09 3.39 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.182 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -78.97 -35.62 42.75 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.458 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -88.38 -34.75 17.47 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.01 -18.94 1.22 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.77 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 62.6 m -51.17 114.61 1.25 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.499 0.65 . . . . 0.0 111.148 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.634 ' HG2' HG23 ' A' ' 82' ' ' THR . 6.9 mt-30 -106.71 138.95 41.93 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.99 0.424 . . . . 0.0 111.984 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.409 ' O ' HG21 ' A' ' 5' ' ' VAL . 6.0 p -125.97 108.0 10.99 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -104.4 177.91 4.71 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -149.38 169.7 20.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.936 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.66 152.09 37.27 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.999 0.428 . . . . 0.0 111.399 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.635 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.0 p -139.72 114.59 7.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.897 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.59 87.58 1.22 Allowed 'General case' 0 C--O 1.235 0.331 0 O-C-N 123.511 0.507 . . . . 0.0 110.34 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.415 ' CG1' ' HE2' ' A' ' 20' ' ' LYS . 18.4 t -87.4 130.08 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.396 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -115.46 158.13 22.98 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.815 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.768 HD12 ' O ' ' A' ' 70' ' ' ASN . 9.5 mt -148.25 135.19 13.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.736 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.91 129.96 52.25 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.561 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.018 -179.776 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.485 HD23 HG12 ' A' ' 81' ' ' VAL . 10.3 mp . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.629 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -133.97 141.42 47.28 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.468 178.749 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 89' ' ' SER . 9.6 t -148.1 144.38 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 123.169 0.293 . . . . 0.0 111.189 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -154.88 148.21 25.02 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.597 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.8 mt -122.29 108.61 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.8 t -92.74 126.41 51.92 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.552 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -83.64 175.31 37.08 Favored 'Cis proline' 0 C--N 1.364 1.353 0 CA-C-N 119.969 1.025 . . . . 0.0 112.21 -0.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.2 p -71.1 -40.23 71.63 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -141.04 118.63 11.59 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.753 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.55 105.63 1.66 Allowed Glycine 0 C--N 1.343 0.934 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.974 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.544 ' C ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -85.73 130.71 34.49 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.554 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.544 HD12 ' C ' ' A' ' 13' ' ' GLU . 3.7 mp -146.71 164.96 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.09 157.66 17.38 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.842 0.353 . . . . 0.0 110.507 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.4 t -62.07 141.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.164 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.06 -7.38 81.57 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.356 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -104.78 152.0 23.1 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 76.6 p -92.58 155.66 17.63 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.576 0.227 . . . . 0.0 110.888 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.649 ' HD2' HD12 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -154.8 119.58 4.87 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.949 -178.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.728 ' HB3' HG23 ' A' ' 65' ' ' THR . 22.2 p90 -112.47 147.77 35.81 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.913 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.667 ' CD2' HG21 ' A' ' 93' ' ' VAL . 87.6 m-85 -124.75 118.77 27.16 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.196 0.522 . . . . 0.0 111.32 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.6 HD12 ' HG3' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -77.8 130.57 36.86 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.813 -178.579 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.496 ' N ' HD13 ' A' ' 23' ' ' LEU . 18.0 t -114.48 98.46 6.91 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.6 ' HG3' HD12 ' A' ' 23' ' ' LEU . 36.6 mt-30 -88.87 157.69 18.35 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.849 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.741 HG21 ' CB ' ' A' ' 60' ' ' ASP . 24.7 m -137.89 169.9 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.234 0.269 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.47 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.595 HG21 ' OG ' ' A' ' 62' ' ' SER . 5.1 mp -72.13 147.99 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.925 0.393 . . . . 0.0 110.994 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.9 m -147.06 154.49 41.24 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.318 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.428 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 43.3 m95 -129.59 113.86 15.34 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.062 0.145 . . . . 0.0 111.24 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -113.35 110.96 21.2 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 p -59.73 154.23 47.95 Favored Pre-proline 0 C--O 1.244 0.809 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.472 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 C--N 1.379 2.176 0 C-N-CA 125.252 3.968 . . . . 0.0 113.779 -179.169 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 11.1 tttt . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 pp -80.55 148.69 30.26 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.203 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.7 m -67.46 155.47 90.92 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.33 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -83.96 -22.11 3.66 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 122.522 2.148 . . . . 0.0 113.388 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -139.4 73.39 1.43 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.282 0.563 . . . . 0.0 110.328 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -104.94 -57.38 2.03 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.924 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.51 -83.76 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.79 -32.54 11.67 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.534 HG12 HG23 ' A' ' 66' ' ' ILE . 40.6 mt -90.47 107.56 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 120.662 0.267 . . . . 0.0 110.374 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.8 t -112.77 121.63 45.27 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.587 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 55' ' ' VAL . 18.8 t -92.82 159.9 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.413 ' N ' HG12 ' A' ' 54' ' ' VAL . 7.6 p -156.22 147.13 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -125.84 123.01 37.74 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.101 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.55 -73.94 0.63 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.2 -173.14 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -53.71 -40.28 65.9 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.663 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.741 ' CB ' HG21 ' A' ' 26' ' ' VAL . 9.7 m-20 -152.6 22.91 0.61 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.948 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.75 141.31 31.72 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.595 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.8 m -135.28 -170.56 2.62 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.055 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -159.24 142.05 14.18 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.664 0.269 . . . . 0.0 110.697 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.679 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -113.15 92.76 4.12 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.902 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.728 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -86.79 138.88 31.23 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.269 0.355 . . . . 0.0 110.131 -179.661 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.649 HD12 ' HD2' ' A' ' 20' ' ' LYS . 40.5 mt -135.22 82.12 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -49.36 -56.81 8.29 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -176.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 3.7 t-20 -71.06 -71.69 0.24 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 68' ' ' ASN . . . 81.12 120.97 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.501 0.721 . . . . 0.0 110.679 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.806 ' O ' HD12 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -141.7 159.99 41.1 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.267 0.556 . . . . 0.0 110.564 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 30.3 pt -51.01 -25.84 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -75.14 -39.83 60.13 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -64.46 -32.55 74.23 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.929 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.526 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -53.51 106.22 0.17 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.92 178.64 48.65 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.869 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.542 HG23 ' HB ' ' A' ' 92' ' ' THR . 1.1 mp -79.21 100.49 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.915 0.357 . . . . 0.0 110.816 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.679 ' CD2' HD11 ' A' ' 64' ' ' LEU . 48.0 m-85 -72.14 172.73 9.63 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -135.3 157.5 46.75 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 6.4 t -141.18 97.93 3.27 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.634 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.616 HG13 ' HB3' ' A' ' 90' ' ' GLU . 3.5 t -104.24 132.54 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.485 HG12 HD23 ' A' ' 3' ' ' LEU . 0.7 OUTLIER -112.29 139.96 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.014 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.73 HG23 ' HG2' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -127.68 132.91 49.61 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -179.378 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.5 -176.06 5.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.441 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -72.26 -52.78 14.8 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.158 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -63.77 -29.33 70.55 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.86 0.85 5.99 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.59 -0.561 . . . . 0.0 114.225 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.8 m -65.95 113.74 4.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.807 0.804 . . . . 0.0 110.019 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.73 ' HG2' HG23 ' A' ' 82' ' ' THR . 4.3 mt-30 -105.46 145.64 30.59 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.873 0.368 . . . . 0.0 111.658 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.435 ' O ' HG21 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -144.7 107.41 4.45 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.25 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.616 ' HB3' HG13 ' A' ' 80' ' ' VAL . 13.7 pt-20 -109.01 -179.28 3.81 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -151.49 176.11 11.63 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.193 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.542 ' HB ' HG23 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -147.13 155.89 42.53 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.633 0.254 . . . . 0.0 111.138 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.667 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.9 p -139.6 117.81 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.205 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -71.6 93.32 1.22 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.814 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.469 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 14.6 t -95.48 116.59 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.621 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -101.91 150.33 23.3 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.292 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.806 HD12 ' O ' ' A' ' 70' ' ' ASN . 8.5 mt -141.59 130.93 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.221 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -117.77 129.12 55.49 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.028 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.191 -179.547 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 C--O 1.239 0.537 0 CA-C-O 121.157 0.503 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.637 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -85.21 139.51 31.6 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.545 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 89' ' ' SER . 11.6 t -145.78 135.02 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 123.419 0.449 . . . . 0.0 110.105 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -154.34 121.73 5.75 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.628 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.4 HD11 ' CB ' ' A' ' 79' ' ' CYS . 48.4 mt -89.74 138.94 18.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.35 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.4 t -122.96 129.4 24.99 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.086 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.463 ' O ' HG23 ' A' ' 93' ' ' VAL . 92.5 Cg_endo -79.63 166.61 77.35 Favored 'Cis proline' 0 C--N 1.364 1.362 0 CA-C-N 119.655 0.913 . . . . 0.0 112.105 -0.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 p -64.06 -41.17 97.46 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.133 0.492 . . . . 0.0 109.92 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -133.96 110.81 9.93 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.755 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.8 102.01 1.52 Allowed Glycine 0 C--N 1.341 0.859 0 C-N-CA 121.008 -0.615 . . . . 0.0 114.44 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.549 ' C ' HD12 ' A' ' 14' ' ' ILE . 13.6 mt-10 -87.82 134.93 33.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.549 HD12 ' C ' ' A' ' 13' ' ' GLU . 4.4 mp -146.48 163.64 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.653 0.263 . . . . 0.0 110.47 -178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.21 154.58 18.64 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.542 HG21 ' HB3' ' A' ' 99' ' ' GLN . 46.3 t -63.09 138.27 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.95 -7.91 78.52 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.522 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -103.03 155.82 18.11 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 117.49 0.645 . . . . 0.0 109.418 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.2 p -92.95 159.46 15.32 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 123.081 0.238 . . . . 0.0 110.784 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.57 ' HZ1' HD11 ' A' ' 97' ' ' ILE . 0.4 OUTLIER -156.24 119.99 4.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.662 -177.258 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.855 ' HB3' HG23 ' A' ' 65' ' ' THR . 49.0 p90 -114.72 140.24 49.03 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.506 0.193 . . . . 0.0 110.795 178.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.461 ' CD2' HG21 ' A' ' 93' ' ' VAL . 84.8 m-85 -117.12 110.64 18.43 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.312 0.577 . . . . 0.0 110.512 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.0 tp -79.03 107.16 11.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.206 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.8 t -89.79 106.3 18.38 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.041 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -95.17 165.5 12.37 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.725 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.9 m -141.95 173.23 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.637 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.235 0.3 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.017 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 19.6 t0 . . . . . 0 N--CA 1.462 0.147 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.662 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.1 mp -126.93 150.29 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 123.245 0.341 . . . . 0.0 110.865 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 57.6 m -147.81 162.82 38.47 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.024 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.43 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 56.5 m95 -138.46 134.58 34.2 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 75.6 m-85 -129.18 115.73 18.12 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.0 p -65.1 154.57 86.56 Favored Pre-proline 0 C--O 1.253 1.266 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.974 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo . . . . . 0 C--N 1.38 2.194 0 C-N-CA 124.97 3.78 . . . . 0.0 115.59 -179.228 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 9.0 tttm . . . . . 0 N--CA 1.464 0.228 0 CA-C-O 120.693 0.282 . . . . 0.0 111.382 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.56 HD23 HG21 ' A' ' 52' ' ' ILE . 0.5 OUTLIER -117.01 135.09 53.97 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.472 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.72 171.75 11.07 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.783 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.52 -39.12 2.13 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 122.651 2.234 . . . . 0.0 112.623 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -142.36 74.11 1.44 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.134 0.492 . . . . 0.0 111.613 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.69 -48.77 3.85 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -146.51 -155.6 0.64 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -24.29 3.86 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.668 HG12 HG23 ' A' ' 66' ' ' ILE . 42.3 mt -78.92 113.92 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.867 0.365 . . . . 0.0 111.046 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.9 t -118.0 117.96 30.64 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.572 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 55' ' ' VAL . 11.7 t -93.99 158.81 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.413 ' N ' HG12 ' A' ' 54' ' ' VAL . 12.3 p -156.48 156.74 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 16.1 m-90 -129.99 118.93 22.36 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.58 -77.07 0.57 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -54.53 -177.72 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -51.65 -37.85 52.16 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -155.25 26.08 0.41 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.078 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.4 t -107.97 140.95 40.36 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.662 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.4 m -130.04 -171.72 2.6 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 m -155.23 138.11 15.38 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.641 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -108.31 91.53 3.68 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.284 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.855 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -85.9 146.95 26.49 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.668 HG23 HG12 ' A' ' 52' ' ' ILE . 49.6 mt -145.46 91.19 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -56.43 -107.18 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.096 0 O-C-N 123.721 0.638 . . . . 0.0 111.63 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -59.98 93.42 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.892 1.223 . . . . 0.0 110.335 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.791 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -76.25 159.85 30.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.205 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.75 ' O ' HD12 ' A' ' 97' ' ' ILE . 8.7 m120 -152.36 162.89 40.52 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.26 0.552 . . . . 0.0 111.323 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 27.4 pt -55.39 -26.4 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.791 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -69.84 -40.51 75.78 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.281 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.02 -32.31 73.43 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.426 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.505 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -54.54 106.33 0.2 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.49 173.44 44.63 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.2 mt -78.42 98.04 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.812 0.306 . . . . 0.0 111.262 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.641 ' CD2' HD11 ' A' ' 64' ' ' LEU . 64.3 m-85 -72.37 173.25 9.01 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 155.68 50.25 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.4 ' CB ' HD11 ' A' ' 7' ' ' ILE . 47.3 t -136.44 96.18 3.31 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.585 HG13 ' HB3' ' A' ' 90' ' ' GLU . 11.7 t -101.28 126.74 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.954 0.407 . . . . 0.0 111.557 -178.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 34' ' ' ASP . 2.3 t -106.72 147.85 11.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.482 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.2 m -127.76 150.7 49.69 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.05 -178.39 5.43 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.865 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -72.08 -34.6 68.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.343 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -90.33 -39.37 12.76 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.491 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.38 -25.17 0.28 Allowed Glycine 0 C--N 1.34 0.8 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.885 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.5 m -55.14 108.1 0.38 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 117.387 0.593 . . . . 0.0 111.99 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.482 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.7 OUTLIER -113.1 136.5 52.64 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.466 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.472 ' O ' HG21 ' A' ' 5' ' ' VAL . 2.8 t -119.89 117.65 28.69 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.585 ' HB3' HG13 ' A' ' 80' ' ' VAL . 9.0 pt-20 -105.53 -179.41 3.93 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -176.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.63 174.65 13.71 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.532 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.27 155.36 43.81 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.576 0.227 . . . . 0.0 111.251 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 9' ' ' PRO . 7.8 p -138.57 116.51 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.119 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -72.83 98.43 2.43 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 123.416 0.447 . . . . 0.0 110.763 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.4 t -98.35 124.5 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.238 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -109.31 152.64 24.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.928 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.791 HD13 ' HB1' ' A' ' 69' ' ' ALA . 9.1 mt -146.67 139.27 19.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.071 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.99 133.03 29.5 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.729 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.542 ' HB3' HG21 ' A' ' 16' ' ' VAL . 6.5 pt20 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.171 -0.919 . . . . 0.0 111.016 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 tp . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.651 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 10.4 tp-100 -118.28 144.83 45.51 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.772 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -145.69 143.74 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.626 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -160.19 131.62 5.9 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.407 HD11 ' HB2' ' A' ' 79' ' ' CYS . 40.3 mt -104.06 136.99 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.727 0.299 . . . . 0.0 110.768 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.61 130.97 24.44 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.059 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.448 ' O ' HG23 ' A' ' 93' ' ' VAL . 84.2 Cg_endo -78.81 170.27 69.93 Favored 'Cis proline' 0 C--N 1.364 1.386 0 CA-C-N 119.549 0.875 . . . . 0.0 112.07 -0.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 p -67.67 -44.02 78.82 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.102 0.477 . . . . 0.0 109.819 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -131.26 105.47 7.67 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.569 ' O ' HD12 ' A' ' 14' ' ' ILE . . . -102.76 97.33 1.51 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 121.156 -0.545 . . . . 0.0 114.331 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -83.92 131.13 34.88 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.569 HD12 ' O ' ' A' ' 12' ' ' GLY . 3.4 mp -141.69 165.0 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 123.049 0.218 . . . . 0.0 110.701 -178.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.83 153.61 22.75 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.098 0.475 . . . . 0.0 110.848 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 69' ' ' ALA . 21.3 t -66.36 134.84 29.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.344 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.97 -15.83 56.37 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.228 -177.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -115.86 149.24 38.95 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 117.661 0.73 . . . . 0.0 110.098 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.8 p -78.13 174.71 10.86 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.58 ' HZ1' HD11 ' A' ' 97' ' ' ILE . 1.3 ptmm? -165.34 118.37 1.19 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.965 -177.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.72 ' HB3' HG23 ' A' ' 65' ' ' THR . 44.1 p90 -117.93 147.18 43.39 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.7 0.286 . . . . 0.0 111.13 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.593 ' CD2' HG21 ' A' ' 93' ' ' VAL . 76.3 m-85 -123.83 112.72 17.63 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.869 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.4 tp -79.21 112.97 16.95 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.5 t -95.2 100.48 12.27 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.71 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -92.28 160.45 15.13 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.525 HG21 ' HB2' ' A' ' 60' ' ' ASP . 34.8 m -139.99 165.71 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.651 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.235 0.342 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.232 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 111.173 0.064 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.751 HD11 ' HA ' ' A' ' 60' ' ' ASP . 4.4 mp -71.08 156.36 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 123.493 0.496 . . . . 0.0 111.657 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.418 ' N ' HG22 ' A' ' 35' ' ' ILE . 75.2 m -152.76 160.13 43.12 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.727 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.421 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 52.3 m95 -137.4 118.69 14.61 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.143 0.177 . . . . 0.0 110.662 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 96.5 m-85 -112.63 113.03 24.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 80.3 p -63.28 150.67 88.77 Favored Pre-proline 0 C--O 1.245 0.834 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.043 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo . . . . . 0 C--N 1.38 2.222 1 C-N-CA 125.397 4.065 . . . . 0.0 115.927 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 5.1 ttpt . . . . . 0 N--CA 1.468 0.439 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.406 HD11 ' CG2' ' A' ' 54' ' ' VAL . 4.0 pp -103.14 141.12 36.4 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.96 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m -75.61 158.03 83.57 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.799 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -90.04 19.65 1.17 Allowed 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.592 2.195 . . . . 0.0 113.8 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -155.73 34.26 0.35 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.735 0.303 . . . . 0.0 111.034 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -69.14 -70.4 0.28 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.696 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -154.89 -78.62 0.09 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -100.08 -35.11 9.8 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.717 0.407 . . . . 0.0 111.734 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.581 HG12 HG23 ' A' ' 66' ' ' ILE . 17.1 mt -78.02 97.82 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 123.224 0.328 . . . . 0.0 110.714 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 t -108.65 122.48 47.2 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.797 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 55' ' ' VAL . 21.7 t -94.81 159.88 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.418 ' N ' HG12 ' A' ' 54' ' ' VAL . 7.7 p -154.63 136.22 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.166 0.508 . . . . 0.0 111.634 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -109.91 110.59 21.59 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -100.63 -76.19 0.56 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -175.37 0.11 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.35 0.119 . . . . 0.0 110.972 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -57.16 -36.61 70.97 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.26 0.224 . . . . 0.0 111.519 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.751 ' HA ' HD11 ' A' ' 35' ' ' ILE . 67.2 m-20 -145.74 16.22 1.43 Allowed 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 p -102.44 141.01 35.96 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.482 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.9 m -135.88 -168.52 2.23 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.891 -0.141 . . . . 0.0 110.902 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.7 m -157.91 140.95 15.05 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.893 0.378 . . . . 0.0 110.779 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.694 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -109.49 91.2 3.55 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.36 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.72 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -86.87 142.86 27.74 Favored 'General case' 0 C--N 1.333 -0.135 0 O-C-N 123.463 0.477 . . . . 0.0 109.793 -179.733 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.581 HG23 HG12 ' A' ' 52' ' ' ILE . 60.1 mt -141.19 94.84 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -60.64 -111.95 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.157 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.0 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.089 1.313 . . . . 0.0 110.699 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.776 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -77.6 153.06 33.6 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.367 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.733 ' O ' HD12 ' A' ' 97' ' ' ILE . 9.0 m120 -149.99 161.4 42.41 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.493 0.663 . . . . 0.0 111.202 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.7 pt -55.48 -23.55 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.198 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -71.36 -41.28 69.94 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.44 -34.42 77.17 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.83 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.52 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -51.25 114.54 1.24 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.84 174.06 42.07 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.11 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.9 mt -81.81 100.54 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.734 0.267 . . . . 0.0 110.418 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.694 ' CD2' HD11 ' A' ' 64' ' ' LEU . 65.4 m-85 -75.67 171.77 13.76 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -134.76 157.73 45.96 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.885 0.374 . . . . 0.0 111.885 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.407 ' HB2' HD11 ' A' ' 7' ' ' ILE . 14.7 t -140.14 113.14 8.22 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 89' ' ' SER . 12.7 t -119.08 137.93 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.902 0.382 . . . . 0.0 111.94 -178.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.9 134.89 64.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.677 HG23 ' HB3' ' A' ' 88' ' ' GLN . 2.0 m -115.48 150.07 37.07 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.78 -175.01 2.94 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.296 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -71.24 -57.84 4.11 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.389 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.34 -28.65 70.15 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.46 -10.03 4.05 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 119.568 -0.573 . . . . 0.0 113.743 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 38.3 m -62.11 107.04 0.81 Allowed 'General case' 0 C--N 1.345 0.394 0 CA-C-N 117.793 0.796 . . . . 0.0 110.938 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.677 ' HB3' HG23 ' A' ' 82' ' ' THR . 10.1 pt20 -121.9 130.12 53.1 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.182 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.522 ' O ' HG13 ' A' ' 80' ' ' VAL . 7.6 t -102.47 177.39 4.88 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -154.53 179.2 9.26 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -158.25 171.56 19.98 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.284 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.6 155.1 42.22 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.737 0.303 . . . . 0.0 111.17 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.593 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.3 p -140.57 116.54 7.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.693 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -70.8 96.86 1.3 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.8 t -99.21 129.67 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.597 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.5 155.25 31.16 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.096 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.776 HD13 ' HB1' ' A' ' 69' ' ' ALA . 10.6 mt -147.93 125.37 3.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.646 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.42 137.08 53.99 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.284 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.072 -179.774 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.638 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -150.65 142.65 23.97 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.417 179.426 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 89' ' ' SER . 8.4 t -148.02 141.35 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 123.15 0.281 . . . . 0.0 110.452 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -159.62 124.84 4.09 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.367 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.612 HD11 ' HB2' ' A' ' 79' ' ' CYS . 50.2 mt -91.77 141.33 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.892 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.8 t -126.74 128.27 24.3 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.146 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -79.11 173.88 53.36 Favored 'Cis proline' 0 C--N 1.365 1.44 0 CA-C-N 119.885 0.995 . . . . 0.0 112.076 -0.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 93.6 p -71.36 -47.21 57.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.621 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -128.52 102.83 6.8 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.08 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.02 99.27 1.68 Allowed Glycine 0 C--N 1.341 0.807 0 CA-C-N 116.202 -0.453 . . . . 0.0 114.19 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.509 ' C ' HD12 ' A' ' 14' ' ' ILE . 6.4 mt-10 -83.24 143.56 30.35 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.664 HG23 ' HG3' ' A' ' 18' ' ' GLU . 1.2 mp -150.32 158.57 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.692 0.282 . . . . 0.0 111.192 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.72 152.63 20.25 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.792 HG13 ' O ' ' A' ' 69' ' ' ALA . 50.1 t -68.11 127.45 29.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.29 -14.16 25.7 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.841 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.664 ' HG3' HG23 ' A' ' 14' ' ' ILE . 5.0 pt-20 -115.21 145.41 42.44 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 117.506 0.653 . . . . 0.0 110.286 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.6 p -81.7 171.53 14.47 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.579 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -164.02 120.98 1.7 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.584 -178.909 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.721 ' HB3' HG23 ' A' ' 65' ' ' THR . 43.1 p90 -114.21 143.59 44.59 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.626 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.633 ' CD2' HG21 ' A' ' 93' ' ' VAL . 87.2 m-85 -119.63 115.72 24.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.059 0.457 . . . . 0.0 111.214 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp -79.43 111.62 15.87 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.3 t -92.32 102.14 14.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.101 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -90.88 163.0 14.55 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.581 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.777 HG21 ' CB ' ' A' ' 60' ' ' ASP . 23.6 m -138.94 172.88 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.638 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.236 0.36 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.417 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 10.3 t70 . . . . . 0 N--CA 1.464 0.232 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.712 HD13 HG22 ' A' ' 81' ' ' VAL . 27.2 mm -114.27 151.91 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 120.749 0.309 . . . . 0.0 111.164 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 m -151.37 156.71 41.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.69 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.427 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 67.3 m95 -134.74 131.46 37.64 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.394 0.278 . . . . 0.0 111.272 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 94.8 m-85 -120.71 117.81 28.44 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.0 p -69.42 150.6 97.01 Favored Pre-proline 0 C--O 1.25 1.105 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.882 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo . . . . . 0 C--N 1.382 2.327 0 C-N-CA 124.932 3.755 . . . . 0.0 116.062 -179.188 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 36.7 tttt . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.02 132.27 36.58 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.153 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.97 162.37 74.88 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.762 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -75.92 -28.8 7.41 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 122.719 2.279 . . . . 0.0 112.221 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -138.31 77.42 1.63 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.22 0.533 . . . . 0.0 109.85 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.07 -58.89 1.53 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.348 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -140.27 -160.57 1.09 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -50.6 -26.65 5.59 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.722 HG12 HG23 ' A' ' 66' ' ' ILE . 54.4 mt -83.68 96.89 4.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.67 0.271 . . . . 0.0 110.825 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.0 t -94.14 169.77 10.01 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.505 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 55' ' ' VAL . 11.7 t -141.9 159.7 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.419 ' N ' HG12 ' A' ' 54' ' ' VAL . 7.3 p -159.46 137.89 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.248 0.547 . . . . 0.0 112.221 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 17.4 m-90 -115.1 113.96 24.7 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.82 -77.82 0.59 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -57.65 -177.44 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -56.53 -35.48 68.14 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.777 ' CB ' HG21 ' A' ' 26' ' ' VAL . 58.8 m-20 -149.03 22.32 0.97 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 t -109.19 138.73 45.09 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.543 ' OG ' HG21 ' A' ' 35' ' ' ILE . 2.1 m -132.26 -170.64 2.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 m -158.24 137.88 12.0 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.715 0.293 . . . . 0.0 110.837 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.575 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -109.37 93.79 4.69 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.752 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.721 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -84.59 143.12 29.49 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.4 0.438 . . . . 0.0 110.245 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.722 HG23 HG12 ' A' ' 52' ' ' ILE . 57.9 mt -140.28 91.36 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -59.86 -112.8 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 O-C-N 123.641 0.588 . . . . 0.0 111.581 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.9 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.726 1.148 . . . . 0.0 110.921 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.833 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -75.13 146.0 41.73 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.414 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.745 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -144.21 159.01 43.4 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.322 0.582 . . . . 0.0 110.454 178.782 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.7 pt -51.75 -26.13 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -42.87 74.03 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -66.21 -34.3 77.72 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.736 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.555 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -53.27 107.04 0.2 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.73 179.25 46.16 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.249 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' A' ' 94' ' ' ASN . 33.2 mm -83.13 92.41 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.575 ' CD2' HD11 ' A' ' 64' ' ' LEU . 70.1 m-85 -68.39 165.6 18.43 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -129.94 155.66 45.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.248 0.547 . . . . 0.0 111.925 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.612 ' HB2' HD11 ' A' ' 7' ' ' ILE . 8.9 t -139.23 94.52 2.81 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 90' ' ' GLU . 7.3 t -101.36 135.91 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.174 0.512 . . . . 0.0 112.203 -177.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.712 HG22 HD13 ' A' ' 35' ' ' ILE . 14.4 t -118.16 157.13 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.221 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.713 HG23 ' CG ' ' A' ' 88' ' ' GLN . 1.3 m -135.07 150.64 50.29 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.57 -179.62 4.26 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.337 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -71.05 -46.4 62.06 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.75 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.91 -29.62 58.49 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.557 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 141.37 -10.34 2.72 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-O 119.561 -0.577 . . . . 0.0 113.828 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.2 m -59.46 108.43 0.71 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.97 0.885 . . . . 0.0 111.064 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.713 ' CG ' HG23 ' A' ' 82' ' ' THR . 26.8 mt-30 -105.22 135.57 46.33 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.376 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.584 ' O ' HG21 ' A' ' 5' ' ' VAL . 18.6 t -122.97 110.92 15.99 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.528 ' HB3' HG13 ' A' ' 80' ' ' VAL . 5.7 pt-20 -106.45 178.93 4.42 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -157.43 179.5 9.19 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.203 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.39 157.71 41.64 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.775 0.321 . . . . 0.0 111.538 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.633 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.4 p -141.61 121.52 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.607 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.473 ' HA ' HD13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -78.01 98.21 5.64 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.684 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.435 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 13.3 t -102.84 122.65 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.352 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -108.41 159.71 16.45 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.808 0.337 . . . . 0.0 111.145 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.833 HD13 ' HB1' ' A' ' 69' ' ' ALA . 11.3 mt -149.1 123.03 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.597 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.36 130.71 53.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.104 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.224 -0.894 . . . . 0.0 110.973 -179.76 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 120.522 0.201 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.71 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 6.5 tt0 -129.53 152.45 49.04 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.868 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -152.5 148.76 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.415 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -159.68 130.41 5.79 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.827 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.46 HD11 ' HB3' ' A' ' 79' ' ' CYS . 22.7 mt -95.13 133.86 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.277 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.5 t -116.31 126.17 27.84 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 119.266 -0.397 . . . . 0.0 109.977 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.47 -176.34 16.64 Favored 'Cis proline' 0 C--N 1.366 1.473 0 CA-C-N 119.993 1.033 . . . . 0.0 112.343 -0.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.8 p -77.77 -46.85 20.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.297 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -131.92 111.29 11.43 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.14 103.04 1.63 Allowed Glycine 0 C--N 1.34 0.766 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.962 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -84.65 134.06 34.38 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.523 HG23 ' HG3' ' A' ' 18' ' ' GLU . 1.7 mp -143.94 162.4 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.154 0.502 . . . . 0.0 111.618 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.29 150.09 23.35 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.503 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 69' ' ' ALA . 51.8 t -66.25 131.77 31.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.88 -15.25 44.69 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.149 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.523 ' HG3' HG23 ' A' ' 14' ' ' ILE . 4.3 pt-20 -116.14 147.26 41.55 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 117.625 0.712 . . . . 0.0 110.11 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 93.5 p -79.49 173.7 12.32 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.613 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -167.26 121.68 1.02 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.996 -178.742 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.749 ' HB3' HG23 ' A' ' 65' ' ' THR . 30.5 p90 -113.69 152.35 30.58 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.693 ' CD2' HG21 ' A' ' 93' ' ' VAL . 89.3 m-85 -129.64 119.18 23.14 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.17 0.509 . . . . 0.0 112.152 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.539 HD12 ' HG3' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -78.68 109.67 13.12 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -177.09 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.477 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 44.8 t -89.5 88.17 7.34 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.539 ' HG3' HD12 ' A' ' 23' ' ' LEU . 4.2 mt-30 -81.17 158.78 24.81 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.17 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.68 HG21 ' HB2' ' A' ' 60' ' ' ASP . 22.5 m -129.43 167.97 23.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.516 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.71 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.235 0.303 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.248 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.2 t70 . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.511 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.4 mp -75.24 157.13 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.991 0.425 . . . . 0.0 111.507 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.427 ' N ' HG22 ' A' ' 35' ' ' ILE . 5.7 m -155.48 160.79 40.86 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.484 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.477 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 46.1 m95 -136.11 115.07 12.23 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.245 0.091 . . . . 0.0 111.245 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -111.74 116.24 30.4 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.0 p -61.7 152.5 75.08 Favored Pre-proline 0 C--O 1.246 0.908 0 CA-C-O 119.092 -0.48 . . . . 0.0 110.135 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo . . . . . 0 C--N 1.381 2.24 1 C-N-CA 125.655 4.237 . . . . 0.0 114.133 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 pp -76.97 156.01 32.25 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.953 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 m -78.29 159.18 75.7 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.079 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.75 -35.69 1.4 Allowed 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 122.618 2.212 . . . . 0.0 112.289 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -125.11 68.59 1.12 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.404 0.621 . . . . 0.0 110.124 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.29 -53.06 2.73 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.412 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -145.97 -157.48 0.8 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -51.08 -24.28 3.81 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.651 HG12 HG23 ' A' ' 66' ' ' ILE . 53.1 mt -82.82 104.94 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 120.704 0.288 . . . . 0.0 110.574 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.3 t -108.55 122.67 47.55 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.073 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 55' ' ' VAL . 11.6 t -94.19 159.85 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.701 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.422 ' N ' HG12 ' A' ' 54' ' ' VAL . 8.0 p -151.42 155.31 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.777 0.323 . . . . 0.0 111.537 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 -132.86 112.14 11.66 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -106.49 -79.47 0.57 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.28 -174.19 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -51.96 -40.65 61.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.676 0.39 . . . . 0.0 111.922 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.68 ' HB2' HG21 ' A' ' 26' ' ' VAL . 25.1 m-20 -148.9 21.55 0.99 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.103 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 p -99.76 141.34 32.7 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.511 ' OG ' HG21 ' A' ' 35' ' ' ILE . 2.1 m -136.22 -172.88 3.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.293 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.3 m -157.52 145.51 18.98 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.905 0.383 . . . . 0.0 110.754 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.643 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -115.34 93.65 4.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.392 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.749 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -86.81 140.66 29.48 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 123.497 0.498 . . . . 0.0 109.95 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.651 HG23 HG12 ' A' ' 52' ' ' ILE . 59.1 mt -137.01 95.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -61.42 -115.75 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.361 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -53.13 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.846 1.203 . . . . 0.0 111.197 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.775 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -74.46 147.44 41.96 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.394 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.784 ' O ' HD12 ' A' ' 97' ' ' ILE . 9.8 m120 -143.31 152.26 41.45 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.828 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.5 pt -51.3 -24.43 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 112.702 0.631 . . . . 0.0 112.702 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.22 -44.33 75.97 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -65.8 -35.4 80.6 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.677 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.536 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -48.26 102.23 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.79 172.61 45.39 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.762 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.5 mt -77.17 94.02 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.783 0.292 . . . . 0.0 111.289 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.643 ' CD2' HD11 ' A' ' 64' ' ' LEU . 62.8 m-85 -65.59 177.04 1.29 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.412 ' O ' ' CE3' ' A' ' 37' ' ' TRP . 8.3 ttmt -139.54 155.4 47.53 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 120.74 0.305 . . . . 0.0 111.633 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.46 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -141.34 102.78 4.29 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.06 140.51 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.83 139.49 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.653 HG23 ' HB3' ' A' ' 88' ' ' GLN . 0.6 OUTLIER -124.19 146.09 48.91 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.14 -174.43 4.66 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.968 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -76.74 -35.06 58.02 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.514 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -86.49 -37.97 17.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.498 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.74 -24.3 0.63 Allowed Glycine 0 C--N 1.34 0.758 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.369 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.9 m -55.38 107.96 0.37 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.247 0.523 . . . . 0.0 111.492 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.653 ' HB3' HG23 ' A' ' 82' ' ' THR . 7.3 pt20 -116.87 134.61 54.55 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.551 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.4 t -114.37 121.55 43.95 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -107.35 -178.14 3.55 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.404 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -150.88 174.54 12.98 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.256 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.442 ' C ' HD12 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -151.84 155.54 38.38 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 123.119 0.262 . . . . 0.0 110.781 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.693 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.2 p -144.89 114.58 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.172 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -71.2 94.15 1.14 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.86 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.467 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 16.8 t -96.2 113.69 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -98.67 157.11 16.47 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.729 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.784 HD12 ' O ' ' A' ' 70' ' ' ASN . 13.3 mt -146.64 143.6 20.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.107 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.42 131.69 14.55 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.752 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.527 ' HB3' HG21 ' A' ' 16' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.898 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' A' ' 83' ' ' ALA . 0.3 OUTLIER . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.538 0.208 . . . . 0.0 110.586 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.594 ' CB ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -139.5 140.18 37.15 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.308 -179.376 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.579 HG21 ' O ' ' A' ' 89' ' ' SER . 9.5 t -145.23 140.41 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.058 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -160.49 125.78 3.88 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.488 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.538 HD11 ' HB2' ' A' ' 79' ' ' CYS . 49.9 mt -95.52 137.6 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.688 0.28 . . . . 0.0 110.833 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.93 130.1 24.54 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.807 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.25 168.91 75.98 Favored 'Cis proline' 0 C--N 1.365 1.406 0 CA-C-N 119.704 0.93 . . . . 0.0 112.042 0.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 p -67.39 -44.59 78.51 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.761 0.315 . . . . 0.0 110.415 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -133.54 107.17 7.84 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.585 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.35 160.46 36.36 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.266 -0.492 . . . . 0.0 114.196 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -154.77 103.78 2.46 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.9 mp -128.42 161.85 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.658 0.266 . . . . 0.0 111.178 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.01 153.1 17.79 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 69' ' ' ALA . 26.1 t -64.86 139.84 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.29 -19.33 55.0 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.774 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -96.72 160.84 14.16 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.412 ' CB ' ' HA ' ' A' ' 67' ' ' TYR . 91.8 p -96.08 162.52 13.51 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.687 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -155.06 115.15 3.79 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.601 -178.201 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.808 ' HB3' HG23 ' A' ' 65' ' ' THR . 41.3 p90 -111.22 140.38 45.83 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.583 0.23 . . . . 0.0 110.956 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.424 ' CE2' HG22 ' A' ' 95' ' ' VAL . 81.5 m-85 -117.81 114.63 23.56 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.052 0.454 . . . . 0.0 110.807 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.2 tp -79.99 110.51 15.44 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.3 t -92.67 97.1 10.58 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.465 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -87.33 163.93 16.54 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.7 m -147.43 175.91 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.594 ' HB3' ' CB ' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.234 0.272 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.608 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.465 0.321 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.783 HG21 ' OG ' ' A' ' 62' ' ' SER . 5.4 mp -125.71 144.55 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 123.368 0.418 . . . . 0.0 111.204 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 m -144.04 149.94 37.43 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.088 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.442 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 52.5 m95 -125.85 122.3 35.72 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.305 0.242 . . . . 0.0 111.133 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -119.52 112.7 19.69 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.466 ' OG ' HD23 ' A' ' 45' ' ' LEU . 5.5 m -55.88 150.45 28.27 Favored Pre-proline 0 C--O 1.244 0.814 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.365 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 C--N 1.381 2.242 1 C-N-CA 125.499 4.133 . . . . 0.0 113.634 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 2.0 ttmt . . . . . 0 N--CA 1.469 0.499 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.466 HD23 ' OG ' ' A' ' 39' ' ' SER . 3.9 pp -84.26 143.05 29.82 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.142 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.5 m -66.41 150.18 97.37 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.215 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.24 -14.72 13.13 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.472 2.115 . . . . 0.0 113.701 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -136.42 37.24 2.71 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.87 0.367 . . . . 0.0 110.976 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.15 -75.2 0.07 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.736 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -151.8 -75.35 0.14 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.603 0.24 . . . . 0.0 111.12 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -99.66 -31.34 11.62 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.566 HG12 HG23 ' A' ' 66' ' ' ILE . 22.4 mt -89.18 104.82 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 t -108.48 120.39 42.29 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.1 t -93.93 154.03 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.2 m -150.9 173.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.337 0.589 . . . . 0.0 112.421 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -141.82 120.17 12.32 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.97 -82.52 0.54 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -42.04 -64.47 0.58 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 179.49 -44.09 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.382 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -114.71 -35.8 4.73 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.329 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.6 t -65.53 136.91 56.99 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.048 0.452 . . . . 0.0 111.099 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.783 ' OG ' HG21 ' A' ' 35' ' ' ILE . 2.7 m -122.76 -173.62 2.74 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.81 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.0 m -156.57 130.73 8.56 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.87 0.366 . . . . 0.0 111.04 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.628 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -101.42 93.05 5.2 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.944 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.808 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -88.18 139.1 30.84 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 123.254 0.346 . . . . 0.0 110.323 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.566 HG23 HG12 ' A' ' 52' ' ' ILE . 44.9 mt -135.39 85.02 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.412 ' HA ' ' CB ' ' A' ' 19' ' ' SER . 12.3 m-85 -50.29 -59.56 3.84 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -176.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -63.96 -65.6 0.66 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 16' ' ' VAL . . . 73.98 118.82 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.051 0.54 . . . . 0.0 110.869 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.788 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -145.39 164.64 30.88 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.706 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 34.5 pt -54.85 -27.07 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -73.51 -36.53 65.76 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -68.13 -33.75 75.07 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.597 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.543 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -53.77 117.18 2.96 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.42 176.69 40.06 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.52 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.825 HD13 ' HA ' ' A' ' 94' ' ' ASN . 13.7 mm -75.99 89.61 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 122.283 0.233 . . . . 0.0 111.435 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.628 ' CD2' HD11 ' A' ' 64' ' ' LEU . 58.2 m-85 -66.85 171.66 5.13 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -131.87 155.79 47.22 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.538 ' HB2' HD11 ' A' ' 7' ' ' ILE . 11.9 t -142.48 88.43 2.07 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.759 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 90' ' ' GLU . 4.4 t -96.25 126.22 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.078 -177.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.88 157.91 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.715 HG23 ' CG ' ' A' ' 88' ' ' GLN . 6.5 m -139.48 148.74 43.11 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.404 ' HB2' HD11 ' A' ' 3' ' ' LEU . . . -96.56 -177.18 3.84 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.552 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -71.31 -54.2 11.65 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.121 0.263 . . . . 0.0 111.068 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.7 -31.12 70.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.621 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 141.73 -10.47 2.63 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.603 -0.554 . . . . 0.0 113.978 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.5 m -58.55 104.65 0.23 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 117.902 0.851 . . . . 0.0 111.173 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.715 ' CG ' HG23 ' A' ' 82' ' ' THR . 31.9 mt-30 -102.31 136.1 42.74 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.847 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.579 ' O ' HG21 ' A' ' 5' ' ' VAL . 5.6 t -128.43 109.89 11.82 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.591 ' HB3' HG13 ' A' ' 80' ' ' VAL . 11.0 pt-20 -101.47 179.43 4.36 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -153.62 175.89 12.7 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.916 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.05 155.18 36.37 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.7 p -139.89 120.87 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.668 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.825 ' HA ' HD13 ' A' ' 76' ' ' ILE . 1.8 t-20 -76.5 84.88 3.21 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.337 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.424 HG22 ' CE2' ' A' ' 22' ' ' PHE . 38.6 t -84.07 138.5 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.511 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -124.97 156.84 37.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.471 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.788 HD12 ' O ' ' A' ' 70' ' ' ASN . 9.6 mt -148.7 140.38 17.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.775 177.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -127.27 128.53 46.14 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.273 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.994 -179.589 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.576 HD23 HG12 ' A' ' 81' ' ' VAL . 1.8 mp . . . . . 0 CA--C 1.531 0.237 0 CA-C-O 120.783 0.325 . . . . 0.0 111.862 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.764 ' CB ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -150.84 151.25 31.98 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.113 179.327 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 t -150.56 144.59 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.606 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -157.07 130.59 8.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.429 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.544 HD11 ' HB2' ' A' ' 79' ' ' CYS . 37.7 mt -107.91 120.46 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.143 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t -105.64 130.07 23.64 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.461 ' O ' HG23 ' A' ' 93' ' ' VAL . 69.8 Cg_endo -81.93 173.49 48.03 Favored 'Cis proline' 0 C--N 1.367 1.545 0 CA-C-N 119.882 0.994 . . . . 0.0 112.282 -0.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 76.1 p -69.27 -41.48 76.81 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -137.2 109.77 7.48 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.649 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.631 ' O ' HD12 ' A' ' 14' ' ' ILE . . . -102.92 98.73 1.7 Allowed Glycine 0 C--N 1.343 0.937 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.927 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -83.09 126.48 32.62 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 12' ' ' GLY . 3.7 mp -140.45 164.5 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 123.21 0.319 . . . . 0.0 110.389 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.57 156.28 18.1 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 69' ' ' ALA . 39.7 t -63.07 141.07 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.09 -11.58 71.71 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.301 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -101.67 150.09 23.47 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 117.33 0.565 . . . . 0.0 109.536 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.3 p -90.45 164.46 14.27 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.623 ' HD2' HD12 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -162.62 129.47 3.6 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.996 -178.155 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.486 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 28.9 p90 -120.77 157.96 28.58 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.2 0.313 . . . . 0.0 110.732 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.597 ' CD2' HG21 ' A' ' 93' ' ' VAL . 80.7 m-85 -133.36 120.35 20.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.68 117.27 19.67 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 t -102.07 96.37 6.96 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.626 0.251 . . . . 0.0 111.148 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -93.62 162.19 14.05 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.94 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.706 HG21 ' CB ' ' A' ' 60' ' ' ASP . 32.7 m -137.93 152.93 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.764 ' HB3' ' CB ' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.235 0.323 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 10.9 m-20 . . . . . 0 N--CA 1.462 0.17 0 N-CA-C 111.199 0.074 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.809 HD13 HG23 ' A' ' 81' ' ' VAL . 15.5 mm -65.5 152.44 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.459 0.647 . . . . 0.0 111.653 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.4 m -147.23 161.25 41.31 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.022 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -138.69 109.41 6.65 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 119.632 -0.223 . . . . 0.0 110.616 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -110.75 111.04 21.95 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 p -60.02 154.07 51.92 Favored Pre-proline 0 C--O 1.243 0.722 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.388 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 C--N 1.375 1.955 0 C-N-CA 125.105 3.87 . . . . 0.0 113.704 -179.282 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.5 tttm . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 45' ' ' LEU . 0.7 OUTLIER -93.48 153.94 18.19 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.056 -179.327 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 m -78.2 164.37 57.01 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.334 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.43 -25.4 2.6 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 122.816 2.344 . . . . 0.0 113.42 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -129.42 22.4 5.57 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.58 -59.02 3.68 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -137.63 -159.83 1.0 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.24 0.216 . . . . 0.0 110.574 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 mtm-85 -51.35 -22.8 3.13 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.624 HG12 HG23 ' A' ' 66' ' ' ILE . 52.6 mt -84.59 105.78 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.7 t -111.65 115.28 28.86 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.337 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.9 t -85.83 150.88 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.452 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -143.43 139.21 26.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 CA-C-O 120.75 0.31 . . . . 0.0 111.286 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 24.5 m-90 -109.18 107.49 17.79 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -92.37 -77.84 0.43 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -72.43 -178.6 2.62 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.494 -0.188 . . . . 0.0 110.494 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.82 -35.85 69.26 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.706 ' CB ' HG21 ' A' ' 26' ' ' VAL . 61.1 m-20 -134.84 5.7 3.38 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 p -100.56 137.34 39.09 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.999 0.363 . . . . 0.0 110.317 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.407 ' OG ' HG21 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -149.02 136.82 20.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.52 -179.097 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.0 m -108.85 139.34 43.82 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.842 0.353 . . . . 0.0 111.787 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.587 HD11 ' CG2' ' A' ' 52' ' ' ILE . 27.8 tp -94.85 113.67 25.44 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -98.36 141.42 31.27 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.624 HG23 HG12 ' A' ' 52' ' ' ILE . 63.7 mt -138.0 90.78 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -59.94 -110.97 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.657 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.2 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.794 1.179 . . . . 0.0 111.063 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.795 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -70.47 148.06 48.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.674 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.808 ' O ' HD12 ' A' ' 97' ' ' ILE . 13.8 m120 -140.98 153.56 45.64 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.276 0.56 . . . . 0.0 110.901 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.2 pt -54.3 -23.94 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.81 -41.24 68.47 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -66.67 -34.81 78.69 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.704 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.502 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -49.61 99.63 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.76 176.23 46.31 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.528 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.2 mt -80.24 101.16 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.877 0.339 . . . . 0.0 111.701 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.4 ' CD2' HD21 ' A' ' 64' ' ' LEU . 58.2 m-85 -71.37 172.37 9.54 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -135.51 157.95 45.6 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.544 ' HB2' HD11 ' A' ' 7' ' ' ILE . 2.9 t -143.13 118.6 10.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.341 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.7 t -126.54 133.03 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.809 HG23 HD13 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -115.24 129.58 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.498 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.3 m -110.73 148.25 32.69 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -178.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.95 173.06 7.48 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.091 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.0 -46.32 78.43 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.195 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -71.97 -28.24 63.3 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.632 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.31 -12.31 4.36 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 119.899 -0.389 . . . . 0.0 113.521 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.8 m -60.82 108.05 0.79 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 117.455 0.627 . . . . 0.0 111.278 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.498 ' HB3' HG23 ' A' ' 82' ' ' THR . 3.9 pt20 -119.75 132.43 55.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.762 0.315 . . . . 0.0 111.288 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.2 t -114.71 125.35 53.62 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -105.02 -177.71 3.44 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -158.28 172.38 18.48 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.004 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.86 156.46 41.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.69 0.281 . . . . 0.0 111.375 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.597 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.1 p -144.63 115.26 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.405 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -70.25 94.63 0.93 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.928 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.514 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 15.1 t -96.27 115.52 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.573 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -101.03 155.06 18.2 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.409 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.808 HD12 ' O ' ' A' ' 70' ' ' ASN . 10.6 mt -146.79 122.97 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.473 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -111.39 127.63 55.73 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.505 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.306 -0.854 . . . . 0.0 111.087 -179.727 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 tp . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 111.43 0.159 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.603 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -121.32 140.59 51.89 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.741 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 t -149.31 137.69 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.653 -0.248 . . . . 0.0 110.973 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -159.29 123.71 3.97 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.311 0.382 . . . . 0.0 110.514 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.538 HD11 ' HB2' ' A' ' 79' ' ' CYS . 43.1 mt -89.87 140.2 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 O-C-N 123.15 0.281 . . . . 0.0 111.042 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.9 t -128.1 134.39 26.18 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.856 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.437 ' O ' HG23 ' A' ' 93' ' ' VAL . 93.5 Cg_endo -76.44 173.82 56.13 Favored 'Cis proline' 0 C--N 1.365 1.436 0 CA-C-N 119.698 0.928 . . . . 0.0 112.161 0.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.4 p -69.14 -49.01 60.82 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -128.37 114.22 16.58 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 14' ' ' ILE . . . -110.44 93.16 0.72 Allowed Glycine 0 C--N 1.343 0.94 0 C-N-CA 121.087 -0.578 . . . . 0.0 114.46 -177.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -79.99 132.86 36.1 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 12' ' ' GLY . 2.0 mp -143.47 164.12 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.09 0.472 . . . . 0.0 111.384 -177.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.47 150.22 22.87 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.549 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 69' ' ' ALA . 29.2 t -66.0 135.28 28.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.599 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.17 -15.07 59.45 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.251 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -114.67 146.63 40.65 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 117.747 0.773 . . . . 0.0 110.111 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.442 ' CB ' ' HA ' ' A' ' 67' ' ' TYR . 60.1 p -79.42 168.56 19.31 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -176.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.619 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -159.31 121.38 3.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.805 -179.542 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.845 ' HB3' HG23 ' A' ' 65' ' ' THR . 49.5 p90 -115.2 142.22 46.96 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.578 0.227 . . . . 0.0 110.951 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.69 ' CD2' HG21 ' A' ' 93' ' ' VAL . 81.1 m-85 -117.51 117.0 28.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.918 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.8 tp -82.43 109.81 17.0 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.935 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.66 107.44 19.17 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -92.01 163.11 14.1 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.716 HG21 ' HB3' ' A' ' 60' ' ' ASP . 22.2 m -147.42 176.64 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.603 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.234 0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.508 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 . . . . . 0 N--CA 1.464 0.247 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.974 HD13 HG23 ' A' ' 81' ' ' VAL . 14.8 mm -70.93 148.66 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 123.603 0.565 . . . . 0.0 110.168 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.7 m -144.93 156.12 43.8 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.183 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.427 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 55.9 m95 -134.65 121.84 21.43 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -119.5 110.84 17.38 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 m -62.73 152.6 81.6 Favored Pre-proline 0 C--O 1.249 1.071 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.117 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo . . . . . 0 C--N 1.38 2.209 1 C-N-CA 126.047 4.498 . . . . 0.0 116.532 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp . . . . . 0 C--O 1.234 0.242 0 CA-C-O 120.649 0.261 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.496 HD11 ' CG2' ' A' ' 54' ' ' VAL . 2.9 pp -86.84 131.64 34.06 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.495 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.8 m -63.52 163.29 20.79 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.667 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.34 -60.29 0.11 Allowed 'Trans proline' 0 C--N 1.363 1.321 0 C-N-CA 122.621 2.214 . . . . 0.0 112.597 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -114.38 62.65 0.67 Allowed 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.285 0.564 . . . . 0.0 110.697 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.83 -62.13 1.41 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.102 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -139.03 -154.42 0.52 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.0 -23.91 1.32 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.652 HG12 HG23 ' A' ' 66' ' ' ILE . 39.2 mt -86.17 105.04 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.5 t -109.07 122.17 46.7 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.189 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.496 ' CG2' HD11 ' A' ' 45' ' ' LEU . 21.5 t -95.77 158.07 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.15 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.407 ' N ' HG12 ' A' ' 54' ' ' VAL . 8.2 m -150.32 171.75 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.852 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -139.58 120.1 14.07 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.1 -81.78 0.57 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -56.33 -178.43 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -52.96 -34.19 54.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.716 ' HB3' HG21 ' A' ' 26' ' ' VAL . 23.5 m-20 -141.37 -12.97 0.9 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.6 p -76.89 147.55 36.97 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 118.725 0.693 . . . . 0.0 111.297 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.587 ' OG ' HG21 ' A' ' 35' ' ' ILE . 3.2 m -134.79 -170.17 2.5 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.817 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.2 m -154.23 138.49 16.61 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 111.799 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.652 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -108.08 94.68 5.2 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.684 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.845 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -89.54 140.1 29.88 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 123.295 0.372 . . . . 0.0 110.563 -179.517 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.652 HG23 HG12 ' A' ' 52' ' ' ILE . 47.0 mt -136.44 91.06 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.442 ' HA ' ' CB ' ' A' ' 19' ' ' SER . 11.0 m-85 -56.25 -69.92 0.13 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.6 OUTLIER -57.18 -66.19 0.5 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.459 ' O ' HG13 ' A' ' 16' ' ' VAL . . . 73.76 119.77 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.1 0.56 . . . . 0.0 111.232 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.788 ' O ' HD12 ' A' ' 97' ' ' ILE . 15.6 m-80 -142.39 163.03 33.95 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.03 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.7 pt -51.73 -26.28 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.95 -43.77 70.92 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.437 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -65.7 -33.39 75.77 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.004 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.519 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -51.14 109.31 0.32 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.14 174.9 45.68 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.726 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.7 mt -80.54 99.78 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.829 0.315 . . . . 0.0 111.296 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.652 ' CD2' HD11 ' A' ' 64' ' ' LEU . 53.5 m-85 -72.57 171.5 12.31 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -132.89 158.01 43.64 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.538 ' HB2' HD11 ' A' ' 7' ' ' ILE . 34.2 t -139.82 100.8 4.03 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.895 178.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.441 HG13 ' HB3' ' A' ' 90' ' ' GLU . 4.0 t -107.22 133.02 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.974 HG23 HD13 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -115.69 134.83 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.55 HG23 ' HB3' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -115.17 146.43 41.39 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.32 -175.59 4.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.464 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -73.7 -46.32 46.89 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 123.132 0.27 . . . . 0.0 111.49 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.4 -35.46 65.88 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.559 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.48 -19.31 1.5 Allowed Glycine 0 C--N 1.339 0.719 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.643 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.8 m -56.14 108.7 0.49 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.348 0.574 . . . . 0.0 111.7 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.55 ' HB3' HG23 ' A' ' 82' ' ' THR . 5.7 pt20 -117.78 133.81 55.56 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.867 0.365 . . . . 0.0 111.565 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.2 t -120.94 127.18 51.59 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.441 ' HB3' HG13 ' A' ' 80' ' ' VAL . 8.6 pt-20 -111.49 -177.94 3.32 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.75 177.13 10.39 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.614 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.82 158.39 44.13 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.822 0.344 . . . . 0.0 111.816 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.69 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.6 p -143.18 114.36 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.908 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -71.33 91.48 0.99 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.914 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.434 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 15.4 t -92.39 129.37 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.549 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -115.76 158.42 22.87 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.798 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.788 HD12 ' O ' ' A' ' 70' ' ' ASN . 11.2 mt -148.99 135.47 12.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.178 178.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.25 135.56 45.03 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.355 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.878 -179.838 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.566 HD11 ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 121.08 0.466 . . . . 0.0 111.088 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -132.9 147.71 52.29 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.883 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 89' ' ' SER . 0.3 OUTLIER -152.41 140.22 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 O-C-N 123.188 0.305 . . . . 0.0 111.068 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -154.99 130.61 9.89 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.601 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.494 HD12 ' C ' ' A' ' 92' ' ' THR . 22.4 mt -91.69 130.11 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 123.196 0.31 . . . . 0.0 110.992 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.0 t -115.07 123.76 31.31 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.83 -179.29 24.9 Favored 'Cis proline' 0 C--N 1.364 1.374 0 CA-C-N 119.985 1.03 . . . . 0.0 112.276 0.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 86.3 p -78.69 -40.97 32.34 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.307 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -132.85 118.15 18.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.699 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.467 ' O ' HD12 ' A' ' 14' ' ' ILE . . . -117.93 99.37 0.8 Allowed Glycine 0 C--N 1.341 0.844 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.97 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.413 ' C ' HD12 ' A' ' 14' ' ' ILE . 14.5 mt-10 -87.55 132.26 34.11 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 12' ' ' GLY . 4.5 mp -143.59 163.63 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.811 0.338 . . . . 0.0 111.083 -178.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.36 154.46 18.17 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 69' ' ' ALA . 93.5 t -63.49 140.43 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.901 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.64 -12.0 70.8 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.24 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.06 156.64 17.54 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.8 p -96.16 165.51 12.2 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.63 0.253 . . . . 0.0 111.286 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.776 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 2.1 pttt -162.61 126.58 3.03 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.643 ' HB3' HG23 ' A' ' 65' ' ' THR . 33.9 p90 -119.72 153.42 35.65 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.072 0.232 . . . . 0.0 111.039 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.646 ' CD1' HG21 ' A' ' 93' ' ' VAL . 88.9 m-85 -131.57 119.17 21.12 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.287 0.565 . . . . 0.0 112.078 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -77.9 111.96 14.29 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -176.795 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.461 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 54.0 t -87.61 87.53 7.41 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -79.9 158.39 26.69 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.427 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.453 HG21 ' HB2' ' A' ' 60' ' ' ASP . 27.5 m -133.49 165.07 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 O-C-N 123.473 0.483 . . . . 0.0 112.081 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.684 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 N--CA 1.467 0.403 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.715 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.519 ' O ' HG22 ' A' ' 81' ' ' VAL . 13.5 m-20 . . . . . 0 N--CA 1.468 0.435 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.471 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.4 mp -121.7 158.75 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 123.189 0.306 . . . . 0.0 111.155 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.441 ' N ' HG22 ' A' ' 35' ' ' ILE . 64.1 m -159.88 160.92 34.2 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.768 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.461 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 58.8 m95 -136.96 130.89 32.22 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.673 0.273 . . . . 0.0 111.134 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 91.6 m-85 -118.92 117.55 29.14 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.5 p -65.73 152.76 92.36 Favored Pre-proline 0 C--O 1.249 1.055 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.903 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo . . . . . 0 C--N 1.38 2.225 0 C-N-CA 124.904 3.736 . . . . 0.0 116.133 -178.778 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 21.9 tttt . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -110.35 134.4 52.33 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.172 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.4 m -68.55 158.01 86.5 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.085 -178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -85.93 -26.7 1.13 Allowed 'Trans proline' 0 C--N 1.363 1.334 0 C-N-CA 122.831 2.354 . . . . 0.0 113.55 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -121.28 69.59 0.91 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.375 0.607 . . . . 0.0 110.182 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.99 -60.01 1.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.149 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -141.79 -159.5 0.97 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 121.99 0.116 . . . . 0.0 110.856 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.7 mtm-85 -47.54 -25.57 1.16 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.663 HG23 HG12 ' A' ' 66' ' ' ILE . 47.9 mt -84.83 106.62 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.801 0.334 . . . . 0.0 110.378 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 t -112.52 123.06 49.45 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.517 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 55' ' ' VAL . 11.4 t -92.81 159.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.361 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.409 ' N ' HG12 ' A' ' 54' ' ' VAL . 7.1 p -154.09 153.43 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.734 0.302 . . . . 0.0 111.422 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.406 ' HD1' ' HG ' ' A' ' 62' ' ' SER . 23.0 m-90 -126.08 112.57 16.0 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -105.35 -75.33 0.63 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.2 -179.05 0.13 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.494 0.188 . . . . 0.0 111.421 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -54.62 -35.76 63.78 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.496 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.453 ' HB2' HG21 ' A' ' 26' ' ' VAL . 55.8 m-20 -151.07 24.45 0.74 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.946 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.9 t -110.4 136.25 49.85 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.471 ' OG ' HG21 ' A' ' 35' ' ' ILE . 4.3 m -128.66 -169.38 2.07 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.525 -177.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 m -159.33 144.85 15.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.937 0.399 . . . . 0.0 110.995 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.629 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -113.82 93.55 4.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.334 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.643 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -86.22 144.25 27.55 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.561 0.538 . . . . 0.0 110.286 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.663 HG12 HG23 ' A' ' 52' ' ' ILE . 61.9 mt -142.52 93.05 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -59.71 -108.51 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.405 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -56.61 95.17 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.465 1.03 . . . . 0.0 110.551 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.838 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -74.25 151.8 39.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.153 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.792 ' O ' HD12 ' A' ' 97' ' ' ILE . 11.6 m120 -145.71 154.43 42.07 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.139 0.495 . . . . 0.0 111.281 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.5 pt -53.98 -24.52 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -72.64 -41.3 65.61 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.92 -34.23 77.91 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.736 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.54 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -51.69 104.25 0.08 Allowed 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.02 171.44 44.17 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.81 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.9 mt -79.62 95.92 2.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.81 0.305 . . . . 0.0 110.245 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.629 ' CD2' HD11 ' A' ' 64' ' ' LEU . 63.0 m-85 -69.93 171.42 9.41 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -133.66 154.69 50.73 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.741 0.305 . . . . 0.0 111.155 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.449 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -138.31 97.71 3.44 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 t -101.01 140.85 18.8 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.857 -176.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 34' ' ' ASP . 1.7 t -125.78 144.92 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.3 m -124.3 155.97 37.76 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.28 -176.01 3.39 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.26 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -77.3 -37.93 51.73 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 123.023 0.202 . . . . 0.0 110.901 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -79.87 -35.8 37.57 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.256 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 148.37 -19.49 1.34 Allowed Glycine 0 C--N 1.34 0.751 0 C-N-CA 121.232 -0.509 . . . . 0.0 113.563 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.566 ' O ' HD11 ' A' ' 3' ' ' LEU . 89.4 m -59.87 112.83 2.0 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 117.314 0.557 . . . . 0.0 111.333 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.531 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.9 OUTLIER -118.63 134.06 55.39 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.488 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.42 ' O ' HG21 ' A' ' 5' ' ' VAL . 2.6 t -114.73 124.98 53.17 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -108.83 -179.86 3.98 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -147.84 173.94 12.34 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.148 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.494 ' C ' HD12 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -150.0 154.95 39.08 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 111.269 179.698 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.646 HG21 ' CD1' ' A' ' 22' ' ' PHE . 7.2 p -144.87 112.71 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.979 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -70.88 93.26 0.96 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.919 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.467 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 12.5 t -95.05 118.03 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.553 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.63 157.73 16.86 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.153 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.838 HD13 ' HB1' ' A' ' 69' ' ' ALA . 10.5 mt -148.57 139.73 17.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.8 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.86 131.58 51.15 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.404 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.962 -179.788 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.887 HD21 ' HB2' ' A' ' 83' ' ' ALA . 29.6 mt . . . . . 0 C--O 1.234 0.274 0 CA-C-O 120.566 0.222 . . . . 0.0 111.529 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.655 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -146.71 134.48 21.19 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.293 179.233 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.583 HG21 ' O ' ' A' ' 89' ' ' SER . 10.7 t -143.91 139.56 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 123.22 0.325 . . . . 0.0 110.499 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -155.66 121.14 4.92 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.413 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.579 HD11 ' HB2' ' A' ' 79' ' ' CYS . 53.5 mt -89.64 136.24 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.023 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.48 128.05 25.83 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.549 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -74.4 -172.9 11.05 Favored 'Cis proline' 0 C--N 1.366 1.489 0 CA-C-N 119.669 0.917 . . . . 0.0 112.041 -0.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 97.2 p -85.57 -50.12 7.49 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.574 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -131.92 104.07 6.65 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.326 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.78 144.88 17.19 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 121.421 -0.418 . . . . 0.0 113.596 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.53 ' C ' HD12 ' A' ' 14' ' ' ILE . 2.6 mp0 -126.6 129.52 48.69 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.53 HD12 ' C ' ' A' ' 13' ' ' GLU . 4.9 mp -141.75 165.12 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 120.579 0.228 . . . . 0.0 111.226 -178.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.4 157.45 17.33 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 69' ' ' ALA . 21.2 t -62.47 136.91 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.393 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.69 -8.25 80.08 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.942 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -100.78 153.06 19.78 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.0 p -100.06 134.73 42.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.193 0.521 . . . . 0.0 112.083 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.651 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 3.9 pttt -116.98 172.04 7.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.582 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.559 ' HB2' HG23 ' A' ' 65' ' ' THR . 0.1 OUTLIER -162.65 149.91 13.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 178.054 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.781 ' CD2' HG21 ' A' ' 93' ' ' VAL . 73.5 m-85 -137.87 105.14 5.47 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.444 0.64 . . . . 0.0 110.812 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.6 tp -79.41 111.92 16.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 114.88 -1.054 . . . . 0.0 112.228 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.4 t -90.49 108.87 20.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.786 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -92.32 160.24 15.21 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.531 HG21 ' CB ' ' A' ' 60' ' ' ASP . 30.9 m -140.71 176.52 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.655 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.235 0.332 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.332 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 18.4 m-20 . . . . . 0 N--CA 1.466 0.372 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.617 HG21 ' OG ' ' A' ' 62' ' ' SER . 3.9 mp -130.87 155.7 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 123.39 0.431 . . . . 0.0 110.845 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.402 ' N ' HG22 ' A' ' 35' ' ' ILE . 71.8 m -156.65 162.0 39.86 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.079 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.409 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 59.0 m95 -133.08 135.55 45.38 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.941 0.151 . . . . 0.0 110.783 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 95.2 m-85 -128.91 109.07 10.93 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.6 p -58.77 151.44 53.43 Favored Pre-proline 0 C--O 1.251 1.151 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.166 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 C--N 1.382 2.33 0 C-N-CA 124.648 3.565 . . . . 0.0 115.534 -178.865 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 10.9 ttmt . . . . . 0 N--CA 1.464 0.243 0 CA-C-O 120.664 0.268 . . . . 0.0 111.384 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.7 mt -111.85 139.21 47.52 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.694 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.26 155.92 66.51 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.215 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.22 -24.46 9.44 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.439 2.093 . . . . 0.0 113.321 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -138.98 78.61 1.68 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.213 0.53 . . . . 0.0 109.97 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.95 -59.05 1.28 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.585 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -146.02 -157.95 0.85 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -24.28 3.48 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.694 HG12 HG23 ' A' ' 66' ' ' ILE . 29.1 mt -84.17 97.81 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.692 0.282 . . . . 0.0 110.457 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.8 t -101.32 117.96 36.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.552 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 55' ' ' VAL . 13.6 t -93.63 160.33 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.412 ' N ' HG12 ' A' ' 54' ' ' VAL . 11.0 p -158.58 157.69 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 13.1 m-90 -136.04 121.9 19.92 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -81.73 0.64 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.69 -177.9 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -31.55 -59.33 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.323 1.049 . . . . 0.0 113.08 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.531 ' CB ' HG21 ' A' ' 26' ' ' VAL . 15.7 m-20 -147.24 21.62 1.21 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.034 178.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.6 145.22 25.41 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.617 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.3 m -134.58 -170.78 2.62 Favored 'General case' 0 N--CA 1.458 -0.07 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.069 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.4 m -160.12 145.71 15.27 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.868 0.366 . . . . 0.0 111.325 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.666 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -117.7 98.44 6.37 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.172 178.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.559 HG23 ' HB2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -97.61 138.68 34.65 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.607 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.694 HG23 HG12 ' A' ' 52' ' ' ILE . 22.5 mt -134.95 89.2 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -53.97 -98.65 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.94 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.75 100.78 0.73 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.234 0.925 . . . . 0.0 110.109 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.843 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -81.17 149.18 29.21 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.79 ' O ' HD12 ' A' ' 97' ' ' ILE . 12.7 m-80 -142.72 155.54 44.89 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.545 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.3 pt -53.1 -24.54 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -71.56 -42.31 68.0 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -65.33 -35.1 79.94 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.115 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.536 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -50.36 126.81 15.92 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.63 -177.64 37.82 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.895 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 76' ' ' ILE . 0.6 OUTLIER -85.42 108.61 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.666 ' CD2' HD11 ' A' ' 64' ' ' LEU . 49.5 m-85 -83.52 166.18 18.49 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -127.57 158.4 37.57 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.139 0.495 . . . . 0.0 112.303 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.579 ' HB2' HD11 ' A' ' 7' ' ' ILE . 23.7 t -138.84 94.01 2.77 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.272 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 90' ' ' GLU . 6.6 t -100.46 132.31 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -177.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 34' ' ' ASP . 3.6 t -111.73 153.6 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.619 HG23 ' CG ' ' A' ' 88' ' ' GLN . 4.4 m -137.61 111.04 7.97 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.887 ' HB2' HD21 ' A' ' 3' ' ' LEU . . . -62.56 -176.19 0.1 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.244 178.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -73.08 -49.97 25.53 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.715 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -62.62 -31.28 72.1 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 134.28 -19.19 4.1 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 121.348 -0.453 . . . . 0.0 113.51 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 m -61.59 114.02 3.03 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.397 0.599 . . . . 0.0 110.505 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.619 ' CG ' HG23 ' A' ' 82' ' ' THR . 14.4 mt-30 -100.64 136.92 39.76 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.279 0.362 . . . . 0.0 111.973 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.583 ' O ' HG21 ' A' ' 5' ' ' VAL . 35.6 t -116.79 106.42 13.47 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.569 ' HB3' HG13 ' A' ' 80' ' ' VAL . 5.0 pt-20 -102.85 -179.39 3.94 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -177.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -155.86 -178.62 7.43 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.161 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.11 160.58 43.39 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.701 0.286 . . . . 0.0 111.463 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.781 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.3 p -142.09 120.47 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.55 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -74.85 91.43 2.44 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.752 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.9 t -95.27 142.42 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.31 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.88 156.34 46.27 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.938 0.399 . . . . 0.0 111.398 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.843 HD13 ' HB1' ' A' ' 69' ' ' ALA . 11.3 mt -145.09 132.27 15.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.052 178.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.23 132.2 39.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.249 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.219 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.653 HD11 ' HB2' ' A' ' 83' ' ' ALA . 5.6 mp . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 121.192 0.52 . . . . 0.0 112.287 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.769 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 2.6 tt0 -146.43 124.58 12.16 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.14 150.89 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.236 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -160.1 130.37 5.46 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.765 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.462 HD12 ' C ' ' A' ' 92' ' ' THR . 38.9 mt -92.1 144.69 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.361 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -128.42 126.13 23.43 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.19 179.69 28.5 Favored 'Cis proline' 0 C--N 1.365 1.421 0 CA-C-N 120.149 1.089 . . . . 0.0 112.348 0.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 96.4 p -73.33 -51.67 16.64 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.451 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -130.53 101.25 5.63 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.885 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.2 111.24 4.19 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 121.3 -0.476 . . . . 0.0 113.799 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.02 123.06 35.1 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.48 HD13 ' CB ' ' A' ' 20' ' ' LYS . 2.8 mp -137.73 164.69 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.593 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.75 162.23 14.17 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.634 0.731 . . . . 0.0 111.625 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 69' ' ' ALA . 36.8 t -68.51 135.7 27.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.323 178.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.07 -17.35 58.82 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-O 119.545 -0.586 . . . . 0.0 112.449 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -111.46 146.55 37.03 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-N 117.799 0.8 . . . . 0.0 109.896 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 96.7 p -79.67 176.95 9.25 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.602 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -171.33 118.74 0.46 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.249 -178.302 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.751 ' HB3' HG23 ' A' ' 65' ' ' THR . 29.6 p90 -112.09 150.6 30.48 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.469 0.176 . . . . 0.0 111.137 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.714 ' CD2' HG21 ' A' ' 93' ' ' VAL . 86.4 m-85 -128.58 118.52 23.12 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.197 0.522 . . . . 0.0 111.44 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.8 tp -79.13 117.3 20.04 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.432 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 41.6 t -94.74 96.56 9.46 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -88.41 148.72 24.08 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.168 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.818 HG21 ' CB ' ' A' ' 60' ' ' ASP . 33.7 m -120.89 175.96 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.769 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 CA--C 1.532 0.252 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.093 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.503 HG21 ' OG ' ' A' ' 62' ' ' SER . 3.9 mp -73.25 157.98 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 123.385 0.428 . . . . 0.0 111.136 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.42 ' N ' HG22 ' A' ' 35' ' ' ILE . 18.0 m -157.88 161.79 38.3 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.249 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.438 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 60.3 m95 -137.39 124.99 22.2 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.65 0.262 . . . . 0.0 111.094 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 94.8 m-85 -114.38 117.32 30.7 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.419 ' HB3' HD23 ' A' ' 45' ' ' LEU . 14.9 p -68.12 153.12 95.89 Favored Pre-proline 0 C--O 1.249 1.074 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.947 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo . . . . . 0 C--N 1.382 2.314 0 C-N-CA 124.887 3.725 . . . . 0.0 116.048 -178.595 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 19.8 tttm . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -110.76 152.85 26.11 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.268 179.37 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m -79.33 159.48 72.44 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.984 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.79 -8.06 13.4 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.29 1.994 . . . . 0.0 113.548 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -141.92 48.59 1.6 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.03 0.443 . . . . 0.0 110.763 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -66.33 -77.31 0.07 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.658 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -150.76 -74.53 0.15 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 -99.86 -34.71 10.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.639 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.663 HG12 HG23 ' A' ' 66' ' ' ILE . 53.4 mt -84.54 107.23 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.849 0.357 . . . . 0.0 111.189 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.5 t -110.64 124.35 51.74 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.597 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.437 HG22 HD23 ' A' ' 64' ' ' LEU . 13.5 t -98.42 159.3 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.742 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.409 ' N ' HG12 ' A' ' 54' ' ' VAL . 5.0 m -149.95 170.32 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.862 0.363 . . . . 0.0 111.518 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.1 m-90 -139.64 104.5 4.93 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -90.79 -85.57 0.22 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -175.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -174.56 0.07 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.952 0.342 . . . . 0.0 111.804 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.89 -36.05 62.26 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.844 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.818 ' CB ' HG21 ' A' ' 26' ' ' VAL . 61.0 m-20 -145.18 17.77 1.56 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.5 t -103.09 139.12 39.03 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.503 ' OG ' HG21 ' A' ' 35' ' ' ILE . 5.6 m -133.27 -173.73 3.29 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.993 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m -155.73 146.55 22.2 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.902 0.382 . . . . 0.0 111.826 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.652 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -115.84 91.57 3.64 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.447 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.751 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -86.2 139.01 31.45 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.605 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.663 HG23 HG12 ' A' ' 52' ' ' ILE . 66.2 mt -135.56 95.59 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -61.93 -116.07 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 O-C-N 123.759 0.662 . . . . 0.0 110.884 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.43 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.824 1.193 . . . . 0.0 111.409 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.846 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -74.56 142.53 44.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.992 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.775 ' O ' HD12 ' A' ' 97' ' ' ILE . 11.5 m120 -136.9 152.28 50.03 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.63 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.2 pt -51.41 -26.01 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -69.08 -43.67 74.08 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -65.21 -33.42 75.95 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.88 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.484 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -50.47 104.3 0.07 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.54 174.27 46.47 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.043 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.3 mt -81.23 98.66 4.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.652 ' CD2' HD11 ' A' ' 64' ' ' LEU . 59.9 m-85 -71.73 172.47 9.71 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -134.01 155.11 50.56 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.744 0.307 . . . . 0.0 111.095 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.461 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -138.74 101.38 4.31 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.224 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.431 HG13 ' HB3' ' A' ' 90' ' ' GLU . 5.0 t -104.73 140.85 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.427 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.469 HG12 HD23 ' A' ' 3' ' ' LEU . 0.7 OUTLIER -127.36 135.49 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.084 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.658 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.1 m -117.14 149.88 39.63 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.653 ' HB2' HD11 ' A' ' 3' ' ' LEU . . . -90.55 -177.63 5.09 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.357 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -74.23 -34.46 63.66 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.314 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.32 -35.6 23.15 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.361 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.61 -22.15 1.5 Allowed Glycine 0 C--N 1.34 0.785 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.584 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.8 m -59.19 111.66 1.42 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.208 0.504 . . . . 0.0 111.446 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.658 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.1 OUTLIER -119.12 135.22 54.76 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.922 0.391 . . . . 0.0 111.687 179.852 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.7 t -116.61 127.13 54.18 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.431 ' HB3' HG13 ' A' ' 80' ' ' VAL . 4.7 pt-20 -111.19 -178.54 3.49 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -177.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -147.67 173.55 12.64 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.18 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.462 ' C ' HD12 ' A' ' 7' ' ' ILE . 0.7 OUTLIER -147.48 155.78 42.23 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.613 0.244 . . . . 0.0 111.051 179.394 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.714 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.5 p -144.97 116.82 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.273 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.02 102.68 2.49 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.439 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 15.1 t -105.57 111.49 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.681 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.0 mtmm -98.91 149.73 22.64 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.406 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.846 HD13 ' HB1' ' A' ' 69' ' ' ALA . 10.3 mt -139.36 117.72 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.42 132.3 56.29 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.382 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.895 -179.718 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.238 0 CA-C-O 120.698 0.285 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.762 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 13.6 tt0 -134.76 142.17 46.66 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.901 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 89' ' ' SER . 0.4 OUTLIER -149.59 141.1 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.82 -179.785 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -155.04 132.55 11.21 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.644 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.483 HD11 ' HB3' ' A' ' 79' ' ' CYS . 17.6 mt -92.17 131.93 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 O-C-N 123.173 0.295 . . . . 0.0 111.11 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.04 125.91 28.74 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.57 172.7 48.93 Favored 'Cis proline' 0 C--N 1.364 1.365 0 CA-C-N 120.103 1.072 . . . . 0.0 112.369 0.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.9 p -70.05 -39.8 75.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.458 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -134.42 113.15 11.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.85 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.03 97.89 1.11 Allowed Glycine 0 C--N 1.342 0.867 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.803 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.589 ' C ' HD12 ' A' ' 14' ' ' ILE . 6.6 mt-10 -86.19 124.19 32.31 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.589 HD12 ' C ' ' A' ' 13' ' ' GLU . 3.5 mp -141.06 164.45 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.593 0.235 . . . . 0.0 110.727 -178.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.76 156.98 17.17 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.786 0.327 . . . . 0.0 110.439 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.0 t -63.52 140.77 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.38 -11.57 70.85 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.472 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -98.99 159.55 14.88 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 117.481 0.64 . . . . 0.0 109.454 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.4 ' CB ' ' HA ' ' A' ' 67' ' ' TYR . 66.7 p -101.49 149.24 24.28 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.63 0.252 . . . . 0.0 111.213 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.625 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -148.26 124.53 10.86 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.552 -178.514 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.772 ' HB3' HG23 ' A' ' 65' ' ' THR . 34.2 p90 -114.57 148.32 38.19 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.958 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.648 ' CD1' HG21 ' A' ' 93' ' ' VAL . 92.8 m-85 -127.45 119.85 27.04 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.223 0.535 . . . . 0.0 112.028 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 62' ' ' SER . 0.0 OUTLIER -78.05 109.49 12.18 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -177.117 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.491 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 35.5 t -84.54 90.7 7.7 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -83.35 150.82 25.86 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.093 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.753 HG21 ' CB ' ' A' ' 60' ' ' ASP . 30.9 m -122.35 169.96 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.3 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.762 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 N--CA 1.465 0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.799 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 t70 . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.542 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.2 mp -76.43 155.44 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.064 0.459 . . . . 0.0 112.01 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.401 ' N ' HG22 ' A' ' 35' ' ' ILE . 74.9 m -152.3 159.2 43.53 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.645 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.491 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 44.2 m95 -135.4 115.18 12.9 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 119.684 -0.198 . . . . 0.0 111.384 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -116.51 112.16 20.98 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.517 ' HB3' HD21 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -61.52 156.01 55.74 Favored Pre-proline 0 C--O 1.245 0.821 0 CA-C-O 119.325 -0.369 . . . . 0.0 110.627 178.364 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo . . . . . 0 C--N 1.381 2.253 0 C-N-CA 125.094 3.863 . . . . 0.0 113.484 -179.387 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 23.2 tttm . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.517 HD21 ' HB3' ' A' ' 39' ' ' SER . 2.2 mt -72.39 171.48 12.16 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.987 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m -86.75 150.4 50.55 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.06 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.08 -24.75 23.39 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.254 1.97 . . . . 0.0 112.886 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -150.01 80.3 1.37 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.989 0.423 . . . . 0.0 110.301 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.71 -79.08 0.46 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.295 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -145.04 -74.3 0.24 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.588 0.232 . . . . 0.0 110.902 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -97.95 -39.57 8.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.565 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.464 HG12 HG23 ' A' ' 66' ' ' ILE . 47.9 mt -88.33 112.83 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.6 t -119.37 117.98 29.97 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.364 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.3 t -89.04 157.61 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.4 HG22 ' N ' ' A' ' 56' ' ' TRP . 9.8 p -155.0 157.98 3.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 CA-C-O 120.963 0.411 . . . . 0.0 111.894 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.4 ' N ' HG22 ' A' ' 55' ' ' VAL . 25.7 m-90 -131.72 107.51 8.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -97.39 -79.28 0.46 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.73 -178.82 0.22 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.587 0.232 . . . . 0.0 111.473 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -52.71 -34.26 51.54 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.753 ' CB ' HG21 ' A' ' 26' ' ' VAL . 22.1 m-20 -148.29 16.51 1.05 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 p -103.14 139.15 39.02 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.97 0.35 . . . . 0.0 110.078 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.542 ' OG ' HG21 ' A' ' 35' ' ' ILE . 4.2 m -130.84 -174.29 3.33 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.455 -177.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -155.82 147.57 23.07 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.003 0.43 . . . . 0.0 111.35 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.642 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -118.94 92.51 3.82 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.285 179.425 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.772 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -84.87 145.14 27.96 Favored 'General case' 0 N--CA 1.461 0.106 0 O-C-N 123.37 0.419 . . . . 0.0 110.157 -179.42 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.614 HD12 ' HD2' ' A' ' 20' ' ' LYS . 51.2 mt -141.19 79.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.4 ' HA ' ' CB ' ' A' ' 19' ' ' SER . 13.5 m-85 -45.79 -66.94 0.33 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 2.1 t30 -64.38 -67.07 0.46 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 68' ' ' ASN . . . 78.22 123.75 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.345 0.658 . . . . 0.0 110.926 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.822 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.4 OUTLIER -144.24 159.77 42.1 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.069 0.462 . . . . 0.0 110.737 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.3 pt -50.23 -27.79 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -71.19 -41.42 70.33 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -64.08 -34.05 77.15 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.98 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.548 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -52.76 102.87 0.06 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.75 178.23 46.59 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.656 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.564 HG23 ' HB ' ' A' ' 92' ' ' THR . 1.1 mp -80.77 100.58 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 117.051 0.426 . . . . 0.0 110.437 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.642 ' CD2' HD11 ' A' ' 64' ' ' LEU . 60.8 m-85 -73.32 174.57 7.91 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -135.01 154.27 51.78 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.483 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -140.31 101.26 4.09 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.231 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 90' ' ' GLU . 5.0 t -106.89 137.41 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -176.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -120.39 142.42 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.643 HG23 ' HG2' ' A' ' 88' ' ' GLN . 2.4 m -128.2 126.31 40.74 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.89 -175.84 2.27 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.752 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -78.18 -39.54 40.47 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.181 0.301 . . . . 0.0 111.04 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.38 -33.84 65.24 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.394 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.02 -8.52 4.16 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-O 119.72 -0.489 . . . . 0.0 114.013 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.3 m -62.58 110.32 1.66 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.687 0.744 . . . . 0.0 110.61 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.643 ' HG2' HG23 ' A' ' 82' ' ' THR . 35.7 mt-30 -103.07 134.36 46.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.889 0.376 . . . . 0.0 111.784 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.402 ' O ' HG21 ' A' ' 5' ' ' VAL . 7.8 t -131.22 115.01 15.77 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.582 ' HB3' HG13 ' A' ' 80' ' ' VAL . 7.0 pt-20 -112.1 -176.97 3.05 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -177.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.5 172.77 16.04 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.34 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.564 ' HB ' HG23 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -145.23 152.29 39.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.66 0.266 . . . . 0.0 110.535 179.289 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.648 HG21 ' CD1' ' A' ' 22' ' ' PHE . 7.4 p -135.55 117.71 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.126 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -71.7 92.24 1.17 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.084 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.485 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 14.6 t -95.09 112.73 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.476 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.95 155.54 17.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.948 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.822 HD12 ' O ' ' A' ' 70' ' ' ASN . 11.2 mt -144.04 135.49 22.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.144 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.67 127.62 37.32 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.229 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.951 -179.901 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.467 HD22 HG22 ' A' ' 87' ' ' THR . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 120.625 0.25 . . . . 0.0 110.705 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.668 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -119.84 150.08 41.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.903 -179.571 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.572 HG21 ' O ' ' A' ' 89' ' ' SER . 17.1 t -147.35 138.14 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.456 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -155.31 125.84 6.86 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.878 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.672 HD11 ' HB2' ' A' ' 79' ' ' CYS . 71.2 mt -89.71 135.14 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -134.6 120.68 14.66 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 118.918 -0.563 . . . . 0.0 110.908 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -66.23 149.56 78.42 Favored 'Cis proline' 0 C--N 1.364 1.343 0 CA-C-N 120.531 1.225 . . . . 0.0 113.053 -0.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.642 ' O ' HG23 ' A' ' 93' ' ' VAL . 78.1 p -71.72 -40.4 69.49 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.888 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -112.16 120.2 40.99 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.64 75.74 0.21 Allowed Glycine 0 C--N 1.341 0.854 0 N-CA-C 114.542 0.577 . . . . 0.0 114.542 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.583 ' C ' HD12 ' A' ' 14' ' ' ILE . 25.8 mt-10 -81.24 115.25 20.54 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.583 HD12 ' C ' ' A' ' 13' ' ' GLU . 2.9 mp -141.74 162.17 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.411 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.34 153.94 18.26 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.94 0.4 . . . . 0.0 110.488 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 69' ' ' ALA . 47.1 t -63.01 141.18 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.093 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.8 -13.1 67.68 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.188 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -102.61 159.51 15.39 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.2 p -94.35 168.51 10.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.578 0.228 . . . . 0.0 110.648 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.79 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 2.3 pttt -167.0 115.34 0.83 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.222 -178.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.469 ' HB3' HG23 ' A' ' 65' ' ' THR . 45.1 p90 -120.66 151.79 39.03 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.69 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -131.74 122.68 26.26 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.264 0.554 . . . . 0.0 111.339 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp -79.81 114.43 18.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.718 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 t -90.19 104.32 16.91 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.075 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -95.44 166.99 11.6 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.512 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.0 m -139.58 171.48 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.691 0.281 . . . . 0.0 111.596 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.668 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.234 0.274 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.041 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.465 ' O ' HG22 ' A' ' 81' ' ' VAL . 30.1 t70 . . . . . 0 N--CA 1.464 0.248 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.679 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.6 mp -130.51 152.17 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 123.322 0.389 . . . . 0.0 111.205 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.5 m -152.68 157.66 41.24 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.297 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.446 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 60.5 m95 -131.98 122.38 25.45 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -119.22 111.95 18.87 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 p -57.02 152.83 26.65 Favored Pre-proline 0 C--O 1.244 0.793 0 CA-C-O 119.327 -0.368 . . . . 0.0 110.783 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 C--N 1.379 2.135 0 C-N-CA 125.273 3.982 . . . . 0.0 114.15 -178.923 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 14.2 tttt . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.469 HD22 HG21 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -91.89 158.15 16.45 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.797 -179.301 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.6 m -75.25 147.22 82.65 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.451 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.47 -27.16 81.02 Favored 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 122.39 2.06 . . . . 0.0 113.066 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -148.63 79.24 1.43 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.004 0.431 . . . . 0.0 110.807 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.72 -68.45 0.79 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.991 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -150.95 -79.26 0.12 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -99.7 -32.77 10.89 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.554 HG12 HG23 ' A' ' 66' ' ' ILE . 63.3 mt -88.53 100.4 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 120.868 0.366 . . . . 0.0 111.212 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.6 t -107.19 123.21 47.94 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.027 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 55' ' ' VAL . 20.9 t -95.91 158.13 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.268 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.415 ' N ' HG12 ' A' ' 54' ' ' VAL . 11.3 m -150.54 172.5 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 120.938 0.399 . . . . 0.0 111.642 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.7 m-90 -142.23 117.0 9.83 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.55 -79.55 0.57 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -59.48 -179.92 0.1 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.598 0.181 . . . . 0.0 111.024 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -57.08 -32.35 66.18 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -136.99 -12.37 1.69 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.8 t -85.25 139.75 31.39 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 118.734 0.697 . . . . 0.0 111.499 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.679 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.8 m -126.0 -169.37 2.0 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.268 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.3 m -160.53 132.92 6.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.738 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -99.98 99.08 9.78 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.225 178.635 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -92.38 131.4 37.59 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.242 0.339 . . . . 0.0 110.092 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.554 HG23 HG12 ' A' ' 52' ' ' ILE . 63.7 mt -130.1 93.14 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -60.68 -116.06 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 CA-C-O 118.895 -0.574 . . . . 0.0 111.199 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -51.48 95.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.912 1.233 . . . . 0.0 110.876 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.837 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -75.22 154.05 37.77 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.883 -178.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.785 ' O ' HD12 ' A' ' 97' ' ' ILE . 1.1 p30 -148.34 154.13 39.55 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.382 0.61 . . . . 0.0 111.326 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.4 pt -53.42 -25.97 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -71.53 -40.52 70.02 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.29 -34.23 77.84 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.584 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.519 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -50.89 108.4 0.24 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.49 179.69 48.83 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 121.411 -0.423 . . . . 0.0 112.299 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.731 HD13 ' HA ' ' A' ' 94' ' ' ASN . 23.0 mm -82.04 90.26 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 122.152 0.181 . . . . 0.0 111.459 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.738 ' CD2' HD11 ' A' ' 64' ' ' LEU . 40.3 m-85 -67.68 176.0 2.67 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -136.58 159.0 43.12 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.672 ' HB2' HD11 ' A' ' 7' ' ' ILE . 8.3 t -140.4 92.54 2.53 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.705 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.505 HG13 ' HB3' ' A' ' 90' ' ' GLU . 5.2 t -96.51 128.74 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 34' ' ' ASP . 2.3 t -112.92 159.1 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.73 HG23 ' HG2' ' A' ' 88' ' ' GLN . 1.5 m -136.34 154.06 50.96 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.47 -172.66 2.2 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.315 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -76.79 -45.6 28.2 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.233 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -74.74 -32.01 61.97 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 141.73 -9.88 2.6 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.402 -0.666 . . . . 0.0 114.433 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.467 HG22 HD22 ' A' ' 3' ' ' LEU . 49.6 m -63.79 116.98 6.27 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 117.98 0.89 . . . . 0.0 110.336 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.73 ' HG2' HG23 ' A' ' 82' ' ' THR . 8.2 mt-30 -108.92 135.77 49.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.466 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.572 ' O ' HG21 ' A' ' 5' ' ' VAL . 21.8 t -122.0 108.38 13.32 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.505 ' HB3' HG13 ' A' ' 80' ' ' VAL . 6.2 pt-20 -99.78 179.83 4.4 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.2 -179.39 7.48 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.716 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.26 152.56 31.31 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.025 0.44 . . . . 0.0 111.478 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 10' ' ' SER . 2.7 p -132.01 119.87 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.34 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.731 ' HA ' HD13 ' A' ' 76' ' ' ILE . 8.1 t30 -80.72 88.4 5.78 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.524 HG22 HG22 ' A' ' 93' ' ' VAL . 3.5 t -91.96 124.66 44.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.934 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -111.99 155.19 24.15 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.585 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.837 HD13 ' HB1' ' A' ' 69' ' ' ALA . 7.9 mt -145.96 132.04 13.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.697 177.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -119.29 125.65 49.59 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.535 -178.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.856 -179.844 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.519 HD11 ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.75 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 10.8 tp-100 -99.95 152.01 20.67 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.518 HG21 ' O ' ' A' ' 89' ' ' SER . 2.0 t -146.57 146.76 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -158.13 127.95 5.97 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.705 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.458 HD11 ' HB3' ' A' ' 79' ' ' CYS . 42.4 mt -94.2 142.83 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.2 t -124.46 122.91 25.87 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-O 119.21 -0.424 . . . . 0.0 110.03 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.49 -171.17 9.36 Favored 'Cis proline' 0 C--N 1.366 1.452 0 CA-C-N 119.925 1.009 . . . . 0.0 112.361 -0.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.3 p -85.83 -50.22 7.3 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.309 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -125.38 99.98 6.29 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.733 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.28 156.55 37.6 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.874 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -151.75 104.92 3.07 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.3 mp -130.15 166.85 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.806 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.6 155.46 18.27 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.603 0.716 . . . . 0.0 111.339 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 69' ' ' ALA . 17.0 t -65.88 138.49 22.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.887 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.87 -16.96 60.11 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.312 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -115.52 149.94 37.35 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 117.87 0.835 . . . . 0.0 110.116 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.436 ' CB ' ' HA ' ' A' ' 67' ' ' TYR . 60.4 p -79.86 165.58 22.55 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.821 ' HE3' HD12 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -158.77 119.88 3.36 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.267 -179.646 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.726 ' HB3' HG23 ' A' ' 65' ' ' THR . 39.6 p90 -112.8 153.57 27.63 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.538 0.209 . . . . 0.0 111.245 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.713 ' CD2' HG21 ' A' ' 93' ' ' VAL . 78.3 m-85 -129.33 113.58 15.15 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.271 0.558 . . . . 0.0 111.234 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.438 HD23 ' OE1' ' A' ' 25' ' ' GLN . 12.1 tp -78.42 111.73 14.73 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -177.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.472 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 43.7 t -93.4 90.1 6.6 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.438 ' OE1' HD23 ' A' ' 23' ' ' LEU . 6.4 mt-30 -86.7 157.51 19.63 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.861 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.666 HG21 ' CB ' ' A' ' 60' ' ' ASP . 30.7 m -124.96 169.15 16.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.448 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.75 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.234 0.271 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.503 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 . . . . . 0 N--CA 1.466 0.342 0 N-CA-C 111.207 0.077 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 35' ' ' ILE . 4.7 mp -77.74 156.62 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.183 0.516 . . . . 0.0 111.411 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.409 ' N ' HG22 ' A' ' 35' ' ' ILE . 4.7 m -152.36 157.74 41.72 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.087 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.472 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 39.8 m95 -135.13 109.13 8.17 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 117.61 0.187 . . . . 0.0 110.934 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -107.73 112.07 24.57 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.593 ' HB3' HD23 ' A' ' 45' ' ' LEU . 56.0 p -62.33 153.78 74.33 Favored Pre-proline 0 C--O 1.246 0.918 0 CA-C-O 119.159 -0.448 . . . . 0.0 110.535 178.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo . . . . . 0 C--N 1.382 2.334 1 C-N-CA 125.938 4.425 . . . . 0.0 115.038 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 8.6 ttpp . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.593 HD23 ' HB3' ' A' ' 39' ' ' SER . 4.0 pp -69.85 148.05 49.56 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.542 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.36 150.75 95.37 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.067 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.88 -30.84 6.96 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 122.286 1.99 . . . . 0.0 112.579 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.61 52.13 1.19 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.028 0.442 . . . . 0.0 111.254 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -68.81 -82.2 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.352 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -150.98 -73.17 0.16 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -98.99 -31.56 11.74 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.689 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.579 HG12 HG23 ' A' ' 66' ' ' ILE . 37.6 mt -89.05 101.66 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.735 0.302 . . . . 0.0 110.405 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.0 t -108.42 122.77 47.7 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.157 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 55' ' ' VAL . 19.3 t -95.63 159.62 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.407 ' N ' HG12 ' A' ' 54' ' ' VAL . 9.8 p -153.97 146.95 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.077 0.465 . . . . 0.0 112.239 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 21.2 m-90 -123.73 112.06 16.9 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -109.49 -74.35 0.66 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.745 1.016 . . . . 0.0 113.745 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -60.74 -175.16 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -53.26 -36.55 61.23 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.745 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.666 ' CB ' HG21 ' A' ' 26' ' ' VAL . 1.9 m-20 -153.96 22.32 0.51 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.2 t -103.47 139.23 39.1 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.473 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.5 m -134.64 -174.03 3.46 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.603 -178.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -155.8 145.29 21.0 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.022 0.439 . . . . 0.0 111.256 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.664 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -113.29 91.23 3.57 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.247 179.466 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.726 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -87.71 138.02 31.83 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.338 0.399 . . . . 0.0 110.295 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.821 HD12 ' HE3' ' A' ' 20' ' ' LYS . 58.9 mt -134.79 87.29 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.436 ' HA ' ' CB ' ' A' ' 19' ' ' SER . 12.5 m-85 -52.89 -67.46 0.25 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -176.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 1.2 t-20 -60.57 -63.64 1.23 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -177.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.44 ' O ' HG13 ' A' ' 16' ' ' VAL . . . 73.6 120.55 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.883 0.473 . . . . 0.0 110.952 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.797 ' O ' HD12 ' A' ' 97' ' ' ILE . 4.1 m-80 -141.71 162.4 35.57 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.033 0.444 . . . . 0.0 110.356 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.6 pt -54.83 -24.59 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -72.95 -40.45 65.35 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -66.52 -32.97 74.66 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.792 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.501 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -50.58 114.65 1.19 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.26 171.45 37.89 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.037 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.0 mt -76.93 95.86 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.786 0.293 . . . . 0.0 111.691 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.664 ' CD2' HD11 ' A' ' 64' ' ' LEU . 46.5 m-85 -70.23 179.03 2.55 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -140.66 156.25 46.29 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 120.757 0.313 . . . . 0.0 111.626 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.458 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -142.96 102.38 4.0 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.976 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 90' ' ' GLU . 7.3 t -104.59 139.78 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.11 137.96 53.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.592 HG23 ' HB3' ' A' ' 88' ' ' GLN . 3.4 m -127.93 150.95 49.66 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.51 -173.65 2.7 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.532 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -73.01 -52.86 12.82 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.504 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -65.47 -36.26 83.35 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 146.78 -19.23 1.63 Allowed Glycine 0 C--N 1.34 0.76 0 C-N-CA 121.161 -0.542 . . . . 0.0 113.644 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.519 ' O ' HD11 ' A' ' 3' ' ' LEU . 77.5 m -57.85 109.1 0.66 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.39 0.595 . . . . 0.0 111.213 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.592 ' HB3' HG23 ' A' ' 82' ' ' THR . 1.0 OUTLIER -119.67 134.26 55.3 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.682 -179.88 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.518 ' O ' HG21 ' A' ' 5' ' ' VAL . 40.9 t -110.96 117.64 33.9 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.423 ' HB3' HG13 ' A' ' 80' ' ' VAL . 12.6 pt-20 -105.65 -178.57 3.69 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.41 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -150.46 172.38 15.54 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.255 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.01 153.23 36.17 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.46 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.713 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.7 p -141.26 111.67 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.757 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.68 89.51 0.74 Allowed 'General case' 0 C--O 1.235 0.293 0 O-C-N 123.408 0.442 . . . . 0.0 110.281 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.496 HG11 ' NZ ' ' A' ' 20' ' ' LYS . 21.3 t -87.29 138.05 19.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.589 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -122.83 156.96 33.51 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.625 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.797 HD12 ' O ' ' A' ' 70' ' ' ASN . 7.2 mt -147.11 136.02 15.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.785 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.7 133.36 43.42 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.335 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.949 -179.664 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.549 HD11 ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 111.498 0.185 . . . . 0.0 111.498 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.658 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 11.0 tp-100 -92.78 149.53 21.23 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 89' ' ' SER . 1.7 t -144.02 146.4 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 123.162 0.289 . . . . 0.0 110.933 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -160.38 133.06 6.41 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.64 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.53 HD11 ' HB3' ' A' ' 79' ' ' CYS . 33.1 mt -99.72 124.31 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 36.3 t -108.1 128.44 25.73 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.598 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.77 -172.9 11.78 Favored 'Cis proline' 0 C--N 1.365 1.433 0 CA-C-N 119.946 1.016 . . . . 0.0 112.327 -0.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.9 p -78.84 -48.82 14.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.932 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -132.0 112.34 12.29 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.883 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.08 106.99 2.34 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.071 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.55 ' C ' HD12 ' A' ' 14' ' ' ILE . 11.0 mt-10 -88.31 132.54 34.37 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.55 HD12 ' C ' ' A' ' 13' ' ' GLU . 4.1 mp -145.47 162.87 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 120.628 0.252 . . . . 0.0 110.697 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.41 154.34 19.17 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.284 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 69' ' ' ALA . 43.6 t -61.53 136.3 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.231 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.71 -6.81 74.09 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.417 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -104.39 158.18 16.64 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.3 p -101.48 149.71 23.79 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.628 0.251 . . . . 0.0 111.58 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.576 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -147.25 119.11 8.1 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.607 -178.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.773 ' HB3' HG23 ' A' ' 65' ' ' THR . 20.5 p90 -113.74 148.13 37.02 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.684 0.278 . . . . 0.0 110.537 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.66 ' CD2' HG21 ' A' ' 93' ' ' VAL . 58.9 m-85 -125.92 144.74 50.56 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.048 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.21 110.03 22.28 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.405 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 42.5 t -87.48 86.35 7.22 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -92.4 161.62 14.58 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.014 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.746 HG21 ' HB2' ' A' ' 60' ' ' ASP . 33.9 m -126.93 175.46 8.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.658 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.236 0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.727 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 t0 . . . . . 0 N--CA 1.462 0.151 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 60' ' ' ASP . 4.7 mp -75.4 156.1 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.294 0.568 . . . . 0.0 112.173 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.42 ' N ' HG22 ' A' ' 35' ' ' ILE . 5.0 m -157.55 162.96 38.82 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.499 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.405 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 46.1 m95 -135.61 130.36 34.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 110.53 -0.174 . . . . 0.0 110.53 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 87.1 m-85 -125.54 112.68 16.49 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.449 ' OG ' HD13 ' A' ' 45' ' ' LEU . 4.7 p -57.71 154.67 25.1 Favored Pre-proline 0 C--O 1.251 1.152 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo . . . . . 0 C--N 1.377 2.042 0 C-N-CA 124.649 3.566 . . . . 0.0 116.084 -178.375 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 10.0 tttt . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 120.57 0.224 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.477 ' CD2' HG21 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -131.18 122.02 25.87 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.047 -179.458 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.98 158.91 73.83 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.252 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -83.52 -13.76 8.31 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 122.511 2.141 . . . . 0.0 113.808 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -153.85 84.74 1.16 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.011 0.434 . . . . 0.0 110.536 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.91 -57.75 0.81 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.977 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -137.24 -159.17 0.93 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -48.91 -26.47 2.49 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.477 HG21 ' CD2' ' A' ' 45' ' ' LEU . 61.7 mt -82.58 122.78 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.8 t -134.44 124.29 25.41 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.971 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.6 t -98.33 156.91 3.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.218 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.2 p -152.21 141.29 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.876 0.37 . . . . 0.0 111.735 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -117.11 121.91 42.62 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.44 -76.73 0.57 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -58.04 -175.68 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -56.33 -37.55 70.13 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.954 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.746 ' HB2' HG21 ' A' ' 26' ' ' VAL . 30.0 m-20 -148.98 20.87 0.99 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.7 t -105.25 142.05 35.69 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 120.65 0.262 . . . . 0.0 110.441 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.462 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.9 m -138.36 -176.53 4.49 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.023 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 22' ' ' PHE . 2.0 m -157.69 136.69 11.61 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.921 0.391 . . . . 0.0 111.629 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.421 HD21 ' CD2' ' A' ' 77' ' ' TYR . 15.8 tp -96.08 141.67 29.19 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.773 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -136.46 96.46 3.36 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.772 0.715 . . . . 0.0 112.676 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.493 HD13 ' HZ3' ' A' ' 20' ' ' LYS . 1.6 mt -92.47 90.74 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.469 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -57.51 -96.05 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.975 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.46 97.64 0.78 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.066 0.848 . . . . 0.0 110.142 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.553 ' O ' HG13 ' A' ' 16' ' ' VAL . . . -77.76 157.52 29.99 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -152.21 158.18 42.5 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.059 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -52.34 -24.82 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -72.54 -42.72 64.41 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 110.478 -0.194 . . . . 0.0 110.478 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.441 ' OD1' HD11 ' A' ' 52' ' ' ILE . 32.6 m-20 -63.73 -33.69 76.21 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.03 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.589 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -51.12 105.57 0.11 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.95 178.92 48.11 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.485 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.643 HD13 ' HA ' ' A' ' 94' ' ' ASN . 24.6 mm -81.0 92.89 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 123.394 0.114 . . . . 0.0 110.758 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.421 ' CD2' HD21 ' A' ' 64' ' ' LEU . 67.4 m-85 -68.24 161.74 26.53 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -127.79 155.75 43.57 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.53 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -142.09 103.21 4.27 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.444 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.403 HG13 ' HB3' ' A' ' 90' ' ' GLU . 6.8 t -106.74 141.96 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.03 140.47 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.678 HG23 ' HG2' ' A' ' 88' ' ' GLN . 1.2 m -120.5 138.1 54.01 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.495 ' HB2' ' CD2' ' A' ' 3' ' ' LEU . . . -89.22 -174.27 4.35 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.11 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -73.47 -58.3 3.4 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.396 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -63.68 -22.78 67.08 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 120.9 19.77 3.58 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-O 119.785 -0.453 . . . . 0.0 113.811 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.549 ' O ' HD11 ' A' ' 3' ' ' LEU . 93.7 m -84.68 109.05 17.73 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.678 ' HG2' HG23 ' A' ' 82' ' ' THR . 22.8 mt-30 -101.93 130.82 48.52 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.516 ' HB2' HD12 ' A' ' 3' ' ' LEU . 7.3 t -122.2 113.98 20.21 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.403 ' HB3' HG13 ' A' ' 80' ' ' VAL . 6.2 pt-20 -108.68 -177.84 3.43 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.402 ' HB1' HG13 ' A' ' 7' ' ' ILE . . . -150.16 170.44 18.93 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.325 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.45 154.76 39.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.742 0.306 . . . . 0.0 111.113 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.66 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.1 p -143.2 121.04 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.963 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.643 ' HA ' HD13 ' A' ' 76' ' ' ILE . 7.0 t30 -76.85 95.62 4.12 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.845 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.428 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 20.2 t -97.07 108.12 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.524 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -90.46 149.97 22.01 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.599 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.589 HD12 ' N ' ' A' ' 74' ' ' ALA . 9.8 mt -146.56 115.41 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.731 0.3 . . . . 0.0 110.424 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.17 134.2 55.07 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.961 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.82 179.87 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.357 0.122 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -156.49 -43.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 120.752 0.311 . . . . 0.0 111.228 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.427 HD12 HG22 ' A' ' 87' ' ' THR . 16.2 mt -57.21 134.06 55.59 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.594 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -139.39 141.73 37.54 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.746 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 t -149.38 143.32 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 O-C-N 123.253 0.346 . . . . 0.0 110.867 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -160.07 127.07 4.44 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.771 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' A' ' 79' ' ' CYS . 45.7 mt -99.74 138.63 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.367 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.7 t -128.49 135.48 27.63 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.671 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.429 ' O ' HG23 ' A' ' 93' ' ' VAL . 91.4 Cg_endo -77.23 170.26 71.93 Favored 'Cis proline' 0 C--N 1.366 1.492 0 C-N-CA 124.767 -0.93 . . . . 0.0 111.815 -0.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.2 p -66.63 -45.08 80.21 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.809 0.338 . . . . 0.0 110.323 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -131.8 110.86 11.15 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.398 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -111.54 97.94 0.98 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.756 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.805 ' O ' HD13 ' A' ' 14' ' ' ILE . 16.2 mt-10 -78.62 134.44 37.18 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.805 HD13 ' O ' ' A' ' 13' ' ' GLU . 4.3 mm -136.84 170.01 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.401 -178.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.492 ' H ' HG22 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -119.03 156.68 29.22 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.791 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.18 137.81 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.53 -8.75 78.49 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.6 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.426 ' HB2' HG22 ' A' ' 14' ' ' ILE . 4.0 mm-40 -100.03 155.05 17.92 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 117.302 0.551 . . . . 0.0 109.751 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.1 p -98.62 163.53 12.62 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.582 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -164.16 119.52 1.54 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -178.137 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.772 ' HB3' HG23 ' A' ' 65' ' ' THR . 31.5 p90 -112.97 141.4 46.84 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.601 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.644 ' CD2' HG21 ' A' ' 93' ' ' VAL . 94.7 m-85 -117.79 118.49 32.17 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.839 0.352 . . . . 0.0 111.205 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.94 115.07 18.39 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.9 t -99.6 94.89 6.62 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.355 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -88.91 158.75 17.97 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.744 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.661 HG21 ' CB ' ' A' ' 60' ' ' ASP . 32.1 m -138.49 171.77 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -158.72 137.61 11.23 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.51 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 140.5 -161.44 26.56 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.551 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -173.32 37.97 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.894 0.378 . . . . 0.0 110.761 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.19 79.24 9.16 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.067 0.46 . . . . 0.0 111.173 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm 60.22 -167.87 0.17 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.5 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -64.31 133.66 53.13 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -116.53 145.4 43.37 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.988 0.423 . . . . 0.0 111.712 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.638 ' C ' HD12 ' A' ' 35' ' ' ILE . 11.2 m-20 -121.85 164.91 16.72 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.485 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.638 HD12 ' C ' ' A' ' 34' ' ' ASP . 3.6 mp -127.9 146.83 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 123.373 0.421 . . . . 0.0 110.787 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 m -144.47 158.94 43.51 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.308 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.457 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 55.4 m95 -133.7 128.02 34.09 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.04 0.212 . . . . 0.0 110.44 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 94.0 m-85 -116.6 117.98 31.36 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.7 p -66.61 149.43 98.19 Favored Pre-proline 0 C--O 1.247 0.932 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.477 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -49.93 -16.85 1.84 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 124.741 3.627 . . . . 0.0 115.516 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -79.14 7.71 7.06 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 117.972 0.351 . . . . 0.0 111.83 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.78 41.75 22.79 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 111.824 -0.511 . . . . 0.0 111.824 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -163.79 135.79 4.93 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 119.658 -0.817 . . . . 0.0 112.995 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 31.0 tttt -54.88 143.37 26.16 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.531 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 pp -109.42 143.62 38.76 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.58 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.9 m -84.24 157.11 62.73 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.219 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.64 -27.6 3.97 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.444 2.096 . . . . 0.0 112.731 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -118.34 65.86 0.76 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.369 0.604 . . . . 0.0 110.025 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.11 -59.7 1.31 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.564 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -140.95 -162.21 1.33 Allowed 'General case' 0 CA--C 1.54 0.575 0 O-C-N 123.008 0.193 . . . . 0.0 110.508 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -51.76 -23.06 4.11 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.664 HG23 HG12 ' A' ' 66' ' ' ILE . 46.3 mt -82.18 99.15 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.7 t -105.04 122.88 46.79 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.949 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.414 HG22 HD23 ' A' ' 64' ' ' LEU . 16.3 t -93.07 158.03 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.139 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 p -151.55 147.9 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 20.4 m-90 -122.1 114.9 21.55 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.51 -80.35 0.58 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -56.24 -176.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -51.17 -37.83 48.67 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.661 ' CB ' HG21 ' A' ' 26' ' ' VAL . 5.4 m-20 -152.78 22.68 0.59 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 p -99.6 138.89 36.05 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.554 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.1 m -143.28 134.4 25.74 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.104 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.455 HG22 ' HB2' ' A' ' 21' ' ' PHE . 1.2 m -103.11 141.05 36.5 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 111.626 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.614 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -103.66 94.32 5.39 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.324 179.35 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.772 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -85.96 139.59 31.07 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 123.468 0.48 . . . . 0.0 110.351 -179.278 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.664 HG12 HG23 ' A' ' 52' ' ' ILE . 67.1 mt -137.44 93.22 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -60.2 -113.88 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.473 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.21 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.81 1.186 . . . . 0.0 110.967 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.864 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -69.84 148.92 48.45 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.16 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.768 ' O ' HD12 ' A' ' 97' ' ' ILE . 9.4 m120 -141.52 154.68 45.64 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.715 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.5 pt -53.9 -24.48 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -71.51 -40.97 69.81 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.421 ' OD1' HD11 ' A' ' 52' ' ' ILE . 77.8 m-20 -66.47 -35.53 80.5 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.885 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.568 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -51.37 107.81 0.21 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.69 -179.35 47.81 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.446 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.59 HD13 ' HA ' ' A' ' 94' ' ' ASN . 32.2 mm -82.18 95.22 3.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.588 0.194 . . . . 0.0 111.006 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.614 ' CD2' HD11 ' A' ' 64' ' ' LEU . 70.0 m-85 -71.76 160.12 33.16 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -128.09 158.15 38.78 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.908 0.385 . . . . 0.0 111.563 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.533 ' HB2' HD11 ' A' ' 7' ' ' ILE . 9.5 t -138.93 99.86 3.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 89' ' ' SER . 4.4 t -109.8 126.33 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 121.066 0.46 . . . . 0.0 112.116 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.503 HG22 HG13 ' A' ' 35' ' ' ILE . 2.3 t -102.72 155.1 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.699 HG23 ' HB3' ' A' ' 88' ' ' GLN . 0.5 OUTLIER -132.66 143.45 49.66 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.13 176.5 6.95 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.371 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.94 -40.77 87.66 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.199 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.8 -36.24 28.63 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.392 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 150.06 -18.15 1.07 Allowed Glycine 0 C--N 1.339 0.75 0 CA-C-O 119.556 -0.58 . . . . 0.0 113.813 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.427 HG22 HD12 ' A' ' 3' ' ' LEU . 55.7 m -58.52 103.46 0.16 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.876 0.838 . . . . 0.0 110.702 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.699 ' HB3' HG23 ' A' ' 82' ' ' THR . 6.2 pt20 -109.39 132.54 54.03 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.796 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.497 ' O ' HG13 ' A' ' 80' ' ' VAL . 66.1 p -99.65 -176.86 3.39 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -161.3 175.51 12.19 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -159.7 176.42 12.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.127 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.2 163.86 39.61 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.644 HG21 ' CD2' ' A' ' 22' ' ' PHE . 8.5 p -152.63 123.11 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.75 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.59 ' HA ' HD13 ' A' ' 76' ' ' ILE . 1.9 t-20 -80.97 96.03 6.96 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.988 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.433 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 14.0 t -97.94 123.59 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.531 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -108.53 160.28 16.04 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.911 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.864 HD13 ' HB1' ' A' ' 69' ' ' ALA . 12.0 mt -151.58 125.74 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.684 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -116.58 127.98 54.99 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.342 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.735 -179.873 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.46 0.171 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.985 HG23 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -152.87 37.29 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 121.103 0.478 . . . . 0.0 110.977 -179.604 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.493 HD11 ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -135.26 124.3 24.28 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.957 179.677 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.722 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 9.2 tp-100 -127.18 148.37 50.18 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.422 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 t -145.76 147.23 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 123.12 0.262 . . . . 0.0 111.445 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -160.3 126.2 4.09 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.323 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.516 HD11 ' HB2' ' A' ' 79' ' ' CYS . 43.7 mt -97.28 139.48 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.656 0.265 . . . . 0.0 110.648 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.6 t -128.17 130.86 23.55 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.942 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.56 172.03 64.51 Favored 'Cis proline' 0 C--N 1.365 1.443 0 CA-C-N 119.73 0.939 . . . . 0.0 112.377 -0.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 p -69.83 -53.2 19.23 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.337 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -129.96 107.61 9.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.211 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.41 158.97 24.81 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 116.077 -0.51 . . . . 0.0 113.545 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -143.37 119.5 10.76 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.13 164.24 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.711 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.97 157.62 16.73 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 69' ' ' ALA . 38.9 t -63.69 138.49 22.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.87 -15.18 63.68 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.436 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -99.04 162.63 12.96 Favored 'General case' 0 C--N 1.348 0.511 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.1 p -102.73 168.35 9.31 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.639 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -163.94 121.44 1.77 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.483 -178.643 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.753 ' HB3' HG23 ' A' ' 65' ' ' THR . 35.7 p90 -115.05 142.29 46.84 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.622 178.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.644 ' CD2' HG21 ' A' ' 93' ' ' VAL . 93.4 m-85 -118.42 118.4 31.64 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.004 0.43 . . . . 0.0 111.283 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.0 tp -79.21 116.44 19.48 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.9 t -97.93 100.65 12.01 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.404 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 -91.4 158.78 16.32 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.777 HG21 ' CB ' ' A' ' 60' ' ' ASP . 34.1 m -134.86 174.36 13.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.722 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -159.27 118.55 2.96 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.764 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 140.11 179.45 17.9 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.982 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -147.9 78.6 1.45 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.117 0.484 . . . . 0.0 110.777 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.985 ' HB2' HG23 ' A' ' 2' ' ' VAL . . . -100.23 24.35 8.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.261 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? 59.98 -86.48 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -48.51 -28.45 3.36 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -3.63 106.47 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.551 ' O ' HG22 ' A' ' 81' ' ' VAL . 54.7 m-20 -121.1 168.35 11.65 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.906 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.518 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.2 mp -130.21 153.39 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 123.318 0.386 . . . . 0.0 110.856 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.2 m -152.31 160.63 43.3 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.34 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.463 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 59.1 m95 -132.63 130.82 40.68 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.216 0.206 . . . . 0.0 110.792 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 67.3 m-85 -122.12 117.96 27.53 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.9 p -62.51 152.85 79.42 Favored Pre-proline 0 C--O 1.253 1.285 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.425 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.32 -12.34 5.55 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 124.472 3.448 . . . . 0.0 115.947 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -76.73 -3.89 40.48 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.104 0.411 . . . . 0.0 111.388 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.03 41.04 4.43 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.758 -0.468 . . . . 0.0 112.019 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -162.14 177.15 9.95 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 119.76 -0.776 . . . . 0.0 112.122 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 19.1 tttt -91.41 149.58 21.65 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.522 0.514 . . . . 0.0 111.021 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 45' ' ' LEU . 1.0 OUTLIER -111.12 152.69 26.68 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.605 179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 m -79.36 163.05 61.36 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.341 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.22 -28.06 12.99 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.66 2.24 . . . . 0.0 112.696 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -139.41 72.99 1.41 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.13 0.491 . . . . 0.0 111.009 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.416 ' NE2' ' HB2' ' A' ' 45' ' ' LEU . 4.2 mt-30 -80.61 -68.76 0.65 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.992 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -156.67 -72.73 0.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -99.74 -35.85 9.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.426 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.539 HG12 HG23 ' A' ' 66' ' ' ILE . 48.7 mt -85.7 110.33 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.777 0.322 . . . . 0.0 110.78 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.3 t -114.49 118.66 34.4 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.659 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 55' ' ' VAL . 12.6 t -90.33 158.78 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.268 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.41 ' N ' HG12 ' A' ' 54' ' ' VAL . 12.3 p -153.99 152.09 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.963 0.411 . . . . 0.0 111.64 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 24.8 m-90 -123.16 104.56 9.25 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -91.16 -80.77 0.33 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -176.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -65.26 -177.92 0.44 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.41 0.148 . . . . 0.0 110.912 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.94 -33.73 62.53 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.777 ' CB ' HG21 ' A' ' 26' ' ' VAL . 45.3 m-20 -141.43 7.4 1.94 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.9 p -94.52 136.41 34.85 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.282 0.492 . . . . 0.0 110.459 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.518 ' OG ' HG21 ' A' ' 35' ' ' ILE . 0.7 OUTLIER -140.93 132.99 27.85 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.372 -178.835 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 m -102.89 146.3 28.51 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 111.921 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.622 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -111.47 94.95 5.23 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.532 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.753 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -85.18 142.49 29.43 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.822 0.344 . . . . 0.0 110.274 -179.534 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.539 HG23 HG12 ' A' ' 52' ' ' ILE . 67.9 mt -139.53 90.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -59.57 -113.46 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.304 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -53.28 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.968 1.258 . . . . 0.0 111.154 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.877 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -75.63 143.0 42.5 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.294 -178.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.757 ' O ' HD12 ' A' ' 97' ' ' ILE . 10.7 m120 -136.11 153.49 51.28 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.689 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.492 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -52.67 -25.68 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -71.21 -42.15 69.31 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.432 ' OD2' HD11 ' A' ' 52' ' ' ILE . 4.6 m-20 -62.99 -34.72 78.14 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.678 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.535 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -53.28 112.03 0.8 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.67 179.06 47.69 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.547 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.828 HD13 ' HA ' ' A' ' 94' ' ' ASN . 23.4 mm -80.72 95.5 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 122.051 0.14 . . . . 0.0 111.175 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.622 ' CD2' HD11 ' A' ' 64' ' ' LEU . 61.0 m-85 -71.95 167.08 20.85 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -132.03 158.16 42.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 112.258 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.516 ' HB2' HD11 ' A' ' 7' ' ' ILE . 4.2 t -140.12 100.39 3.9 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.304 178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 89' ' ' SER . 5.2 t -107.67 129.7 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 111.872 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 34' ' ' ASP . 1.6 t -108.2 156.41 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.55 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.9 m -132.78 149.11 52.31 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.28 -173.65 3.14 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.692 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.69 -48.47 21.88 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.116 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.27 -37.81 71.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.23 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 150.0 -18.54 1.08 Allowed Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.06 -0.59 . . . . 0.0 113.86 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.493 ' O ' HD11 ' A' ' 3' ' ' LEU . 96.2 m -57.92 108.3 0.57 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.859 0.829 . . . . 0.0 110.582 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.55 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -113.53 134.55 54.62 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.265 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.569 ' O ' HG13 ' A' ' 80' ' ' VAL . 83.6 p -97.15 -177.89 4.0 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -160.53 171.76 18.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -154.51 172.83 17.17 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.009 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.79 155.76 38.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.728 0.299 . . . . 0.0 111.248 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.644 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.5 p -142.92 118.93 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.348 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.828 ' HA ' HD13 ' A' ' 76' ' ' ILE . 7.9 t30 -76.15 88.27 3.04 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.347 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.465 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 16.0 t -87.9 131.63 35.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.058 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.23 153.57 32.66 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.559 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.877 HD13 ' HB1' ' A' ' 69' ' ' ALA . 9.8 mt -145.67 128.61 10.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.563 178.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.77 133.24 53.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.358 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.929 -179.817 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.528 ' O ' HG13 ' A' ' 2' ' ' VAL . 6.4 ttm-85 . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.312 0.101 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.589 ' O ' HD12 ' A' ' 3' ' ' LEU . 2.9 m -159.64 49.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 121.039 0.447 . . . . 0.0 111.258 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.589 HD12 ' O ' ' A' ' 2' ' ' VAL . 1.4 mp -148.44 118.13 7.06 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.798 0.332 . . . . 0.0 111.583 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.649 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 10.6 tp-100 -138.74 140.55 38.72 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.232 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.533 HG21 ' O ' ' A' ' 89' ' ' SER . 11.4 t -144.92 141.25 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.672 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -157.37 124.82 5.25 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.587 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.516 HD11 ' HB2' ' A' ' 79' ' ' CYS . 48.6 mt -92.39 143.66 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.594 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.6 t -131.11 133.03 24.18 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.887 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.24 169.99 73.05 Favored 'Cis proline' 0 C--N 1.363 1.303 0 CA-C-N 119.719 0.935 . . . . 0.0 112.029 0.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.4 p -68.2 -42.15 80.3 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -133.47 111.87 11.08 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.289 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.451 ' O ' HD12 ' A' ' 14' ' ' ILE . . . -106.2 100.39 1.64 Allowed Glycine 0 C--N 1.341 0.855 0 C-N-CA 120.895 -0.669 . . . . 0.0 114.251 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.51 ' C ' HD12 ' A' ' 14' ' ' ILE . 0.8 OUTLIER -85.64 128.91 34.91 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.487 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.51 HD12 ' C ' ' A' ' 13' ' ' GLU . 5.0 mp -144.53 162.92 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.662 0.268 . . . . 0.0 110.733 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.17 156.45 17.7 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.729 0.3 . . . . 0.0 110.367 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.647 HG13 ' O ' ' A' ' 69' ' ' ALA . 28.4 t -62.91 138.55 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.999 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.1 -15.75 62.47 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.343 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -97.16 159.17 15.07 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.0 p -97.36 164.47 12.45 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.647 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -159.31 116.62 2.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -177.192 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.879 ' HB3' HG23 ' A' ' 65' ' ' THR . 39.1 p90 -111.52 143.28 42.63 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.64 0.257 . . . . 0.0 111.143 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.523 ' CZ ' HG22 ' A' ' 95' ' ' VAL . 85.5 m-85 -120.72 110.02 15.88 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.5 tp -77.56 112.53 14.44 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.2 t -94.05 108.17 20.02 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.208 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -96.88 155.37 16.8 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.755 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.62 HG21 ' CB ' ' A' ' 60' ' ' ASP . 30.1 m -129.24 175.49 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.649 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -168.57 124.26 0.96 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.828 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 166.24 153.45 7.76 Favored Glycine 0 C--N 1.34 0.764 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.452 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -104.67 31.27 4.83 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.714 0.257 . . . . 0.0 111.647 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.492 ' HB2' HG23 ' A' ' 2' ' ' VAL . . . -68.48 -178.8 1.19 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.853 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -86.43 -38.28 17.5 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.285 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -153.41 148.45 26.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.911 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -132.12 147.5 52.43 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -132.67 100.94 5.1 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.121 0.168 . . . . 0.0 111.133 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.634 HD11 ' HA ' ' A' ' 60' ' ' ASP . 4.2 mp -66.77 150.01 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.209 0.528 . . . . 0.0 112.115 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.3 m -150.46 155.54 39.72 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.463 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.478 ' O ' ' HA ' ' A' ' 44' ' ' LYS . 43.8 m95 -134.86 117.92 16.41 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 119.239 -0.41 . . . . 0.0 111.136 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -117.5 109.83 17.22 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.287 0.367 . . . . 0.0 111.885 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 p -59.89 154.67 47.11 Favored Pre-proline 0 C--O 1.246 0.905 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.941 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -29.12 -74.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.383 2.385 1 C-N-CA 125.696 4.264 . . . . 0.0 114.618 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.92 36.78 4.49 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.03 -16.78 4.3 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-O 119.41 -0.661 . . . . 0.0 113.198 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 71.04 -168.72 0.15 Allowed 'General case' 0 C--N 1.35 0.609 0 CA-C-N 117.958 0.879 . . . . 0.0 109.156 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 27.9 tttt -54.9 118.62 4.43 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.472 HD13 HG21 ' A' ' 52' ' ' ILE . 12.2 mt -77.95 175.9 9.62 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.587 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.5 m -94.28 156.11 39.17 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.884 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.91 -34.53 90.94 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.322 2.015 . . . . 0.0 112.5 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -152.69 63.6 0.8 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.229 0.538 . . . . 0.0 110.568 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.11 -73.58 0.12 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.577 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -147.84 -74.51 0.19 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.638 0.256 . . . . 0.0 110.782 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -99.35 -36.62 9.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.758 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.579 HG12 HG23 ' A' ' 66' ' ' ILE . 18.0 mt -84.64 104.96 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.936 0.398 . . . . 0.0 110.796 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.3 t -107.56 120.34 41.92 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.838 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.2 t -90.99 159.1 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.6 p -151.63 146.43 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.96 0.409 . . . . 0.0 111.839 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 23.1 m-90 -121.38 106.59 11.59 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -98.72 -79.97 0.47 Allowed 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -62.64 -177.63 0.16 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.653 0.263 . . . . 0.0 111.628 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -50.25 -35.92 28.97 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.634 ' HA ' HD11 ' A' ' 35' ' ' ILE . 42.0 m-20 -149.37 17.89 0.94 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.9 t -98.06 139.07 34.42 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.563 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -145.71 131.28 18.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -178.311 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.87 151.96 19.69 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.043 0.449 . . . . 0.0 111.958 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.605 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -114.25 92.9 4.12 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.254 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.879 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -87.43 139.99 29.99 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 123.382 0.426 . . . . 0.0 110.614 -179.027 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.579 HG23 HG12 ' A' ' 52' ' ' ILE . 49.3 mt -136.84 93.9 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -58.36 -107.59 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 119.049 -0.5 . . . . 0.0 111.251 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.42 95.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.796 1.18 . . . . 0.0 110.591 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.791 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -79.77 149.74 31.0 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.676 -178.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.764 ' O ' HD12 ' A' ' 97' ' ' ILE . 1.1 p30 -146.37 157.42 43.78 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.174 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.7 pt -53.86 -24.68 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -71.68 -39.87 69.95 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -67.07 -35.93 80.9 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.591 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -50.36 117.57 2.48 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.97 174.87 38.52 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.023 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.851 HD13 ' HA ' ' A' ' 94' ' ' ASN . 17.6 mm -73.75 91.27 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 122.18 0.192 . . . . 0.0 111.271 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.605 ' CD2' HD11 ' A' ' 64' ' ' LEU . 63.3 m-85 -68.43 172.6 5.83 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -135.32 158.21 44.95 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.516 ' HB2' HD11 ' A' ' 7' ' ' ILE . 12.3 t -142.0 97.78 3.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.149 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 90' ' ' GLU . 4.6 t -102.85 131.65 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.0 0.429 . . . . 0.0 111.931 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.87 139.84 43.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.643 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.9 m -125.71 143.99 50.8 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.582 ' HB2' HD11 ' A' ' 3' ' ' LEU . . . -93.26 -176.13 4.04 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.958 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -69.76 -57.41 5.14 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.076 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -60.55 -31.78 70.87 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 138.84 -18.85 3.16 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.477 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.8 m -59.55 107.81 0.64 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.335 0.568 . . . . 0.0 111.199 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.643 ' HB3' HG23 ' A' ' 82' ' ' THR . 1.1 pt20 -115.2 134.14 55.41 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.444 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.533 ' O ' HG21 ' A' ' 5' ' ' VAL . 31.8 t -115.12 119.76 37.5 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.458 ' HB3' HG13 ' A' ' 80' ' ' VAL . 18.6 pt-20 -104.63 -179.62 4.0 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -154.06 178.06 10.38 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.132 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.04 154.85 36.78 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.592 0.234 . . . . 0.0 111.051 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.505 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.2 p -138.86 123.17 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.965 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.851 ' HA ' HD13 ' A' ' 76' ' ' ILE . 6.0 t30 -75.2 96.91 3.39 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.26 0.553 . . . . 0.0 110.261 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.523 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 60.8 t -96.71 131.96 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.441 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -121.4 147.63 45.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.383 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.791 HD13 ' HB1' ' A' ' 69' ' ' ALA . 13.1 mt -141.25 137.22 33.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.22 134.01 37.68 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.948 -177.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.472 ' HB3' HG21 ' A' ' 16' ' ' VAL . 4.7 pt20 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.305 -0.855 . . . . 0.0 110.94 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.592 0.234 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.52 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 2.3 m -122.02 119.51 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.02 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.3 tp -168.72 118.16 0.72 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.252 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.649 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -135.85 136.47 40.61 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.654 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -143.77 142.66 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.46 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -156.43 158.83 37.99 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.127 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.421 HD11 ' HB2' ' A' ' 79' ' ' CYS . 50.9 mt -128.13 138.71 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.8 128.1 24.98 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.269 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.448 ' O ' HG23 ' A' ' 93' ' ' VAL . 98.5 Cg_endo -80.37 173.79 50.97 Favored 'Cis proline' 0 C--N 1.366 1.498 0 CA-C-N 119.68 0.922 . . . . 0.0 112.332 -0.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.8 p -69.66 -46.5 65.98 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -130.69 101.96 5.9 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.46 101.75 2.61 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.786 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.85 119.95 26.72 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.588 HD13 ' CB ' ' A' ' 20' ' ' LYS . 2.4 mp -135.6 166.57 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.42 161.6 18.83 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.481 0.657 . . . . 0.0 111.962 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 69' ' ' ALA . 57.6 t -65.42 137.4 25.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.861 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.72 -18.47 57.21 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.194 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -114.76 145.22 42.34 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 117.593 0.696 . . . . 0.0 110.291 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.5 p -79.01 173.99 12.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.638 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -166.79 118.99 0.97 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.976 -178.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.646 ' HB3' HG23 ' A' ' 65' ' ' THR . 44.6 p90 -115.81 146.57 41.85 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.612 0.244 . . . . 0.0 110.831 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.648 ' CD2' HG21 ' A' ' 93' ' ' VAL . 75.9 m-85 -121.49 112.85 19.02 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.07 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.0 tp -79.12 111.26 15.16 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.5 t -92.82 110.1 21.54 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.217 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -95.31 164.73 12.71 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.871 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' ' 60' ' ' ASP . 27.5 m -142.01 170.6 12.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.649 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -161.89 125.15 3.09 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.252 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 145.91 151.91 5.52 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.264 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -106.87 42.72 1.25 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.065 0.46 . . . . 0.0 110.669 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 2' ' ' VAL . . . -85.69 5.68 31.01 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? 57.96 -85.47 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -37.48 -31.76 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -12.52 80.73 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -95.48 111.7 23.55 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.963 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.904 HD13 HG23 ' A' ' 81' ' ' VAL . 13.1 mm -70.51 155.16 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.371 0.605 . . . . 0.0 111.779 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.9 m -155.11 157.66 37.82 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.275 178.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.433 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 58.7 m95 -131.82 123.69 28.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.577 0.172 . . . . 0.0 111.004 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 80.0 m-85 -116.76 113.22 22.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.9 p -62.78 152.51 82.1 Favored Pre-proline 0 C--O 1.254 1.323 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.306 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -58.18 -9.15 5.89 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 124.374 3.383 . . . . 0.0 115.267 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -75.84 -6.25 49.85 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 118.097 0.408 . . . . 0.0 110.81 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.78 40.98 3.69 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-O 119.705 -0.497 . . . . 0.0 112.006 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -166.98 178.22 5.89 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 119.788 -0.765 . . . . 0.0 112.43 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 12.6 ttmt -91.37 125.81 36.24 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 123.589 0.556 . . . . 0.0 111.068 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.3 pp -83.99 135.16 34.56 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.815 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.5 m -69.75 155.03 94.22 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.046 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.62 -30.57 7.72 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 122.364 2.043 . . . . 0.0 112.761 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -117.19 56.5 0.82 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.151 0.501 . . . . 0.0 111.155 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -76.01 -80.46 0.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.285 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -155.78 -72.68 0.11 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -99.74 -29.72 12.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.718 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.499 HG12 HG23 ' A' ' 66' ' ' ILE . 47.4 mt -89.36 106.01 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.811 0.338 . . . . 0.0 110.871 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 t -111.91 123.38 50.12 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.724 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 t -95.5 157.33 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -152.87 143.36 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.5 m-90 -116.41 115.02 25.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.09 -76.34 0.58 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.92 -173.41 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -48.94 -42.1 36.19 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.563 0.345 . . . . 0.0 111.818 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.533 ' HB2' HG21 ' A' ' 26' ' ' VAL . 10.4 m-20 -156.57 28.61 0.33 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.228 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.9 t -99.73 141.33 32.68 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.421 ' OG ' HG21 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -147.66 132.49 18.01 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -177.759 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.46 HG22 ' HB2' ' A' ' 21' ' ' PHE . 1.5 m -98.36 143.68 28.56 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.142 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.669 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -106.17 92.78 4.29 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.646 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -84.67 136.83 33.58 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 123.426 0.453 . . . . 0.0 110.745 -178.713 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.561 HD12 ' HD2' ' A' ' 20' ' ' LYS . 53.9 mt -134.87 91.0 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -60.46 -111.84 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 118.921 -0.562 . . . . 0.0 111.283 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.55 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.841 1.2 . . . . 0.0 110.923 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.814 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -75.59 136.71 40.5 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.04 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.781 ' O ' HD12 ' A' ' 97' ' ' ILE . 10.9 m120 -132.86 152.63 51.81 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.127 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.0 pt -51.72 -25.11 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -68.39 -44.49 74.99 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -64.96 -35.47 81.27 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.81 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.506 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -49.79 118.31 2.78 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.43 176.48 39.36 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.064 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.3 mt -82.29 101.82 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.638 0.219 . . . . 0.0 110.892 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.669 ' CD2' HD11 ' A' ' 64' ' ' LEU . 52.0 m-85 -75.35 171.28 14.5 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -132.84 156.5 47.04 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.421 ' HB2' HD11 ' A' ' 7' ' ' ILE . 13.9 t -140.72 105.73 4.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.296 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.1 t -109.19 144.79 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.904 HG23 HD13 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -129.39 130.61 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.537 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.3 m -110.17 148.19 32.28 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.22 -178.92 4.91 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.616 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -74.33 -37.69 63.5 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.162 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -81.6 -31.08 32.67 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.422 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.92 -16.58 2.8 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-O 119.856 -0.413 . . . . 0.0 113.281 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 59.3 m -59.0 110.06 0.96 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.328 0.564 . . . . 0.0 111.23 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.537 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -120.65 134.26 55.3 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.146 179.27 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.4 t -121.98 133.63 54.82 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -117.25 -178.59 3.49 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.62 173.99 13.5 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.848 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.57 155.92 43.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.564 0.221 . . . . 0.0 110.87 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.648 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.2 p -140.84 115.75 6.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.746 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.8 97.36 1.37 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.453 0.471 . . . . 0.0 110.535 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.484 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 14.3 t -99.92 136.29 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.769 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -125.54 152.41 45.08 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.226 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.814 HD13 ' HB1' ' A' ' 69' ' ' ALA . 12.3 mt -139.86 110.77 4.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.357 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.56 125.35 52.44 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.353 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.258 -179.657 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.453 0.168 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.685 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 2.1 m -79.11 94.16 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.157 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -173.66 97.18 0.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.301 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.764 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 22.9 tt0 -133.33 157.74 44.73 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.591 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 89' ' ' SER . 0.9 OUTLIER -151.87 155.27 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.433 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -160.04 130.33 5.49 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.156 0.285 . . . . 0.0 110.84 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.46 HD11 ' HB3' ' A' ' 79' ' ' CYS . 28.0 mt -96.25 142.53 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.639 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.89 128.69 24.17 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.38 -176.17 17.06 Favored 'Cis proline' 0 C--N 1.365 1.396 0 CA-C-N 120.084 1.066 . . . . 0.0 112.301 0.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.1 p -76.24 -40.67 51.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.144 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -126.03 124.68 41.19 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.032 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.407 ' C ' HD12 ' A' ' 14' ' ' ILE . . . -106.06 72.53 0.22 Allowed Glycine 0 C--N 1.341 0.86 0 C-N-CA 121.142 -0.551 . . . . 0.0 114.359 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.472 ' C ' HD12 ' A' ' 14' ' ' ILE . 27.7 mt-10 -76.92 112.65 13.76 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.472 HD12 ' C ' ' A' ' 13' ' ' GLU . 2.9 mp -135.77 164.83 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.7 154.88 17.64 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.8 t -63.06 141.52 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.094 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.86 -11.0 71.86 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.463 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -101.95 153.3 20.0 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.1 p -91.45 156.55 17.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.517 0.199 . . . . 0.0 111.061 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.675 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -151.59 117.39 5.46 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.666 -177.69 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.84 ' HB3' HG23 ' A' ' 65' ' ' THR . 36.1 p90 -112.64 144.11 42.69 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.65 0.262 . . . . 0.0 111.12 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.635 ' CD2' HG21 ' A' ' 93' ' ' VAL . 82.6 m-85 -122.99 118.0 26.78 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.38 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.8 tp -79.26 113.8 17.69 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.436 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 23.2 t -96.6 97.56 9.49 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -92.54 162.86 14.03 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.16 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.513 HG21 ' HB2' ' A' ' 60' ' ' ASP . 35.1 m -119.31 174.86 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.764 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -163.97 98.77 0.86 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.305 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.13 139.72 2.72 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.028 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -96.08 44.9 1.07 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.115 0.483 . . . . 0.0 111.253 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 2' ' ' VAL . . . -72.4 -174.64 1.38 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.627 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.5 -63.95 1.28 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.617 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -129.7 136.9 50.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.537 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -127.63 87.71 2.67 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.051 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -79.93 110.79 15.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.388 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.522 ' H ' HD12 ' A' ' 35' ' ' ILE . 5.1 mp -73.84 157.41 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 O-C-N 123.476 0.485 . . . . 0.0 111.36 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.418 ' N ' HG22 ' A' ' 35' ' ' ILE . 11.6 m -155.6 162.49 40.63 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.686 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.443 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 56.5 m95 -139.94 126.68 20.56 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.873 0.108 . . . . 0.0 110.942 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 84.2 m-85 -121.98 111.68 17.35 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.766 ' OG ' HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -65.76 161.39 53.81 Favored Pre-proline 0 C--O 1.256 1.423 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.384 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -52.24 -15.83 4.13 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 125.298 3.999 . . . . 0.0 115.805 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -78.31 3.66 14.92 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.626 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.82 43.6 14.14 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -158.29 159.71 36.26 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.357 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 9.7 ttpt -84.88 125.87 33.0 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 123.536 0.523 . . . . 0.0 111.425 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.766 HD11 ' OG ' ' A' ' 39' ' ' SER . 10.6 mt -74.37 145.67 43.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.548 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.5 m -77.42 162.14 69.9 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.776 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.15 -30.42 65.15 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 122.318 2.012 . . . . 0.0 112.432 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -141.98 75.31 1.49 Allowed 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.01 0.433 . . . . 0.0 111.032 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -76.21 -82.81 0.07 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.827 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -150.15 -72.8 0.17 Allowed 'General case' 0 C--N 1.342 0.277 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 -99.8 -33.36 10.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.504 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.697 HG12 HG23 ' A' ' 66' ' ' ILE . 21.2 mt -88.1 103.3 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.726 0.298 . . . . 0.0 110.779 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.6 t -109.28 122.14 46.7 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.255 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 55' ' ' VAL . 11.8 t -94.34 160.8 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.414 ' N ' HG12 ' A' ' 54' ' ' VAL . 7.2 p -156.99 133.99 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -109.58 114.97 29.04 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -113.94 -73.84 0.64 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -171.47 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.84 -36.16 74.1 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.59 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.513 ' HB2' HG21 ' A' ' 26' ' ' VAL . 42.3 m-20 -153.37 23.17 0.54 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.174 -0.467 . . . . 0.0 112.177 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.2 t -109.47 141.18 42.27 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.459 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.4 m -134.36 -173.77 3.37 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.342 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 m -154.91 142.15 19.45 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.011 0.434 . . . . 0.0 111.213 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.686 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -109.69 93.84 4.71 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.756 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.84 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -90.33 139.05 31.03 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.363 0.415 . . . . 0.0 110.64 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.697 HG23 HG12 ' A' ' 52' ' ' ILE . 14.7 mt -135.17 86.46 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -49.49 -65.57 0.54 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -176.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.422 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 5.0 t-20 -63.59 -66.33 0.56 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.477 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . . . 75.4 125.96 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.084 0.553 . . . . 0.0 111.37 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.768 ' O ' HD12 ' A' ' 97' ' ' ILE . 9.8 m120 -147.16 167.37 24.32 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.4 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.8 pt -55.92 -22.98 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -75.29 -38.25 60.47 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -68.75 -32.96 73.09 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.542 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.514 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -51.95 109.17 0.34 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.06 173.42 45.59 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.742 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.7 mt -79.95 97.1 2.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.978 0.389 . . . . 0.0 110.823 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.686 ' CD2' HD11 ' A' ' 64' ' ' LEU . 58.8 m-85 -72.16 169.32 16.35 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -132.06 154.55 49.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.023 0.44 . . . . 0.0 111.777 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.46 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -138.17 103.47 4.95 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.71 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.6 t -108.36 143.33 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.26 147.15 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.634 HG23 ' HG2' ' A' ' 88' ' ' GLN . 0.5 OUTLIER -126.07 140.93 52.19 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.933 0.397 . . . . 0.0 111.751 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.24 -171.09 3.39 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.182 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -78.97 -35.62 42.75 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.458 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -88.38 -34.75 17.47 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.01 -18.94 1.22 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.77 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 62.6 m -51.17 114.61 1.25 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.499 0.65 . . . . 0.0 111.148 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.634 ' HG2' HG23 ' A' ' 82' ' ' THR . 6.9 mt-30 -106.71 138.95 41.93 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.99 0.424 . . . . 0.0 111.984 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.409 ' O ' HG21 ' A' ' 5' ' ' VAL . 6.0 p -125.97 108.0 10.99 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -104.4 177.91 4.71 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -149.38 169.7 20.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.936 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.66 152.09 37.27 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.999 0.428 . . . . 0.0 111.399 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.635 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.0 p -139.72 114.59 7.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.897 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.59 87.58 1.22 Allowed 'General case' 0 C--O 1.235 0.331 0 O-C-N 123.511 0.507 . . . . 0.0 110.34 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.415 ' CG1' ' HE2' ' A' ' 20' ' ' LYS . 18.4 t -87.4 130.08 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.396 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -115.46 158.13 22.98 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.815 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.768 HD12 ' O ' ' A' ' 70' ' ' ASN . 9.5 mt -148.25 135.19 13.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.736 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.91 129.96 52.25 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.561 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.018 -179.776 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.493 0.187 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.594 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -131.97 -37.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.387 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.604 ' CD1' ' HB3' ' A' ' 30' ' ' ALA . 10.3 mp -57.69 127.09 30.29 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.629 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -133.97 141.42 47.28 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.468 178.749 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 89' ' ' SER . 9.6 t -148.1 144.38 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 123.169 0.293 . . . . 0.0 111.189 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -154.88 148.21 25.02 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.597 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.8 mt -122.29 108.61 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.8 t -92.74 126.41 51.92 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.552 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -83.64 175.31 37.08 Favored 'Cis proline' 0 C--N 1.364 1.353 0 CA-C-N 119.969 1.025 . . . . 0.0 112.21 -0.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.2 p -71.1 -40.23 71.63 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -141.04 118.63 11.59 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.753 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.55 105.63 1.66 Allowed Glycine 0 C--N 1.343 0.934 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.974 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.544 ' C ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -85.73 130.71 34.49 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.554 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.544 HD12 ' C ' ' A' ' 13' ' ' GLU . 3.7 mp -146.71 164.96 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.09 157.66 17.38 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.842 0.353 . . . . 0.0 110.507 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.4 t -62.07 141.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.164 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.06 -7.38 81.57 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.356 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -104.78 152.0 23.1 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 76.6 p -92.58 155.66 17.63 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.576 0.227 . . . . 0.0 110.888 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.649 ' HD2' HD12 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -154.8 119.58 4.87 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.949 -178.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.728 ' HB3' HG23 ' A' ' 65' ' ' THR . 22.2 p90 -112.47 147.77 35.81 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.913 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.667 ' CD2' HG21 ' A' ' 93' ' ' VAL . 87.6 m-85 -124.75 118.77 27.16 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.196 0.522 . . . . 0.0 111.32 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.6 HD12 ' HG3' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -77.8 130.57 36.86 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.813 -178.579 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.496 ' N ' HD13 ' A' ' 23' ' ' LEU . 18.0 t -114.48 98.46 6.91 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.6 ' HG3' HD12 ' A' ' 23' ' ' LEU . 36.6 mt-30 -88.87 157.69 18.35 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.849 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.741 HG21 ' CB ' ' A' ' 60' ' ' ASP . 24.7 m -137.89 169.9 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -160.8 125.68 3.69 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.47 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.451 ' HA2' HG12 ' A' ' 2' ' ' VAL . . . 153.48 -168.55 32.13 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.638 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -168.87 33.55 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.652 0.263 . . . . 0.0 111.358 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.604 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . . . -87.98 84.43 6.97 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.724 0.297 . . . . 0.0 110.479 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.11 -174.33 0.07 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.901 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -60.75 136.87 58.2 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.616 0.246 . . . . 0.0 111.319 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.41 152.52 24.57 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.145 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -135.28 106.21 6.62 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.55 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.595 HG21 ' OG ' ' A' ' 62' ' ' SER . 5.1 mp -72.13 147.99 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.925 0.393 . . . . 0.0 110.994 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.9 m -147.06 154.49 41.24 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.318 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.428 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 43.3 m95 -129.59 113.86 15.34 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.062 0.145 . . . . 0.0 111.24 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -113.35 110.96 21.2 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 p -59.73 154.23 47.95 Favored Pre-proline 0 C--O 1.244 0.809 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.472 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -33.26 -74.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 125.252 3.968 . . . . 0.0 113.779 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.83 36.72 4.06 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.38 -18.69 4.44 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.464 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 71.13 -171.45 0.16 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 117.815 0.808 . . . . 0.0 109.057 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 11.1 tttt -56.22 104.31 0.14 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 pp -80.55 148.69 30.26 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.203 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.7 m -67.46 155.47 90.92 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.33 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -83.96 -22.11 3.66 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 122.522 2.148 . . . . 0.0 113.388 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -139.4 73.39 1.43 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.282 0.563 . . . . 0.0 110.328 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -104.94 -57.38 2.03 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.924 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.51 -83.76 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.79 -32.54 11.67 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.534 HG12 HG23 ' A' ' 66' ' ' ILE . 40.6 mt -90.47 107.56 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 120.662 0.267 . . . . 0.0 110.374 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.8 t -112.77 121.63 45.27 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.587 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 55' ' ' VAL . 18.8 t -92.82 159.9 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.413 ' N ' HG12 ' A' ' 54' ' ' VAL . 7.6 p -156.22 147.13 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -125.84 123.01 37.74 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.101 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.55 -73.94 0.63 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.2 -173.14 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -53.71 -40.28 65.9 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.663 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.741 ' CB ' HG21 ' A' ' 26' ' ' VAL . 9.7 m-20 -152.6 22.91 0.61 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.948 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.75 141.31 31.72 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.595 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.8 m -135.28 -170.56 2.62 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.055 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -159.24 142.05 14.18 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.664 0.269 . . . . 0.0 110.697 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.679 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -113.15 92.76 4.12 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.902 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.728 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -86.79 138.88 31.23 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.269 0.355 . . . . 0.0 110.131 -179.661 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.649 HD12 ' HD2' ' A' ' 20' ' ' LYS . 40.5 mt -135.22 82.12 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -49.36 -56.81 8.29 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -176.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 3.7 t-20 -71.06 -71.69 0.24 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 68' ' ' ASN . . . 81.12 120.97 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.501 0.721 . . . . 0.0 110.679 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.806 ' O ' HD12 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -141.7 159.99 41.1 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.267 0.556 . . . . 0.0 110.564 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 30.3 pt -51.01 -25.84 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -75.14 -39.83 60.13 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -64.46 -32.55 74.23 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.929 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.526 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -53.51 106.22 0.17 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.92 178.64 48.65 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.869 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.542 HG23 ' HB ' ' A' ' 92' ' ' THR . 1.1 mp -79.21 100.49 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.915 0.357 . . . . 0.0 110.816 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.679 ' CD2' HD11 ' A' ' 64' ' ' LEU . 48.0 m-85 -72.14 172.73 9.63 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -135.3 157.5 46.75 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 6.4 t -141.18 97.93 3.27 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.634 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.616 HG13 ' HB3' ' A' ' 90' ' ' GLU . 3.5 t -104.24 132.54 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.485 HG12 HD23 ' A' ' 3' ' ' LEU . 0.7 OUTLIER -112.29 139.96 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.014 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.73 HG23 ' HG2' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -127.68 132.91 49.61 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -179.378 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.5 -176.06 5.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.441 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -72.26 -52.78 14.8 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.158 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -63.77 -29.33 70.55 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.86 0.85 5.99 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.59 -0.561 . . . . 0.0 114.225 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.8 m -65.95 113.74 4.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.807 0.804 . . . . 0.0 110.019 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.73 ' HG2' HG23 ' A' ' 82' ' ' THR . 4.3 mt-30 -105.46 145.64 30.59 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.873 0.368 . . . . 0.0 111.658 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.435 ' O ' HG21 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -144.7 107.41 4.45 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.25 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.616 ' HB3' HG13 ' A' ' 80' ' ' VAL . 13.7 pt-20 -109.01 -179.28 3.81 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -151.49 176.11 11.63 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.193 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.542 ' HB ' HG23 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -147.13 155.89 42.53 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.633 0.254 . . . . 0.0 111.138 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.667 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.9 p -139.6 117.81 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.205 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -71.6 93.32 1.22 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.814 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.469 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 14.6 t -95.48 116.59 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.621 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -101.91 150.33 23.3 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.292 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.806 HD12 ' O ' ' A' ' 70' ' ' ASN . 8.5 mt -141.59 130.93 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.221 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -117.77 129.12 55.49 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.028 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.191 -179.547 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.567 0.222 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.016 HG23 ' HB2' ' A' ' 30' ' ' ALA . 0.6 OUTLIER -92.2 85.28 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.541 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.4 mt -150.43 68.85 0.98 Allowed 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.157 0.503 . . . . 0.0 110.649 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.637 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -85.21 139.51 31.6 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.545 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 89' ' ' SER . 11.6 t -145.78 135.02 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 123.419 0.449 . . . . 0.0 110.105 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -154.34 121.73 5.75 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.628 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.4 HD11 ' CB ' ' A' ' 79' ' ' CYS . 48.4 mt -89.74 138.94 18.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.35 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.4 t -122.96 129.4 24.99 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.086 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.463 ' O ' HG23 ' A' ' 93' ' ' VAL . 92.5 Cg_endo -79.63 166.61 77.35 Favored 'Cis proline' 0 C--N 1.364 1.362 0 CA-C-N 119.655 0.913 . . . . 0.0 112.105 -0.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 p -64.06 -41.17 97.46 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.133 0.492 . . . . 0.0 109.92 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -133.96 110.81 9.93 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.755 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.8 102.01 1.52 Allowed Glycine 0 C--N 1.341 0.859 0 C-N-CA 121.008 -0.615 . . . . 0.0 114.44 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.549 ' C ' HD12 ' A' ' 14' ' ' ILE . 13.6 mt-10 -87.82 134.93 33.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.549 HD12 ' C ' ' A' ' 13' ' ' GLU . 4.4 mp -146.48 163.64 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.653 0.263 . . . . 0.0 110.47 -178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.21 154.58 18.64 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.542 HG21 ' HB3' ' A' ' 99' ' ' GLN . 46.3 t -63.09 138.27 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.95 -7.91 78.52 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.522 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -103.03 155.82 18.11 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 117.49 0.645 . . . . 0.0 109.418 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.2 p -92.95 159.46 15.32 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 123.081 0.238 . . . . 0.0 110.784 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.57 ' HZ1' HD11 ' A' ' 97' ' ' ILE . 0.4 OUTLIER -156.24 119.99 4.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.662 -177.258 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.855 ' HB3' HG23 ' A' ' 65' ' ' THR . 49.0 p90 -114.72 140.24 49.03 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.506 0.193 . . . . 0.0 110.795 178.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.461 ' CD2' HG21 ' A' ' 93' ' ' VAL . 84.8 m-85 -117.12 110.64 18.43 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.312 0.577 . . . . 0.0 110.512 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.0 tp -79.03 107.16 11.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.206 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.8 t -89.79 106.3 18.38 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.041 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -95.17 165.5 12.37 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.725 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.9 m -141.95 173.23 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.637 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -158.83 91.04 1.03 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.017 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -179.8 134.26 2.21 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.296 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.91 40.05 2.0 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 120.923 0.392 . . . . 0.0 110.649 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 1.016 ' HB2' HG23 ' A' ' 2' ' ' VAL . . . -75.58 87.27 2.68 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.822 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.77 -90.67 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.789 0.836 . . . . 0.0 113.043 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -127.96 138.73 52.74 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -130.59 164.34 25.14 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.888 0.375 . . . . 0.0 111.771 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 19.6 t0 -137.73 166.05 24.92 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.124 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.662 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.1 mp -126.93 150.29 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 123.245 0.341 . . . . 0.0 110.865 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 57.6 m -147.81 162.82 38.47 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.024 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.43 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 56.5 m95 -138.46 134.58 34.2 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 75.6 m-85 -129.18 115.73 18.12 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.0 p -65.1 154.57 86.56 Favored Pre-proline 0 C--O 1.253 1.266 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.974 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -53.23 -12.94 2.71 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 124.97 3.78 . . . . 0.0 115.59 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -77.33 -0.05 24.1 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.164 0.438 . . . . 0.0 111.611 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.1 39.74 7.83 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -156.47 170.51 22.16 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.129 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 9.0 tttm -85.07 162.32 19.35 Favored 'General case' 0 C--N 1.341 0.23 0 O-C-N 123.729 0.643 . . . . 0.0 111.382 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.56 HD23 HG21 ' A' ' 52' ' ' ILE . 0.5 OUTLIER -117.01 135.09 53.97 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.472 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.72 171.75 11.07 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.783 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.52 -39.12 2.13 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 122.651 2.234 . . . . 0.0 112.623 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -142.36 74.11 1.44 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.134 0.492 . . . . 0.0 111.613 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.69 -48.77 3.85 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -146.51 -155.6 0.64 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -24.29 3.86 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.668 HG12 HG23 ' A' ' 66' ' ' ILE . 42.3 mt -78.92 113.92 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.867 0.365 . . . . 0.0 111.046 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.9 t -118.0 117.96 30.64 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.572 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 55' ' ' VAL . 11.7 t -93.99 158.81 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.413 ' N ' HG12 ' A' ' 54' ' ' VAL . 12.3 p -156.48 156.74 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 16.1 m-90 -129.99 118.93 22.36 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.58 -77.07 0.57 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -54.53 -177.72 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -51.65 -37.85 52.16 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -155.25 26.08 0.41 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.078 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.4 t -107.97 140.95 40.36 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.662 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.4 m -130.04 -171.72 2.6 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 m -155.23 138.11 15.38 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.641 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -108.31 91.53 3.68 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.284 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.855 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -85.9 146.95 26.49 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.668 HG23 HG12 ' A' ' 52' ' ' ILE . 49.6 mt -145.46 91.19 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -56.43 -107.18 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.096 0 O-C-N 123.721 0.638 . . . . 0.0 111.63 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -59.98 93.42 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.892 1.223 . . . . 0.0 110.335 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.791 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -76.25 159.85 30.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.205 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.75 ' O ' HD12 ' A' ' 97' ' ' ILE . 8.7 m120 -152.36 162.89 40.52 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.26 0.552 . . . . 0.0 111.323 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 27.4 pt -55.39 -26.4 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.791 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -69.84 -40.51 75.78 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.281 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.02 -32.31 73.43 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.426 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.505 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -54.54 106.33 0.2 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.49 173.44 44.63 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.2 mt -78.42 98.04 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.812 0.306 . . . . 0.0 111.262 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.641 ' CD2' HD11 ' A' ' 64' ' ' LEU . 64.3 m-85 -72.37 173.25 9.01 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 155.68 50.25 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.4 ' CB ' HD11 ' A' ' 7' ' ' ILE . 47.3 t -136.44 96.18 3.31 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.585 HG13 ' HB3' ' A' ' 90' ' ' GLU . 11.7 t -101.28 126.74 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.954 0.407 . . . . 0.0 111.557 -178.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 34' ' ' ASP . 2.3 t -106.72 147.85 11.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.482 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.2 m -127.76 150.7 49.69 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.05 -178.39 5.43 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.865 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -72.08 -34.6 68.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.343 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -90.33 -39.37 12.76 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.491 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.38 -25.17 0.28 Allowed Glycine 0 C--N 1.34 0.8 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.885 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.5 m -55.14 108.1 0.38 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 117.387 0.593 . . . . 0.0 111.99 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.482 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.7 OUTLIER -113.1 136.5 52.64 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.466 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.472 ' O ' HG21 ' A' ' 5' ' ' VAL . 2.8 t -119.89 117.65 28.69 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.585 ' HB3' HG13 ' A' ' 80' ' ' VAL . 9.0 pt-20 -105.53 -179.41 3.93 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -176.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.63 174.65 13.71 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.532 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.27 155.36 43.81 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.576 0.227 . . . . 0.0 111.251 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 9' ' ' PRO . 7.8 p -138.57 116.51 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.119 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -72.83 98.43 2.43 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 123.416 0.447 . . . . 0.0 110.763 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.4 t -98.35 124.5 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.238 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -109.31 152.64 24.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.928 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.791 HD13 ' HB1' ' A' ' 69' ' ' ALA . 9.1 mt -146.67 139.27 19.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.071 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.99 133.03 29.5 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.729 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.542 ' HB3' HG21 ' A' ' 16' ' ' VAL . 6.5 pt20 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.171 -0.919 . . . . 0.0 111.016 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.527 0.204 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' A' ' 30' ' ' ALA . 10.7 m -135.21 109.43 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.067 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 tp -168.39 94.48 0.37 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.651 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 10.4 tp-100 -118.28 144.83 45.51 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.772 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -145.69 143.74 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.626 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -160.19 131.62 5.9 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.407 HD11 ' HB2' ' A' ' 79' ' ' CYS . 40.3 mt -104.06 136.99 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.727 0.299 . . . . 0.0 110.768 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.61 130.97 24.44 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.059 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.448 ' O ' HG23 ' A' ' 93' ' ' VAL . 84.2 Cg_endo -78.81 170.27 69.93 Favored 'Cis proline' 0 C--N 1.364 1.386 0 CA-C-N 119.549 0.875 . . . . 0.0 112.07 -0.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 p -67.67 -44.02 78.82 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.102 0.477 . . . . 0.0 109.819 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -131.26 105.47 7.67 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.569 ' O ' HD12 ' A' ' 14' ' ' ILE . . . -102.76 97.33 1.51 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 121.156 -0.545 . . . . 0.0 114.331 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -83.92 131.13 34.88 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.569 HD12 ' O ' ' A' ' 12' ' ' GLY . 3.4 mp -141.69 165.0 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 123.049 0.218 . . . . 0.0 110.701 -178.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.83 153.61 22.75 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.098 0.475 . . . . 0.0 110.848 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 69' ' ' ALA . 21.3 t -66.36 134.84 29.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.344 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.97 -15.83 56.37 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.228 -177.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -115.86 149.24 38.95 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 117.661 0.73 . . . . 0.0 110.098 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.8 p -78.13 174.71 10.86 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.58 ' HZ1' HD11 ' A' ' 97' ' ' ILE . 1.3 ptmm? -165.34 118.37 1.19 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.965 -177.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.72 ' HB3' HG23 ' A' ' 65' ' ' THR . 44.1 p90 -117.93 147.18 43.39 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.7 0.286 . . . . 0.0 111.13 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.593 ' CD2' HG21 ' A' ' 93' ' ' VAL . 76.3 m-85 -123.83 112.72 17.63 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.869 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.4 tp -79.21 112.97 16.95 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.5 t -95.2 100.48 12.27 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.71 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -92.28 160.45 15.13 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.525 HG21 ' HB2' ' A' ' 60' ' ' ASP . 34.8 m -139.99 165.71 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.651 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -146.76 104.19 3.71 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.232 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 154.74 144.75 3.99 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.955 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -113.23 64.1 0.64 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.5 0.666 . . . . 0.0 110.209 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.573 ' HB2' HG23 ' A' ' 2' ' ' VAL . . . -96.53 40.16 1.14 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.491 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.37 -85.51 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -41.78 -40.02 1.91 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp 1.4 70.38 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.51 111.46 22.38 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.173 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.751 HD11 ' HA ' ' A' ' 60' ' ' ASP . 4.4 mp -71.08 156.36 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 123.493 0.496 . . . . 0.0 111.657 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.418 ' N ' HG22 ' A' ' 35' ' ' ILE . 75.2 m -152.76 160.13 43.12 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.727 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.421 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 52.3 m95 -137.4 118.69 14.61 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.143 0.177 . . . . 0.0 110.662 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 96.5 m-85 -112.63 113.03 24.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 80.3 p -63.28 150.67 88.77 Favored Pre-proline 0 C--O 1.245 0.834 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.043 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -41.96 -22.06 0.18 Allowed 'Trans proline' 0 C--N 1.38 2.222 1 C-N-CA 125.397 4.065 . . . . 0.0 115.927 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -80.1 12.16 3.0 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.29 39.71 81.54 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -154.5 135.74 14.02 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 120.074 -0.65 . . . . 0.0 112.718 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 5.1 ttpt -60.01 136.04 57.89 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.978 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.406 HD11 ' CG2' ' A' ' 54' ' ' VAL . 4.0 pp -103.14 141.12 36.4 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.96 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m -75.61 158.03 83.57 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.799 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -90.04 19.65 1.17 Allowed 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.592 2.195 . . . . 0.0 113.8 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -155.73 34.26 0.35 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.735 0.303 . . . . 0.0 111.034 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -69.14 -70.4 0.28 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.696 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -154.89 -78.62 0.09 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -100.08 -35.11 9.8 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.717 0.407 . . . . 0.0 111.734 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.581 HG12 HG23 ' A' ' 66' ' ' ILE . 17.1 mt -78.02 97.82 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 123.224 0.328 . . . . 0.0 110.714 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 t -108.65 122.48 47.2 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.797 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 55' ' ' VAL . 21.7 t -94.81 159.88 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.418 ' N ' HG12 ' A' ' 54' ' ' VAL . 7.7 p -154.63 136.22 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.166 0.508 . . . . 0.0 111.634 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -109.91 110.59 21.59 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -100.63 -76.19 0.56 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -175.37 0.11 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.35 0.119 . . . . 0.0 110.972 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -57.16 -36.61 70.97 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.26 0.224 . . . . 0.0 111.519 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.751 ' HA ' HD11 ' A' ' 35' ' ' ILE . 67.2 m-20 -145.74 16.22 1.43 Allowed 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 p -102.44 141.01 35.96 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.482 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.9 m -135.88 -168.52 2.23 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.891 -0.141 . . . . 0.0 110.902 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.7 m -157.91 140.95 15.05 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.893 0.378 . . . . 0.0 110.779 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.694 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -109.49 91.2 3.55 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.36 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.72 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -86.87 142.86 27.74 Favored 'General case' 0 C--N 1.333 -0.135 0 O-C-N 123.463 0.477 . . . . 0.0 109.793 -179.733 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.581 HG23 HG12 ' A' ' 52' ' ' ILE . 60.1 mt -141.19 94.84 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -60.64 -111.95 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.157 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.0 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.089 1.313 . . . . 0.0 110.699 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.776 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -77.6 153.06 33.6 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.367 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.733 ' O ' HD12 ' A' ' 97' ' ' ILE . 9.0 m120 -149.99 161.4 42.41 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.493 0.663 . . . . 0.0 111.202 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.7 pt -55.48 -23.55 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.198 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -71.36 -41.28 69.94 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.44 -34.42 77.17 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.83 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.52 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -51.25 114.54 1.24 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.84 174.06 42.07 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.11 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.9 mt -81.81 100.54 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.734 0.267 . . . . 0.0 110.418 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.694 ' CD2' HD11 ' A' ' 64' ' ' LEU . 65.4 m-85 -75.67 171.77 13.76 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -134.76 157.73 45.96 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.885 0.374 . . . . 0.0 111.885 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.407 ' HB2' HD11 ' A' ' 7' ' ' ILE . 14.7 t -140.14 113.14 8.22 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 89' ' ' SER . 12.7 t -119.08 137.93 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.902 0.382 . . . . 0.0 111.94 -178.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.9 134.89 64.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.677 HG23 ' HB3' ' A' ' 88' ' ' GLN . 2.0 m -115.48 150.07 37.07 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.78 -175.01 2.94 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.296 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -71.24 -57.84 4.11 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.389 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.34 -28.65 70.15 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.46 -10.03 4.05 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 119.568 -0.573 . . . . 0.0 113.743 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 38.3 m -62.11 107.04 0.81 Allowed 'General case' 0 C--N 1.345 0.394 0 CA-C-N 117.793 0.796 . . . . 0.0 110.938 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.677 ' HB3' HG23 ' A' ' 82' ' ' THR . 10.1 pt20 -121.9 130.12 53.1 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.182 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.522 ' O ' HG13 ' A' ' 80' ' ' VAL . 7.6 t -102.47 177.39 4.88 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -154.53 179.2 9.26 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -158.25 171.56 19.98 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.284 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.6 155.1 42.22 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.737 0.303 . . . . 0.0 111.17 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.593 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.3 p -140.57 116.54 7.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.693 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -70.8 96.86 1.3 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.8 t -99.21 129.67 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.597 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.5 155.25 31.16 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.096 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.776 HD13 ' HB1' ' A' ' 69' ' ' ALA . 10.6 mt -147.93 125.37 3.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.646 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.42 137.08 53.99 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.284 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.072 -179.774 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.511 ' O ' HG13 ' A' ' 2' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.618 HG23 ' HB2' ' A' ' 30' ' ' ALA . 8.5 m -159.79 52.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.229 0.538 . . . . 0.0 110.36 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 mp -143.38 142.17 31.17 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.638 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -150.65 142.65 23.97 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.417 179.426 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 89' ' ' SER . 8.4 t -148.02 141.35 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 123.15 0.281 . . . . 0.0 110.452 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -159.62 124.84 4.09 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.367 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.612 HD11 ' HB2' ' A' ' 79' ' ' CYS . 50.2 mt -91.77 141.33 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.892 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.8 t -126.74 128.27 24.3 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.146 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -79.11 173.88 53.36 Favored 'Cis proline' 0 C--N 1.365 1.44 0 CA-C-N 119.885 0.995 . . . . 0.0 112.076 -0.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 93.6 p -71.36 -47.21 57.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.621 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -128.52 102.83 6.8 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.08 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.02 99.27 1.68 Allowed Glycine 0 C--N 1.341 0.807 0 CA-C-N 116.202 -0.453 . . . . 0.0 114.19 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.509 ' C ' HD12 ' A' ' 14' ' ' ILE . 6.4 mt-10 -83.24 143.56 30.35 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.664 HG23 ' HG3' ' A' ' 18' ' ' GLU . 1.2 mp -150.32 158.57 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.692 0.282 . . . . 0.0 111.192 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.72 152.63 20.25 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.792 HG13 ' O ' ' A' ' 69' ' ' ALA . 50.1 t -68.11 127.45 29.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.29 -14.16 25.7 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.841 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.664 ' HG3' HG23 ' A' ' 14' ' ' ILE . 5.0 pt-20 -115.21 145.41 42.44 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 117.506 0.653 . . . . 0.0 110.286 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.6 p -81.7 171.53 14.47 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.579 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -164.02 120.98 1.7 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.584 -178.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.721 ' HB3' HG23 ' A' ' 65' ' ' THR . 43.1 p90 -114.21 143.59 44.59 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.626 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.633 ' CD2' HG21 ' A' ' 93' ' ' VAL . 87.2 m-85 -119.63 115.72 24.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.059 0.457 . . . . 0.0 111.214 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp -79.43 111.62 15.87 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.3 t -92.32 102.14 14.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.101 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -90.88 163.0 14.55 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.581 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.777 HG21 ' CB ' ' A' ' 60' ' ' ASP . 23.6 m -138.94 172.88 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.638 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -162.06 165.23 27.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.417 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.59 -133.97 7.89 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.405 -0.426 . . . . 0.0 112.342 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -174.13 34.01 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.644 0.259 . . . . 0.0 111.639 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.618 ' HB2' HG23 ' A' ' 2' ' ' VAL . . . -79.66 -171.76 2.98 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -124.75 -25.6 3.93 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -97.72 -32.47 11.73 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt 1.26 69.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 10.3 t70 -78.26 156.28 29.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.667 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.712 HD13 HG22 ' A' ' 81' ' ' VAL . 27.2 mm -114.27 151.91 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 120.749 0.309 . . . . 0.0 111.164 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 m -151.37 156.71 41.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.69 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.427 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 67.3 m95 -134.74 131.46 37.64 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.394 0.278 . . . . 0.0 111.272 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 94.8 m-85 -120.71 117.81 28.44 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.0 p -69.42 150.6 97.01 Favored Pre-proline 0 C--O 1.25 1.105 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.882 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -43.91 -20.79 0.29 Allowed 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 124.932 3.755 . . . . 0.0 116.062 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -79.85 12.14 2.86 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.33 39.67 81.13 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 111.819 -0.512 . . . . 0.0 111.819 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -153.25 133.93 13.78 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.43 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 36.7 tttt -54.65 118.91 4.59 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.02 132.27 36.58 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.153 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.97 162.37 74.88 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.762 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -75.92 -28.8 7.41 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 122.719 2.279 . . . . 0.0 112.221 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -138.31 77.42 1.63 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.22 0.533 . . . . 0.0 109.85 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.07 -58.89 1.53 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.348 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -140.27 -160.57 1.09 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -50.6 -26.65 5.59 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.722 HG12 HG23 ' A' ' 66' ' ' ILE . 54.4 mt -83.68 96.89 4.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.67 0.271 . . . . 0.0 110.825 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.0 t -94.14 169.77 10.01 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.505 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 55' ' ' VAL . 11.7 t -141.9 159.7 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.419 ' N ' HG12 ' A' ' 54' ' ' VAL . 7.3 p -159.46 137.89 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.248 0.547 . . . . 0.0 112.221 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 17.4 m-90 -115.1 113.96 24.7 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.82 -77.82 0.59 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -57.65 -177.44 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -56.53 -35.48 68.14 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.777 ' CB ' HG21 ' A' ' 26' ' ' VAL . 58.8 m-20 -149.03 22.32 0.97 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 t -109.19 138.73 45.09 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.543 ' OG ' HG21 ' A' ' 35' ' ' ILE . 2.1 m -132.26 -170.64 2.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 m -158.24 137.88 12.0 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.715 0.293 . . . . 0.0 110.837 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.575 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -109.37 93.79 4.69 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.752 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.721 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -84.59 143.12 29.49 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.4 0.438 . . . . 0.0 110.245 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.722 HG23 HG12 ' A' ' 52' ' ' ILE . 57.9 mt -140.28 91.36 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -59.86 -112.8 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 O-C-N 123.641 0.588 . . . . 0.0 111.581 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.9 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.726 1.148 . . . . 0.0 110.921 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.833 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -75.13 146.0 41.73 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.414 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.745 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -144.21 159.01 43.4 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.322 0.582 . . . . 0.0 110.454 178.782 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.7 pt -51.75 -26.13 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -42.87 74.03 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -66.21 -34.3 77.72 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.736 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.555 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -53.27 107.04 0.2 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.73 179.25 46.16 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.249 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' A' ' 94' ' ' ASN . 33.2 mm -83.13 92.41 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.575 ' CD2' HD11 ' A' ' 64' ' ' LEU . 70.1 m-85 -68.39 165.6 18.43 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -129.94 155.66 45.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.248 0.547 . . . . 0.0 111.925 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.612 ' HB2' HD11 ' A' ' 7' ' ' ILE . 8.9 t -139.23 94.52 2.81 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 90' ' ' GLU . 7.3 t -101.36 135.91 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.174 0.512 . . . . 0.0 112.203 -177.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.712 HG22 HD13 ' A' ' 35' ' ' ILE . 14.4 t -118.16 157.13 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.221 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.713 HG23 ' CG ' ' A' ' 88' ' ' GLN . 1.3 m -135.07 150.64 50.29 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.57 -179.62 4.26 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.337 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -71.05 -46.4 62.06 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.75 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.91 -29.62 58.49 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.557 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 141.37 -10.34 2.72 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-O 119.561 -0.577 . . . . 0.0 113.828 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.2 m -59.46 108.43 0.71 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.97 0.885 . . . . 0.0 111.064 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.713 ' CG ' HG23 ' A' ' 82' ' ' THR . 26.8 mt-30 -105.22 135.57 46.33 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.376 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.584 ' O ' HG21 ' A' ' 5' ' ' VAL . 18.6 t -122.97 110.92 15.99 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.528 ' HB3' HG13 ' A' ' 80' ' ' VAL . 5.7 pt-20 -106.45 178.93 4.42 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -157.43 179.5 9.19 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.203 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.39 157.71 41.64 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.775 0.321 . . . . 0.0 111.538 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.633 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.4 p -141.61 121.52 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.607 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.473 ' HA ' HD13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -78.01 98.21 5.64 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.684 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.435 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 13.3 t -102.84 122.65 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.352 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -108.41 159.71 16.45 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.808 0.337 . . . . 0.0 111.145 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.833 HD13 ' HB1' ' A' ' 69' ' ' ALA . 11.3 mt -149.1 123.03 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.597 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.36 130.71 53.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.104 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.224 -0.894 . . . . 0.0 110.973 -179.76 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.846 0.355 . . . . 0.0 111.054 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.762 HG23 ' HB2' ' A' ' 30' ' ' ALA . 2.3 m -92.2 94.49 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.98 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -171.34 93.18 0.16 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.005 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.71 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 6.5 tt0 -129.53 152.45 49.04 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.868 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -152.5 148.76 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.415 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -159.68 130.41 5.79 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.827 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.46 HD11 ' HB3' ' A' ' 79' ' ' CYS . 22.7 mt -95.13 133.86 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.277 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.5 t -116.31 126.17 27.84 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 119.266 -0.397 . . . . 0.0 109.977 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.47 -176.34 16.64 Favored 'Cis proline' 0 C--N 1.366 1.473 0 CA-C-N 119.993 1.033 . . . . 0.0 112.343 -0.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.8 p -77.77 -46.85 20.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.297 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -131.92 111.29 11.43 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.14 103.04 1.63 Allowed Glycine 0 C--N 1.34 0.766 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.962 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -84.65 134.06 34.38 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.523 HG23 ' HG3' ' A' ' 18' ' ' GLU . 1.7 mp -143.94 162.4 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.154 0.502 . . . . 0.0 111.618 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.29 150.09 23.35 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.503 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 69' ' ' ALA . 51.8 t -66.25 131.77 31.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.88 -15.25 44.69 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.149 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.523 ' HG3' HG23 ' A' ' 14' ' ' ILE . 4.3 pt-20 -116.14 147.26 41.55 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 117.625 0.712 . . . . 0.0 110.11 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 93.5 p -79.49 173.7 12.32 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.613 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -167.26 121.68 1.02 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.996 -178.742 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.749 ' HB3' HG23 ' A' ' 65' ' ' THR . 30.5 p90 -113.69 152.35 30.58 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.693 ' CD2' HG21 ' A' ' 93' ' ' VAL . 89.3 m-85 -129.64 119.18 23.14 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.17 0.509 . . . . 0.0 112.152 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.539 HD12 ' HG3' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -78.68 109.67 13.12 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -177.09 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.477 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 44.8 t -89.5 88.17 7.34 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.539 ' HG3' HD12 ' A' ' 23' ' ' LEU . 4.2 mt-30 -81.17 158.78 24.81 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.17 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.68 HG21 ' HB2' ' A' ' 60' ' ' ASP . 22.5 m -129.43 167.97 23.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.516 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.71 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -161.54 103.89 1.23 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.248 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 164.04 126.66 0.83 Allowed Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.634 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -90.61 48.32 1.53 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.05 0.453 . . . . 0.0 111.542 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.762 ' HB2' HG23 ' A' ' 2' ' ' VAL . . . -76.14 -173.89 2.55 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.353 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -77.61 -28.63 51.56 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.286 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.71 161.43 11.22 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.682 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.548 ' HE2' ' HB3' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -153.3 86.22 1.22 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.361 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -69.55 109.62 4.37 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.504 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.511 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.4 mp -75.24 157.13 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.991 0.425 . . . . 0.0 111.507 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.427 ' N ' HG22 ' A' ' 35' ' ' ILE . 5.7 m -155.48 160.79 40.86 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.484 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.477 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 46.1 m95 -136.11 115.07 12.23 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.245 0.091 . . . . 0.0 111.245 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -111.74 116.24 30.4 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.0 p -61.7 152.5 75.08 Favored Pre-proline 0 C--O 1.246 0.908 0 CA-C-O 119.092 -0.48 . . . . 0.0 110.135 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -29.52 -73.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.24 1 C-N-CA 125.655 4.237 . . . . 0.0 114.133 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.82 35.46 4.88 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.23 -17.96 5.59 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.187 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 75.23 -176.27 0.14 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 117.788 0.794 . . . . 0.0 109.438 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -52.44 102.41 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 pp -76.97 156.01 32.25 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.953 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 m -78.29 159.18 75.7 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.079 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.75 -35.69 1.4 Allowed 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 122.618 2.212 . . . . 0.0 112.289 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -125.11 68.59 1.12 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.404 0.621 . . . . 0.0 110.124 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.29 -53.06 2.73 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.412 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -145.97 -157.48 0.8 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -51.08 -24.28 3.81 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.651 HG12 HG23 ' A' ' 66' ' ' ILE . 53.1 mt -82.82 104.94 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 120.704 0.288 . . . . 0.0 110.574 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.3 t -108.55 122.67 47.55 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.073 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 55' ' ' VAL . 11.6 t -94.19 159.85 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.701 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.422 ' N ' HG12 ' A' ' 54' ' ' VAL . 8.0 p -151.42 155.31 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.777 0.323 . . . . 0.0 111.537 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 -132.86 112.14 11.66 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -106.49 -79.47 0.57 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.28 -174.19 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -51.96 -40.65 61.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.676 0.39 . . . . 0.0 111.922 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.68 ' HB2' HG21 ' A' ' 26' ' ' VAL . 25.1 m-20 -148.9 21.55 0.99 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.103 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 p -99.76 141.34 32.7 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.511 ' OG ' HG21 ' A' ' 35' ' ' ILE . 2.1 m -136.22 -172.88 3.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.293 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.3 m -157.52 145.51 18.98 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.905 0.383 . . . . 0.0 110.754 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.643 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -115.34 93.65 4.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.392 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.749 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -86.81 140.66 29.48 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 123.497 0.498 . . . . 0.0 109.95 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.651 HG23 HG12 ' A' ' 52' ' ' ILE . 59.1 mt -137.01 95.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -61.42 -115.75 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.361 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -53.13 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.846 1.203 . . . . 0.0 111.197 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.775 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -74.46 147.44 41.96 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.394 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.784 ' O ' HD12 ' A' ' 97' ' ' ILE . 9.8 m120 -143.31 152.26 41.45 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.828 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.5 pt -51.3 -24.43 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 112.702 0.631 . . . . 0.0 112.702 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.22 -44.33 75.97 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -65.8 -35.4 80.6 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.677 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.536 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -48.26 102.23 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.79 172.61 45.39 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.762 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.5 mt -77.17 94.02 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.783 0.292 . . . . 0.0 111.289 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.643 ' CD2' HD11 ' A' ' 64' ' ' LEU . 62.8 m-85 -65.59 177.04 1.29 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.412 ' O ' ' CE3' ' A' ' 37' ' ' TRP . 8.3 ttmt -139.54 155.4 47.53 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 120.74 0.305 . . . . 0.0 111.633 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.46 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -141.34 102.78 4.29 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.06 140.51 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.83 139.49 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.653 HG23 ' HB3' ' A' ' 88' ' ' GLN . 0.6 OUTLIER -124.19 146.09 48.91 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.14 -174.43 4.66 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.968 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -76.74 -35.06 58.02 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.514 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -86.49 -37.97 17.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.498 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.74 -24.3 0.63 Allowed Glycine 0 C--N 1.34 0.758 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.369 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.9 m -55.38 107.96 0.37 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.247 0.523 . . . . 0.0 111.492 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.653 ' HB3' HG23 ' A' ' 82' ' ' THR . 7.3 pt20 -116.87 134.61 54.55 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.551 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.4 t -114.37 121.55 43.95 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -107.35 -178.14 3.55 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.404 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -150.88 174.54 12.98 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.256 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.442 ' C ' HD12 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -151.84 155.54 38.38 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 123.119 0.262 . . . . 0.0 110.781 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.693 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.2 p -144.89 114.58 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.172 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -71.2 94.15 1.14 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.86 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.467 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 16.8 t -96.2 113.69 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -98.67 157.11 16.47 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.729 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.784 HD12 ' O ' ' A' ' 70' ' ' ASN . 13.3 mt -146.64 143.6 20.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.107 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.42 131.69 14.55 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.752 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.527 ' HB3' HG21 ' A' ' 16' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.898 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.59 ' HD3' HG22 ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 111.408 0.151 . . . . 0.0 111.408 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.137 HG23 ' HB2' ' A' ' 30' ' ' ALA . 1.3 m -145.74 58.63 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.302 0.572 . . . . 0.0 110.843 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 2' ' ' VAL . 0.3 OUTLIER -147.24 122.05 9.94 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.586 179.788 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.594 ' CB ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -139.5 140.18 37.15 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.308 -179.376 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.579 HG21 ' O ' ' A' ' 89' ' ' SER . 9.5 t -145.23 140.41 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.058 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -160.49 125.78 3.88 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.488 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.538 HD11 ' HB2' ' A' ' 79' ' ' CYS . 49.9 mt -95.52 137.6 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.688 0.28 . . . . 0.0 110.833 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.93 130.1 24.54 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.807 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.25 168.91 75.98 Favored 'Cis proline' 0 C--N 1.365 1.406 0 CA-C-N 119.704 0.93 . . . . 0.0 112.042 0.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 p -67.39 -44.59 78.51 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.761 0.315 . . . . 0.0 110.415 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -133.54 107.17 7.84 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.585 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.35 160.46 36.36 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.266 -0.492 . . . . 0.0 114.196 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -154.77 103.78 2.46 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.9 mp -128.42 161.85 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.658 0.266 . . . . 0.0 111.178 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.01 153.1 17.79 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 69' ' ' ALA . 26.1 t -64.86 139.84 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.29 -19.33 55.0 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.774 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -96.72 160.84 14.16 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.412 ' CB ' ' HA ' ' A' ' 67' ' ' TYR . 91.8 p -96.08 162.52 13.51 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.687 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -155.06 115.15 3.79 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.601 -178.201 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.808 ' HB3' HG23 ' A' ' 65' ' ' THR . 41.3 p90 -111.22 140.38 45.83 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.583 0.23 . . . . 0.0 110.956 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.424 ' CE2' HG22 ' A' ' 95' ' ' VAL . 81.5 m-85 -117.81 114.63 23.56 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.052 0.454 . . . . 0.0 110.807 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.2 tp -79.99 110.51 15.44 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.3 t -92.67 97.1 10.58 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.465 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -87.33 163.93 16.54 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.7 m -147.43 175.91 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.594 ' HB3' ' CB ' ' A' ' 4' ' ' GLN . . . -158.1 129.16 6.48 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.608 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 135.69 147.0 5.38 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 121.364 -0.446 . . . . 0.0 112.583 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -121.06 55.81 1.04 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.38 0.61 . . . . 0.0 110.364 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 1.137 ' HB2' HG23 ' A' ' 2' ' ' VAL . . . -89.45 68.43 7.85 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.404 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.8 mptt 61.29 -87.98 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.814 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -122.72 140.26 53.07 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.375 0.27 . . . . 0.0 110.765 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.22 90.15 3.18 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.204 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -73.74 153.91 39.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.247 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.783 HG21 ' OG ' ' A' ' 62' ' ' SER . 5.4 mp -125.71 144.55 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 123.368 0.418 . . . . 0.0 111.204 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 m -144.04 149.94 37.43 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.088 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.442 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 52.5 m95 -125.85 122.3 35.72 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.305 0.242 . . . . 0.0 111.133 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -119.52 112.7 19.69 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.466 ' OG ' HD23 ' A' ' 45' ' ' LEU . 5.5 m -55.88 150.45 28.27 Favored Pre-proline 0 C--O 1.244 0.814 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.365 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -31.57 -73.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.242 1 C-N-CA 125.499 4.133 . . . . 0.0 113.634 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -120.46 37.06 4.37 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.8 -17.34 5.54 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.074 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 72.88 -174.99 0.16 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 117.807 0.804 . . . . 0.0 109.168 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 2.0 ttmt -53.63 110.21 0.54 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.466 HD23 ' OG ' ' A' ' 39' ' ' SER . 3.9 pp -84.26 143.05 29.82 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.142 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.5 m -66.41 150.18 97.37 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.215 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.24 -14.72 13.13 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.472 2.115 . . . . 0.0 113.701 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -136.42 37.24 2.71 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.87 0.367 . . . . 0.0 110.976 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.15 -75.2 0.07 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.736 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -151.8 -75.35 0.14 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.603 0.24 . . . . 0.0 111.12 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -99.66 -31.34 11.62 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.566 HG12 HG23 ' A' ' 66' ' ' ILE . 22.4 mt -89.18 104.82 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 t -108.48 120.39 42.29 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.1 t -93.93 154.03 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.2 m -150.9 173.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.337 0.589 . . . . 0.0 112.421 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -141.82 120.17 12.32 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.97 -82.52 0.54 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -42.04 -64.47 0.58 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 179.49 -44.09 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.382 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -114.71 -35.8 4.73 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.329 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.6 t -65.53 136.91 56.99 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.048 0.452 . . . . 0.0 111.099 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.783 ' OG ' HG21 ' A' ' 35' ' ' ILE . 2.7 m -122.76 -173.62 2.74 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.81 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.0 m -156.57 130.73 8.56 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.87 0.366 . . . . 0.0 111.04 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.628 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -101.42 93.05 5.2 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.944 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.808 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -88.18 139.1 30.84 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 123.254 0.346 . . . . 0.0 110.323 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.566 HG23 HG12 ' A' ' 52' ' ' ILE . 44.9 mt -135.39 85.02 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.412 ' HA ' ' CB ' ' A' ' 19' ' ' SER . 12.3 m-85 -50.29 -59.56 3.84 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -176.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -63.96 -65.6 0.66 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 16' ' ' VAL . . . 73.98 118.82 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.051 0.54 . . . . 0.0 110.869 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.788 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -145.39 164.64 30.88 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.706 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 34.5 pt -54.85 -27.07 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -73.51 -36.53 65.76 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -68.13 -33.75 75.07 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.597 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.543 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -53.77 117.18 2.96 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.42 176.69 40.06 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.52 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.825 HD13 ' HA ' ' A' ' 94' ' ' ASN . 13.7 mm -75.99 89.61 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 122.283 0.233 . . . . 0.0 111.435 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.628 ' CD2' HD11 ' A' ' 64' ' ' LEU . 58.2 m-85 -66.85 171.66 5.13 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -131.87 155.79 47.22 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.538 ' HB2' HD11 ' A' ' 7' ' ' ILE . 11.9 t -142.48 88.43 2.07 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.759 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 90' ' ' GLU . 4.4 t -96.25 126.22 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.078 -177.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.88 157.91 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.715 HG23 ' CG ' ' A' ' 88' ' ' GLN . 6.5 m -139.48 148.74 43.11 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.404 ' HB2' HD11 ' A' ' 3' ' ' LEU . . . -96.56 -177.18 3.84 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.552 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -71.31 -54.2 11.65 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.121 0.263 . . . . 0.0 111.068 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.7 -31.12 70.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.621 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 141.73 -10.47 2.63 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.603 -0.554 . . . . 0.0 113.978 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.5 m -58.55 104.65 0.23 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 117.902 0.851 . . . . 0.0 111.173 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.715 ' CG ' HG23 ' A' ' 82' ' ' THR . 31.9 mt-30 -102.31 136.1 42.74 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.847 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.579 ' O ' HG21 ' A' ' 5' ' ' VAL . 5.6 t -128.43 109.89 11.82 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.591 ' HB3' HG13 ' A' ' 80' ' ' VAL . 11.0 pt-20 -101.47 179.43 4.36 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -153.62 175.89 12.7 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.916 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.05 155.18 36.37 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.7 p -139.89 120.87 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.668 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.825 ' HA ' HD13 ' A' ' 76' ' ' ILE . 1.8 t-20 -76.5 84.88 3.21 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.337 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.424 HG22 ' CE2' ' A' ' 22' ' ' PHE . 38.6 t -84.07 138.5 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.511 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -124.97 156.84 37.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.471 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.788 HD12 ' O ' ' A' ' 70' ' ' ASN . 9.6 mt -148.7 140.38 17.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.775 177.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -127.27 128.53 46.14 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.273 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.994 -179.589 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.468 ' O ' HG13 ' A' ' 2' ' ' VAL . 11.8 ttm-85 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.395 0.141 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.534 HG23 ' HB2' ' A' ' 30' ' ' ALA . 4.7 m -156.58 58.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.362 0.601 . . . . 0.0 110.895 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.576 HD23 HG12 ' A' ' 81' ' ' VAL . 1.8 mp -151.03 133.72 15.67 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.862 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.764 ' CB ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -150.84 151.25 31.98 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.113 179.327 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 t -150.56 144.59 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.606 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -157.07 130.59 8.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.429 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.544 HD11 ' HB2' ' A' ' 79' ' ' CYS . 37.7 mt -107.91 120.46 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.143 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t -105.64 130.07 23.64 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.461 ' O ' HG23 ' A' ' 93' ' ' VAL . 69.8 Cg_endo -81.93 173.49 48.03 Favored 'Cis proline' 0 C--N 1.367 1.545 0 CA-C-N 119.882 0.994 . . . . 0.0 112.282 -0.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 76.1 p -69.27 -41.48 76.81 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -137.2 109.77 7.48 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.649 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.631 ' O ' HD12 ' A' ' 14' ' ' ILE . . . -102.92 98.73 1.7 Allowed Glycine 0 C--N 1.343 0.937 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.927 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -83.09 126.48 32.62 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 12' ' ' GLY . 3.7 mp -140.45 164.5 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 123.21 0.319 . . . . 0.0 110.389 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.57 156.28 18.1 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 69' ' ' ALA . 39.7 t -63.07 141.07 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.09 -11.58 71.71 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.301 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -101.67 150.09 23.47 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 117.33 0.565 . . . . 0.0 109.536 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.3 p -90.45 164.46 14.27 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.623 ' HD2' HD12 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -162.62 129.47 3.6 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.996 -178.155 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.486 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 28.9 p90 -120.77 157.96 28.58 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.2 0.313 . . . . 0.0 110.732 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.597 ' CD2' HG21 ' A' ' 93' ' ' VAL . 80.7 m-85 -133.36 120.35 20.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.68 117.27 19.67 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 t -102.07 96.37 6.96 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.626 0.251 . . . . 0.0 111.148 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -93.62 162.19 14.05 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.94 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.706 HG21 ' CB ' ' A' ' 60' ' ' ASP . 32.7 m -137.93 152.93 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.764 ' HB3' ' CB ' ' A' ' 4' ' ' GLN . . . -132.0 163.55 28.15 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.57 -124.31 6.24 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -166.32 -82.16 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.557 ' HB3' ' HD2' ' A' ' 33' ' ' LYS . . . 45.82 -160.16 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 122.92 0.488 . . . . 0.0 112.255 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.48 -51.61 0.26 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -64.28 -36.86 85.49 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.557 ' HD2' ' HB3' ' A' ' 30' ' ' ALA . 40.7 mtpt 1.61 85.18 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 10.9 m-20 -104.19 108.81 20.36 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.199 -179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.809 HD13 HG23 ' A' ' 81' ' ' VAL . 15.5 mm -65.5 152.44 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.459 0.647 . . . . 0.0 111.653 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.4 m -147.23 161.25 41.31 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.022 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -138.69 109.41 6.65 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 119.632 -0.223 . . . . 0.0 110.616 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -110.75 111.04 21.95 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 p -60.02 154.07 51.92 Favored Pre-proline 0 C--O 1.243 0.722 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.388 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -34.15 -73.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 125.105 3.87 . . . . 0.0 113.704 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.62 38.53 3.42 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -123.0 -18.63 3.12 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.592 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 69.01 -172.16 0.18 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 117.909 0.855 . . . . 0.0 108.911 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -53.27 115.63 2.0 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 45' ' ' LEU . 0.7 OUTLIER -93.48 153.94 18.19 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.056 -179.327 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 m -78.2 164.37 57.01 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.334 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.43 -25.4 2.6 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 122.816 2.344 . . . . 0.0 113.42 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -129.42 22.4 5.57 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.58 -59.02 3.68 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -137.63 -159.83 1.0 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.24 0.216 . . . . 0.0 110.574 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 mtm-85 -51.35 -22.8 3.13 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.624 HG12 HG23 ' A' ' 66' ' ' ILE . 52.6 mt -84.59 105.78 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.7 t -111.65 115.28 28.86 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.337 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.9 t -85.83 150.88 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.452 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -143.43 139.21 26.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 CA-C-O 120.75 0.31 . . . . 0.0 111.286 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 24.5 m-90 -109.18 107.49 17.79 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -92.37 -77.84 0.43 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -72.43 -178.6 2.62 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.494 -0.188 . . . . 0.0 110.494 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.82 -35.85 69.26 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.706 ' CB ' HG21 ' A' ' 26' ' ' VAL . 61.1 m-20 -134.84 5.7 3.38 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 p -100.56 137.34 39.09 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.999 0.363 . . . . 0.0 110.317 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.407 ' OG ' HG21 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -149.02 136.82 20.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.52 -179.097 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.0 m -108.85 139.34 43.82 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.842 0.353 . . . . 0.0 111.787 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.587 HD11 ' CG2' ' A' ' 52' ' ' ILE . 27.8 tp -94.85 113.67 25.44 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -98.36 141.42 31.27 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.624 HG23 HG12 ' A' ' 52' ' ' ILE . 63.7 mt -138.0 90.78 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -59.94 -110.97 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.657 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.2 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.794 1.179 . . . . 0.0 111.063 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.795 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -70.47 148.06 48.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.674 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.808 ' O ' HD12 ' A' ' 97' ' ' ILE . 13.8 m120 -140.98 153.56 45.64 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.276 0.56 . . . . 0.0 110.901 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.2 pt -54.3 -23.94 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.81 -41.24 68.47 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -66.67 -34.81 78.69 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.704 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.502 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -49.61 99.63 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.76 176.23 46.31 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.528 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.2 mt -80.24 101.16 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.877 0.339 . . . . 0.0 111.701 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.4 ' CD2' HD21 ' A' ' 64' ' ' LEU . 58.2 m-85 -71.37 172.37 9.54 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -135.51 157.95 45.6 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.544 ' HB2' HD11 ' A' ' 7' ' ' ILE . 2.9 t -143.13 118.6 10.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.341 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.7 t -126.54 133.03 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.809 HG23 HD13 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -115.24 129.58 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.498 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.3 m -110.73 148.25 32.69 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -178.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.95 173.06 7.48 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.091 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.0 -46.32 78.43 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.195 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -71.97 -28.24 63.3 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.632 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.31 -12.31 4.36 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 119.899 -0.389 . . . . 0.0 113.521 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.8 m -60.82 108.05 0.79 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 117.455 0.627 . . . . 0.0 111.278 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.498 ' HB3' HG23 ' A' ' 82' ' ' THR . 3.9 pt20 -119.75 132.43 55.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.762 0.315 . . . . 0.0 111.288 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.2 t -114.71 125.35 53.62 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -105.02 -177.71 3.44 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -158.28 172.38 18.48 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.004 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.86 156.46 41.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.69 0.281 . . . . 0.0 111.375 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.597 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.1 p -144.63 115.26 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.405 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -70.25 94.63 0.93 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.928 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.514 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 15.1 t -96.27 115.52 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.573 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -101.03 155.06 18.2 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.409 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.808 HD12 ' O ' ' A' ' 70' ' ' ASN . 10.6 mt -146.79 122.97 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.473 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -111.39 127.63 55.73 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.505 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.306 -0.854 . . . . 0.0 111.087 -179.727 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.433 0.159 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.709 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 3.4 m -106.99 104.48 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.456 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 tp -176.0 94.1 0.06 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.43 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.603 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -121.32 140.59 51.89 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.741 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 t -149.31 137.69 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.653 -0.248 . . . . 0.0 110.973 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -159.29 123.71 3.97 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.311 0.382 . . . . 0.0 110.514 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.538 HD11 ' HB2' ' A' ' 79' ' ' CYS . 43.1 mt -89.87 140.2 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 O-C-N 123.15 0.281 . . . . 0.0 111.042 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.9 t -128.1 134.39 26.18 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.856 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.437 ' O ' HG23 ' A' ' 93' ' ' VAL . 93.5 Cg_endo -76.44 173.82 56.13 Favored 'Cis proline' 0 C--N 1.365 1.436 0 CA-C-N 119.698 0.928 . . . . 0.0 112.161 0.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.4 p -69.14 -49.01 60.82 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -128.37 114.22 16.58 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 14' ' ' ILE . . . -110.44 93.16 0.72 Allowed Glycine 0 C--N 1.343 0.94 0 C-N-CA 121.087 -0.578 . . . . 0.0 114.46 -177.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -79.99 132.86 36.1 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 12' ' ' GLY . 2.0 mp -143.47 164.12 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.09 0.472 . . . . 0.0 111.384 -177.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.47 150.22 22.87 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.549 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 69' ' ' ALA . 29.2 t -66.0 135.28 28.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.599 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.17 -15.07 59.45 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.251 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -114.67 146.63 40.65 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 117.747 0.773 . . . . 0.0 110.111 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.442 ' CB ' ' HA ' ' A' ' 67' ' ' TYR . 60.1 p -79.42 168.56 19.31 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -176.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.619 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -159.31 121.38 3.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.805 -179.542 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.845 ' HB3' HG23 ' A' ' 65' ' ' THR . 49.5 p90 -115.2 142.22 46.96 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.578 0.227 . . . . 0.0 110.951 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.69 ' CD2' HG21 ' A' ' 93' ' ' VAL . 81.1 m-85 -117.51 117.0 28.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.918 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.8 tp -82.43 109.81 17.0 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.935 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.66 107.44 19.17 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -92.01 163.11 14.1 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.716 HG21 ' HB3' ' A' ' 60' ' ' ASP . 22.2 m -147.42 176.64 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.603 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -165.84 108.59 0.78 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.508 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 154.04 132.87 1.72 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.689 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -93.43 60.18 3.07 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.543 0.687 . . . . 0.0 109.505 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 2' ' ' VAL . . . -85.58 18.04 2.99 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.54 -87.07 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 177.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -51.86 -28.52 16.24 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.446 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 0.3 OUTLIER 0.69 79.79 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -179.483 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -101.65 111.32 23.53 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.777 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.974 HD13 HG23 ' A' ' 81' ' ' VAL . 14.8 mm -70.93 148.66 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 123.603 0.565 . . . . 0.0 110.168 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.7 m -144.93 156.12 43.8 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.183 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.427 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 55.9 m95 -134.65 121.84 21.43 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -119.5 110.84 17.38 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 m -62.73 152.6 81.6 Favored Pre-proline 0 C--O 1.249 1.071 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.117 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -36.68 -24.29 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.209 1 C-N-CA 126.047 4.498 . . . . 0.0 116.532 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -80.12 12.17 3.0 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.29 37.76 91.06 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -142.15 147.34 36.48 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.266 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp -79.53 125.25 29.34 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.231 0.332 . . . . 0.0 111.66 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.496 HD11 ' CG2' ' A' ' 54' ' ' VAL . 2.9 pp -86.84 131.64 34.06 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.495 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.8 m -63.52 163.29 20.79 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.667 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.34 -60.29 0.11 Allowed 'Trans proline' 0 C--N 1.363 1.321 0 C-N-CA 122.621 2.214 . . . . 0.0 112.597 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -114.38 62.65 0.67 Allowed 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.285 0.564 . . . . 0.0 110.697 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.83 -62.13 1.41 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.102 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -139.03 -154.42 0.52 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.0 -23.91 1.32 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.652 HG12 HG23 ' A' ' 66' ' ' ILE . 39.2 mt -86.17 105.04 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.5 t -109.07 122.17 46.7 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.189 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.496 ' CG2' HD11 ' A' ' 45' ' ' LEU . 21.5 t -95.77 158.07 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.15 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.407 ' N ' HG12 ' A' ' 54' ' ' VAL . 8.2 m -150.32 171.75 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.852 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -139.58 120.1 14.07 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.1 -81.78 0.57 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -56.33 -178.43 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -52.96 -34.19 54.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.716 ' HB3' HG21 ' A' ' 26' ' ' VAL . 23.5 m-20 -141.37 -12.97 0.9 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.6 p -76.89 147.55 36.97 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 118.725 0.693 . . . . 0.0 111.297 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.587 ' OG ' HG21 ' A' ' 35' ' ' ILE . 3.2 m -134.79 -170.17 2.5 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.817 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.2 m -154.23 138.49 16.61 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 111.799 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.652 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -108.08 94.68 5.2 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.684 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.845 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -89.54 140.1 29.88 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 123.295 0.372 . . . . 0.0 110.563 -179.517 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.652 HG23 HG12 ' A' ' 52' ' ' ILE . 47.0 mt -136.44 91.06 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.442 ' HA ' ' CB ' ' A' ' 19' ' ' SER . 11.0 m-85 -56.25 -69.92 0.13 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.6 OUTLIER -57.18 -66.19 0.5 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.459 ' O ' HG13 ' A' ' 16' ' ' VAL . . . 73.76 119.77 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.1 0.56 . . . . 0.0 111.232 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.788 ' O ' HD12 ' A' ' 97' ' ' ILE . 15.6 m-80 -142.39 163.03 33.95 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.03 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.7 pt -51.73 -26.28 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.95 -43.77 70.92 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.437 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -65.7 -33.39 75.77 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.004 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.519 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -51.14 109.31 0.32 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.14 174.9 45.68 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.726 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.7 mt -80.54 99.78 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.829 0.315 . . . . 0.0 111.296 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.652 ' CD2' HD11 ' A' ' 64' ' ' LEU . 53.5 m-85 -72.57 171.5 12.31 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -132.89 158.01 43.64 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.538 ' HB2' HD11 ' A' ' 7' ' ' ILE . 34.2 t -139.82 100.8 4.03 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.895 178.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.441 HG13 ' HB3' ' A' ' 90' ' ' GLU . 4.0 t -107.22 133.02 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.974 HG23 HD13 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -115.69 134.83 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.55 HG23 ' HB3' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -115.17 146.43 41.39 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.32 -175.59 4.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.464 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -73.7 -46.32 46.89 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 123.132 0.27 . . . . 0.0 111.49 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.4 -35.46 65.88 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.559 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.48 -19.31 1.5 Allowed Glycine 0 C--N 1.339 0.719 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.643 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.8 m -56.14 108.7 0.49 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.348 0.574 . . . . 0.0 111.7 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.55 ' HB3' HG23 ' A' ' 82' ' ' THR . 5.7 pt20 -117.78 133.81 55.56 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.867 0.365 . . . . 0.0 111.565 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.2 t -120.94 127.18 51.59 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.441 ' HB3' HG13 ' A' ' 80' ' ' VAL . 8.6 pt-20 -111.49 -177.94 3.32 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.75 177.13 10.39 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.614 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.82 158.39 44.13 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.822 0.344 . . . . 0.0 111.816 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.69 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.6 p -143.18 114.36 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.908 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -71.33 91.48 0.99 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.914 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.434 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 15.4 t -92.39 129.37 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.549 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -115.76 158.42 22.87 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.798 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.788 HD12 ' O ' ' A' ' 70' ' ' ASN . 11.2 mt -148.99 135.47 12.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.178 178.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.25 135.56 45.03 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.355 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.878 -179.838 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -150.69 59.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.422 0.629 . . . . 0.0 109.869 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.566 HD11 ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -135.03 139.33 44.72 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.088 -179.147 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -132.9 147.71 52.29 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.883 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 89' ' ' SER . 0.3 OUTLIER -152.41 140.22 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 O-C-N 123.188 0.305 . . . . 0.0 111.068 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -154.99 130.61 9.89 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.601 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.494 HD12 ' C ' ' A' ' 92' ' ' THR . 22.4 mt -91.69 130.11 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 123.196 0.31 . . . . 0.0 110.992 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.0 t -115.07 123.76 31.31 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.83 -179.29 24.9 Favored 'Cis proline' 0 C--N 1.364 1.374 0 CA-C-N 119.985 1.03 . . . . 0.0 112.276 0.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 86.3 p -78.69 -40.97 32.34 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.307 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -132.85 118.15 18.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.699 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.467 ' O ' HD12 ' A' ' 14' ' ' ILE . . . -117.93 99.37 0.8 Allowed Glycine 0 C--N 1.341 0.844 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.97 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.413 ' C ' HD12 ' A' ' 14' ' ' ILE . 14.5 mt-10 -87.55 132.26 34.11 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 12' ' ' GLY . 4.5 mp -143.59 163.63 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.811 0.338 . . . . 0.0 111.083 -178.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.36 154.46 18.17 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 69' ' ' ALA . 93.5 t -63.49 140.43 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.901 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.64 -12.0 70.8 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.24 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.06 156.64 17.54 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.8 p -96.16 165.51 12.2 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.63 0.253 . . . . 0.0 111.286 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.776 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 2.1 pttt -162.61 126.58 3.03 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.643 ' HB3' HG23 ' A' ' 65' ' ' THR . 33.9 p90 -119.72 153.42 35.65 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.072 0.232 . . . . 0.0 111.039 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.646 ' CD1' HG21 ' A' ' 93' ' ' VAL . 88.9 m-85 -131.57 119.17 21.12 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.287 0.565 . . . . 0.0 112.078 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -77.9 111.96 14.29 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -176.795 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.461 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 54.0 t -87.61 87.53 7.41 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -79.9 158.39 26.69 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.427 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.453 HG21 ' HB2' ' A' ' 60' ' ' ASP . 27.5 m -133.49 165.07 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 O-C-N 123.473 0.483 . . . . 0.0 112.081 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.684 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -160.08 129.73 5.25 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.715 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 149.66 -177.68 27.66 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.9 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -140.45 36.92 1.86 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.141 0.496 . . . . 0.0 110.759 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.797 ' HB3' ' HD3' ' A' ' 33' ' ' LYS . . . -65.16 -163.81 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.87 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.74 -52.4 4.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.848 0.356 . . . . 0.0 110.266 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -124.36 138.85 54.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.821 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.797 ' HD3' ' HB3' ' A' ' 30' ' ' ALA . 0.2 OUTLIER -137.72 83.25 1.97 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.801 0.334 . . . . 0.0 111.517 -179.125 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.519 ' O ' HG22 ' A' ' 81' ' ' VAL . 13.5 m-20 -81.67 159.33 23.98 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.471 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.4 mp -121.7 158.75 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 123.189 0.306 . . . . 0.0 111.155 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.441 ' N ' HG22 ' A' ' 35' ' ' ILE . 64.1 m -159.88 160.92 34.2 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.768 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.461 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 58.8 m95 -136.96 130.89 32.22 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.673 0.273 . . . . 0.0 111.134 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 91.6 m-85 -118.92 117.55 29.14 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.5 p -65.73 152.76 92.36 Favored Pre-proline 0 C--O 1.249 1.055 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.903 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -48.12 -17.14 0.77 Allowed 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 124.904 3.736 . . . . 0.0 116.133 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -78.86 6.79 8.31 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 118.155 0.434 . . . . 0.0 111.915 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.77 37.62 33.66 Favored Glycine 0 C--N 1.351 1.409 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -158.2 140.04 13.88 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 120.103 -0.639 . . . . 0.0 112.333 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 21.9 tttt -54.5 138.0 41.53 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -110.35 134.4 52.33 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.172 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.4 m -68.55 158.01 86.5 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.085 -178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -85.93 -26.7 1.13 Allowed 'Trans proline' 0 C--N 1.363 1.334 0 C-N-CA 122.831 2.354 . . . . 0.0 113.55 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -121.28 69.59 0.91 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.375 0.607 . . . . 0.0 110.182 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.99 -60.01 1.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.149 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -141.79 -159.5 0.97 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 121.99 0.116 . . . . 0.0 110.856 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.7 mtm-85 -47.54 -25.57 1.16 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.663 HG23 HG12 ' A' ' 66' ' ' ILE . 47.9 mt -84.83 106.62 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.801 0.334 . . . . 0.0 110.378 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 t -112.52 123.06 49.45 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.517 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 55' ' ' VAL . 11.4 t -92.81 159.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.361 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.409 ' N ' HG12 ' A' ' 54' ' ' VAL . 7.1 p -154.09 153.43 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.734 0.302 . . . . 0.0 111.422 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.406 ' HD1' ' HG ' ' A' ' 62' ' ' SER . 23.0 m-90 -126.08 112.57 16.0 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -105.35 -75.33 0.63 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.2 -179.05 0.13 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.494 0.188 . . . . 0.0 111.421 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -54.62 -35.76 63.78 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.496 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.453 ' HB2' HG21 ' A' ' 26' ' ' VAL . 55.8 m-20 -151.07 24.45 0.74 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.946 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.9 t -110.4 136.25 49.85 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.471 ' OG ' HG21 ' A' ' 35' ' ' ILE . 4.3 m -128.66 -169.38 2.07 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.525 -177.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 m -159.33 144.85 15.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.937 0.399 . . . . 0.0 110.995 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.629 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -113.82 93.55 4.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.334 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.643 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -86.22 144.25 27.55 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.561 0.538 . . . . 0.0 110.286 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.663 HG12 HG23 ' A' ' 52' ' ' ILE . 61.9 mt -142.52 93.05 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -59.71 -108.51 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.405 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -56.61 95.17 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.465 1.03 . . . . 0.0 110.551 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.838 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -74.25 151.8 39.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.153 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.792 ' O ' HD12 ' A' ' 97' ' ' ILE . 11.6 m120 -145.71 154.43 42.07 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.139 0.495 . . . . 0.0 111.281 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.5 pt -53.98 -24.52 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -72.64 -41.3 65.61 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.92 -34.23 77.91 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.736 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.54 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -51.69 104.25 0.08 Allowed 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.02 171.44 44.17 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.81 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.9 mt -79.62 95.92 2.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.81 0.305 . . . . 0.0 110.245 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.629 ' CD2' HD11 ' A' ' 64' ' ' LEU . 63.0 m-85 -69.93 171.42 9.41 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -133.66 154.69 50.73 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.741 0.305 . . . . 0.0 111.155 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.449 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -138.31 97.71 3.44 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 t -101.01 140.85 18.8 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.857 -176.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 34' ' ' ASP . 1.7 t -125.78 144.92 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.3 m -124.3 155.97 37.76 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.28 -176.01 3.39 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.26 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -77.3 -37.93 51.73 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 123.023 0.202 . . . . 0.0 110.901 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -79.87 -35.8 37.57 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.256 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 148.37 -19.49 1.34 Allowed Glycine 0 C--N 1.34 0.751 0 C-N-CA 121.232 -0.509 . . . . 0.0 113.563 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.566 ' O ' HD11 ' A' ' 3' ' ' LEU . 89.4 m -59.87 112.83 2.0 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 117.314 0.557 . . . . 0.0 111.333 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.531 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.9 OUTLIER -118.63 134.06 55.39 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.488 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.42 ' O ' HG21 ' A' ' 5' ' ' VAL . 2.6 t -114.73 124.98 53.17 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -108.83 -179.86 3.98 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -147.84 173.94 12.34 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.148 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.494 ' C ' HD12 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -150.0 154.95 39.08 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 111.269 179.698 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.646 HG21 ' CD1' ' A' ' 22' ' ' PHE . 7.2 p -144.87 112.71 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.979 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -70.88 93.26 0.96 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.919 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.467 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 12.5 t -95.05 118.03 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.553 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.63 157.73 16.86 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.153 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.838 HD13 ' HB1' ' A' ' 69' ' ' ALA . 10.5 mt -148.57 139.73 17.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.8 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.86 131.58 51.15 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.404 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.962 -179.788 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.384 0.135 . . . . 0.0 110.775 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.606 HG23 ' HB2' ' A' ' 30' ' ' ALA . 2.5 m -98.38 77.01 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.082 0.468 . . . . 0.0 111.11 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.887 HD21 ' HB2' ' A' ' 83' ' ' ALA . 29.6 mt -149.11 131.08 15.26 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.529 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.655 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -146.71 134.48 21.19 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.293 179.233 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.583 HG21 ' O ' ' A' ' 89' ' ' SER . 10.7 t -143.91 139.56 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 123.22 0.325 . . . . 0.0 110.499 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -155.66 121.14 4.92 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.413 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.579 HD11 ' HB2' ' A' ' 79' ' ' CYS . 53.5 mt -89.64 136.24 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.023 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.48 128.05 25.83 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.549 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -74.4 -172.9 11.05 Favored 'Cis proline' 0 C--N 1.366 1.489 0 CA-C-N 119.669 0.917 . . . . 0.0 112.041 -0.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 97.2 p -85.57 -50.12 7.49 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.574 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -131.92 104.07 6.65 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.326 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.78 144.88 17.19 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 121.421 -0.418 . . . . 0.0 113.596 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.53 ' C ' HD12 ' A' ' 14' ' ' ILE . 2.6 mp0 -126.6 129.52 48.69 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.53 HD12 ' C ' ' A' ' 13' ' ' GLU . 4.9 mp -141.75 165.12 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 120.579 0.228 . . . . 0.0 111.226 -178.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.4 157.45 17.33 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 69' ' ' ALA . 21.2 t -62.47 136.91 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.393 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.69 -8.25 80.08 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.942 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -100.78 153.06 19.78 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.0 p -100.06 134.73 42.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.193 0.521 . . . . 0.0 112.083 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.651 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 3.9 pttt -116.98 172.04 7.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.582 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.559 ' HB2' HG23 ' A' ' 65' ' ' THR . 0.1 OUTLIER -162.65 149.91 13.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 178.054 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.781 ' CD2' HG21 ' A' ' 93' ' ' VAL . 73.5 m-85 -137.87 105.14 5.47 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.444 0.64 . . . . 0.0 110.812 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.6 tp -79.41 111.92 16.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 114.88 -1.054 . . . . 0.0 112.228 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.4 t -90.49 108.87 20.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.786 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -92.32 160.24 15.21 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.531 HG21 ' CB ' ' A' ' 60' ' ' ASP . 30.9 m -140.71 176.52 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.655 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -168.61 143.76 3.41 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.332 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 139.62 143.32 4.37 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -95.06 40.39 1.1 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.768 0.318 . . . . 0.0 111.802 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.702 ' HB3' ' HD2' ' A' ' 33' ' ' LYS . . . -71.06 -172.8 0.73 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.412 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -111.92 -24.06 10.18 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -125.62 -34.07 2.69 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.702 ' HD2' ' HB3' ' A' ' 30' ' ' ALA . 10.8 ptmm? 1.66 66.58 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 18.4 m-20 -69.59 179.4 2.13 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.631 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.617 HG21 ' OG ' ' A' ' 62' ' ' SER . 3.9 mp -130.87 155.7 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 123.39 0.431 . . . . 0.0 110.845 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.402 ' N ' HG22 ' A' ' 35' ' ' ILE . 71.8 m -156.65 162.0 39.86 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.079 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.409 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 59.0 m95 -133.08 135.55 45.38 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.941 0.151 . . . . 0.0 110.783 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 95.2 m-85 -128.91 109.07 10.93 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.6 p -58.77 151.44 53.43 Favored Pre-proline 0 C--O 1.251 1.151 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.166 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -55.19 -13.02 6.15 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 124.648 3.565 . . . . 0.0 115.534 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -76.63 -3.72 39.26 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.11 0.414 . . . . 0.0 111.38 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.97 41.92 4.83 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.638 -0.534 . . . . 0.0 112.073 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.85 155.59 16.79 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.579 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 10.9 ttmt -68.84 159.42 32.49 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.517 0.51 . . . . 0.0 111.384 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.7 mt -111.85 139.21 47.52 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.694 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.26 155.92 66.51 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.215 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.22 -24.46 9.44 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.439 2.093 . . . . 0.0 113.321 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -138.98 78.61 1.68 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.213 0.53 . . . . 0.0 109.97 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.95 -59.05 1.28 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.585 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -146.02 -157.95 0.85 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -24.28 3.48 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.694 HG12 HG23 ' A' ' 66' ' ' ILE . 29.1 mt -84.17 97.81 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.692 0.282 . . . . 0.0 110.457 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.8 t -101.32 117.96 36.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.552 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 55' ' ' VAL . 13.6 t -93.63 160.33 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.412 ' N ' HG12 ' A' ' 54' ' ' VAL . 11.0 p -158.58 157.69 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 13.1 m-90 -136.04 121.9 19.92 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -81.73 0.64 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.69 -177.9 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -31.55 -59.33 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.323 1.049 . . . . 0.0 113.08 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.531 ' CB ' HG21 ' A' ' 26' ' ' VAL . 15.7 m-20 -147.24 21.62 1.21 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.034 178.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.6 145.22 25.41 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.617 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.3 m -134.58 -170.78 2.62 Favored 'General case' 0 N--CA 1.458 -0.07 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.069 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.4 m -160.12 145.71 15.27 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.868 0.366 . . . . 0.0 111.325 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.666 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -117.7 98.44 6.37 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.172 178.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.559 HG23 ' HB2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -97.61 138.68 34.65 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.607 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.694 HG23 HG12 ' A' ' 52' ' ' ILE . 22.5 mt -134.95 89.2 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -53.97 -98.65 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.94 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.75 100.78 0.73 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.234 0.925 . . . . 0.0 110.109 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.843 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -81.17 149.18 29.21 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.79 ' O ' HD12 ' A' ' 97' ' ' ILE . 12.7 m-80 -142.72 155.54 44.89 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.545 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.3 pt -53.1 -24.54 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -71.56 -42.31 68.0 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -65.33 -35.1 79.94 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.115 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.536 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -50.36 126.81 15.92 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.63 -177.64 37.82 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.895 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 76' ' ' ILE . 0.6 OUTLIER -85.42 108.61 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.666 ' CD2' HD11 ' A' ' 64' ' ' LEU . 49.5 m-85 -83.52 166.18 18.49 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -127.57 158.4 37.57 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.139 0.495 . . . . 0.0 112.303 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.579 ' HB2' HD11 ' A' ' 7' ' ' ILE . 23.7 t -138.84 94.01 2.77 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.272 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 90' ' ' GLU . 6.6 t -100.46 132.31 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -177.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 34' ' ' ASP . 3.6 t -111.73 153.6 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.619 HG23 ' CG ' ' A' ' 88' ' ' GLN . 4.4 m -137.61 111.04 7.97 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.887 ' HB2' HD21 ' A' ' 3' ' ' LEU . . . -62.56 -176.19 0.1 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.244 178.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -73.08 -49.97 25.53 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.715 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -62.62 -31.28 72.1 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 134.28 -19.19 4.1 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 121.348 -0.453 . . . . 0.0 113.51 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 m -61.59 114.02 3.03 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.397 0.599 . . . . 0.0 110.505 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.619 ' CG ' HG23 ' A' ' 82' ' ' THR . 14.4 mt-30 -100.64 136.92 39.76 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.279 0.362 . . . . 0.0 111.973 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.583 ' O ' HG21 ' A' ' 5' ' ' VAL . 35.6 t -116.79 106.42 13.47 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.569 ' HB3' HG13 ' A' ' 80' ' ' VAL . 5.0 pt-20 -102.85 -179.39 3.94 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -177.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -155.86 -178.62 7.43 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.161 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.11 160.58 43.39 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.701 0.286 . . . . 0.0 111.463 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.781 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.3 p -142.09 120.47 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.55 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -74.85 91.43 2.44 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.752 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.9 t -95.27 142.42 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.31 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.88 156.34 46.27 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.938 0.399 . . . . 0.0 111.398 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.843 HD13 ' HB1' ' A' ' 69' ' ' ALA . 11.3 mt -145.09 132.27 15.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.052 178.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.23 132.2 39.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.249 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.219 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.469 ' HD3' HG22 ' A' ' 2' ' ' VAL . 10.9 ttt85 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.598 0.237 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 30' ' ' ALA . 1.5 m -153.55 55.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-O 121.228 0.537 . . . . 0.0 110.074 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.653 HD11 ' HB2' ' A' ' 83' ' ' ALA . 5.6 mp -142.97 123.49 13.99 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.287 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.769 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 2.6 tt0 -146.43 124.58 12.16 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.14 150.89 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.236 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -160.1 130.37 5.46 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.765 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.462 HD12 ' C ' ' A' ' 92' ' ' THR . 38.9 mt -92.1 144.69 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.361 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -128.42 126.13 23.43 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.19 179.69 28.5 Favored 'Cis proline' 0 C--N 1.365 1.421 0 CA-C-N 120.149 1.089 . . . . 0.0 112.348 0.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 96.4 p -73.33 -51.67 16.64 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.451 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -130.53 101.25 5.63 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.885 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.2 111.24 4.19 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 121.3 -0.476 . . . . 0.0 113.799 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.02 123.06 35.1 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.48 HD13 ' CB ' ' A' ' 20' ' ' LYS . 2.8 mp -137.73 164.69 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.593 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.75 162.23 14.17 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.634 0.731 . . . . 0.0 111.625 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 69' ' ' ALA . 36.8 t -68.51 135.7 27.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.323 178.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.07 -17.35 58.82 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-O 119.545 -0.586 . . . . 0.0 112.449 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -111.46 146.55 37.03 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-N 117.799 0.8 . . . . 0.0 109.896 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 96.7 p -79.67 176.95 9.25 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.602 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -171.33 118.74 0.46 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.249 -178.302 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.751 ' HB3' HG23 ' A' ' 65' ' ' THR . 29.6 p90 -112.09 150.6 30.48 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.469 0.176 . . . . 0.0 111.137 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.714 ' CD2' HG21 ' A' ' 93' ' ' VAL . 86.4 m-85 -128.58 118.52 23.12 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.197 0.522 . . . . 0.0 111.44 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.8 tp -79.13 117.3 20.04 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.432 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 41.6 t -94.74 96.56 9.46 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -88.41 148.72 24.08 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.168 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.818 HG21 ' CB ' ' A' ' 60' ' ' ASP . 33.7 m -120.89 175.96 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.769 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -171.06 112.63 0.38 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.093 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 150.34 149.42 5.01 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.228 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -96.64 51.01 1.14 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.006 0.431 . . . . 0.0 111.612 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.686 ' HB2' HG23 ' A' ' 2' ' ' VAL . . . -93.67 18.7 9.69 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.66 -84.32 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 114.555 1.316 . . . . 0.0 114.555 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -39.89 -31.12 0.1 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.639 ' HD3' ' HB3' ' A' ' 30' ' ' ALA . 6.8 mmmm 1.91 73.45 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 125.526 1.53 . . . . 0.0 115.04 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -83.16 108.8 16.67 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.652 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.503 HG21 ' OG ' ' A' ' 62' ' ' SER . 3.9 mp -73.25 157.98 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 123.385 0.428 . . . . 0.0 111.136 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.42 ' N ' HG22 ' A' ' 35' ' ' ILE . 18.0 m -157.88 161.79 38.3 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.249 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.438 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 60.3 m95 -137.39 124.99 22.2 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.65 0.262 . . . . 0.0 111.094 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 94.8 m-85 -114.38 117.32 30.7 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.419 ' HB3' HD23 ' A' ' 45' ' ' LEU . 14.9 p -68.12 153.12 95.89 Favored Pre-proline 0 C--O 1.249 1.074 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.947 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -50.51 -16.05 1.93 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 124.887 3.725 . . . . 0.0 116.048 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -77.98 3.02 15.76 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.072 0.397 . . . . 0.0 111.908 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.76 38.88 10.0 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-O 119.611 -0.55 . . . . 0.0 112.276 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -167.96 143.72 3.86 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 119.561 -0.856 . . . . 0.0 113.205 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 19.8 tttm -54.33 146.29 15.92 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -110.76 152.85 26.11 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.268 179.37 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m -79.33 159.48 72.44 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.984 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.79 -8.06 13.4 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.29 1.994 . . . . 0.0 113.548 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -141.92 48.59 1.6 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.03 0.443 . . . . 0.0 110.763 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -66.33 -77.31 0.07 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.658 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -150.76 -74.53 0.15 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 -99.86 -34.71 10.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.639 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.663 HG12 HG23 ' A' ' 66' ' ' ILE . 53.4 mt -84.54 107.23 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.849 0.357 . . . . 0.0 111.189 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.5 t -110.64 124.35 51.74 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.597 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.437 HG22 HD23 ' A' ' 64' ' ' LEU . 13.5 t -98.42 159.3 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.742 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.409 ' N ' HG12 ' A' ' 54' ' ' VAL . 5.0 m -149.95 170.32 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.862 0.363 . . . . 0.0 111.518 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.1 m-90 -139.64 104.5 4.93 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -90.79 -85.57 0.22 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -175.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -174.56 0.07 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.952 0.342 . . . . 0.0 111.804 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.89 -36.05 62.26 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.844 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.818 ' CB ' HG21 ' A' ' 26' ' ' VAL . 61.0 m-20 -145.18 17.77 1.56 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.5 t -103.09 139.12 39.03 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.503 ' OG ' HG21 ' A' ' 35' ' ' ILE . 5.6 m -133.27 -173.73 3.29 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.993 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m -155.73 146.55 22.2 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.902 0.382 . . . . 0.0 111.826 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.652 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -115.84 91.57 3.64 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.447 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.751 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -86.2 139.01 31.45 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.605 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.663 HG23 HG12 ' A' ' 52' ' ' ILE . 66.2 mt -135.56 95.59 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -61.93 -116.07 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 O-C-N 123.759 0.662 . . . . 0.0 110.884 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.43 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.824 1.193 . . . . 0.0 111.409 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.846 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -74.56 142.53 44.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.992 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.775 ' O ' HD12 ' A' ' 97' ' ' ILE . 11.5 m120 -136.9 152.28 50.03 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.63 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.2 pt -51.41 -26.01 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -69.08 -43.67 74.08 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -65.21 -33.42 75.95 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.88 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.484 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -50.47 104.3 0.07 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.54 174.27 46.47 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.043 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.3 mt -81.23 98.66 4.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.652 ' CD2' HD11 ' A' ' 64' ' ' LEU . 59.9 m-85 -71.73 172.47 9.71 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -134.01 155.11 50.56 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.744 0.307 . . . . 0.0 111.095 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.461 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -138.74 101.38 4.31 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.224 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.431 HG13 ' HB3' ' A' ' 90' ' ' GLU . 5.0 t -104.73 140.85 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.427 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.469 HG12 HD23 ' A' ' 3' ' ' LEU . 0.7 OUTLIER -127.36 135.49 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.084 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.658 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.1 m -117.14 149.88 39.63 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.653 ' HB2' HD11 ' A' ' 3' ' ' LEU . . . -90.55 -177.63 5.09 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.357 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -74.23 -34.46 63.66 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.314 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.32 -35.6 23.15 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.361 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.61 -22.15 1.5 Allowed Glycine 0 C--N 1.34 0.785 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.584 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.8 m -59.19 111.66 1.42 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.208 0.504 . . . . 0.0 111.446 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.658 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.1 OUTLIER -119.12 135.22 54.76 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.922 0.391 . . . . 0.0 111.687 179.852 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.7 t -116.61 127.13 54.18 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.431 ' HB3' HG13 ' A' ' 80' ' ' VAL . 4.7 pt-20 -111.19 -178.54 3.49 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -177.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -147.67 173.55 12.64 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.18 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.462 ' C ' HD12 ' A' ' 7' ' ' ILE . 0.7 OUTLIER -147.48 155.78 42.23 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.613 0.244 . . . . 0.0 111.051 179.394 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.714 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.5 p -144.97 116.82 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.273 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.02 102.68 2.49 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.439 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 15.1 t -105.57 111.49 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.681 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.0 mtmm -98.91 149.73 22.64 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.406 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.846 HD13 ' HB1' ' A' ' 69' ' ' ALA . 10.3 mt -139.36 117.72 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.42 132.3 56.29 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.382 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.895 -179.718 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.581 HG23 ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -117.34 72.91 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.069 0.461 . . . . 0.0 109.97 -179.76 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.42 HD12 ' O ' ' A' ' 2' ' ' VAL . 0.2 OUTLIER -148.85 105.8 3.59 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.237 -179.744 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.762 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 13.6 tt0 -134.76 142.17 46.66 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.901 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 89' ' ' SER . 0.4 OUTLIER -149.59 141.1 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.82 -179.785 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -155.04 132.55 11.21 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.644 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.483 HD11 ' HB3' ' A' ' 79' ' ' CYS . 17.6 mt -92.17 131.93 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 O-C-N 123.173 0.295 . . . . 0.0 111.11 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.04 125.91 28.74 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.57 172.7 48.93 Favored 'Cis proline' 0 C--N 1.364 1.365 0 CA-C-N 120.103 1.072 . . . . 0.0 112.369 0.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.9 p -70.05 -39.8 75.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.458 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -134.42 113.15 11.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.85 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.03 97.89 1.11 Allowed Glycine 0 C--N 1.342 0.867 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.803 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.589 ' C ' HD12 ' A' ' 14' ' ' ILE . 6.6 mt-10 -86.19 124.19 32.31 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.589 HD12 ' C ' ' A' ' 13' ' ' GLU . 3.5 mp -141.06 164.45 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.593 0.235 . . . . 0.0 110.727 -178.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.76 156.98 17.17 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.786 0.327 . . . . 0.0 110.439 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.0 t -63.52 140.77 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.38 -11.57 70.85 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.472 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -98.99 159.55 14.88 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 117.481 0.64 . . . . 0.0 109.454 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.4 ' CB ' ' HA ' ' A' ' 67' ' ' TYR . 66.7 p -101.49 149.24 24.28 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.63 0.252 . . . . 0.0 111.213 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.625 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -148.26 124.53 10.86 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.552 -178.514 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.772 ' HB3' HG23 ' A' ' 65' ' ' THR . 34.2 p90 -114.57 148.32 38.19 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.958 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.648 ' CD1' HG21 ' A' ' 93' ' ' VAL . 92.8 m-85 -127.45 119.85 27.04 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.223 0.535 . . . . 0.0 112.028 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 62' ' ' SER . 0.0 OUTLIER -78.05 109.49 12.18 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -177.117 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.491 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 35.5 t -84.54 90.7 7.7 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -83.35 150.82 25.86 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.093 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.753 HG21 ' CB ' ' A' ' 60' ' ' ASP . 30.9 m -122.35 169.96 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.3 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.762 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -169.66 103.84 0.33 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.799 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 155.61 134.19 1.81 Allowed Glycine 0 C--N 1.338 0.664 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.529 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -95.54 50.98 1.26 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.167 0.508 . . . . 0.0 110.905 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.581 ' HB2' HG23 ' A' ' 2' ' ' VAL . . . -88.65 78.23 7.78 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.328 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.75 -88.0 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -128.69 137.6 51.7 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.735 0.303 . . . . 0.0 111.136 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -128.07 145.39 51.01 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.639 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -124.26 114.48 19.65 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.635 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.542 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.2 mp -76.43 155.44 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.064 0.459 . . . . 0.0 112.01 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.401 ' N ' HG22 ' A' ' 35' ' ' ILE . 74.9 m -152.3 159.2 43.53 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.645 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.491 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 44.2 m95 -135.4 115.18 12.9 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 119.684 -0.198 . . . . 0.0 111.384 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -116.51 112.16 20.98 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.517 ' HB3' HD21 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -61.52 156.01 55.74 Favored Pre-proline 0 C--O 1.245 0.821 0 CA-C-O 119.325 -0.369 . . . . 0.0 110.627 178.364 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -33.79 -72.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 125.094 3.863 . . . . 0.0 113.484 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.86 37.3 4.14 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 176.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.9 -19.86 3.92 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.816 -0.629 . . . . 0.0 113.401 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 70.71 -170.89 0.16 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 117.893 0.846 . . . . 0.0 109.003 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 23.2 tttm -55.2 108.83 0.45 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.517 HD21 ' HB3' ' A' ' 39' ' ' SER . 2.2 mt -72.39 171.48 12.16 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.987 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m -86.75 150.4 50.55 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.06 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.08 -24.75 23.39 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.254 1.97 . . . . 0.0 112.886 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -150.01 80.3 1.37 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.989 0.423 . . . . 0.0 110.301 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.71 -79.08 0.46 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.295 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -145.04 -74.3 0.24 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.588 0.232 . . . . 0.0 110.902 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -97.95 -39.57 8.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.565 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.464 HG12 HG23 ' A' ' 66' ' ' ILE . 47.9 mt -88.33 112.83 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.6 t -119.37 117.98 29.97 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.364 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.3 t -89.04 157.61 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.4 HG22 ' N ' ' A' ' 56' ' ' TRP . 9.8 p -155.0 157.98 3.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 CA-C-O 120.963 0.411 . . . . 0.0 111.894 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.4 ' N ' HG22 ' A' ' 55' ' ' VAL . 25.7 m-90 -131.72 107.51 8.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -97.39 -79.28 0.46 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.73 -178.82 0.22 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.587 0.232 . . . . 0.0 111.473 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -52.71 -34.26 51.54 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.753 ' CB ' HG21 ' A' ' 26' ' ' VAL . 22.1 m-20 -148.29 16.51 1.05 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 p -103.14 139.15 39.02 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.97 0.35 . . . . 0.0 110.078 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.542 ' OG ' HG21 ' A' ' 35' ' ' ILE . 4.2 m -130.84 -174.29 3.33 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.455 -177.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -155.82 147.57 23.07 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.003 0.43 . . . . 0.0 111.35 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.642 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -118.94 92.51 3.82 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.285 179.425 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.772 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -84.87 145.14 27.96 Favored 'General case' 0 N--CA 1.461 0.106 0 O-C-N 123.37 0.419 . . . . 0.0 110.157 -179.42 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.614 HD12 ' HD2' ' A' ' 20' ' ' LYS . 51.2 mt -141.19 79.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.4 ' HA ' ' CB ' ' A' ' 19' ' ' SER . 13.5 m-85 -45.79 -66.94 0.33 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 2.1 t30 -64.38 -67.07 0.46 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 68' ' ' ASN . . . 78.22 123.75 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.345 0.658 . . . . 0.0 110.926 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.822 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.4 OUTLIER -144.24 159.77 42.1 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.069 0.462 . . . . 0.0 110.737 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.3 pt -50.23 -27.79 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -71.19 -41.42 70.33 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -64.08 -34.05 77.15 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.98 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.548 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -52.76 102.87 0.06 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.75 178.23 46.59 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.656 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.564 HG23 ' HB ' ' A' ' 92' ' ' THR . 1.1 mp -80.77 100.58 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 117.051 0.426 . . . . 0.0 110.437 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.642 ' CD2' HD11 ' A' ' 64' ' ' LEU . 60.8 m-85 -73.32 174.57 7.91 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -135.01 154.27 51.78 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.483 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -140.31 101.26 4.09 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.231 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 90' ' ' GLU . 5.0 t -106.89 137.41 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -176.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -120.39 142.42 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.643 HG23 ' HG2' ' A' ' 88' ' ' GLN . 2.4 m -128.2 126.31 40.74 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.89 -175.84 2.27 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.752 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -78.18 -39.54 40.47 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.181 0.301 . . . . 0.0 111.04 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.38 -33.84 65.24 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.394 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.02 -8.52 4.16 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-O 119.72 -0.489 . . . . 0.0 114.013 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.3 m -62.58 110.32 1.66 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.687 0.744 . . . . 0.0 110.61 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.643 ' HG2' HG23 ' A' ' 82' ' ' THR . 35.7 mt-30 -103.07 134.36 46.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.889 0.376 . . . . 0.0 111.784 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.402 ' O ' HG21 ' A' ' 5' ' ' VAL . 7.8 t -131.22 115.01 15.77 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.582 ' HB3' HG13 ' A' ' 80' ' ' VAL . 7.0 pt-20 -112.1 -176.97 3.05 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -177.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.5 172.77 16.04 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.34 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.564 ' HB ' HG23 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -145.23 152.29 39.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.66 0.266 . . . . 0.0 110.535 179.289 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.648 HG21 ' CD1' ' A' ' 22' ' ' PHE . 7.4 p -135.55 117.71 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.126 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -71.7 92.24 1.17 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.084 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.485 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 14.6 t -95.09 112.73 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.476 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.95 155.54 17.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.948 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.822 HD12 ' O ' ' A' ' 70' ' ' ASN . 11.2 mt -144.04 135.49 22.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.144 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.67 127.62 37.32 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.229 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.951 -179.901 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.493 ' CD ' HG22 ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.6 HG23 ' HB2' ' A' ' 30' ' ' ALA . 5.9 m -144.82 61.92 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 121.389 0.614 . . . . 0.0 110.25 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 2' ' ' VAL . 0.5 OUTLIER -159.27 89.37 0.91 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.705 -179.698 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.668 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -119.84 150.08 41.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.903 -179.571 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.572 HG21 ' O ' ' A' ' 89' ' ' SER . 17.1 t -147.35 138.14 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.456 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -155.31 125.84 6.86 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.878 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.672 HD11 ' HB2' ' A' ' 79' ' ' CYS . 71.2 mt -89.71 135.14 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -134.6 120.68 14.66 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 118.918 -0.563 . . . . 0.0 110.908 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -66.23 149.56 78.42 Favored 'Cis proline' 0 C--N 1.364 1.343 0 CA-C-N 120.531 1.225 . . . . 0.0 113.053 -0.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.642 ' O ' HG23 ' A' ' 93' ' ' VAL . 78.1 p -71.72 -40.4 69.49 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.888 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -112.16 120.2 40.99 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.64 75.74 0.21 Allowed Glycine 0 C--N 1.341 0.854 0 N-CA-C 114.542 0.577 . . . . 0.0 114.542 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.583 ' C ' HD12 ' A' ' 14' ' ' ILE . 25.8 mt-10 -81.24 115.25 20.54 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.583 HD12 ' C ' ' A' ' 13' ' ' GLU . 2.9 mp -141.74 162.17 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.411 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.34 153.94 18.26 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.94 0.4 . . . . 0.0 110.488 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 69' ' ' ALA . 47.1 t -63.01 141.18 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.093 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.8 -13.1 67.68 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.188 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -102.61 159.51 15.39 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.2 p -94.35 168.51 10.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.578 0.228 . . . . 0.0 110.648 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.79 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 2.3 pttt -167.0 115.34 0.83 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.222 -178.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.469 ' HB3' HG23 ' A' ' 65' ' ' THR . 45.1 p90 -120.66 151.79 39.03 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.69 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -131.74 122.68 26.26 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.264 0.554 . . . . 0.0 111.339 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp -79.81 114.43 18.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.718 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 t -90.19 104.32 16.91 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.075 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -95.44 166.99 11.6 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.512 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.0 m -139.58 171.48 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.691 0.281 . . . . 0.0 111.596 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.668 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -151.7 104.72 3.06 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.041 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 167.02 131.55 1.28 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.368 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -97.7 43.35 1.07 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.033 0.444 . . . . 0.0 111.071 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.6 ' HB2' HG23 ' A' ' 2' ' ' VAL . . . -68.76 -170.69 0.23 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.756 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -74.84 -59.52 2.7 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.934 0.397 . . . . 0.0 110.155 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -124.61 151.36 44.93 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.028 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt -133.57 84.42 2.12 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.78 0.324 . . . . 0.0 111.255 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.465 ' O ' HG22 ' A' ' 81' ' ' VAL . 30.1 t70 -79.88 155.68 27.67 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.679 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.6 mp -130.51 152.17 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 123.322 0.389 . . . . 0.0 111.205 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.5 m -152.68 157.66 41.24 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.297 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.446 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 60.5 m95 -131.98 122.38 25.45 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -119.22 111.95 18.87 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 p -57.02 152.83 26.65 Favored Pre-proline 0 C--O 1.244 0.793 0 CA-C-O 119.327 -0.368 . . . . 0.0 110.783 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -32.03 -76.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 125.273 3.982 . . . . 0.0 114.15 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.58 37.27 3.64 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 176.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.51 -16.16 4.74 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.617 -0.72 . . . . 0.0 113.371 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 70.02 -170.3 0.17 Allowed 'General case' 0 C--N 1.353 0.743 0 CA-C-N 117.978 0.889 . . . . 0.0 108.768 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 14.2 tttt -54.52 125.51 19.92 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.469 HD22 HG21 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -91.89 158.15 16.45 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.797 -179.301 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.6 m -75.25 147.22 82.65 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.451 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.47 -27.16 81.02 Favored 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 122.39 2.06 . . . . 0.0 113.066 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -148.63 79.24 1.43 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.004 0.431 . . . . 0.0 110.807 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.72 -68.45 0.79 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.991 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -150.95 -79.26 0.12 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -99.7 -32.77 10.89 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.554 HG12 HG23 ' A' ' 66' ' ' ILE . 63.3 mt -88.53 100.4 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 120.868 0.366 . . . . 0.0 111.212 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.6 t -107.19 123.21 47.94 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.027 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 55' ' ' VAL . 20.9 t -95.91 158.13 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.268 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.415 ' N ' HG12 ' A' ' 54' ' ' VAL . 11.3 m -150.54 172.5 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 120.938 0.399 . . . . 0.0 111.642 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.7 m-90 -142.23 117.0 9.83 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.55 -79.55 0.57 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -59.48 -179.92 0.1 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.598 0.181 . . . . 0.0 111.024 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -57.08 -32.35 66.18 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -136.99 -12.37 1.69 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.8 t -85.25 139.75 31.39 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 118.734 0.697 . . . . 0.0 111.499 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.679 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.8 m -126.0 -169.37 2.0 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.268 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.3 m -160.53 132.92 6.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.738 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -99.98 99.08 9.78 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.225 178.635 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -92.38 131.4 37.59 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.242 0.339 . . . . 0.0 110.092 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.554 HG23 HG12 ' A' ' 52' ' ' ILE . 63.7 mt -130.1 93.14 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -60.68 -116.06 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 CA-C-O 118.895 -0.574 . . . . 0.0 111.199 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -51.48 95.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.912 1.233 . . . . 0.0 110.876 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.837 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -75.22 154.05 37.77 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.883 -178.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.785 ' O ' HD12 ' A' ' 97' ' ' ILE . 1.1 p30 -148.34 154.13 39.55 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.382 0.61 . . . . 0.0 111.326 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.4 pt -53.42 -25.97 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -71.53 -40.52 70.02 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.29 -34.23 77.84 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.584 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.519 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -50.89 108.4 0.24 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.49 179.69 48.83 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 121.411 -0.423 . . . . 0.0 112.299 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.731 HD13 ' HA ' ' A' ' 94' ' ' ASN . 23.0 mm -82.04 90.26 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 122.152 0.181 . . . . 0.0 111.459 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.738 ' CD2' HD11 ' A' ' 64' ' ' LEU . 40.3 m-85 -67.68 176.0 2.67 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -136.58 159.0 43.12 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.672 ' HB2' HD11 ' A' ' 7' ' ' ILE . 8.3 t -140.4 92.54 2.53 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.705 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.505 HG13 ' HB3' ' A' ' 90' ' ' GLU . 5.2 t -96.51 128.74 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 34' ' ' ASP . 2.3 t -112.92 159.1 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.73 HG23 ' HG2' ' A' ' 88' ' ' GLN . 1.5 m -136.34 154.06 50.96 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.47 -172.66 2.2 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.315 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -76.79 -45.6 28.2 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.233 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -74.74 -32.01 61.97 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 141.73 -9.88 2.6 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.402 -0.666 . . . . 0.0 114.433 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.467 HG22 HD22 ' A' ' 3' ' ' LEU . 49.6 m -63.79 116.98 6.27 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 117.98 0.89 . . . . 0.0 110.336 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.73 ' HG2' HG23 ' A' ' 82' ' ' THR . 8.2 mt-30 -108.92 135.77 49.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.466 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.572 ' O ' HG21 ' A' ' 5' ' ' VAL . 21.8 t -122.0 108.38 13.32 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.505 ' HB3' HG13 ' A' ' 80' ' ' VAL . 6.2 pt-20 -99.78 179.83 4.4 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.2 -179.39 7.48 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.716 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.26 152.56 31.31 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.025 0.44 . . . . 0.0 111.478 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 10' ' ' SER . 2.7 p -132.01 119.87 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.34 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.731 ' HA ' HD13 ' A' ' 76' ' ' ILE . 8.1 t30 -80.72 88.4 5.78 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.524 HG22 HG22 ' A' ' 93' ' ' VAL . 3.5 t -91.96 124.66 44.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.934 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -111.99 155.19 24.15 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.585 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.837 HD13 ' HB1' ' A' ' 69' ' ' ALA . 7.9 mt -145.96 132.04 13.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.697 177.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -119.29 125.65 49.59 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.535 -178.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.856 -179.844 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.553 ' O ' HG13 ' A' ' 2' ' ' VAL . 8.5 ttt85 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.427 0.156 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.665 HG23 ' HB2' ' A' ' 30' ' ' ALA . 0.6 OUTLIER -160.94 42.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-O 121.019 0.438 . . . . 0.0 110.617 -179.475 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.519 HD11 ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -147.75 96.38 2.66 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.05 -179.316 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.75 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 10.8 tp-100 -99.95 152.01 20.67 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.518 HG21 ' O ' ' A' ' 89' ' ' SER . 2.0 t -146.57 146.76 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -158.13 127.95 5.97 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.705 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.458 HD11 ' HB3' ' A' ' 79' ' ' CYS . 42.4 mt -94.2 142.83 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.2 t -124.46 122.91 25.87 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-O 119.21 -0.424 . . . . 0.0 110.03 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.49 -171.17 9.36 Favored 'Cis proline' 0 C--N 1.366 1.452 0 CA-C-N 119.925 1.009 . . . . 0.0 112.361 -0.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.3 p -85.83 -50.22 7.3 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.309 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -125.38 99.98 6.29 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.733 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.28 156.55 37.6 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.874 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -151.75 104.92 3.07 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.3 mp -130.15 166.85 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.806 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.6 155.46 18.27 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.603 0.716 . . . . 0.0 111.339 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 69' ' ' ALA . 17.0 t -65.88 138.49 22.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.887 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.87 -16.96 60.11 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.312 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -115.52 149.94 37.35 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 117.87 0.835 . . . . 0.0 110.116 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.436 ' CB ' ' HA ' ' A' ' 67' ' ' TYR . 60.4 p -79.86 165.58 22.55 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.821 ' HE3' HD12 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -158.77 119.88 3.36 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.267 -179.646 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.726 ' HB3' HG23 ' A' ' 65' ' ' THR . 39.6 p90 -112.8 153.57 27.63 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.538 0.209 . . . . 0.0 111.245 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.713 ' CD2' HG21 ' A' ' 93' ' ' VAL . 78.3 m-85 -129.33 113.58 15.15 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.271 0.558 . . . . 0.0 111.234 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.438 HD23 ' OE1' ' A' ' 25' ' ' GLN . 12.1 tp -78.42 111.73 14.73 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -177.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.472 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 43.7 t -93.4 90.1 6.6 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.438 ' OE1' HD23 ' A' ' 23' ' ' LEU . 6.4 mt-30 -86.7 157.51 19.63 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.861 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.666 HG21 ' CB ' ' A' ' 60' ' ' ASP . 30.7 m -124.96 169.15 16.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.448 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.75 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -157.9 98.04 1.59 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.503 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 175.76 -175.69 47.35 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.984 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -129.03 30.55 5.03 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.767 ' HB3' ' CG ' ' A' ' 33' ' ' LYS . . . -68.67 -176.09 0.76 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 110.484 -0.191 . . . . 0.0 110.484 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.48 -50.58 1.87 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.659 0.266 . . . . 0.0 111.638 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.67 -36.49 83.04 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.879 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.767 ' CG ' ' HB3' ' A' ' 30' ' ' ALA . 29.5 mtpt 0.15 96.68 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 125.61 1.564 . . . . 0.0 115.041 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -118.21 113.87 22.17 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.207 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 35' ' ' ILE . 4.7 mp -77.74 156.62 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.183 0.516 . . . . 0.0 111.411 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.409 ' N ' HG22 ' A' ' 35' ' ' ILE . 4.7 m -152.36 157.74 41.72 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.087 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.472 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 39.8 m95 -135.13 109.13 8.17 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 117.61 0.187 . . . . 0.0 110.934 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -107.73 112.07 24.57 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.593 ' HB3' HD23 ' A' ' 45' ' ' LEU . 56.0 p -62.33 153.78 74.33 Favored Pre-proline 0 C--O 1.246 0.918 0 CA-C-O 119.159 -0.448 . . . . 0.0 110.535 178.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -26.42 -71.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.334 1 C-N-CA 125.938 4.425 . . . . 0.0 115.038 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.97 36.48 4.59 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.35 -15.52 4.56 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.063 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 72.32 -170.2 0.14 Allowed 'General case' 0 C--N 1.354 0.773 0 CA-C-N 117.959 0.88 . . . . 0.0 109.363 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 8.6 ttpp -52.28 96.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.593 HD23 ' HB3' ' A' ' 39' ' ' SER . 4.0 pp -69.85 148.05 49.56 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.542 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.36 150.75 95.37 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.067 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.88 -30.84 6.96 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 122.286 1.99 . . . . 0.0 112.579 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.61 52.13 1.19 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.028 0.442 . . . . 0.0 111.254 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -68.81 -82.2 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.352 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -150.98 -73.17 0.16 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -98.99 -31.56 11.74 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.689 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.579 HG12 HG23 ' A' ' 66' ' ' ILE . 37.6 mt -89.05 101.66 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.735 0.302 . . . . 0.0 110.405 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.0 t -108.42 122.77 47.7 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.157 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 55' ' ' VAL . 19.3 t -95.63 159.62 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.407 ' N ' HG12 ' A' ' 54' ' ' VAL . 9.8 p -153.97 146.95 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.077 0.465 . . . . 0.0 112.239 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 21.2 m-90 -123.73 112.06 16.9 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -109.49 -74.35 0.66 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.745 1.016 . . . . 0.0 113.745 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -60.74 -175.16 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -53.26 -36.55 61.23 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.745 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.666 ' CB ' HG21 ' A' ' 26' ' ' VAL . 1.9 m-20 -153.96 22.32 0.51 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.2 t -103.47 139.23 39.1 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.473 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.5 m -134.64 -174.03 3.46 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.603 -178.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -155.8 145.29 21.0 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.022 0.439 . . . . 0.0 111.256 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.664 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -113.29 91.23 3.57 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.247 179.466 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.726 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -87.71 138.02 31.83 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.338 0.399 . . . . 0.0 110.295 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.821 HD12 ' HE3' ' A' ' 20' ' ' LYS . 58.9 mt -134.79 87.29 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.436 ' HA ' ' CB ' ' A' ' 19' ' ' SER . 12.5 m-85 -52.89 -67.46 0.25 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -176.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 1.2 t-20 -60.57 -63.64 1.23 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -177.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.44 ' O ' HG13 ' A' ' 16' ' ' VAL . . . 73.6 120.55 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.883 0.473 . . . . 0.0 110.952 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.797 ' O ' HD12 ' A' ' 97' ' ' ILE . 4.1 m-80 -141.71 162.4 35.57 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.033 0.444 . . . . 0.0 110.356 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.6 pt -54.83 -24.59 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -72.95 -40.45 65.35 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -66.52 -32.97 74.66 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.792 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.501 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -50.58 114.65 1.19 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.26 171.45 37.89 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.037 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.0 mt -76.93 95.86 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.786 0.293 . . . . 0.0 111.691 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.664 ' CD2' HD11 ' A' ' 64' ' ' LEU . 46.5 m-85 -70.23 179.03 2.55 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -140.66 156.25 46.29 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 120.757 0.313 . . . . 0.0 111.626 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.458 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -142.96 102.38 4.0 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 90' ' ' GLU . 7.3 t -104.59 139.78 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.11 137.96 53.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.592 HG23 ' HB3' ' A' ' 88' ' ' GLN . 3.4 m -127.93 150.95 49.66 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.51 -173.65 2.7 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.532 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -73.01 -52.86 12.82 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.504 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -65.47 -36.26 83.35 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 146.78 -19.23 1.63 Allowed Glycine 0 C--N 1.34 0.76 0 C-N-CA 121.161 -0.542 . . . . 0.0 113.644 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.519 ' O ' HD11 ' A' ' 3' ' ' LEU . 77.5 m -57.85 109.1 0.66 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.39 0.595 . . . . 0.0 111.213 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.592 ' HB3' HG23 ' A' ' 82' ' ' THR . 1.0 OUTLIER -119.67 134.26 55.3 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.682 -179.88 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.518 ' O ' HG21 ' A' ' 5' ' ' VAL . 40.9 t -110.96 117.64 33.9 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.423 ' HB3' HG13 ' A' ' 80' ' ' VAL . 12.6 pt-20 -105.65 -178.57 3.69 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.41 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -150.46 172.38 15.54 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.255 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.01 153.23 36.17 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.46 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.713 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.7 p -141.26 111.67 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.757 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.68 89.51 0.74 Allowed 'General case' 0 C--O 1.235 0.293 0 O-C-N 123.408 0.442 . . . . 0.0 110.281 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.496 HG11 ' NZ ' ' A' ' 20' ' ' LYS . 21.3 t -87.29 138.05 19.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.589 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -122.83 156.96 33.51 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.625 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.797 HD12 ' O ' ' A' ' 70' ' ' ASN . 7.2 mt -147.11 136.02 15.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.785 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.7 133.36 43.42 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.335 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.949 -179.664 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.542 ' O ' HG13 ' A' ' 2' ' ' VAL . 7.0 ttt180 . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.517 0.198 . . . . 0.0 111.378 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.704 HG23 ' HB2' ' A' ' 30' ' ' ALA . 1.9 m -160.14 54.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.286 0.565 . . . . 0.0 110.542 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.549 HD11 ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -150.19 93.31 1.98 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.498 -179.51 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.658 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 11.0 tp-100 -92.78 149.53 21.23 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 89' ' ' SER . 1.7 t -144.02 146.4 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 123.162 0.289 . . . . 0.0 110.933 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -160.38 133.06 6.41 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.64 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.53 HD11 ' HB3' ' A' ' 79' ' ' CYS . 33.1 mt -99.72 124.31 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 36.3 t -108.1 128.44 25.73 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.598 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.77 -172.9 11.78 Favored 'Cis proline' 0 C--N 1.365 1.433 0 CA-C-N 119.946 1.016 . . . . 0.0 112.327 -0.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.9 p -78.84 -48.82 14.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.932 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -132.0 112.34 12.29 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.883 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.08 106.99 2.34 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.071 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.55 ' C ' HD12 ' A' ' 14' ' ' ILE . 11.0 mt-10 -88.31 132.54 34.37 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.55 HD12 ' C ' ' A' ' 13' ' ' GLU . 4.1 mp -145.47 162.87 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 120.628 0.252 . . . . 0.0 110.697 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.41 154.34 19.17 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.284 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 69' ' ' ALA . 43.6 t -61.53 136.3 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.231 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.71 -6.81 74.09 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.417 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -104.39 158.18 16.64 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.3 p -101.48 149.71 23.79 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.628 0.251 . . . . 0.0 111.58 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.576 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -147.25 119.11 8.1 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.607 -178.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.773 ' HB3' HG23 ' A' ' 65' ' ' THR . 20.5 p90 -113.74 148.13 37.02 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.684 0.278 . . . . 0.0 110.537 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.66 ' CD2' HG21 ' A' ' 93' ' ' VAL . 58.9 m-85 -125.92 144.74 50.56 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.048 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.21 110.03 22.28 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.405 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 42.5 t -87.48 86.35 7.22 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -92.4 161.62 14.58 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.014 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.746 HG21 ' HB2' ' A' ' 60' ' ' ASP . 33.9 m -126.93 175.46 8.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.658 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -163.74 98.62 0.88 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.727 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -178.06 -143.77 5.24 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.794 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -162.27 32.15 0.11 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.598 0.237 . . . . 0.0 111.566 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.704 ' HB2' HG23 ' A' ' 2' ' ' VAL . . . -77.48 -167.32 0.91 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.09 -42.34 0.99 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.24 -34.3 68.17 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.695 ' HD2' ' HB3' ' A' ' 30' ' ' ALA . 21.8 mtpt -9.86 82.03 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -179.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -97.96 116.34 29.97 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.34 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 60' ' ' ASP . 4.7 mp -75.4 156.1 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.294 0.568 . . . . 0.0 112.173 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.42 ' N ' HG22 ' A' ' 35' ' ' ILE . 5.0 m -157.55 162.96 38.82 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.499 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.405 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 46.1 m95 -135.61 130.36 34.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 110.53 -0.174 . . . . 0.0 110.53 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 87.1 m-85 -125.54 112.68 16.49 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.449 ' OG ' HD13 ' A' ' 45' ' ' LEU . 4.7 p -57.71 154.67 25.1 Favored Pre-proline 0 C--O 1.251 1.152 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.78 -15.81 4.98 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 124.649 3.566 . . . . 0.0 116.084 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -78.32 0.9 23.65 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.0 42.95 6.9 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -154.56 163.29 40.43 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.367 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 10.0 tttt -73.36 170.85 14.21 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.437 0.46 . . . . 0.0 110.722 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.477 ' CD2' HG21 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -131.18 122.02 25.87 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.047 -179.458 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.98 158.91 73.83 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.252 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -83.52 -13.76 8.31 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 122.511 2.141 . . . . 0.0 113.808 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -153.85 84.74 1.16 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.011 0.434 . . . . 0.0 110.536 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.91 -57.75 0.81 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.977 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -137.24 -159.17 0.93 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -48.91 -26.47 2.49 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.477 HG21 ' CD2' ' A' ' 45' ' ' LEU . 61.7 mt -82.58 122.78 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.8 t -134.44 124.29 25.41 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.971 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.6 t -98.33 156.91 3.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.218 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.2 p -152.21 141.29 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.876 0.37 . . . . 0.0 111.735 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -117.11 121.91 42.62 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.44 -76.73 0.57 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -58.04 -175.68 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -56.33 -37.55 70.13 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.954 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.746 ' HB2' HG21 ' A' ' 26' ' ' VAL . 30.0 m-20 -148.98 20.87 0.99 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.7 t -105.25 142.05 35.69 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 120.65 0.262 . . . . 0.0 110.441 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.462 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.9 m -138.36 -176.53 4.49 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.023 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 22' ' ' PHE . 2.0 m -157.69 136.69 11.61 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.921 0.391 . . . . 0.0 111.629 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.421 HD21 ' CD2' ' A' ' 77' ' ' TYR . 15.8 tp -96.08 141.67 29.19 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.773 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -136.46 96.46 3.36 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.772 0.715 . . . . 0.0 112.676 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.493 HD13 ' HZ3' ' A' ' 20' ' ' LYS . 1.6 mt -92.47 90.74 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.469 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -57.51 -96.05 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.975 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.46 97.64 0.78 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.066 0.848 . . . . 0.0 110.142 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.553 ' O ' HG13 ' A' ' 16' ' ' VAL . . . -77.76 157.52 29.99 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -152.21 158.18 42.5 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.059 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -52.34 -24.82 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -72.54 -42.72 64.41 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 110.478 -0.194 . . . . 0.0 110.478 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.441 ' OD1' HD11 ' A' ' 52' ' ' ILE . 32.6 m-20 -63.73 -33.69 76.21 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.03 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.589 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -51.12 105.57 0.11 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.95 178.92 48.11 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.485 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.643 HD13 ' HA ' ' A' ' 94' ' ' ASN . 24.6 mm -81.0 92.89 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 123.394 0.114 . . . . 0.0 110.758 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.421 ' CD2' HD21 ' A' ' 64' ' ' LEU . 67.4 m-85 -68.24 161.74 26.53 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -127.79 155.75 43.57 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.53 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -142.09 103.21 4.27 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.444 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.403 HG13 ' HB3' ' A' ' 90' ' ' GLU . 6.8 t -106.74 141.96 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.03 140.47 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.678 HG23 ' HG2' ' A' ' 88' ' ' GLN . 1.2 m -120.5 138.1 54.01 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.495 ' HB2' ' CD2' ' A' ' 3' ' ' LEU . . . -89.22 -174.27 4.35 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.11 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -73.47 -58.3 3.4 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.396 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -63.68 -22.78 67.08 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 120.9 19.77 3.58 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-O 119.785 -0.453 . . . . 0.0 113.811 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.549 ' O ' HD11 ' A' ' 3' ' ' LEU . 93.7 m -84.68 109.05 17.73 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.678 ' HG2' HG23 ' A' ' 82' ' ' THR . 22.8 mt-30 -101.93 130.82 48.52 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.516 ' HB2' HD12 ' A' ' 3' ' ' LEU . 7.3 t -122.2 113.98 20.21 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.403 ' HB3' HG13 ' A' ' 80' ' ' VAL . 6.2 pt-20 -108.68 -177.84 3.43 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.402 ' HB1' HG13 ' A' ' 7' ' ' ILE . . . -150.16 170.44 18.93 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.325 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.45 154.76 39.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.742 0.306 . . . . 0.0 111.113 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.66 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.1 p -143.2 121.04 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.963 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.643 ' HA ' HD13 ' A' ' 76' ' ' ILE . 7.0 t30 -76.85 95.62 4.12 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.845 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.428 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 20.2 t -97.07 108.12 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.524 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -90.46 149.97 22.01 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.599 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.589 HD12 ' N ' ' A' ' 74' ' ' ALA . 9.8 mt -146.56 115.41 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.731 0.3 . . . . 0.0 110.424 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.17 134.2 55.07 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.961 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.82 179.87 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.427 HD12 HG22 ' A' ' 87' ' ' THR . 16.2 mt . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.594 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -139.39 141.73 37.54 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.746 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 t -149.38 143.32 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 O-C-N 123.253 0.346 . . . . 0.0 110.867 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -160.07 127.07 4.44 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.771 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' A' ' 79' ' ' CYS . 45.7 mt -99.74 138.63 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.367 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.7 t -128.49 135.48 27.63 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.671 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.429 ' O ' HG23 ' A' ' 93' ' ' VAL . 91.4 Cg_endo -77.23 170.26 71.93 Favored 'Cis proline' 0 C--N 1.366 1.492 0 C-N-CA 124.767 -0.93 . . . . 0.0 111.815 -0.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.2 p -66.63 -45.08 80.21 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.809 0.338 . . . . 0.0 110.323 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -131.8 110.86 11.15 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.398 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -111.54 97.94 0.98 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.756 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.805 ' O ' HD13 ' A' ' 14' ' ' ILE . 16.2 mt-10 -78.62 134.44 37.18 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.805 HD13 ' O ' ' A' ' 13' ' ' GLU . 4.3 mm -136.84 170.01 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.401 -178.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.492 ' H ' HG22 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -119.03 156.68 29.22 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.18 137.81 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.53 -8.75 78.49 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.6 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.426 ' HB2' HG22 ' A' ' 14' ' ' ILE . 4.0 mm-40 -100.03 155.05 17.92 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 117.302 0.551 . . . . 0.0 109.751 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.1 p -98.62 163.53 12.62 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.582 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -164.16 119.52 1.54 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -178.137 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.772 ' HB3' HG23 ' A' ' 65' ' ' THR . 31.5 p90 -112.97 141.4 46.84 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.601 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.644 ' CD2' HG21 ' A' ' 93' ' ' VAL . 94.7 m-85 -117.79 118.49 32.17 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.839 0.352 . . . . 0.0 111.205 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.94 115.07 18.39 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.9 t -99.6 94.89 6.62 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.355 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -88.91 158.75 17.97 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.744 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.661 HG21 ' CB ' ' A' ' 60' ' ' ASP . 32.1 m -138.49 171.77 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.233 0.208 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.51 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.638 ' C ' HD12 ' A' ' 35' ' ' ILE . 11.2 m-20 . . . . . 0 N--CA 1.461 0.081 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.638 HD12 ' C ' ' A' ' 34' ' ' ASP . 3.6 mp -127.9 146.83 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 123.373 0.421 . . . . 0.0 110.787 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 m -144.47 158.94 43.51 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.308 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.457 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 55.4 m95 -133.7 128.02 34.09 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.04 0.212 . . . . 0.0 110.44 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 94.0 m-85 -116.6 117.98 31.36 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.7 p -66.61 149.43 98.19 Favored Pre-proline 0 C--O 1.247 0.932 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.477 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo . . . . . 0 C--N 1.378 2.112 0 C-N-CA 124.741 3.627 . . . . 0.0 115.516 -178.955 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 31.0 tttt . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 pp -109.42 143.62 38.76 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.58 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.9 m -84.24 157.11 62.73 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.219 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.64 -27.6 3.97 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.444 2.096 . . . . 0.0 112.731 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -118.34 65.86 0.76 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.369 0.604 . . . . 0.0 110.025 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.11 -59.7 1.31 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.564 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -140.95 -162.21 1.33 Allowed 'General case' 0 CA--C 1.54 0.575 0 O-C-N 123.008 0.193 . . . . 0.0 110.508 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -51.76 -23.06 4.11 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.664 HG23 HG12 ' A' ' 66' ' ' ILE . 46.3 mt -82.18 99.15 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.7 t -105.04 122.88 46.79 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.949 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.414 HG22 HD23 ' A' ' 64' ' ' LEU . 16.3 t -93.07 158.03 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.139 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 p -151.55 147.9 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 20.4 m-90 -122.1 114.9 21.55 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.51 -80.35 0.58 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -56.24 -176.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -51.17 -37.83 48.67 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.661 ' CB ' HG21 ' A' ' 26' ' ' VAL . 5.4 m-20 -152.78 22.68 0.59 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 p -99.6 138.89 36.05 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.554 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.1 m -143.28 134.4 25.74 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.104 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.455 HG22 ' HB2' ' A' ' 21' ' ' PHE . 1.2 m -103.11 141.05 36.5 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 111.626 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.614 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -103.66 94.32 5.39 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.324 179.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.772 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -85.96 139.59 31.07 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 123.468 0.48 . . . . 0.0 110.351 -179.278 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.664 HG12 HG23 ' A' ' 52' ' ' ILE . 67.1 mt -137.44 93.22 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -60.2 -113.88 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.473 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.21 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.81 1.186 . . . . 0.0 110.967 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.864 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -69.84 148.92 48.45 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.16 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.768 ' O ' HD12 ' A' ' 97' ' ' ILE . 12.1 m-80 -141.52 154.68 45.64 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.715 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.5 pt -53.9 -24.48 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -71.51 -40.97 69.81 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.421 ' OD1' HD11 ' A' ' 52' ' ' ILE . 77.8 m-20 -66.47 -35.53 80.5 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.885 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.568 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -51.37 107.81 0.21 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.69 -179.35 47.81 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.446 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.59 HD13 ' HA ' ' A' ' 94' ' ' ASN . 32.2 mm -82.18 95.22 3.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.588 0.194 . . . . 0.0 111.006 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.614 ' CD2' HD11 ' A' ' 64' ' ' LEU . 70.0 m-85 -71.76 160.12 33.16 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -128.09 158.15 38.78 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.908 0.385 . . . . 0.0 111.563 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.533 ' HB2' HD11 ' A' ' 7' ' ' ILE . 9.5 t -138.93 99.86 3.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 89' ' ' SER . 4.4 t -109.8 126.33 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 121.066 0.46 . . . . 0.0 112.116 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.503 HG22 HG13 ' A' ' 35' ' ' ILE . 2.3 t -102.72 155.1 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.699 HG23 ' HB3' ' A' ' 88' ' ' GLN . 0.5 OUTLIER -132.66 143.45 49.66 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.13 176.5 6.95 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.371 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.94 -40.77 87.66 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.199 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.8 -36.24 28.63 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.392 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 150.06 -18.15 1.07 Allowed Glycine 0 C--N 1.339 0.75 0 CA-C-O 119.556 -0.58 . . . . 0.0 113.813 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.427 HG22 HD12 ' A' ' 3' ' ' LEU . 55.7 m -58.52 103.46 0.16 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.876 0.838 . . . . 0.0 110.702 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.699 ' HB3' HG23 ' A' ' 82' ' ' THR . 2.1 pt20 -109.39 132.54 54.03 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.796 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.497 ' O ' HG13 ' A' ' 80' ' ' VAL . 66.1 p -99.65 -176.86 3.39 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -161.3 175.51 12.19 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -159.7 176.42 12.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.127 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.2 163.86 39.61 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.644 HG21 ' CD2' ' A' ' 22' ' ' PHE . 8.5 p -152.63 123.11 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.75 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.59 ' HA ' HD13 ' A' ' 76' ' ' ILE . 1.9 t-20 -80.97 96.03 6.96 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.988 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.433 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 14.0 t -97.94 123.59 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.531 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -108.53 160.28 16.04 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.911 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.864 HD13 ' HB1' ' A' ' 69' ' ' ALA . 12.0 mt -151.58 125.74 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.684 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -116.58 127.98 54.99 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.342 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.735 -179.873 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.493 HD11 ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 120.803 0.335 . . . . 0.0 110.957 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.722 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 9.2 tp-100 -127.18 148.37 50.18 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.422 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 t -145.76 147.23 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 123.12 0.262 . . . . 0.0 111.445 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -160.3 126.2 4.09 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.323 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.516 HD11 ' HB2' ' A' ' 79' ' ' CYS . 43.7 mt -97.28 139.48 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.656 0.265 . . . . 0.0 110.648 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.6 t -128.17 130.86 23.55 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.942 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.56 172.03 64.51 Favored 'Cis proline' 0 C--N 1.365 1.443 0 CA-C-N 119.73 0.939 . . . . 0.0 112.377 -0.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 p -69.83 -53.2 19.23 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.337 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -129.96 107.61 9.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.211 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.41 158.97 24.81 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 116.077 -0.51 . . . . 0.0 113.545 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -143.37 119.5 10.76 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.13 164.24 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.711 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.97 157.62 16.73 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 69' ' ' ALA . 38.9 t -63.69 138.49 22.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.87 -15.18 63.68 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.436 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -99.04 162.63 12.96 Favored 'General case' 0 C--N 1.348 0.511 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.1 p -102.73 168.35 9.31 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.639 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -163.94 121.44 1.77 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.483 -178.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.753 ' HB3' HG23 ' A' ' 65' ' ' THR . 35.7 p90 -115.05 142.29 46.84 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.622 178.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.644 ' CD2' HG21 ' A' ' 93' ' ' VAL . 93.4 m-85 -118.42 118.4 31.64 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.004 0.43 . . . . 0.0 111.283 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.0 tp -79.21 116.44 19.48 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.9 t -97.93 100.65 12.01 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.404 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 -91.4 158.78 16.32 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.777 HG21 ' CB ' ' A' ' 60' ' ' ASP . 34.1 m -134.86 174.36 13.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.722 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.234 0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.764 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.551 ' O ' HG22 ' A' ' 81' ' ' VAL . 54.7 m-20 . . . . . 0 N--CA 1.466 0.331 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.518 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.2 mp -130.21 153.39 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 123.318 0.386 . . . . 0.0 110.856 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.2 m -152.31 160.63 43.3 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.34 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.463 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 59.1 m95 -132.63 130.82 40.68 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.216 0.206 . . . . 0.0 110.792 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 67.3 m-85 -122.12 117.96 27.53 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.9 p -62.51 152.85 79.42 Favored Pre-proline 0 C--O 1.253 1.285 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.425 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 C--N 1.38 2.235 0 C-N-CA 124.472 3.448 . . . . 0.0 115.947 -178.77 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 19.1 tttt . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 120.549 0.214 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 45' ' ' LEU . 1.0 OUTLIER -111.12 152.69 26.68 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.605 179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 m -79.36 163.05 61.36 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.341 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.22 -28.06 12.99 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.66 2.24 . . . . 0.0 112.696 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -139.41 72.99 1.41 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.13 0.491 . . . . 0.0 111.009 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -80.61 -68.76 0.65 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.992 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -156.67 -72.73 0.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -99.74 -35.85 9.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.426 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.539 HG12 HG23 ' A' ' 66' ' ' ILE . 48.7 mt -85.7 110.33 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.777 0.322 . . . . 0.0 110.78 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.3 t -114.49 118.66 34.4 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.659 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 55' ' ' VAL . 12.6 t -90.33 158.78 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.268 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.41 ' N ' HG12 ' A' ' 54' ' ' VAL . 12.3 p -153.99 152.09 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.963 0.411 . . . . 0.0 111.64 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 24.8 m-90 -123.16 104.56 9.25 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -91.16 -80.77 0.33 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -176.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -65.26 -177.92 0.44 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.41 0.148 . . . . 0.0 110.912 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.94 -33.73 62.53 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.777 ' CB ' HG21 ' A' ' 26' ' ' VAL . 45.3 m-20 -141.43 7.4 1.94 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.9 p -94.52 136.41 34.85 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.282 0.492 . . . . 0.0 110.459 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.518 ' OG ' HG21 ' A' ' 35' ' ' ILE . 0.7 OUTLIER -140.93 132.99 27.85 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.372 -178.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 m -102.89 146.3 28.51 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 111.921 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.622 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -111.47 94.95 5.23 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.532 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.753 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -85.18 142.49 29.43 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.822 0.344 . . . . 0.0 110.274 -179.534 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.539 HG23 HG12 ' A' ' 52' ' ' ILE . 67.9 mt -139.53 90.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -59.57 -113.46 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.304 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -53.28 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.968 1.258 . . . . 0.0 111.154 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.877 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -75.63 143.0 42.5 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.294 -178.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.757 ' O ' HD12 ' A' ' 97' ' ' ILE . 9.9 m-80 -136.11 153.49 51.28 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.689 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.492 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -52.67 -25.68 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -71.21 -42.15 69.31 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.432 ' OD2' HD11 ' A' ' 52' ' ' ILE . 4.6 m-20 -62.99 -34.72 78.14 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.678 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.535 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -53.28 112.03 0.8 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.67 179.06 47.69 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.547 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.828 HD13 ' HA ' ' A' ' 94' ' ' ASN . 23.4 mm -80.72 95.5 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 122.051 0.14 . . . . 0.0 111.175 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.622 ' CD2' HD11 ' A' ' 64' ' ' LEU . 61.0 m-85 -71.95 167.08 20.85 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -132.03 158.16 42.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 112.258 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.516 ' HB2' HD11 ' A' ' 7' ' ' ILE . 4.2 t -140.12 100.39 3.9 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.304 178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 89' ' ' SER . 5.2 t -107.67 129.7 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 111.872 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 34' ' ' ASP . 1.6 t -108.2 156.41 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.55 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.9 m -132.78 149.11 52.31 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.28 -173.65 3.14 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.692 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.69 -48.47 21.88 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.116 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.27 -37.81 71.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.23 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 150.0 -18.54 1.08 Allowed Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.06 -0.59 . . . . 0.0 113.86 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.493 ' O ' HD11 ' A' ' 3' ' ' LEU . 96.2 m -57.92 108.3 0.57 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.859 0.829 . . . . 0.0 110.582 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.55 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -113.53 134.55 54.62 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.265 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.569 ' O ' HG13 ' A' ' 80' ' ' VAL . 83.6 p -97.15 -177.89 4.0 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -160.53 171.76 18.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -154.51 172.83 17.17 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.009 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.79 155.76 38.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.728 0.299 . . . . 0.0 111.248 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.644 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.5 p -142.92 118.93 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.348 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.828 ' HA ' HD13 ' A' ' 76' ' ' ILE . 7.9 t30 -76.15 88.27 3.04 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.347 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.465 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 16.0 t -87.9 131.63 35.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.058 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.23 153.57 32.66 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.559 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.877 HD13 ' HB1' ' A' ' 69' ' ' ALA . 9.8 mt -145.67 128.61 10.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.563 178.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.77 133.24 53.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.358 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.929 -179.817 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.582 HD11 ' HB2' ' A' ' 83' ' ' ALA . 1.4 mp . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.798 0.332 . . . . 0.0 111.583 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.649 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 10.6 tp-100 -138.74 140.55 38.72 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.232 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.533 HG21 ' O ' ' A' ' 89' ' ' SER . 11.4 t -144.92 141.25 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.672 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -157.37 124.82 5.25 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.587 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.516 HD11 ' HB2' ' A' ' 79' ' ' CYS . 48.6 mt -92.39 143.66 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.594 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.6 t -131.11 133.03 24.18 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.887 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.24 169.99 73.05 Favored 'Cis proline' 0 C--N 1.363 1.303 0 CA-C-N 119.719 0.935 . . . . 0.0 112.029 0.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.4 p -68.2 -42.15 80.3 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -133.47 111.87 11.08 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.289 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.451 ' O ' HD12 ' A' ' 14' ' ' ILE . . . -106.2 100.39 1.64 Allowed Glycine 0 C--N 1.341 0.855 0 C-N-CA 120.895 -0.669 . . . . 0.0 114.251 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.51 ' C ' HD12 ' A' ' 14' ' ' ILE . 0.8 OUTLIER -85.64 128.91 34.91 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.51 HD12 ' C ' ' A' ' 13' ' ' GLU . 5.0 mp -144.53 162.92 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.662 0.268 . . . . 0.0 110.733 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.17 156.45 17.7 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.729 0.3 . . . . 0.0 110.367 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.647 HG13 ' O ' ' A' ' 69' ' ' ALA . 28.4 t -62.91 138.55 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.999 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.1 -15.75 62.47 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.343 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -97.16 159.17 15.07 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.0 p -97.36 164.47 12.45 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.647 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -159.31 116.62 2.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -177.192 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.879 ' HB3' HG23 ' A' ' 65' ' ' THR . 39.1 p90 -111.52 143.28 42.63 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.64 0.257 . . . . 0.0 111.143 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.523 ' CZ ' HG22 ' A' ' 95' ' ' VAL . 85.5 m-85 -120.72 110.02 15.88 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.5 tp -77.56 112.53 14.44 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.2 t -94.05 108.17 20.02 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.208 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -96.88 155.37 16.8 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.755 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.62 HG21 ' CB ' ' A' ' 60' ' ' ASP . 30.1 m -129.24 175.49 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.649 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 CA--C 1.532 0.281 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.828 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.469 0.524 0 CA-C-O 120.357 0.122 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.634 HD11 ' HA ' ' A' ' 60' ' ' ASP . 4.2 mp -66.77 150.01 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.209 0.528 . . . . 0.0 112.115 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.3 m -150.46 155.54 39.72 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.463 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.478 ' O ' ' HA ' ' A' ' 44' ' ' LYS . 43.8 m95 -134.86 117.92 16.41 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 119.239 -0.41 . . . . 0.0 111.136 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -117.5 109.83 17.22 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.287 0.367 . . . . 0.0 111.885 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 p -59.89 154.67 47.11 Favored Pre-proline 0 C--O 1.246 0.905 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.941 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo . . . . . 0 C--N 1.383 2.385 1 C-N-CA 125.696 4.264 . . . . 0.0 114.618 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 27.9 tttt . . . . . 0 N--CA 1.466 0.367 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.472 HD13 HG21 ' A' ' 52' ' ' ILE . 12.2 mt -77.95 175.9 9.62 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.587 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.5 m -94.28 156.11 39.17 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.884 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.91 -34.53 90.94 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.322 2.015 . . . . 0.0 112.5 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -152.69 63.6 0.8 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.229 0.538 . . . . 0.0 110.568 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.11 -73.58 0.12 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.577 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -147.84 -74.51 0.19 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.638 0.256 . . . . 0.0 110.782 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -99.35 -36.62 9.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.758 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.579 HG12 HG23 ' A' ' 66' ' ' ILE . 18.0 mt -84.64 104.96 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.936 0.398 . . . . 0.0 110.796 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.3 t -107.56 120.34 41.92 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.838 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.2 t -90.99 159.1 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.6 p -151.63 146.43 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.96 0.409 . . . . 0.0 111.839 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 23.1 m-90 -121.38 106.59 11.59 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -98.72 -79.97 0.47 Allowed 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -62.64 -177.63 0.16 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.653 0.263 . . . . 0.0 111.628 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -50.25 -35.92 28.97 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.634 ' HA ' HD11 ' A' ' 35' ' ' ILE . 42.0 m-20 -149.37 17.89 0.94 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.9 t -98.06 139.07 34.42 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.563 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -145.71 131.28 18.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -178.311 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.87 151.96 19.69 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.043 0.449 . . . . 0.0 111.958 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.605 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -114.25 92.9 4.12 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.879 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -87.43 139.99 29.99 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 123.382 0.426 . . . . 0.0 110.614 -179.027 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.579 HG23 HG12 ' A' ' 52' ' ' ILE . 49.3 mt -136.84 93.9 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -58.36 -107.59 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 119.049 -0.5 . . . . 0.0 111.251 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.42 95.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.796 1.18 . . . . 0.0 110.591 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.791 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -79.77 149.74 31.0 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.676 -178.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.764 ' O ' HD12 ' A' ' 97' ' ' ILE . 1.1 p30 -146.37 157.42 43.78 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.174 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.7 pt -53.86 -24.68 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -71.68 -39.87 69.95 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -67.07 -35.93 80.9 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.591 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -50.36 117.57 2.48 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.97 174.87 38.52 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.023 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.851 HD13 ' HA ' ' A' ' 94' ' ' ASN . 17.6 mm -73.75 91.27 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 122.18 0.192 . . . . 0.0 111.271 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.605 ' CD2' HD11 ' A' ' 64' ' ' LEU . 63.3 m-85 -68.43 172.6 5.83 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -135.32 158.21 44.95 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.516 ' HB2' HD11 ' A' ' 7' ' ' ILE . 12.3 t -142.0 97.78 3.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.149 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 90' ' ' GLU . 4.6 t -102.85 131.65 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.0 0.429 . . . . 0.0 111.931 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.87 139.84 43.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.643 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.9 m -125.71 143.99 50.8 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.582 ' HB2' HD11 ' A' ' 3' ' ' LEU . . . -93.26 -176.13 4.04 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.958 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -69.76 -57.41 5.14 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.076 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -60.55 -31.78 70.87 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 138.84 -18.85 3.16 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.477 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.8 m -59.55 107.81 0.64 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.335 0.568 . . . . 0.0 111.199 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.643 ' HB3' HG23 ' A' ' 82' ' ' THR . 1.1 pt20 -115.2 134.14 55.41 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.444 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.533 ' O ' HG21 ' A' ' 5' ' ' VAL . 31.8 t -115.12 119.76 37.5 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.458 ' HB3' HG13 ' A' ' 80' ' ' VAL . 18.6 pt-20 -104.63 -179.62 4.0 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -154.06 178.06 10.38 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.132 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.04 154.85 36.78 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.592 0.234 . . . . 0.0 111.051 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.505 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.2 p -138.86 123.17 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.965 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.851 ' HA ' HD13 ' A' ' 76' ' ' ILE . 6.0 t30 -75.2 96.91 3.39 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.26 0.553 . . . . 0.0 110.261 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.523 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 60.8 t -96.71 131.96 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.441 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -121.4 147.63 45.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.383 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.791 HD13 ' HB1' ' A' ' 69' ' ' ALA . 13.1 mt -141.25 137.22 33.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.22 134.01 37.68 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.948 -177.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.472 ' HB3' HG21 ' A' ' 16' ' ' VAL . 4.7 pt20 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.305 -0.855 . . . . 0.0 110.94 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.3 tp . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 120.658 0.266 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.649 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -135.85 136.47 40.61 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.654 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -143.77 142.66 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.46 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -156.43 158.83 37.99 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.127 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.421 HD11 ' HB2' ' A' ' 79' ' ' CYS . 50.9 mt -128.13 138.71 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.8 128.1 24.98 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.269 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.448 ' O ' HG23 ' A' ' 93' ' ' VAL . 98.5 Cg_endo -80.37 173.79 50.97 Favored 'Cis proline' 0 C--N 1.366 1.498 0 CA-C-N 119.68 0.922 . . . . 0.0 112.332 -0.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.8 p -69.66 -46.5 65.98 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.69 101.96 5.9 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.46 101.75 2.61 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.786 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.85 119.95 26.72 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.588 HD13 ' CB ' ' A' ' 20' ' ' LYS . 2.4 mp -135.6 166.57 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.42 161.6 18.83 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.481 0.657 . . . . 0.0 111.962 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 69' ' ' ALA . 57.6 t -65.42 137.4 25.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.861 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.72 -18.47 57.21 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.194 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -114.76 145.22 42.34 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 117.593 0.696 . . . . 0.0 110.291 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.5 p -79.01 173.99 12.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.638 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -166.79 118.99 0.97 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.976 -178.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.646 ' HB3' HG23 ' A' ' 65' ' ' THR . 44.6 p90 -115.81 146.57 41.85 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.612 0.244 . . . . 0.0 110.831 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.648 ' CD2' HG21 ' A' ' 93' ' ' VAL . 75.9 m-85 -121.49 112.85 19.02 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.07 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.0 tp -79.12 111.26 15.16 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.5 t -92.82 110.1 21.54 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.217 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -95.31 164.73 12.71 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.871 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' ' 60' ' ' ASP . 27.5 m -142.01 170.6 12.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.649 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.233 0.235 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.252 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.904 HD13 HG23 ' A' ' 81' ' ' VAL . 13.1 mm -70.51 155.16 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.371 0.605 . . . . 0.0 111.779 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.9 m -155.11 157.66 37.82 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.275 178.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.433 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 58.7 m95 -131.82 123.69 28.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.577 0.172 . . . . 0.0 111.004 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 80.0 m-85 -116.76 113.22 22.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.9 p -62.78 152.51 82.1 Favored Pre-proline 0 C--O 1.254 1.323 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.306 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo . . . . . 0 C--N 1.381 2.265 0 C-N-CA 124.374 3.383 . . . . 0.0 115.267 -179.274 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 12.6 ttmt . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.459 0.171 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.3 pp -83.99 135.16 34.56 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.815 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.5 m -69.75 155.03 94.22 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.046 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.62 -30.57 7.72 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 122.364 2.043 . . . . 0.0 112.761 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -117.19 56.5 0.82 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.151 0.501 . . . . 0.0 111.155 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -76.01 -80.46 0.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.285 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -155.78 -72.68 0.11 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -99.74 -29.72 12.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.718 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.499 HG12 HG23 ' A' ' 66' ' ' ILE . 47.4 mt -89.36 106.01 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.811 0.338 . . . . 0.0 110.871 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 t -111.91 123.38 50.12 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.724 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 t -95.5 157.33 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -152.87 143.36 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.5 m-90 -116.41 115.02 25.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.09 -76.34 0.58 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.92 -173.41 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -48.94 -42.1 36.19 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.563 0.345 . . . . 0.0 111.818 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.533 ' HB2' HG21 ' A' ' 26' ' ' VAL . 10.4 m-20 -156.57 28.61 0.33 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.228 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.9 t -99.73 141.33 32.68 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.421 ' OG ' HG21 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -147.66 132.49 18.01 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -177.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.46 HG22 ' HB2' ' A' ' 21' ' ' PHE . 1.5 m -98.36 143.68 28.56 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.142 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.669 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -106.17 92.78 4.29 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.646 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -84.67 136.83 33.58 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 123.426 0.453 . . . . 0.0 110.745 -178.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.561 HD12 ' HD2' ' A' ' 20' ' ' LYS . 53.9 mt -134.87 91.0 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -60.46 -111.84 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 118.921 -0.562 . . . . 0.0 111.283 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.55 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.841 1.2 . . . . 0.0 110.923 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.814 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -75.59 136.71 40.5 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.04 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.781 ' O ' HD12 ' A' ' 97' ' ' ILE . 14.2 m-80 -132.86 152.63 51.81 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.127 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.401 HG21 ' NE2' ' A' ' 99' ' ' GLN . 23.0 pt -51.72 -25.11 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -68.39 -44.49 74.99 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -64.96 -35.47 81.27 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.81 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.506 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -49.79 118.31 2.78 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.43 176.48 39.36 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.064 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.3 mt -82.29 101.82 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.638 0.219 . . . . 0.0 110.892 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.669 ' CD2' HD11 ' A' ' 64' ' ' LEU . 52.0 m-85 -75.35 171.28 14.5 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -132.84 156.5 47.04 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.421 ' HB2' HD11 ' A' ' 7' ' ' ILE . 13.9 t -140.72 105.73 4.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.296 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.1 t -109.19 144.79 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.904 HG23 HD13 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -129.39 130.61 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.537 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.3 m -110.17 148.19 32.28 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.22 -178.92 4.91 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.616 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -74.33 -37.69 63.5 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.162 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -81.6 -31.08 32.67 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.422 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.92 -16.58 2.8 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-O 119.856 -0.413 . . . . 0.0 113.281 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 59.3 m -59.0 110.06 0.96 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.328 0.564 . . . . 0.0 111.23 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.537 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -120.65 134.26 55.3 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.146 179.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.4 t -121.98 133.63 54.82 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -117.25 -178.59 3.49 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.62 173.99 13.5 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.848 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.57 155.92 43.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.564 0.221 . . . . 0.0 110.87 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.648 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.2 p -140.84 115.75 6.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.746 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.8 97.36 1.37 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.453 0.471 . . . . 0.0 110.535 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.484 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 14.3 t -99.92 136.29 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.769 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -125.54 152.41 45.08 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.226 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.814 HD13 ' HB1' ' A' ' 69' ' ' ALA . 12.3 mt -139.86 110.77 4.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.357 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.56 125.35 52.44 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.353 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.401 ' NE2' HG21 ' A' ' 71' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.258 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 120.394 0.14 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.764 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 22.9 tt0 -133.33 157.74 44.73 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.591 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 89' ' ' SER . 0.9 OUTLIER -151.87 155.27 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.433 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -160.04 130.33 5.49 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.156 0.285 . . . . 0.0 110.84 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.46 HD11 ' HB3' ' A' ' 79' ' ' CYS . 28.0 mt -96.25 142.53 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.639 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.89 128.69 24.17 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.38 -176.17 17.06 Favored 'Cis proline' 0 C--N 1.365 1.396 0 CA-C-N 120.084 1.066 . . . . 0.0 112.301 0.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.1 p -76.24 -40.67 51.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.144 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -126.03 124.68 41.19 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.032 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.407 ' C ' HD12 ' A' ' 14' ' ' ILE . . . -106.06 72.53 0.22 Allowed Glycine 0 C--N 1.341 0.86 0 C-N-CA 121.142 -0.551 . . . . 0.0 114.359 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.472 ' C ' HD12 ' A' ' 14' ' ' ILE . 27.7 mt-10 -76.92 112.65 13.76 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.472 HD12 ' C ' ' A' ' 13' ' ' GLU . 2.9 mp -135.77 164.83 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.7 154.88 17.64 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.8 t -63.06 141.52 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.094 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.86 -11.0 71.86 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.463 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -101.95 153.3 20.0 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.1 p -91.45 156.55 17.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.517 0.199 . . . . 0.0 111.061 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.675 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -151.59 117.39 5.46 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.666 -177.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.84 ' HB3' HG23 ' A' ' 65' ' ' THR . 36.1 p90 -112.64 144.11 42.69 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.65 0.262 . . . . 0.0 111.12 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.635 ' CD2' HG21 ' A' ' 93' ' ' VAL . 82.6 m-85 -122.99 118.0 26.78 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.38 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.8 tp -79.26 113.8 17.69 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.436 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 23.2 t -96.6 97.56 9.49 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -92.54 162.86 14.03 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.16 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.513 HG21 ' HB2' ' A' ' 60' ' ' ASP . 35.1 m -119.31 174.86 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.764 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 CA--C 1.533 0.3 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.305 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 t70 . . . . . 0 N--CA 1.466 0.357 0 N-CA-C 111.388 0.144 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.522 ' H ' HD12 ' A' ' 35' ' ' ILE . 5.1 mp -73.84 157.41 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 O-C-N 123.476 0.485 . . . . 0.0 111.36 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.418 ' N ' HG22 ' A' ' 35' ' ' ILE . 11.6 m -155.6 162.49 40.63 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.686 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.443 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 56.5 m95 -139.94 126.68 20.56 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.873 0.108 . . . . 0.0 110.942 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 84.2 m-85 -121.98 111.68 17.35 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.766 ' OG ' HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -65.76 161.39 53.81 Favored Pre-proline 0 C--O 1.256 1.423 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.384 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo . . . . . 0 C--N 1.382 2.294 0 C-N-CA 125.298 3.999 . . . . 0.0 115.805 -179.093 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 9.7 ttpt . . . . . 0 C--O 1.234 0.256 0 CA-C-O 120.455 0.169 . . . . 0.0 111.425 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.766 HD11 ' OG ' ' A' ' 39' ' ' SER . 10.6 mt -74.37 145.67 43.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.548 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.5 m -77.42 162.14 69.9 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.776 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.15 -30.42 65.15 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 122.318 2.012 . . . . 0.0 112.432 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -141.98 75.31 1.49 Allowed 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.01 0.433 . . . . 0.0 111.032 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -76.21 -82.81 0.07 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.827 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -150.15 -72.8 0.17 Allowed 'General case' 0 C--N 1.342 0.277 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 -99.8 -33.36 10.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.504 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.697 HG12 HG23 ' A' ' 66' ' ' ILE . 21.2 mt -88.1 103.3 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.726 0.298 . . . . 0.0 110.779 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.6 t -109.28 122.14 46.7 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.255 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 55' ' ' VAL . 11.8 t -94.34 160.8 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.414 ' N ' HG12 ' A' ' 54' ' ' VAL . 7.2 p -156.99 133.99 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -109.58 114.97 29.04 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -113.94 -73.84 0.64 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -171.47 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.84 -36.16 74.1 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.59 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.513 ' HB2' HG21 ' A' ' 26' ' ' VAL . 42.3 m-20 -153.37 23.17 0.54 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.174 -0.467 . . . . 0.0 112.177 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.2 t -109.47 141.18 42.27 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.459 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.4 m -134.36 -173.77 3.37 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.342 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 m -154.91 142.15 19.45 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.011 0.434 . . . . 0.0 111.213 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.686 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -109.69 93.84 4.71 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.756 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.84 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -90.33 139.05 31.03 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.363 0.415 . . . . 0.0 110.64 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.697 HG23 HG12 ' A' ' 52' ' ' ILE . 14.7 mt -135.17 86.46 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -49.49 -65.57 0.54 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -176.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.422 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.6 OUTLIER -63.59 -66.33 0.56 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.477 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . . . 75.4 125.96 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.084 0.553 . . . . 0.0 111.37 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.768 ' O ' HD12 ' A' ' 97' ' ' ILE . 9.0 m-80 -147.16 167.37 24.32 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.4 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.8 pt -55.92 -22.98 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -75.29 -38.25 60.47 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -68.75 -32.96 73.09 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.542 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.514 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -51.95 109.17 0.34 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.06 173.42 45.59 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.742 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.7 mt -79.95 97.1 2.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.978 0.389 . . . . 0.0 110.823 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.686 ' CD2' HD11 ' A' ' 64' ' ' LEU . 58.8 m-85 -72.16 169.32 16.35 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -132.06 154.55 49.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.023 0.44 . . . . 0.0 111.777 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.46 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -138.17 103.47 4.95 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.6 t -108.36 143.33 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.26 147.15 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.634 HG23 ' HG2' ' A' ' 88' ' ' GLN . 0.5 OUTLIER -126.07 140.93 52.19 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.933 0.397 . . . . 0.0 111.751 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.24 -171.09 3.39 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.182 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -78.97 -35.62 42.75 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.458 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -88.38 -34.75 17.47 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.01 -18.94 1.22 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.77 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 62.6 m -51.17 114.61 1.25 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.499 0.65 . . . . 0.0 111.148 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.634 ' HG2' HG23 ' A' ' 82' ' ' THR . 6.9 mt-30 -106.71 138.95 41.93 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.99 0.424 . . . . 0.0 111.984 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.409 ' O ' HG21 ' A' ' 5' ' ' VAL . 6.0 p -125.97 108.0 10.99 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -104.4 177.91 4.71 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -149.38 169.7 20.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.936 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.66 152.09 37.27 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.999 0.428 . . . . 0.0 111.399 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.635 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.0 p -139.72 114.59 7.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.897 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.59 87.58 1.22 Allowed 'General case' 0 C--O 1.235 0.331 0 O-C-N 123.511 0.507 . . . . 0.0 110.34 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.415 ' CG1' ' HE2' ' A' ' 20' ' ' LYS . 18.4 t -87.4 130.08 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.396 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -115.46 158.13 22.98 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.815 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.768 HD12 ' O ' ' A' ' 70' ' ' ASN . 9.5 mt -148.25 135.19 13.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.736 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.91 129.96 52.25 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.561 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.018 -179.776 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.485 HD23 HG12 ' A' ' 81' ' ' VAL . 10.3 mp . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.629 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -133.97 141.42 47.28 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.468 178.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 89' ' ' SER . 9.6 t -148.1 144.38 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 123.169 0.293 . . . . 0.0 111.189 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -154.88 148.21 25.02 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.597 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.8 mt -122.29 108.61 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.8 t -92.74 126.41 51.92 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.552 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -83.64 175.31 37.08 Favored 'Cis proline' 0 C--N 1.364 1.353 0 CA-C-N 119.969 1.025 . . . . 0.0 112.21 -0.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.2 p -71.1 -40.23 71.63 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -141.04 118.63 11.59 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.753 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.55 105.63 1.66 Allowed Glycine 0 C--N 1.343 0.934 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.974 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.544 ' C ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -85.73 130.71 34.49 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.544 HD12 ' C ' ' A' ' 13' ' ' GLU . 3.7 mp -146.71 164.96 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.09 157.66 17.38 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.842 0.353 . . . . 0.0 110.507 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.4 t -62.07 141.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.164 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.06 -7.38 81.57 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.356 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -104.78 152.0 23.1 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 76.6 p -92.58 155.66 17.63 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.576 0.227 . . . . 0.0 110.888 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.649 ' HD2' HD12 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -154.8 119.58 4.87 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.949 -178.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.728 ' HB3' HG23 ' A' ' 65' ' ' THR . 22.2 p90 -112.47 147.77 35.81 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.913 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.667 ' CD2' HG21 ' A' ' 93' ' ' VAL . 87.6 m-85 -124.75 118.77 27.16 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.196 0.522 . . . . 0.0 111.32 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.6 HD12 ' HG3' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -77.8 130.57 36.86 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.813 -178.579 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.496 ' N ' HD13 ' A' ' 23' ' ' LEU . 18.0 t -114.48 98.46 6.91 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.6 ' HG3' HD12 ' A' ' 23' ' ' LEU . 36.6 mt-30 -88.87 157.69 18.35 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.849 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.741 HG21 ' CB ' ' A' ' 60' ' ' ASP . 24.7 m -137.89 169.9 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.234 0.269 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.47 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.595 HG21 ' OG ' ' A' ' 62' ' ' SER . 5.1 mp -72.13 147.99 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.925 0.393 . . . . 0.0 110.994 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.9 m -147.06 154.49 41.24 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.318 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.428 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 43.3 m95 -129.59 113.86 15.34 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.062 0.145 . . . . 0.0 111.24 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -113.35 110.96 21.2 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 p -59.73 154.23 47.95 Favored Pre-proline 0 C--O 1.244 0.809 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.472 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 C--N 1.379 2.176 0 C-N-CA 125.252 3.968 . . . . 0.0 113.779 -179.169 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 11.1 tttt . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 pp -80.55 148.69 30.26 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.203 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.7 m -67.46 155.47 90.92 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.33 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -83.96 -22.11 3.66 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 122.522 2.148 . . . . 0.0 113.388 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -139.4 73.39 1.43 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.282 0.563 . . . . 0.0 110.328 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -104.94 -57.38 2.03 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.924 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.51 -83.76 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.79 -32.54 11.67 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.534 HG12 HG23 ' A' ' 66' ' ' ILE . 40.6 mt -90.47 107.56 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 120.662 0.267 . . . . 0.0 110.374 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.8 t -112.77 121.63 45.27 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.587 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 55' ' ' VAL . 18.8 t -92.82 159.9 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.413 ' N ' HG12 ' A' ' 54' ' ' VAL . 7.6 p -156.22 147.13 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -125.84 123.01 37.74 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.101 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.55 -73.94 0.63 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.2 -173.14 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -53.71 -40.28 65.9 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.663 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.741 ' CB ' HG21 ' A' ' 26' ' ' VAL . 9.7 m-20 -152.6 22.91 0.61 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.948 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.75 141.31 31.72 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.595 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.8 m -135.28 -170.56 2.62 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.055 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -159.24 142.05 14.18 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.664 0.269 . . . . 0.0 110.697 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.679 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -113.15 92.76 4.12 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.902 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.728 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -86.79 138.88 31.23 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.269 0.355 . . . . 0.0 110.131 -179.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.649 HD12 ' HD2' ' A' ' 20' ' ' LYS . 40.5 mt -135.22 82.12 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -49.36 -56.81 8.29 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -176.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 3.7 t-20 -71.06 -71.69 0.24 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 68' ' ' ASN . . . 81.12 120.97 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.501 0.721 . . . . 0.0 110.679 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.806 ' O ' HD12 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -141.7 159.99 41.1 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.267 0.556 . . . . 0.0 110.564 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 30.3 pt -51.01 -25.84 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -75.14 -39.83 60.13 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -64.46 -32.55 74.23 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.929 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.526 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -53.51 106.22 0.17 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.92 178.64 48.65 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.869 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.542 HG23 ' HB ' ' A' ' 92' ' ' THR . 1.1 mp -79.21 100.49 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.915 0.357 . . . . 0.0 110.816 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.679 ' CD2' HD11 ' A' ' 64' ' ' LEU . 48.0 m-85 -72.14 172.73 9.63 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -135.3 157.5 46.75 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 6.4 t -141.18 97.93 3.27 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.634 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.616 HG13 ' HB3' ' A' ' 90' ' ' GLU . 3.5 t -104.24 132.54 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.485 HG12 HD23 ' A' ' 3' ' ' LEU . 0.7 OUTLIER -112.29 139.96 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.73 HG23 ' HG2' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -127.68 132.91 49.61 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -179.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.5 -176.06 5.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.441 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -72.26 -52.78 14.8 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.158 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -63.77 -29.33 70.55 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.86 0.85 5.99 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.59 -0.561 . . . . 0.0 114.225 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.8 m -65.95 113.74 4.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.807 0.804 . . . . 0.0 110.019 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.73 ' HG2' HG23 ' A' ' 82' ' ' THR . 4.3 mt-30 -105.46 145.64 30.59 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.873 0.368 . . . . 0.0 111.658 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.435 ' O ' HG21 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -144.7 107.41 4.45 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.25 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.616 ' HB3' HG13 ' A' ' 80' ' ' VAL . 13.7 pt-20 -109.01 -179.28 3.81 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -151.49 176.11 11.63 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.193 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.542 ' HB ' HG23 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -147.13 155.89 42.53 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.633 0.254 . . . . 0.0 111.138 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.667 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.9 p -139.6 117.81 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.205 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -71.6 93.32 1.22 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.814 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.469 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 14.6 t -95.48 116.59 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.621 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -101.91 150.33 23.3 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.292 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.806 HD12 ' O ' ' A' ' 70' ' ' ASN . 8.5 mt -141.59 130.93 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.221 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -117.77 129.12 55.49 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.028 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.191 -179.547 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 C--O 1.239 0.537 0 CA-C-O 121.157 0.503 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.637 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -85.21 139.51 31.6 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.545 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 89' ' ' SER . 11.6 t -145.78 135.02 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 123.419 0.449 . . . . 0.0 110.105 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -154.34 121.73 5.75 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.628 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.4 HD11 ' CB ' ' A' ' 79' ' ' CYS . 48.4 mt -89.74 138.94 18.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.35 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.4 t -122.96 129.4 24.99 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.086 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.463 ' O ' HG23 ' A' ' 93' ' ' VAL . 92.5 Cg_endo -79.63 166.61 77.35 Favored 'Cis proline' 0 C--N 1.364 1.362 0 CA-C-N 119.655 0.913 . . . . 0.0 112.105 -0.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 p -64.06 -41.17 97.46 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.133 0.492 . . . . 0.0 109.92 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -133.96 110.81 9.93 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.755 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.8 102.01 1.52 Allowed Glycine 0 C--N 1.341 0.859 0 C-N-CA 121.008 -0.615 . . . . 0.0 114.44 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.549 ' C ' HD12 ' A' ' 14' ' ' ILE . 13.6 mt-10 -87.82 134.93 33.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.549 HD12 ' C ' ' A' ' 13' ' ' GLU . 4.4 mp -146.48 163.64 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.653 0.263 . . . . 0.0 110.47 -178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.21 154.58 18.64 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.542 HG21 ' HB3' ' A' ' 99' ' ' GLN . 46.3 t -63.09 138.27 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.95 -7.91 78.52 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.522 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -103.03 155.82 18.11 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 117.49 0.645 . . . . 0.0 109.418 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.2 p -92.95 159.46 15.32 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 123.081 0.238 . . . . 0.0 110.784 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.57 ' HZ1' HD11 ' A' ' 97' ' ' ILE . 0.4 OUTLIER -156.24 119.99 4.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.662 -177.258 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.855 ' HB3' HG23 ' A' ' 65' ' ' THR . 49.0 p90 -114.72 140.24 49.03 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.506 0.193 . . . . 0.0 110.795 178.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.461 ' CD2' HG21 ' A' ' 93' ' ' VAL . 84.8 m-85 -117.12 110.64 18.43 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.312 0.577 . . . . 0.0 110.512 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.0 tp -79.03 107.16 11.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.206 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.8 t -89.79 106.3 18.38 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.041 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -95.17 165.5 12.37 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.725 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.9 m -141.95 173.23 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.637 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.235 0.3 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.017 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 19.6 t0 . . . . . 0 N--CA 1.462 0.147 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.662 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.1 mp -126.93 150.29 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 123.245 0.341 . . . . 0.0 110.865 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 57.6 m -147.81 162.82 38.47 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.024 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.43 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 56.5 m95 -138.46 134.58 34.2 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 75.6 m-85 -129.18 115.73 18.12 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.0 p -65.1 154.57 86.56 Favored Pre-proline 0 C--O 1.253 1.266 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.974 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo . . . . . 0 C--N 1.38 2.194 0 C-N-CA 124.97 3.78 . . . . 0.0 115.59 -179.228 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 9.0 tttm . . . . . 0 N--CA 1.464 0.228 0 CA-C-O 120.693 0.282 . . . . 0.0 111.382 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.56 HD23 HG21 ' A' ' 52' ' ' ILE . 0.5 OUTLIER -117.01 135.09 53.97 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.472 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.72 171.75 11.07 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.783 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.52 -39.12 2.13 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 122.651 2.234 . . . . 0.0 112.623 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -142.36 74.11 1.44 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.134 0.492 . . . . 0.0 111.613 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.69 -48.77 3.85 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -146.51 -155.6 0.64 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -24.29 3.86 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.668 HG12 HG23 ' A' ' 66' ' ' ILE . 42.3 mt -78.92 113.92 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.867 0.365 . . . . 0.0 111.046 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.9 t -118.0 117.96 30.64 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.572 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 55' ' ' VAL . 11.7 t -93.99 158.81 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.413 ' N ' HG12 ' A' ' 54' ' ' VAL . 12.3 p -156.48 156.74 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 16.1 m-90 -129.99 118.93 22.36 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.58 -77.07 0.57 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -54.53 -177.72 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -51.65 -37.85 52.16 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -155.25 26.08 0.41 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.078 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.4 t -107.97 140.95 40.36 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.662 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.4 m -130.04 -171.72 2.6 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 m -155.23 138.11 15.38 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.641 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -108.31 91.53 3.68 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.284 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.855 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -85.9 146.95 26.49 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.668 HG23 HG12 ' A' ' 52' ' ' ILE . 49.6 mt -145.46 91.19 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -56.43 -107.18 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.096 0 O-C-N 123.721 0.638 . . . . 0.0 111.63 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.98 93.42 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.892 1.223 . . . . 0.0 110.335 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.791 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -76.25 159.85 30.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.205 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.75 ' O ' HD12 ' A' ' 97' ' ' ILE . 9.6 m-80 -152.36 162.89 40.52 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.26 0.552 . . . . 0.0 111.323 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 27.4 pt -55.39 -26.4 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.791 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -69.84 -40.51 75.78 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.281 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.02 -32.31 73.43 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.426 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.505 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -54.54 106.33 0.2 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.49 173.44 44.63 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.2 mt -78.42 98.04 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.812 0.306 . . . . 0.0 111.262 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.641 ' CD2' HD11 ' A' ' 64' ' ' LEU . 64.3 m-85 -72.37 173.25 9.01 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 155.68 50.25 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.4 ' CB ' HD11 ' A' ' 7' ' ' ILE . 47.3 t -136.44 96.18 3.31 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.585 HG13 ' HB3' ' A' ' 90' ' ' GLU . 11.7 t -101.28 126.74 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.954 0.407 . . . . 0.0 111.557 -178.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 34' ' ' ASP . 2.3 t -106.72 147.85 11.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.482 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.2 m -127.76 150.7 49.69 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.05 -178.39 5.43 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.865 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -72.08 -34.6 68.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.343 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -90.33 -39.37 12.76 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.491 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.38 -25.17 0.28 Allowed Glycine 0 C--N 1.34 0.8 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.885 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.5 m -55.14 108.1 0.38 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 117.387 0.593 . . . . 0.0 111.99 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.482 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.7 OUTLIER -113.1 136.5 52.64 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.466 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.472 ' O ' HG21 ' A' ' 5' ' ' VAL . 2.8 t -119.89 117.65 28.69 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.585 ' HB3' HG13 ' A' ' 80' ' ' VAL . 9.0 pt-20 -105.53 -179.41 3.93 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -176.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.63 174.65 13.71 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.532 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.27 155.36 43.81 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.576 0.227 . . . . 0.0 111.251 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 9' ' ' PRO . 7.8 p -138.57 116.51 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.119 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -72.83 98.43 2.43 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 123.416 0.447 . . . . 0.0 110.763 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.4 t -98.35 124.5 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.238 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -109.31 152.64 24.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.928 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.791 HD13 ' HB1' ' A' ' 69' ' ' ALA . 9.1 mt -146.67 139.27 19.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.071 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.99 133.03 29.5 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.729 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.542 ' HB3' HG21 ' A' ' 16' ' ' VAL . 6.5 pt20 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.171 -0.919 . . . . 0.0 111.016 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 tp . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.651 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 10.4 tp-100 -118.28 144.83 45.51 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.772 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -145.69 143.74 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.626 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -160.19 131.62 5.9 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.407 HD11 ' HB2' ' A' ' 79' ' ' CYS . 40.3 mt -104.06 136.99 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.727 0.299 . . . . 0.0 110.768 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.61 130.97 24.44 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.059 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.448 ' O ' HG23 ' A' ' 93' ' ' VAL . 84.2 Cg_endo -78.81 170.27 69.93 Favored 'Cis proline' 0 C--N 1.364 1.386 0 CA-C-N 119.549 0.875 . . . . 0.0 112.07 -0.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 p -67.67 -44.02 78.82 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.102 0.477 . . . . 0.0 109.819 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -131.26 105.47 7.67 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.569 ' O ' HD12 ' A' ' 14' ' ' ILE . . . -102.76 97.33 1.51 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 121.156 -0.545 . . . . 0.0 114.331 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -83.92 131.13 34.88 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.569 HD12 ' O ' ' A' ' 12' ' ' GLY . 3.4 mp -141.69 165.0 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 123.049 0.218 . . . . 0.0 110.701 -178.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.83 153.61 22.75 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.098 0.475 . . . . 0.0 110.848 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 69' ' ' ALA . 21.3 t -66.36 134.84 29.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.344 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.97 -15.83 56.37 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.228 -177.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -115.86 149.24 38.95 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 117.661 0.73 . . . . 0.0 110.098 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.8 p -78.13 174.71 10.86 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.58 ' HZ1' HD11 ' A' ' 97' ' ' ILE . 1.3 ptmm? -165.34 118.37 1.19 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.965 -177.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.72 ' HB3' HG23 ' A' ' 65' ' ' THR . 44.1 p90 -117.93 147.18 43.39 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.7 0.286 . . . . 0.0 111.13 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.593 ' CD2' HG21 ' A' ' 93' ' ' VAL . 76.3 m-85 -123.83 112.72 17.63 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.869 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.4 tp -79.21 112.97 16.95 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.5 t -95.2 100.48 12.27 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.71 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -92.28 160.45 15.13 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.525 HG21 ' HB2' ' A' ' 60' ' ' ASP . 34.8 m -139.99 165.71 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.651 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.235 0.342 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.232 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 111.173 0.064 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.751 HD11 ' HA ' ' A' ' 60' ' ' ASP . 4.4 mp -71.08 156.36 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 123.493 0.496 . . . . 0.0 111.657 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.418 ' N ' HG22 ' A' ' 35' ' ' ILE . 75.2 m -152.76 160.13 43.12 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.727 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.421 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 52.3 m95 -137.4 118.69 14.61 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.143 0.177 . . . . 0.0 110.662 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 96.5 m-85 -112.63 113.03 24.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 80.3 p -63.28 150.67 88.77 Favored Pre-proline 0 C--O 1.245 0.834 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.043 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo . . . . . 0 C--N 1.38 2.222 1 C-N-CA 125.397 4.065 . . . . 0.0 115.927 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 5.1 ttpt . . . . . 0 N--CA 1.468 0.439 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.406 HD11 ' CG2' ' A' ' 54' ' ' VAL . 4.0 pp -103.14 141.12 36.4 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.96 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m -75.61 158.03 83.57 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.799 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -90.04 19.65 1.17 Allowed 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.592 2.195 . . . . 0.0 113.8 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -155.73 34.26 0.35 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.735 0.303 . . . . 0.0 111.034 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -69.14 -70.4 0.28 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.696 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -154.89 -78.62 0.09 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -100.08 -35.11 9.8 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.717 0.407 . . . . 0.0 111.734 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.581 HG12 HG23 ' A' ' 66' ' ' ILE . 17.1 mt -78.02 97.82 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 123.224 0.328 . . . . 0.0 110.714 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 t -108.65 122.48 47.2 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.797 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 55' ' ' VAL . 21.7 t -94.81 159.88 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.418 ' N ' HG12 ' A' ' 54' ' ' VAL . 7.7 p -154.63 136.22 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.166 0.508 . . . . 0.0 111.634 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -109.91 110.59 21.59 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -100.63 -76.19 0.56 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -175.37 0.11 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.35 0.119 . . . . 0.0 110.972 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -57.16 -36.61 70.97 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.26 0.224 . . . . 0.0 111.519 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.751 ' HA ' HD11 ' A' ' 35' ' ' ILE . 67.2 m-20 -145.74 16.22 1.43 Allowed 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 p -102.44 141.01 35.96 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.482 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.9 m -135.88 -168.52 2.23 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.891 -0.141 . . . . 0.0 110.902 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.7 m -157.91 140.95 15.05 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.893 0.378 . . . . 0.0 110.779 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.694 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -109.49 91.2 3.55 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.36 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.72 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -86.87 142.86 27.74 Favored 'General case' 0 C--N 1.333 -0.135 0 O-C-N 123.463 0.477 . . . . 0.0 109.793 -179.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.581 HG23 HG12 ' A' ' 52' ' ' ILE . 60.1 mt -141.19 94.84 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -60.64 -111.95 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.157 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.0 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.089 1.313 . . . . 0.0 110.699 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.776 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -77.6 153.06 33.6 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.367 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.733 ' O ' HD12 ' A' ' 97' ' ' ILE . 8.6 m-80 -149.99 161.4 42.41 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.493 0.663 . . . . 0.0 111.202 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.7 pt -55.48 -23.55 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.198 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -71.36 -41.28 69.94 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.44 -34.42 77.17 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.83 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.52 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -51.25 114.54 1.24 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.84 174.06 42.07 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.11 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.9 mt -81.81 100.54 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.734 0.267 . . . . 0.0 110.418 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.694 ' CD2' HD11 ' A' ' 64' ' ' LEU . 65.4 m-85 -75.67 171.77 13.76 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -134.76 157.73 45.96 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.885 0.374 . . . . 0.0 111.885 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.407 ' HB2' HD11 ' A' ' 7' ' ' ILE . 14.7 t -140.14 113.14 8.22 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 89' ' ' SER . 12.7 t -119.08 137.93 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.902 0.382 . . . . 0.0 111.94 -178.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.9 134.89 64.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.677 HG23 ' HB3' ' A' ' 88' ' ' GLN . 2.0 m -115.48 150.07 37.07 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.78 -175.01 2.94 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.296 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -71.24 -57.84 4.11 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.389 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.34 -28.65 70.15 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.46 -10.03 4.05 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 119.568 -0.573 . . . . 0.0 113.743 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 38.3 m -62.11 107.04 0.81 Allowed 'General case' 0 C--N 1.345 0.394 0 CA-C-N 117.793 0.796 . . . . 0.0 110.938 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.677 ' HB3' HG23 ' A' ' 82' ' ' THR . 4.2 pt20 -121.9 130.12 53.1 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.182 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.522 ' O ' HG13 ' A' ' 80' ' ' VAL . 7.6 t -102.47 177.39 4.88 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -154.53 179.2 9.26 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -158.25 171.56 19.98 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.284 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.6 155.1 42.22 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.737 0.303 . . . . 0.0 111.17 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.593 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.3 p -140.57 116.54 7.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.693 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -70.8 96.86 1.3 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.8 t -99.21 129.67 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.597 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.5 155.25 31.16 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.096 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.776 HD13 ' HB1' ' A' ' 69' ' ' ALA . 10.6 mt -147.93 125.37 3.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.646 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.42 137.08 53.99 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.284 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.072 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.638 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -150.65 142.65 23.97 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.417 179.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 89' ' ' SER . 8.4 t -148.02 141.35 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 123.15 0.281 . . . . 0.0 110.452 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -159.62 124.84 4.09 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.367 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.612 HD11 ' HB2' ' A' ' 79' ' ' CYS . 50.2 mt -91.77 141.33 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.892 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.8 t -126.74 128.27 24.3 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.146 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -79.11 173.88 53.36 Favored 'Cis proline' 0 C--N 1.365 1.44 0 CA-C-N 119.885 0.995 . . . . 0.0 112.076 -0.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 93.6 p -71.36 -47.21 57.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.621 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -128.52 102.83 6.8 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.08 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.02 99.27 1.68 Allowed Glycine 0 C--N 1.341 0.807 0 CA-C-N 116.202 -0.453 . . . . 0.0 114.19 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.509 ' C ' HD12 ' A' ' 14' ' ' ILE . 6.4 mt-10 -83.24 143.56 30.35 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.664 HG23 ' HG3' ' A' ' 18' ' ' GLU . 1.2 mp -150.32 158.57 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.692 0.282 . . . . 0.0 111.192 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.72 152.63 20.25 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.792 HG13 ' O ' ' A' ' 69' ' ' ALA . 50.1 t -68.11 127.45 29.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.29 -14.16 25.7 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.841 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.664 ' HG3' HG23 ' A' ' 14' ' ' ILE . 5.0 pt-20 -115.21 145.41 42.44 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 117.506 0.653 . . . . 0.0 110.286 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.6 p -81.7 171.53 14.47 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.579 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -164.02 120.98 1.7 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.584 -178.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.721 ' HB3' HG23 ' A' ' 65' ' ' THR . 43.1 p90 -114.21 143.59 44.59 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.626 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.633 ' CD2' HG21 ' A' ' 93' ' ' VAL . 87.2 m-85 -119.63 115.72 24.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.059 0.457 . . . . 0.0 111.214 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp -79.43 111.62 15.87 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.3 t -92.32 102.14 14.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.101 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -90.88 163.0 14.55 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.581 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.777 HG21 ' CB ' ' A' ' 60' ' ' ASP . 23.6 m -138.94 172.88 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.638 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.236 0.36 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.417 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 10.3 t70 . . . . . 0 N--CA 1.464 0.232 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.712 HD13 HG22 ' A' ' 81' ' ' VAL . 27.2 mm -114.27 151.91 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 120.749 0.309 . . . . 0.0 111.164 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 m -151.37 156.71 41.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.69 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.427 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 67.3 m95 -134.74 131.46 37.64 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.394 0.278 . . . . 0.0 111.272 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 94.8 m-85 -120.71 117.81 28.44 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.0 p -69.42 150.6 97.01 Favored Pre-proline 0 C--O 1.25 1.105 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.882 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo . . . . . 0 C--N 1.382 2.327 0 C-N-CA 124.932 3.755 . . . . 0.0 116.062 -179.188 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 36.7 tttt . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.02 132.27 36.58 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.153 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.97 162.37 74.88 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.762 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -75.92 -28.8 7.41 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 122.719 2.279 . . . . 0.0 112.221 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -138.31 77.42 1.63 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.22 0.533 . . . . 0.0 109.85 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.07 -58.89 1.53 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.348 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -140.27 -160.57 1.09 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -50.6 -26.65 5.59 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.722 HG12 HG23 ' A' ' 66' ' ' ILE . 54.4 mt -83.68 96.89 4.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.67 0.271 . . . . 0.0 110.825 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.0 t -94.14 169.77 10.01 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.505 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 55' ' ' VAL . 11.7 t -141.9 159.7 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.419 ' N ' HG12 ' A' ' 54' ' ' VAL . 7.3 p -159.46 137.89 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.248 0.547 . . . . 0.0 112.221 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 17.4 m-90 -115.1 113.96 24.7 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.82 -77.82 0.59 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -57.65 -177.44 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -56.53 -35.48 68.14 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.777 ' CB ' HG21 ' A' ' 26' ' ' VAL . 58.8 m-20 -149.03 22.32 0.97 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 t -109.19 138.73 45.09 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.543 ' OG ' HG21 ' A' ' 35' ' ' ILE . 2.1 m -132.26 -170.64 2.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 m -158.24 137.88 12.0 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.715 0.293 . . . . 0.0 110.837 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.575 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -109.37 93.79 4.69 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.752 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.721 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -84.59 143.12 29.49 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.4 0.438 . . . . 0.0 110.245 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.722 HG23 HG12 ' A' ' 52' ' ' ILE . 57.9 mt -140.28 91.36 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -59.86 -112.8 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 O-C-N 123.641 0.588 . . . . 0.0 111.581 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.9 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.726 1.148 . . . . 0.0 110.921 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.833 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -75.13 146.0 41.73 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.414 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.745 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -144.21 159.01 43.4 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.322 0.582 . . . . 0.0 110.454 178.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.7 pt -51.75 -26.13 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -42.87 74.03 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -66.21 -34.3 77.72 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.736 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.555 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -53.27 107.04 0.2 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.73 179.25 46.16 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.249 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' A' ' 94' ' ' ASN . 33.2 mm -83.13 92.41 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.575 ' CD2' HD11 ' A' ' 64' ' ' LEU . 70.1 m-85 -68.39 165.6 18.43 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -129.94 155.66 45.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.248 0.547 . . . . 0.0 111.925 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.612 ' HB2' HD11 ' A' ' 7' ' ' ILE . 8.9 t -139.23 94.52 2.81 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 90' ' ' GLU . 7.3 t -101.36 135.91 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.174 0.512 . . . . 0.0 112.203 -177.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.712 HG22 HD13 ' A' ' 35' ' ' ILE . 14.4 t -118.16 157.13 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.221 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.713 HG23 ' CG ' ' A' ' 88' ' ' GLN . 1.3 m -135.07 150.64 50.29 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.57 -179.62 4.26 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.337 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -71.05 -46.4 62.06 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.75 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.91 -29.62 58.49 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.557 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 141.37 -10.34 2.72 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-O 119.561 -0.577 . . . . 0.0 113.828 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.2 m -59.46 108.43 0.71 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.97 0.885 . . . . 0.0 111.064 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.713 ' CG ' HG23 ' A' ' 82' ' ' THR . 26.8 mt-30 -105.22 135.57 46.33 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.376 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.584 ' O ' HG21 ' A' ' 5' ' ' VAL . 18.6 t -122.97 110.92 15.99 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.528 ' HB3' HG13 ' A' ' 80' ' ' VAL . 5.7 pt-20 -106.45 178.93 4.42 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -157.43 179.5 9.19 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.203 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.39 157.71 41.64 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.775 0.321 . . . . 0.0 111.538 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.633 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.4 p -141.61 121.52 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.607 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.473 ' HA ' HD13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -78.01 98.21 5.64 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.684 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.435 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 13.3 t -102.84 122.65 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.352 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -108.41 159.71 16.45 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.808 0.337 . . . . 0.0 111.145 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.833 HD13 ' HB1' ' A' ' 69' ' ' ALA . 11.3 mt -149.1 123.03 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.597 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.36 130.71 53.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.104 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.224 -0.894 . . . . 0.0 110.973 -179.76 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 120.522 0.201 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.71 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 6.5 tt0 -129.53 152.45 49.04 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.868 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -152.5 148.76 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.415 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -159.68 130.41 5.79 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.827 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.46 HD11 ' HB3' ' A' ' 79' ' ' CYS . 22.7 mt -95.13 133.86 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.277 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.5 t -116.31 126.17 27.84 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 119.266 -0.397 . . . . 0.0 109.977 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.47 -176.34 16.64 Favored 'Cis proline' 0 C--N 1.366 1.473 0 CA-C-N 119.993 1.033 . . . . 0.0 112.343 -0.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.8 p -77.77 -46.85 20.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.297 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -131.92 111.29 11.43 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.14 103.04 1.63 Allowed Glycine 0 C--N 1.34 0.766 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.962 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -84.65 134.06 34.38 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.523 HG23 ' HG3' ' A' ' 18' ' ' GLU . 1.7 mp -143.94 162.4 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.154 0.502 . . . . 0.0 111.618 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.29 150.09 23.35 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.503 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 69' ' ' ALA . 51.8 t -66.25 131.77 31.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.88 -15.25 44.69 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.149 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.523 ' HG3' HG23 ' A' ' 14' ' ' ILE . 4.3 pt-20 -116.14 147.26 41.55 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 117.625 0.712 . . . . 0.0 110.11 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 93.5 p -79.49 173.7 12.32 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.613 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -167.26 121.68 1.02 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.996 -178.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.749 ' HB3' HG23 ' A' ' 65' ' ' THR . 30.5 p90 -113.69 152.35 30.58 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.693 ' CD2' HG21 ' A' ' 93' ' ' VAL . 89.3 m-85 -129.64 119.18 23.14 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.17 0.509 . . . . 0.0 112.152 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.539 HD12 ' HG3' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -78.68 109.67 13.12 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -177.09 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.477 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 44.8 t -89.5 88.17 7.34 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.539 ' HG3' HD12 ' A' ' 23' ' ' LEU . 4.2 mt-30 -81.17 158.78 24.81 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.17 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.68 HG21 ' HB2' ' A' ' 60' ' ' ASP . 22.5 m -129.43 167.97 23.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.516 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.71 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.235 0.303 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.248 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.2 t70 . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.511 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.4 mp -75.24 157.13 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.991 0.425 . . . . 0.0 111.507 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.427 ' N ' HG22 ' A' ' 35' ' ' ILE . 5.7 m -155.48 160.79 40.86 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.484 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.477 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 46.1 m95 -136.11 115.07 12.23 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.245 0.091 . . . . 0.0 111.245 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -111.74 116.24 30.4 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.0 p -61.7 152.5 75.08 Favored Pre-proline 0 C--O 1.246 0.908 0 CA-C-O 119.092 -0.48 . . . . 0.0 110.135 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo . . . . . 0 C--N 1.381 2.24 1 C-N-CA 125.655 4.237 . . . . 0.0 114.133 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 pp -76.97 156.01 32.25 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.953 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 m -78.29 159.18 75.7 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.079 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.75 -35.69 1.4 Allowed 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 122.618 2.212 . . . . 0.0 112.289 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -125.11 68.59 1.12 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.404 0.621 . . . . 0.0 110.124 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.29 -53.06 2.73 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.412 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -145.97 -157.48 0.8 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -51.08 -24.28 3.81 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.651 HG12 HG23 ' A' ' 66' ' ' ILE . 53.1 mt -82.82 104.94 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 120.704 0.288 . . . . 0.0 110.574 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.3 t -108.55 122.67 47.55 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.073 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 55' ' ' VAL . 11.6 t -94.19 159.85 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.701 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.422 ' N ' HG12 ' A' ' 54' ' ' VAL . 8.0 p -151.42 155.31 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.777 0.323 . . . . 0.0 111.537 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 -132.86 112.14 11.66 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -106.49 -79.47 0.57 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.28 -174.19 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -51.96 -40.65 61.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.676 0.39 . . . . 0.0 111.922 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.68 ' HB2' HG21 ' A' ' 26' ' ' VAL . 25.1 m-20 -148.9 21.55 0.99 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.103 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 p -99.76 141.34 32.7 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.511 ' OG ' HG21 ' A' ' 35' ' ' ILE . 2.1 m -136.22 -172.88 3.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.293 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.3 m -157.52 145.51 18.98 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.905 0.383 . . . . 0.0 110.754 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.643 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -115.34 93.65 4.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.392 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.749 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -86.81 140.66 29.48 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 123.497 0.498 . . . . 0.0 109.95 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.651 HG23 HG12 ' A' ' 52' ' ' ILE . 59.1 mt -137.01 95.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -61.42 -115.75 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.361 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -53.13 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.846 1.203 . . . . 0.0 111.197 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.775 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -74.46 147.44 41.96 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.394 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.784 ' O ' HD12 ' A' ' 97' ' ' ILE . 11.0 m-80 -143.31 152.26 41.45 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.828 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.55 HG21 HE22 ' A' ' 99' ' ' GLN . 15.5 pt -51.3 -24.43 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 112.702 0.631 . . . . 0.0 112.702 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.22 -44.33 75.97 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -65.8 -35.4 80.6 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.677 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.536 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -48.26 102.23 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.79 172.61 45.39 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.762 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.5 mt -77.17 94.02 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.783 0.292 . . . . 0.0 111.289 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.643 ' CD2' HD11 ' A' ' 64' ' ' LEU . 62.8 m-85 -65.59 177.04 1.29 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.412 ' O ' ' CE3' ' A' ' 37' ' ' TRP . 8.3 ttmt -139.54 155.4 47.53 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 120.74 0.305 . . . . 0.0 111.633 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.46 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -141.34 102.78 4.29 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.06 140.51 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.83 139.49 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.653 HG23 ' HB3' ' A' ' 88' ' ' GLN . 0.6 OUTLIER -124.19 146.09 48.91 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.14 -174.43 4.66 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.968 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -76.74 -35.06 58.02 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.514 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -86.49 -37.97 17.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.498 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.74 -24.3 0.63 Allowed Glycine 0 C--N 1.34 0.758 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.369 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.9 m -55.38 107.96 0.37 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.247 0.523 . . . . 0.0 111.492 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.653 ' HB3' HG23 ' A' ' 82' ' ' THR . 3.0 pt20 -116.87 134.61 54.55 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.551 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.4 t -114.37 121.55 43.95 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -107.35 -178.14 3.55 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.404 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -150.88 174.54 12.98 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.256 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.442 ' C ' HD12 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -151.84 155.54 38.38 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 123.119 0.262 . . . . 0.0 110.781 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.693 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.2 p -144.89 114.58 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.172 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -71.2 94.15 1.14 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.86 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.467 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 16.8 t -96.2 113.69 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -98.67 157.11 16.47 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.729 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.784 HD12 ' O ' ' A' ' 70' ' ' ASN . 13.3 mt -146.64 143.6 20.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.107 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.42 131.69 14.55 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.752 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.55 HE22 HG21 ' A' ' 71' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.898 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' A' ' 83' ' ' ALA . 0.3 OUTLIER . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.538 0.208 . . . . 0.0 110.586 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.594 ' CB ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -139.5 140.18 37.15 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.308 -179.376 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.579 HG21 ' O ' ' A' ' 89' ' ' SER . 9.5 t -145.23 140.41 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.058 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -160.49 125.78 3.88 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.488 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.538 HD11 ' HB2' ' A' ' 79' ' ' CYS . 49.9 mt -95.52 137.6 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.688 0.28 . . . . 0.0 110.833 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.93 130.1 24.54 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.807 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.25 168.91 75.98 Favored 'Cis proline' 0 C--N 1.365 1.406 0 CA-C-N 119.704 0.93 . . . . 0.0 112.042 0.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 p -67.39 -44.59 78.51 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.761 0.315 . . . . 0.0 110.415 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -133.54 107.17 7.84 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.585 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.35 160.46 36.36 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.266 -0.492 . . . . 0.0 114.196 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -154.77 103.78 2.46 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.9 mp -128.42 161.85 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.658 0.266 . . . . 0.0 111.178 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.01 153.1 17.79 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 69' ' ' ALA . 26.1 t -64.86 139.84 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.29 -19.33 55.0 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.774 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -96.72 160.84 14.16 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.412 ' CB ' ' HA ' ' A' ' 67' ' ' TYR . 91.8 p -96.08 162.52 13.51 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.687 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -155.06 115.15 3.79 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.601 -178.201 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.808 ' HB3' HG23 ' A' ' 65' ' ' THR . 41.3 p90 -111.22 140.38 45.83 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.583 0.23 . . . . 0.0 110.956 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.424 ' CE2' HG22 ' A' ' 95' ' ' VAL . 81.5 m-85 -117.81 114.63 23.56 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.052 0.454 . . . . 0.0 110.807 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.2 tp -79.99 110.51 15.44 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.3 t -92.67 97.1 10.58 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.465 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -87.33 163.93 16.54 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.7 m -147.43 175.91 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.594 ' HB3' ' CB ' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.234 0.272 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.608 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.465 0.321 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.783 HG21 ' OG ' ' A' ' 62' ' ' SER . 5.4 mp -125.71 144.55 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 123.368 0.418 . . . . 0.0 111.204 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 m -144.04 149.94 37.43 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.088 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.442 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 52.5 m95 -125.85 122.3 35.72 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.305 0.242 . . . . 0.0 111.133 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -119.52 112.7 19.69 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.466 ' OG ' HD23 ' A' ' 45' ' ' LEU . 5.5 m -55.88 150.45 28.27 Favored Pre-proline 0 C--O 1.244 0.814 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.365 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 C--N 1.381 2.242 1 C-N-CA 125.499 4.133 . . . . 0.0 113.634 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 2.0 ttmt . . . . . 0 N--CA 1.469 0.499 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.466 HD23 ' OG ' ' A' ' 39' ' ' SER . 3.9 pp -84.26 143.05 29.82 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.142 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.5 m -66.41 150.18 97.37 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.215 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.24 -14.72 13.13 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.472 2.115 . . . . 0.0 113.701 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -136.42 37.24 2.71 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.87 0.367 . . . . 0.0 110.976 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.15 -75.2 0.07 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.736 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -151.8 -75.35 0.14 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.603 0.24 . . . . 0.0 111.12 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -99.66 -31.34 11.62 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.566 HG12 HG23 ' A' ' 66' ' ' ILE . 22.4 mt -89.18 104.82 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 t -108.48 120.39 42.29 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.1 t -93.93 154.03 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.2 m -150.9 173.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.337 0.589 . . . . 0.0 112.421 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -141.82 120.17 12.32 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.97 -82.52 0.54 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -42.04 -64.47 0.58 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 179.49 -44.09 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.382 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -114.71 -35.8 4.73 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.329 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.6 t -65.53 136.91 56.99 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.048 0.452 . . . . 0.0 111.099 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.783 ' OG ' HG21 ' A' ' 35' ' ' ILE . 2.7 m -122.76 -173.62 2.74 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.81 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.0 m -156.57 130.73 8.56 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.87 0.366 . . . . 0.0 111.04 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.628 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -101.42 93.05 5.2 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.944 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.808 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -88.18 139.1 30.84 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 123.254 0.346 . . . . 0.0 110.323 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.566 HG23 HG12 ' A' ' 52' ' ' ILE . 44.9 mt -135.39 85.02 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.412 ' HA ' ' CB ' ' A' ' 19' ' ' SER . 12.3 m-85 -50.29 -59.56 3.84 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -176.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -63.96 -65.6 0.66 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 16' ' ' VAL . . . 73.98 118.82 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.051 0.54 . . . . 0.0 110.869 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.788 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -145.39 164.64 30.88 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.706 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 34.5 pt -54.85 -27.07 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -73.51 -36.53 65.76 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -68.13 -33.75 75.07 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.597 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.543 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -53.77 117.18 2.96 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.42 176.69 40.06 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.52 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.825 HD13 ' HA ' ' A' ' 94' ' ' ASN . 13.7 mm -75.99 89.61 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 122.283 0.233 . . . . 0.0 111.435 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.628 ' CD2' HD11 ' A' ' 64' ' ' LEU . 58.2 m-85 -66.85 171.66 5.13 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -131.87 155.79 47.22 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.538 ' HB2' HD11 ' A' ' 7' ' ' ILE . 11.9 t -142.48 88.43 2.07 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.759 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 90' ' ' GLU . 4.4 t -96.25 126.22 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.078 -177.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.88 157.91 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.715 HG23 ' CG ' ' A' ' 88' ' ' GLN . 6.5 m -139.48 148.74 43.11 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.404 ' HB2' HD11 ' A' ' 3' ' ' LEU . . . -96.56 -177.18 3.84 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.552 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -71.31 -54.2 11.65 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.121 0.263 . . . . 0.0 111.068 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.7 -31.12 70.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.621 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 141.73 -10.47 2.63 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.603 -0.554 . . . . 0.0 113.978 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.5 m -58.55 104.65 0.23 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 117.902 0.851 . . . . 0.0 111.173 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.715 ' CG ' HG23 ' A' ' 82' ' ' THR . 31.9 mt-30 -102.31 136.1 42.74 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.847 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.579 ' O ' HG21 ' A' ' 5' ' ' VAL . 5.6 t -128.43 109.89 11.82 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.591 ' HB3' HG13 ' A' ' 80' ' ' VAL . 11.0 pt-20 -101.47 179.43 4.36 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -153.62 175.89 12.7 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.916 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.05 155.18 36.37 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.7 p -139.89 120.87 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.668 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.825 ' HA ' HD13 ' A' ' 76' ' ' ILE . 1.8 t-20 -76.5 84.88 3.21 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.337 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.424 HG22 ' CE2' ' A' ' 22' ' ' PHE . 38.6 t -84.07 138.5 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.511 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -124.97 156.84 37.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.471 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.788 HD12 ' O ' ' A' ' 70' ' ' ASN . 9.6 mt -148.7 140.38 17.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.775 177.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -127.27 128.53 46.14 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.273 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.994 -179.589 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.576 HD23 HG12 ' A' ' 81' ' ' VAL . 1.8 mp . . . . . 0 CA--C 1.531 0.237 0 CA-C-O 120.783 0.325 . . . . 0.0 111.862 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.764 ' CB ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -150.84 151.25 31.98 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.113 179.327 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 t -150.56 144.59 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.606 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -157.07 130.59 8.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.429 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.544 HD11 ' HB2' ' A' ' 79' ' ' CYS . 37.7 mt -107.91 120.46 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.143 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t -105.64 130.07 23.64 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.461 ' O ' HG23 ' A' ' 93' ' ' VAL . 69.8 Cg_endo -81.93 173.49 48.03 Favored 'Cis proline' 0 C--N 1.367 1.545 0 CA-C-N 119.882 0.994 . . . . 0.0 112.282 -0.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 76.1 p -69.27 -41.48 76.81 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -137.2 109.77 7.48 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.649 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.631 ' O ' HD12 ' A' ' 14' ' ' ILE . . . -102.92 98.73 1.7 Allowed Glycine 0 C--N 1.343 0.937 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.927 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -83.09 126.48 32.62 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 12' ' ' GLY . 3.7 mp -140.45 164.5 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 123.21 0.319 . . . . 0.0 110.389 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.57 156.28 18.1 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 69' ' ' ALA . 39.7 t -63.07 141.07 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.09 -11.58 71.71 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.301 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -101.67 150.09 23.47 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 117.33 0.565 . . . . 0.0 109.536 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.3 p -90.45 164.46 14.27 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.623 ' HD2' HD12 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -162.62 129.47 3.6 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.996 -178.155 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.486 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 28.9 p90 -120.77 157.96 28.58 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.2 0.313 . . . . 0.0 110.732 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.597 ' CD2' HG21 ' A' ' 93' ' ' VAL . 80.7 m-85 -133.36 120.35 20.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.68 117.27 19.67 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 t -102.07 96.37 6.96 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.626 0.251 . . . . 0.0 111.148 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -93.62 162.19 14.05 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.94 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.706 HG21 ' CB ' ' A' ' 60' ' ' ASP . 32.7 m -137.93 152.93 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.764 ' HB3' ' CB ' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.235 0.323 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 10.9 m-20 . . . . . 0 N--CA 1.462 0.17 0 N-CA-C 111.199 0.074 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.809 HD13 HG23 ' A' ' 81' ' ' VAL . 15.5 mm -65.5 152.44 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.459 0.647 . . . . 0.0 111.653 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.4 m -147.23 161.25 41.31 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.022 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -138.69 109.41 6.65 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 119.632 -0.223 . . . . 0.0 110.616 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -110.75 111.04 21.95 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 p -60.02 154.07 51.92 Favored Pre-proline 0 C--O 1.243 0.722 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.388 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 C--N 1.375 1.955 0 C-N-CA 125.105 3.87 . . . . 0.0 113.704 -179.282 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.5 tttm . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 45' ' ' LEU . 0.7 OUTLIER -93.48 153.94 18.19 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.056 -179.327 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 m -78.2 164.37 57.01 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.334 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.43 -25.4 2.6 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 122.816 2.344 . . . . 0.0 113.42 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -129.42 22.4 5.57 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.58 -59.02 3.68 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -137.63 -159.83 1.0 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.24 0.216 . . . . 0.0 110.574 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 mtm-85 -51.35 -22.8 3.13 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.624 HG12 HG23 ' A' ' 66' ' ' ILE . 52.6 mt -84.59 105.78 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.7 t -111.65 115.28 28.86 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.337 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.9 t -85.83 150.88 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.452 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -143.43 139.21 26.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 CA-C-O 120.75 0.31 . . . . 0.0 111.286 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 24.5 m-90 -109.18 107.49 17.79 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -92.37 -77.84 0.43 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -72.43 -178.6 2.62 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.494 -0.188 . . . . 0.0 110.494 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.82 -35.85 69.26 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.706 ' CB ' HG21 ' A' ' 26' ' ' VAL . 61.1 m-20 -134.84 5.7 3.38 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 p -100.56 137.34 39.09 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.999 0.363 . . . . 0.0 110.317 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.407 ' OG ' HG21 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -149.02 136.82 20.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.52 -179.097 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.0 m -108.85 139.34 43.82 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.842 0.353 . . . . 0.0 111.787 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.587 HD11 ' CG2' ' A' ' 52' ' ' ILE . 27.8 tp -94.85 113.67 25.44 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -98.36 141.42 31.27 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.624 HG23 HG12 ' A' ' 52' ' ' ILE . 63.7 mt -138.0 90.78 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -59.94 -110.97 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.657 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.2 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.794 1.179 . . . . 0.0 111.063 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.795 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -70.47 148.06 48.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.674 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.808 ' O ' HD12 ' A' ' 97' ' ' ILE . 24.6 m-80 -140.98 153.56 45.64 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.276 0.56 . . . . 0.0 110.901 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.2 pt -54.3 -23.94 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.81 -41.24 68.47 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -66.67 -34.81 78.69 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.704 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.502 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -49.61 99.63 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.76 176.23 46.31 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.528 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.2 mt -80.24 101.16 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.877 0.339 . . . . 0.0 111.701 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.4 ' CD2' HD21 ' A' ' 64' ' ' LEU . 58.2 m-85 -71.37 172.37 9.54 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -135.51 157.95 45.6 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.544 ' HB2' HD11 ' A' ' 7' ' ' ILE . 2.9 t -143.13 118.6 10.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.341 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.7 t -126.54 133.03 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.809 HG23 HD13 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -115.24 129.58 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.498 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.3 m -110.73 148.25 32.69 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -178.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.95 173.06 7.48 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.091 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.0 -46.32 78.43 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.195 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -71.97 -28.24 63.3 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.632 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.31 -12.31 4.36 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 119.899 -0.389 . . . . 0.0 113.521 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.8 m -60.82 108.05 0.79 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 117.455 0.627 . . . . 0.0 111.278 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.498 ' HB3' HG23 ' A' ' 82' ' ' THR . 3.9 pt20 -119.75 132.43 55.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.762 0.315 . . . . 0.0 111.288 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.2 t -114.71 125.35 53.62 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -105.02 -177.71 3.44 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -158.28 172.38 18.48 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.004 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.86 156.46 41.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.69 0.281 . . . . 0.0 111.375 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.597 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.1 p -144.63 115.26 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.405 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -70.25 94.63 0.93 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.928 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.514 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 15.1 t -96.27 115.52 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.573 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -101.03 155.06 18.2 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.409 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.808 HD12 ' O ' ' A' ' 70' ' ' ASN . 10.6 mt -146.79 122.97 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.473 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -111.39 127.63 55.73 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.505 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.306 -0.854 . . . . 0.0 111.087 -179.727 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 tp . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 111.43 0.159 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.603 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -121.32 140.59 51.89 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.741 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 t -149.31 137.69 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.653 -0.248 . . . . 0.0 110.973 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -159.29 123.71 3.97 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.311 0.382 . . . . 0.0 110.514 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.538 HD11 ' HB2' ' A' ' 79' ' ' CYS . 43.1 mt -89.87 140.2 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 O-C-N 123.15 0.281 . . . . 0.0 111.042 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.9 t -128.1 134.39 26.18 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.856 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.437 ' O ' HG23 ' A' ' 93' ' ' VAL . 93.5 Cg_endo -76.44 173.82 56.13 Favored 'Cis proline' 0 C--N 1.365 1.436 0 CA-C-N 119.698 0.928 . . . . 0.0 112.161 0.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.4 p -69.14 -49.01 60.82 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -128.37 114.22 16.58 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 14' ' ' ILE . . . -110.44 93.16 0.72 Allowed Glycine 0 C--N 1.343 0.94 0 C-N-CA 121.087 -0.578 . . . . 0.0 114.46 -177.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -79.99 132.86 36.1 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 12' ' ' GLY . 2.0 mp -143.47 164.12 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.09 0.472 . . . . 0.0 111.384 -177.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.47 150.22 22.87 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.549 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 69' ' ' ALA . 29.2 t -66.0 135.28 28.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.599 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.17 -15.07 59.45 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.251 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -114.67 146.63 40.65 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 117.747 0.773 . . . . 0.0 110.111 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.442 ' CB ' ' HA ' ' A' ' 67' ' ' TYR . 60.1 p -79.42 168.56 19.31 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -176.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.619 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -159.31 121.38 3.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.805 -179.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.845 ' HB3' HG23 ' A' ' 65' ' ' THR . 49.5 p90 -115.2 142.22 46.96 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.578 0.227 . . . . 0.0 110.951 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.69 ' CD2' HG21 ' A' ' 93' ' ' VAL . 81.1 m-85 -117.51 117.0 28.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.918 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.8 tp -82.43 109.81 17.0 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.935 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.66 107.44 19.17 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -92.01 163.11 14.1 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.716 HG21 ' HB3' ' A' ' 60' ' ' ASP . 22.2 m -147.42 176.64 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.603 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.234 0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.508 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 . . . . . 0 N--CA 1.464 0.247 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.974 HD13 HG23 ' A' ' 81' ' ' VAL . 14.8 mm -70.93 148.66 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 123.603 0.565 . . . . 0.0 110.168 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.7 m -144.93 156.12 43.8 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.183 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.427 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 55.9 m95 -134.65 121.84 21.43 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -119.5 110.84 17.38 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 m -62.73 152.6 81.6 Favored Pre-proline 0 C--O 1.249 1.071 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.117 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo . . . . . 0 C--N 1.38 2.209 1 C-N-CA 126.047 4.498 . . . . 0.0 116.532 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp . . . . . 0 C--O 1.234 0.242 0 CA-C-O 120.649 0.261 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.496 HD11 ' CG2' ' A' ' 54' ' ' VAL . 2.9 pp -86.84 131.64 34.06 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.495 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.8 m -63.52 163.29 20.79 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.667 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.34 -60.29 0.11 Allowed 'Trans proline' 0 C--N 1.363 1.321 0 C-N-CA 122.621 2.214 . . . . 0.0 112.597 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -114.38 62.65 0.67 Allowed 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.285 0.564 . . . . 0.0 110.697 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.83 -62.13 1.41 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.102 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -139.03 -154.42 0.52 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.0 -23.91 1.32 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.652 HG12 HG23 ' A' ' 66' ' ' ILE . 39.2 mt -86.17 105.04 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.5 t -109.07 122.17 46.7 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.189 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.496 ' CG2' HD11 ' A' ' 45' ' ' LEU . 21.5 t -95.77 158.07 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.15 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.407 ' N ' HG12 ' A' ' 54' ' ' VAL . 8.2 m -150.32 171.75 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.852 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -139.58 120.1 14.07 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.1 -81.78 0.57 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -56.33 -178.43 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -52.96 -34.19 54.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.716 ' HB3' HG21 ' A' ' 26' ' ' VAL . 23.5 m-20 -141.37 -12.97 0.9 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.6 p -76.89 147.55 36.97 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 118.725 0.693 . . . . 0.0 111.297 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.587 ' OG ' HG21 ' A' ' 35' ' ' ILE . 3.2 m -134.79 -170.17 2.5 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.817 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.2 m -154.23 138.49 16.61 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 111.799 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.652 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -108.08 94.68 5.2 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.684 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.845 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -89.54 140.1 29.88 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 123.295 0.372 . . . . 0.0 110.563 -179.517 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.652 HG23 HG12 ' A' ' 52' ' ' ILE . 47.0 mt -136.44 91.06 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.442 ' HA ' ' CB ' ' A' ' 19' ' ' SER . 11.0 m-85 -56.25 -69.92 0.13 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.6 OUTLIER -57.18 -66.19 0.5 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.459 ' O ' HG13 ' A' ' 16' ' ' VAL . . . 73.76 119.77 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.1 0.56 . . . . 0.0 111.232 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.788 ' O ' HD12 ' A' ' 97' ' ' ILE . 15.6 m-80 -142.39 163.03 33.95 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.03 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.7 pt -51.73 -26.28 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.95 -43.77 70.92 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.437 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -65.7 -33.39 75.77 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.004 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.519 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -51.14 109.31 0.32 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.14 174.9 45.68 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.726 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.7 mt -80.54 99.78 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.829 0.315 . . . . 0.0 111.296 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.652 ' CD2' HD11 ' A' ' 64' ' ' LEU . 53.5 m-85 -72.57 171.5 12.31 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -132.89 158.01 43.64 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.538 ' HB2' HD11 ' A' ' 7' ' ' ILE . 34.2 t -139.82 100.8 4.03 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.895 178.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.441 HG13 ' HB3' ' A' ' 90' ' ' GLU . 4.0 t -107.22 133.02 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.974 HG23 HD13 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -115.69 134.83 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.55 HG23 ' HB3' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -115.17 146.43 41.39 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.32 -175.59 4.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.464 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -73.7 -46.32 46.89 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 123.132 0.27 . . . . 0.0 111.49 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.4 -35.46 65.88 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.559 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.48 -19.31 1.5 Allowed Glycine 0 C--N 1.339 0.719 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.643 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.8 m -56.14 108.7 0.49 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.348 0.574 . . . . 0.0 111.7 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.55 ' HB3' HG23 ' A' ' 82' ' ' THR . 3.8 pt20 -117.78 133.81 55.56 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.867 0.365 . . . . 0.0 111.565 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.2 t -120.94 127.18 51.59 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.441 ' HB3' HG13 ' A' ' 80' ' ' VAL . 8.6 pt-20 -111.49 -177.94 3.32 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.75 177.13 10.39 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.614 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.82 158.39 44.13 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.822 0.344 . . . . 0.0 111.816 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.69 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.6 p -143.18 114.36 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.908 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -71.33 91.48 0.99 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.914 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.434 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 15.4 t -92.39 129.37 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.549 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -115.76 158.42 22.87 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.798 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.788 HD12 ' O ' ' A' ' 70' ' ' ASN . 11.2 mt -148.99 135.47 12.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.178 178.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.25 135.56 45.03 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.355 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.878 -179.838 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.566 HD11 ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 121.08 0.466 . . . . 0.0 111.088 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -132.9 147.71 52.29 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.883 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 89' ' ' SER . 0.3 OUTLIER -152.41 140.22 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 O-C-N 123.188 0.305 . . . . 0.0 111.068 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -154.99 130.61 9.89 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.601 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.494 HD12 ' C ' ' A' ' 92' ' ' THR . 22.4 mt -91.69 130.11 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 123.196 0.31 . . . . 0.0 110.992 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.0 t -115.07 123.76 31.31 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.83 -179.29 24.9 Favored 'Cis proline' 0 C--N 1.364 1.374 0 CA-C-N 119.985 1.03 . . . . 0.0 112.276 0.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 86.3 p -78.69 -40.97 32.34 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.307 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -132.85 118.15 18.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.699 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.467 ' O ' HD12 ' A' ' 14' ' ' ILE . . . -117.93 99.37 0.8 Allowed Glycine 0 C--N 1.341 0.844 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.97 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.413 ' C ' HD12 ' A' ' 14' ' ' ILE . 14.5 mt-10 -87.55 132.26 34.11 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 12' ' ' GLY . 4.5 mp -143.59 163.63 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.811 0.338 . . . . 0.0 111.083 -178.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.36 154.46 18.17 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 69' ' ' ALA . 93.5 t -63.49 140.43 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.901 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.64 -12.0 70.8 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.24 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.06 156.64 17.54 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.8 p -96.16 165.51 12.2 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.63 0.253 . . . . 0.0 111.286 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.776 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 2.1 pttt -162.61 126.58 3.03 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.643 ' HB3' HG23 ' A' ' 65' ' ' THR . 33.9 p90 -119.72 153.42 35.65 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.072 0.232 . . . . 0.0 111.039 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.646 ' CD1' HG21 ' A' ' 93' ' ' VAL . 88.9 m-85 -131.57 119.17 21.12 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.287 0.565 . . . . 0.0 112.078 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -77.9 111.96 14.29 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -176.795 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.461 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 54.0 t -87.61 87.53 7.41 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -79.9 158.39 26.69 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.427 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.453 HG21 ' HB2' ' A' ' 60' ' ' ASP . 27.5 m -133.49 165.07 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 O-C-N 123.473 0.483 . . . . 0.0 112.081 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.684 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 N--CA 1.467 0.403 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.715 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.519 ' O ' HG22 ' A' ' 81' ' ' VAL . 13.5 m-20 . . . . . 0 N--CA 1.468 0.435 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.471 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.4 mp -121.7 158.75 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 123.189 0.306 . . . . 0.0 111.155 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.441 ' N ' HG22 ' A' ' 35' ' ' ILE . 64.1 m -159.88 160.92 34.2 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.768 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.461 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 58.8 m95 -136.96 130.89 32.22 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.673 0.273 . . . . 0.0 111.134 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 91.6 m-85 -118.92 117.55 29.14 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.5 p -65.73 152.76 92.36 Favored Pre-proline 0 C--O 1.249 1.055 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.903 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo . . . . . 0 C--N 1.38 2.225 0 C-N-CA 124.904 3.736 . . . . 0.0 116.133 -178.778 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 21.9 tttt . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -110.35 134.4 52.33 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.172 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.4 m -68.55 158.01 86.5 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.085 -178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -85.93 -26.7 1.13 Allowed 'Trans proline' 0 C--N 1.363 1.334 0 C-N-CA 122.831 2.354 . . . . 0.0 113.55 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -121.28 69.59 0.91 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.375 0.607 . . . . 0.0 110.182 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.99 -60.01 1.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.149 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -141.79 -159.5 0.97 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 121.99 0.116 . . . . 0.0 110.856 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.7 mtm-85 -47.54 -25.57 1.16 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.663 HG23 HG12 ' A' ' 66' ' ' ILE . 47.9 mt -84.83 106.62 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.801 0.334 . . . . 0.0 110.378 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 t -112.52 123.06 49.45 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.517 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 55' ' ' VAL . 11.4 t -92.81 159.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.361 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.409 ' N ' HG12 ' A' ' 54' ' ' VAL . 7.1 p -154.09 153.43 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.734 0.302 . . . . 0.0 111.422 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.406 ' HD1' ' HG ' ' A' ' 62' ' ' SER . 23.0 m-90 -126.08 112.57 16.0 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -105.35 -75.33 0.63 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.2 -179.05 0.13 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.494 0.188 . . . . 0.0 111.421 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -54.62 -35.76 63.78 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.496 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.453 ' HB2' HG21 ' A' ' 26' ' ' VAL . 55.8 m-20 -151.07 24.45 0.74 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.946 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.9 t -110.4 136.25 49.85 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.471 ' OG ' HG21 ' A' ' 35' ' ' ILE . 4.3 m -128.66 -169.38 2.07 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.525 -177.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 m -159.33 144.85 15.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.937 0.399 . . . . 0.0 110.995 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.629 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -113.82 93.55 4.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.334 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.643 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -86.22 144.25 27.55 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.561 0.538 . . . . 0.0 110.286 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.663 HG12 HG23 ' A' ' 52' ' ' ILE . 61.9 mt -142.52 93.05 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -59.71 -108.51 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.405 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -56.61 95.17 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.465 1.03 . . . . 0.0 110.551 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.838 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -74.25 151.8 39.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.153 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.792 ' O ' HD12 ' A' ' 97' ' ' ILE . 16.5 m-80 -145.71 154.43 42.07 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.139 0.495 . . . . 0.0 111.281 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.5 pt -53.98 -24.52 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -72.64 -41.3 65.61 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.92 -34.23 77.91 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.736 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.54 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -51.69 104.25 0.08 Allowed 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.02 171.44 44.17 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.81 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.9 mt -79.62 95.92 2.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.81 0.305 . . . . 0.0 110.245 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.629 ' CD2' HD11 ' A' ' 64' ' ' LEU . 63.0 m-85 -69.93 171.42 9.41 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -133.66 154.69 50.73 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.741 0.305 . . . . 0.0 111.155 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.449 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -138.31 97.71 3.44 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 t -101.01 140.85 18.8 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.857 -176.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 34' ' ' ASP . 1.7 t -125.78 144.92 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.3 m -124.3 155.97 37.76 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.28 -176.01 3.39 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.26 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -77.3 -37.93 51.73 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 123.023 0.202 . . . . 0.0 110.901 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -79.87 -35.8 37.57 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.256 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 148.37 -19.49 1.34 Allowed Glycine 0 C--N 1.34 0.751 0 C-N-CA 121.232 -0.509 . . . . 0.0 113.563 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.566 ' O ' HD11 ' A' ' 3' ' ' LEU . 89.4 m -59.87 112.83 2.0 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 117.314 0.557 . . . . 0.0 111.333 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.531 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.9 OUTLIER -118.63 134.06 55.39 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.488 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.42 ' O ' HG21 ' A' ' 5' ' ' VAL . 2.6 t -114.73 124.98 53.17 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -108.83 -179.86 3.98 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -147.84 173.94 12.34 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.148 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.494 ' C ' HD12 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -150.0 154.95 39.08 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 111.269 179.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.646 HG21 ' CD1' ' A' ' 22' ' ' PHE . 7.2 p -144.87 112.71 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.979 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -70.88 93.26 0.96 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.919 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.467 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 12.5 t -95.05 118.03 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.553 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.63 157.73 16.86 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.153 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.838 HD13 ' HB1' ' A' ' 69' ' ' ALA . 10.5 mt -148.57 139.73 17.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.8 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.86 131.58 51.15 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.404 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.962 -179.788 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.887 HD21 ' HB2' ' A' ' 83' ' ' ALA . 29.6 mt . . . . . 0 C--O 1.234 0.274 0 CA-C-O 120.566 0.222 . . . . 0.0 111.529 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.655 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -146.71 134.48 21.19 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.293 179.233 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.583 HG21 ' O ' ' A' ' 89' ' ' SER . 10.7 t -143.91 139.56 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 123.22 0.325 . . . . 0.0 110.499 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -155.66 121.14 4.92 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.413 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.579 HD11 ' HB2' ' A' ' 79' ' ' CYS . 53.5 mt -89.64 136.24 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.023 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.48 128.05 25.83 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.549 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -74.4 -172.9 11.05 Favored 'Cis proline' 0 C--N 1.366 1.489 0 CA-C-N 119.669 0.917 . . . . 0.0 112.041 -0.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 97.2 p -85.57 -50.12 7.49 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.574 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -131.92 104.07 6.65 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.326 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.78 144.88 17.19 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 121.421 -0.418 . . . . 0.0 113.596 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.53 ' C ' HD12 ' A' ' 14' ' ' ILE . 2.6 mp0 -126.6 129.52 48.69 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.53 HD12 ' C ' ' A' ' 13' ' ' GLU . 4.9 mp -141.75 165.12 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 120.579 0.228 . . . . 0.0 111.226 -178.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.4 157.45 17.33 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 69' ' ' ALA . 21.2 t -62.47 136.91 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.393 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.69 -8.25 80.08 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.942 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -100.78 153.06 19.78 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.0 p -100.06 134.73 42.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.193 0.521 . . . . 0.0 112.083 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.651 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 3.9 pttt -116.98 172.04 7.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.582 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.559 ' HB2' HG23 ' A' ' 65' ' ' THR . 0.1 OUTLIER -162.65 149.91 13.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 178.054 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.781 ' CD2' HG21 ' A' ' 93' ' ' VAL . 73.5 m-85 -137.87 105.14 5.47 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.444 0.64 . . . . 0.0 110.812 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.6 tp -79.41 111.92 16.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 114.88 -1.054 . . . . 0.0 112.228 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.4 t -90.49 108.87 20.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.786 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -92.32 160.24 15.21 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.531 HG21 ' CB ' ' A' ' 60' ' ' ASP . 30.9 m -140.71 176.52 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.655 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.235 0.332 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.332 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 18.4 m-20 . . . . . 0 N--CA 1.466 0.372 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.617 HG21 ' OG ' ' A' ' 62' ' ' SER . 3.9 mp -130.87 155.7 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 123.39 0.431 . . . . 0.0 110.845 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.402 ' N ' HG22 ' A' ' 35' ' ' ILE . 71.8 m -156.65 162.0 39.86 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.079 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.409 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 59.0 m95 -133.08 135.55 45.38 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.941 0.151 . . . . 0.0 110.783 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 95.2 m-85 -128.91 109.07 10.93 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.6 p -58.77 151.44 53.43 Favored Pre-proline 0 C--O 1.251 1.151 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.166 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 C--N 1.382 2.33 0 C-N-CA 124.648 3.565 . . . . 0.0 115.534 -178.865 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 10.9 ttmt . . . . . 0 N--CA 1.464 0.243 0 CA-C-O 120.664 0.268 . . . . 0.0 111.384 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.7 mt -111.85 139.21 47.52 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.694 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.26 155.92 66.51 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.215 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.22 -24.46 9.44 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.439 2.093 . . . . 0.0 113.321 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -138.98 78.61 1.68 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.213 0.53 . . . . 0.0 109.97 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.95 -59.05 1.28 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.585 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -146.02 -157.95 0.85 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -24.28 3.48 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.694 HG12 HG23 ' A' ' 66' ' ' ILE . 29.1 mt -84.17 97.81 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.692 0.282 . . . . 0.0 110.457 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.8 t -101.32 117.96 36.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.552 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 55' ' ' VAL . 13.6 t -93.63 160.33 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.412 ' N ' HG12 ' A' ' 54' ' ' VAL . 11.0 p -158.58 157.69 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 13.1 m-90 -136.04 121.9 19.92 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -81.73 0.64 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.69 -177.9 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -31.55 -59.33 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.323 1.049 . . . . 0.0 113.08 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.531 ' CB ' HG21 ' A' ' 26' ' ' VAL . 15.7 m-20 -147.24 21.62 1.21 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.034 178.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.6 145.22 25.41 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.617 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.3 m -134.58 -170.78 2.62 Favored 'General case' 0 N--CA 1.458 -0.07 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.069 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.4 m -160.12 145.71 15.27 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.868 0.366 . . . . 0.0 111.325 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.666 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -117.7 98.44 6.37 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.172 178.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.559 HG23 ' HB2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -97.61 138.68 34.65 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.607 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.694 HG23 HG12 ' A' ' 52' ' ' ILE . 22.5 mt -134.95 89.2 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -53.97 -98.65 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.94 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.75 100.78 0.73 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.234 0.925 . . . . 0.0 110.109 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.843 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -81.17 149.18 29.21 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.79 ' O ' HD12 ' A' ' 97' ' ' ILE . 12.7 m-80 -142.72 155.54 44.89 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.545 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.3 pt -53.1 -24.54 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -71.56 -42.31 68.0 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -65.33 -35.1 79.94 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.115 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.536 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -50.36 126.81 15.92 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.63 -177.64 37.82 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.895 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 76' ' ' ILE . 0.6 OUTLIER -85.42 108.61 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.666 ' CD2' HD11 ' A' ' 64' ' ' LEU . 49.5 m-85 -83.52 166.18 18.49 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -127.57 158.4 37.57 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.139 0.495 . . . . 0.0 112.303 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.579 ' HB2' HD11 ' A' ' 7' ' ' ILE . 23.7 t -138.84 94.01 2.77 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.272 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 90' ' ' GLU . 6.6 t -100.46 132.31 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -177.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 34' ' ' ASP . 3.6 t -111.73 153.6 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.619 HG23 ' CG ' ' A' ' 88' ' ' GLN . 4.4 m -137.61 111.04 7.97 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.887 ' HB2' HD21 ' A' ' 3' ' ' LEU . . . -62.56 -176.19 0.1 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.244 178.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -73.08 -49.97 25.53 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.715 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -62.62 -31.28 72.1 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 134.28 -19.19 4.1 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 121.348 -0.453 . . . . 0.0 113.51 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 m -61.59 114.02 3.03 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.397 0.599 . . . . 0.0 110.505 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.619 ' CG ' HG23 ' A' ' 82' ' ' THR . 14.4 mt-30 -100.64 136.92 39.76 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.279 0.362 . . . . 0.0 111.973 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.583 ' O ' HG21 ' A' ' 5' ' ' VAL . 35.6 t -116.79 106.42 13.47 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.569 ' HB3' HG13 ' A' ' 80' ' ' VAL . 5.0 pt-20 -102.85 -179.39 3.94 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -177.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -155.86 -178.62 7.43 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.161 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.11 160.58 43.39 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.701 0.286 . . . . 0.0 111.463 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.781 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.3 p -142.09 120.47 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.55 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -74.85 91.43 2.44 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.752 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.9 t -95.27 142.42 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.31 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.88 156.34 46.27 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.938 0.399 . . . . 0.0 111.398 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.843 HD13 ' HB1' ' A' ' 69' ' ' ALA . 11.3 mt -145.09 132.27 15.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.052 178.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.23 132.2 39.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.249 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.219 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.653 HD11 ' HB2' ' A' ' 83' ' ' ALA . 5.6 mp . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 121.192 0.52 . . . . 0.0 112.287 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.769 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 2.6 tt0 -146.43 124.58 12.16 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.14 150.89 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.236 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -160.1 130.37 5.46 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.765 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.462 HD12 ' C ' ' A' ' 92' ' ' THR . 38.9 mt -92.1 144.69 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.361 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -128.42 126.13 23.43 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.19 179.69 28.5 Favored 'Cis proline' 0 C--N 1.365 1.421 0 CA-C-N 120.149 1.089 . . . . 0.0 112.348 0.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 96.4 p -73.33 -51.67 16.64 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.451 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -130.53 101.25 5.63 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.885 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.2 111.24 4.19 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 121.3 -0.476 . . . . 0.0 113.799 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.02 123.06 35.1 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.48 HD13 ' CB ' ' A' ' 20' ' ' LYS . 2.8 mp -137.73 164.69 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.593 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.75 162.23 14.17 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.634 0.731 . . . . 0.0 111.625 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 69' ' ' ALA . 36.8 t -68.51 135.7 27.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.323 178.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.07 -17.35 58.82 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-O 119.545 -0.586 . . . . 0.0 112.449 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -111.46 146.55 37.03 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-N 117.799 0.8 . . . . 0.0 109.896 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 96.7 p -79.67 176.95 9.25 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.602 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -171.33 118.74 0.46 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.249 -178.302 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.751 ' HB3' HG23 ' A' ' 65' ' ' THR . 29.6 p90 -112.09 150.6 30.48 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.469 0.176 . . . . 0.0 111.137 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.714 ' CD2' HG21 ' A' ' 93' ' ' VAL . 86.4 m-85 -128.58 118.52 23.12 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.197 0.522 . . . . 0.0 111.44 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.432 HD23 HE21 ' A' ' 25' ' ' GLN . 12.8 tp -79.13 117.3 20.04 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.432 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 41.6 t -94.74 96.56 9.46 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.432 HE21 HD23 ' A' ' 23' ' ' LEU . 66.7 mt-30 -88.41 148.72 24.08 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.168 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.818 HG21 ' CB ' ' A' ' 60' ' ' ASP . 33.7 m -120.89 175.96 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.769 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 CA--C 1.532 0.252 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.093 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.503 HG21 ' OG ' ' A' ' 62' ' ' SER . 3.9 mp -73.25 157.98 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 123.385 0.428 . . . . 0.0 111.136 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.42 ' N ' HG22 ' A' ' 35' ' ' ILE . 18.0 m -157.88 161.79 38.3 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.249 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.438 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 60.3 m95 -137.39 124.99 22.2 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.65 0.262 . . . . 0.0 111.094 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 94.8 m-85 -114.38 117.32 30.7 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.419 ' HB3' HD23 ' A' ' 45' ' ' LEU . 14.9 p -68.12 153.12 95.89 Favored Pre-proline 0 C--O 1.249 1.074 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.947 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo . . . . . 0 C--N 1.382 2.314 0 C-N-CA 124.887 3.725 . . . . 0.0 116.048 -178.595 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 19.8 tttm . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -110.76 152.85 26.11 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.268 179.37 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m -79.33 159.48 72.44 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.984 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.79 -8.06 13.4 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.29 1.994 . . . . 0.0 113.548 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -141.92 48.59 1.6 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.03 0.443 . . . . 0.0 110.763 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -66.33 -77.31 0.07 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.658 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -150.76 -74.53 0.15 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 -99.86 -34.71 10.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.639 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.663 HG12 HG23 ' A' ' 66' ' ' ILE . 53.4 mt -84.54 107.23 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.849 0.357 . . . . 0.0 111.189 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.5 t -110.64 124.35 51.74 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.597 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.437 HG22 HD23 ' A' ' 64' ' ' LEU . 13.5 t -98.42 159.3 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.742 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.409 ' N ' HG12 ' A' ' 54' ' ' VAL . 5.0 m -149.95 170.32 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.862 0.363 . . . . 0.0 111.518 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.1 m-90 -139.64 104.5 4.93 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -90.79 -85.57 0.22 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -175.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -174.56 0.07 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.952 0.342 . . . . 0.0 111.804 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.89 -36.05 62.26 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.844 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.818 ' CB ' HG21 ' A' ' 26' ' ' VAL . 61.0 m-20 -145.18 17.77 1.56 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.5 t -103.09 139.12 39.03 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.503 ' OG ' HG21 ' A' ' 35' ' ' ILE . 5.6 m -133.27 -173.73 3.29 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.993 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m -155.73 146.55 22.2 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.902 0.382 . . . . 0.0 111.826 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.652 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -115.84 91.57 3.64 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.447 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.751 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -86.2 139.01 31.45 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.605 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.663 HG23 HG12 ' A' ' 52' ' ' ILE . 66.2 mt -135.56 95.59 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -61.93 -116.07 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 O-C-N 123.759 0.662 . . . . 0.0 110.884 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.43 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.824 1.193 . . . . 0.0 111.409 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.846 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -74.56 142.53 44.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.992 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.775 ' O ' HD12 ' A' ' 97' ' ' ILE . 15.1 m-80 -136.9 152.28 50.03 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.63 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.2 pt -51.41 -26.01 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -69.08 -43.67 74.08 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -65.21 -33.42 75.95 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.88 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.484 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -50.47 104.3 0.07 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.54 174.27 46.47 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.043 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.3 mt -81.23 98.66 4.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.652 ' CD2' HD11 ' A' ' 64' ' ' LEU . 59.9 m-85 -71.73 172.47 9.71 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -134.01 155.11 50.56 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.744 0.307 . . . . 0.0 111.095 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.461 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -138.74 101.38 4.31 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.224 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.431 HG13 ' HB3' ' A' ' 90' ' ' GLU . 5.0 t -104.73 140.85 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.427 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.469 HG12 HD23 ' A' ' 3' ' ' LEU . 0.7 OUTLIER -127.36 135.49 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.084 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.658 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.1 m -117.14 149.88 39.63 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.653 ' HB2' HD11 ' A' ' 3' ' ' LEU . . . -90.55 -177.63 5.09 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.357 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -74.23 -34.46 63.66 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.314 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.32 -35.6 23.15 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.361 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.61 -22.15 1.5 Allowed Glycine 0 C--N 1.34 0.785 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.584 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.8 m -59.19 111.66 1.42 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.208 0.504 . . . . 0.0 111.446 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.658 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.1 OUTLIER -119.12 135.22 54.76 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.922 0.391 . . . . 0.0 111.687 179.852 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.7 t -116.61 127.13 54.18 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.431 ' HB3' HG13 ' A' ' 80' ' ' VAL . 4.7 pt-20 -111.19 -178.54 3.49 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -177.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -147.67 173.55 12.64 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.18 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.462 ' C ' HD12 ' A' ' 7' ' ' ILE . 0.7 OUTLIER -147.48 155.78 42.23 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.613 0.244 . . . . 0.0 111.051 179.394 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.714 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.5 p -144.97 116.82 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.273 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.02 102.68 2.49 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.439 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 15.1 t -105.57 111.49 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.681 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.0 mtmm -98.91 149.73 22.64 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.406 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.846 HD13 ' HB1' ' A' ' 69' ' ' ALA . 10.3 mt -139.36 117.72 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.42 132.3 56.29 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.382 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.895 -179.718 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.238 0 CA-C-O 120.698 0.285 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.762 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 13.6 tt0 -134.76 142.17 46.66 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.901 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 89' ' ' SER . 0.4 OUTLIER -149.59 141.1 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.82 -179.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -155.04 132.55 11.21 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.644 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.483 HD11 ' HB3' ' A' ' 79' ' ' CYS . 17.6 mt -92.17 131.93 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 O-C-N 123.173 0.295 . . . . 0.0 111.11 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.04 125.91 28.74 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.57 172.7 48.93 Favored 'Cis proline' 0 C--N 1.364 1.365 0 CA-C-N 120.103 1.072 . . . . 0.0 112.369 0.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.9 p -70.05 -39.8 75.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.458 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -134.42 113.15 11.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.85 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.03 97.89 1.11 Allowed Glycine 0 C--N 1.342 0.867 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.803 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.589 ' C ' HD12 ' A' ' 14' ' ' ILE . 6.6 mt-10 -86.19 124.19 32.31 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.589 HD12 ' C ' ' A' ' 13' ' ' GLU . 3.5 mp -141.06 164.45 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.593 0.235 . . . . 0.0 110.727 -178.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.76 156.98 17.17 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.786 0.327 . . . . 0.0 110.439 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.0 t -63.52 140.77 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.38 -11.57 70.85 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.472 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -98.99 159.55 14.88 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 117.481 0.64 . . . . 0.0 109.454 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.4 ' CB ' ' HA ' ' A' ' 67' ' ' TYR . 66.7 p -101.49 149.24 24.28 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.63 0.252 . . . . 0.0 111.213 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.625 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -148.26 124.53 10.86 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.552 -178.514 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.772 ' HB3' HG23 ' A' ' 65' ' ' THR . 34.2 p90 -114.57 148.32 38.19 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.958 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.648 ' CD1' HG21 ' A' ' 93' ' ' VAL . 92.8 m-85 -127.45 119.85 27.04 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.223 0.535 . . . . 0.0 112.028 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 62' ' ' SER . 0.0 OUTLIER -78.05 109.49 12.18 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -177.117 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.491 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 35.5 t -84.54 90.7 7.7 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -83.35 150.82 25.86 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.093 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.753 HG21 ' CB ' ' A' ' 60' ' ' ASP . 30.9 m -122.35 169.96 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.3 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.762 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 N--CA 1.465 0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.799 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 t70 . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.542 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.2 mp -76.43 155.44 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.064 0.459 . . . . 0.0 112.01 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.401 ' N ' HG22 ' A' ' 35' ' ' ILE . 74.9 m -152.3 159.2 43.53 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.645 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.491 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 44.2 m95 -135.4 115.18 12.9 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 119.684 -0.198 . . . . 0.0 111.384 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -116.51 112.16 20.98 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.517 ' HB3' HD21 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -61.52 156.01 55.74 Favored Pre-proline 0 C--O 1.245 0.821 0 CA-C-O 119.325 -0.369 . . . . 0.0 110.627 178.364 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo . . . . . 0 C--N 1.381 2.253 0 C-N-CA 125.094 3.863 . . . . 0.0 113.484 -179.387 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 23.2 tttm . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.517 HD21 ' HB3' ' A' ' 39' ' ' SER . 2.2 mt -72.39 171.48 12.16 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.987 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m -86.75 150.4 50.55 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.06 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.08 -24.75 23.39 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.254 1.97 . . . . 0.0 112.886 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -150.01 80.3 1.37 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.989 0.423 . . . . 0.0 110.301 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.71 -79.08 0.46 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.295 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -145.04 -74.3 0.24 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.588 0.232 . . . . 0.0 110.902 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -97.95 -39.57 8.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.565 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.464 HG12 HG23 ' A' ' 66' ' ' ILE . 47.9 mt -88.33 112.83 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.6 t -119.37 117.98 29.97 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.364 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.3 t -89.04 157.61 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.4 HG22 ' N ' ' A' ' 56' ' ' TRP . 9.8 p -155.0 157.98 3.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 CA-C-O 120.963 0.411 . . . . 0.0 111.894 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.4 ' N ' HG22 ' A' ' 55' ' ' VAL . 25.7 m-90 -131.72 107.51 8.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -97.39 -79.28 0.46 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.73 -178.82 0.22 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.587 0.232 . . . . 0.0 111.473 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -52.71 -34.26 51.54 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.753 ' CB ' HG21 ' A' ' 26' ' ' VAL . 22.1 m-20 -148.29 16.51 1.05 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 p -103.14 139.15 39.02 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.97 0.35 . . . . 0.0 110.078 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.542 ' OG ' HG21 ' A' ' 35' ' ' ILE . 4.2 m -130.84 -174.29 3.33 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.455 -177.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -155.82 147.57 23.07 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.003 0.43 . . . . 0.0 111.35 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.642 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -118.94 92.51 3.82 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.285 179.425 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.772 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -84.87 145.14 27.96 Favored 'General case' 0 N--CA 1.461 0.106 0 O-C-N 123.37 0.419 . . . . 0.0 110.157 -179.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.614 HD12 ' HD2' ' A' ' 20' ' ' LYS . 51.2 mt -141.19 79.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.4 ' HA ' ' CB ' ' A' ' 19' ' ' SER . 13.5 m-85 -45.79 -66.94 0.33 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 2.1 t30 -64.38 -67.07 0.46 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 68' ' ' ASN . . . 78.22 123.75 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.345 0.658 . . . . 0.0 110.926 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.822 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.4 OUTLIER -144.24 159.77 42.1 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.069 0.462 . . . . 0.0 110.737 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.3 pt -50.23 -27.79 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -71.19 -41.42 70.33 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -64.08 -34.05 77.15 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.98 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.548 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -52.76 102.87 0.06 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.75 178.23 46.59 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.656 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.564 HG23 ' HB ' ' A' ' 92' ' ' THR . 1.1 mp -80.77 100.58 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 117.051 0.426 . . . . 0.0 110.437 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.642 ' CD2' HD11 ' A' ' 64' ' ' LEU . 60.8 m-85 -73.32 174.57 7.91 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -135.01 154.27 51.78 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.483 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -140.31 101.26 4.09 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 90' ' ' GLU . 5.0 t -106.89 137.41 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -176.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -120.39 142.42 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.643 HG23 ' HG2' ' A' ' 88' ' ' GLN . 2.4 m -128.2 126.31 40.74 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.89 -175.84 2.27 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.752 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -78.18 -39.54 40.47 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.181 0.301 . . . . 0.0 111.04 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.38 -33.84 65.24 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.394 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.02 -8.52 4.16 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-O 119.72 -0.489 . . . . 0.0 114.013 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.3 m -62.58 110.32 1.66 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.687 0.744 . . . . 0.0 110.61 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.643 ' HG2' HG23 ' A' ' 82' ' ' THR . 35.7 mt-30 -103.07 134.36 46.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.889 0.376 . . . . 0.0 111.784 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.402 ' O ' HG21 ' A' ' 5' ' ' VAL . 7.8 t -131.22 115.01 15.77 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.582 ' HB3' HG13 ' A' ' 80' ' ' VAL . 7.0 pt-20 -112.1 -176.97 3.05 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -177.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.5 172.77 16.04 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.34 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.564 ' HB ' HG23 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -145.23 152.29 39.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.66 0.266 . . . . 0.0 110.535 179.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.648 HG21 ' CD1' ' A' ' 22' ' ' PHE . 7.4 p -135.55 117.71 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.126 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -71.7 92.24 1.17 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.084 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.485 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 14.6 t -95.09 112.73 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.476 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.95 155.54 17.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.948 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.822 HD12 ' O ' ' A' ' 70' ' ' ASN . 11.2 mt -144.04 135.49 22.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.144 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.67 127.62 37.32 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.229 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.951 -179.901 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.467 HD22 HG22 ' A' ' 87' ' ' THR . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 120.625 0.25 . . . . 0.0 110.705 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.668 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -119.84 150.08 41.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.903 -179.571 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.572 HG21 ' O ' ' A' ' 89' ' ' SER . 17.1 t -147.35 138.14 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.456 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -155.31 125.84 6.86 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.878 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.672 HD11 ' HB2' ' A' ' 79' ' ' CYS . 71.2 mt -89.71 135.14 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -134.6 120.68 14.66 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 118.918 -0.563 . . . . 0.0 110.908 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -66.23 149.56 78.42 Favored 'Cis proline' 0 C--N 1.364 1.343 0 CA-C-N 120.531 1.225 . . . . 0.0 113.053 -0.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.642 ' O ' HG23 ' A' ' 93' ' ' VAL . 78.1 p -71.72 -40.4 69.49 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.888 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -112.16 120.2 40.99 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.64 75.74 0.21 Allowed Glycine 0 C--N 1.341 0.854 0 N-CA-C 114.542 0.577 . . . . 0.0 114.542 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.583 ' C ' HD12 ' A' ' 14' ' ' ILE . 25.8 mt-10 -81.24 115.25 20.54 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.583 HD12 ' C ' ' A' ' 13' ' ' GLU . 2.9 mp -141.74 162.17 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.411 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.34 153.94 18.26 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.94 0.4 . . . . 0.0 110.488 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 69' ' ' ALA . 47.1 t -63.01 141.18 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.093 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.8 -13.1 67.68 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.188 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -102.61 159.51 15.39 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.2 p -94.35 168.51 10.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.578 0.228 . . . . 0.0 110.648 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.79 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 2.3 pttt -167.0 115.34 0.83 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.222 -178.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.469 ' HB3' HG23 ' A' ' 65' ' ' THR . 45.1 p90 -120.66 151.79 39.03 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.69 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -131.74 122.68 26.26 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.264 0.554 . . . . 0.0 111.339 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp -79.81 114.43 18.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.718 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 t -90.19 104.32 16.91 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.075 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -95.44 166.99 11.6 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.512 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.0 m -139.58 171.48 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.691 0.281 . . . . 0.0 111.596 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.668 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.234 0.274 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.041 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.465 ' O ' HG22 ' A' ' 81' ' ' VAL . 30.1 t70 . . . . . 0 N--CA 1.464 0.248 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.679 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.6 mp -130.51 152.17 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 123.322 0.389 . . . . 0.0 111.205 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.5 m -152.68 157.66 41.24 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.297 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.446 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 60.5 m95 -131.98 122.38 25.45 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -119.22 111.95 18.87 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 p -57.02 152.83 26.65 Favored Pre-proline 0 C--O 1.244 0.793 0 CA-C-O 119.327 -0.368 . . . . 0.0 110.783 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 C--N 1.379 2.135 0 C-N-CA 125.273 3.982 . . . . 0.0 114.15 -178.923 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 14.2 tttt . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.469 HD22 HG21 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -91.89 158.15 16.45 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.797 -179.301 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.6 m -75.25 147.22 82.65 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.451 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.47 -27.16 81.02 Favored 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 122.39 2.06 . . . . 0.0 113.066 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -148.63 79.24 1.43 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.004 0.431 . . . . 0.0 110.807 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.72 -68.45 0.79 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.991 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -150.95 -79.26 0.12 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -99.7 -32.77 10.89 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.554 HG12 HG23 ' A' ' 66' ' ' ILE . 63.3 mt -88.53 100.4 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 120.868 0.366 . . . . 0.0 111.212 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.6 t -107.19 123.21 47.94 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.027 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 55' ' ' VAL . 20.9 t -95.91 158.13 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.268 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.415 ' N ' HG12 ' A' ' 54' ' ' VAL . 11.3 m -150.54 172.5 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 120.938 0.399 . . . . 0.0 111.642 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.7 m-90 -142.23 117.0 9.83 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.55 -79.55 0.57 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -59.48 -179.92 0.1 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.598 0.181 . . . . 0.0 111.024 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -57.08 -32.35 66.18 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -136.99 -12.37 1.69 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.8 t -85.25 139.75 31.39 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 118.734 0.697 . . . . 0.0 111.499 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.679 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.8 m -126.0 -169.37 2.0 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.268 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.3 m -160.53 132.92 6.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.738 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -99.98 99.08 9.78 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.225 178.635 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -92.38 131.4 37.59 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.242 0.339 . . . . 0.0 110.092 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.554 HG23 HG12 ' A' ' 52' ' ' ILE . 63.7 mt -130.1 93.14 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -60.68 -116.06 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 CA-C-O 118.895 -0.574 . . . . 0.0 111.199 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -51.48 95.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.912 1.233 . . . . 0.0 110.876 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.837 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -75.22 154.05 37.77 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.883 -178.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.785 ' O ' HD12 ' A' ' 97' ' ' ILE . 1.1 p30 -148.34 154.13 39.55 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.382 0.61 . . . . 0.0 111.326 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.4 pt -53.42 -25.97 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -71.53 -40.52 70.02 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.29 -34.23 77.84 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.584 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.519 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -50.89 108.4 0.24 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.49 179.69 48.83 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 121.411 -0.423 . . . . 0.0 112.299 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.731 HD13 ' HA ' ' A' ' 94' ' ' ASN . 23.0 mm -82.04 90.26 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 122.152 0.181 . . . . 0.0 111.459 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.738 ' CD2' HD11 ' A' ' 64' ' ' LEU . 40.3 m-85 -67.68 176.0 2.67 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -136.58 159.0 43.12 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.672 ' HB2' HD11 ' A' ' 7' ' ' ILE . 8.3 t -140.4 92.54 2.53 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.705 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.505 HG13 ' HB3' ' A' ' 90' ' ' GLU . 5.2 t -96.51 128.74 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 34' ' ' ASP . 2.3 t -112.92 159.1 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.73 HG23 ' HG2' ' A' ' 88' ' ' GLN . 1.5 m -136.34 154.06 50.96 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.47 -172.66 2.2 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.315 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -76.79 -45.6 28.2 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.233 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -74.74 -32.01 61.97 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 141.73 -9.88 2.6 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.402 -0.666 . . . . 0.0 114.433 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.467 HG22 HD22 ' A' ' 3' ' ' LEU . 49.6 m -63.79 116.98 6.27 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 117.98 0.89 . . . . 0.0 110.336 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.73 ' HG2' HG23 ' A' ' 82' ' ' THR . 8.2 mt-30 -108.92 135.77 49.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.466 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.572 ' O ' HG21 ' A' ' 5' ' ' VAL . 21.8 t -122.0 108.38 13.32 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.505 ' HB3' HG13 ' A' ' 80' ' ' VAL . 6.2 pt-20 -99.78 179.83 4.4 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.2 -179.39 7.48 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.716 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.26 152.56 31.31 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.025 0.44 . . . . 0.0 111.478 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 10' ' ' SER . 2.7 p -132.01 119.87 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.34 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.731 ' HA ' HD13 ' A' ' 76' ' ' ILE . 1.3 t-20 -80.72 88.4 5.78 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.524 HG22 HG22 ' A' ' 93' ' ' VAL . 3.5 t -91.96 124.66 44.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.934 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -111.99 155.19 24.15 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.585 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.837 HD13 ' HB1' ' A' ' 69' ' ' ALA . 7.9 mt -145.96 132.04 13.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.697 177.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -119.29 125.65 49.59 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.535 -178.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.856 -179.844 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.519 HD11 ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.75 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 10.8 tp-100 -99.95 152.01 20.67 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.518 HG21 ' O ' ' A' ' 89' ' ' SER . 2.0 t -146.57 146.76 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -158.13 127.95 5.97 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.705 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.458 HD11 ' HB3' ' A' ' 79' ' ' CYS . 42.4 mt -94.2 142.83 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.2 t -124.46 122.91 25.87 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-O 119.21 -0.424 . . . . 0.0 110.03 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.49 -171.17 9.36 Favored 'Cis proline' 0 C--N 1.366 1.452 0 CA-C-N 119.925 1.009 . . . . 0.0 112.361 -0.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.3 p -85.83 -50.22 7.3 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.309 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -125.38 99.98 6.29 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.733 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.28 156.55 37.6 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.874 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -151.75 104.92 3.07 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.3 mp -130.15 166.85 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.806 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.6 155.46 18.27 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.603 0.716 . . . . 0.0 111.339 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 69' ' ' ALA . 17.0 t -65.88 138.49 22.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.887 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.87 -16.96 60.11 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.312 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -115.52 149.94 37.35 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 117.87 0.835 . . . . 0.0 110.116 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.436 ' CB ' ' HA ' ' A' ' 67' ' ' TYR . 60.4 p -79.86 165.58 22.55 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.821 ' HE3' HD12 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -158.77 119.88 3.36 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.267 -179.646 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.726 ' HB3' HG23 ' A' ' 65' ' ' THR . 39.6 p90 -112.8 153.57 27.63 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.538 0.209 . . . . 0.0 111.245 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.713 ' CD2' HG21 ' A' ' 93' ' ' VAL . 78.3 m-85 -129.33 113.58 15.15 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.271 0.558 . . . . 0.0 111.234 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.594 HD23 ' NE2' ' A' ' 25' ' ' GLN . 12.1 tp -78.42 111.73 14.73 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -177.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.472 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 43.7 t -93.4 90.1 6.6 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.594 ' NE2' HD23 ' A' ' 23' ' ' LEU . 7.6 mt-30 -86.7 157.51 19.63 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.861 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.666 HG21 ' CB ' ' A' ' 60' ' ' ASP . 30.7 m -124.96 169.15 16.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.448 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.75 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.234 0.271 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.503 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 . . . . . 0 N--CA 1.466 0.342 0 N-CA-C 111.207 0.077 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 35' ' ' ILE . 4.7 mp -77.74 156.62 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.183 0.516 . . . . 0.0 111.411 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.409 ' N ' HG22 ' A' ' 35' ' ' ILE . 4.7 m -152.36 157.74 41.72 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.087 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.472 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 39.8 m95 -135.13 109.13 8.17 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 117.61 0.187 . . . . 0.0 110.934 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -107.73 112.07 24.57 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.593 ' HB3' HD23 ' A' ' 45' ' ' LEU . 56.0 p -62.33 153.78 74.33 Favored Pre-proline 0 C--O 1.246 0.918 0 CA-C-O 119.159 -0.448 . . . . 0.0 110.535 178.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo . . . . . 0 C--N 1.382 2.334 1 C-N-CA 125.938 4.425 . . . . 0.0 115.038 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 8.6 ttpp . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.593 HD23 ' HB3' ' A' ' 39' ' ' SER . 4.0 pp -69.85 148.05 49.56 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.542 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.36 150.75 95.37 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.067 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.88 -30.84 6.96 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 122.286 1.99 . . . . 0.0 112.579 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -120.61 52.13 1.19 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.028 0.442 . . . . 0.0 111.254 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -68.81 -82.2 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.352 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -150.98 -73.17 0.16 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -98.99 -31.56 11.74 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.689 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.579 HG12 HG23 ' A' ' 66' ' ' ILE . 37.6 mt -89.05 101.66 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.735 0.302 . . . . 0.0 110.405 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.0 t -108.42 122.77 47.7 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.157 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 55' ' ' VAL . 19.3 t -95.63 159.62 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.407 ' N ' HG12 ' A' ' 54' ' ' VAL . 9.8 p -153.97 146.95 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.077 0.465 . . . . 0.0 112.239 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 21.2 m-90 -123.73 112.06 16.9 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -109.49 -74.35 0.66 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.745 1.016 . . . . 0.0 113.745 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -60.74 -175.16 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -53.26 -36.55 61.23 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.745 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.666 ' CB ' HG21 ' A' ' 26' ' ' VAL . 1.9 m-20 -153.96 22.32 0.51 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.2 t -103.47 139.23 39.1 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.473 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.5 m -134.64 -174.03 3.46 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.603 -178.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -155.8 145.29 21.0 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.022 0.439 . . . . 0.0 111.256 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.664 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -113.29 91.23 3.57 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.247 179.466 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.726 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -87.71 138.02 31.83 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.338 0.399 . . . . 0.0 110.295 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.821 HD12 ' HE3' ' A' ' 20' ' ' LYS . 58.9 mt -134.79 87.29 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.436 ' HA ' ' CB ' ' A' ' 19' ' ' SER . 12.5 m-85 -52.89 -67.46 0.25 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -176.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 1.2 t-20 -60.57 -63.64 1.23 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -177.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.44 ' O ' HG13 ' A' ' 16' ' ' VAL . . . 73.6 120.55 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.883 0.473 . . . . 0.0 110.952 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.797 ' O ' HD12 ' A' ' 97' ' ' ILE . 4.1 m-80 -141.71 162.4 35.57 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.033 0.444 . . . . 0.0 110.356 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.6 pt -54.83 -24.59 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -72.95 -40.45 65.35 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -66.52 -32.97 74.66 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.792 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.501 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -50.58 114.65 1.19 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.26 171.45 37.89 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.037 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.0 mt -76.93 95.86 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.786 0.293 . . . . 0.0 111.691 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.664 ' CD2' HD11 ' A' ' 64' ' ' LEU . 46.5 m-85 -70.23 179.03 2.55 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -140.66 156.25 46.29 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 120.757 0.313 . . . . 0.0 111.626 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.458 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -142.96 102.38 4.0 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 90' ' ' GLU . 7.3 t -104.59 139.78 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.11 137.96 53.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.592 HG23 ' HB3' ' A' ' 88' ' ' GLN . 3.4 m -127.93 150.95 49.66 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.51 -173.65 2.7 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.532 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -73.01 -52.86 12.82 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.504 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -65.47 -36.26 83.35 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 146.78 -19.23 1.63 Allowed Glycine 0 C--N 1.34 0.76 0 C-N-CA 121.161 -0.542 . . . . 0.0 113.644 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.519 ' O ' HD11 ' A' ' 3' ' ' LEU . 77.5 m -57.85 109.1 0.66 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.39 0.595 . . . . 0.0 111.213 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.592 ' HB3' HG23 ' A' ' 82' ' ' THR . 1.0 OUTLIER -119.67 134.26 55.3 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.682 -179.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.518 ' O ' HG21 ' A' ' 5' ' ' VAL . 40.9 t -110.96 117.64 33.9 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.423 ' HB3' HG13 ' A' ' 80' ' ' VAL . 12.6 pt-20 -105.65 -178.57 3.69 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.41 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -150.46 172.38 15.54 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.255 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.01 153.23 36.17 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.46 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.713 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.7 p -141.26 111.67 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.757 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.68 89.51 0.74 Allowed 'General case' 0 C--O 1.235 0.293 0 O-C-N 123.408 0.442 . . . . 0.0 110.281 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.496 HG11 ' NZ ' ' A' ' 20' ' ' LYS . 21.3 t -87.29 138.05 19.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.589 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -122.83 156.96 33.51 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.625 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.797 HD12 ' O ' ' A' ' 70' ' ' ASN . 7.2 mt -147.11 136.02 15.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.785 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.7 133.36 43.42 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.335 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.949 -179.664 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.549 HD11 ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 111.498 0.185 . . . . 0.0 111.498 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.658 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 11.0 tp-100 -92.78 149.53 21.23 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 89' ' ' SER . 1.7 t -144.02 146.4 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 123.162 0.289 . . . . 0.0 110.933 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -160.38 133.06 6.41 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.64 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.53 HD11 ' HB3' ' A' ' 79' ' ' CYS . 33.1 mt -99.72 124.31 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 36.3 t -108.1 128.44 25.73 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.598 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.77 -172.9 11.78 Favored 'Cis proline' 0 C--N 1.365 1.433 0 CA-C-N 119.946 1.016 . . . . 0.0 112.327 -0.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.9 p -78.84 -48.82 14.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.932 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -132.0 112.34 12.29 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.883 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.08 106.99 2.34 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.071 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.55 ' C ' HD12 ' A' ' 14' ' ' ILE . 11.0 mt-10 -88.31 132.54 34.37 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.55 HD12 ' C ' ' A' ' 13' ' ' GLU . 4.1 mp -145.47 162.87 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 120.628 0.252 . . . . 0.0 110.697 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.41 154.34 19.17 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.284 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 69' ' ' ALA . 43.6 t -61.53 136.3 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.231 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.71 -6.81 74.09 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.417 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -104.39 158.18 16.64 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.3 p -101.48 149.71 23.79 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.628 0.251 . . . . 0.0 111.58 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.576 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -147.25 119.11 8.1 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.607 -178.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.773 ' HB3' HG23 ' A' ' 65' ' ' THR . 20.5 p90 -113.74 148.13 37.02 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.684 0.278 . . . . 0.0 110.537 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.66 ' CD2' HG21 ' A' ' 93' ' ' VAL . 58.9 m-85 -125.92 144.74 50.56 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.048 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.21 110.03 22.28 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.405 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 42.5 t -87.48 86.35 7.22 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -92.4 161.62 14.58 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.014 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.746 HG21 ' HB2' ' A' ' 60' ' ' ASP . 33.9 m -126.93 175.46 8.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.658 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . . . . . . 0 C--O 1.236 0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.727 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 t0 . . . . . 0 N--CA 1.462 0.151 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 60' ' ' ASP . 4.7 mp -75.4 156.1 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.294 0.568 . . . . 0.0 112.173 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.42 ' N ' HG22 ' A' ' 35' ' ' ILE . 5.0 m -157.55 162.96 38.82 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.499 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.405 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 46.1 m95 -135.61 130.36 34.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 110.53 -0.174 . . . . 0.0 110.53 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 87.1 m-85 -125.54 112.68 16.49 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.449 ' OG ' HD13 ' A' ' 45' ' ' LEU . 4.7 p -57.71 154.67 25.1 Favored Pre-proline 0 C--O 1.251 1.152 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo . . . . . 0 C--N 1.377 2.042 0 C-N-CA 124.649 3.566 . . . . 0.0 116.084 -178.375 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 10.0 tttt . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 120.57 0.224 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.477 ' CD2' HG21 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -131.18 122.02 25.87 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.047 -179.458 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.98 158.91 73.83 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.252 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -83.52 -13.76 8.31 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 122.511 2.141 . . . . 0.0 113.808 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -153.85 84.74 1.16 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.011 0.434 . . . . 0.0 110.536 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.91 -57.75 0.81 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.977 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -137.24 -159.17 0.93 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -48.91 -26.47 2.49 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.477 HG21 ' CD2' ' A' ' 45' ' ' LEU . 61.7 mt -82.58 122.78 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.8 t -134.44 124.29 25.41 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.971 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.6 t -98.33 156.91 3.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.218 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.2 p -152.21 141.29 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.876 0.37 . . . . 0.0 111.735 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -117.11 121.91 42.62 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.44 -76.73 0.57 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -58.04 -175.68 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -56.33 -37.55 70.13 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.954 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.746 ' HB2' HG21 ' A' ' 26' ' ' VAL . 30.0 m-20 -148.98 20.87 0.99 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.7 t -105.25 142.05 35.69 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 120.65 0.262 . . . . 0.0 110.441 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.462 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.9 m -138.36 -176.53 4.49 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.023 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 22' ' ' PHE . 2.0 m -157.69 136.69 11.61 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.921 0.391 . . . . 0.0 111.629 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.421 HD21 ' CD2' ' A' ' 77' ' ' TYR . 15.8 tp -96.08 141.67 29.19 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.773 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -136.46 96.46 3.36 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.772 0.715 . . . . 0.0 112.676 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.493 HD13 ' HZ3' ' A' ' 20' ' ' LYS . 1.6 mt -92.47 90.74 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.469 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -57.51 -96.05 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.975 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.46 97.64 0.78 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.066 0.848 . . . . 0.0 110.142 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.553 ' O ' HG13 ' A' ' 16' ' ' VAL . . . -77.76 157.52 29.99 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -152.21 158.18 42.5 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.059 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -52.34 -24.82 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -72.54 -42.72 64.41 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 110.478 -0.194 . . . . 0.0 110.478 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.441 ' OD1' HD11 ' A' ' 52' ' ' ILE . 32.6 m-20 -63.73 -33.69 76.21 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.03 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.589 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -51.12 105.57 0.11 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.95 178.92 48.11 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.485 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.643 HD13 ' HA ' ' A' ' 94' ' ' ASN . 24.6 mm -81.0 92.89 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 123.394 0.114 . . . . 0.0 110.758 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.421 ' CD2' HD21 ' A' ' 64' ' ' LEU . 67.4 m-85 -68.24 161.74 26.53 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -127.79 155.75 43.57 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.53 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -142.09 103.21 4.27 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.403 HG13 ' HB3' ' A' ' 90' ' ' GLU . 6.8 t -106.74 141.96 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.03 140.47 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.678 HG23 ' HG2' ' A' ' 88' ' ' GLN . 1.2 m -120.5 138.1 54.01 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.495 ' HB2' ' CD2' ' A' ' 3' ' ' LEU . . . -89.22 -174.27 4.35 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.11 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -73.47 -58.3 3.4 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.396 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -63.68 -22.78 67.08 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 120.9 19.77 3.58 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-O 119.785 -0.453 . . . . 0.0 113.811 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.549 ' O ' HD11 ' A' ' 3' ' ' LEU . 93.7 m -84.68 109.05 17.73 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.678 ' HG2' HG23 ' A' ' 82' ' ' THR . 22.8 mt-30 -101.93 130.82 48.52 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.516 ' HB2' HD12 ' A' ' 3' ' ' LEU . 7.3 t -122.2 113.98 20.21 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.403 ' HB3' HG13 ' A' ' 80' ' ' VAL . 6.2 pt-20 -108.68 -177.84 3.43 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.402 ' HB1' HG13 ' A' ' 7' ' ' ILE . . . -150.16 170.44 18.93 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.325 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.45 154.76 39.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.742 0.306 . . . . 0.0 111.113 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.66 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.1 p -143.2 121.04 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.963 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.643 ' HA ' HD13 ' A' ' 76' ' ' ILE . 1.4 t-20 -76.85 95.62 4.12 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.845 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.428 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 20.2 t -97.07 108.12 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.524 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -90.46 149.97 22.01 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.599 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.589 HD12 ' N ' ' A' ' 74' ' ' ALA . 9.8 mt -146.56 115.41 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.731 0.3 . . . . 0.0 110.424 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.17 134.2 55.07 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.961 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.82 179.87 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.357 0.122 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -156.49 -43.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 120.752 0.311 . . . . 0.0 111.228 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.427 HD12 HG22 ' A' ' 87' ' ' THR . 16.2 mt -57.21 134.06 55.59 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.594 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -139.39 141.73 37.54 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.746 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 t -149.38 143.32 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 O-C-N 123.253 0.346 . . . . 0.0 110.867 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -160.07 127.07 4.44 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.771 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' A' ' 79' ' ' CYS . 45.7 mt -99.74 138.63 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.367 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.7 t -128.49 135.48 27.63 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.671 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.429 ' O ' HG23 ' A' ' 93' ' ' VAL . 91.4 Cg_endo -77.23 170.26 71.93 Favored 'Cis proline' 0 C--N 1.366 1.492 0 C-N-CA 124.767 -0.93 . . . . 0.0 111.815 -0.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.2 p -66.63 -45.08 80.21 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.809 0.338 . . . . 0.0 110.323 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -131.8 110.86 11.15 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.398 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -111.54 97.94 0.98 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.756 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.805 ' O ' HD13 ' A' ' 14' ' ' ILE . 16.2 mt-10 -78.62 134.44 37.18 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.805 HD13 ' O ' ' A' ' 13' ' ' GLU . 4.3 mm -136.84 170.01 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.401 -178.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.492 ' H ' HG22 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -119.03 156.68 29.22 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.18 137.81 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.53 -8.75 78.49 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.6 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.426 ' HB2' HG22 ' A' ' 14' ' ' ILE . 4.0 mm-40 -100.03 155.05 17.92 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 117.302 0.551 . . . . 0.0 109.751 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.1 p -98.62 163.53 12.62 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.582 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -164.16 119.52 1.54 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -178.137 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.772 ' HB3' HG23 ' A' ' 65' ' ' THR . 31.5 p90 -112.97 141.4 46.84 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.601 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.644 ' CD2' HG21 ' A' ' 93' ' ' VAL . 94.7 m-85 -117.79 118.49 32.17 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.839 0.352 . . . . 0.0 111.205 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.94 115.07 18.39 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.9 t -99.6 94.89 6.62 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.355 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -88.91 158.75 17.97 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.744 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.661 HG21 ' CB ' ' A' ' 60' ' ' ASP . 32.1 m -138.49 171.77 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -158.72 137.61 11.23 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.51 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 140.5 -161.44 26.56 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.551 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -173.32 37.97 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.894 0.378 . . . . 0.0 110.761 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.19 79.24 9.16 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.067 0.46 . . . . 0.0 111.173 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm 60.22 -167.87 0.17 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.5 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -64.31 133.66 53.13 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -116.53 145.4 43.37 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.988 0.423 . . . . 0.0 111.712 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.638 ' C ' HD12 ' A' ' 35' ' ' ILE . 11.2 m-20 -121.85 164.91 16.72 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.485 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.638 HD12 ' C ' ' A' ' 34' ' ' ASP . 3.6 mp -127.9 146.83 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 123.373 0.421 . . . . 0.0 110.787 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 m -144.47 158.94 43.51 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.308 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.457 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 55.4 m95 -133.7 128.02 34.09 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.04 0.212 . . . . 0.0 110.44 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 94.0 m-85 -116.6 117.98 31.36 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.7 p -66.61 149.43 98.19 Favored Pre-proline 0 C--O 1.247 0.932 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.477 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -49.93 -16.85 1.84 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 124.741 3.627 . . . . 0.0 115.516 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -79.14 7.71 7.06 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 117.972 0.351 . . . . 0.0 111.83 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.78 41.75 22.79 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 111.824 -0.511 . . . . 0.0 111.824 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -163.79 135.79 4.93 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 119.658 -0.817 . . . . 0.0 112.995 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 31.0 tttt -54.88 143.37 26.16 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.531 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 pp -109.42 143.62 38.76 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.58 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.9 m -84.24 157.11 62.73 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.219 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.64 -27.6 3.97 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.444 2.096 . . . . 0.0 112.731 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -118.34 65.86 0.76 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.369 0.604 . . . . 0.0 110.025 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.11 -59.7 1.31 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.564 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -140.95 -162.21 1.33 Allowed 'General case' 0 CA--C 1.54 0.575 0 O-C-N 123.008 0.193 . . . . 0.0 110.508 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -51.76 -23.06 4.11 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.664 HG23 HG12 ' A' ' 66' ' ' ILE . 46.3 mt -82.18 99.15 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.7 t -105.04 122.88 46.79 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.949 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.414 HG22 HD23 ' A' ' 64' ' ' LEU . 16.3 t -93.07 158.03 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.139 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 p -151.55 147.9 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 20.4 m-90 -122.1 114.9 21.55 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.51 -80.35 0.58 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -56.24 -176.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -51.17 -37.83 48.67 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.661 ' CB ' HG21 ' A' ' 26' ' ' VAL . 5.4 m-20 -152.78 22.68 0.59 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 p -99.6 138.89 36.05 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.554 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.1 m -143.28 134.4 25.74 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.104 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.455 HG22 ' HB2' ' A' ' 21' ' ' PHE . 1.2 m -103.11 141.05 36.5 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 111.626 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.614 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -103.66 94.32 5.39 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.324 179.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.772 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -85.96 139.59 31.07 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 123.468 0.48 . . . . 0.0 110.351 -179.278 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.664 HG12 HG23 ' A' ' 52' ' ' ILE . 67.1 mt -137.44 93.22 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -60.2 -113.88 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.473 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.21 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.81 1.186 . . . . 0.0 110.967 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.864 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -69.84 148.92 48.45 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.16 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.768 ' O ' HD12 ' A' ' 97' ' ' ILE . 12.1 m-80 -141.52 154.68 45.64 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.715 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.5 pt -53.9 -24.48 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -71.51 -40.97 69.81 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.421 ' OD1' HD11 ' A' ' 52' ' ' ILE . 77.8 m-20 -66.47 -35.53 80.5 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.885 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.568 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -51.37 107.81 0.21 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.69 -179.35 47.81 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.446 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.59 HD13 ' HA ' ' A' ' 94' ' ' ASN . 32.2 mm -82.18 95.22 3.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.588 0.194 . . . . 0.0 111.006 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.614 ' CD2' HD11 ' A' ' 64' ' ' LEU . 70.0 m-85 -71.76 160.12 33.16 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -128.09 158.15 38.78 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.908 0.385 . . . . 0.0 111.563 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.533 ' HB2' HD11 ' A' ' 7' ' ' ILE . 9.5 t -138.93 99.86 3.89 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 89' ' ' SER . 4.4 t -109.8 126.33 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 121.066 0.46 . . . . 0.0 112.116 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.503 HG22 HG13 ' A' ' 35' ' ' ILE . 2.3 t -102.72 155.1 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.699 HG23 ' HB3' ' A' ' 88' ' ' GLN . 0.5 OUTLIER -132.66 143.45 49.66 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.13 176.5 6.95 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.371 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.94 -40.77 87.66 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.199 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.8 -36.24 28.63 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.392 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 150.06 -18.15 1.07 Allowed Glycine 0 C--N 1.339 0.75 0 CA-C-O 119.556 -0.58 . . . . 0.0 113.813 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.427 HG22 HD12 ' A' ' 3' ' ' LEU . 55.7 m -58.52 103.46 0.16 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.876 0.838 . . . . 0.0 110.702 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.699 ' HB3' HG23 ' A' ' 82' ' ' THR . 2.1 pt20 -109.39 132.54 54.03 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.796 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.497 ' O ' HG13 ' A' ' 80' ' ' VAL . 66.1 p -99.65 -176.86 3.39 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -161.3 175.51 12.19 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -159.7 176.42 12.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.127 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.2 163.86 39.61 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.644 HG21 ' CD2' ' A' ' 22' ' ' PHE . 8.5 p -152.63 123.11 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.75 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.59 ' HA ' HD13 ' A' ' 76' ' ' ILE . 1.9 t-20 -80.97 96.03 6.96 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.988 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.433 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 14.0 t -97.94 123.59 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.531 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -108.53 160.28 16.04 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.911 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.864 HD13 ' HB1' ' A' ' 69' ' ' ALA . 12.0 mt -151.58 125.74 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.684 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -116.58 127.98 54.99 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.342 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.735 -179.873 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.46 0.171 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.985 HG23 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -152.87 37.29 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 121.103 0.478 . . . . 0.0 110.977 -179.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.493 HD11 ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -135.26 124.3 24.28 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.957 179.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.722 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 9.2 tp-100 -127.18 148.37 50.18 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.422 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 t -145.76 147.23 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 123.12 0.262 . . . . 0.0 111.445 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -160.3 126.2 4.09 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.323 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.516 HD11 ' HB2' ' A' ' 79' ' ' CYS . 43.7 mt -97.28 139.48 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.656 0.265 . . . . 0.0 110.648 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.6 t -128.17 130.86 23.55 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.942 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.56 172.03 64.51 Favored 'Cis proline' 0 C--N 1.365 1.443 0 CA-C-N 119.73 0.939 . . . . 0.0 112.377 -0.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.3 p -69.83 -53.2 19.23 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.337 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -129.96 107.61 9.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.211 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.41 158.97 24.81 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 116.077 -0.51 . . . . 0.0 113.545 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -143.37 119.5 10.76 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.13 164.24 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.711 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.97 157.62 16.73 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 69' ' ' ALA . 38.9 t -63.69 138.49 22.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.87 -15.18 63.68 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.436 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -99.04 162.63 12.96 Favored 'General case' 0 C--N 1.348 0.511 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.1 p -102.73 168.35 9.31 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.639 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -163.94 121.44 1.77 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.483 -178.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.753 ' HB3' HG23 ' A' ' 65' ' ' THR . 35.7 p90 -115.05 142.29 46.84 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.622 178.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.644 ' CD2' HG21 ' A' ' 93' ' ' VAL . 93.4 m-85 -118.42 118.4 31.64 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.004 0.43 . . . . 0.0 111.283 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.0 tp -79.21 116.44 19.48 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.9 t -97.93 100.65 12.01 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.404 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 -91.4 158.78 16.32 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.777 HG21 ' CB ' ' A' ' 60' ' ' ASP . 34.1 m -134.86 174.36 13.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.722 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -159.27 118.55 2.96 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.764 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 140.11 179.45 17.9 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.982 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -147.9 78.6 1.45 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.117 0.484 . . . . 0.0 110.777 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.985 ' HB2' HG23 ' A' ' 2' ' ' VAL . . . -100.23 24.35 8.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.261 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? 59.98 -86.48 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -48.51 -28.45 3.36 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -3.63 106.47 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.551 ' O ' HG22 ' A' ' 81' ' ' VAL . 54.7 m-20 -121.1 168.35 11.65 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.906 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.518 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.2 mp -130.21 153.39 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 123.318 0.386 . . . . 0.0 110.856 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.2 m -152.31 160.63 43.3 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.34 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.463 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 59.1 m95 -132.63 130.82 40.68 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.216 0.206 . . . . 0.0 110.792 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 67.3 m-85 -122.12 117.96 27.53 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.9 p -62.51 152.85 79.42 Favored Pre-proline 0 C--O 1.253 1.285 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.425 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.32 -12.34 5.55 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 124.472 3.448 . . . . 0.0 115.947 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -76.73 -3.89 40.48 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.104 0.411 . . . . 0.0 111.388 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.03 41.04 4.43 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.758 -0.468 . . . . 0.0 112.019 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -162.14 177.15 9.95 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 119.76 -0.776 . . . . 0.0 112.122 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 19.1 tttt -91.41 149.58 21.65 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.522 0.514 . . . . 0.0 111.021 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 45' ' ' LEU . 1.0 OUTLIER -111.12 152.69 26.68 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.605 179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 m -79.36 163.05 61.36 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.341 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.22 -28.06 12.99 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.66 2.24 . . . . 0.0 112.696 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -139.41 72.99 1.41 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.13 0.491 . . . . 0.0 111.009 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -80.61 -68.76 0.65 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.992 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -156.67 -72.73 0.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -99.74 -35.85 9.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.426 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.539 HG12 HG23 ' A' ' 66' ' ' ILE . 48.7 mt -85.7 110.33 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.777 0.322 . . . . 0.0 110.78 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.3 t -114.49 118.66 34.4 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.659 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 55' ' ' VAL . 12.6 t -90.33 158.78 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.268 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.41 ' N ' HG12 ' A' ' 54' ' ' VAL . 12.3 p -153.99 152.09 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.963 0.411 . . . . 0.0 111.64 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 24.8 m-90 -123.16 104.56 9.25 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -91.16 -80.77 0.33 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -176.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -65.26 -177.92 0.44 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.41 0.148 . . . . 0.0 110.912 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.94 -33.73 62.53 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.777 ' CB ' HG21 ' A' ' 26' ' ' VAL . 45.3 m-20 -141.43 7.4 1.94 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.9 p -94.52 136.41 34.85 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.282 0.492 . . . . 0.0 110.459 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.518 ' OG ' HG21 ' A' ' 35' ' ' ILE . 0.7 OUTLIER -140.93 132.99 27.85 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.372 -178.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 m -102.89 146.3 28.51 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 111.921 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.622 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -111.47 94.95 5.23 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.532 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.753 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -85.18 142.49 29.43 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.822 0.344 . . . . 0.0 110.274 -179.534 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.539 HG23 HG12 ' A' ' 52' ' ' ILE . 67.9 mt -139.53 90.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -59.57 -113.46 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.304 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -53.28 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.968 1.258 . . . . 0.0 111.154 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.877 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -75.63 143.0 42.5 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.294 -178.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.757 ' O ' HD12 ' A' ' 97' ' ' ILE . 9.9 m-80 -136.11 153.49 51.28 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.689 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.492 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -52.67 -25.68 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -71.21 -42.15 69.31 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.432 ' OD2' HD11 ' A' ' 52' ' ' ILE . 4.6 m-20 -62.99 -34.72 78.14 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.678 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.535 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -53.28 112.03 0.8 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.67 179.06 47.69 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.547 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.828 HD13 ' HA ' ' A' ' 94' ' ' ASN . 23.4 mm -80.72 95.5 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 122.051 0.14 . . . . 0.0 111.175 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.622 ' CD2' HD11 ' A' ' 64' ' ' LEU . 61.0 m-85 -71.95 167.08 20.85 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -132.03 158.16 42.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 112.258 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.516 ' HB2' HD11 ' A' ' 7' ' ' ILE . 4.2 t -140.12 100.39 3.9 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.304 178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 89' ' ' SER . 5.2 t -107.67 129.7 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 111.872 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 34' ' ' ASP . 1.6 t -108.2 156.41 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.55 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.9 m -132.78 149.11 52.31 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.28 -173.65 3.14 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.692 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.69 -48.47 21.88 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.116 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -71.27 -37.81 71.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.23 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 150.0 -18.54 1.08 Allowed Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.06 -0.59 . . . . 0.0 113.86 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.493 ' O ' HD11 ' A' ' 3' ' ' LEU . 96.2 m -57.92 108.3 0.57 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.859 0.829 . . . . 0.0 110.582 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.55 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -113.53 134.55 54.62 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.265 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.569 ' O ' HG13 ' A' ' 80' ' ' VAL . 83.6 p -97.15 -177.89 4.0 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -160.53 171.76 18.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -154.51 172.83 17.17 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.009 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.79 155.76 38.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.728 0.299 . . . . 0.0 111.248 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.644 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.5 p -142.92 118.93 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.348 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.828 ' HA ' HD13 ' A' ' 76' ' ' ILE . 7.9 t30 -76.15 88.27 3.04 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.347 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.465 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 16.0 t -87.9 131.63 35.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.058 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.23 153.57 32.66 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.559 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.877 HD13 ' HB1' ' A' ' 69' ' ' ALA . 9.8 mt -145.67 128.61 10.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.563 178.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.77 133.24 53.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.358 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.929 -179.817 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.528 ' O ' HG13 ' A' ' 2' ' ' VAL . 6.4 ttm-85 . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.312 0.101 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.589 ' O ' HD12 ' A' ' 3' ' ' LEU . 2.9 m -159.64 49.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 121.039 0.447 . . . . 0.0 111.258 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.589 HD12 ' O ' ' A' ' 2' ' ' VAL . 1.4 mp -148.44 118.13 7.06 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.798 0.332 . . . . 0.0 111.583 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.649 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 10.6 tp-100 -138.74 140.55 38.72 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.232 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.533 HG21 ' O ' ' A' ' 89' ' ' SER . 11.4 t -144.92 141.25 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.672 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -157.37 124.82 5.25 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.587 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.516 HD11 ' HB2' ' A' ' 79' ' ' CYS . 48.6 mt -92.39 143.66 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.594 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.6 t -131.11 133.03 24.18 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.887 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.24 169.99 73.05 Favored 'Cis proline' 0 C--N 1.363 1.303 0 CA-C-N 119.719 0.935 . . . . 0.0 112.029 0.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 79.4 p -68.2 -42.15 80.3 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -133.47 111.87 11.08 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.289 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.451 ' O ' HD12 ' A' ' 14' ' ' ILE . . . -106.2 100.39 1.64 Allowed Glycine 0 C--N 1.341 0.855 0 C-N-CA 120.895 -0.669 . . . . 0.0 114.251 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.51 ' C ' HD12 ' A' ' 14' ' ' ILE . 0.8 OUTLIER -85.64 128.91 34.91 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.51 HD12 ' C ' ' A' ' 13' ' ' GLU . 5.0 mp -144.53 162.92 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.662 0.268 . . . . 0.0 110.733 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.17 156.45 17.7 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.729 0.3 . . . . 0.0 110.367 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.647 HG13 ' O ' ' A' ' 69' ' ' ALA . 28.4 t -62.91 138.55 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.999 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.1 -15.75 62.47 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.343 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -97.16 159.17 15.07 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.0 p -97.36 164.47 12.45 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.647 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -159.31 116.62 2.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -177.192 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.879 ' HB3' HG23 ' A' ' 65' ' ' THR . 39.1 p90 -111.52 143.28 42.63 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.64 0.257 . . . . 0.0 111.143 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.523 ' CZ ' HG22 ' A' ' 95' ' ' VAL . 85.5 m-85 -120.72 110.02 15.88 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.5 tp -77.56 112.53 14.44 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.2 t -94.05 108.17 20.02 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.208 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -96.88 155.37 16.8 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.755 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.62 HG21 ' CB ' ' A' ' 60' ' ' ASP . 30.1 m -129.24 175.49 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.649 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -168.57 124.26 0.96 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.828 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 166.24 153.45 7.76 Favored Glycine 0 C--N 1.34 0.764 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.452 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -104.67 31.27 4.83 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.714 0.257 . . . . 0.0 111.647 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.492 ' HB2' HG23 ' A' ' 2' ' ' VAL . . . -68.48 -178.8 1.19 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.853 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -86.43 -38.28 17.5 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.285 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -153.41 148.45 26.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.911 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -132.12 147.5 52.43 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -132.67 100.94 5.1 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.121 0.168 . . . . 0.0 111.133 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.634 HD11 ' HA ' ' A' ' 60' ' ' ASP . 4.2 mp -66.77 150.01 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.209 0.528 . . . . 0.0 112.115 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.3 m -150.46 155.54 39.72 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.463 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.478 ' O ' ' HA ' ' A' ' 44' ' ' LYS . 43.8 m95 -134.86 117.92 16.41 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 119.239 -0.41 . . . . 0.0 111.136 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -117.5 109.83 17.22 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.287 0.367 . . . . 0.0 111.885 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 p -59.89 154.67 47.11 Favored Pre-proline 0 C--O 1.246 0.905 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.941 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -29.12 -74.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.383 2.385 1 C-N-CA 125.696 4.264 . . . . 0.0 114.618 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.92 36.78 4.49 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.03 -16.78 4.3 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-O 119.41 -0.661 . . . . 0.0 113.198 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 71.04 -168.72 0.15 Allowed 'General case' 0 C--N 1.35 0.609 0 CA-C-N 117.958 0.879 . . . . 0.0 109.156 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 27.9 tttt -54.9 118.62 4.43 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.472 HD13 HG21 ' A' ' 52' ' ' ILE . 12.2 mt -77.95 175.9 9.62 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.587 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.5 m -94.28 156.11 39.17 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.884 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.91 -34.53 90.94 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.322 2.015 . . . . 0.0 112.5 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -152.69 63.6 0.8 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.229 0.538 . . . . 0.0 110.568 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.11 -73.58 0.12 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.577 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -147.84 -74.51 0.19 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.638 0.256 . . . . 0.0 110.782 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -99.35 -36.62 9.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.758 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.579 HG12 HG23 ' A' ' 66' ' ' ILE . 18.0 mt -84.64 104.96 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.936 0.398 . . . . 0.0 110.796 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.3 t -107.56 120.34 41.92 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.838 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.2 t -90.99 159.1 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.6 p -151.63 146.43 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.96 0.409 . . . . 0.0 111.839 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 23.1 m-90 -121.38 106.59 11.59 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -98.72 -79.97 0.47 Allowed 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -62.64 -177.63 0.16 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.653 0.263 . . . . 0.0 111.628 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -50.25 -35.92 28.97 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.634 ' HA ' HD11 ' A' ' 35' ' ' ILE . 42.0 m-20 -149.37 17.89 0.94 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.9 t -98.06 139.07 34.42 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.563 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -145.71 131.28 18.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -178.311 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.87 151.96 19.69 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.043 0.449 . . . . 0.0 111.958 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.605 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -114.25 92.9 4.12 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.879 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -87.43 139.99 29.99 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 123.382 0.426 . . . . 0.0 110.614 -179.027 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.579 HG23 HG12 ' A' ' 52' ' ' ILE . 49.3 mt -136.84 93.9 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -58.36 -107.59 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 119.049 -0.5 . . . . 0.0 111.251 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.42 95.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.796 1.18 . . . . 0.0 110.591 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.791 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -79.77 149.74 31.0 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.676 -178.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.764 ' O ' HD12 ' A' ' 97' ' ' ILE . 1.1 p30 -146.37 157.42 43.78 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.174 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.7 pt -53.86 -24.68 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -71.68 -39.87 69.95 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -67.07 -35.93 80.9 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.591 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -50.36 117.57 2.48 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.97 174.87 38.52 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.023 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.851 HD13 ' HA ' ' A' ' 94' ' ' ASN . 17.6 mm -73.75 91.27 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 122.18 0.192 . . . . 0.0 111.271 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.605 ' CD2' HD11 ' A' ' 64' ' ' LEU . 63.3 m-85 -68.43 172.6 5.83 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -135.32 158.21 44.95 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.516 ' HB2' HD11 ' A' ' 7' ' ' ILE . 12.3 t -142.0 97.78 3.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.149 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 90' ' ' GLU . 4.6 t -102.85 131.65 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.0 0.429 . . . . 0.0 111.931 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.87 139.84 43.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.643 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.9 m -125.71 143.99 50.8 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.582 ' HB2' HD11 ' A' ' 3' ' ' LEU . . . -93.26 -176.13 4.04 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.958 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -69.76 -57.41 5.14 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.076 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -60.55 -31.78 70.87 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 138.84 -18.85 3.16 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.477 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.8 m -59.55 107.81 0.64 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.335 0.568 . . . . 0.0 111.199 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.643 ' HB3' HG23 ' A' ' 82' ' ' THR . 1.1 pt20 -115.2 134.14 55.41 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.444 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.533 ' O ' HG21 ' A' ' 5' ' ' VAL . 31.8 t -115.12 119.76 37.5 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.458 ' HB3' HG13 ' A' ' 80' ' ' VAL . 18.6 pt-20 -104.63 -179.62 4.0 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -154.06 178.06 10.38 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.132 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.04 154.85 36.78 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.592 0.234 . . . . 0.0 111.051 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.505 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.2 p -138.86 123.17 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.965 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.851 ' HA ' HD13 ' A' ' 76' ' ' ILE . 6.0 t30 -75.2 96.91 3.39 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.26 0.553 . . . . 0.0 110.261 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.523 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 60.8 t -96.71 131.96 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.441 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -121.4 147.63 45.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.383 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.791 HD13 ' HB1' ' A' ' 69' ' ' ALA . 13.1 mt -141.25 137.22 33.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.22 134.01 37.68 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.948 -177.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.472 ' HB3' HG21 ' A' ' 16' ' ' VAL . 4.7 pt20 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.305 -0.855 . . . . 0.0 110.94 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.592 0.234 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.52 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 2.3 m -122.02 119.51 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.02 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.3 tp -168.72 118.16 0.72 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.252 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.649 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -135.85 136.47 40.61 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.654 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -143.77 142.66 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.46 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -156.43 158.83 37.99 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.127 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.421 HD11 ' HB2' ' A' ' 79' ' ' CYS . 50.9 mt -128.13 138.71 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.8 128.1 24.98 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.269 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.448 ' O ' HG23 ' A' ' 93' ' ' VAL . 98.5 Cg_endo -80.37 173.79 50.97 Favored 'Cis proline' 0 C--N 1.366 1.498 0 CA-C-N 119.68 0.922 . . . . 0.0 112.332 -0.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.8 p -69.66 -46.5 65.98 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.69 101.96 5.9 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.46 101.75 2.61 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.786 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.85 119.95 26.72 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.588 HD13 ' CB ' ' A' ' 20' ' ' LYS . 2.4 mp -135.6 166.57 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.42 161.6 18.83 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.481 0.657 . . . . 0.0 111.962 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 69' ' ' ALA . 57.6 t -65.42 137.4 25.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.861 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.72 -18.47 57.21 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.194 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -114.76 145.22 42.34 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 117.593 0.696 . . . . 0.0 110.291 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.5 p -79.01 173.99 12.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.638 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -166.79 118.99 0.97 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.976 -178.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.646 ' HB3' HG23 ' A' ' 65' ' ' THR . 44.6 p90 -115.81 146.57 41.85 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.612 0.244 . . . . 0.0 110.831 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.648 ' CD2' HG21 ' A' ' 93' ' ' VAL . 75.9 m-85 -121.49 112.85 19.02 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.07 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.0 tp -79.12 111.26 15.16 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.5 t -92.82 110.1 21.54 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.217 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -95.31 164.73 12.71 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.871 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' ' 60' ' ' ASP . 27.5 m -142.01 170.6 12.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.649 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -161.89 125.15 3.09 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.252 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 145.91 151.91 5.52 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.264 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -106.87 42.72 1.25 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.065 0.46 . . . . 0.0 110.669 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 2' ' ' VAL . . . -85.69 5.68 31.01 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? 57.96 -85.47 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -37.48 -31.76 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -12.52 80.73 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -95.48 111.7 23.55 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.963 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.904 HD13 HG23 ' A' ' 81' ' ' VAL . 13.1 mm -70.51 155.16 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.371 0.605 . . . . 0.0 111.779 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.9 m -155.11 157.66 37.82 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.275 178.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.433 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 58.7 m95 -131.82 123.69 28.09 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.577 0.172 . . . . 0.0 111.004 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 80.0 m-85 -116.76 113.22 22.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.9 p -62.78 152.51 82.1 Favored Pre-proline 0 C--O 1.254 1.323 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.306 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -58.18 -9.15 5.89 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 124.374 3.383 . . . . 0.0 115.267 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -75.84 -6.25 49.85 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 118.097 0.408 . . . . 0.0 110.81 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.78 40.98 3.69 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-O 119.705 -0.497 . . . . 0.0 112.006 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -166.98 178.22 5.89 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 119.788 -0.765 . . . . 0.0 112.43 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 12.6 ttmt -91.37 125.81 36.24 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 123.589 0.556 . . . . 0.0 111.068 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.3 pp -83.99 135.16 34.56 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.815 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.5 m -69.75 155.03 94.22 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.046 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.62 -30.57 7.72 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 122.364 2.043 . . . . 0.0 112.761 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -117.19 56.5 0.82 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.151 0.501 . . . . 0.0 111.155 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -76.01 -80.46 0.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.285 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -155.78 -72.68 0.11 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -99.74 -29.72 12.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.718 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.499 HG12 HG23 ' A' ' 66' ' ' ILE . 47.4 mt -89.36 106.01 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.811 0.338 . . . . 0.0 110.871 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 t -111.91 123.38 50.12 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.724 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 t -95.5 157.33 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -152.87 143.36 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.5 m-90 -116.41 115.02 25.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.09 -76.34 0.58 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.92 -173.41 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -48.94 -42.1 36.19 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.563 0.345 . . . . 0.0 111.818 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.533 ' HB2' HG21 ' A' ' 26' ' ' VAL . 10.4 m-20 -156.57 28.61 0.33 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.228 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.9 t -99.73 141.33 32.68 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.421 ' OG ' HG21 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -147.66 132.49 18.01 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -177.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.46 HG22 ' HB2' ' A' ' 21' ' ' PHE . 1.5 m -98.36 143.68 28.56 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.142 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.669 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -106.17 92.78 4.29 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.646 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -84.67 136.83 33.58 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 123.426 0.453 . . . . 0.0 110.745 -178.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.561 HD12 ' HD2' ' A' ' 20' ' ' LYS . 53.9 mt -134.87 91.0 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -60.46 -111.84 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 118.921 -0.562 . . . . 0.0 111.283 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.55 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.841 1.2 . . . . 0.0 110.923 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.814 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -75.59 136.71 40.5 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.04 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.781 ' O ' HD12 ' A' ' 97' ' ' ILE . 14.2 m-80 -132.86 152.63 51.81 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.127 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.401 HG21 ' NE2' ' A' ' 99' ' ' GLN . 23.0 pt -51.72 -25.11 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -68.39 -44.49 74.99 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -64.96 -35.47 81.27 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.81 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.506 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -49.79 118.31 2.78 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.43 176.48 39.36 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.064 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.3 mt -82.29 101.82 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.638 0.219 . . . . 0.0 110.892 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.669 ' CD2' HD11 ' A' ' 64' ' ' LEU . 52.0 m-85 -75.35 171.28 14.5 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -132.84 156.5 47.04 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.421 ' HB2' HD11 ' A' ' 7' ' ' ILE . 13.9 t -140.72 105.73 4.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.296 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.1 t -109.19 144.79 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.904 HG23 HD13 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -129.39 130.61 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.537 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.3 m -110.17 148.19 32.28 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.22 -178.92 4.91 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.616 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -74.33 -37.69 63.5 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.162 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -81.6 -31.08 32.67 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.422 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.92 -16.58 2.8 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-O 119.856 -0.413 . . . . 0.0 113.281 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 59.3 m -59.0 110.06 0.96 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.328 0.564 . . . . 0.0 111.23 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.537 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.0 OUTLIER -120.65 134.26 55.3 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.146 179.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.4 t -121.98 133.63 54.82 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -117.25 -178.59 3.49 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.62 173.99 13.5 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.848 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.57 155.92 43.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.564 0.221 . . . . 0.0 110.87 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.648 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.2 p -140.84 115.75 6.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.746 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.8 97.36 1.37 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.453 0.471 . . . . 0.0 110.535 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.484 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 14.3 t -99.92 136.29 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.769 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -125.54 152.41 45.08 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.226 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.814 HD13 ' HB1' ' A' ' 69' ' ' ALA . 12.3 mt -139.86 110.77 4.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.357 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.56 125.35 52.44 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.353 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.401 ' NE2' HG21 ' A' ' 71' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.258 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.453 0.168 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.685 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 2.1 m -79.11 94.16 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.157 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -173.66 97.18 0.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.301 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.764 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 22.9 tt0 -133.33 157.74 44.73 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.591 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 89' ' ' SER . 0.9 OUTLIER -151.87 155.27 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.433 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -160.04 130.33 5.49 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.156 0.285 . . . . 0.0 110.84 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.46 HD11 ' HB3' ' A' ' 79' ' ' CYS . 28.0 mt -96.25 142.53 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.639 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.89 128.69 24.17 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.38 -176.17 17.06 Favored 'Cis proline' 0 C--N 1.365 1.396 0 CA-C-N 120.084 1.066 . . . . 0.0 112.301 0.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.1 p -76.24 -40.67 51.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.144 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -126.03 124.68 41.19 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.032 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.407 ' C ' HD12 ' A' ' 14' ' ' ILE . . . -106.06 72.53 0.22 Allowed Glycine 0 C--N 1.341 0.86 0 C-N-CA 121.142 -0.551 . . . . 0.0 114.359 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.472 ' C ' HD12 ' A' ' 14' ' ' ILE . 27.7 mt-10 -76.92 112.65 13.76 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.472 HD12 ' C ' ' A' ' 13' ' ' GLU . 2.9 mp -135.77 164.83 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.7 154.88 17.64 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.8 t -63.06 141.52 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.094 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.86 -11.0 71.86 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.463 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -101.95 153.3 20.0 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.1 p -91.45 156.55 17.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.517 0.199 . . . . 0.0 111.061 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.675 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -151.59 117.39 5.46 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.666 -177.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.84 ' HB3' HG23 ' A' ' 65' ' ' THR . 36.1 p90 -112.64 144.11 42.69 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.65 0.262 . . . . 0.0 111.12 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.635 ' CD2' HG21 ' A' ' 93' ' ' VAL . 82.6 m-85 -122.99 118.0 26.78 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.38 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.8 tp -79.26 113.8 17.69 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -177.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.436 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 23.2 t -96.6 97.56 9.49 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -92.54 162.86 14.03 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.16 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.513 HG21 ' HB2' ' A' ' 60' ' ' ASP . 35.1 m -119.31 174.86 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.764 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -163.97 98.77 0.86 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.305 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.13 139.72 2.72 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.028 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -96.08 44.9 1.07 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.115 0.483 . . . . 0.0 111.253 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 2' ' ' VAL . . . -72.4 -174.64 1.38 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.627 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.5 -63.95 1.28 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.617 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -129.7 136.9 50.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.537 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -127.63 87.71 2.67 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.051 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -79.93 110.79 15.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.388 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.522 ' H ' HD12 ' A' ' 35' ' ' ILE . 5.1 mp -73.84 157.41 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 O-C-N 123.476 0.485 . . . . 0.0 111.36 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.418 ' N ' HG22 ' A' ' 35' ' ' ILE . 11.6 m -155.6 162.49 40.63 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.686 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.443 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 56.5 m95 -139.94 126.68 20.56 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.873 0.108 . . . . 0.0 110.942 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 84.2 m-85 -121.98 111.68 17.35 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.766 ' OG ' HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -65.76 161.39 53.81 Favored Pre-proline 0 C--O 1.256 1.423 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.384 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -52.24 -15.83 4.13 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 125.298 3.999 . . . . 0.0 115.805 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -78.31 3.66 14.92 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.626 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.82 43.6 14.14 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -158.29 159.71 36.26 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.357 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 9.7 ttpt -84.88 125.87 33.0 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 123.536 0.523 . . . . 0.0 111.425 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.766 HD11 ' OG ' ' A' ' 39' ' ' SER . 10.6 mt -74.37 145.67 43.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.548 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.5 m -77.42 162.14 69.9 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.776 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.15 -30.42 65.15 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 122.318 2.012 . . . . 0.0 112.432 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -141.98 75.31 1.49 Allowed 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.01 0.433 . . . . 0.0 111.032 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -76.21 -82.81 0.07 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.827 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -150.15 -72.8 0.17 Allowed 'General case' 0 C--N 1.342 0.277 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 -99.8 -33.36 10.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.504 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.697 HG12 HG23 ' A' ' 66' ' ' ILE . 21.2 mt -88.1 103.3 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.726 0.298 . . . . 0.0 110.779 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.6 t -109.28 122.14 46.7 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.255 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 55' ' ' VAL . 11.8 t -94.34 160.8 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.414 ' N ' HG12 ' A' ' 54' ' ' VAL . 7.2 p -156.99 133.99 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -109.58 114.97 29.04 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -113.94 -73.84 0.64 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -171.47 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.84 -36.16 74.1 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.59 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.513 ' HB2' HG21 ' A' ' 26' ' ' VAL . 42.3 m-20 -153.37 23.17 0.54 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.174 -0.467 . . . . 0.0 112.177 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.2 t -109.47 141.18 42.27 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.459 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.4 m -134.36 -173.77 3.37 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.342 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 m -154.91 142.15 19.45 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.011 0.434 . . . . 0.0 111.213 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.686 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -109.69 93.84 4.71 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.756 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.84 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -90.33 139.05 31.03 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.363 0.415 . . . . 0.0 110.64 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.697 HG23 HG12 ' A' ' 52' ' ' ILE . 14.7 mt -135.17 86.46 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -49.49 -65.57 0.54 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -176.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.422 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.6 OUTLIER -63.59 -66.33 0.56 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.477 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . . . 75.4 125.96 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.084 0.553 . . . . 0.0 111.37 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.768 ' O ' HD12 ' A' ' 97' ' ' ILE . 9.0 m-80 -147.16 167.37 24.32 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.4 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.8 pt -55.92 -22.98 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -75.29 -38.25 60.47 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -68.75 -32.96 73.09 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.542 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.514 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -51.95 109.17 0.34 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.06 173.42 45.59 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.742 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.7 mt -79.95 97.1 2.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.978 0.389 . . . . 0.0 110.823 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.686 ' CD2' HD11 ' A' ' 64' ' ' LEU . 58.8 m-85 -72.16 169.32 16.35 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -132.06 154.55 49.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.023 0.44 . . . . 0.0 111.777 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.46 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -138.17 103.47 4.95 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.6 t -108.36 143.33 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.26 147.15 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.634 HG23 ' HG2' ' A' ' 88' ' ' GLN . 0.5 OUTLIER -126.07 140.93 52.19 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.933 0.397 . . . . 0.0 111.751 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.24 -171.09 3.39 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.182 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -78.97 -35.62 42.75 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.458 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -88.38 -34.75 17.47 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.01 -18.94 1.22 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.77 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 62.6 m -51.17 114.61 1.25 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.499 0.65 . . . . 0.0 111.148 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.634 ' HG2' HG23 ' A' ' 82' ' ' THR . 6.9 mt-30 -106.71 138.95 41.93 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.99 0.424 . . . . 0.0 111.984 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.409 ' O ' HG21 ' A' ' 5' ' ' VAL . 6.0 p -125.97 108.0 10.99 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -104.4 177.91 4.71 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -149.38 169.7 20.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.936 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.66 152.09 37.27 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.999 0.428 . . . . 0.0 111.399 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.635 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.0 p -139.72 114.59 7.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.897 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.59 87.58 1.22 Allowed 'General case' 0 C--O 1.235 0.331 0 O-C-N 123.511 0.507 . . . . 0.0 110.34 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.415 ' CG1' ' HE2' ' A' ' 20' ' ' LYS . 18.4 t -87.4 130.08 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.396 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -115.46 158.13 22.98 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.815 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.768 HD12 ' O ' ' A' ' 70' ' ' ASN . 9.5 mt -148.25 135.19 13.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.736 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.91 129.96 52.25 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.561 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.018 -179.776 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.493 0.187 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.594 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -131.97 -37.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.387 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.604 ' CD1' ' HB3' ' A' ' 30' ' ' ALA . 10.3 mp -57.69 127.09 30.29 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.629 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -133.97 141.42 47.28 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.468 178.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 89' ' ' SER . 9.6 t -148.1 144.38 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 123.169 0.293 . . . . 0.0 111.189 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -154.88 148.21 25.02 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.597 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.8 mt -122.29 108.61 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.8 t -92.74 126.41 51.92 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.552 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -83.64 175.31 37.08 Favored 'Cis proline' 0 C--N 1.364 1.353 0 CA-C-N 119.969 1.025 . . . . 0.0 112.21 -0.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.2 p -71.1 -40.23 71.63 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -141.04 118.63 11.59 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.753 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.55 105.63 1.66 Allowed Glycine 0 C--N 1.343 0.934 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.974 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.544 ' C ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -85.73 130.71 34.49 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.544 HD12 ' C ' ' A' ' 13' ' ' GLU . 3.7 mp -146.71 164.96 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.09 157.66 17.38 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.842 0.353 . . . . 0.0 110.507 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.4 t -62.07 141.52 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.164 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.06 -7.38 81.57 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.356 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -104.78 152.0 23.1 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 76.6 p -92.58 155.66 17.63 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.576 0.227 . . . . 0.0 110.888 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.649 ' HD2' HD12 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -154.8 119.58 4.87 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.949 -178.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.728 ' HB3' HG23 ' A' ' 65' ' ' THR . 22.2 p90 -112.47 147.77 35.81 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.913 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.667 ' CD2' HG21 ' A' ' 93' ' ' VAL . 87.6 m-85 -124.75 118.77 27.16 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.196 0.522 . . . . 0.0 111.32 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.6 HD12 ' HG3' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -77.8 130.57 36.86 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.813 -178.579 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.496 ' N ' HD13 ' A' ' 23' ' ' LEU . 18.0 t -114.48 98.46 6.91 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.6 ' HG3' HD12 ' A' ' 23' ' ' LEU . 36.6 mt-30 -88.87 157.69 18.35 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.849 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.741 HG21 ' CB ' ' A' ' 60' ' ' ASP . 24.7 m -137.89 169.9 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -160.8 125.68 3.69 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.47 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.451 ' HA2' HG12 ' A' ' 2' ' ' VAL . . . 153.48 -168.55 32.13 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.638 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -168.87 33.55 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.652 0.263 . . . . 0.0 111.358 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.604 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . . . -87.98 84.43 6.97 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.724 0.297 . . . . 0.0 110.479 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.11 -174.33 0.07 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.901 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -60.75 136.87 58.2 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.616 0.246 . . . . 0.0 111.319 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.41 152.52 24.57 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.145 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -135.28 106.21 6.62 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.55 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.595 HG21 ' OG ' ' A' ' 62' ' ' SER . 5.1 mp -72.13 147.99 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.925 0.393 . . . . 0.0 110.994 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.9 m -147.06 154.49 41.24 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.318 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.428 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 43.3 m95 -129.59 113.86 15.34 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.062 0.145 . . . . 0.0 111.24 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -113.35 110.96 21.2 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 p -59.73 154.23 47.95 Favored Pre-proline 0 C--O 1.244 0.809 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.472 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -33.26 -74.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 125.252 3.968 . . . . 0.0 113.779 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.83 36.72 4.06 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.38 -18.69 4.44 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.464 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 71.13 -171.45 0.16 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 117.815 0.808 . . . . 0.0 109.057 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 11.1 tttt -56.22 104.31 0.14 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 pp -80.55 148.69 30.26 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.203 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.7 m -67.46 155.47 90.92 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.33 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -83.96 -22.11 3.66 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 122.522 2.148 . . . . 0.0 113.388 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -139.4 73.39 1.43 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.282 0.563 . . . . 0.0 110.328 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -104.94 -57.38 2.03 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.924 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.51 -83.76 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.79 -32.54 11.67 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.534 HG12 HG23 ' A' ' 66' ' ' ILE . 40.6 mt -90.47 107.56 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 120.662 0.267 . . . . 0.0 110.374 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.8 t -112.77 121.63 45.27 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.587 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 55' ' ' VAL . 18.8 t -92.82 159.9 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.413 ' N ' HG12 ' A' ' 54' ' ' VAL . 7.6 p -156.22 147.13 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -125.84 123.01 37.74 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.101 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.55 -73.94 0.63 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.2 -173.14 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -53.71 -40.28 65.9 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.663 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.741 ' CB ' HG21 ' A' ' 26' ' ' VAL . 9.7 m-20 -152.6 22.91 0.61 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.948 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.75 141.31 31.72 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.595 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.8 m -135.28 -170.56 2.62 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.055 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -159.24 142.05 14.18 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.664 0.269 . . . . 0.0 110.697 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.679 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -113.15 92.76 4.12 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.902 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.728 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -86.79 138.88 31.23 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.269 0.355 . . . . 0.0 110.131 -179.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.649 HD12 ' HD2' ' A' ' 20' ' ' LYS . 40.5 mt -135.22 82.12 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -49.36 -56.81 8.29 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -176.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 3.7 t-20 -71.06 -71.69 0.24 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 68' ' ' ASN . . . 81.12 120.97 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.501 0.721 . . . . 0.0 110.679 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.806 ' O ' HD12 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -141.7 159.99 41.1 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.267 0.556 . . . . 0.0 110.564 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 30.3 pt -51.01 -25.84 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -75.14 -39.83 60.13 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -64.46 -32.55 74.23 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.929 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.526 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -53.51 106.22 0.17 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.92 178.64 48.65 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.869 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.542 HG23 ' HB ' ' A' ' 92' ' ' THR . 1.1 mp -79.21 100.49 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.915 0.357 . . . . 0.0 110.816 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.679 ' CD2' HD11 ' A' ' 64' ' ' LEU . 48.0 m-85 -72.14 172.73 9.63 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -135.3 157.5 46.75 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 6.4 t -141.18 97.93 3.27 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.634 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.616 HG13 ' HB3' ' A' ' 90' ' ' GLU . 3.5 t -104.24 132.54 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.485 HG12 HD23 ' A' ' 3' ' ' LEU . 0.7 OUTLIER -112.29 139.96 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.73 HG23 ' HG2' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -127.68 132.91 49.61 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -179.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.5 -176.06 5.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.441 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -72.26 -52.78 14.8 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.158 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -63.77 -29.33 70.55 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.86 0.85 5.99 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.59 -0.561 . . . . 0.0 114.225 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.8 m -65.95 113.74 4.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.807 0.804 . . . . 0.0 110.019 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.73 ' HG2' HG23 ' A' ' 82' ' ' THR . 4.3 mt-30 -105.46 145.64 30.59 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.873 0.368 . . . . 0.0 111.658 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.435 ' O ' HG21 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -144.7 107.41 4.45 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.25 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.616 ' HB3' HG13 ' A' ' 80' ' ' VAL . 13.7 pt-20 -109.01 -179.28 3.81 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -151.49 176.11 11.63 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.193 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.542 ' HB ' HG23 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -147.13 155.89 42.53 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.633 0.254 . . . . 0.0 111.138 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.667 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.9 p -139.6 117.81 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.205 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -71.6 93.32 1.22 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.814 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.469 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 14.6 t -95.48 116.59 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.621 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -101.91 150.33 23.3 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.292 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.806 HD12 ' O ' ' A' ' 70' ' ' ASN . 8.5 mt -141.59 130.93 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.221 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -117.77 129.12 55.49 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.028 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.191 -179.547 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.567 0.222 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.016 HG23 ' HB2' ' A' ' 30' ' ' ALA . 0.6 OUTLIER -92.2 85.28 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.541 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.4 mt -150.43 68.85 0.98 Allowed 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.157 0.503 . . . . 0.0 110.649 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.637 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -85.21 139.51 31.6 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.545 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 89' ' ' SER . 11.6 t -145.78 135.02 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 O-C-N 123.419 0.449 . . . . 0.0 110.105 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -154.34 121.73 5.75 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.628 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.4 HD11 ' CB ' ' A' ' 79' ' ' CYS . 48.4 mt -89.74 138.94 18.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.35 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.4 t -122.96 129.4 24.99 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.086 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.463 ' O ' HG23 ' A' ' 93' ' ' VAL . 92.5 Cg_endo -79.63 166.61 77.35 Favored 'Cis proline' 0 C--N 1.364 1.362 0 CA-C-N 119.655 0.913 . . . . 0.0 112.105 -0.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 p -64.06 -41.17 97.46 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.133 0.492 . . . . 0.0 109.92 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -133.96 110.81 9.93 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.755 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.8 102.01 1.52 Allowed Glycine 0 C--N 1.341 0.859 0 C-N-CA 121.008 -0.615 . . . . 0.0 114.44 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.549 ' C ' HD12 ' A' ' 14' ' ' ILE . 13.6 mt-10 -87.82 134.93 33.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.549 HD12 ' C ' ' A' ' 13' ' ' GLU . 4.4 mp -146.48 163.64 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.653 0.263 . . . . 0.0 110.47 -178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.21 154.58 18.64 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.542 HG21 ' HB3' ' A' ' 99' ' ' GLN . 46.3 t -63.09 138.27 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.95 -7.91 78.52 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.522 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -103.03 155.82 18.11 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 117.49 0.645 . . . . 0.0 109.418 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.2 p -92.95 159.46 15.32 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 123.081 0.238 . . . . 0.0 110.784 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.57 ' HZ1' HD11 ' A' ' 97' ' ' ILE . 0.4 OUTLIER -156.24 119.99 4.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.662 -177.258 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.855 ' HB3' HG23 ' A' ' 65' ' ' THR . 49.0 p90 -114.72 140.24 49.03 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.506 0.193 . . . . 0.0 110.795 178.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.461 ' CD2' HG21 ' A' ' 93' ' ' VAL . 84.8 m-85 -117.12 110.64 18.43 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.312 0.577 . . . . 0.0 110.512 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.0 tp -79.03 107.16 11.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.206 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.8 t -89.79 106.3 18.38 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.041 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -95.17 165.5 12.37 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.725 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.9 m -141.95 173.23 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.637 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -158.83 91.04 1.03 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.017 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -179.8 134.26 2.21 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.296 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.91 40.05 2.0 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 120.923 0.392 . . . . 0.0 110.649 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 1.016 ' HB2' HG23 ' A' ' 2' ' ' VAL . . . -75.58 87.27 2.68 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.822 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.77 -90.67 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.789 0.836 . . . . 0.0 113.043 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -127.96 138.73 52.74 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -130.59 164.34 25.14 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.888 0.375 . . . . 0.0 111.771 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 19.6 t0 -137.73 166.05 24.92 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.124 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.662 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.1 mp -126.93 150.29 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 123.245 0.341 . . . . 0.0 110.865 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 57.6 m -147.81 162.82 38.47 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.024 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.43 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 56.5 m95 -138.46 134.58 34.2 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 75.6 m-85 -129.18 115.73 18.12 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.0 p -65.1 154.57 86.56 Favored Pre-proline 0 C--O 1.253 1.266 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.974 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -53.23 -12.94 2.71 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 124.97 3.78 . . . . 0.0 115.59 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -77.33 -0.05 24.1 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 118.164 0.438 . . . . 0.0 111.611 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.1 39.74 7.83 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -156.47 170.51 22.16 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.129 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 9.0 tttm -85.07 162.32 19.35 Favored 'General case' 0 C--N 1.341 0.23 0 O-C-N 123.729 0.643 . . . . 0.0 111.382 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.56 HD23 HG21 ' A' ' 52' ' ' ILE . 0.5 OUTLIER -117.01 135.09 53.97 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.472 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.72 171.75 11.07 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.783 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.52 -39.12 2.13 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 122.651 2.234 . . . . 0.0 112.623 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -142.36 74.11 1.44 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.134 0.492 . . . . 0.0 111.613 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.69 -48.77 3.85 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -146.51 -155.6 0.64 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -24.29 3.86 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.668 HG12 HG23 ' A' ' 66' ' ' ILE . 42.3 mt -78.92 113.92 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.867 0.365 . . . . 0.0 111.046 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.9 t -118.0 117.96 30.64 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.572 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 55' ' ' VAL . 11.7 t -93.99 158.81 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.413 ' N ' HG12 ' A' ' 54' ' ' VAL . 12.3 p -156.48 156.74 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 16.1 m-90 -129.99 118.93 22.36 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.58 -77.07 0.57 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -54.53 -177.72 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -51.65 -37.85 52.16 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -155.25 26.08 0.41 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.078 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.4 t -107.97 140.95 40.36 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.662 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.4 m -130.04 -171.72 2.6 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 m -155.23 138.11 15.38 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.641 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -108.31 91.53 3.68 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.284 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.855 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -85.9 146.95 26.49 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.668 HG23 HG12 ' A' ' 52' ' ' ILE . 49.6 mt -145.46 91.19 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -56.43 -107.18 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.096 0 O-C-N 123.721 0.638 . . . . 0.0 111.63 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.98 93.42 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.892 1.223 . . . . 0.0 110.335 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.791 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -76.25 159.85 30.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.205 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.75 ' O ' HD12 ' A' ' 97' ' ' ILE . 9.6 m-80 -152.36 162.89 40.52 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.26 0.552 . . . . 0.0 111.323 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 27.4 pt -55.39 -26.4 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.791 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -69.84 -40.51 75.78 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.281 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.02 -32.31 73.43 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.426 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.505 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -54.54 106.33 0.2 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.49 173.44 44.63 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.2 mt -78.42 98.04 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.812 0.306 . . . . 0.0 111.262 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.641 ' CD2' HD11 ' A' ' 64' ' ' LEU . 64.3 m-85 -72.37 173.25 9.01 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 155.68 50.25 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.4 ' CB ' HD11 ' A' ' 7' ' ' ILE . 47.3 t -136.44 96.18 3.31 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.585 HG13 ' HB3' ' A' ' 90' ' ' GLU . 11.7 t -101.28 126.74 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.954 0.407 . . . . 0.0 111.557 -178.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 34' ' ' ASP . 2.3 t -106.72 147.85 11.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.482 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.2 m -127.76 150.7 49.69 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.05 -178.39 5.43 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.865 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -72.08 -34.6 68.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.343 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -90.33 -39.37 12.76 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.491 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.38 -25.17 0.28 Allowed Glycine 0 C--N 1.34 0.8 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.885 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.5 m -55.14 108.1 0.38 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 117.387 0.593 . . . . 0.0 111.99 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.482 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.7 OUTLIER -113.1 136.5 52.64 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.466 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.472 ' O ' HG21 ' A' ' 5' ' ' VAL . 2.8 t -119.89 117.65 28.69 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.585 ' HB3' HG13 ' A' ' 80' ' ' VAL . 9.0 pt-20 -105.53 -179.41 3.93 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -176.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.63 174.65 13.71 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.532 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.27 155.36 43.81 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.576 0.227 . . . . 0.0 111.251 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 9' ' ' PRO . 7.8 p -138.57 116.51 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.119 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -72.83 98.43 2.43 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 123.416 0.447 . . . . 0.0 110.763 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.4 t -98.35 124.5 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.238 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -109.31 152.64 24.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.928 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.791 HD13 ' HB1' ' A' ' 69' ' ' ALA . 9.1 mt -146.67 139.27 19.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.071 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.99 133.03 29.5 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.729 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.542 ' HB3' HG21 ' A' ' 16' ' ' VAL . 6.5 pt20 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.171 -0.919 . . . . 0.0 111.016 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.527 0.204 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' A' ' 30' ' ' ALA . 10.7 m -135.21 109.43 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.067 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 tp -168.39 94.48 0.37 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.651 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 10.4 tp-100 -118.28 144.83 45.51 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.772 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -145.69 143.74 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.626 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -160.19 131.62 5.9 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.407 HD11 ' HB2' ' A' ' 79' ' ' CYS . 40.3 mt -104.06 136.99 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.727 0.299 . . . . 0.0 110.768 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.61 130.97 24.44 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.059 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.448 ' O ' HG23 ' A' ' 93' ' ' VAL . 84.2 Cg_endo -78.81 170.27 69.93 Favored 'Cis proline' 0 C--N 1.364 1.386 0 CA-C-N 119.549 0.875 . . . . 0.0 112.07 -0.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 p -67.67 -44.02 78.82 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.102 0.477 . . . . 0.0 109.819 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -131.26 105.47 7.67 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.569 ' O ' HD12 ' A' ' 14' ' ' ILE . . . -102.76 97.33 1.51 Allowed Glycine 0 C--N 1.339 0.717 0 C-N-CA 121.156 -0.545 . . . . 0.0 114.331 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -83.92 131.13 34.88 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.569 HD12 ' O ' ' A' ' 12' ' ' GLY . 3.4 mp -141.69 165.0 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 123.049 0.218 . . . . 0.0 110.701 -178.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.83 153.61 22.75 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.098 0.475 . . . . 0.0 110.848 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 69' ' ' ALA . 21.3 t -66.36 134.84 29.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.344 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.97 -15.83 56.37 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.228 -177.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -115.86 149.24 38.95 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 117.661 0.73 . . . . 0.0 110.098 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.8 p -78.13 174.71 10.86 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.58 ' HZ1' HD11 ' A' ' 97' ' ' ILE . 1.3 ptmm? -165.34 118.37 1.19 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.965 -177.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.72 ' HB3' HG23 ' A' ' 65' ' ' THR . 44.1 p90 -117.93 147.18 43.39 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.7 0.286 . . . . 0.0 111.13 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.593 ' CD2' HG21 ' A' ' 93' ' ' VAL . 76.3 m-85 -123.83 112.72 17.63 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.869 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.4 tp -79.21 112.97 16.95 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.5 t -95.2 100.48 12.27 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.71 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -92.28 160.45 15.13 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.525 HG21 ' HB2' ' A' ' 60' ' ' ASP . 34.8 m -139.99 165.71 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.651 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -146.76 104.19 3.71 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.232 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 154.74 144.75 3.99 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.955 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -113.23 64.1 0.64 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.5 0.666 . . . . 0.0 110.209 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.573 ' HB2' HG23 ' A' ' 2' ' ' VAL . . . -96.53 40.16 1.14 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.491 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.37 -85.51 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -41.78 -40.02 1.91 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp 1.4 70.38 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.51 111.46 22.38 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.173 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.751 HD11 ' HA ' ' A' ' 60' ' ' ASP . 4.4 mp -71.08 156.36 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 123.493 0.496 . . . . 0.0 111.657 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.418 ' N ' HG22 ' A' ' 35' ' ' ILE . 75.2 m -152.76 160.13 43.12 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.727 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.421 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 52.3 m95 -137.4 118.69 14.61 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.143 0.177 . . . . 0.0 110.662 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 96.5 m-85 -112.63 113.03 24.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 80.3 p -63.28 150.67 88.77 Favored Pre-proline 0 C--O 1.245 0.834 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.043 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -41.96 -22.06 0.18 Allowed 'Trans proline' 0 C--N 1.38 2.222 1 C-N-CA 125.397 4.065 . . . . 0.0 115.927 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -80.1 12.16 3.0 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.29 39.71 81.54 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -154.5 135.74 14.02 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 120.074 -0.65 . . . . 0.0 112.718 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 5.1 ttpt -60.01 136.04 57.89 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.978 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.406 HD11 ' CG2' ' A' ' 54' ' ' VAL . 4.0 pp -103.14 141.12 36.4 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.96 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m -75.61 158.03 83.57 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.799 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -90.04 19.65 1.17 Allowed 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.592 2.195 . . . . 0.0 113.8 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -155.73 34.26 0.35 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.735 0.303 . . . . 0.0 111.034 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -69.14 -70.4 0.28 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.696 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -154.89 -78.62 0.09 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -100.08 -35.11 9.8 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 122.717 0.407 . . . . 0.0 111.734 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.581 HG12 HG23 ' A' ' 66' ' ' ILE . 17.1 mt -78.02 97.82 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 123.224 0.328 . . . . 0.0 110.714 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 t -108.65 122.48 47.2 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.797 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 55' ' ' VAL . 21.7 t -94.81 159.88 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.418 ' N ' HG12 ' A' ' 54' ' ' VAL . 7.7 p -154.63 136.22 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.166 0.508 . . . . 0.0 111.634 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -109.91 110.59 21.59 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -100.63 -76.19 0.56 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -175.37 0.11 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.35 0.119 . . . . 0.0 110.972 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -57.16 -36.61 70.97 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.26 0.224 . . . . 0.0 111.519 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.751 ' HA ' HD11 ' A' ' 35' ' ' ILE . 67.2 m-20 -145.74 16.22 1.43 Allowed 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 p -102.44 141.01 35.96 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.482 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.9 m -135.88 -168.52 2.23 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.891 -0.141 . . . . 0.0 110.902 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.7 m -157.91 140.95 15.05 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.893 0.378 . . . . 0.0 110.779 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.694 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -109.49 91.2 3.55 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.36 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.72 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -86.87 142.86 27.74 Favored 'General case' 0 C--N 1.333 -0.135 0 O-C-N 123.463 0.477 . . . . 0.0 109.793 -179.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.581 HG23 HG12 ' A' ' 52' ' ' ILE . 60.1 mt -141.19 94.84 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -60.64 -111.95 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.157 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.0 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.089 1.313 . . . . 0.0 110.699 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.776 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -77.6 153.06 33.6 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.367 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.733 ' O ' HD12 ' A' ' 97' ' ' ILE . 8.6 m-80 -149.99 161.4 42.41 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.493 0.663 . . . . 0.0 111.202 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.7 pt -55.48 -23.55 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.198 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -71.36 -41.28 69.94 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.44 -34.42 77.17 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.83 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.52 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -51.25 114.54 1.24 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.84 174.06 42.07 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.11 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.9 mt -81.81 100.54 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.734 0.267 . . . . 0.0 110.418 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.694 ' CD2' HD11 ' A' ' 64' ' ' LEU . 65.4 m-85 -75.67 171.77 13.76 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -134.76 157.73 45.96 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.885 0.374 . . . . 0.0 111.885 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.407 ' HB2' HD11 ' A' ' 7' ' ' ILE . 14.7 t -140.14 113.14 8.22 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 89' ' ' SER . 12.7 t -119.08 137.93 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.902 0.382 . . . . 0.0 111.94 -178.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.9 134.89 64.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.677 HG23 ' HB3' ' A' ' 88' ' ' GLN . 2.0 m -115.48 150.07 37.07 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.78 -175.01 2.94 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.296 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -71.24 -57.84 4.11 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.389 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.34 -28.65 70.15 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.46 -10.03 4.05 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 119.568 -0.573 . . . . 0.0 113.743 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 38.3 m -62.11 107.04 0.81 Allowed 'General case' 0 C--N 1.345 0.394 0 CA-C-N 117.793 0.796 . . . . 0.0 110.938 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.677 ' HB3' HG23 ' A' ' 82' ' ' THR . 4.2 pt20 -121.9 130.12 53.1 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.182 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.522 ' O ' HG13 ' A' ' 80' ' ' VAL . 7.6 t -102.47 177.39 4.88 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -154.53 179.2 9.26 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -158.25 171.56 19.98 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.284 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.6 155.1 42.22 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.737 0.303 . . . . 0.0 111.17 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.593 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.3 p -140.57 116.54 7.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.693 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -70.8 96.86 1.3 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.8 t -99.21 129.67 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.597 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.5 155.25 31.16 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.096 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.776 HD13 ' HB1' ' A' ' 69' ' ' ALA . 10.6 mt -147.93 125.37 3.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.646 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.42 137.08 53.99 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.284 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.072 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.511 ' O ' HG13 ' A' ' 2' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.618 HG23 ' HB2' ' A' ' 30' ' ' ALA . 8.5 m -159.79 52.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.229 0.538 . . . . 0.0 110.36 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 mp -143.38 142.17 31.17 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.638 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -150.65 142.65 23.97 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.417 179.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 89' ' ' SER . 8.4 t -148.02 141.35 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 123.15 0.281 . . . . 0.0 110.452 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -159.62 124.84 4.09 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.367 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.612 HD11 ' HB2' ' A' ' 79' ' ' CYS . 50.2 mt -91.77 141.33 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.892 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.8 t -126.74 128.27 24.3 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.146 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -79.11 173.88 53.36 Favored 'Cis proline' 0 C--N 1.365 1.44 0 CA-C-N 119.885 0.995 . . . . 0.0 112.076 -0.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 93.6 p -71.36 -47.21 57.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.621 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -128.52 102.83 6.8 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.08 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.02 99.27 1.68 Allowed Glycine 0 C--N 1.341 0.807 0 CA-C-N 116.202 -0.453 . . . . 0.0 114.19 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.509 ' C ' HD12 ' A' ' 14' ' ' ILE . 6.4 mt-10 -83.24 143.56 30.35 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.664 HG23 ' HG3' ' A' ' 18' ' ' GLU . 1.2 mp -150.32 158.57 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.692 0.282 . . . . 0.0 111.192 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.72 152.63 20.25 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.792 HG13 ' O ' ' A' ' 69' ' ' ALA . 50.1 t -68.11 127.45 29.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.29 -14.16 25.7 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.841 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.664 ' HG3' HG23 ' A' ' 14' ' ' ILE . 5.0 pt-20 -115.21 145.41 42.44 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 117.506 0.653 . . . . 0.0 110.286 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.6 p -81.7 171.53 14.47 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.579 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -164.02 120.98 1.7 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.584 -178.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.721 ' HB3' HG23 ' A' ' 65' ' ' THR . 43.1 p90 -114.21 143.59 44.59 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.626 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.633 ' CD2' HG21 ' A' ' 93' ' ' VAL . 87.2 m-85 -119.63 115.72 24.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.059 0.457 . . . . 0.0 111.214 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp -79.43 111.62 15.87 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.3 t -92.32 102.14 14.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.101 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -90.88 163.0 14.55 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.581 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.777 HG21 ' CB ' ' A' ' 60' ' ' ASP . 23.6 m -138.94 172.88 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.638 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -162.06 165.23 27.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.417 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.59 -133.97 7.89 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.405 -0.426 . . . . 0.0 112.342 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -174.13 34.01 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.644 0.259 . . . . 0.0 111.639 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.618 ' HB2' HG23 ' A' ' 2' ' ' VAL . . . -79.66 -171.76 2.98 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -124.75 -25.6 3.93 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -97.72 -32.47 11.73 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt 1.26 69.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 10.3 t70 -78.26 156.28 29.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.667 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.712 HD13 HG22 ' A' ' 81' ' ' VAL . 27.2 mm -114.27 151.91 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-O 120.749 0.309 . . . . 0.0 111.164 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 m -151.37 156.71 41.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.69 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.427 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 67.3 m95 -134.74 131.46 37.64 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.394 0.278 . . . . 0.0 111.272 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 94.8 m-85 -120.71 117.81 28.44 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.0 p -69.42 150.6 97.01 Favored Pre-proline 0 C--O 1.25 1.105 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.882 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -43.91 -20.79 0.29 Allowed 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 124.932 3.755 . . . . 0.0 116.062 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -79.85 12.14 2.86 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.33 39.67 81.13 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 111.819 -0.512 . . . . 0.0 111.819 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -153.25 133.93 13.78 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.43 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 36.7 tttt -54.65 118.91 4.59 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.02 132.27 36.58 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.153 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.97 162.37 74.88 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.762 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -75.92 -28.8 7.41 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 122.719 2.279 . . . . 0.0 112.221 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -138.31 77.42 1.63 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.22 0.533 . . . . 0.0 109.85 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.07 -58.89 1.53 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.348 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -140.27 -160.57 1.09 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -50.6 -26.65 5.59 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.722 HG12 HG23 ' A' ' 66' ' ' ILE . 54.4 mt -83.68 96.89 4.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.67 0.271 . . . . 0.0 110.825 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.0 t -94.14 169.77 10.01 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.505 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 55' ' ' VAL . 11.7 t -141.9 159.7 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.419 ' N ' HG12 ' A' ' 54' ' ' VAL . 7.3 p -159.46 137.89 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.248 0.547 . . . . 0.0 112.221 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 17.4 m-90 -115.1 113.96 24.7 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.82 -77.82 0.59 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -177.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -57.65 -177.44 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -56.53 -35.48 68.14 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.777 ' CB ' HG21 ' A' ' 26' ' ' VAL . 58.8 m-20 -149.03 22.32 0.97 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 t -109.19 138.73 45.09 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.543 ' OG ' HG21 ' A' ' 35' ' ' ILE . 2.1 m -132.26 -170.64 2.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 m -158.24 137.88 12.0 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.715 0.293 . . . . 0.0 110.837 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.575 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -109.37 93.79 4.69 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.752 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.721 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -84.59 143.12 29.49 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.4 0.438 . . . . 0.0 110.245 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.722 HG23 HG12 ' A' ' 52' ' ' ILE . 57.9 mt -140.28 91.36 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -59.86 -112.8 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 O-C-N 123.641 0.588 . . . . 0.0 111.581 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.9 94.66 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.726 1.148 . . . . 0.0 110.921 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.833 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -75.13 146.0 41.73 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.414 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.745 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -144.21 159.01 43.4 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.322 0.582 . . . . 0.0 110.454 178.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.7 pt -51.75 -26.13 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -42.87 74.03 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -66.21 -34.3 77.72 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.736 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.555 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -53.27 107.04 0.2 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.73 179.25 46.16 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.249 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' A' ' 94' ' ' ASN . 33.2 mm -83.13 92.41 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.575 ' CD2' HD11 ' A' ' 64' ' ' LEU . 70.1 m-85 -68.39 165.6 18.43 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -129.94 155.66 45.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.248 0.547 . . . . 0.0 111.925 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.612 ' HB2' HD11 ' A' ' 7' ' ' ILE . 8.9 t -139.23 94.52 2.81 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 90' ' ' GLU . 7.3 t -101.36 135.91 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.174 0.512 . . . . 0.0 112.203 -177.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.712 HG22 HD13 ' A' ' 35' ' ' ILE . 14.4 t -118.16 157.13 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.221 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.713 HG23 ' CG ' ' A' ' 88' ' ' GLN . 1.3 m -135.07 150.64 50.29 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.57 -179.62 4.26 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.337 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -71.05 -46.4 62.06 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.75 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.91 -29.62 58.49 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.557 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 141.37 -10.34 2.72 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-O 119.561 -0.577 . . . . 0.0 113.828 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.2 m -59.46 108.43 0.71 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.97 0.885 . . . . 0.0 111.064 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.713 ' CG ' HG23 ' A' ' 82' ' ' THR . 26.8 mt-30 -105.22 135.57 46.33 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.376 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.584 ' O ' HG21 ' A' ' 5' ' ' VAL . 18.6 t -122.97 110.92 15.99 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.528 ' HB3' HG13 ' A' ' 80' ' ' VAL . 5.7 pt-20 -106.45 178.93 4.42 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -157.43 179.5 9.19 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.203 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.39 157.71 41.64 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.775 0.321 . . . . 0.0 111.538 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.633 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.4 p -141.61 121.52 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.607 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.473 ' HA ' HD13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -78.01 98.21 5.64 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.684 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.435 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 13.3 t -102.84 122.65 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.352 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -108.41 159.71 16.45 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.808 0.337 . . . . 0.0 111.145 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.833 HD13 ' HB1' ' A' ' 69' ' ' ALA . 11.3 mt -149.1 123.03 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.597 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.36 130.71 53.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.104 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.224 -0.894 . . . . 0.0 110.973 -179.76 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.846 0.355 . . . . 0.0 111.054 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.762 HG23 ' HB2' ' A' ' 30' ' ' ALA . 2.3 m -92.2 94.49 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.98 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -171.34 93.18 0.16 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.005 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.71 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 6.5 tt0 -129.53 152.45 49.04 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.868 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -152.5 148.76 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.415 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -159.68 130.41 5.79 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.827 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.46 HD11 ' HB3' ' A' ' 79' ' ' CYS . 22.7 mt -95.13 133.86 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.277 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.5 t -116.31 126.17 27.84 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-O 119.266 -0.397 . . . . 0.0 109.977 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.47 -176.34 16.64 Favored 'Cis proline' 0 C--N 1.366 1.473 0 CA-C-N 119.993 1.033 . . . . 0.0 112.343 -0.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.8 p -77.77 -46.85 20.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.297 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -131.92 111.29 11.43 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.14 103.04 1.63 Allowed Glycine 0 C--N 1.34 0.766 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.962 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -84.65 134.06 34.38 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.523 HG23 ' HG3' ' A' ' 18' ' ' GLU . 1.7 mp -143.94 162.4 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.154 0.502 . . . . 0.0 111.618 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.29 150.09 23.35 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.503 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 69' ' ' ALA . 51.8 t -66.25 131.77 31.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.88 -15.25 44.69 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.149 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.523 ' HG3' HG23 ' A' ' 14' ' ' ILE . 4.3 pt-20 -116.14 147.26 41.55 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 117.625 0.712 . . . . 0.0 110.11 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 93.5 p -79.49 173.7 12.32 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.613 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -167.26 121.68 1.02 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.996 -178.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.749 ' HB3' HG23 ' A' ' 65' ' ' THR . 30.5 p90 -113.69 152.35 30.58 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.693 ' CD2' HG21 ' A' ' 93' ' ' VAL . 89.3 m-85 -129.64 119.18 23.14 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.17 0.509 . . . . 0.0 112.152 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.539 HD12 ' HG3' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -78.68 109.67 13.12 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -177.09 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.477 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 44.8 t -89.5 88.17 7.34 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.539 ' HG3' HD12 ' A' ' 23' ' ' LEU . 4.2 mt-30 -81.17 158.78 24.81 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.17 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.68 HG21 ' HB2' ' A' ' 60' ' ' ASP . 22.5 m -129.43 167.97 23.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.516 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.71 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -161.54 103.89 1.23 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.248 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 164.04 126.66 0.83 Allowed Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.634 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -90.61 48.32 1.53 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.05 0.453 . . . . 0.0 111.542 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.762 ' HB2' HG23 ' A' ' 2' ' ' VAL . . . -76.14 -173.89 2.55 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.353 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -77.61 -28.63 51.56 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.286 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.71 161.43 11.22 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.682 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.548 ' HE2' ' HB3' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -153.3 86.22 1.22 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.361 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -69.55 109.62 4.37 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.504 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.511 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.4 mp -75.24 157.13 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.991 0.425 . . . . 0.0 111.507 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.427 ' N ' HG22 ' A' ' 35' ' ' ILE . 5.7 m -155.48 160.79 40.86 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.484 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.477 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 46.1 m95 -136.11 115.07 12.23 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.245 0.091 . . . . 0.0 111.245 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -111.74 116.24 30.4 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.0 p -61.7 152.5 75.08 Favored Pre-proline 0 C--O 1.246 0.908 0 CA-C-O 119.092 -0.48 . . . . 0.0 110.135 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -29.52 -73.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.24 1 C-N-CA 125.655 4.237 . . . . 0.0 114.133 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.82 35.46 4.88 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.23 -17.96 5.59 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.187 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 75.23 -176.27 0.14 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 117.788 0.794 . . . . 0.0 109.438 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -52.44 102.41 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 pp -76.97 156.01 32.25 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.953 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.6 m -78.29 159.18 75.7 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.079 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.75 -35.69 1.4 Allowed 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 122.618 2.212 . . . . 0.0 112.289 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -125.11 68.59 1.12 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.404 0.621 . . . . 0.0 110.124 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.29 -53.06 2.73 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.412 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -145.97 -157.48 0.8 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -51.08 -24.28 3.81 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.651 HG12 HG23 ' A' ' 66' ' ' ILE . 53.1 mt -82.82 104.94 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 120.704 0.288 . . . . 0.0 110.574 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.3 t -108.55 122.67 47.55 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.073 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 55' ' ' VAL . 11.6 t -94.19 159.85 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.701 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.422 ' N ' HG12 ' A' ' 54' ' ' VAL . 8.0 p -151.42 155.31 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 120.777 0.323 . . . . 0.0 111.537 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 -132.86 112.14 11.66 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -106.49 -79.47 0.57 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.28 -174.19 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -51.96 -40.65 61.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.676 0.39 . . . . 0.0 111.922 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.68 ' HB2' HG21 ' A' ' 26' ' ' VAL . 25.1 m-20 -148.9 21.55 0.99 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.103 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 p -99.76 141.34 32.7 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.511 ' OG ' HG21 ' A' ' 35' ' ' ILE . 2.1 m -136.22 -172.88 3.24 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.293 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.3 m -157.52 145.51 18.98 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.905 0.383 . . . . 0.0 110.754 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.643 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -115.34 93.65 4.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.392 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.749 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -86.81 140.66 29.48 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 123.497 0.498 . . . . 0.0 109.95 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.651 HG23 HG12 ' A' ' 52' ' ' ILE . 59.1 mt -137.01 95.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -61.42 -115.75 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.361 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -53.13 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.846 1.203 . . . . 0.0 111.197 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.775 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -74.46 147.44 41.96 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.394 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.784 ' O ' HD12 ' A' ' 97' ' ' ILE . 11.0 m-80 -143.31 152.26 41.45 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.828 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.55 HG21 HE22 ' A' ' 99' ' ' GLN . 15.5 pt -51.3 -24.43 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 112.702 0.631 . . . . 0.0 112.702 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.22 -44.33 75.97 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -65.8 -35.4 80.6 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.677 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.536 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -48.26 102.23 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.79 172.61 45.39 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.762 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.5 mt -77.17 94.02 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.783 0.292 . . . . 0.0 111.289 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.643 ' CD2' HD11 ' A' ' 64' ' ' LEU . 62.8 m-85 -65.59 177.04 1.29 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.412 ' O ' ' CE3' ' A' ' 37' ' ' TRP . 8.3 ttmt -139.54 155.4 47.53 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 120.74 0.305 . . . . 0.0 111.633 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.46 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -141.34 102.78 4.29 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.7 t -106.06 140.51 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.83 139.49 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.653 HG23 ' HB3' ' A' ' 88' ' ' GLN . 0.6 OUTLIER -124.19 146.09 48.91 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.14 -174.43 4.66 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.968 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -76.74 -35.06 58.02 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.514 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -86.49 -37.97 17.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.498 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.74 -24.3 0.63 Allowed Glycine 0 C--N 1.34 0.758 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.369 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.9 m -55.38 107.96 0.37 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 117.247 0.523 . . . . 0.0 111.492 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.653 ' HB3' HG23 ' A' ' 82' ' ' THR . 3.0 pt20 -116.87 134.61 54.55 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.551 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.4 t -114.37 121.55 43.95 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -107.35 -178.14 3.55 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.404 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -150.88 174.54 12.98 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.256 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.442 ' C ' HD12 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -151.84 155.54 38.38 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 123.119 0.262 . . . . 0.0 110.781 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.693 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.2 p -144.89 114.58 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.172 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -71.2 94.15 1.14 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.86 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.467 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 16.8 t -96.2 113.69 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -98.67 157.11 16.47 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.729 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.784 HD12 ' O ' ' A' ' 70' ' ' ASN . 13.3 mt -146.64 143.6 20.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.107 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.42 131.69 14.55 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.752 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.55 HE22 HG21 ' A' ' 71' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.898 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.59 ' HD3' HG22 ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 111.408 0.151 . . . . 0.0 111.408 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.137 HG23 ' HB2' ' A' ' 30' ' ' ALA . 1.3 m -145.74 58.63 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.302 0.572 . . . . 0.0 110.843 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 2' ' ' VAL . 0.3 OUTLIER -147.24 122.05 9.94 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.586 179.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.594 ' CB ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -139.5 140.18 37.15 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.308 -179.376 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.579 HG21 ' O ' ' A' ' 89' ' ' SER . 9.5 t -145.23 140.41 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.058 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -160.49 125.78 3.88 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.488 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.538 HD11 ' HB2' ' A' ' 79' ' ' CYS . 49.9 mt -95.52 137.6 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.688 0.28 . . . . 0.0 110.833 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.93 130.1 24.54 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.807 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.25 168.91 75.98 Favored 'Cis proline' 0 C--N 1.365 1.406 0 CA-C-N 119.704 0.93 . . . . 0.0 112.042 0.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 p -67.39 -44.59 78.51 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.761 0.315 . . . . 0.0 110.415 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -133.54 107.17 7.84 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.585 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.35 160.46 36.36 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.266 -0.492 . . . . 0.0 114.196 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -154.77 103.78 2.46 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.9 mp -128.42 161.85 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.658 0.266 . . . . 0.0 111.178 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.01 153.1 17.79 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 69' ' ' ALA . 26.1 t -64.86 139.84 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.29 -19.33 55.0 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.774 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -96.72 160.84 14.16 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.412 ' CB ' ' HA ' ' A' ' 67' ' ' TYR . 91.8 p -96.08 162.52 13.51 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.687 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -155.06 115.15 3.79 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.601 -178.201 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.808 ' HB3' HG23 ' A' ' 65' ' ' THR . 41.3 p90 -111.22 140.38 45.83 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.583 0.23 . . . . 0.0 110.956 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.424 ' CE2' HG22 ' A' ' 95' ' ' VAL . 81.5 m-85 -117.81 114.63 23.56 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.052 0.454 . . . . 0.0 110.807 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.2 tp -79.99 110.51 15.44 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.3 t -92.67 97.1 10.58 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.465 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -87.33 163.93 16.54 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.7 m -147.43 175.91 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.594 ' HB3' ' CB ' ' A' ' 4' ' ' GLN . . . -158.1 129.16 6.48 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.608 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 135.69 147.0 5.38 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 121.364 -0.446 . . . . 0.0 112.583 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -121.06 55.81 1.04 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.38 0.61 . . . . 0.0 110.364 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 1.137 ' HB2' HG23 ' A' ' 2' ' ' VAL . . . -89.45 68.43 7.85 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.404 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.8 mptt 61.29 -87.98 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.814 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -122.72 140.26 53.07 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.375 0.27 . . . . 0.0 110.765 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.22 90.15 3.18 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.204 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -73.74 153.91 39.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.247 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.783 HG21 ' OG ' ' A' ' 62' ' ' SER . 5.4 mp -125.71 144.55 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 123.368 0.418 . . . . 0.0 111.204 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 m -144.04 149.94 37.43 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.088 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.442 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 52.5 m95 -125.85 122.3 35.72 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.305 0.242 . . . . 0.0 111.133 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -119.52 112.7 19.69 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.466 ' OG ' HD23 ' A' ' 45' ' ' LEU . 5.5 m -55.88 150.45 28.27 Favored Pre-proline 0 C--O 1.244 0.814 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.365 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -31.57 -73.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.242 1 C-N-CA 125.499 4.133 . . . . 0.0 113.634 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -120.46 37.06 4.37 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.8 -17.34 5.54 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.074 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 72.88 -174.99 0.16 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 117.807 0.804 . . . . 0.0 109.168 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 2.0 ttmt -53.63 110.21 0.54 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.466 HD23 ' OG ' ' A' ' 39' ' ' SER . 3.9 pp -84.26 143.05 29.82 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.142 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.5 m -66.41 150.18 97.37 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.215 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.24 -14.72 13.13 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.472 2.115 . . . . 0.0 113.701 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -136.42 37.24 2.71 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.87 0.367 . . . . 0.0 110.976 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.15 -75.2 0.07 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.736 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -151.8 -75.35 0.14 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.603 0.24 . . . . 0.0 111.12 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -99.66 -31.34 11.62 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.566 HG12 HG23 ' A' ' 66' ' ' ILE . 22.4 mt -89.18 104.82 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 t -108.48 120.39 42.29 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.1 t -93.93 154.03 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.2 m -150.9 173.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.337 0.589 . . . . 0.0 112.421 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -141.82 120.17 12.32 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.97 -82.52 0.54 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -42.04 -64.47 0.58 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 179.49 -44.09 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.382 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -114.71 -35.8 4.73 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.329 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.6 t -65.53 136.91 56.99 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.048 0.452 . . . . 0.0 111.099 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.783 ' OG ' HG21 ' A' ' 35' ' ' ILE . 2.7 m -122.76 -173.62 2.74 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.81 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.0 m -156.57 130.73 8.56 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.87 0.366 . . . . 0.0 111.04 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.628 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -101.42 93.05 5.2 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.944 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.808 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -88.18 139.1 30.84 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 123.254 0.346 . . . . 0.0 110.323 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.566 HG23 HG12 ' A' ' 52' ' ' ILE . 44.9 mt -135.39 85.02 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.412 ' HA ' ' CB ' ' A' ' 19' ' ' SER . 12.3 m-85 -50.29 -59.56 3.84 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -176.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -63.96 -65.6 0.66 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 16' ' ' VAL . . . 73.98 118.82 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.051 0.54 . . . . 0.0 110.869 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.788 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -145.39 164.64 30.88 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.706 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 34.5 pt -54.85 -27.07 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -73.51 -36.53 65.76 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -68.13 -33.75 75.07 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.597 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.543 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -53.77 117.18 2.96 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.42 176.69 40.06 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.52 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.825 HD13 ' HA ' ' A' ' 94' ' ' ASN . 13.7 mm -75.99 89.61 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 122.283 0.233 . . . . 0.0 111.435 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.628 ' CD2' HD11 ' A' ' 64' ' ' LEU . 58.2 m-85 -66.85 171.66 5.13 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -131.87 155.79 47.22 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.538 ' HB2' HD11 ' A' ' 7' ' ' ILE . 11.9 t -142.48 88.43 2.07 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.759 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 90' ' ' GLU . 4.4 t -96.25 126.22 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.078 -177.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.88 157.91 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.715 HG23 ' CG ' ' A' ' 88' ' ' GLN . 6.5 m -139.48 148.74 43.11 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.404 ' HB2' HD11 ' A' ' 3' ' ' LEU . . . -96.56 -177.18 3.84 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.552 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -71.31 -54.2 11.65 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.121 0.263 . . . . 0.0 111.068 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.7 -31.12 70.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.621 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 141.73 -10.47 2.63 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.603 -0.554 . . . . 0.0 113.978 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.5 m -58.55 104.65 0.23 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 117.902 0.851 . . . . 0.0 111.173 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.715 ' CG ' HG23 ' A' ' 82' ' ' THR . 31.9 mt-30 -102.31 136.1 42.74 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.847 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.579 ' O ' HG21 ' A' ' 5' ' ' VAL . 5.6 t -128.43 109.89 11.82 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.591 ' HB3' HG13 ' A' ' 80' ' ' VAL . 11.0 pt-20 -101.47 179.43 4.36 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -153.62 175.89 12.7 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.916 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.05 155.18 36.37 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.7 p -139.89 120.87 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.668 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.825 ' HA ' HD13 ' A' ' 76' ' ' ILE . 1.8 t-20 -76.5 84.88 3.21 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.337 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.424 HG22 ' CE2' ' A' ' 22' ' ' PHE . 38.6 t -84.07 138.5 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.511 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -124.97 156.84 37.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.471 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.788 HD12 ' O ' ' A' ' 70' ' ' ASN . 9.6 mt -148.7 140.38 17.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.775 177.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -127.27 128.53 46.14 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.273 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.994 -179.589 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.468 ' O ' HG13 ' A' ' 2' ' ' VAL . 11.8 ttm-85 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.395 0.141 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.534 HG23 ' HB2' ' A' ' 30' ' ' ALA . 4.7 m -156.58 58.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.362 0.601 . . . . 0.0 110.895 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.576 HD23 HG12 ' A' ' 81' ' ' VAL . 1.8 mp -151.03 133.72 15.67 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.862 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.764 ' CB ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -150.84 151.25 31.98 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.113 179.327 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 t -150.56 144.59 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.606 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -157.07 130.59 8.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.429 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.544 HD11 ' HB2' ' A' ' 79' ' ' CYS . 37.7 mt -107.91 120.46 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.143 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t -105.64 130.07 23.64 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.461 ' O ' HG23 ' A' ' 93' ' ' VAL . 69.8 Cg_endo -81.93 173.49 48.03 Favored 'Cis proline' 0 C--N 1.367 1.545 0 CA-C-N 119.882 0.994 . . . . 0.0 112.282 -0.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 76.1 p -69.27 -41.48 76.81 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -137.2 109.77 7.48 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.649 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.631 ' O ' HD12 ' A' ' 14' ' ' ILE . . . -102.92 98.73 1.7 Allowed Glycine 0 C--N 1.343 0.937 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.927 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -83.09 126.48 32.62 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 12' ' ' GLY . 3.7 mp -140.45 164.5 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 123.21 0.319 . . . . 0.0 110.389 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.57 156.28 18.1 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 69' ' ' ALA . 39.7 t -63.07 141.07 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.09 -11.58 71.71 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.301 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -101.67 150.09 23.47 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 117.33 0.565 . . . . 0.0 109.536 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.3 p -90.45 164.46 14.27 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.623 ' HD2' HD12 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -162.62 129.47 3.6 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.996 -178.155 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.486 ' HA ' ' O ' ' A' ' 64' ' ' LEU . 28.9 p90 -120.77 157.96 28.58 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.2 0.313 . . . . 0.0 110.732 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.597 ' CD2' HG21 ' A' ' 93' ' ' VAL . 80.7 m-85 -133.36 120.35 20.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.68 117.27 19.67 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 t -102.07 96.37 6.96 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.626 0.251 . . . . 0.0 111.148 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -93.62 162.19 14.05 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.94 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.706 HG21 ' CB ' ' A' ' 60' ' ' ASP . 32.7 m -137.93 152.93 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.764 ' HB3' ' CB ' ' A' ' 4' ' ' GLN . . . -132.0 163.55 28.15 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.57 -124.31 6.24 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -166.32 -82.16 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.557 ' HB3' ' HD2' ' A' ' 33' ' ' LYS . . . 45.82 -160.16 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 122.92 0.488 . . . . 0.0 112.255 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.48 -51.61 0.26 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -64.28 -36.86 85.49 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.557 ' HD2' ' HB3' ' A' ' 30' ' ' ALA . 40.7 mtpt 1.61 85.18 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 10.9 m-20 -104.19 108.81 20.36 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.199 -179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.809 HD13 HG23 ' A' ' 81' ' ' VAL . 15.5 mm -65.5 152.44 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.459 0.647 . . . . 0.0 111.653 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.4 m -147.23 161.25 41.31 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.022 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -138.69 109.41 6.65 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 119.632 -0.223 . . . . 0.0 110.616 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -110.75 111.04 21.95 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 p -60.02 154.07 51.92 Favored Pre-proline 0 C--O 1.243 0.722 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.388 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -34.15 -73.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 125.105 3.87 . . . . 0.0 113.704 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.62 38.53 3.42 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -123.0 -18.63 3.12 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.592 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 69.01 -172.16 0.18 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 117.909 0.855 . . . . 0.0 108.911 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -53.27 115.63 2.0 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 45' ' ' LEU . 0.7 OUTLIER -93.48 153.94 18.19 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.056 -179.327 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 m -78.2 164.37 57.01 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.334 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.43 -25.4 2.6 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 122.816 2.344 . . . . 0.0 113.42 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -129.42 22.4 5.57 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.58 -59.02 3.68 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -137.63 -159.83 1.0 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.24 0.216 . . . . 0.0 110.574 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 mtm-85 -51.35 -22.8 3.13 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.624 HG12 HG23 ' A' ' 66' ' ' ILE . 52.6 mt -84.59 105.78 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.7 t -111.65 115.28 28.86 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.337 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.9 t -85.83 150.88 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.452 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -143.43 139.21 26.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 CA-C-O 120.75 0.31 . . . . 0.0 111.286 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 24.5 m-90 -109.18 107.49 17.79 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -92.37 -77.84 0.43 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -72.43 -178.6 2.62 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.494 -0.188 . . . . 0.0 110.494 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.82 -35.85 69.26 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.706 ' CB ' HG21 ' A' ' 26' ' ' VAL . 61.1 m-20 -134.84 5.7 3.38 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 p -100.56 137.34 39.09 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.999 0.363 . . . . 0.0 110.317 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.407 ' OG ' HG21 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -149.02 136.82 20.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.52 -179.097 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.0 m -108.85 139.34 43.82 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.842 0.353 . . . . 0.0 111.787 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.587 HD11 ' CG2' ' A' ' 52' ' ' ILE . 27.8 tp -94.85 113.67 25.44 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -98.36 141.42 31.27 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.624 HG23 HG12 ' A' ' 52' ' ' ILE . 63.7 mt -138.0 90.78 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -59.94 -110.97 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.657 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.2 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.794 1.179 . . . . 0.0 111.063 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.795 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -70.47 148.06 48.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.674 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.808 ' O ' HD12 ' A' ' 97' ' ' ILE . 24.6 m-80 -140.98 153.56 45.64 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.276 0.56 . . . . 0.0 110.901 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.2 pt -54.3 -23.94 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.81 -41.24 68.47 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -66.67 -34.81 78.69 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.704 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.502 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -49.61 99.63 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.76 176.23 46.31 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.528 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.2 mt -80.24 101.16 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.877 0.339 . . . . 0.0 111.701 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.4 ' CD2' HD21 ' A' ' 64' ' ' LEU . 58.2 m-85 -71.37 172.37 9.54 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -135.51 157.95 45.6 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.544 ' HB2' HD11 ' A' ' 7' ' ' ILE . 2.9 t -143.13 118.6 10.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.341 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.7 t -126.54 133.03 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.809 HG23 HD13 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -115.24 129.58 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.498 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.3 m -110.73 148.25 32.69 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -178.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.95 173.06 7.48 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.091 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.0 -46.32 78.43 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.195 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -71.97 -28.24 63.3 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.632 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.31 -12.31 4.36 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 119.899 -0.389 . . . . 0.0 113.521 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.8 m -60.82 108.05 0.79 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 117.455 0.627 . . . . 0.0 111.278 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.498 ' HB3' HG23 ' A' ' 82' ' ' THR . 3.9 pt20 -119.75 132.43 55.63 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.762 0.315 . . . . 0.0 111.288 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.2 t -114.71 125.35 53.62 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -105.02 -177.71 3.44 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -158.28 172.38 18.48 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.004 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.86 156.46 41.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.69 0.281 . . . . 0.0 111.375 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.597 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.1 p -144.63 115.26 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.405 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -70.25 94.63 0.93 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.928 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.514 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 15.1 t -96.27 115.52 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.573 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -101.03 155.06 18.2 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.409 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.808 HD12 ' O ' ' A' ' 70' ' ' ASN . 10.6 mt -146.79 122.97 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.473 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -111.39 127.63 55.73 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.505 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.306 -0.854 . . . . 0.0 111.087 -179.727 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.433 0.159 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.709 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 3.4 m -106.99 104.48 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.456 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 tp -176.0 94.1 0.06 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.43 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.603 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -121.32 140.59 51.89 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.741 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 t -149.31 137.69 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.653 -0.248 . . . . 0.0 110.973 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -159.29 123.71 3.97 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.311 0.382 . . . . 0.0 110.514 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.538 HD11 ' HB2' ' A' ' 79' ' ' CYS . 43.1 mt -89.87 140.2 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 O-C-N 123.15 0.281 . . . . 0.0 111.042 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.9 t -128.1 134.39 26.18 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.856 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.437 ' O ' HG23 ' A' ' 93' ' ' VAL . 93.5 Cg_endo -76.44 173.82 56.13 Favored 'Cis proline' 0 C--N 1.365 1.436 0 CA-C-N 119.698 0.928 . . . . 0.0 112.161 0.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.4 p -69.14 -49.01 60.82 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -128.37 114.22 16.58 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 14' ' ' ILE . . . -110.44 93.16 0.72 Allowed Glycine 0 C--N 1.343 0.94 0 C-N-CA 121.087 -0.578 . . . . 0.0 114.46 -177.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -79.99 132.86 36.1 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 12' ' ' GLY . 2.0 mp -143.47 164.12 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.09 0.472 . . . . 0.0 111.384 -177.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.47 150.22 22.87 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.549 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 69' ' ' ALA . 29.2 t -66.0 135.28 28.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.599 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.17 -15.07 59.45 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.251 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -114.67 146.63 40.65 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 117.747 0.773 . . . . 0.0 110.111 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.442 ' CB ' ' HA ' ' A' ' 67' ' ' TYR . 60.1 p -79.42 168.56 19.31 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -176.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.619 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -159.31 121.38 3.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.805 -179.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.845 ' HB3' HG23 ' A' ' 65' ' ' THR . 49.5 p90 -115.2 142.22 46.96 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.578 0.227 . . . . 0.0 110.951 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.69 ' CD2' HG21 ' A' ' 93' ' ' VAL . 81.1 m-85 -117.51 117.0 28.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.918 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.8 tp -82.43 109.81 17.0 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.935 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.66 107.44 19.17 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -92.01 163.11 14.1 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.716 HG21 ' HB3' ' A' ' 60' ' ' ASP . 22.2 m -147.42 176.64 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.603 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -165.84 108.59 0.78 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.508 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 154.04 132.87 1.72 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.689 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -93.43 60.18 3.07 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.543 0.687 . . . . 0.0 109.505 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 2' ' ' VAL . . . -85.58 18.04 2.99 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.54 -87.07 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 177.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -51.86 -28.52 16.24 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.446 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 0.3 OUTLIER 0.69 79.79 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -179.483 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -101.65 111.32 23.53 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.777 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.974 HD13 HG23 ' A' ' 81' ' ' VAL . 14.8 mm -70.93 148.66 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 123.603 0.565 . . . . 0.0 110.168 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.7 m -144.93 156.12 43.8 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.183 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.427 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 55.9 m95 -134.65 121.84 21.43 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -119.5 110.84 17.38 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 m -62.73 152.6 81.6 Favored Pre-proline 0 C--O 1.249 1.071 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.117 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -36.68 -24.29 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.209 1 C-N-CA 126.047 4.498 . . . . 0.0 116.532 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -80.12 12.17 3.0 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.29 37.76 91.06 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -142.15 147.34 36.48 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.266 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.9 ttpp -79.53 125.25 29.34 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.231 0.332 . . . . 0.0 111.66 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.496 HD11 ' CG2' ' A' ' 54' ' ' VAL . 2.9 pp -86.84 131.64 34.06 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.495 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.8 m -63.52 163.29 20.79 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.667 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.34 -60.29 0.11 Allowed 'Trans proline' 0 C--N 1.363 1.321 0 C-N-CA 122.621 2.214 . . . . 0.0 112.597 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -114.38 62.65 0.67 Allowed 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.285 0.564 . . . . 0.0 110.697 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.83 -62.13 1.41 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.102 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -139.03 -154.42 0.52 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.0 -23.91 1.32 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.652 HG12 HG23 ' A' ' 66' ' ' ILE . 39.2 mt -86.17 105.04 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.5 t -109.07 122.17 46.7 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.189 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.496 ' CG2' HD11 ' A' ' 45' ' ' LEU . 21.5 t -95.77 158.07 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.15 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.407 ' N ' HG12 ' A' ' 54' ' ' VAL . 8.2 m -150.32 171.75 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.852 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -139.58 120.1 14.07 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.1 -81.78 0.57 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -56.33 -178.43 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -52.96 -34.19 54.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.716 ' HB3' HG21 ' A' ' 26' ' ' VAL . 23.5 m-20 -141.37 -12.97 0.9 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.6 p -76.89 147.55 36.97 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 118.725 0.693 . . . . 0.0 111.297 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.587 ' OG ' HG21 ' A' ' 35' ' ' ILE . 3.2 m -134.79 -170.17 2.5 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.817 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.2 m -154.23 138.49 16.61 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 111.799 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.652 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -108.08 94.68 5.2 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.684 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.845 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -89.54 140.1 29.88 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 123.295 0.372 . . . . 0.0 110.563 -179.517 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.652 HG23 HG12 ' A' ' 52' ' ' ILE . 47.0 mt -136.44 91.06 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.442 ' HA ' ' CB ' ' A' ' 19' ' ' SER . 11.0 m-85 -56.25 -69.92 0.13 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.6 OUTLIER -57.18 -66.19 0.5 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.459 ' O ' HG13 ' A' ' 16' ' ' VAL . . . 73.76 119.77 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.1 0.56 . . . . 0.0 111.232 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.788 ' O ' HD12 ' A' ' 97' ' ' ILE . 15.6 m-80 -142.39 163.03 33.95 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.03 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.7 pt -51.73 -26.28 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.95 -43.77 70.92 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.437 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -65.7 -33.39 75.77 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.004 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.519 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -51.14 109.31 0.32 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.14 174.9 45.68 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.726 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.7 mt -80.54 99.78 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.829 0.315 . . . . 0.0 111.296 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.652 ' CD2' HD11 ' A' ' 64' ' ' LEU . 53.5 m-85 -72.57 171.5 12.31 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -132.89 158.01 43.64 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.538 ' HB2' HD11 ' A' ' 7' ' ' ILE . 34.2 t -139.82 100.8 4.03 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.895 178.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.441 HG13 ' HB3' ' A' ' 90' ' ' GLU . 4.0 t -107.22 133.02 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.974 HG23 HD13 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -115.69 134.83 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.55 HG23 ' HB3' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -115.17 146.43 41.39 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.32 -175.59 4.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.464 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -73.7 -46.32 46.89 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 123.132 0.27 . . . . 0.0 111.49 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.4 -35.46 65.88 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.559 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.48 -19.31 1.5 Allowed Glycine 0 C--N 1.339 0.719 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.643 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.8 m -56.14 108.7 0.49 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.348 0.574 . . . . 0.0 111.7 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.55 ' HB3' HG23 ' A' ' 82' ' ' THR . 3.8 pt20 -117.78 133.81 55.56 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.867 0.365 . . . . 0.0 111.565 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.2 t -120.94 127.18 51.59 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.441 ' HB3' HG13 ' A' ' 80' ' ' VAL . 8.6 pt-20 -111.49 -177.94 3.32 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.75 177.13 10.39 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.614 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.82 158.39 44.13 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.822 0.344 . . . . 0.0 111.816 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.69 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.6 p -143.18 114.36 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.908 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -71.33 91.48 0.99 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.914 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.434 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 15.4 t -92.39 129.37 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.549 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -115.76 158.42 22.87 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.798 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.788 HD12 ' O ' ' A' ' 70' ' ' ASN . 11.2 mt -148.99 135.47 12.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.178 178.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.25 135.56 45.03 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.355 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.878 -179.838 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -150.69 59.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.422 0.629 . . . . 0.0 109.869 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.566 HD11 ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -135.03 139.33 44.72 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.088 -179.147 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -132.9 147.71 52.29 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.883 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 89' ' ' SER . 0.3 OUTLIER -152.41 140.22 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 O-C-N 123.188 0.305 . . . . 0.0 111.068 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -154.99 130.61 9.89 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.601 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.494 HD12 ' C ' ' A' ' 92' ' ' THR . 22.4 mt -91.69 130.11 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 123.196 0.31 . . . . 0.0 110.992 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.0 t -115.07 123.76 31.31 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.83 -179.29 24.9 Favored 'Cis proline' 0 C--N 1.364 1.374 0 CA-C-N 119.985 1.03 . . . . 0.0 112.276 0.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 86.3 p -78.69 -40.97 32.34 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.307 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -132.85 118.15 18.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.699 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.467 ' O ' HD12 ' A' ' 14' ' ' ILE . . . -117.93 99.37 0.8 Allowed Glycine 0 C--N 1.341 0.844 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.97 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.413 ' C ' HD12 ' A' ' 14' ' ' ILE . 14.5 mt-10 -87.55 132.26 34.11 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 12' ' ' GLY . 4.5 mp -143.59 163.63 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.811 0.338 . . . . 0.0 111.083 -178.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.36 154.46 18.17 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 69' ' ' ALA . 93.5 t -63.49 140.43 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.901 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.64 -12.0 70.8 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.24 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.06 156.64 17.54 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.8 p -96.16 165.51 12.2 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.63 0.253 . . . . 0.0 111.286 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.776 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 2.1 pttt -162.61 126.58 3.03 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.643 ' HB3' HG23 ' A' ' 65' ' ' THR . 33.9 p90 -119.72 153.42 35.65 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.072 0.232 . . . . 0.0 111.039 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.646 ' CD1' HG21 ' A' ' 93' ' ' VAL . 88.9 m-85 -131.57 119.17 21.12 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.287 0.565 . . . . 0.0 112.078 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -77.9 111.96 14.29 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -176.795 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.461 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 54.0 t -87.61 87.53 7.41 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -79.9 158.39 26.69 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.427 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.453 HG21 ' HB2' ' A' ' 60' ' ' ASP . 27.5 m -133.49 165.07 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 O-C-N 123.473 0.483 . . . . 0.0 112.081 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.684 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -160.08 129.73 5.25 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.715 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 149.66 -177.68 27.66 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.9 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -140.45 36.92 1.86 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.141 0.496 . . . . 0.0 110.759 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.797 ' HB3' ' HD3' ' A' ' 33' ' ' LYS . . . -65.16 -163.81 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.87 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.74 -52.4 4.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.848 0.356 . . . . 0.0 110.266 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -124.36 138.85 54.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.821 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.797 ' HD3' ' HB3' ' A' ' 30' ' ' ALA . 0.2 OUTLIER -137.72 83.25 1.97 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.801 0.334 . . . . 0.0 111.517 -179.125 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.519 ' O ' HG22 ' A' ' 81' ' ' VAL . 13.5 m-20 -81.67 159.33 23.98 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.471 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.4 mp -121.7 158.75 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 123.189 0.306 . . . . 0.0 111.155 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.441 ' N ' HG22 ' A' ' 35' ' ' ILE . 64.1 m -159.88 160.92 34.2 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.768 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.461 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 58.8 m95 -136.96 130.89 32.22 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.673 0.273 . . . . 0.0 111.134 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 91.6 m-85 -118.92 117.55 29.14 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.5 p -65.73 152.76 92.36 Favored Pre-proline 0 C--O 1.249 1.055 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.903 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -48.12 -17.14 0.77 Allowed 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 124.904 3.736 . . . . 0.0 116.133 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -78.86 6.79 8.31 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 118.155 0.434 . . . . 0.0 111.915 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.77 37.62 33.66 Favored Glycine 0 C--N 1.351 1.409 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -158.2 140.04 13.88 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 120.103 -0.639 . . . . 0.0 112.333 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 21.9 tttt -54.5 138.0 41.53 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -110.35 134.4 52.33 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.172 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.4 m -68.55 158.01 86.5 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.085 -178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -85.93 -26.7 1.13 Allowed 'Trans proline' 0 C--N 1.363 1.334 0 C-N-CA 122.831 2.354 . . . . 0.0 113.55 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -121.28 69.59 0.91 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.375 0.607 . . . . 0.0 110.182 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.99 -60.01 1.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.149 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -141.79 -159.5 0.97 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 121.99 0.116 . . . . 0.0 110.856 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.7 mtm-85 -47.54 -25.57 1.16 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.663 HG23 HG12 ' A' ' 66' ' ' ILE . 47.9 mt -84.83 106.62 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.801 0.334 . . . . 0.0 110.378 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 t -112.52 123.06 49.45 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.517 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 55' ' ' VAL . 11.4 t -92.81 159.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.361 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.409 ' N ' HG12 ' A' ' 54' ' ' VAL . 7.1 p -154.09 153.43 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.734 0.302 . . . . 0.0 111.422 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.406 ' HD1' ' HG ' ' A' ' 62' ' ' SER . 23.0 m-90 -126.08 112.57 16.0 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -105.35 -75.33 0.63 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.2 -179.05 0.13 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.494 0.188 . . . . 0.0 111.421 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -54.62 -35.76 63.78 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.496 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.453 ' HB2' HG21 ' A' ' 26' ' ' VAL . 55.8 m-20 -151.07 24.45 0.74 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.946 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.9 t -110.4 136.25 49.85 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.471 ' OG ' HG21 ' A' ' 35' ' ' ILE . 4.3 m -128.66 -169.38 2.07 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.525 -177.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 m -159.33 144.85 15.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.937 0.399 . . . . 0.0 110.995 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.629 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -113.82 93.55 4.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.334 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.643 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -86.22 144.25 27.55 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.561 0.538 . . . . 0.0 110.286 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.663 HG12 HG23 ' A' ' 52' ' ' ILE . 61.9 mt -142.52 93.05 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -59.71 -108.51 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.405 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -56.61 95.17 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.465 1.03 . . . . 0.0 110.551 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.838 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -74.25 151.8 39.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.153 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.792 ' O ' HD12 ' A' ' 97' ' ' ILE . 16.5 m-80 -145.71 154.43 42.07 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.139 0.495 . . . . 0.0 111.281 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.5 pt -53.98 -24.52 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -72.64 -41.3 65.61 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.92 -34.23 77.91 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.736 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.54 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -51.69 104.25 0.08 Allowed 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.02 171.44 44.17 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.81 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.9 mt -79.62 95.92 2.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.81 0.305 . . . . 0.0 110.245 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.629 ' CD2' HD11 ' A' ' 64' ' ' LEU . 63.0 m-85 -69.93 171.42 9.41 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -133.66 154.69 50.73 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.741 0.305 . . . . 0.0 111.155 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.449 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -138.31 97.71 3.44 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 t -101.01 140.85 18.8 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.857 -176.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 34' ' ' ASP . 1.7 t -125.78 144.92 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.3 m -124.3 155.97 37.76 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.28 -176.01 3.39 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.26 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -77.3 -37.93 51.73 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 123.023 0.202 . . . . 0.0 110.901 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -79.87 -35.8 37.57 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.256 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 148.37 -19.49 1.34 Allowed Glycine 0 C--N 1.34 0.751 0 C-N-CA 121.232 -0.509 . . . . 0.0 113.563 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.566 ' O ' HD11 ' A' ' 3' ' ' LEU . 89.4 m -59.87 112.83 2.0 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 117.314 0.557 . . . . 0.0 111.333 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.531 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.9 OUTLIER -118.63 134.06 55.39 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.488 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.42 ' O ' HG21 ' A' ' 5' ' ' VAL . 2.6 t -114.73 124.98 53.17 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -108.83 -179.86 3.98 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -147.84 173.94 12.34 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.148 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.494 ' C ' HD12 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -150.0 154.95 39.08 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 111.269 179.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.646 HG21 ' CD1' ' A' ' 22' ' ' PHE . 7.2 p -144.87 112.71 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.979 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -70.88 93.26 0.96 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.919 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.467 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 12.5 t -95.05 118.03 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.553 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.63 157.73 16.86 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.153 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.838 HD13 ' HB1' ' A' ' 69' ' ' ALA . 10.5 mt -148.57 139.73 17.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.8 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.86 131.58 51.15 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.404 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.962 -179.788 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.384 0.135 . . . . 0.0 110.775 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.606 HG23 ' HB2' ' A' ' 30' ' ' ALA . 2.5 m -98.38 77.01 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.082 0.468 . . . . 0.0 111.11 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.887 HD21 ' HB2' ' A' ' 83' ' ' ALA . 29.6 mt -149.11 131.08 15.26 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.529 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.655 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -146.71 134.48 21.19 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.293 179.233 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.583 HG21 ' O ' ' A' ' 89' ' ' SER . 10.7 t -143.91 139.56 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 123.22 0.325 . . . . 0.0 110.499 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -155.66 121.14 4.92 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.413 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.579 HD11 ' HB2' ' A' ' 79' ' ' CYS . 53.5 mt -89.64 136.24 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.023 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.48 128.05 25.83 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.549 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -74.4 -172.9 11.05 Favored 'Cis proline' 0 C--N 1.366 1.489 0 CA-C-N 119.669 0.917 . . . . 0.0 112.041 -0.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 97.2 p -85.57 -50.12 7.49 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.574 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -131.92 104.07 6.65 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.326 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.78 144.88 17.19 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 121.421 -0.418 . . . . 0.0 113.596 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.53 ' C ' HD12 ' A' ' 14' ' ' ILE . 2.6 mp0 -126.6 129.52 48.69 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.53 HD12 ' C ' ' A' ' 13' ' ' GLU . 4.9 mp -141.75 165.12 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 120.579 0.228 . . . . 0.0 111.226 -178.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.4 157.45 17.33 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 69' ' ' ALA . 21.2 t -62.47 136.91 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.393 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.69 -8.25 80.08 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.942 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -100.78 153.06 19.78 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.0 p -100.06 134.73 42.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.193 0.521 . . . . 0.0 112.083 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.651 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 3.9 pttt -116.98 172.04 7.52 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.582 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.559 ' HB2' HG23 ' A' ' 65' ' ' THR . 0.1 OUTLIER -162.65 149.91 13.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 178.054 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.781 ' CD2' HG21 ' A' ' 93' ' ' VAL . 73.5 m-85 -137.87 105.14 5.47 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.444 0.64 . . . . 0.0 110.812 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.6 tp -79.41 111.92 16.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 114.88 -1.054 . . . . 0.0 112.228 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.4 t -90.49 108.87 20.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.786 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -92.32 160.24 15.21 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.531 HG21 ' CB ' ' A' ' 60' ' ' ASP . 30.9 m -140.71 176.52 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.655 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -168.61 143.76 3.41 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.332 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 139.62 143.32 4.37 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -95.06 40.39 1.1 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.768 0.318 . . . . 0.0 111.802 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.702 ' HB3' ' HD2' ' A' ' 33' ' ' LYS . . . -71.06 -172.8 0.73 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.412 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -111.92 -24.06 10.18 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -125.62 -34.07 2.69 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.702 ' HD2' ' HB3' ' A' ' 30' ' ' ALA . 10.8 ptmm? 1.66 66.58 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 18.4 m-20 -69.59 179.4 2.13 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.631 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.617 HG21 ' OG ' ' A' ' 62' ' ' SER . 3.9 mp -130.87 155.7 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 123.39 0.431 . . . . 0.0 110.845 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.402 ' N ' HG22 ' A' ' 35' ' ' ILE . 71.8 m -156.65 162.0 39.86 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.079 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.409 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 59.0 m95 -133.08 135.55 45.38 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.941 0.151 . . . . 0.0 110.783 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 95.2 m-85 -128.91 109.07 10.93 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.6 p -58.77 151.44 53.43 Favored Pre-proline 0 C--O 1.251 1.151 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.166 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -55.19 -13.02 6.15 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 124.648 3.565 . . . . 0.0 115.534 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -76.63 -3.72 39.26 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.11 0.414 . . . . 0.0 111.38 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.97 41.92 4.83 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.638 -0.534 . . . . 0.0 112.073 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.85 155.59 16.79 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.579 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 10.9 ttmt -68.84 159.42 32.49 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.517 0.51 . . . . 0.0 111.384 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.7 mt -111.85 139.21 47.52 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.694 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.26 155.92 66.51 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.215 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.22 -24.46 9.44 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.439 2.093 . . . . 0.0 113.321 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -138.98 78.61 1.68 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.213 0.53 . . . . 0.0 109.97 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.95 -59.05 1.28 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.585 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -146.02 -157.95 0.85 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -24.28 3.48 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.694 HG12 HG23 ' A' ' 66' ' ' ILE . 29.1 mt -84.17 97.81 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.692 0.282 . . . . 0.0 110.457 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.8 t -101.32 117.96 36.02 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.552 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 55' ' ' VAL . 13.6 t -93.63 160.33 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.412 ' N ' HG12 ' A' ' 54' ' ' VAL . 11.0 p -158.58 157.69 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 13.1 m-90 -136.04 121.9 19.92 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -81.73 0.64 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.69 -177.9 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -31.55 -59.33 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.323 1.049 . . . . 0.0 113.08 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.531 ' CB ' HG21 ' A' ' 26' ' ' VAL . 15.7 m-20 -147.24 21.62 1.21 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.034 178.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.6 145.22 25.41 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.617 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.3 m -134.58 -170.78 2.62 Favored 'General case' 0 N--CA 1.458 -0.07 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.069 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.4 m -160.12 145.71 15.27 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.868 0.366 . . . . 0.0 111.325 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.666 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -117.7 98.44 6.37 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.172 178.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.559 HG23 ' HB2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -97.61 138.68 34.65 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.607 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.694 HG23 HG12 ' A' ' 52' ' ' ILE . 22.5 mt -134.95 89.2 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -53.97 -98.65 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.94 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.75 100.78 0.73 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.234 0.925 . . . . 0.0 110.109 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.843 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -81.17 149.18 29.21 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.79 ' O ' HD12 ' A' ' 97' ' ' ILE . 12.7 m-80 -142.72 155.54 44.89 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.545 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.3 pt -53.1 -24.54 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -71.56 -42.31 68.0 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -65.33 -35.1 79.94 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.115 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.536 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -50.36 126.81 15.92 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.63 -177.64 37.82 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.895 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 76' ' ' ILE . 0.6 OUTLIER -85.42 108.61 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.666 ' CD2' HD11 ' A' ' 64' ' ' LEU . 49.5 m-85 -83.52 166.18 18.49 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -127.57 158.4 37.57 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.139 0.495 . . . . 0.0 112.303 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.579 ' HB2' HD11 ' A' ' 7' ' ' ILE . 23.7 t -138.84 94.01 2.77 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.272 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 90' ' ' GLU . 6.6 t -100.46 132.31 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -177.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 34' ' ' ASP . 3.6 t -111.73 153.6 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.619 HG23 ' CG ' ' A' ' 88' ' ' GLN . 4.4 m -137.61 111.04 7.97 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.887 ' HB2' HD21 ' A' ' 3' ' ' LEU . . . -62.56 -176.19 0.1 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.244 178.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -73.08 -49.97 25.53 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.715 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -62.62 -31.28 72.1 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 134.28 -19.19 4.1 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 121.348 -0.453 . . . . 0.0 113.51 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 m -61.59 114.02 3.03 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.397 0.599 . . . . 0.0 110.505 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.619 ' CG ' HG23 ' A' ' 82' ' ' THR . 14.4 mt-30 -100.64 136.92 39.76 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.279 0.362 . . . . 0.0 111.973 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.583 ' O ' HG21 ' A' ' 5' ' ' VAL . 35.6 t -116.79 106.42 13.47 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.569 ' HB3' HG13 ' A' ' 80' ' ' VAL . 5.0 pt-20 -102.85 -179.39 3.94 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -177.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -155.86 -178.62 7.43 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.161 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.11 160.58 43.39 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.701 0.286 . . . . 0.0 111.463 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.781 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.3 p -142.09 120.47 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.55 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -74.85 91.43 2.44 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.752 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.9 t -95.27 142.42 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.31 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.88 156.34 46.27 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.938 0.399 . . . . 0.0 111.398 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.843 HD13 ' HB1' ' A' ' 69' ' ' ALA . 11.3 mt -145.09 132.27 15.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.052 178.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.23 132.2 39.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.249 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.219 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.469 ' HD3' HG22 ' A' ' 2' ' ' VAL . 10.9 ttt85 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.598 0.237 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 30' ' ' ALA . 1.5 m -153.55 55.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-O 121.228 0.537 . . . . 0.0 110.074 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.653 HD11 ' HB2' ' A' ' 83' ' ' ALA . 5.6 mp -142.97 123.49 13.99 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.287 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.769 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 2.6 tt0 -146.43 124.58 12.16 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.14 150.89 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.236 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -160.1 130.37 5.46 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.765 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.462 HD12 ' C ' ' A' ' 92' ' ' THR . 38.9 mt -92.1 144.69 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.361 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -128.42 126.13 23.43 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.19 179.69 28.5 Favored 'Cis proline' 0 C--N 1.365 1.421 0 CA-C-N 120.149 1.089 . . . . 0.0 112.348 0.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 96.4 p -73.33 -51.67 16.64 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.451 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -130.53 101.25 5.63 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.885 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.2 111.24 4.19 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 121.3 -0.476 . . . . 0.0 113.799 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.02 123.06 35.1 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.48 HD13 ' CB ' ' A' ' 20' ' ' LYS . 2.8 mp -137.73 164.69 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.593 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.75 162.23 14.17 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.634 0.731 . . . . 0.0 111.625 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 69' ' ' ALA . 36.8 t -68.51 135.7 27.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.323 178.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.07 -17.35 58.82 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-O 119.545 -0.586 . . . . 0.0 112.449 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -111.46 146.55 37.03 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-N 117.799 0.8 . . . . 0.0 109.896 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 96.7 p -79.67 176.95 9.25 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.602 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -171.33 118.74 0.46 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.249 -178.302 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.751 ' HB3' HG23 ' A' ' 65' ' ' THR . 29.6 p90 -112.09 150.6 30.48 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.469 0.176 . . . . 0.0 111.137 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.714 ' CD2' HG21 ' A' ' 93' ' ' VAL . 86.4 m-85 -128.58 118.52 23.12 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.197 0.522 . . . . 0.0 111.44 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.432 HD23 HE21 ' A' ' 25' ' ' GLN . 12.8 tp -79.13 117.3 20.04 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.432 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 41.6 t -94.74 96.56 9.46 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.432 HE21 HD23 ' A' ' 23' ' ' LEU . 66.7 mt-30 -88.41 148.72 24.08 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.168 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.818 HG21 ' CB ' ' A' ' 60' ' ' ASP . 33.7 m -120.89 175.96 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.769 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -171.06 112.63 0.38 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.093 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 150.34 149.42 5.01 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.228 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -96.64 51.01 1.14 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.006 0.431 . . . . 0.0 111.612 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.686 ' HB2' HG23 ' A' ' 2' ' ' VAL . . . -93.67 18.7 9.69 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.66 -84.32 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 114.555 1.316 . . . . 0.0 114.555 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -39.89 -31.12 0.1 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.639 ' HD3' ' HB3' ' A' ' 30' ' ' ALA . 6.8 mmmm 1.91 73.45 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 125.526 1.53 . . . . 0.0 115.04 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -83.16 108.8 16.67 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.652 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.503 HG21 ' OG ' ' A' ' 62' ' ' SER . 3.9 mp -73.25 157.98 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 123.385 0.428 . . . . 0.0 111.136 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.42 ' N ' HG22 ' A' ' 35' ' ' ILE . 18.0 m -157.88 161.79 38.3 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.249 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.438 ' CE2' ' HB2' ' A' ' 64' ' ' LEU . 60.3 m95 -137.39 124.99 22.2 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.65 0.262 . . . . 0.0 111.094 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 94.8 m-85 -114.38 117.32 30.7 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.419 ' HB3' HD23 ' A' ' 45' ' ' LEU . 14.9 p -68.12 153.12 95.89 Favored Pre-proline 0 C--O 1.249 1.074 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.947 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -50.51 -16.05 1.93 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 124.887 3.725 . . . . 0.0 116.048 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -77.98 3.02 15.76 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.072 0.397 . . . . 0.0 111.908 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.76 38.88 10.0 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-O 119.611 -0.55 . . . . 0.0 112.276 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -167.96 143.72 3.86 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 119.561 -0.856 . . . . 0.0 113.205 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 19.8 tttm -54.33 146.29 15.92 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -110.76 152.85 26.11 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.268 179.37 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m -79.33 159.48 72.44 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.984 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.79 -8.06 13.4 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.29 1.994 . . . . 0.0 113.548 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -141.92 48.59 1.6 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.03 0.443 . . . . 0.0 110.763 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -66.33 -77.31 0.07 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.658 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -150.76 -74.53 0.15 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 -99.86 -34.71 10.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.639 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.663 HG12 HG23 ' A' ' 66' ' ' ILE . 53.4 mt -84.54 107.23 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.849 0.357 . . . . 0.0 111.189 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.5 t -110.64 124.35 51.74 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.597 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.437 HG22 HD23 ' A' ' 64' ' ' LEU . 13.5 t -98.42 159.3 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.742 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.409 ' N ' HG12 ' A' ' 54' ' ' VAL . 5.0 m -149.95 170.32 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.862 0.363 . . . . 0.0 111.518 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.1 m-90 -139.64 104.5 4.93 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -90.79 -85.57 0.22 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -175.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -174.56 0.07 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.952 0.342 . . . . 0.0 111.804 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.89 -36.05 62.26 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.844 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.818 ' CB ' HG21 ' A' ' 26' ' ' VAL . 61.0 m-20 -145.18 17.77 1.56 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.5 t -103.09 139.12 39.03 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.503 ' OG ' HG21 ' A' ' 35' ' ' ILE . 5.6 m -133.27 -173.73 3.29 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.993 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m -155.73 146.55 22.2 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.902 0.382 . . . . 0.0 111.826 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.652 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -115.84 91.57 3.64 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.447 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.751 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -86.2 139.01 31.45 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.605 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.663 HG23 HG12 ' A' ' 52' ' ' ILE . 66.2 mt -135.56 95.59 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -61.93 -116.07 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 O-C-N 123.759 0.662 . . . . 0.0 110.884 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.43 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.824 1.193 . . . . 0.0 111.409 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.846 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -74.56 142.53 44.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.992 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.775 ' O ' HD12 ' A' ' 97' ' ' ILE . 15.1 m-80 -136.9 152.28 50.03 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.63 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.2 pt -51.41 -26.01 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -69.08 -43.67 74.08 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -65.21 -33.42 75.95 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.88 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.484 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -50.47 104.3 0.07 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.54 174.27 46.47 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.043 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.3 mt -81.23 98.66 4.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.652 ' CD2' HD11 ' A' ' 64' ' ' LEU . 59.9 m-85 -71.73 172.47 9.71 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -134.01 155.11 50.56 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.744 0.307 . . . . 0.0 111.095 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.461 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -138.74 101.38 4.31 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.224 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.431 HG13 ' HB3' ' A' ' 90' ' ' GLU . 5.0 t -104.73 140.85 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.427 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.469 HG12 HD23 ' A' ' 3' ' ' LEU . 0.7 OUTLIER -127.36 135.49 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.084 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.658 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.1 m -117.14 149.88 39.63 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.653 ' HB2' HD11 ' A' ' 3' ' ' LEU . . . -90.55 -177.63 5.09 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.357 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -74.23 -34.46 63.66 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.314 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.32 -35.6 23.15 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.361 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.61 -22.15 1.5 Allowed Glycine 0 C--N 1.34 0.785 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.584 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.8 m -59.19 111.66 1.42 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.208 0.504 . . . . 0.0 111.446 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.658 ' HB3' HG23 ' A' ' 82' ' ' THR . 0.1 OUTLIER -119.12 135.22 54.76 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.922 0.391 . . . . 0.0 111.687 179.852 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.7 t -116.61 127.13 54.18 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.431 ' HB3' HG13 ' A' ' 80' ' ' VAL . 4.7 pt-20 -111.19 -178.54 3.49 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -177.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -147.67 173.55 12.64 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.18 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.462 ' C ' HD12 ' A' ' 7' ' ' ILE . 0.7 OUTLIER -147.48 155.78 42.23 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.613 0.244 . . . . 0.0 111.051 179.394 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.714 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.5 p -144.97 116.82 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.273 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.02 102.68 2.49 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.439 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 15.1 t -105.57 111.49 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.681 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.0 mtmm -98.91 149.73 22.64 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.406 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.846 HD13 ' HB1' ' A' ' 69' ' ' ALA . 10.3 mt -139.36 117.72 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.42 132.3 56.29 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.382 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.895 -179.718 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.581 HG23 ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -117.34 72.91 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.069 0.461 . . . . 0.0 109.97 -179.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.42 HD12 ' O ' ' A' ' 2' ' ' VAL . 0.2 OUTLIER -148.85 105.8 3.59 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.237 -179.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.762 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 13.6 tt0 -134.76 142.17 46.66 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.901 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 89' ' ' SER . 0.4 OUTLIER -149.59 141.1 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.82 -179.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -155.04 132.55 11.21 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.644 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.483 HD11 ' HB3' ' A' ' 79' ' ' CYS . 17.6 mt -92.17 131.93 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 O-C-N 123.173 0.295 . . . . 0.0 111.11 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.04 125.91 28.74 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.57 172.7 48.93 Favored 'Cis proline' 0 C--N 1.364 1.365 0 CA-C-N 120.103 1.072 . . . . 0.0 112.369 0.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.9 p -70.05 -39.8 75.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.458 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -134.42 113.15 11.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.85 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.03 97.89 1.11 Allowed Glycine 0 C--N 1.342 0.867 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.803 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.589 ' C ' HD12 ' A' ' 14' ' ' ILE . 6.6 mt-10 -86.19 124.19 32.31 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.589 HD12 ' C ' ' A' ' 13' ' ' GLU . 3.5 mp -141.06 164.45 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.593 0.235 . . . . 0.0 110.727 -178.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.76 156.98 17.17 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.786 0.327 . . . . 0.0 110.439 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.0 t -63.52 140.77 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.38 -11.57 70.85 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.472 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -98.99 159.55 14.88 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 117.481 0.64 . . . . 0.0 109.454 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.4 ' CB ' ' HA ' ' A' ' 67' ' ' TYR . 66.7 p -101.49 149.24 24.28 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.63 0.252 . . . . 0.0 111.213 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.625 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -148.26 124.53 10.86 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.552 -178.514 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.772 ' HB3' HG23 ' A' ' 65' ' ' THR . 34.2 p90 -114.57 148.32 38.19 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.958 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.648 ' CD1' HG21 ' A' ' 93' ' ' VAL . 92.8 m-85 -127.45 119.85 27.04 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.223 0.535 . . . . 0.0 112.028 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 62' ' ' SER . 0.0 OUTLIER -78.05 109.49 12.18 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -177.117 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.491 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 35.5 t -84.54 90.7 7.7 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -83.35 150.82 25.86 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.093 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.753 HG21 ' CB ' ' A' ' 60' ' ' ASP . 30.9 m -122.35 169.96 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.3 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.762 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -169.66 103.84 0.33 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.799 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 155.61 134.19 1.81 Allowed Glycine 0 C--N 1.338 0.664 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.529 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -95.54 50.98 1.26 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.167 0.508 . . . . 0.0 110.905 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.581 ' HB2' HG23 ' A' ' 2' ' ' VAL . . . -88.65 78.23 7.78 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.328 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.75 -88.0 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -128.69 137.6 51.7 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.735 0.303 . . . . 0.0 111.136 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -128.07 145.39 51.01 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.639 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -124.26 114.48 19.65 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.635 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.542 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.2 mp -76.43 155.44 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.064 0.459 . . . . 0.0 112.01 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.401 ' N ' HG22 ' A' ' 35' ' ' ILE . 74.9 m -152.3 159.2 43.53 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.645 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.491 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 44.2 m95 -135.4 115.18 12.9 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 119.684 -0.198 . . . . 0.0 111.384 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -116.51 112.16 20.98 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.517 ' HB3' HD21 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -61.52 156.01 55.74 Favored Pre-proline 0 C--O 1.245 0.821 0 CA-C-O 119.325 -0.369 . . . . 0.0 110.627 178.364 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -33.79 -72.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 125.094 3.863 . . . . 0.0 113.484 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.86 37.3 4.14 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 176.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.9 -19.86 3.92 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.816 -0.629 . . . . 0.0 113.401 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 70.71 -170.89 0.16 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 117.893 0.846 . . . . 0.0 109.003 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 23.2 tttm -55.2 108.83 0.45 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.517 HD21 ' HB3' ' A' ' 39' ' ' SER . 2.2 mt -72.39 171.48 12.16 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.987 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m -86.75 150.4 50.55 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.06 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.08 -24.75 23.39 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.254 1.97 . . . . 0.0 112.886 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -150.01 80.3 1.37 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.989 0.423 . . . . 0.0 110.301 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.71 -79.08 0.46 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.295 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -145.04 -74.3 0.24 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.588 0.232 . . . . 0.0 110.902 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -97.95 -39.57 8.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.565 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.464 HG12 HG23 ' A' ' 66' ' ' ILE . 47.9 mt -88.33 112.83 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.6 t -119.37 117.98 29.97 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.364 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.3 t -89.04 157.61 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.4 HG22 ' N ' ' A' ' 56' ' ' TRP . 9.8 p -155.0 157.98 3.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 CA-C-O 120.963 0.411 . . . . 0.0 111.894 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.4 ' N ' HG22 ' A' ' 55' ' ' VAL . 25.7 m-90 -131.72 107.51 8.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -97.39 -79.28 0.46 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.73 -178.82 0.22 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.587 0.232 . . . . 0.0 111.473 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -52.71 -34.26 51.54 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.753 ' CB ' HG21 ' A' ' 26' ' ' VAL . 22.1 m-20 -148.29 16.51 1.05 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 p -103.14 139.15 39.02 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.97 0.35 . . . . 0.0 110.078 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.542 ' OG ' HG21 ' A' ' 35' ' ' ILE . 4.2 m -130.84 -174.29 3.33 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.455 -177.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -155.82 147.57 23.07 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.003 0.43 . . . . 0.0 111.35 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.642 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -118.94 92.51 3.82 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.285 179.425 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.772 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -84.87 145.14 27.96 Favored 'General case' 0 N--CA 1.461 0.106 0 O-C-N 123.37 0.419 . . . . 0.0 110.157 -179.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.614 HD12 ' HD2' ' A' ' 20' ' ' LYS . 51.2 mt -141.19 79.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.4 ' HA ' ' CB ' ' A' ' 19' ' ' SER . 13.5 m-85 -45.79 -66.94 0.33 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 2.1 t30 -64.38 -67.07 0.46 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 68' ' ' ASN . . . 78.22 123.75 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.345 0.658 . . . . 0.0 110.926 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.822 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.4 OUTLIER -144.24 159.77 42.1 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.069 0.462 . . . . 0.0 110.737 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.3 pt -50.23 -27.79 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -71.19 -41.42 70.33 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -64.08 -34.05 77.15 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.98 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.548 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -52.76 102.87 0.06 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.75 178.23 46.59 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.656 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.564 HG23 ' HB ' ' A' ' 92' ' ' THR . 1.1 mp -80.77 100.58 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 117.051 0.426 . . . . 0.0 110.437 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.642 ' CD2' HD11 ' A' ' 64' ' ' LEU . 60.8 m-85 -73.32 174.57 7.91 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -135.01 154.27 51.78 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.483 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -140.31 101.26 4.09 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 90' ' ' GLU . 5.0 t -106.89 137.41 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -176.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -120.39 142.42 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.643 HG23 ' HG2' ' A' ' 88' ' ' GLN . 2.4 m -128.2 126.31 40.74 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.89 -175.84 2.27 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.752 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -78.18 -39.54 40.47 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.181 0.301 . . . . 0.0 111.04 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.38 -33.84 65.24 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.394 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.02 -8.52 4.16 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-O 119.72 -0.489 . . . . 0.0 114.013 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.3 m -62.58 110.32 1.66 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.687 0.744 . . . . 0.0 110.61 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.643 ' HG2' HG23 ' A' ' 82' ' ' THR . 35.7 mt-30 -103.07 134.36 46.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.889 0.376 . . . . 0.0 111.784 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.402 ' O ' HG21 ' A' ' 5' ' ' VAL . 7.8 t -131.22 115.01 15.77 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.582 ' HB3' HG13 ' A' ' 80' ' ' VAL . 7.0 pt-20 -112.1 -176.97 3.05 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -177.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.5 172.77 16.04 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.34 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.564 ' HB ' HG23 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -145.23 152.29 39.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.66 0.266 . . . . 0.0 110.535 179.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.648 HG21 ' CD1' ' A' ' 22' ' ' PHE . 7.4 p -135.55 117.71 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.126 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -71.7 92.24 1.17 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.084 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.485 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 14.6 t -95.09 112.73 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.476 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.95 155.54 17.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.948 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.822 HD12 ' O ' ' A' ' 70' ' ' ASN . 11.2 mt -144.04 135.49 22.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.144 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.67 127.62 37.32 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.229 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.951 -179.901 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.493 ' CD ' HG22 ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.6 HG23 ' HB2' ' A' ' 30' ' ' ALA . 5.9 m -144.82 61.92 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 121.389 0.614 . . . . 0.0 110.25 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 2' ' ' VAL . 0.5 OUTLIER -159.27 89.37 0.91 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.705 -179.698 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.668 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -119.84 150.08 41.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.903 -179.571 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.572 HG21 ' O ' ' A' ' 89' ' ' SER . 17.1 t -147.35 138.14 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.456 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -155.31 125.84 6.86 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.878 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.672 HD11 ' HB2' ' A' ' 79' ' ' CYS . 71.2 mt -89.71 135.14 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -134.6 120.68 14.66 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-O 118.918 -0.563 . . . . 0.0 110.908 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -66.23 149.56 78.42 Favored 'Cis proline' 0 C--N 1.364 1.343 0 CA-C-N 120.531 1.225 . . . . 0.0 113.053 -0.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.642 ' O ' HG23 ' A' ' 93' ' ' VAL . 78.1 p -71.72 -40.4 69.49 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.888 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -112.16 120.2 40.99 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.64 75.74 0.21 Allowed Glycine 0 C--N 1.341 0.854 0 N-CA-C 114.542 0.577 . . . . 0.0 114.542 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.583 ' C ' HD12 ' A' ' 14' ' ' ILE . 25.8 mt-10 -81.24 115.25 20.54 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.583 HD12 ' C ' ' A' ' 13' ' ' GLU . 2.9 mp -141.74 162.17 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.411 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.34 153.94 18.26 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.94 0.4 . . . . 0.0 110.488 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 69' ' ' ALA . 47.1 t -63.01 141.18 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.093 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.8 -13.1 67.68 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.188 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -102.61 159.51 15.39 Favored 'General case' 0 C--N 1.35 0.589 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.2 p -94.35 168.51 10.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.578 0.228 . . . . 0.0 110.648 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.79 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 2.3 pttt -167.0 115.34 0.83 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.222 -178.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.469 ' HB3' HG23 ' A' ' 65' ' ' THR . 45.1 p90 -120.66 151.79 39.03 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.69 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -131.74 122.68 26.26 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.264 0.554 . . . . 0.0 111.339 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp -79.81 114.43 18.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.718 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 t -90.19 104.32 16.91 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.075 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -95.44 166.99 11.6 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.512 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.0 m -139.58 171.48 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.691 0.281 . . . . 0.0 111.596 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.668 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -151.7 104.72 3.06 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.041 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 167.02 131.55 1.28 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.368 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -97.7 43.35 1.07 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.033 0.444 . . . . 0.0 111.071 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.6 ' HB2' HG23 ' A' ' 2' ' ' VAL . . . -68.76 -170.69 0.23 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.756 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -74.84 -59.52 2.7 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.934 0.397 . . . . 0.0 110.155 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -124.61 151.36 44.93 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.028 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt -133.57 84.42 2.12 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.78 0.324 . . . . 0.0 111.255 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.465 ' O ' HG22 ' A' ' 81' ' ' VAL . 30.1 t70 -79.88 155.68 27.67 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.679 HG21 ' OG ' ' A' ' 62' ' ' SER . 4.6 mp -130.51 152.17 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 123.322 0.389 . . . . 0.0 111.205 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.5 m -152.68 157.66 41.24 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.297 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.446 ' CZ2' ' HB2' ' A' ' 64' ' ' LEU . 60.5 m95 -131.98 122.38 25.45 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -119.22 111.95 18.87 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 p -57.02 152.83 26.65 Favored Pre-proline 0 C--O 1.244 0.793 0 CA-C-O 119.327 -0.368 . . . . 0.0 110.783 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -32.03 -76.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 125.273 3.982 . . . . 0.0 114.15 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.58 37.27 3.64 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 176.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.51 -16.16 4.74 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.617 -0.72 . . . . 0.0 113.371 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 70.02 -170.3 0.17 Allowed 'General case' 0 C--N 1.353 0.743 0 CA-C-N 117.978 0.889 . . . . 0.0 108.768 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 14.2 tttt -54.52 125.51 19.92 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.469 HD22 HG21 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -91.89 158.15 16.45 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.797 -179.301 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.6 m -75.25 147.22 82.65 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.451 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.47 -27.16 81.02 Favored 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 122.39 2.06 . . . . 0.0 113.066 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -148.63 79.24 1.43 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.004 0.431 . . . . 0.0 110.807 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.72 -68.45 0.79 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.991 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -150.95 -79.26 0.12 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -99.7 -32.77 10.89 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.554 HG12 HG23 ' A' ' 66' ' ' ILE . 63.3 mt -88.53 100.4 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 120.868 0.366 . . . . 0.0 111.212 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.6 t -107.19 123.21 47.94 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.027 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 55' ' ' VAL . 20.9 t -95.91 158.13 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.268 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.415 ' N ' HG12 ' A' ' 54' ' ' VAL . 11.3 m -150.54 172.5 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 120.938 0.399 . . . . 0.0 111.642 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.7 m-90 -142.23 117.0 9.83 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.55 -79.55 0.57 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -59.48 -179.92 0.1 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.598 0.181 . . . . 0.0 111.024 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -57.08 -32.35 66.18 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -136.99 -12.37 1.69 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.8 t -85.25 139.75 31.39 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 118.734 0.697 . . . . 0.0 111.499 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.679 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.8 m -126.0 -169.37 2.0 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.268 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.3 m -160.53 132.92 6.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.738 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -99.98 99.08 9.78 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.225 178.635 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -92.38 131.4 37.59 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.242 0.339 . . . . 0.0 110.092 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.554 HG23 HG12 ' A' ' 52' ' ' ILE . 63.7 mt -130.1 93.14 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -60.68 -116.06 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 CA-C-O 118.895 -0.574 . . . . 0.0 111.199 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -51.48 95.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.912 1.233 . . . . 0.0 110.876 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.837 ' HB1' HD13 ' A' ' 97' ' ' ILE . . . -75.22 154.05 37.77 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.883 -178.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.785 ' O ' HD12 ' A' ' 97' ' ' ILE . 1.1 p30 -148.34 154.13 39.55 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.382 0.61 . . . . 0.0 111.326 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.4 pt -53.42 -25.97 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -71.53 -40.52 70.02 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.29 -34.23 77.84 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.584 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.519 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -50.89 108.4 0.24 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.49 179.69 48.83 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 121.411 -0.423 . . . . 0.0 112.299 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.731 HD13 ' HA ' ' A' ' 94' ' ' ASN . 23.0 mm -82.04 90.26 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 122.152 0.181 . . . . 0.0 111.459 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.738 ' CD2' HD11 ' A' ' 64' ' ' LEU . 40.3 m-85 -67.68 176.0 2.67 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -136.58 159.0 43.12 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.672 ' HB2' HD11 ' A' ' 7' ' ' ILE . 8.3 t -140.4 92.54 2.53 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.705 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.505 HG13 ' HB3' ' A' ' 90' ' ' GLU . 5.2 t -96.51 128.74 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 34' ' ' ASP . 2.3 t -112.92 159.1 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.73 HG23 ' HG2' ' A' ' 88' ' ' GLN . 1.5 m -136.34 154.06 50.96 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.47 -172.66 2.2 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.315 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -76.79 -45.6 28.2 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.233 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -74.74 -32.01 61.97 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 141.73 -9.88 2.6 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-O 119.402 -0.666 . . . . 0.0 114.433 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.467 HG22 HD22 ' A' ' 3' ' ' LEU . 49.6 m -63.79 116.98 6.27 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 117.98 0.89 . . . . 0.0 110.336 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.73 ' HG2' HG23 ' A' ' 82' ' ' THR . 8.2 mt-30 -108.92 135.77 49.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.466 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.572 ' O ' HG21 ' A' ' 5' ' ' VAL . 21.8 t -122.0 108.38 13.32 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.505 ' HB3' HG13 ' A' ' 80' ' ' VAL . 6.2 pt-20 -99.78 179.83 4.4 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.2 -179.39 7.48 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.716 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.26 152.56 31.31 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.025 0.44 . . . . 0.0 111.478 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 10' ' ' SER . 2.7 p -132.01 119.87 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.34 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.731 ' HA ' HD13 ' A' ' 76' ' ' ILE . 1.3 t-20 -80.72 88.4 5.78 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.524 HG22 HG22 ' A' ' 93' ' ' VAL . 3.5 t -91.96 124.66 44.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.934 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -111.99 155.19 24.15 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.585 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.837 HD13 ' HB1' ' A' ' 69' ' ' ALA . 7.9 mt -145.96 132.04 13.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.697 177.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -119.29 125.65 49.59 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.535 -178.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.856 -179.844 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.553 ' O ' HG13 ' A' ' 2' ' ' VAL . 8.5 ttt85 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.427 0.156 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.665 HG23 ' HB2' ' A' ' 30' ' ' ALA . 0.6 OUTLIER -160.94 42.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-O 121.019 0.438 . . . . 0.0 110.617 -179.475 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.519 HD11 ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -147.75 96.38 2.66 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.05 -179.316 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.75 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 10.8 tp-100 -99.95 152.01 20.67 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.518 HG21 ' O ' ' A' ' 89' ' ' SER . 2.0 t -146.57 146.76 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -158.13 127.95 5.97 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.705 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.458 HD11 ' HB3' ' A' ' 79' ' ' CYS . 42.4 mt -94.2 142.83 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.2 t -124.46 122.91 25.87 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-O 119.21 -0.424 . . . . 0.0 110.03 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.49 -171.17 9.36 Favored 'Cis proline' 0 C--N 1.366 1.452 0 CA-C-N 119.925 1.009 . . . . 0.0 112.361 -0.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.3 p -85.83 -50.22 7.3 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.309 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -125.38 99.98 6.29 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.733 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.28 156.55 37.6 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.874 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -151.75 104.92 3.07 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.3 mp -130.15 166.85 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.806 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.6 155.46 18.27 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.603 0.716 . . . . 0.0 111.339 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 69' ' ' ALA . 17.0 t -65.88 138.49 22.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.887 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.87 -16.96 60.11 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.312 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -115.52 149.94 37.35 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 117.87 0.835 . . . . 0.0 110.116 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.436 ' CB ' ' HA ' ' A' ' 67' ' ' TYR . 60.4 p -79.86 165.58 22.55 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.821 ' HE3' HD12 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -158.77 119.88 3.36 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.267 -179.646 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.726 ' HB3' HG23 ' A' ' 65' ' ' THR . 39.6 p90 -112.8 153.57 27.63 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.538 0.209 . . . . 0.0 111.245 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.713 ' CD2' HG21 ' A' ' 93' ' ' VAL . 78.3 m-85 -129.33 113.58 15.15 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.271 0.558 . . . . 0.0 111.234 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.594 HD23 ' NE2' ' A' ' 25' ' ' GLN . 12.1 tp -78.42 111.73 14.73 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -177.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.472 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 43.7 t -93.4 90.1 6.6 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.594 ' NE2' HD23 ' A' ' 23' ' ' LEU . 7.6 mt-30 -86.7 157.51 19.63 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.861 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.666 HG21 ' CB ' ' A' ' 60' ' ' ASP . 30.7 m -124.96 169.15 16.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.448 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.75 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -157.9 98.04 1.59 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.503 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 175.76 -175.69 47.35 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.984 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -129.03 30.55 5.03 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.767 ' HB3' ' CG ' ' A' ' 33' ' ' LYS . . . -68.67 -176.09 0.76 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 110.484 -0.191 . . . . 0.0 110.484 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.48 -50.58 1.87 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.659 0.266 . . . . 0.0 111.638 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.67 -36.49 83.04 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.879 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.767 ' CG ' ' HB3' ' A' ' 30' ' ' ALA . 29.5 mtpt 0.15 96.68 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 125.61 1.564 . . . . 0.0 115.041 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -118.21 113.87 22.17 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.207 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 35' ' ' ILE . 4.7 mp -77.74 156.62 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.183 0.516 . . . . 0.0 111.411 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.409 ' N ' HG22 ' A' ' 35' ' ' ILE . 4.7 m -152.36 157.74 41.72 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.087 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.472 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 39.8 m95 -135.13 109.13 8.17 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 117.61 0.187 . . . . 0.0 110.934 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -107.73 112.07 24.57 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.593 ' HB3' HD23 ' A' ' 45' ' ' LEU . 56.0 p -62.33 153.78 74.33 Favored Pre-proline 0 C--O 1.246 0.918 0 CA-C-O 119.159 -0.448 . . . . 0.0 110.535 178.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -26.42 -71.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.334 1 C-N-CA 125.938 4.425 . . . . 0.0 115.038 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.97 36.48 4.59 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.35 -15.52 4.56 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.063 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 72.32 -170.2 0.14 Allowed 'General case' 0 C--N 1.354 0.773 0 CA-C-N 117.959 0.88 . . . . 0.0 109.363 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 8.6 ttpp -52.28 96.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.593 HD23 ' HB3' ' A' ' 39' ' ' SER . 4.0 pp -69.85 148.05 49.56 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.542 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.36 150.75 95.37 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.067 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.88 -30.84 6.96 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 122.286 1.99 . . . . 0.0 112.579 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -120.61 52.13 1.19 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.028 0.442 . . . . 0.0 111.254 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -68.81 -82.2 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.352 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -150.98 -73.17 0.16 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -98.99 -31.56 11.74 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.689 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.579 HG12 HG23 ' A' ' 66' ' ' ILE . 37.6 mt -89.05 101.66 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.735 0.302 . . . . 0.0 110.405 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.0 t -108.42 122.77 47.7 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.157 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 55' ' ' VAL . 19.3 t -95.63 159.62 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.407 ' N ' HG12 ' A' ' 54' ' ' VAL . 9.8 p -153.97 146.95 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.077 0.465 . . . . 0.0 112.239 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 21.2 m-90 -123.73 112.06 16.9 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -109.49 -74.35 0.66 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.745 1.016 . . . . 0.0 113.745 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -60.74 -175.16 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -53.26 -36.55 61.23 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.745 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.666 ' CB ' HG21 ' A' ' 26' ' ' VAL . 1.9 m-20 -153.96 22.32 0.51 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.2 t -103.47 139.23 39.1 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.473 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.5 m -134.64 -174.03 3.46 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.603 -178.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -155.8 145.29 21.0 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.022 0.439 . . . . 0.0 111.256 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.664 HD11 ' CD2' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -113.29 91.23 3.57 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.247 179.466 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.726 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -87.71 138.02 31.83 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.338 0.399 . . . . 0.0 110.295 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.821 HD12 ' HE3' ' A' ' 20' ' ' LYS . 58.9 mt -134.79 87.29 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.436 ' HA ' ' CB ' ' A' ' 19' ' ' SER . 12.5 m-85 -52.89 -67.46 0.25 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -176.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 1.2 t-20 -60.57 -63.64 1.23 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -177.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.44 ' O ' HG13 ' A' ' 16' ' ' VAL . . . 73.6 120.55 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.883 0.473 . . . . 0.0 110.952 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.797 ' O ' HD12 ' A' ' 97' ' ' ILE . 4.1 m-80 -141.71 162.4 35.57 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.033 0.444 . . . . 0.0 110.356 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.6 pt -54.83 -24.59 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -72.95 -40.45 65.35 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -66.52 -32.97 74.66 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.792 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.501 ' HB2' HG13 ' A' ' 97' ' ' ILE . . . -50.58 114.65 1.19 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.26 171.45 37.89 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.037 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.0 mt -76.93 95.86 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.786 0.293 . . . . 0.0 111.691 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.664 ' CD2' HD11 ' A' ' 64' ' ' LEU . 46.5 m-85 -70.23 179.03 2.55 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -140.66 156.25 46.29 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 120.757 0.313 . . . . 0.0 111.626 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.458 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -142.96 102.38 4.0 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 90' ' ' GLU . 7.3 t -104.59 139.78 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.11 137.96 53.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.592 HG23 ' HB3' ' A' ' 88' ' ' GLN . 3.4 m -127.93 150.95 49.66 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.51 -173.65 2.7 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.532 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -73.01 -52.86 12.82 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.504 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -65.47 -36.26 83.35 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 146.78 -19.23 1.63 Allowed Glycine 0 C--N 1.34 0.76 0 C-N-CA 121.161 -0.542 . . . . 0.0 113.644 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.519 ' O ' HD11 ' A' ' 3' ' ' LEU . 77.5 m -57.85 109.1 0.66 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.39 0.595 . . . . 0.0 111.213 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.592 ' HB3' HG23 ' A' ' 82' ' ' THR . 1.0 OUTLIER -119.67 134.26 55.3 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.682 -179.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.518 ' O ' HG21 ' A' ' 5' ' ' VAL . 40.9 t -110.96 117.64 33.9 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.423 ' HB3' HG13 ' A' ' 80' ' ' VAL . 12.6 pt-20 -105.65 -178.57 3.69 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.41 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . . . -150.46 172.38 15.54 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.255 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.01 153.23 36.17 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.46 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.713 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.7 p -141.26 111.67 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.757 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.68 89.51 0.74 Allowed 'General case' 0 C--O 1.235 0.293 0 O-C-N 123.408 0.442 . . . . 0.0 110.281 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.496 HG11 ' NZ ' ' A' ' 20' ' ' LYS . 21.3 t -87.29 138.05 19.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.589 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -122.83 156.96 33.51 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.625 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.797 HD12 ' O ' ' A' ' 70' ' ' ASN . 7.2 mt -147.11 136.02 15.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.785 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.7 133.36 43.42 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.335 -178.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.949 -179.664 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.542 ' O ' HG13 ' A' ' 2' ' ' VAL . 7.0 ttt180 . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.517 0.198 . . . . 0.0 111.378 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.704 HG23 ' HB2' ' A' ' 30' ' ' ALA . 1.9 m -160.14 54.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.286 0.565 . . . . 0.0 110.542 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.549 HD11 ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -150.19 93.31 1.98 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.498 -179.51 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.658 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 11.0 tp-100 -92.78 149.53 21.23 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 89' ' ' SER . 1.7 t -144.02 146.4 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 123.162 0.289 . . . . 0.0 110.933 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -160.38 133.06 6.41 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.64 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.53 HD11 ' HB3' ' A' ' 79' ' ' CYS . 33.1 mt -99.72 124.31 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 36.3 t -108.1 128.44 25.73 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.598 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.77 -172.9 11.78 Favored 'Cis proline' 0 C--N 1.365 1.433 0 CA-C-N 119.946 1.016 . . . . 0.0 112.327 -0.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.9 p -78.84 -48.82 14.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.932 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -132.0 112.34 12.29 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.883 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.08 106.99 2.34 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.071 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.55 ' C ' HD12 ' A' ' 14' ' ' ILE . 11.0 mt-10 -88.31 132.54 34.37 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.55 HD12 ' C ' ' A' ' 13' ' ' GLU . 4.1 mp -145.47 162.87 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 120.628 0.252 . . . . 0.0 110.697 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.41 154.34 19.17 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.284 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 69' ' ' ALA . 43.6 t -61.53 136.3 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.231 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.71 -6.81 74.09 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.417 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -104.39 158.18 16.64 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.3 p -101.48 149.71 23.79 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.628 0.251 . . . . 0.0 111.58 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.576 ' NZ ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -147.25 119.11 8.1 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.607 -178.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.773 ' HB3' HG23 ' A' ' 65' ' ' THR . 20.5 p90 -113.74 148.13 37.02 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.684 0.278 . . . . 0.0 110.537 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.66 ' CD2' HG21 ' A' ' 93' ' ' VAL . 58.9 m-85 -125.92 144.74 50.56 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.048 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.21 110.03 22.28 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.405 ' HB2' ' CZ2' ' A' ' 37' ' ' TRP . 42.5 t -87.48 86.35 7.22 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -92.4 161.62 14.58 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.014 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.746 HG21 ' HB2' ' A' ' 60' ' ' ASP . 33.9 m -126.93 175.46 8.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.658 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . . . -163.74 98.62 0.88 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.727 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -178.06 -143.77 5.24 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.794 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -162.27 32.15 0.11 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.598 0.237 . . . . 0.0 111.566 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.704 ' HB2' HG23 ' A' ' 2' ' ' VAL . . . -77.48 -167.32 0.91 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.09 -42.34 0.99 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.24 -34.3 68.17 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.695 ' HD2' ' HB3' ' A' ' 30' ' ' ALA . 21.8 mtpt -9.86 82.03 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -179.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -97.96 116.34 29.97 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.34 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 60' ' ' ASP . 4.7 mp -75.4 156.1 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.294 0.568 . . . . 0.0 112.173 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.42 ' N ' HG22 ' A' ' 35' ' ' ILE . 5.0 m -157.55 162.96 38.82 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.499 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.405 ' CZ2' ' HB2' ' A' ' 24' ' ' CYS . 46.1 m95 -135.61 130.36 34.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 110.53 -0.174 . . . . 0.0 110.53 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 87.1 m-85 -125.54 112.68 16.49 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.449 ' OG ' HD13 ' A' ' 45' ' ' LEU . 4.7 p -57.71 154.67 25.1 Favored Pre-proline 0 C--O 1.251 1.152 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.78 -15.81 4.98 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 124.649 3.566 . . . . 0.0 116.084 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -78.32 0.9 23.65 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.0 42.95 6.9 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -154.56 163.29 40.43 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.367 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 10.0 tttt -73.36 170.85 14.21 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.437 0.46 . . . . 0.0 110.722 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.477 ' CD2' HG21 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -131.18 122.02 25.87 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.047 -179.458 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.98 158.91 73.83 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.252 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -83.52 -13.76 8.31 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 122.511 2.141 . . . . 0.0 113.808 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -153.85 84.74 1.16 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.011 0.434 . . . . 0.0 110.536 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.91 -57.75 0.81 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.977 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -137.24 -159.17 0.93 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -48.91 -26.47 2.49 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.477 HG21 ' CD2' ' A' ' 45' ' ' LEU . 61.7 mt -82.58 122.78 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.8 t -134.44 124.29 25.41 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.971 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.6 t -98.33 156.91 3.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.218 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.2 p -152.21 141.29 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.876 0.37 . . . . 0.0 111.735 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -117.11 121.91 42.62 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.44 -76.73 0.57 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -58.04 -175.68 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -56.33 -37.55 70.13 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.954 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.746 ' HB2' HG21 ' A' ' 26' ' ' VAL . 30.0 m-20 -148.98 20.87 0.99 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.7 t -105.25 142.05 35.69 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 120.65 0.262 . . . . 0.0 110.441 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.462 ' OG ' HG21 ' A' ' 35' ' ' ILE . 1.9 m -138.36 -176.53 4.49 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.023 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 22' ' ' PHE . 2.0 m -157.69 136.69 11.61 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.921 0.391 . . . . 0.0 111.629 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.421 HD21 ' CD2' ' A' ' 77' ' ' TYR . 15.8 tp -96.08 141.67 29.19 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.773 HG23 ' HB3' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -136.46 96.46 3.36 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.772 0.715 . . . . 0.0 112.676 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.493 HD13 ' HZ3' ' A' ' 20' ' ' LYS . 1.6 mt -92.47 90.74 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.469 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -57.51 -96.05 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.975 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.46 97.64 0.78 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.066 0.848 . . . . 0.0 110.142 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.553 ' O ' HG13 ' A' ' 16' ' ' VAL . . . -77.76 157.52 29.99 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -152.21 158.18 42.5 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.059 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -52.34 -24.82 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -72.54 -42.72 64.41 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 110.478 -0.194 . . . . 0.0 110.478 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.441 ' OD1' HD11 ' A' ' 52' ' ' ILE . 32.6 m-20 -63.73 -33.69 76.21 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.03 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.589 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -51.12 105.57 0.11 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.95 178.92 48.11 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.485 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.643 HD13 ' HA ' ' A' ' 94' ' ' ASN . 24.6 mm -81.0 92.89 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 123.394 0.114 . . . . 0.0 110.758 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.421 ' CD2' HD21 ' A' ' 64' ' ' LEU . 67.4 m-85 -68.24 161.74 26.53 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -127.79 155.75 43.57 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.53 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -142.09 103.21 4.27 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.403 HG13 ' HB3' ' A' ' 90' ' ' GLU . 6.8 t -106.74 141.96 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.03 140.47 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.678 HG23 ' HG2' ' A' ' 88' ' ' GLN . 1.2 m -120.5 138.1 54.01 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.495 ' HB2' ' CD2' ' A' ' 3' ' ' LEU . . . -89.22 -174.27 4.35 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.11 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -73.47 -58.3 3.4 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.396 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -63.68 -22.78 67.08 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 120.9 19.77 3.58 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-O 119.785 -0.453 . . . . 0.0 113.811 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.549 ' O ' HD11 ' A' ' 3' ' ' LEU . 93.7 m -84.68 109.05 17.73 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.678 ' HG2' HG23 ' A' ' 82' ' ' THR . 22.8 mt-30 -101.93 130.82 48.52 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.516 ' HB2' HD12 ' A' ' 3' ' ' LEU . 7.3 t -122.2 113.98 20.21 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.403 ' HB3' HG13 ' A' ' 80' ' ' VAL . 6.2 pt-20 -108.68 -177.84 3.43 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.402 ' HB1' HG13 ' A' ' 7' ' ' ILE . . . -150.16 170.44 18.93 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.325 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.45 154.76 39.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.742 0.306 . . . . 0.0 111.113 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.66 HG21 ' CD2' ' A' ' 22' ' ' PHE . 7.1 p -143.2 121.04 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.963 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.643 ' HA ' HD13 ' A' ' 76' ' ' ILE . 1.4 t-20 -76.85 95.62 4.12 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.845 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.428 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 20.2 t -97.07 108.12 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.524 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -90.46 149.97 22.01 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.599 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.589 HD12 ' N ' ' A' ' 74' ' ' ALA . 9.8 mt -146.56 115.41 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.731 0.3 . . . . 0.0 110.424 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.17 134.2 55.07 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.961 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.82 179.87 . . . . . . . . 0 0 . 1 stop_ save_